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The Adviser’s Guide to Healthcare, Second Edition is a comprehensive resource and reference guide for
professionals seeking a working knowledge of the myriad factors involved in consulting with and valuing
healthcare practices. Developed by two of the foremost consultants in the healthcare industry, Robert
James Cimasi and Todd A. Zigrang, this Guide is founded on their seasoned knowledge and industry
experience. This 18-chapter, two-volume set is built around a new taxonomy framework for approaching
economic value for the healthcare industry—the Four Pillars of reimbursement, regulation, competition,
and technology. The Four Pillars framework is carried throughout each of the two volumes that comprise
this book:
Volume I: An Era of Reform—The Four Pillars provides in-depth discussions of the Four Pillars,
the reimbursement environment, the regulatory environment, the impact of the competitive forces,
technology, and the landmark legislation that has contributed to the current healthcare environment.
Volume II: Consulting Services introduces different models of emerging healthcare organizations,
details industry subspecialties in terms of the Four Pillars framework, and addresses issues related
to consulting services for healthcare practices, including valuation services for enterprises, assets,
and services.
Keep up with the changing face of healthcare services and consulting practices with The Adviser’s Guide
to Healthcare!

An Era of Reform—The Four Pillars, Volume I of AICPA’s Adviser’s Guide to Healthcare, Second Edition,
is your resource for understanding the driving forces that have changed the face of the healthcare system
in the United States. You’ll receive a detailed understanding of both the short- and long-term effects of
the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation
Act of 2010, as well as direct insight into the key topics that factor into healthcare industry accounting and
valuation activities, making it easy for you to interpret the healthcare reforms that affect your clients or
your business.
In addition, An Era of Reform—The Four Pillars introduces an in-depth discussion of a new taxonomy
framework for approaching healthcare industry issues. This framework serves as a vehicle to analyze the
viability, efficiency, efficacy, and productivity of healthcare enterprises in terms of the Four Pillars:
• Reimbursement Environment
• Regulatory Environment
• Impact of Competitive Forces
• Technology Development
An Era of Reform—The Four Pillars is an essential resource that gives you the tools to
provide specialized advice to your clients or your organization in the wake of recent
healthcare reform legislation, and for years to come.
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Foreword
In November 2010, the first edition of “The Adviser’s Guide to Healthcare,” authored by Robert
James Cimasi, MHA, ASA, FRICS, MCBA, CVA, CM&AA, was published by the American
Institute of CPAs (AICPA). This best-selling, three-volume book established a framework for
CPAs, business valuation professionals, healthcare attorneys, c-suite executives, and healthcare
providers, to explore the foundational, complex and interrelated issues concerning the
reimbursement, regulatory, competition, and technology environments of the healthcare industry.
Since then, much has happened in the healthcare industry that is of great importance to those of
us who professionally advise healthcare providers and their c-suite executives. These changes
include:
• The implementation of the Patient Protection and Affordable Care Act of 2010 (ACA),
which was signed into law by President Barack Obama on March 23, 2010;
• The affirmation of the constitutionality of the ACA by the Supreme Court of the United
States, in both National Federation of Independent Business v. Sebelius (2012), and King
vs. Burwell (2015);
• The imposition of a tax on individuals who do not have qualifying health insurance
coverage, known as the Individual Mandate;
• The expansion of Medicaid to 30 states (including Washington, DC), which covers most
individuals up to 138% of the federal poverty level (FPL);
• A continuing shift from volume-based to value-based reimbursement models (through the
utilization of evidence-based metrics, bundled payment, shared savings, co-management
agreements and other alternative payment methodologies that focus less on productivity
and more on quality);
• The advent of emerging healthcare organizations (EHOs), such as Medicare/Medicaid
and commercial accountable care organizations (ACOs) and clinically integrated
networks (CINs), and the resulting focus of health care providers on population health
data and analytics to analyze and drive changes that result in more cost efficient care
while maintaining or improving quality;
• The reduction of Medicare reimbursement to hospitals with high readmission rates, as
well as to hospitals that have relatively high rates of hospital acquired conditions along
with the continuing trend of reductions in inpatient hospital service utilization, increases
in outpatient service utilization and technology advancements in telehealth;
• The passage of the Medicare Access and CHIP Reauthorization Act (MACRA)
legislation with the impact of the sustainable growth rate (SGR) fix on future physician
quality initiatives and reimbursement and the implementation of ICD-10 and new chronic
care management billing codes;
• A significant increase in the number of providers that utilize (and have achieved
“meaningful use” of) electronic health records (EHR) and the advent of internet or
electronic physician visits for patient care;
• The increasing purchase of many physician practices by hospitals and subsequent
employment of these physicians;
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•
•
•
•

Health care providers developing their own insurance plans or joint venturing with
existing health plans in order to gain direct access to insurance premium dollars;
Health insurance plans acquiring health care providers;
The emergence of patient medical information and data hacking and resulting private
lawsuits and government enforcement of the Health Insurance Portability and
Accountability Act (HIPAA) and privacy laws; and
Finally, because the governments gets a return of approximately 8-9 dollars related to
refunds, fines and penalties for every dollar it spends on false claims, Stark and AntiKickback Statute enforcement, the continued emphasis on this area of enforcement with
more reliance on private qui tam actions.

H E A L T H C A P I T A L C O N S U L T A N T S (HCC) has managed to assemble an authoritative body of
information on these rapidly evolving subjects and present their updated findings in an easily
understood, yet comprehensive, manner. I have had the pleasure and opportunity to work with
both Bob Cimasi and Todd Zigrang, and their colleagues at HCC, over many years and on many
different innovative arrangements resulting from the aforementioned health care reform
initiatives, and know first-hand the depth of their technical knowledge, creative problem-solving
abilities, and overall understanding of the evolving elements of the U.S. healthcare industry.
Their signature research resources and capabilities have now been assembled into a
comprehensive textbook presented in a concise, organized method—well-sourced and indexed
for ease of repeated use. This useful, second edition is a robust text structured as a sourcebook
for both CPAs and the clients they serve, as well as a textbook for both aspiring professionals
and those pursuing continuing professional education.
Volume I of this two-volume book presents, in six chapters:
(1) An in-depth review of the historical development of medicine in healthcare [Chapter 1];
(2) The Four Pillars of Healthcare (i.e., reimbursement, regulatory, competition, and
technology) [Chapters 2-5]; and,
(3) Continuing efforts to reform the U.S. healthcare delivery system [Chapter 6].
Volume II of the book explores, in 12 chapters:
(1) The concepts associated with healthcare consulting [Chapter 1] and benchmarking
[Chapter 2];
(2) Compensation and income distribution [Chapter 3];
(3) The financial valuation of enterprises, assets, and services [Chapter 4];
(4) Organizational structures [Chapter 5] and emerging models [Chapter 6];
(5) Various types of physician practices [Chapter 7] and mid-level providers practices
[Chapter 8];
(6) Technicians and paraprofessionals [Chapter 9], as well as allied health professionals
[Chapter 10];
(7) Alternative medicine practices [Chapter 11]; and,
(8) A new paradigm for professional practices [Chapter 12].
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Both volumes are structured so that the reader can quickly and efficiently gain a thorough
understanding of the healthcare provider medical specialty that he or she has been engaged to
value.
This disciplined analysis allows the reader to use this book in a variety of ways. For those who
are new to the healthcare industry, they would be well-advised to first read Chapter 1 and
Chapter 12, in order to obtain an adequate knowledge basis. Second, I recommend that the reader
read the rest of the chapters of Volume I and Volume II for research and reference. In addition,
the textbook can be used as a regular sourcebook to return to time and again.
The second edition of “The Adviser’s Guide to Healthcare” is exhaustively researched and
provides keen insight into the trends and value drivers of the healthcare field. With this book,
Bob Cimasi and Todd Zigrang have made a significant contribution to the canon of professional
literature. It will prove to be an important part of the professional library of healthcare and
medical practice consulting professionals.
David W. Grauer, Esq.
Partner, Jones Day
July 31, 2015

vii

Preface

“Tho’ much is taken, much abides.” (Ulysses) Lord Alfred Tennyson, 1833
Even as recently as the post–World War II era of the 1950s, when an injury or sudden illness
required a response by emergency services, the dispatcher would sound the community sirens,
signaling the volunteer firemen on duty to radio ahead from their emergency vehicle to the small,
four-bed, rural hospital, which would then alert one of the three physicians in the community to
rush to the hospital to provide emergency care. In a still largely rural society, when our neighbors
developed musculoskeletal conditions from working on the farms or in small manufacturing
plants and machine shops, they might visit the town chiropractor, who would perform
manipulation and prescribe vitamins and various homeopathic remedies. The local dentist’s
services were in great demand with the widespread prefluorination incidence of juvenile tooth
decay. In the more urban areas, with a greater supply of trained healthcare professionals, access
to care was still based, to a great degree, on the ability of patients and their families to pay or on
charity care. This was a time in U.S. history when Marcus Welby1 was not only a regular family
television drama but was also a reasonable characterization of how healthcare services were
perceived to be delivered by professional practices throughout much of the country.
During the 65-year period since 1950, the U.S. population has doubled from just more than
152 million to an estimated 320 million in 2015,2 and the average life expectancy has increased
from approximately 68 years to over 78 years.3 With the record number of births of the “baby
boomer” generation from the late 1940s through the early 1960s, the proportion of the U.S.
population over the age of 65 increased from 8.1 percent in 1950 to an approximately 15 percent
in 2014.4 This demographic shift is expected to continue, with the proportion of Americans over
65 expected to reach 20 percent of the total population by 2030.5
This increased life expectancy and the subsequent “graying” of the baby boomer population,
with the accompanying rise in the incidence and prevalence of the diseases, conditions, and
injuries for which the elderly are more at risk, is expected to continue driving demand for
healthcare services, as well as a dynamic evolution in the demand for, the supply of, and the very
nature of healthcare professional practices.6

1
2
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6

Marcus Welby was the main character in the television show, Marcus Welby, M.D, portrayed by Robert Young between 1969 and 1976,
who portrayed Dr. Welby as an idealized version of the quintessentially altruistic, kindly, and unfailingly non-corporate family physician.
“Marcus Welby, M.D.” Internet Movie Database, http://www.imdb.com/title/tt0063927/?ref_=ttep_ep_tt (Accessed 7/9/2015).
“Historical National Population Estimates: July 1, 1900 to July 1, 1999” U.S. Census Bureau, June 28, 2000, https://www.census.gov/
popest/data/national/totals/pre-1980/tables/popclockest.txt (Accessed 4/1/2015); “Monthly Population Estimates for the United States: April
1, 2010 to December 1, 2015” U.S. Census Bureau, http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk
(Accessed 4/1/2015).
“United States Life Tables, 2003,” Centers for Disease Control and Prevention, National Vital Statistics Report, Volume 54, Number 14
(April 19, 2006), p. 34; “Health, United States, 2013: With Special Feature on Prescription Drugs” Centers for Disease Control and
Prevention: Hyattsville, MD, 2014, p. 2.
“Demographic Trends in the 20th Century: Census 2000 Special Reports” By Frank Hobbs and Nicole Stoops, U.S. Census Bureau,
November 2002, p. 58; “An Aging Nation: The Older Population in the United States” By Jennifer M. Ortman et al., U.S. Census Bureau,
May 2014, http://www.census.gov/prod/2014pubs/p25-1140.pdf (Accessed 2/20/15), p. 2.
“An Aging Nation: The Older Population in the United States” By Jennifer M. Ortman et al., U.S. Census Bureau, May 2014,
http://www.census.gov/prod/2014pubs/p25-1140.pdf (Accessed 2/20/15), p. 2–3.
“The Impact of the Aging Population on the Health Workforce in the United States” Health Resources and Services Administration,
December 2005, p. 2; “Health, United States, 2008: With Special Feature on the Health of Young Adults” Centers for Disease Control and
Prevention, March 2009, http://www.cdc.gov/nchs/data/hus/hus08.pdf#120 (Accessed 09/11/2009), p. 3–4.
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Although age-related population trends are one of the key contributors to the changing demand
for health services, other changes in the U.S. demographic and economic climate have significant
bearing as well. The accelerated population shift from rural to urban areas during the last
60 years also may have influenced the increased incidence and prevalence of disease. Although
the urbanization of the United States was already under way in 1950, this shift accelerated and
continued to reshape the population distribution, with the urban population increasing from
64 percent of the U.S. population in 1950 to approximately 81 percent in 2014.7
Additionally, the shift from an agrarian into an industrialized society, and once again into a
service-driven economy, has affected the American lifestyle and related health trends. The
waning of family farms and rise of industrialized agriculture resulted in a shift in the U.S. diet.
High-calorie commodities laden with fats, oils, and sugars were mass produced at the expense of
farming affordable, fresh, and nutritious produce.8 With this increased availability, and,
consequently, the consumption of high caloric energy, came a decrease in energy expended,
arising from the sedentary, high stress, and extended work day practices characteristic of many
service industry sectors (for example, finance, legal, insurance and real estate, retail trade, and
public utilities), as well as an increased reliance on technology (e.g., television, phones, and
computers) as a form of entertainment. The emergence and proliferation of automobile
transportation decreased emphasis on the family unit, and sedentary recreational habits led to a
decrease in physical activity. These factors further fueled the impact of the fast food industry and
processed food consumption on the health of the U.S. population, now plagued by chronic
diseases for which obesity and poor diet are often major co-morbidities.9
The increased demand for healthcare services, driven by these changes and other economic and
demographic variables, may have, in part, fueled the increase in healthcare expenditures from
5 percent of GDP in 1950 to 17.9 percent in 2012.10 Increased spending also may be a
consequence of the surge in technological and other medical advances in the healthcare industry,
promulgated at the close of World War II and encouraged by the increase in federal and state
funding for healthcare expenditures.11 Since the adoption of Medicare in 1965, public
(government) payors have come to fund more about 40% of all healthcare expenditures.12
Also among the driving forces of U.S. healthcare industry trends that impact professional
practices are the supply and distribution of various types and multiple levels of healthcare
professionals who work within a dynamic framework of myriad competing interests in order to
meet the growing needs of an aging and, in many ways, less healthy population. As a result of
technological and medical advances, specialized medicine flourished across the healthcare
7
8
9
10
11
12
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“Table 1. Urban and Rural population: 1900–1990” U.S. Census Bureau, October 1995, http://www.census.gov/population/censusdata/
urpop0090.txt (Accessed 03/26/2010); “World Urbanization Prospects: 2014 Revision” United Nations, 2014, http://esa.un.org/unpd/wup/
Highlights/WUP2014-Highlights.pdf (Accessed 2/20/15), p. 24.
“Obesity and the Economy: From Crisis to Opportunity” By Davis S. Ludwig, MD, PhD and Harold A. Pollack PhD, the Journal of the
American Medical Association, Volume 301, Number 5 (February 4, 2009), p. 533.
“Obesity and the Economy: From Crisis to Opportunity” By Davis S. Ludwig, MD, PhD and Harold A. Pollack PhD, the Journal of the
American Medical Association, Volume 301, Number 5 (February 4, 2009), p. 533.
“Health Care Expenditures in the OECD” National Bureau of Economic Research, http://www.nber.org/aginghealth/winter06/w11833.html
(Accessed 03/26/2010); “Health Expenditure, Total (% of GDP)” The World Bank, 2015, http://data.worldbank.org/indicator/
SH.XPD.TOTL.ZS (Accessed 2/20/15).
“Plunkett’s Health Care Industry Trends and Statistics 2008 (Summary)” By Jack W. Plunkett, Plunkett Research Ltd., 2007, p. 3.
“National Health Expenditure Projections 2013-2023” Center for Medicare & Medicaid Services, September 17, 2014, http://www.cms.gov/
Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsProjected.html
(Accessed 11/19/2014), Table 3.

workforce,13 growing into a significant trend in the 1950s. One response to the past and present
surge in demand associated with these medical advances is the growth in the physician
population. The number of physicians has increased from 292,088 in 1965 to 1,045,910 in 2013,
and the number of physicians per 100,000 individuals has increased from 148 to 311 over the
same period.14
Despite these growing workforce trends, it is expected that, with a disproportionate number of
physicians retiring or reducing their workload, an inadequate supply of medical graduates, and
the expected continuing growth in demand, the present shortage in supply of physician
manpower will continue to worsen.15 As a result, there has been a further increase in
diversification of the healthcare workforce, comprised of more than 18 million individuals, with
fewer than one million being professionally active physicians.16 The diversification,
specialization, and collaboration of physician and nonphysician practitioners has increased,
expanded, and enhanced to meet the compounding demand. This Guide addresses not just
physician medical practices, but discusses a comprehensive array of professional practice types,
as well as the various practitioners that comprise the healthcare workforce, including allied
health professionals, mid-level providers, and technicians and paraprofessionals, as well as
complementary and alternative medical practitioners.
Although physician, clinical, and other professional services currently account for $667 billion of
a $2.9 trillion healthcare market (i.e., 23 percent),17 recent efforts at regulatory and
reimbursement reform suggest that healthcare professional practices may be facing an
unprecedented dramatic transition. The evolution and increasing complexity of healthcare
reimbursement, regulatory, competitive, and technological environments has made it more
difficult for professionals to maintain revenue yield while avoiding running afoul of regulatory
edicts.
A notable element of these challenges is an industry transition reflected in the recent increase in
the number of hospital-employed physicians, and the dwindling of physician ownership of
private, independent practices.18 A growing number of young physicians, plagued by medical
school debt and intent upon achieving a more comfortable work-life balance, are opting out of
private, independent practice and pursuing salaried employment with hospitals and health
systems.19

13
14
15

16
17
18
19

“Health Care USA: Understanding its Organization and Delivery” By Harry A. Sultz and Kristina M. Young, Sixth Edition, Sudbury, MA:
Jones and Bartlett Publishers, 2009, p. 231.
“Physician Characteristics and Distribution in the US” American Medical Association, 2015 Edition, 2015, p. 453.
“The Complexities of Physician Supply and Demand: Projections from 2013 to 2025” IHS, Inc., Report for Association of American
Medical Colleges, March 2015, p. v-viii; “Results and Data: 2013 Main Residency Match," National Resident Matching Program, April
2013, http://www.nrmp.org/wp-content/uploads/2013/08/resultsanddata2013.pdf (Accessed 10/23/2014), p. 1. In 2013, 34,355 applicants
competed for fewer than 30,000 graduate medical education positions.
“Healthcare Workers” Centers for Disease Control and Prevention, December 12, 2014, http://www.cdc.gov/niosh/topics/healthcare/
(Accessed 2/20/15); “Total Professionally Active Physicians” The Henry J. Kaiser Family Foundation, September 2014,
http://kff.org/other/state-indicator/total-active-physicians/ (Accessed 2/20/15).
“National Health Expenditure 2013 Highlights” Centers for Medicare & Medicaid Services, http://www.cms.gov/Research-Statistics-Dataand-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf (Accessed 2/20/15).
“A Guide to Physician Integration Models for Sustainable Success” American Hospital Association, September 2012, http://www.hpoe.org/
Reports-HPOE/guide_to_physician_integration_models_for_sustainable_success.pdf (Accessed 5/19/2014), p 5.
“Wanting it All: A New Generation of Doctors Places Higher Value on Work-Life Balance” By Eve Glicksman, Association of American
Medical Colleges, May 2013, https://www.aamc.org/newsroom/reporter/336402/work-life.html (Accessed 5/22/2014).
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These trends have made it increasingly difficult for older independent practitioners to recruit
junior partners,20 a struggle which, paired with the burden of rising costs, has led many
physician-owners to sell their practices to hospitals and enter into salaried employment
arrangements as well.21 This shift further away from the independent practice of medicine as a
“cottage industry” in the United States may be viewed by patients as both a blessing and a
burden of the changing healthcare delivery system. On one hand, the trend away from small,
physician- or provider-owned, independent private practices holds the promise of improved
quality and cost efficiency for the delivery of better and integrated medical care. Alternately, the
“corporatization” of healthcare professional practices may result in a weakening of the
independent physician- or provider-patient relationship, an intimacy and level of trust that was
long a characteristic of the cottage industry healthcare delivery system of old.22 Given these
trends in healthcare professional practices, it may not be far-fetched to believe that “Marcus
Welby is dead!” (see chapter 2 of Consulting Services).
Over the past century, U.S. healthcare reform initiatives have been driven by complex,
polarizing, and potentially conflicting market factors, including demographic, socio-political,
and economic issues, manifested by increased spending, workforce disruptions, increased
prevalence and incidence of chronic and acute medical conditions, a growing and aging
population, and inefficient delivery and shortcomings in translating emerging technologies into
the delivery of quality and affordable care.
The passage of President Obama’s signature healthcare reform initiatives (often referred to as
“Obamacare”) is a landmark event in the history of U.S. healthcare reform. Comprised of the
March 23, 2010 enactment of the Patient Protection and Affordable Care Act23 and the March
25, 2010 passage of the Health Care and Education Reconciliation Act of 2010,24 the Affordable
Care Act (ACA) is neither unique nor is it the first of such reform efforts. The ACA is still in
flux, with a multitude of unresolved issues and uncertainties remaining. The first major challenge
to the ACA was posed by the National Federation of Independent Business v. Sebelius case,
where the Supreme Court upheld the ACA’s individual mandate, but ruled that the ACA’s
Medicaid expansion would be optional for states.25 More recently, the ACA was challenged in
the Supreme Court in the King v. Burwell case, where the Supreme Court once again upheld the
ACA, holding that tax credits provided to individuals who purchased insurance on federallyestablished health insurance exchanges were, in fact, legal.26 Despite these victories, there still
remain challenges to the implementation of the ACA’s provisions.27 The resolution of these
issues, both within the political and market environments, will have a significant impact on the
operation of healthcare organizations, as well as on the value of those enterprises, assets, and
services.
20
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“2012 Review of Physician Recruiting Incentives” Merritt Hawkins, 2012, http://www.merritthawkins.com/uploadedFiles/
MerrittHawkins/Pdf/mha2012survpreview.pdf (Accessed 4/1/2015), p. 4.
“A Guide to Physician Integration Models for Sustainable Success” American Hospital Association, September 2012, http://www.hpoe.org/
Reports-HPOE/guide_to_physician_integration_models_for_sustainable_success.pdf (Accessed 5/19/2014), p. 5.
“More Doctors Giving Up Private Practices” By Gardiner Harris, New York Times, March 25, 2010, http://www.nytimes.com/2010/03/26/
health/policy/26docs.html?pagewanted=print (Accessed 5/25/2010); “The Social Transformation of American Medicine” By Paul Starr,
Basic Books Inc. 1982, p. ix.
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, 124 Stat. 119 (March 23, 2010).
“Health Care and Education Reconciliation Act of 2010” Pub. L. No. 111-152, 124 Stat. 1029 (March 25, 2010).
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2600-2604 (2012).
“King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 21.
See Chapter 6, Healthcare Reform, for a further discussion regarding further challenges to the ACA.

The volatility of the U.S. healthcare delivery system, with its continuing uncertainty, impacts
suppliers, payors, and providers alike. In addition to navigating through the turbulence of
healthcare reform, suppliers, payors, and providers must reckon with capricious capital markets
and challenging economic conditions. The direction and ultimate consequence of this process of
change on investor perceptions of growth, risk, and capital demands is, in many ways, simply a
recasting of failed reform efforts from the 1990s. President Harry S. Truman once said, “The
only thing new in the world is the history you don’t yet know.”
A continued and unsustainable rise in healthcare expenditures followed the failed cost reform
efforts of the 1990s and served as one of several catalysts that precipitated the need for national
healthcare reform initiatives, e.g., the ACA. Other forces that may have driven the passage of
some kind of national healthcare reform legislation include:
(1) Declining reimbursement for physician services and provider manpower shortages;
(2) The growing and aging “baby boomer” patient demographic;
(3) The amount of the population that remains uninsured and is increasingly underinsured
and/or unable to access care; and,
(4) The increasing public demand for transparency, disclosure, and awareness as the burden
of healthcare costs shifts from insurance companies to patients.
These circumstances, together with the aftermath of the recent economic recession, an
unprecedented intensity and political discourse regarding U.S. government deficit and debt, and
an increasing political polarization (especially related to asserting states’ rights in opposing
federal initiatives), have created a “perfect storm” that may fuel real changes to the current
system of healthcare delivery in the United States.
These dramatic and ongoing changes, as well as the sheer size and complexity of the healthcare
delivery system, have provided new opportunities in healthcare consultancy. Responding to the
expanding market in the current era of reform, many financial and management consulting firms
have extended their service line to include healthcare advisory services. Accounting firms, which
traditionally have served as primary business and financial advisors for their clients, also have
steadily increased the scope of their healthcare professional practice advisory services.
The persistent volatility of the healthcare industry landscape can be difficult to navigate. To be
effective in offering services to healthcare professional practice clients, consulting professionals
should possess an understanding of the history and background of professional practice
enterprises, as well as the market mechanisms at work in the current healthcare environment—in
particular, how those forces interact to shape the future direction of professional practices in the
healthcare delivery system under pending legislative reform.
Although consultancy for healthcare professional practices may present an attractive business
development opportunity for consultants, it is not an area that lends itself to ad hoc, generic
advisory services. In light of the increasingly complex, diverse, and ever-changing scope and
volume of information that contributes to a comprehensive understanding of the healthcare
industry, consulting professionals who possess a more general background and expertise and
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pursue providing services to healthcare professional practices may endeavor to become better
informed to avoid being viewed, in some regard, as jacks of all trades and masters of none.
This two-volume book set is designed to serve as a reference guide for those seeking a more indepth knowledge of the healthcare marketplace; a working and applied understanding of the
forces that affect the industry within which healthcare providers operate; and a primer regarding
how consulting services may be offered to these enterprises specifically, healthcare professional
practices, in an ever-changing reimbursement, regulatory, competitive, and technological
healthcare environment. Such industry-specific knowledge should serve as a catalyst for these
consulting professionals to better serve their existing clients and expand their services for
potential new engagements.
This Guide may also prove useful to the licensed healthcare professionals who own independent
practices, as well as their professional advisors, managers, and administrators. Providing these
stakeholders with in-depth background information and a context within which to view
professional practice enterprises as part of a dynamic healthcare marketplace may enhance their
ability to assist their organizations in surviving and thriving in the future.
With the second edition of this Guide, we earnestly solicit reader comments, criticisms, and
suggestions for improvements in future editions.
Sincerely,
Robert James Cimasi
MHA, ASA, FRICS, MCBA, CVA, CM&AA
Chief Executive Officer
HEALTH CAPITAL CONSULTANTS
Saint Louis, Missouri
July 31, 2015
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Todd A. Zigrang
MBA, MHA, FACHE, ASA
President
HEALTH CAPITAL CONSULTANTS

Table of Contents
Introduction ............................................................................... 1
The Four Pillars of the Healthcare Industry................................ 1
Reimbursement ................................................................... 2
Regulatory ........................................................................... 3
Competition......................................................................... 3
Technology ......................................................................... 4
Structure of this Guide ................................................................ 5
Reader Tools: Sidebars, Tables, and Figures ...................... 6
Professional Practice Taxonomy................................................. 6
Chapter 1: Historical Development ..................................... 25
Overview ................................................................................... 27

The Rising Costs of Healthcare......................................... 58
Responses of Rising Costs of Healthcare .......................... 59
Clinton Era Healthcare Reforms ....................................... 64
Medicare Part C and The Children’s Health Insurance
Program (CHIP) ............................................................ 65
Medicare Part D ................................................................ 66
Federal Fraud and Abuse Statutes ..................................... 66
The Patient Protection and Affordable Care Act (ACA) .. 69
The Shift from Inpatient to Outpatient Treatment ............ 71
The Healthcare Manpower Shortage: A Barrier to
Managed Care ............................................................... 71
The Healthcare Professional’s Duty to the State....................... 74

Origins of Medicine .................................................................. 27

The History You Don’t Know ................................................... 75

Medicine and Religion and Astrology .............................. 28

Chapter 2: Reimbursement Environment ............................ 79

Philosophy and Science of Medicine ................................ 30
Hippoocrates ..................................................................... 32
Professional Practice and Status of the Physician............. 34
Galenic Medicine .............................................................. 34
Rise of the Medical University ......................................... 35
Eastern Medical Traditions ............................................... 36
Renaissance: Revival of Anatomy and Physiology .................. 37
Seventeenth Century: The Dawn of Scientific Liberty ............. 39
Anatomical Advances ....................................................... 39
Progress in Hygiene .......................................................... 39
Eighteenth Century: The Shift Toward the "Science"
of Medicine ........................................................................... 41
Nineteenth Century: The Practice of Medicine ........................ 43
Study of the Medical Sciences .......................................... 43
Impact of the Industrial Revolution on the Practice of
Medicine ....................................................................... 44
Diversified Schools of Medicine ...................................... 44
Diversified Roles of Medicine .......................................... 46
Specialization of the Sciences........................................... 47
Specialization of Medicine ............................................... 47

Overview ................................................................................... 84
Healthcare Revenue Cycle ........................................................ 84
Elements of the Revenue Cycle ........................................ 85
Changing Nature of the Revenue Cycle ............................ 97
Current Reimbursement Environment ...................................... 98
Public Payors ..................................................................... 99
Private Payors..................................................................... 154
Methods of Reimbursement ............................................... 167
Payor Mix and the Effect on the Revenue Cycle ............... 173
Emerging Reimbursement Trends .............................................. 174
Healthcare Reform Efforts ................................................. 174
Move From Fee For Service............................................... 175
Increased Emphasis on Quality: Pay-for-Performance
(P4P) ............................................................................... 176
Increased Reimbursement to Encourage
Implementation of Electronic Health Records
(EHR) Through Meaningful Use.................................... 179
Reimbursement of Aesthetic and Reconstructive
Procedures ...................................................................... 182
Concierge Medicine ........................................................... 183
Medical Home Model......................................................... 183

Twentieth and Twenty-First Centuries: The Transformation
of Modern Healthcare ........................................................... 52

Conclusion .................................................................................. 186

The Introduction of Health Insurance ............................... 52

Chapter Appendix A................................................................... 188

The Inception of Medicare and Medicaid Services .......... 54

xv

Chapter 3: Regulatory Environment ..................................... 191

ACOs and Fraud and Abuse ............................................... 256

Overview .................................................................................... 197

Federal Antitrust Laws ............................................................... 257

Healthcare Liability ........................................................... 197

Statutory Background and General Application ................ 257

The Shift from Cottage Industry to Corporate
Practice of Medicine ...................................................... 198

Antitrust Case Law ............................................................. 258

Corporate Practice of Medicine (CPOM) .................................. 198
Healthcare Regulation at Federal and State Levels ................... 200
Licensure .................................................................................... 200

Internal Revenue Service and the Internal Revenue Code ......... 267
IRS Tax Status .................................................................... 267

Individual Professional Licensure...................................... 200

Inurement of Private Benefit and Excess Benefit
Transactions ................................................................... 269

Physician Versus Non-physician Scopes of Practice ......... 201

“Reasonable Compensation Defined by the IRS” .............. 270

Specialty Licensure and Certification ................................ 203

IRS Definitions of “Bona Fide Employees” and
“Form 1099 Independent Contractors” .......................... 270

Healthcare Facility and Practice Licensure........................ 204
Accreditation .............................................................................. 204
The Joint Commission ....................................................... 205
American Osteopathic Association .................................... 205
National Committee on Quality Assurance ....................... 206
Medicare and Medicaid Certification ........................................ 206
Certificate of Need (CON) ......................................................... 207
Overview: The Federal Certificate of Need Program ........ 207
The Federal Trade Commission and CON......................... 209
The Application Process .................................................... 210
The Appeal Process............................................................ 211
Privacy Laws .............................................................................. 211
Health Insurance Portability and Accountability
Act of 1996 .................................................................... 212
Health Information Technology for Economic and
Clinical Health (HITECH) Act ...................................... 214
Red Flags Rule ................................................................... 216
The Patient Safety and Quality Improvement
Act of 2005 .................................................................... 217
Fraud and Abuse Laws............................................................... 217
False Claims Act (FCA) .................................................... 217
Anti-Kickback Statute ........................................................ 221
Stark Law ........................................................................... 228
Civil Monetary Penalties.................................................... 235
CMS Reimbursement Monitoring Programs ..................... 236
Physician Compensation Restrictions ................................ 238
State Fraud and Abuse Statutes.......................................... 251
Racketeer Influenced and Corrupt Organizations
Act (RICO)..................................................................... 256

xvi

ACOs and Antitrust ............................................................ 266

Internal Revenue Code Section 501(R) .............................. 271
IRS Audits and Compliance with Section 409A ................ 274
Other Tax Provisions.......................................................... 275
Other Federal Regulations.......................................................... 277
Occupational Safety and Health Act (OSHA).................... 277
Clinical Laboratory Improvement Act (CLIA) .................. 277
United States Nuclear Regulatory Commission (NRC) ..... 278
Emergency Medical Treatment and Active Labor Act
(EMTALA) .................................................................... 278
Tort Reform ........................................................................ 279
Physician Payments Sunshine Act ..................................... 281
Conclusion .................................................................................. 282
Chapter 4: Impact of Competitive Forces ............................. 287
Overview .................................................................................... 289
Economics of Healthcare ........................................................... 290
Supply and Demand in Healthcare ............................................. 292
Impact of Government Regulation ............................................. 296
Supply: Cooperation and Competition Between
Hospitals and Physicians ................................................ 297
Demand: Third-Party Payors and Consumer
Driven Healthcare .......................................................... 305
Barriers to Free Market Competition in Healthcare
Delivery .................................................................................. 309
Difficulties in Measuring Quality and Outcomes .............. 310
The Application of Porter’s Five Forces to Hospitals
and Physician Groups ..................................................... 310
Antitrust Issues ................................................................... 320
Healthcare Reform and Its Effect on Competition ..................... 322
Managed Competition ........................................................ 322

Reform of the Insurance and Pharmaceutical Industries ... 323

Healthcare Expenditures .................................................... 405

Commoditization of Healthcare ......................................... 325

Increased Scrutiny of Fraud and Abuse ............................. 405

Conclusion ................................................................................. 328

Healthcare Provider Manpower: Supply and Demand ....... 407

Chapter 5: Technology Development..................................... 331

Restructuring Reimbursement ............................................ 408

Overview .................................................................................... 335
Management Technology........................................................... 335
Technology as Process ....................................................... 336
Electronic Health Records (HER) ...................................... 338
Electronic Prescribing: Computerized Physician
Order Entry (CPOE) ...................................................... 347
Outsourcing Billing Services ............................................. 354
Telemedicine and Telehealth ............................................. 354
Clinical Technology ................................................................... 364
The Gateway: Genetics, Genomics, and
Genome Technology ...................................................... 365
Stem Cell Research ............................................................ 367
Diagnostic Medicine and Technology ............................... 368
Therapeutic Technology .................................................... 377
Home Health Technology .................................................. 389
Conclusion ................................................................................. 392

Demand For Quality Improvements................................... 413
Passage of the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation
Act of 2010 ............................................................................. 414
Legislative Events Leading to the Passage of
Healthcare Reform ......................................................... 414
Timeline for Implementation of THE ACA ....................... 418
Obstacles to the Implementation of Healthcare Reform .... 420
Proposed Supplemental Reform Initiatives ........................ 422
Paying for Healthcare Reform.................................................... 423
Healthcare Reform Impact on the Future of U.S. Healthcare
Delivery .................................................................................. 424
Impact on Individuals ......................................................... 424
Impact on Small and Mid-Sized Employers ...................... 426
Impact on All Larger Employers ........................................ 427
Impact on Insurers .............................................................. 428
Impact on Professional Practice Providers ......................... 436

Chapter 6: Healthcare Reform: Past as Prologue to
the Future ............................................................................. 395

Future of the ACA ...................................................................... 439

Overview .................................................................................... 398

Conclusion .................................................................................. 442

A Historical Perspective on Healthcare Reform ........................ 398
The Affordable Care Act and Healthcare Reform ............. 399
What Is Driving Healthcare Reform? ........................................ 404

King v. Burwell .................................................................. 439
Glossary .................................................................................... 445
Index .......................................................................................... 455

Exploding Time Bomb: Changing Patient Population
Demographic .................................................................. 404

xvii

About the Authors
Robert James Cimasi, MHA, ASA, MCBA, FRICS, CVA, CM&AA
Robert James Cimasi serves as Chief Executive Officer of HEALTH CAPITAL CONSULTANTS
(HCC), a nationally recognized healthcare financial and economic consulting firm headquartered
in St. Louis, MO, serving clients in 49 states since 1993. Mr. Cimasi has over thirty years of
experience in serving clients, with a professional focus on the financial and economic aspects of
healthcare service sector entities including valuation consulting and capital formation services;
healthcare industry transactions, including joint ventures, mergers, acquisitions, and divestitures;
litigation support & expert testimony; and certificate-of-need and other regulatory and policy
planning consulting.
Mr. Cimasi holds a Master in Health Administration from the University of Maryland, as well as
several professional designations: Accredited Senior Appraiser (ASA—American Society of
Appraisers); Fellow Royal Institution of Chartered Surveyors (FRICS—Royal Institution of
Chartered Surveyors); Master Certified Business Appraiser (MCBA—Institute of Business
Appraisers); Certified Valuation Analyst (CVA—National Association of Certified Valuators
and Analysts); and Certified Merger & Acquisition Advisor (CM&AA—Alliance of Merger &
Acquisition Advisors). He has served as an expert witness on cases in numerous courts, and has
provided testimony before federal and state legislative committees. He is a nationally known
speaker on healthcare industry topics and the author of several nationally published books, the
latest of which include: “Accountable Care Organizations: Value Metrics and Capital
Formation” [2013—Taylor & Francis, a division of CRC Press]; “The Adviser’s Guide to
Healthcare”—Vols. I, II & III [2010—AICPA]; “The U.S. Healthcare Certificate of Need
Sourcebook” [2005—Beard Books]; and, his most recent book, “Healthcare Valuation: The
Financial Appraisal of Enterprises, Assets, and Services” [2014 - John Wiley & Sons].
Mr. Cimasi is the author of numerous additional chapters in anthologies textbooks, and legal
treatises; has published articles in peer reviewed and industry trade journals, research papers, and
case studies; and is often quoted by healthcare industry press. Additionally, Mr. Cimasi has
served as faculty before numerous professional and academic certification and continuing
education classes, including: the CPA Leadership Institute; the American Health Lawyers
Association (AHLA); the American Bar Association (ABA); the American Institute of CPAs
(AICPA); the American Society of Appraisers (ASA); the National Association for Certified
Valuators and Analysts (NACVA); and, the Internal Revenue Service (IRS).
In 2006, Mr. Cimasi was honored with the prestigious “Shannon Pratt Award in Business
Valuation” conferred by the Institute of Business Appraisers. In 2013, Mr. Cimasi achieved the
Certificate of Completion of the American Society of Appraisers Healthcare Special Interest
Group’s (ASA HSIG) Multidisciplinary Advanced Education in Healthcare Valuation Program.
Mr. Cimasi serves on the Editorial Board of the Business Appraisal Practice of the Institute of
Business Appraisers, of which he is a member of the College of Fellows; and as Chair Emeritus
of the ASA HSIG. In 2011, he was named a Fellow of the Royal Institution of Chartered
Surveyors (RICS).
xix

Todd A. Zigrang, MBA, MHA, FACHE, ASA
Todd Zigrang is the President of HEALTH CAPITAL CONSULTANTS (HCC), where he focuses on
the areas of valuation and financial analysis for hospitals, physician practices, and other
healthcare enterprises. Mr. Zigrang has over 20 years of experience providing valuation,
financial, transaction, and strategic advisory services nationwide in over 1,000 transactions and
joint ventures involving acute care hospitals and health systems; physician practices; ambulatory
surgery centers; diagnostic imaging centers; accountable care organizations, managed care
organizations, and other third-party payors; dialysis centers; home health agencies; long-term
care facilities; and numerous other ancillary healthcare service businesses. Mr. Zigrang is also
considered an expert in the field of healthcare compensation for physicians, executives, and other
professionals.
Mr. Zigrang holds a Master of Science in Health Administration (MHA) and a Master of
Business Administration (MBA) from the University of Missouri at Columbia. He is a Fellow of
the American College of Healthcare Executives (FACHE) and holds the Accredited Senior
Appraiser (ASA) designation from the American Society of Appraisers, where he has served as
President of the St. Louis Chapter, and currently serves as Chair of the ASA Healthcare Special
Interest Group (HSIG).
Mr. Zigrang is the author of numerous chapters in legal treatises and anthologies and peerreviewed and industry articles such as The Accountant’s Business Manual (AICPA); Valuing
Professional Practices and Licenses (Aspen Publishers); Valuation Strategies; Business
Appraisal Practice; and NACVA QuickRead.
Additionally, Mr. Zigrang has served as faculty before professional and trade associations such
as the ASA; the American Bar Association (ABA); the National Association of Certified
Valuators and Analysts (NACVA); Physician Hospitals of America (PHA); the Institute of
Business Appraisers (IBA); the Healthcare Financial Management Association (HFMA); and,
the CPA Leadership Institute.

xx

Introduction

These papers, advocating a more active
participation in public affairs by physicians than
has been the custom in this country, are reprinted
with the belief that such broader activity on the
part of my colleagues will help to free the State
from many present evils. A good doctor must be
educated, honest, sensible and brave. Nothing
more is needed in its citizens to make a state
great.
John B. Roberts, 1908

THE FOUR PILLARS OF THE HEALTHCARE INDUSTRY
When developing an understanding of the forces and stakeholders that have the potential to drive
healthcare markets, it is useful to examine professional practice enterprises as they relate to the
“Four Pillars” of the healthcare industry: reimbursement, regulatory, competition, and
technology (see the following figure I-1). These four elements shape the professional practice
and provider dynamic, while serving as a framework for analyzing the viability, efficiency,
efficacy, and productivity of healthcare enterprises. The four pillars, discussed briefly in this
introduction, will be further addressed in subsequent chapters devoted to each of these four
topics.

Adviser's Guide to Healthcare

Figure I-1: Four Pillars of Healthcare Value

REIMBURSEMENT
Chapter 2, Reimbursement Environment, provides an overview of current and future trends in
healthcare reimbursement. In the current era of healthcare reform, it is vital for providers to
maintain an applied understanding of healthcare payment sources (e.g., Medicare, Medicaid,
State Children’s Health Insurance Program); revenue and billing procedures (e.g., the resourcebased relative value scale payment system, relative value units and their components); Current
Procedural Terminology (CPT) codes; and, payment plans (e.g., fee-for-service plans,
performance-based payment plans, and consumer driven health plans).
As healthcare expenditures rise, proponents of reform advocate for both a reduction in service
costs and increases in quality of care. To achieve these goals, the healthcare industry has
generally moved toward models that shift the risk toward providers, such as managed care, payfor-performance programs, gainsharing arrangements, and patient-centered models of medical
practice (e.g., boutique medicine, the medical home model, accountable care organizations). In
addition, reimbursement for physician services has become a highly contested issue; repeated
annual congressional overrides of reductions to physician payment rates for services under the
sustainable growth rate system have created a large gap in current healthcare spending and target
(sustainable) expenditures. To combat these rising costs, for example, the high expenditures for
imaging services, billing codes have, during the past decade, been “bundled.” Bundling has been
utilized to reduce the overall payment for certain interrelated services by billing for them under
one, combined code, rather than under independent codes. The emergence of bundled codes,
among other trends, is evidence of the rapidly changing reimbursement environment within the
U.S. healthcare delivery system.
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Figure I-2: U.S. Health Insurance Reimbursement Options

REGULATORY
The U.S. healthcare industry is governed by a network of ever-changing state and federal
regulations, relating to both physician and nonphysician professionals. Chapter 3, Regulatory
Environment, contains a detailed overview of the general provisions that apply to the various
practitioners and providers in the healthcare industry.
Various key regulatory issues may influence the healthcare climate. For example, in recent years,
there has been increased government scrutiny of regulatory violations of fraud and abuse laws,
particularly as the violations relate to acquisition and compensation transactions between
hospitals and physicians. Failure to comply with valuation standards for physician and executive
compensation arrangements (for example, fair market value and commercial reasonableness)
may result in liability under the False Claims Act, the Antikickback Statute, and the Stark law.
Chapter 3, Regulatory Environment includes a discussion of these concepts and regulations along
with the definitions, applications, implications, and trends of additional federal and state
healthcare laws and regulations (for example, Certificate of Need programs).

COMPETITION
Additionally, rapid changes in the healthcare competitive market may be attributed to the everincreasing demand for care from the aging baby boomer population; the influx of newly insured
individuals as a result of the ACA; and, the continuous development of new technologies, the
latter which may enhance the quality and efficiency of the healthcare delivery system.
The changing demographics of the patient population (i.e., the "baby boomer" population) and
the physician workforce also may have a lasting impact on the healthcare competitive
environment. There has been an increase in concern related to the shortage of physician
manpower and the limited number of available residency slots that restrict physician entry into
the healthcare market. Among the most notable concerns is the perceived shortage of primary
care physicians; with many medical students opting for careers in higher-paying medical
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specialties, primary care physicians are pressed more than ever to meet patient demand for
services. Additionally, women and minorities make up a much higher percentage of the
physician workforce than they have in the past (in most specialties), effectively diversifying the
traditionally Caucasian male physician demographic. Although they provide patients with more
choices for care, they also are presenting challenges related to the demands of achieving a
practice—lifestyle balance. However, one factor which may help alleviate the physician
manpower shortage is the increasing supply and autonomy of mid-level providers such as nurse
practitioners and physician assistants, who can provide a specific scope of services independent
of physician oversight.
These issues and numerous others, such as healthcare and insurance reform, shape the unique
and dynamic healthcare competitive environment. Chapter 4, Impact of Competitive Forces,
includes a more detailed examination of these issues within the context of Porter’s five forces of
competition.

TECHNOLOGY
Significant technological advances during the past few decades have had a notable impact on the
U.S. healthcare delivery system. Electronic health record technologies gradually have been
integrated into medical records maintenance systems, replacing traditional paper files. Similarly,
computerized physician order entry has streamlined the process of ordering prescriptions and
minimized error caused by handwritten orders. Although these new electronic approaches to
healthcare delivery are saving employers money, physician unwillingness to adopt these new
technologies has impeded their widespread emergence into the healthcare market. Regardless,
new and improved management technology is has become an important facet of the healthcare
industry.
Progress in clinical technology also has flourished in recent years, including highly controversial
practices such as stem cell research. However, one of the various genres of medical services that
may have drawn the most attention is imaging; services that utilize the technology, such as the
various types of magnetic resonance imaging, computed tomography (for example, positron
emission tomography-computed tomography, single photon emission computed tomography, and
picture archiving and communications systems), and teleradiology services, have become a
staple in modern diagnostic radiology practice.
Oncologists and surgeons also have seen major advancements in the treatment and detection of
cancer and in minimally invasive or noninvasive surgery, respectively. For oncologists, radiation
therapy methods are improving continuously, and their use of innovative alternative and
supporting technologies, such as image-guided radiation therapy, which is used during intensitymodulated radiation therapy; gamma knives; and stereotactic radiosurgery, is increasing. The use
of robotics has become a rapidly advancing trend, and surgeons with robotics experience are
sought after for their skills. Robotic technologies have been used for urologic, gynecologic, and
cardiothoracic procedures, among others. Although expensive, robotic technology minimizes the
degree of invasiveness, shortens recovery time, and improves patient outcomes.
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These advancements in medical technology have helped to revolutionize modern medicine. The
cost of implementing and maintaining these new devices and procedures, however, may
counterbalance efforts to control healthcare expenditures. The future of healthcare may well
depend on a compromise between the advancement of medical technological capabilities and the
cost of supporting those technologies that allows practitioners to provide the best quality care
possible. Chapter 5, Technology Development includes a more detailed discussion of the impact
of technology on healthcare practices.

STRUCTURE OF THIS GUIDE
This Guide serves as a resource for consulting professionals who provide services to professional
practices and related healthcare providers. It is divided into two books:
1. An Era of Reform—The Four Pillars, consisting of 6 chapters, begins with an abridged
history of healthcare, from the origins of medicine to the transformation of modern
healthcare in the twentieth and twenty-first centuries (chapter 1). The next several
chapters (chapters 2–5) provide a more comprehensive look at the reimbursement,
regulatory, competitive, and technological environments as they apply to healthcare
practice. Chapter 6 provides an overview of the healthcare environment and related
healthcare reform bills, at the time of the submission of this Guide.
2. Consulting Services, consisting of twelve chapters, the first four of which provide a
descriptive overview for consultants advising professional practice clients on matters
related to healthcare consulting (chapter 7); benchmarking strategies related to healthcare
and valuation (chapter 8); compensation and income distribution (chapter 9); and, the
financial valuation of healthcare enterprises, assets, and services (chapter 10). The next
chapters describe a myriad of practice structures (chapter 5), medical specialties, and
professionals seen in healthcare to date. This discussion includes emerging models of
healthcare enterprises, physicians, mid-level providers, technicians and paraprofessionals,
allied health professionals, alternative medicine practitioners, and a new paradigm for
professional practices (chapters 6–11, respectively), as well as information regarding the
scope of subspecialties, types of providers, and practitioners of each service type.
It should be noted that Consulting Services focuses on the professional practice component of the
U.S. healthcare delivery system and does not directly address other healthcare sectors, including
inpatient (for example, hospitals), outpatient and ambulatory (for example, ambulatory surgery
centers and diagnostic imaging centers), long term care (for example, nursing homes and
hospice), and home health sectors. However, many of the concepts and much of the content in
the aforementioned sections of this Guide may be applicable to consulting projects in these other
healthcare sectors, as well.
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READER TOOLS: SIDEBARS, TABLES, AND FIGURES
To enhance the utility of this Guide as a navigable source for readers of various backgrounds,
certain tools have been developed and appear throughout:
1. Sidebars. These supplemental features have been integrated into the content of each
chapter and have been grouped as follows:
a. Key terms. Key terms are important words used in text that may need to be defined
for the reader. This tool can be found at the beginning of each chapter and serves to
identify those terms that appear within the text of corresponding chapters as well as in
the glossary at the end of this book. Key terms may be discussed, or, at least,
mentioned in multiple chapters.
b. Key concepts. Similar to key terms, key concepts are the important concepts
mentioned in text that may require further elaboration or emphasis and a list of key
concepts can be found at the beginning of each chapter. This tool serves a bimodal
role, to further stress important ideas discussed in the chapter and to further discuss
ideas that may have only been mentioned in passing.
c. Key sources. This feature points to significant sources, both used within this Guide
and fundamental to the chapter content. These sources serve as chapter-specific
bibliographies, and, therefore, may be found in multiple chapters. Key sources can be
found at the end of each chapter.
d. Associations. A brief list of topic-relevant associations provides the reader with
contact information for associations referenced within a chapter. A list of related
associations can be found at the end of each chapter.
e. Factoids. These are brief, related facts of interest either mentioned in text or
supplemental to a topic discussed in a particular chapter that help build a contextual
framework for the reader that may aid in explaining the material. You will find
factoids located close to the content that they address within each chapter.
2. Tables. Tables are used to display benchmark data, to demonstrate numerical trends, and
to draw comparisons. They are referenced in text, but they may be used to display extra
information not discussed in the content of the chapter.
3. Figures. Pictorial and graphical depictions have been used to complement the text and
enhance the reader’s comprehension of the material. These figures are referenced and
discussed in text.

PROFESSIONAL PRACTICE TAXONOMY
Healthcare reform is driven by complex, polar, and potentially conflicting market factors, such as
increased spending; a growing and graying demographic; workforce shortages and inefficiencies;
problematic chronic and acute health indicators; and shortcomings in the delivery of efficient,
quality care. The subsequent chapters detail these issues, their implications, and the reform
initiatives proposed to delicately counterbalance the U.S. healthcare delivery system on the
nation’s scale of justice. However, before delving into the complexities of healthcare
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reimbursement, regulation, competition, and technology, the dynamic healthcare provider
workforce should be addressed.
Provider versatility has been growing and changing to complement an evolving healthcare
industry.1 The diverse healthcare workforce is instrumental to improving efficacy, quality of
care, financial efficiency, patient satisfaction, workforce productivity, and professional
satisfaction.2 In order to capitalize on this potential, institutions adopt models that strategically
allocate physician and nonphysician manpower resources on the basis of scope and skill set—
ensuring that the right care is provided by the right provider at the right time and place.”3
Implementation models are characterized by (1) the site of service (for example, hospital, clinic,
or community); (2) the guidelines that regulate provider practice and compensation within an
intraprofessional care model; (3) the system by which scope of practice is defined for each
provider classification; (4) the degree to which providers are liable for their professional actions;
and, (5) the degree to which they model efficacy and efficiency.4
The intraprofessional care models that have been implemented most successfully stem from
several provider taxonomies, which were intended to mirror the complex relationships within the
existing healthcare workforce. The most influential provider taxonomies (detailed in tables
I-1[A-D] and I-2) are each based on a different system of classification that focuses on a portion
of the industry dynamic and include those developed by (1) the Human Resources and Services
Administration, which utilizes a four-tiered hierarchal system and aggregates specific
occupations based on the degree of training and type of services provided (table I-1A); (2) the
Centers for Medicare and Medicaid Services, which classifies professionals based on the
specialized area of medical practice under which they provide their services (table I-1B); and
(3) the American Medical Association, which categorizes professionals based on how they bill
these professionals for services (table I-1C). Although these taxonomies are based on key
structural considerations, they each neglect certain industry facets, and discrepancies arise due to
the limitations that this unilateral rationale presents. The models used to enhance the delivery of
intraprofessional care face similar limitations, as institutions typically focus on only one, highly
customized model, foregoing a more industrywide perspective by neglecting models that
represent the other industry sectors.5
Alternately, multiple models can be synthesized to represent an industrywide, intrapersonal
dynamic.6 Elements from three models, the physician extender model, the triage model, and the

1
2
3
4
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“Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice” By Fred G. DoniniLenhoff, Journal of Allied Health, Vol. 37, No. 1 (2008), p. 47; “Interprofessional Healthcare: A Common Taxonomy to Assist with
Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl, PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-92.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-92-e-93.
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parallel model, were used to derive the taxonomical system for classifying healthcare
professionals that is utilized in this Guide (detailed in tables I-1D and I-2).
Traditionally, all nonphysician clinicians are referred to as “allied health professionals.”7
However, advances in technology and capability paired with the change in healthcare demand
during the course of medical history have rendered this system of classification far too
rudimentary for the diversity that the workforce now holds. As the healthcare industry continues
to change and market demand for primary, preventative, and rehabilitative care increases, the
varying degrees of responsibility, expertise, and autonomy afforded to the increasingly diverse
nonphysician healthcare workforce is reassessed and the scope of practice continues to expand.8
By creating a taxonomy based on these three representative models, allied health professionals
may be partitioned into appropriate substrata of nonphysician providers, because they would
function within the ideal intraprofessional workforce dynamic.
Under the physician extender model, the scope of nonphysician professional practice lies entirely
within the scope of physician practice.9 These physician extenders (hereinafter “technicians and
paraprofessionals”) supplement physician care, either as highly technical or technological
support or as manpower support.10 Specifically, one subset of the professionals defined within
this model is trained in a highly specialized technical or technological field and provides services
that physicians rely upon but are incapable of providing independently. The other subset of
professionals, physician extenders, provides routine medical and administrative services to
relieve physicians of a portion of their workload, allowing them to focus on more difficult and
complex tasks. From an official standpoint, these professionals may or may not be licensed or
certified (depending on which subset of the provider population they belong to or which role
they tend to fill most appropriately).
The original rationale behind the classification of “mid-level providers,” as defined for the
purposes of this Guide, derives from the triage model.11 Under this model, nonphysician
professionals are trained to provide a specific subset of physician services, and they traditionally
serve as a source of physician relief by providing triage care and enhancing patient throughput.12
Historically, these providers could only practice under direct or indirect supervision of a
physician.13 As demand has increased, namely for the provision of primary care services, the
supply and autonomy of mid-level providers (e.g., nurse practitioners and physician assistants)
have increased.14 To date, these professionals are relied upon for the provision of specialized
7
8
9
10
11
12
13
14
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“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-92.
“The Impact of Nonphysician Clinicians: Do They Improve the Quality and Cost-Effectiveness of Health Care Services?” By Miranda
Laurant; Mirjam Harmsen, Hub Wollersheim, Richard Grol, Marjan Faber, and Bonnie Sibald, Medical Care Research and Review,
Vol. 66, No. 6 (December 2009), p. 36S.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-93.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-93.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94.
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services that are incident to physician services, but also exercise a certain measure of
independence, because they can autonomously provide a specific scope of services in lieu of
physicians.15 The services which mid-level providers are authorized to provide in lieu of
physicians typically are limited to a portion of primary care practice healthcare services, and,
consistent with the triage model, complex cases are handed off to physicians, because they may
fall outside that predetermined scope of service.16
The parallel model lies on the opposite end of the spectrum. Under this model, the scope of the
allied health professional practice is separate, distinct, and, essentially, parallel to the scope of
physician practice.17 These allied health professionals are nonphysician practitioners who
practice independently and offer services that, despite some overlap with physician care, are
largely outside the scope of physician practices.18 Although allied health professionals (as
defined in this Guide) and physicians sometimes may compete due to shared patient populations
and practice objectives, the specific services they provide typically have distinct differences.
Table I-1A: Healthcare Professional Practices Provider Taxonomies
Organization: Human Resources and Services Administration
Classification System: A six-digit hierarchal structure resulting in four levels of aggregation (categories): Category
1=Major Group, Category 2=Minor Group, Category 3=Broad Occupation, Category 4=Detailed Occupation.
Category

Healthcare
Practitioners
and Technical
Occupations

Definition

Subcategories

Major Occupational Group A—
Professional occupations concerns with
the study, application, and/or
administration of medical practices or
theories. Some occupations are
concerned with interpreting, informing,
expressing, or promoting ideas, products,
etc. by written, artistic, sound, or
physical medium. This category also
includes technical occupations, involved
in carrying out technical and
technological functions in health. May
perform research, development, testing,
and related activities. May operate
technical equipment and systems. **,†

Health Diagnosing Occupations
Chiropractors
Dentists
Dentists, General

Prosthodontists

Oral and Maxillofacial
Surgeons

Dentists, All Other Specialties

Orthodontists
Optometrists
Physicians and Surgeons
Podiatrists
Veterinarians
(continued)

15
16

17
18

“Special Issues in Physician Compensation,” in “Physician Compensation Plans: State-of-the-Art Strategies” By Bruce A. Johnson, JD,
MPA and Deborah Walker Keegan, PhD, FACMPE, Englewood, CO: Medical Group Management Association, 2006, p. 193-194.
“Special Issues in Physician Compensation,” in “Physician Compensation Plans: State-of-the-Art Strategies” By Bruce A. Johnson, JD,
MPA and Deborah Walker Keegan, PhD, FACMPE, Englewood CO: Medical Group Management Association, 2006, p. 193-194;
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94-e-95.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94-e-95.
“Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding” By Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Vol. 38, No. 3 (Fall 2009), p. e-94-e-95.
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Category

Definition

Subcategories
Health Assessment and Treating Occupations
Dietitians and Nutritionists
Pharmacists
Physician Assistants
Therapists
Occupational Therapist

Respiratory Therapists

Physical Therapist

Speech-Language Pathologist

Radiation Therapists

Exercise Physiologists

Recreational Therapists

Therapists, All Other

Registered Nurses
Nurse Anesthetists
Nurse Midwives
Nurse Practitioners

Healthcare
Practitioners
and Technical
Occupations

Major Occupational Group A—
Professional occupations concerns with
the study, application, and/or
administration of medical practices or
theories. Some occupations are
concerned with interpreting, informing,
expressing, or promoting ideas, products,
etc. by written, artistic, sound, or
physical medium. This category also
includes technical occupations, involved
in carrying out technical and
technological functions in health. May
perform research, development, testing,
and related activities. May operate
technical equipment and systems. **,†

Miscellaneous Health Diagnosing/Treating Practitioners
Health Technologists and Technicians
Clinical Laboratory Technologists/Technicians
Medical and Clinical
Laboratory Technologists

Medical and Clinical
Laboratory Technicians

Dental Hygienists
Diagnostic Related Technologists and Technicians
Cardiovascular Technologists
and Technicians

Radiologic Technologists

Diagnostic Medical

Magnetic Resonance Imaging
Technologists
Sonographers

Nuclear Medicine Technologists
Emergency Medical Technicians/Paramedics
Health Practitioner Support Technologists/Technicians
Dietetic Technicians

Surgical Technicians

Pharmacy Technicians

Veterinary Technicians

Psychiatric Technicians

Ophthalmic Medical
Technicians

Respiratory Technicians
Licensed Practical and Licensed Vocational Nurses
Medical Records and Health Information Technicians
Opticians, Dispensing
Miscellaneous Health Technologists/Technicians
Orthotists and Prosthetists
Hearing Aid Specialists
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Category

Definition

Subcategories

Healthcare
Practitioners
and Technical
Occupations

Major Occupational Group A—
Professional occupations concerns with
the study, application, and/or
administration of medical practices or
theories. Some occupations are
concerned with interpreting, informing,
expressing, or promoting ideas, products,
etc. by written, artistic, sound, or
physical medium. This category also
includes technical occupations, involved
in carrying out technical and
technological functions in health. May
perform research, development, testing,
and related activities. May operate
technical equipment and systems. **,†

Other Healthcare Practitioners/Technical Occupations
Occupational Health and Safety Specialists/Technicians
Occupational Health and
Safety Specialists

Occupational Health and
Safety Technicians

Miscellaneous Health Practitioners/Technical Workers

Athletic Trainers

Other

Nursing, Psychiatric, and Home Health Aides*
Home Health Aides*

Nursing Assistants*

Psychiatric Aides*

Orderlies*

Occupational Therapy/Physical Therapist Assistants/Aides

Healthcare
Support
Occupations

Major Occupational Group K Occupations concerned with other
healthcare services for children and
adults, and mainly cater to the provision
of support services. **,†

Occupational Therapy
Occupational Therapy
Assistants

Occupational Therapy Aides

Physical Therapy
Physical Therapy Assistants

Physical Therapy Aides

Other Healthcare Support Occupations
Massage Therapists
Miscellaneous Healthcare Support Occupations
Dental Assistants

Medical Equipment Preparers

Medical Assistants
Notes:
* “Chapter 6. Occupation and Industry Classification Systems,” in “Nursing Aides, Home Health Aides, and Related Health Care
Occupations: National and Local Workforce Shortages and Associated Data Needs” U.S. Department of Health and Human Services, Health
Resources and Services Administration, February 2004, http://bhpr.hrsa.gov/healthworkforce/reports/rnhomeaides.pdf (Accessed 2/20/15).
** “2010 Standard Occupational Classification” U.S. Bureau of Labor Statistics, January 2009, p. 16-19.
† “MOG—Level Definitions,” in “Occupational Classification System Manual” U.S. Bureau of Labor Statistics, National Compensation
Survey, http://www.bls.gov/ncs/ocs/ocsm/comMOGADEF.htm#mogaanchor (Accessed 1/27/15).
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Table I-1B: Healthcare Professional Practices Provider Taxonomies
Organization: Centers for Medicare and Medicaid Services
Classification System: Based on System for Billing for Services
Category

Definition

Physician

As stated in Section 1861(r) SSA to
include the professionals listed here

Allied Health
Providers

As stated in 42 USC Section 295p to
include those professionals: "(A) who
[have] received a certificate, an associate’s
degree, a bachelor’s degree, a master’s
degree, a doctoral degree, or
postbaccalaureate training, in a science
relating to health care; (B) who shares in
the responsibility for the delivery of health
care services or related services, including(i) services relating to the identification,
evaluation, and prevention of disease and
disorders; (ii) dietary and nutrition
services; (iii) health promotion services;
(iv) rehabilitation services; or (v) health
systems management services; and (C)
who has not received a degree of doctor of
medicine, a degree of doctor of
osteopathy, a degree of doctor of dentistry
or an equivalent degree, a degree of doctor
of veterinary medicine or an equivalent
degree, a degree of doctor of optometry or
an equivalent degree, a degree of doctor of
podiatric medicine or an equivalent
degree, a degree of bachelor of science in
pharmacy or an equivalent degree, a
degree of doctor of pharmacy or an
equivalent degree, a graduate degree in
public health or an equivalent degree, a
degree of doctor of chiropractic or an
equivalent degree, a graduate degree in
health administration or an equivalent
degree, a doctoral degree in clinical
psychology or an equivalent degree, or a
degree in social work or an equivalent
degree or a degree in counseling or an
equivalent degree.

Subcategories
N/A
MDs*
Doctor of Optometry*
DOs*
Chiropractor*
Doctor of Dental Surgery/
Interns and Residents*
Dental Medicine*
Doctor of Podiatric Medicine*
Mid-Level Provider—also known as: Non-Physician
Practitioner/Physician Extender—Health professionals who may deliver
covered Medicare services if the services are incident to a physician’s
service or if there is specific authorization in the law
Physician Assistant/Advanced Practice Nurses
Physician Assistant*,**,†
Certified Registered Nurse
Anesthetists*,**,†
Nurse Practitioners*,**,†
Certified Nurse Midwives*,**,†
Other
Qualified Clinical
Respiratory Therapy
Psychologists*,**,†
Workers††,‡,‡‡,§
Speech
Clinical Social Workers*,**,†
Pathologist/Audiologists††,‡,‡‡,§
Dieticians/Dietetic
Dietetic Assistants††,‡,‡‡,§
Technicians*,**,†,††,‡,‡‡,§
Dental Hygienists/Assts/Lab
Genetic Assistants††,‡,‡‡,§
Techs††,‡,‡‡,§
Operating Room
EMT/Paramedic††,‡,‡‡,§
Technicians††,‡,‡‡,§
Health Information
Ophthalmic/Optometric Medical
Admin/Tech††,‡,‡‡,§
Assistants††,‡,‡‡,§
Occupational Therapists††,‡,‡‡,§
Medical Transcriptionists††,‡,‡‡,§
Orthotists and
Vocational Rehab
Prosthetists††,‡,‡‡,§
Counselors††,‡,‡‡,§
Other Rehabilitation
Physical Therapists††,‡,‡‡,§
Workers††,‡,‡‡,§

Radiologic Service
Workers††,‡,‡‡,§

Other Social and Mental Health
Workers††,‡,‡‡,§

Notes:
* “Physicians” in “The Public Health and Welfare” 42 U.S.C. § 1395x(r).
** “Ratio of Physician to Physician Extenders (Resolution 303, I-97)” By Kay K. Hanley, MD, December 1998, CMS Report 10-1-98.
† “‘Incident to’ Services” MLN Matters, SE0441.
†† “Definitions, Federal Health Insurance for the Aged and Disabled, Center for Medicare and Medicaid Services, Department of Health and
Human Services” 42 CFR § 405.400.
‡ “Chapter 6A: Definitions, General Provisions, Health Professions Education, Public Health Service, The Public Health and Welfare” 42
U.S.C. § 295.
‡‡ “Civil Remedies Decision CR1961” Departmental Appeals Board, Department of Health and Human Services, June 16, 2009, p. 3.
§ “Interdisciplinary, Community-Based Linkages, Title VII, Part D, Public Health Service Act” Advisory Committee on Interdisciplinary,
Community-Based Linkages, 2006, Fifth Annual Report to the Secretary of the U.S. Department of Health and Human Services and to the
Congress.
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Table I-1C: Healthcare Professional Practices Provider Taxonomies
Organization: American Medical Association
Classification System: As utilized in the Health Care Careers Directory 2012-2013
Category

Physician

Optometry

Complementary
and Alternative
Medicine
Dentistry

Pharmacy

Podiatry

Veterinary
Medicine

Definition

Subcategories

There are two types of
physicians: MD—Doctor of
Medicine—and DO-Doctor of
Osteopathic medicine. Both MDs
and DOs may legally use all
accepted methods of treatment,
including drugs and surgery.
Examine, diagnose, treat, and
manage diseases, injuries, and
disorders of the visual system,
the eye, and associated structures
as well as identify systemic
conditions affecting the eye
A group of diverse medical and
health care systems, practices,
and products that are not
presently considered to be part of
conventional medicine
Diagnose, prevent, and treat
problems with teeth or mouth
tissue
Provide information to patients
about medications and their use
and distribute drugs prescribed
by physicians and other health
practitioners
“Specialize in diagnosing and
treating disorders, diseases, and
injuries of the foot, ankle, and
lower leg”
Provide healthcare professional
and support services for the care
of pets, livestock, and zoo,
sporting, and laboratory animals

N/A

MDs*

DOs*

Optometrist*,**

Chiropractic*,**

Dentist*,**

Pharmacist*,**

N/A
Podiatrist*,**
N/A
Veterinarian*,**
Registered Nurses*,**

Licensed Vocational
Nurses**

Licensed Practical Nurses**

Nursing

Mid-Level Provider - also known as: Non-Physician Practitioner/Physician
Extender - Health professionals who may deliver covered Medicare services
if the services are incident to a physician’s service or if there is specific
authorization in the law
Advanced Practice Nurses
Nurse Practitioners†,††,‡

Psychology

Psychologists in health service
provider fields provide mental
health care in hospitals, clinics,
schools, or private settings.

Certified Registered Nurse
Anesthetists†,††,‡

Certified Nurse
Midwives†,††,‡

Clinical Psychologists
Clinical Psychologists†,††,‡
(continued)
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Category

Definition

Subcategories
Physician Assistant
Physician Assistant†,††,‡

Physician Assistant†,††,‡

Clinical Social Workers†,††,‡

Clinical Social Workers†,††,‡
Dietetics

Dietitian/Nutritionist*,**

Dietitian/Nutritionist*,**

Dentistry and Related Fields
Dentist*,**

Dentist*,**

Dental Assistant*,**

Dental Assistant*,**

Communication Sciences
Speech-Language
Pathologist*,**

Audiologist*,**

Complementary and Alternative Medicine
Massage Therapist*,**

Allied Health
Professional

Participate in the delivery of
health care, diagnostic, and
rehabilitation services,
therapeutic treatments, or related
services,” and excludes “the
MODVOPP professions:
medicine (allopathic),
osteopathic medicine, dentistry,
veterinary medicine, optometry,
podiatry, and pharmacy—as well
as chiropractic, clinical
psychology, any level of nursing
education, and graduate degrees
in public health or health
administration.

Counseling
Counselor*,**

Rehabilitation
Counselor*,**

Genetic Counselor*,**
Expressive/Creative Art Therapies
Art Therapist*,**

Music Therapist*,**

Dance/Movement Therapist*,**
Health Information and Communication
Cancer Registrar*,**

Medical Coder*,**

Health Information Administrator*,**

Medical Librarian*,**

Health Information Technician*,**

Medical
Transcriptionist*,**

Laboratory Science
Blood Bank Technology-Specialist*,**

Clinical Assistant*,**
Clinical Laboratory Scientist/Medical

Clinical Laboratory
Technician/
Medical Laboratory
Technician*,**
Cytogenetic
Technologist*,**
Cytotechnologist*,**

Technologist*,**
Medical Imaging
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Diagnostic Molecular Sonographer*,**

Magnetic Resonance
Technologist*,**

Histotechnician*,**

Medical Dosimetrist*,**

Histotechnologist*,**

Nuclear Medicine
Technologist*,**

Pathologists’ Assistant*,**

Radiation Therapist*,**

Introduction

Category

Definition

Subcategories
Phlebotomist*,**

Radiographer*,**

Diagnostic Medical Sonographer*,**

Registered Radiologist
Assistant*,**

Vision-Related Professions
Ophthalmic Assistant/Technician/

Orthoptist*,**

Technologist*,**
Ophthalmic Dispensing Optician*,**
Optometrist*,**

Teacher of the Visually
Impaired*,**
Vision Rehabilitation
Therapist*,**

Orientation and Mobility Specialist*,**
Therapy and Rehabilitation

Allied Health
Professionals

Participate in the delivery of
health care, diagnostic, and
rehabilitation services,
therapeutic treatments, or related
services,” and excludes “the
MODVOPP professions:
medicine (allopathic),
osteopathic medicine, dentistry,
veterinary medicine, optometry,
podiatry, and pharmacy—as well
as chiropractic, clinical
psychology, any level of nursing
education, and graduate degrees
in public health or health
administration.

Occupational Therapist*,**
Occupational Therapy Assistant*,**

Physical Therapist
Assistant*,**
Therapeutic Recreation
Specialist*,**

Physical Therapist*,**
Other
Anesthesiologist Assistant*,**
Anesthesia Technologist/Technician*,**
Athletic Trainer*,**
Cardiovascular Technician/Technologist*,**
Electroneurodiagnostic Technologist*,**
Emergency Medical TechnicianParamedic*,**
Exercise Science (Personal Fitness Trainer,
Exercise Physiologist, and Exercise Science
Professional)*,**
Home Health, Personal Care, and
Psychiatric Aides*,**
Kinesiotherapist*,**

Nursing Aides, Orderlies,
Attendants*,**
Occupational Health and
Safety Technician*,**
Orthotists and
Prosthetists*,**
Orthotics and Prosthetics
Technicians*,**
Perfusionist*,**
Pharmacy Technician*,**
Polysomnographic
Technologist*,**
Psychiatric
Aides/Technicians*,**

Medical Assistant*,**

Respiratory Therapist*,**
Respiratory Therapy
Technicians*,**

Medical Equipment Preparer*,**

Surgical Assistant*,**

Medical Illustrator*,**

Surgical Technologist*,**

Notes:
* “Health Care Careers Directory 2012-2013” American Medical Association, 2012, p. iii-iv.
** “Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice” By Fred G. DoniniLenhoff, MA, Journal of Allied Health, Vo. 37, No 1 (Spring 2008), p. 46-49.
† “Physicians” in “The Public Health and Welfare” 42 U.S.C. § 1395x(r).
†† “Ratio of Physician to Physician Extenders (Resolution 303, I-97)” By Kay K. Hanley, MD, December 1998, CMS Report 10-I-98.
‡ “‘Incident to’ Services” Centers for Medicare & Medicaid Services, MLN Matters, SE0441.
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Table I-1D: Healthcare Professional Practices Provider Taxonomies
Organization: Health Capital Consultants
Classification System: N/A
Category

Definition

Physicians

Doctors of allopathic or osteopathic
medicine. Both allopathic and
osteopathic physicians may specialize in
many of the same areas, though the
process required to achieve specialization
certifications occasionally differs
between the two forms of medicine.

Allied Health Professionals

Non-physician providers of health
services who provide primary healthcare
services. Allied health professionals may
work with physicians, mid-level
providers, paraprofessionals and
technicians, but they are professionally
licensed to work autonomously in the
provision of services.

Subcategories
N/A

MDs

DOs

N/A
Dentists

Psychologists

Optometrists

Podiatrists

Chiropractors
Clinical Service Providers

Midlevel Providers

Non-physician providers who may or
may not provide healthcare services
independently of a superior licensed
provider. Depending on state licensing
criteria, mid-level provides (e.g. nurse
practitioners, physicians’ assistants,
dental hygienists) may work
independently in the provision of
services, or may need to be supervised by
a licensed physician or allied health
professional.

Therapists

Occupational

Physical

Audiologists/Speech
Physician Assistants
Registered Nurses

Registered Nurses

Nurse Practitioners

APRNS

Nurse Midwives

Certified Registered
Nurse Anesthetists

Dieticians & Nutritionists

Technical Service Providers
Dental Hygienists

Opticians

Dental Assistants

Dental Assistants
Assistants

Technicians &
Paraprofessionals

Non-physician providers who may never
provide healthcare services
independently of a supervising licensed
provider. This category of provider is
divided between licensed and unlicensed
paraprofessionals.

Social and Human
Service Assistants
Anesthesiologists
Assistants
Occupational Therapist
Assistants

Dental Assistants
Medical Assistants
Aides

Personal Care Aides

Psychiatric Aides

Home Health Aides

Physical Therapist Aides

Nursing Aides,
Orderlies,

Pharmacy Aides

Attendants
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Physical Therapist
Assistants
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Category

Definition

Subcategories
Therapists
Radiation Therapists

Respiratory Therapists

Technologists
Medical and Clinical

Nuclear Medicine

Laboratory Technologists
Cardiovascular

Surgical

Radiologic Technicians

Technicians &
Paraprofessionals

Non-physician providers who may never
provide healthcare services
independently of a supervising licensed
provider. This category of provider is
divided between licensed and unlicensed
paraprofessionals.

Cardiovascular

Psychiatric

Medical and Clinical
Laboratory

Respiratory Therapy

Radiologic
Emergency Medical
Dietetic

Medical Records and
Health Information
Occupational Health and
Safety
Orthotics and Prosthetics

Pharmacy
Nurses
Licensed Vocational
Nurses

Licensed Practical Nurses
Other

Medical Dosimetrist

Medical Equipment
Preparers

Diagnostic Medical

Medical Transcriptionists

Sonographers

Athletic Trainers

Whole Medical Systems
Eastern Whole Medical Systems
Traditional Chinese
Medicine

Ayurvedic Medicine

Western Whole Medical Systems
Homeopathic

Alternative Medicine
Providers

Providers who may or may not be
physicians, but who practice forms of
therapy and treatment outside the
mainstream practice of medicine, e.g.
homeopathic medicine. Alternative
medicine practitioners may provide
primary or secondary care, and are
generally licensed to work independently
of supervision by another licensed
provider.

Naturopathic

Mind-Body Medicine
Aromatherapy

Mental Healing

Cognitive Behavioral
Theory

Expressive/Creative Arts
Therapy

Meditation & Prayer
Biologically Based Practices
Dietary Supplements

Herbal Remedies

Manipulative & Body-Based Practices
Massage Therapy

Chiropractic Medicine

Energy Medicine
Biofield Therapy

Reiki

BioelectromagneticBased Therapy

Therapeutic Touch
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Table I-2:

Healthcare Professional Practices Provider Taxonomies Comparison Chart

Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Chiropractors

Allied Health

Health Diagnosing
Occupations

Physician

Complementary and
Alternative Medicine

Dentists

Allied Health

Health Diagnosing
Occupations

Physician

Dentistry and Related
Fields

Psychologists

Allied Health

Social Scientists and Urban
Planners

Mid-Level Provider*

Mid-Level Provider*

Podiatrists

Allied Health

Health Diagnosing
Occupations

Physician

Podiatrists

Optometrists

Allied Health

Health Diagnosing
Occupations

Physician

Optometry

Aromatherapy

Alternative
Medicine

Auxiliary personnel—not
covered for therapy services

Allied Health

Ayuredic
Medicine

Alternative
Medicine

Auxiliary personnel—not
covered for therapy services

Allied Health

Bioelectromagnet
ic-Based Therapy

Alternative
Medicine

Complementary and
Alternative Medicine

Allied Health

Biofield Therapy

Alternative
Medicine

Complementary and
Alternative Medicine

Allied Health

Cognitive
Behavioral
Theory

Alternative
Medicine

Auxiliary personnel—not
covered for therapy services

Allied Health

Dietary
Supplements

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health

Expressive
Creative Arts
Therapy

Alternative
Medicine

Complementary and
Alternative Medicine

Allied Health

Herbal Remedies

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health

Homeopathic

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health

Massage Therapy

Alternative
Medicine

Auxiliary personnel—not
covered for therapy services

Allied Health

Meditation &
Prayer

Alternative
Medicine

Complementary and
Alternative Medicine

Allied Health

Mental Healing

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health

Naturopathic

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health

Reiki

Alternative
Medicine

Auxiliary personnel—not
covered for medical services

Allied Health
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Practitioners
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Practitioners
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Profession

Health Capital
Consultants

Therapeutic
Touch

Alternative
Medicine

Traditional
Chinese Medicine

Alternative
Medicine

Prosthetists &
Orthotists

Mid-Level

Audiologists/
SpeechLanguage
Pathologists

Mid-Level

BLS1, 2, 3
Other Health
Diagnosing/Treating
Practitioners
Other Health
Diagnosing/Treating
Practitioners

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Complementary and
Alternative Medicine

Allied Health

Auxiliary personnel—not
covered for medical services

Allied Health

Health Technologists and

Allied Health—Professionals/

Technicians

Qualified Auxiliary Personnel

Health Assessment and
Treating Occupations

Allied Health

Allied Health—Professionals/
Qualified Auxiliary Therapy

Allied Health

Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel

Dental Hygienists

Mid-Level

Health Technologists and
Technicians

Dieticians &
Nutritionists

Mid-Level

Health Assessment and
Treating Occupations

Certified
Registered Nurse
Anesthetists

Mid-Level

Health Assessment and
Treating Occupations

Mid-Level Provider16

Mid-Level Provider16

Nurse Midwives

Mid-Level

Health Assessment and
Treating Occupations
Health Assessment and
Treating Occupations
Health Assessment and
Treating Occupations

Mid-Level Provider16

Mid-Level Provider16

Mid-Level Provider16

Mid-Level Provider16

Mid-Level Provider16

Mid-Level Provider16

Nurse
Practitioners
Physician
Assistants

Mid-Level
Mid-Level

Allied Health
Allied Health

Registered Nurses

Mid-Level

Health Assessment and
Treating Occupations

Allied Health—
Professionals/Qualified
Auxiliary Personnel

Nursing

Pharmacists

Mid-Level

Health Assessment and
Treating Occupations

Pharmacists

Pharmacy

Occupational
Therapists

Mid-Level

Health Assessment and
Treating Occupations

Physical
Therapists

Mid-Level

Health Assessment and
Treating Occupations

Opticians

Mid-Level

Health Assessment and
Treating Occupations

DOs

Physician

MDs

Physician

Anesthesiologists
Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Athletic Trainers

Technicians and
Paraprofessionals

Other Healthcare
Practitioners/Technical
Occupations

Health Diagnosing
Occupations
Health Diagnosing
Occupations

Allied Health—
Professionals/Qualified
Auxiliary Therapy Personnel
Allied Health—
Professionals/Qualified
Auxiliary Therapy Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health
Allied Health
Allied Health

Physician

Physician

Physician

Physician

Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—Auxiliary
Personnel—not covered for
therapy services

Allied Health
Allied Health
(continued)
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Profession

Health Capital
Consultants

BLS1, 2, 3

Cardiovascular
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Cardiovascular
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Emergency
Medical
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Home Health
Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and
Home Health Aides

Medical
Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Technicians and
Paraprofessionals

Nursing, Psychiatric, and
Home Health Aides

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Personal Care
Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and
Home Health Aides

Psychiatric Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and
Home Health Aides

Psychiatric
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Respiratory
Therapists

Technicians and
Paraprofessionals

Health Assessment and
Treating Occupations

Respiratory
Therapy
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Surgical
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Social and
Human Service
Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Dental Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Dietetic
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Medical
Equipment
Preparers
Nursing Aides,
Orderlies,
Attendants
Occupational
Health and Safety
Technicians
Orthotics and
Prosthetics
Technicians
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CMS4, 5, 6, 7, 8, 9, 10, 11, 12
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
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Allied Health—
Professionals/Qualified
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Allied Health—
Professionals/Qualified
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Allied Health—
Professionals/Qualified
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Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Clinical Social Workers are
Mid-Level Providers*; others
are Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel

AMA11, 12, 13, 14, 15

Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health

Allied Health

Allied Health
Allied Health
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Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Medical Records
and Health
Information
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health

Medical
Transcriptionists

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Medical
Dosimetrist

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Nuclear Medicine
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Radiation
Therapists

Technicians and
Paraprofessionals

Health Assessment and
Treating Occupations

Radiologic
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Radiologic
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Licensed
Practical Nurses

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Licensed
Vocational
Nurses

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Pharmacy Aides

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Pharmacy
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Occupational
Therapist
Assistants

Technicians and
Paraprofessionals

Physical
Therapist Aides

Technicians and
Paraprofessionals

Physical
Therapist
Assistants

Technicians and
Paraprofessionals

Medical and
Clinical
Laboratory
Technicians
Medical and
Clinical
Laboratory
Technologists
Diagnostic
Medical
Sonographers

Occupational
Therapy/Physical Therapist
Assistants/Aides
Occupational
Therapy/Physical Therapist
Assistants/Aids
Occupational
Therapy/Physical Therapist
Assistants/Aids

Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel
Allied Health—
Professionals/Qualified
Auxiliary Personnel

Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Allied Health
Nursing
Nursing
Pharmacy
Pharmacy
Allied Health
Allied Health
Allied Health
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16 Also known as: Non-Physician Practitioner/Physician Extender.

This Guide distinguishes among five general types of health professionals. The trifurcation of
nonphysician practitioners in mainstream medicine, as described previously, serves as the
rationale behind allied health professionals, mid-level providers, and technicians and
paraprofessionals, as they are defined herein. In addition to the physician and nonphysician
professionals who practice conventional medicine, a class of professionals exists that provides
complementary and alternative medical services that, to date, is treated as a parallel (sometimes
intertwined) but unconventional subset of the healthcare workforce. In brief, the five
taxonomical categories of professional providers, as they are discussed in this Guide, are defined
as:
(1) Physicians—Doctors of allopathic or osteopathic medicine. Both allopathic and
osteopathic physicians may specialize in many of the same areas, though the process
required to achieve specialization certifications occasionally differs between the two
forms of medicine.
(2) Allied health professionals—Nonphysician providers of health services who provide
primary healthcare services. Allied health professionals may work with physicians,
mid-level providers, and paraprofessionals and technicians, but they are
professionally licensed to work autonomously in the provision of services. This Guide
discusses five distinct allied health professions: dentists, optometrists, chiropractors,
psychologists, and podiatrists.
(3) Mid-level providers—Nonphysician providers who may or may not provide
healthcare services independently of a superior licensed provider but are, by in large,
moving into increasingly autonomous practice types. These professionals typically
provide primary care services in lieu of physicians. Depending on state licensing
criteria, mid-level providers (such as nurse practitioners, physicians’ assistants, and
dental hygienists) may work independently in the provision of services. Mid-level
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Introduction

providers are further divided between clinical service providers and technical service
providers.
(4) Technicians and paraprofessionals—Nonphysician providers who may never provide
healthcare services independently of a supervising licensed provider. These
individuals either serve to alleviate a manpower deficit or to contribute to the
technological sophistication, efficiency, and quality of physician services; in either
case, their scope of practice is contingent upon the scope of their physician’s practice
and nonexistent otherwise. On the basis of these two types of physician extenders,
this category of provider is divided between licensed and unlicensed technicians and
paraprofessionals.
(5) Alternative medicine practitioners—Providers who may or may not be physicians but
who practice forms of therapy and treatment outside the mainstream practice of
medicine, for example, homeopathic medicine. Alternative medicine practitioners
may provide primary or secondary care, and they generally are licensed to work
independently of supervision by another licensed provider.
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Chapter 1

Historical Development

The history of medicine is, in fact, the history of
humanity itself, with its ups and downs, its brave
aspirations after truth and finality, its pathetic
failures. The subject may be treated variously as
a pageant, an array of books, a procession of
characters, a succession of theories, an
exposition of human ineptitudes, or as the very
bone and marrow of cultural history. As Matthew
Arnold said of the Act Sanctorum, ‘All human life
is there.’
Fielding Garrison, 1913

KEY TERMS

Allopathic Medicine
Chiropractic
Corpus
Customary Prevailing and Reasonable
Diagnostic Related Groups
Eclectic Medicine
Health Maintenance Organization
Homeopathic Medicine
Industrial Hygiene
Legal Medicine
Medicaid

Medicare
Medicare Part A
Medicare Part B
Naturopathic Medicine
Osteopathic
Pasteurization
Physiotherapy
Preferred Provider Organization (PPO)
Prospective Payment System
Public Health
Resource Based Relative Value System
Studium Generale
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Key Concept

Definition

Citation

Mentioned
on Page #

AssyroBabylonian
Medicine

Established in 4 BC by the people of
southern Mesopotamia; regarded
medicine as an abstraction to be treated
with priestly reverence.

28

The Rod and
Serpent in
AssyroBabylonian
Medicine

“Chapter III: Antiquity,” in “The Greatest
Benefit to Mankind: A Medical History of
Humanity” By Roy Porter, New York: NY:
HarperCollins Publishers Ltd., 1997, p. 46–
47. “A History of Medicine” By Arturo
Castiglioni, New York, NY: Alfred A.
Knopf, Inc., 1947, p. 32.

First seen as the symbol attributed to the
Babylonian lord of physicians, Ninazu,
and his son. The serpent represented the
healing god, Sachan.

“The Rod and Serpent of Asklepios. Symbol
of Medicine” By J. Schouten, London:
Elsevier, 1967, p. ix, 260.

28

“Chapter 3: The Reawakening,” in “Doctors:
The Illustrated History of Medical Pioneers”
By Sherwin B. Nuland, New York, NY:
Black Dog & Leventhal Publishers, Inc.,
2008, p. 71; “The Western Medical Tradition
800 BC to AD 1800” By Lawrence I. Conrad
et al., Cambridge University Press, 1995,
p. 225.
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“The Rod and Serpent of Asklepios. Symbol
of Medicine” By J. Schouten, London:
Elsevier, 1967, p. ix, 260.

29

“A History of Medicine,” by Arturo
Castiglioni, Alfred A. Knopf, Inc., 1947,
p. 325.
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“The Rod and Serpent of Asklepios. Symbol
of Medicine,” by J. Schouten. (Pp. 260+ix;
illustrated. 65s.) London: Elsevier, 1967.
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“Chapter IV: Medicine and Faith,” in “The
Greatest Benefit to Mankind: A Medical
History of Humanity” By Roy Porter, New
York: NY: HarperCollins Publishers Ltd.,
1997, p. 98–99; “A History of Medicine,” by
Arturo Castiglioni, Alfred A. Knopf, Inc.,
1947, p. 325–329.
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“The Rod and Serpent of Asklepios. Symbol
of Medicine” By J. Schouten, London:
Elsevier, 1967, p. ix, 260.
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“A Guide to Consulting Services for
Emerging Healthcare Organizations” By
Robert James Cimasi, CBI, CBC, New York,
NY: John Wiley and Sons, Inc., 1999,
p. 24–25.
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Galenic
Medicine

The Rod and
Serpent in
Galenic
Medicine
Types of
Roman
Universities
The Rod and
Serpent in
Roman
Civilization

GrecoArabian
Medicine

The Rod and
Serpent
Today

Reason for a
ResourceBased
Relative
Value Scale
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Based on the findings of Claudius Galen
and his followers. Pioneered the fields
of anatomy and physiology, methods of
animal dissection, and an understanding
of the circulation of blood. Although
this generation of medicine was
significant to developments in scientific
inquiry, false assumptions about animalto-human anatomic translation and
hematology served in the medical
world’s disfavor as time progressed.
Reappeared in depictions of the Greek
god of healing, Asklepios, in which he
is seen holding a staff with a snake
coiled around it.
(1) community-funded, (2) state-funded,
and (3) ecclesiastically funded.
Reappeared in depictions of the Roman
god of healing, Asclepius, in which he
is seen holding a staff with a snake
coiled around it.
The solution to shortcomings of the
medical education of the Middle Ages;
involved incorporation of Arabian
medical texts, as introduced by scholars
and physicians who infused Arabian
medicine, with the scholarship of
philosophy, and attempted to
compromise their differences.
Used as the modern symbol for
medicine.
Was intended to bring medical practice
more in line with a prospective payment
system in which payments are made
based on set fees for types of procedures
or diagnosis. Medicare payments are
based on the relative value assigned to
each procedure’s work, practice
expense, and malpractice costs with
payment adjusted by a geographic and a
universal conversion factor. Every
physician uses the same payment
schedule under the Medicare program.

Chapter 1: Historical Development

OVERVIEW
Modern medicine is the product of continuous (if sometimes sporadic) advances in scientific,
sociopolitical, and philosophic thought throughout many centuries. Paul Starr1 addresses this
evolution of medical thought and practice in his book, The Social Transformation of American
Medicine, examining “first, the rise of professional sovereignty; and second, the transformation
of medicine into an industry and the growing, though still unsettled, role of corporations and the
state.”2 This chapter describes the chronological progression of medicine in accordance with this
bimodal transformation, specifically, the centuries of progress in healthcare practitioner and
professional practice credibility.

ORIGINS OF MEDICINE
The original concept of the practice of medicine derived from the concern for human pain. From
this source, a sequence of facts, ideas, and discoveries resulted in the development and evolution
of medical thought, knowledge, study, and practice.3 Without an understanding of the basic
origins and principles of medicine, one can neither understand the modern practice of medicine
nor anticipate developments related to healthcare professional practice.

Because it deals with the vital interests of both individuals and societies—
with life and death, and with so much that matters in between—medicine
has long had an unusually complex and intimate relationship to social and
cultural developments at large . . . In other words, medical history involves
social and economic as well as biologic content and presents one of the
central themes in human experience. After all, what is more basic in the life
of any people than life itself?
Richard Harrison Shryock, 1966
The original concept of medicine derived from the concern for human pain
Arturo Castiglioni, 1947

1
2
3

Paul Starr is a reputed scholar of Sociology and Public Affairs, and known for his writings on the development of American medicine.
“The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books Inc., 1982, p. ix.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 3, 12.

27

Adviser's Guide to Healthcare

MEDICINE AND RELIGION AND ASTROLOGY
The Mediterranean region gave rise to civilizations that heavily influenced the advance of human
knowledge, innovation, and society.4 The region endured five thousand years of war, politics,
development, and demise, fostering not only the origin and intensive development of art and
science, but also the birth of monotheistic religion.5 Therefore, the evolution of medicine is
inherently linked to the civilizations that rose and fell in the Fertile Crescent, as well as the
religions and spiritualties on which these societies relied.6 In 4 BC, the people of southern
Mesopotamia attempted to establish a systematic medical concept. The outcome of their effort
became known as Assyro-Babylonian Medicine.7
For the Sumerians, Babylonians, and Assyrians, medicine was a highly revered abstraction
treated with magical and priestly reverence.8 These civilizations intently studied astronomy, and
the assumed relationships between physiology and celestial findings led to the development of
medical concepts.9 As astronomy evolved to include stories, divinities, and beliefs, the concepts
developed into religious systems.10 The reliance on divine healing became a concept of medical
practice: the Assyrians relied on the healing god, Nabu, and the Babylonians turned to the lord of
magicians, Marduk, and the god of medicine, Ea, to sustain and restore health.11 Further, the
Babylonian caste of physicians was led by Ninurta, a god who served as their chief. Ninazu, the
lord of physicians, and his son, Ningischzida, are known most notably for their symbol, the rod
and serpent (the serpent representing the healing god Sachan).12
Sumerian, Assyrian, and Babylonian civilizations intently studied astronomy, and medical concepts developed
as a result of the assumed relationships between physiology and celestial findings.
Arturo Castiglioni, Inc., 1947

4
5
6
7
8
9
10
11
12
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“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 31-32; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 44-45.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 31-32.
“The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997,
p. 46-47.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 32; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 46-47.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 31-44.
Ibid., p. 33.
Ibid., p. 33-41.
Ibid., p. 38.
Ibid.
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Askleopios (left) and Caduceus (right).

The Greek god of healing, Asklepios, was also depicted holding a staff with a snake coiled
around it, similar to the symbol attributed to the Babylonian gods Ninazu and Ningischzida.13
(Aesculapios, his Roman counterpart, carried a rod as well). This single-serpent symbol image in
Greek and Roman cultures was attributed to their healing and medical deities, and it serves as a
modern symbol of medicine in most countries. Note, however, that the United States uses both
the single-serpent symbol, Asklepian, and the double-serpent symbol, Caduceus, to represent
medicine (see preceding photo).14
The people of Israel, dating back to 1500 BC, recognized the practice of medical healing as
attributed to “the one God.”15 This idea was reaffirmed through the traditions of Christianity,
which emerged from a disease-plagued society.16 Jesus Christ’s depiction as a healer translated
not only into spiritual salvation, but also into his divine ability to miraculously heal physical
ailments.17 Christianity centers on “a different valuation of human life, a fraternal concept of
equality and charity which imposed on all the faithful the most severe sacrifices in order to
lessen the suffering of others.”18 This concept influenced attitudes toward medicine in areas
where people were simultaneously adopting religion and fighting widespread disease.
Intellectuals collaborated almost exclusively on religious issues with underlying ethical
implications, and medicine was commonly among the most pressing issues discussed.19 Despite

13
14

15
16
17
18
19

“Rod and Serpent” By Edwin Clarke, Book Review of “The Rod and Serpent of Asklepios. Symbol of Medicine” British Medical Journal,
Vol. 3, No. 5561 (August 5, 1967), p. 358.
“The Symbol of Modern Medicine: Why One Snake Is More Than Two” By Robert A. Wilcox and Emma M. Whitham, Annals of
Internal Medicine, Vol. 138, No. 8 (April 15, 2003), p. 673-674; History of the American Medical Writer’s Association Part 5” By
Cynthia Haggard, Clarifying, April 8, 2009, http://clarifying.wordpress.com/2009/04/08/history-of-the-american-medical-writersassociation-part-5/ (Accessed 2/17/10); “Physician Payment Reform, a California Lesson?” By Steve Sweetman, Healthcare Updates
from Steve Sweetman: Regional Contracts Director for The Scooter Store, September 15, 2009, http://stevesweetman.wordpress.com/
2009/09/15/physician-payment-reform-a-california-lesson/ (Accessed 2/17/10).
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 32, 72.
Ibid., p. 73-77; “The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins
Publishers Ltd., 1997, p. 85-87.
“The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997,
p. 85-87; “The Western Medical Tradition 800 BC to AD 1800” By Lawrence I. Conrad, et al., Cambridge University Press, 1995,
p. 73-74.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 245-246.
Ibid., p. 246.
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stages of resistance, the church ultimately acknowledged the importance of medicine, namely
when it recognized Claudius Galen (see Galenic Medicine) as a canonical authority.20
Table 1-1 summarizes key early religious figures, places, and medical concepts.
Table 1-1: Early Medical Figures, Places, and Concepts
Name

Deities and Religious Figures*,**,†
Location

Claim to Fame

Nabu
Marduk
Ea
Ninurta

Mesopotamia
Mesopotamia
Mesopotamia
Mesopotamia

Ninazu

Mesopotamia

Ningischzida

Mesopotamia

Askleopios
Aesculapios
Buddha (Siddhartha
Gautama)

Greece
Rome, Italy

Assyrian god of healing
Babylonian lord of magicians
Babylonian god of medicine
Babylonian god who led the caste of physicians
Babylonian lord of the physicians, represented by rod
and serpent symbol
Son of Ninazu, also represented by rod and serpent
symbol
Greek god of healing
Roman god of healing

Kapilavastu, Nepal

A spiritual leader and the founder of Buddhism

Jesus Christ

Nazareth, Israel

Son of God, thought to have a divine ability to heal
physical ailments

Fertile Crescent

Western Asia, including the fertile
regions of present-day Iraq and
Syria

Places§

Name
Rod and Serpent
Asklepian
Caduceus
Vedas
Ayurvedic Sages
Palatine Archiaters
*
**
†
§
§§
‡

Medicine rooted in both religious and
empirical treatments evolved from the Mesopotamian
civilization

Medical Concepts and Symbols*,§§,‡
Description
Representation of the healing god Sachan in Babylonia
The staff of Asklepios around which a serpent or serpents are
wrapped to symbolize medicine
Double serpent winding around a staff; a symbol for medicine
A collection of doctrinal Ayurvedic medical texts
Educated by the medical deity prior to transcription of the Vedas
Court physicians

“A History of Medicine” By Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“Rod and Serpent” By Edwin Clarke, Book Review of “The Rod and Serpent of Asklepios. Symbol of Medicine” By J. Schouten. (p. 260+ix;
illustrated. 65s.) London: Elsevier, 1967, in the British Medical Journal, Vol. 3, No. 5561 (August 5, 1967).
“The Western Medical Tradition 800 BC to AD 1800” By Lawrence I. Conrad, et al., Cambridge University Press, 1995.
“The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997.
“The Symbol of Modern Medicine: Why One Snake Is More Than Two” By Robert A. Wilcox and Emma M. Whitham, Annals of Internal Medicine,
Vol. 138, No. 8 (April 15, 2003).
“A History of Medicine” By Louis N. Magner, Marcel Dekker, Inc., 1992.

PHILOSOPHY AND SCIENCE OF MEDICINE
Following from ancient tradition, religion shaped the way early Greeks perceived medicine.21
The dawn of Greek philosophy influenced the origins of a much more scientific approach to
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medicine, spurring a pursuit for cures through “critical thought based on observation and
experience.”22 Philosophers of both Western (for example, Thales of Miletus, Plato, Aristotle,
Anaximander, and Anaximenes) and Eastern (for example, Zoroaster, Confucius, Buddha, and
Pythagoras) origins contributed to a mathematical, cosmic, and physiological concept of nature
and the biologic system.23
Ancient philosophers, including Thales of Miletus, Plato, Aristotle, Anaximander, Anaximenes, Zoroaster,
Confucius, Buddha, and Pythagoras, contributed to a mathematical, cosmic, and physiological concept of
nature and the biologic system.
Arturo Castiglioni, 1947

Similar to their Western counterparts, the people of the Orient viewed medicine as inherently
intertwined in religious tradition. Buddhism and Hinduism were instrumental to ancient Chinese
and Indian medicine.24 Although both Eastern and Western medical traditions stemmed from the
similar religious origins and progressed into parallel eras of proliferative philosophy, they diverged
as a result of the differing roles that religion would play in the centuries that followed. Hinduism
has a profound impact on Indian medicine (known as Ayurvedic Medicine), as does Buddhism on
traditional Chinese medicine (see Chapter 11 of Consulting Services).25 In fact, it is believed that
the Vedas, a collection of doctrinal Ayurvedic medical texts, is inspired by the teachings of the
Hindu divinity Dhanvantari.26 According to Indian tradition, the medical deity transcribed the
Vedas only after educating many Ayurvedic sages.27 Unlike Eastern medicine, and despite
centuries of ecclesiastic resistance, philosophic (and later, scientific) foundations for Western
medicine formed, solidified, and, over time, replaced religion as drivers of medical practice.
Table 1-2 outlines the key philosophers and locations in the history of early medicine.
Table 1-2: Early Medical Figures, Places, and Concepts
Name

Birth/Death

Location

Claim to Fame

Eastern Philosophers*,**
Zoroaster
Confucius

660–583 BC

Iran

551–479 BC

State of Lu
(present-day
Shandong
province, China)

Philosopher and religious reformer; founder of
Zoroastrianism, or Parsiism
Most famous Chinese philosopher/teacher/political theorist

Western Philosophers§

22
23
24
25
26
27

Plato

428–347 BC

Greece

Aristotle

384–322 BC

Greece

Thales of Miletus

639–544 BC

Miletus (presentday Turkey)

Renowned philosopher and author
Student of Plato, renowned for knowledge of art,
science, and philosophy
The first philosopher in the Greek tradition
(continued)

“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 55, 130; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 44-45.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 129-133, 135-142.
“A History of Medicine” By Louis N. Magner, New York, NY: Marcel Dekker, Inc., 1992, p. 38-39.
Ibid.
Ibid.
Ibid,
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Name

Birth/Death

Location

Claim to Fame

Eastern Philosophers*,**
Anaximander

610–546 BC

Anaximenes

570–500 BC

Pythagoras

580–489 BC

Miletus (presentday Turkey)
Miletus (presentday Turkey)
Croton, Italy

Pupil of Thales, who focused on the cyclical rhythm of
generation and corruption
Follower of Thales, who thought the essential
substance of life was air
Founder of Italic School of Philosophy,
who connected math, music, and medicine

Places§§

Place

Location

Role in Medical History

Fertile Crescent

Western Asia,
including the
fertile regions of
present-day Iraq
and Syria

Medicine evolved from the Mesopotamian civilization

HIPPOCRATES

“A physician who is a lover of wisdom is the equal to a god.”
Hippocrates

During its golden age, Greece prospered in countless social aspects, wisdom, knowledge,
development, beauty, literature, and culture, so that “it seemed as if an impulse to grandeur and
glory and a striving for liberty and beauty pervaded all Greece.”28 Among the unmatched
intellectuals of this era was Hippocrates, recognized as “the wisest and the greatest practitioner
of his art.”29 Born in 460 BC, Hippocrates served as both a priestly and empirical authority of
medicine, and he authored the Corpus with his students, which includes works on medical
specialties and pathologies, the practice of medicine, and medical ethics.30 Several influential
philosophers and intellectuals in the area of medicine (for example, Galen and Erotius) published
commentaries on Hippocrates and his teachings.31 Additionally, many of his contemporaries,
including Plato, praised his efforts as an author and inspirer of important medical texts.32
Hippocrates served as both a priestly and empirical authority of medicine during the golden age of Greece; he
was responsible for compiling the Oath of Hippocrates, as well as writing and inspiring works that became part
of the Corpus.
Roy Porter, 1997 and Arturo Castiglioni, 1947

The first of Hippocrates’ ethical texts was the Oath of Hippocrates, “which covers the duty of the
physician to his teacher, his pupils, and his patients, clearly shows that a relationship existed
between Hippocratic medicine and priestly medicine; but it raises medicine to a height and
28
29
30
31
32

32

“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 148.
Ibid.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 55, 148-149, 153; “The
Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997,
p. 55-56.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 150-153.
“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 150-51; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 62-63, 71.
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human dignity that assures it its own position as a science.”33 Figure 1-1 contains an excerpt
from the classic Oath of Hippocrates.
Medical students commonly take the Hippocratic Oath (or a modification thereof) to demonstrate
a commitment to uphold ethical standards as they practice medicine.34 Although many attribute
the physician’s commitment to “first do no harm” (translated from the Latin phrase primum non
nocere) to Hippocrates, the true origins of the phrase are unknown and arguably not of
Hippocratic origin.35 Table 1-3 outlines the three most influential figures and their works during
this time period.
Figure 1-1: Excerpt From the Classic Hippocratic Oath*
I swear by Apollo Physician and Asclepius and Hygieia and Panaceia and all the gods
and goddesses, making them my witnesses, that I will fulfill according to my ability
and judgment this oath and this covenant:
To hold him who has taught me this art as equal to my parents and to live my life in partnership with him,
and if he is in need of money to give him a share of mine, and to regard his offspring as equal to my
brothers in male lineage and to teach them this art—if they desire to learn it—without fee and covenant; to
give a share of precepts and oral instruction and all the other learning to my sons and to the sons of him
who has instructed me and to pupils who have signed the covenant and have taken an oath according to the
medical law, but no one else.
I will apply dietetic measures for the benefit of the sick according to my ability and judgment;
I will keep them from harm and injustice.
I will neither give a deadly drug to anybody who asked for it, nor will I make a suggestion to
this effect. Similarly I will not give to a woman an abortive remedy. In purity and holiness
I will guard my life and my art.
I will not use the knife, not even on sufferers from stone, but will withdraw in favor of
such men as are engaged in this work.
Whatever houses I may visit, I will come for the benefit of the sick, remaining free of all intentional
injustice, of all mischief and in particular of sexual relations with both female and male persons,
be they free or slaves.
What I may see or hear in the course of the treatment or even outside of the treatment in regard to the life
of men, which on no account one must spread abroad, I will keep to myself, holding such things shameful to
be spoken about.
* “Hippocratic Oath” Johns Hopkins University, http://guides.library.jhu.edu/content.php?pid=23699&sid=190555 (Accessed 9/10/09).

Table 1-3: Influential Figures During the Time of Hippocrates*
Name

Birth/Death

Location

Hippocrates

460–370 BC

Greece

Julius Caesar

100–44 BC

Rome, Italy

Claudius Galen

AD 138–201

Pergamon
(Asia Minor)

Claim to Fame
Thought to be one of the wisest authorities on medicine at the time;
authored medical books on specialties and pathologies, the practice of
medicine, and ethics, including the Oath of Hippocrates, which is still
used today to swear in graduating medical students
Granted Roman citizenship to physicians, elevating their social status
A physician and author best known for his study of
anatomy and theories on the circulation of the blood,
in his best known work, Ars Parva

* “A History of Medicine” By Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
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“A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 177.
“The White Coat Ceremony: A Contemporary Medical Ritual” By S. J. Huber, Journal of Medical Ethics, Vol. 29 (2003), p. 364.
“‘Primum Non Nocere’ and the Principle of Non-Maleficence” By Raanan Gillon, British Journal of Medicine, Vol. 21 (July 13, 1985),
p. 130.

33

Adviser's Guide to Healthcare

PROFESSIONAL PRACTICE AND STATUS OF THE PHYSICIAN
The practice of medicine originated in Greece and spread slowly throughout the Roman
Empire.36 People regarded medical practice as a trade of foreigners, and Greek physicians were
regarded with little, if any, respect.37 Many people assumed the title of physician without
obtaining the proper training, which further contributed to the defamation of the profession.38
However, in 46 BC, Julius Caesar granted physicians the right to Roman citizenship, an honor
that elevated the reputation of physicians in Roman society.39 Soon thereafter, it became
necessary to establish medical schools to repel the invasion of unqualified pseudo-physicians
seeking easy profit in Rome.40 The number of medical schools approved by the Roman Empire
increased, the most celebrated of which could be found in Marseille, Lyon, Saragossa, Antioch,
Athens, and Alexandria.41 A medical licensure process was mandated, and both private and
public libraries were developed to preserve the valued texts and manuscripts.42 Court physicians,
called palatine archiaters, played an essential role in politics and legal affairs and designated
celebrated physicians in the empire.43 As the practice of medicine became systemized, so did the
social position of physicians.44 Although the medical advances made by the Roman Empire were
minimal, Rome was first to incorporate a system of medicine that became an important part of its
intricate system of laws.45
The Roman Empire was first to incorporate a system of legal medicine, which was an important part of Rome’s
intricate system of laws.
Arturo Castiglioni, 1947

GALENIC MEDICINE
Solidifying Hippocratic theories through dissection and experimentation helped reduce the
mystery and doubt that surrounded physicians and helped enhance the quality of medical care in
the Roman Empire.46 The first influential strides in this direction were made by Galen of
Pergamon in Asia Minor (AD 129–200), a student of Hippocrates, who published fifteen
commentaries to Hippocrates’ work.47 He was appointed physician of the gladiators, an

36
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39
40
41
42
43
44
45
46
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honorable and sought after position.48 Galen quickly became known as an extraordinary
practitioner, writer, and student.49
A student of philosophy and medicine, Galen was a pioneer in the field of anatomy, translating
his findings from animal dissection to human application.50 His philosophical background drove
many of his hypotheses, chiefly those related to the physiological explanation for human blood
circulation.51 Though Galenic medicine represented a huge step forward for evidence-based
medicine, it also impeded advances in anatomy and physiology due to its inherent flaws and
blind adoption by the medical and religious communities.52
Drawbacks of Galenic Medicine: findings based entirely on animal dissection and false perceptions regarding
the circulation of human blood.
Sherwin B. Nuland, 1988 and Lawrence I. Conrad, 1995

RISE OF THE MEDICAL UNIVERSITY
The oldest universities, though originating from the ancient Latin schools and persevering
through the Roman Empire, did not flourish until the end of the thirteenth century.53 As
academia increased in sophistication, three kinds of universities emerged: community-funded,
state-funded, and ecclesiastically-funded.54 Although some schools focused entirely on medicine,
others (termed Studium Generale) also incorporated law, theology, and philosophy in their
curricula.55
The church’s influence on medical curricula often slowed the advance of anatomical and
physiological understanding due to its resistance to findings of clinical and experimental
research.56 The Christian belief that disease was a consequence of sin left healing to the devices
of nature.57 Through the translation of Arabian medical texts, scholars developed Greco-Arabian
medicine, which confronted the shortcomings of medical education in the early Middle Ages.58
The physician Abu Ali al-Husayn Abdallah ibn Sinna (known in the West as Avicenna) compiled
48
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the first comprehensive medical text in Arabic.59 His work, Kitab al-Qanun (The Canon of
Medicine), synthesized the philosophies and teachings of Hippocrates, Galen, Dioscorides, and
Alexandrian physicians.60 His mastery of medical science became legendary, and ibn Sinna
became known as the “Galen of Islam.”61 One of the most famous scholars following Avicenna
was Moses Maimonides,62 a Jewish physician who is attributed with authoring the “Prayer for
Physicians.”63 In his efforts to reconcile scientific reasoning and religious faith, Maimonides
combined elements of philosophy, logic, theology, and astronomy,64 and published numerous
works, including the Regimen of Health and the Book of Precepts, many of which contained
sound advice regarding diet, hygiene, and first aid.65
Despite the barriers posed by the Inquisition, scholars, philosophers, and physicians, such as
Pietro d’Abano, infused Arabian medicine into the scholarship of philosophy while attempting to
compromise their differences.66 This movement gave rise to the University of Padua, which
pioneered public dissections of human cadavers and gave rise to revolutionary work in dentistry
and medieval medicine and to publications, including Galen’s Ars Parva (a commentary of
Torrigiani), and Aphorisms of Hippocrates.67 Greco-Arabian medicine also gave rise to the
University of Bologna, the first literary collection of clinical cases, and the work of Ugo
Borgognoni of Lucca, the latter of which set the foundation of modern surgery.68 The University
of Montpellier was the first institution to award a doctorate degree, and at one point, Bologna
and Montpellier had the most stringent dissection requirements.69 However, the University of
Montpellier lost its prominence when the popes retreated from Avignon and religious warfare
decimated the area.70

EASTERN MEDICAL TRADITIONS
The contrast between the evolution of western and eastern medicine resulted from western
medicine’s evolution through the development of hypothetical deductions, while eastern
medicine developed by utilizing more inductive methods, where every individual was thought to
possess a balance between internal defenses and external insults, a lack of which balance resulted
in disease.71 Underlying the practice of eastern medicine was the emphasis on the laws of nature
59
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as a parallel to bodily phenomena, leading to traditional concepts that “man is nothing but a
creature living between heaven and earth,”72 the duality of the Yin and Yang, Buddhist
philosophy, and the teachings of Ayurvedic medicine (the science of life).73
Although the practices of western and eastern medicine evolved through different methods, and
on significantly different timelines, their progression was somewhat similar, as both practices
grew from religious roots and ancient texts. In India, the Vedas, a set of ancient texts revered by
Hindus as sacred, referenced medical lore through tales of demons and charms. These teachings
gave way to the science of life, or Ayurvedic medicine, which applied the theory of humors74 to
bodily health. The Ayurvedic system was slightly different from the similar Greek teachings
regarding humors, as the Ayurvedic system also considered the five elements, five winds, two
souls, as well as blood, in the assessment of health. Ancient Indian medicine also encompassed
early forms of surgery, hospitals, and medical colleges.75
Chinese medicine is arguable the oldest practice of medicine, with the Huang-ti Nei Ching (The
Inner Canon of the Yellow Emperor), published during the T’ang Dynasty (618-907). This work
was based on the balance between the Yin and the Yang, which generate the five phases (wood,
fire, earth, metal, and water) that affect health. The Huang-ti Nei Ching influenced folk healing
practices for over 2,500 years. Theories on anatomy, illness, and diagnosis were all founded on
the duality of the Ying and the Yang, espoused by the Huang-ti Nei Ching, and, accordingly, the
focus of Chinese healing became more preventative than reactionary.76
Eastern medicine shows a significant similarity to its origins in India and China, unlike western
medicine, which has changed dramatically throughout its development. Currently utilized
alternative medical techniques, such as acupuncture, were discussed in the ancient Chinese
Cannon of Medicine and aim, even today, are thought to restore the flow of Yin and the Yang in
the body.77

RENAISSANCE: REVIVAL OF ANATOMY AND
PHYSIOLOGY
Liberation from Galenic medicine and the scholasticisms encouraged by the church began with
the work of early Renaissance Anatomists in the late 1400s and early 1500s.78 Artist-anatomists
such as Andrea Verrochio and Leonardo da Vinci were pioneers in the field.79 Da Vinci
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performed dissections of human cadavers and made drawings of his observations.80 He also
refuted many of the statements made by his Galenic predecessors; due to his objective
perspective of anatomy, his work was not immediately recognized with the respect it deserved.81
Andreas Vesalius also refuted aspects of Galen’s work, claiming that Galen’s anatomical
knowledge applied only to animals and was incredibly flawed when applied to humans.82 His
discoveries in anatomy, released in the mid-1500s, are medical landmarks.83 By contradicting
Galen’s deductions from animal dissection and philosophical conjecture, Vesalius was the first to
describe the vasculature and anatomy of the human heart.84 By daring to question the doctrinal
teachings of their honored predecessors, these and other artists, anatomists, philosophers, and
scientists heralded an era of enlightenment, through which “the sluices of objective inquiry and
experiment had been opened.”85 Table 1-4 indicates the most influential figures and important
locations in the history of healthcare during the Renaissance and Inquisition.
Table 1-4: Influential Figures and Important Places During the Time of the Renaissance and
Inquisition*,**
Influential Figures
Location

Name

Birth/Death

Abu Ali al-Husayn
(Abdallah ibn Sinna
or “Avicenna”)

Claim to Fame

AD 980–1037

Bukhara, Persia

Pietro d’Abano

AD 1250–1315

Padua, Italy

Ugo Borgognoni of
Lucca

Second half of the
twelfth century–
1252

Bologna, Italy

Andrea Verrochio

AD 1435–1488

Florence, Italy

Leonardo da Vinci

AD 1452–1519

Florence, Italy

Andreas Vesalius

1515–1564

Brussels, Belgium

Place

Location

Role in Medical History

University of Padua
University of
Bologna
University of
Montpellier

Padua, Italy

Pioneered public dissection of human cadavers

Bologna, Italy

Held the first literary collection of clinical cases

Montpellier, France

Became the first institution to award doctorate degrees

Compiled first comprehensive medical text in Arabic,
Kitab al-Qanun (The Canon of Medicine)
Infused Arabian medicine into the
scholarship of philosophy
A Bolognese surgeon during the Crusades, he simplified
the treatment of lesions of the extremities and fractures;
none of his works exist today, but he has been quoted by
his son, Theodoric of Lucca (AD 1205–1258)
Painter and anatomist; teacher of Leonardo da Vinci; his
students examined cadavers
Greatest artist anatomist; revolutionized anatomy with his
anatomical sketches based on actual cadavers
First to describe vasculature and anatomy of the human
heart; refuted Galen’s theories of anatomy

Important Places

* “A History of Medicine” By Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997.
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SEVENTEENTH CENTURY: THE DAWN OF
SCIENTIFIC LIBERTY
ANATOMICAL ADVANCES
Countless influential figures significantly contributed to the overhaul of Galenic medicine, laying
the foundation for the modern school of medical thought. The work of da Vinci and Vesalius
prompted advances in anatomy and physiology.86 Michael Servetus’s breakthroughs in
pulmonary circulation, Fabrecius’s discovery of the valves in veins, and William Harvey’s
revelations on the enigmatic circulation of the blood gave mathematical, mechanical, and
methodical meaning to the sciences of physiology and pathological anatomy.87 These findings
prompted a contagion of anatomical investigations like Adrien Spigelius’s studies of the liver,
Giulio Casseri’s inquiries of the anatomy of abdominal organs, and Antonio Maria Valsalva’s
observation of the human ear.88
In the early 1670s, microscopes were developed by Marcello Malpighi and Antoni van
Leeuwenhoek, which triggered the interest in the molecular implications of human anatomy.89
The microscope was originally developed by a Dutch spectacle-maker named Zacharias Janssen,
however, Janssen’s early model could only magnify objects ten times.90 Van Leeuwenhoek’s
microscopes could magnify up to 270 times, which allowed him to discover red blood corpuscles
and the structure of skeletal muscles.91
The conceptualization of toxicology, knowledge of contagious diseases, and developments in
surgery were furthered by brilliant minds, including Marcello Malpighi, Jean-Baptiste van
Helmont, and Francois Mauriceau.92

PROGRESS IN HYGIENE
A series of devastating epidemics terrorized Europe from the fourteenth century through
beginning of the eighteenth century. During this period, Europeans suffered from scurvy,
malaria, typhus, smallpox, diphtheria, influenza, and, perhaps most notably, the various
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infestations of The Black Death.93 The Black Death decimated Europe from 1320–1420, with
mortality counts of barely less than two-thirds the original population.94 The notable devastation
endured through the seventeenth century, prompting the focused study of the causes of disease,
the results of which led to the emergence of epidemiology, as well as, perhaps most important,
the rise of modern hygiene.95 Giovanni Maria Lancisi, a renowned clinician and epidemiologist,
responded to the influenza epidemic in Italy by proposing a series of hygiene improvements,
namely, the need to drain stagnant bodies of water and to purify the air in places where disease
ran rampant.96
The epidemic-related devastation of the seventeenth century, which saw outbreaks of scurvy, malaria, typhus,
the Bubonic plague, smallpox, diphtheria, and influenza, prompted the dawn of epidemiology, and, more
important, modern hygiene.
Roy Porter, 1997 and Arturo Castiglioni, 1947

Because disease was a significant problem in the military, sanitary measures and disease
containment within the military became an area of significant focus.97 The first substantial
investigations into military hygiene were conducted by Florentine Orazio Monti and Antonio
Porzio.98 Porzio made notable advances on the subject of epidemic avoidance in armies,
demonstrating the detrimental effects of intra-barrack contamination and, ultimately, civilian
contamination.99
Bernardino Ramazzini of Capri became the father of industrial hygiene and authored the first
treatise on occupational disease: De Morbis Artificum.100 Ramazzini compiled research on the
diseases of miners and issued a report of his findings that resembled a modern occupational risk
assessment.101 He also studied the harmful effects of metals on artisans, the risks associated with
surgeon exposure to mercurial inunctions, and the exposures to lead, antimony, and countless
other toxins endured by chemists, pharmacists, gilders, painters, tinners, and colored-glass
workers.102 Not only was Ramazzini the first investigator of occupational disease, but he was
also a remarkable general clinician, focusing on the methodical investigation of disease toward
the proper course of action.103
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Bernardo Ramazzini of Capri became known as the father of industrial hygiene; he authored the first treatise on
occupational disease, De Morbis Artificum.
Roy Porter, 1997 and Arturo Castiglioni, 1947

Legislators began passing sanitation laws toward the end of the seventeenth century.104 When the
plague broke out in Rome, the city took measures to contain the disease by means of regulatory
sanitary controls.105 For example, the College of Physicians was asked to report all patients who
had been treated for certain diseases in the past six months.106 Physicians took appropriate
measures to disinfect victims of the plague, and the city gave physicians permits to euthanize and
perform autopsies on any patients dying of contamination.107 The executions caused uproar
among civilians, which brought an end to these measures for disease control.108 Nonetheless,
they prompted more efforts toward military hygiene.109 From these advances in hygiene,
preventative and sanitary control measures became areas of legislative reform that developed
throughout the eighteenth and nineteenth centuries.110
Beginning in the seventeenth century and continuing through the eighteenth and nineteenth centuries, advances
in hygiene, methods for arriving at pathological conclusions, and preventative and sanitary control measures
became areas of legislative reform.
Roy Porter, 1997 and Arturo Castiglioni, 1947

EIGHTEENTH CENTURY: THE SHIFT TOWARD THE
“SCIENCE” OF MEDICINE
The reformist attitudes of physicians and scientists initiated scientific progress in the eighteenth
century. They believed that health improvement was imperative “to human emancipation...from
suffering, want, and fear.”111 As the dark age of the ecclesiastic resistance to scientific advance
culminated, advocates argued that medicine should be more philosophical and method-based.112
Although the eighteenth century became known for Immanuel Kant’s suggestion “that
philosophy is the queen of all the sciences,” it is more renowned for landmark progress in the
exact sciences.113 Countless discoveries in chemistry, physics, biology, physiology, anatomy, and
pathology yielded a single conclusion: without an applied understanding of each of these areas of
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science, the practice of medicine is arbitrary.114 Table 1-5 outlines the most influential figures
and a few key events in medical history during the seventeenth and eighteenth centuries.
According to Immanuel Kant and his followers, “philosophy is the queen of all sciences.”
Arturo Castiglioni, 1947

Table 1-5: Influential Figures and Important Events During the Seventeenth and
Eighteenth Centuries
Influential Figures*,**,§
Location

Name

Birth/Death
1511–1553

Villanueva, Spain

Hieronymus Fabricius ab
Aquapendente

1533–1619

Padua, Italy

William Harvey

1578–1657

Folkeston, England

Adrian Spigelius
Giulio Casseri
Antonio Maria Valsalva

1567–1625
1552–1616
1666–1723

Brussels, Belgium
Padua, Italy
Bologna, Italy

Antoni van Leeuwenhoek

1632–1723

Delft, Holland

Marcello Malpighi
Jean-Baptiste van
Helmont

1628–1694

Crevallcore, Italy

Discovered pulmonary circulation
The greatest comparative anatomist; published that
veins contained valves in his work, De Venarum
Ostiolis (On the Valves and the Veins) in 1603
Premier name in the discovery of the modern
theories of circulation
Studied the liver
Studied abdominal organs
Studied the human ear
Invented the microscope in the early 1670s, with
which he is believed to have discovered red blood
corpuscles and advanced the study of vessel walls
Conceptualized toxicity

1577–1644

Brussels, Belgium

Known for his knowledge of contagious diseases

Francois Mauriceau

1637–1709

Paris, France

Giovanni Maria Lancisi

1654–1720

Rome, Italy

Orazio Monti

1724–1787

Vienna, Austria

Antonio Porzio

1637–1715

Vienna, Austria

Bernardino Ramazzini
Immanuel Kant

1633–1714
1724–1804

Capri, Italy
Königsberg, Prussia

Michael Servetus

Claim to Fame

A obstetric pioneer renowned for his contribution
to surgical medicine
Renowned epidemiologist, who, in responding to
an influenza epidemic, improved public hygiene
by draining stagnant bodies of water and purifying
the air in disease-ridden areas
Conducted the first substantial investigations of
military hygiene in his book, Trattato della
Consuetudine, con il Modo do Governare gli
Eserciti ed i Naviganti
Made advances in epidemic avoidance in armies,
with his book De Militum in Castris Sanitate
Tuenda in 1865
Father of industrial hygiene
Philosopher

Events*,§§
Name

Definition

Black Death
De Morbis Artificum

A plague that decimated two thirds of Europe’s population
First treatise on occupational disease written by Bernardino Ramazzini
Physicians association; by the end of the seventeenth century,
reported all patients treated for certain diseases

College of Physicians

* “A History of Medicine” By Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997.
§ “Memorie storico-culturali delle Accademie orcianesi” By Franco Marini, Fondazione Cassa di Risparmio,
www.fondazionecarifano.it/EventsDocs/2007/AccademieOrcianesi.htm (Accessed 3/15/10).
§§ “The Black Death and the Transformation of the West” By David Herlihy, Harvard University Press, 1997.

114 Ibid., p. 580-582.
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NINETEENTH CENTURY: THE PRACTICE OF MEDICINE
STUDY OF THE MEDICAL SCIENCES
The knowledge a man can use is the only knowledge which has life and
growth in it and converts itself into practical power. The rest hangs like
dust about the brain or dries like raindrops off the stones.
(Froude) Sir William Osler, 1899
The nineteenth century saw an increase in the number of medical schools and efforts to teach the
history of scientific advancement in a focused, discipline-centric manner, which heralded the
concept of the practice of medicine. The famed text, Practice, published in 1843 by Sir Thomas
Watson, remained the prominent treatise on general medicine for more than forty years.115
However, with Watson’s work becoming perceived as outdated, in 1891, Sir William Osler
wrote his magnum opus—The Principles and Practice of Medicine: Designed for the Use of
Practitioners and Students of Medicine—while working at Johns Hopkins School of Medicine.116
Osler’s text, first published in 1892, established him as a leading authority on medicine and sold
hundreds of thousands of copies; multiple editions were published throughout his life and
posthumously.117
In the early 19th century, medical licensure was little more than an honorary title and some states
chose not to enact medical licensure requirements, despite the opening of several medical
schools across the country.118 Shortly after the American Revolution, the equivalency of a
medical license was obtained through membership in a state medical society.119 Membership in a
medical society became a kind of required practice if a physician were to become financially
successful. As medical societies became more reputable, and membership within the societies
grew, physicians who were not members of a medical society were seen to be “unacceptable by
his fellow-workers.”120 Near the end of the 19th century, states began to establish licensing laws
and boards of medical examiners, and this popular movement continued for two decades until
every state had a medical licensing law.121

115 “The Life of Sir William Osler” By Harvey Cushing, Third Impression, Vol. 1, Oxford: The Clarendon Press, 1925, p. 339.
116 Ibid., p. 336, 339.
117 “A History of William Osler’s The Principles and Practice of Medicine” By Richard L. Golden, Journal of American Medical Association,
Vol. 293, No. 15 (April 20, 2005), p. 1926.
118 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, Inc., 1982, p. 30.
119 “Two Centuries of American Medicine: 1776-1976” By James Bordley III and A. McGehee Harvey, Philadelphia, PA: W.B. Saunders
Company, 1976, p. 69.
120 “The Doctor’s Duty to the State: Essays on the Public Relations of Physicians” By John B. Roberts, Chicago, IL: American Medical
Association Press, 1908, p. 63.
121 “Two Centuries of American Medicine: 1776-1976” By James Bordley III and A. McGehee Harvey, Philadelphia, PA: W.B. Saunders
Company, 1976, p. 71.
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IMPACT OF THE INDUSTRIAL REVOLUTION ON THE PRACTICE
OF MEDICINE
Following a lull attributed to the French and American revolutions and unrest in central Europe,
medical progress began gaining momentum.122 Urban and industrial growth spurred demand for
sanitary conditions,123 and “[t]ogether with the great increase in material and cultural growth, a
deeper sense of human dignity was penetrating even to the lowest classes.”124 However, in many
countries, a “realistic tendency and the pursuit of materialistic aims” shattered this idealism.125
Finally, medicine was regarded as a necessary scientific field. Efforts to overcome
“transcendental tendencies and to further the progress of the natural sciences” resulted in
experimental investigation and observation of all forms of life.126 Scientists sought to understand
complex biological issues that philosophical hypotheses previously disregarded.127 As a result,
various schools of thought emerged and advances in science fostered medical specialization.128

DIVERSIFIED SCHOOLS OF MEDICINE
Allopathic Medicine
Since its inception as a mythical abstraction, medicine has transformed into a rational science.
Through expansion of logical thought, the study of social value systems,129 medical knowledge,
and technological capabilities, allopathic (traditional) Western physicians adopted “…a method
of healing founded on a scientific basis.”130 At the time of its establishment in 1847, the
American Medical Association (AMA) was largely comprised of allopathic physicians.131 The
AMA recognized the potency of Western medicine and understood that danger may result from
inadequately regulated growth and expansion of biologically based methodologies.132
As the frontiers of scientific medicine extended, quackery found even broader fields of
operation. Scientific explorations into the mysteries of vitamins, hormones, and
antibiotics not only provided better medical care for the public, but also opened up new
sources of gain for the unscrupulous. While scientific research kindled the imagination of
crafty promoters who sought easy ways to riches, its failure to discover cures for various
major ailments made the boastful claims of pretending healers all the more impressive.133

122 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 667.
123 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 405.
124 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668.
125 Ibid.
126 Ibid.
127 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668.
128 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 386-389.
129 “Theory of Valuation” By John Dewey, The University of Chicago Press, Vol. II, No. 4 (1966), p. 1.
130 “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 468.
131 “Our History, Illustrated Highlights” American Medical Association, 2009, http://www.ama-assn.org/ama/pub/about-ama/
our-history/illustrated-highlights.shtml (Accessed 9/10/09); “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion,
Chicago, IL: Chicago Review Press, 1984, p. 468.
132 “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 467-468.
133 “AMA: Voice of American Medicine” By James G. Burrow, Baltimore, MD: The Johns Hopkins Press, 1963, p. 252-253.
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As such, the AMA served to scientifically and ethically appraise innovative medical
developments, as well as educational standards, and hoped to regain public support and trust.134

Alternative Medicine
Allopathic practitioners were skeptical of cultist or sectarian physicians who practiced
unconventional forms of medicine, such as homeopathic, eclectic, naturopathic, chiropractic, and
osteopathic medicine.135 Allopathic sentiments toward alternative medical practices were
distrustful and condemning, to say the least. Oliver Wendell Holmes, a prominent physician,
attributed with coining the term anesthesia, went as far as to call homeopathic practitioners, “a
mingled mass of perverse ingenuity, of tinsel erudition, of imbecile credulity, and of artful
misrepresentation.”136 Though not as prominent as allopathic medicine, practitioners of
alternative medicine exist today. To reduce public aversion and distrust, the alternative medicine
field has developed education and training requirements, as well as regulation and licensing
measures to legitimize its practices.137
One of the two most widely accepted schools of medicine in the United States, apart from
allopathic medicine, is osteopathic medicine.138 Andrew Taylor Still founded osteopathic
medicine, treating patients by assessing not only their symptoms but also their overall health and
environment.139 He opened the American School of Osteopathy in 1892 in Kirksville,
Missouri.140 By the 1960s, there were six schools for osteopathy, and, as of 1985, Doctors of
Osteopathic Medicine were certified in all specialties.141 Because osteopathic medicine
contributes a great deal to the modern practice of medicine, Chapter 7 of Consulting Services
addresses in detail the similarities and differences between Doctors of Medicine and Doctors of
Osteopathic Medicine.
Homeopathic therapies utilize medicine that would typically induce disease symptoms in healthy
individuals to treat individuals with that disease; homeopathy still exists as a school of
medicine.142 Eclectics use herbal medicines and remedies to treat pathologic conditions.143
Among less threatening therapies, eclectics are known primarily for their use of arsenic and
mercury treatments.144 Naturopathic physicians utilize natural elements like water, heat, and
massage in their therapies.145

134 “Two Centuries of American Medicine: 1776-1976” By James Bordley III and A. McGehee Harvey, Philadelphia, PA: W.B. Saunders
Company, 1976, p. 45; “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984,
p. 467-468.
135 “American Medicine and the Public Interest” By Rosemary Stevens, New Haven, CT: Yale University Press, 1971, p. 43-44; “The AMA
and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 468.
136 “Medical Essays: 1842-1882” By Oliver Wendell Holmes, New York, NY: Houghton Mifflin Company, 1911, p. 101.
137 “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 468-469.
138 “An Osteopathic Approach to Diagnosis and Treatment” By Eileen L. DiGiovanna and Stanley Schiowitz, Second Edition, New York, NY:
Lippincott–Raven, 1997, p. 1.
139 Ibid., p. 1-3.
140 Ibid., p. 3.
141 Ibid., p. 1-3.
142 “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 468; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 390-391.
143 “The AMA and U.S. Health Policy Since 1940” By Frank D. Campion, Chicago, IL: Chicago Review Press, 1984, p. 468.
144 Ibid.
145 Ibid., p. 469.
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The practice of chiropractic medicine has transformed from a form of alternative medicine into
an allied health profession. The origins of chiropractic medicine involved beliefs that vertebral
alignment would serve to remedy diseases; progress in science and medicine cultivated
skepticism toward practitioners of this philosophy.146 Over time, a reduced focus on these
abstract chiropractic practices reduced skepticism from medical practitioners; although some
chiropractors still employ questionable methods, modern chiropractic practice is mainstream and
widely accepted.147
As of April 1985, Doctors of Osteopathy (D.O.) were certified in all specialties.
Eileen L. DiGiovanna and Stanley Schiowitz, 1997

DIVERSIFIED ROLES OF MEDICINE
The practice of medicine in the nineteenth century expanded from strictly clinical practice to
include legal medicine, public health, and medical research. Legal medicine involves the
implementation of medical expertise for legal and judicial purposes.148 In the later portion of the
century, the scientific and medical communities began to grapple with the social and economic
implications of healthcare.149 As such, medicine transformed itself from an elite and
sophisticated trade, and “assume[d] its role as a social science.”150 The national prevalence of
infectious disease resulted in an emphasis on community and hygienic medicine.151
Public health is an area of science and medicine characterized by a “community health point of
view,” and was developed as a relationship between human beings and their social environment
rather than a relationship between human beings and their doctors.152 All public health research,
policies, and programs stemmed from the same objective: to provide “defen[s]e against disease
as a social problem” by way of preventative medicine.153 Unfortunately, progress in prevention is
difficult to quantify, and its value within the healthcare industry is not concrete.154 As a result,
preventative care is dismissed as inferior, and public health has faced significant resistance and
alienation from the medical community.155
Lastly, growth in holistic medical research paired with paralleled growth in scientific knowledge
facilitated the publication of substantial medical literature in serial journals, with the American
Journal of Medical Sciences entering print in 1838 and the New England Journal of Medicine
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and Surgery entering print in 1812.156 This constant flow of new research findings and an
increasing knowledge base resulted in the perpetual tendency toward specialization that
continues to drive current trends in medicine.

SPECIALIZATION OF THE SCIENCES
The nineteenth century saw the first significant period in technical progress that proved
extremely important to the advance of both science and medicine.157 Through continued
advances in chemistry and physics, the disciplines of physiological and pathological chemistry
emerged. A more intensive knowledge base was established for biology, chemistry, anatomy,
and physiology, which gave rise to fields like biochemistry, cytology, genetics, endocrinology,
anthropology, immunology, and microbiology.158
Through his investigations of fermentation and pathogenic bacteria, Louis Pasteur pioneered a
branch of microbiology now known as bacteriology.159 Pasteur’s work influenced both clinical
and laboratory medicine through his discovery of pasteurization, a process widely used today in
the preservation of perishable products.160 Pasteurization involves the strategic application of
heat to kill microbes without injuring the quality of its media (for example, wine, beer, etc.).161
Through the discovery of pasteurization, the development of antirabic treatment, and his
observations of anthrax, chicken cholera, staphylococci, and streptococci, Pasteur became
recognized as “one of the greatest and noblest pioneers of civilization.”162 Pasteur improved
healthcare and enhanced its economic benefits through his contributions to the fields of clinical,
hygienic, and social medicine.163

SPECIALIZATION OF MEDICINE
Specialized forms of internal medicine emerged contemporaneously with developments in
pathology and microbiology.164 The nineteenth century marked the discovery of anesthesia and
asepsis, which resulted in unmatched advances in the study of surgery.165 Surgical specialization

156 “Two Centuries of American Medicine: 1776-1976” By James Bordley III and A. McGehee Harvey, Philadelphia, PA: W.B. Saunders
Company, 1976, p. 71-72.
157 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 305.
158 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 668-672, 765; “The
Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 305.
159 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 809; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 428-431.
160 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 810-811.
161 Ibid., p. 811.
162 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 813; “The Greatest Benefit
to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 431-435.
163 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 811-812.
164 Ibid., p. 829.
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fostered the inception of plastic surgery, neurosurgery, pathological (namely, cancer-related)
surgery, surgical procedures in gynecology and obstetrics, and countless other areas.166
The technological advancements in medicine and precise instrumentation in the early 1900s
vastly improved the delivery of healthcare and, as a result of this leap forward in technology,
physicians increasingly began to specialize in specific areas of medicine.167 Although the
concept of specialization was met with initial hesitation by some medical professionals,
pressures of scientific, social, and economic factors eventually led to the widespread acceptance
of the compartmentalization of medicine.168 In 1866, the American Medical Association (AMA)
analyzed the benefits and risks of physician specialization.169 These benefits and risks are set
forth below, in Table 1-6: Benefits and Risks of Specialization According to the AMA.
Table 1-6: Benefits and Risks of Specialization According to the AMA170
Benefits

Risks

Minuteness of observation
Acuteness in study
Wideness in observation
Skill in diagnosis
Multiplicity of invention
Superior skill in manipulation

Narrowness of view
Tendencies of specialists to magnify the effects of their covered disease
Tendencies of specialists to undervalue the treatment
of the disease by general practitioners
Temptation of specialists to utilize unwarranted measures
to gain a popular reputation
Tendencies of specialists to increase fees

Although physicians began to make claims as to the extent of their skill in a specific area of
medicine, there was no formal system in place to validate their claims.171 In 1908, Derrick T.
Vail, Sr. introduced the concept of a medical specialty board, which would establish minimum
qualifications for specialist physicians.172 The establishment of such a system was a slow
process, and through the 1930s individual examining boards were still working with specific
specialties to advance the specialty board concept. These boards included: the American Board
of Ophthalmology; the American Board of Otolaryngology; the American Board of Obstetrics
and Gynecology; and the American Board of Dermatology and Syphiology. 173
The specialty board system of the 1920s and 1930s greatly contributed to the improvement of
medical education and physician competence. Specialty boards began to require physicians to
obtain additional education through programs approved either by AMA or accredited through the
boards and residency review committees.174 Further still, boards began to require physicians to
obtain a certain amount of professional experience and to pass examinations that were
established and independently administered by the various specialty boards. Soon, national board

166 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 829, 843-845, 847, 852,
853, 861-881.
167 “The Specialty Board Movement” American Board of Medical Specialties, 2012,
http://www.abms.org/About_ABMS/ABMS_History/Extended_History/Specialty_Board_Movement.aspx (Accessed 8/6/12).
168 “Medicine: An Illustrated History” By Albert S. Lyons and R. Joseph Petrucelli, New York, NY: Harry N. Abrams, Inc., 1978, p. 538.
169 “American Surgery: An Illustrated History” By Ira M. Rutkow, Philadelphia, PA: Lippicott-Raven Publishers, 1998, p. 173.
170 Ibid.
171 “The Specialty Board Movement” American Board of Medical Specialties, 2012,
http://www.abms.org/About_ABMS/ABMS_History/Extended_History/Specialty_Board_Movement.aspx (Accessed 8/06/12).
172 Ibid.
173 Ibid.
174 Ibid.
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organizations were able to restrain uneducated physicians from designating themselves as
specialists.
Expanding upon the specialty board system, a federation of individual specialty boards, the
Advisory Board of Medical Specialties, was established in 1933.175 In 1970, the Advisory Board
of Medical Specialties reorganized into the American Board of Medical Specialties (ABMS).
The strong central agency was able to deal with matters common to all specialty boards and act
as the public representative of all specialty boards.176

Specialty Diagnostics
Physicians in the nineteenth century were among the first to engage in the identification,
classification, and reporting of various pathologies and diseases.177 In order to conduct the
necessary laboratory procedures, physicians had to possess a substantial amount of knowledge in
a condensed area of medicine.178 As a result, the range of available specialties grew, became
more focused, and ultimately led to more specialized medical research.179 At the turn of the
twentieth century, diagnostic medicine endured a transformation with Wilhelm Conrad
Roentgen’s discovery of x-rays in 1895, which promulgated the rapid advancement of quantum
physics and Antoine Béclère’s implementation of the first x-ray machine in 1906.180 Soon after,
these nuances in radiation diagnostics would leak into therapeutics with discoveries in radiation
therapy.181

Specialty Therapeutics: Pharmacology and Physiology
The practice of medicine has not always been about understanding a problem to arrive at its
solution. For much of history, diagnostic medicine was an enigma—frequently neglected,
unequivocally lacking, and often hypothetical.182 The treatment of diseases, however, has always
been at the apex of the medical practice.183 Physician inquiry in specialized areas of medicine
allowed for the expansion of diagnostic capabilities in the nineteenth century.184 Additionally,
the nineteenth century brought with it the unparalleled evolution of therapeutic technology.185 It
was not until the 1800s that pharmacology gained scientific credibility through animal and
clinical trial investigations.186 Ancient forms of physiotherapy slowly transformed over time,
175 “Becoming ABMS” American Board of Medical Specialties, http://www.abms.org/About_ABMS/ABMS_History/Extended_History/
Becoming_ABMS.aspx (Accessed 8/06/12).
176 Ibid.
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178 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 701-711; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 304-316.
179 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 701-711.
180 “Early History of X Rays” By Alexi Assmus, Beamline Publication, Summer 1995, p. 10-11, 24.
181 Ibid., p. 10-24.
182 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 891.
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184 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 701-711, 891; “The
Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997,
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185 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 891-899.
186 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 891-892; “The Greatest
Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997, p. 333-334.
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only to emerge in various specialized forms including hydrotherapy, massage, mechanotherapy,
electrotherapy, and heat therapy.187

Rise of the Hospital
As physicians developed competence in a continually growing area of specialties, there was an
expectation that their expertise would also apply to the level of care that they administered.188
This increasing demand for innovative technologies allowed for the provision of services that
would require advanced diagnoses. In response to this increased demand, resulting from the
desire for advanced technologies, as well as demographic and disease trends, existing
technologies evolved to improve the quality and efficiency of services delivered.189
Through the 18th and 19th centuries, and in an effort to meet this increased demand, hospitals
began opening across the U.S. (the first, The Pennsylvania Hospital, having been established in
1751 by Benjamin Franklin and Dr. Thomas Bond190), especially in large, urban areas. These
hospitals were plagued by high rates of infection, and in 1859, Florence Nightingale, published
Notes on Hospitals, in which she described the optimal design for hospitals to prevent
infection.191 Developments in organization and medical knowledge following the Civil War led
to increases in hospital hygiene and tidiness.192
As hospital functions and procedures changed in response to technological advances and an
increased focus on acute care, construction and operating costs also increased, gradually
exceeding the capacity of the charities that initially funded these hospitals. 193 These increased
costs were eventually passed to patients, and insurance plans became new revenue streams for
hospitals, as physician-directed revenues, rather than donations, became the hospital’s main
source of income. The influence and managerial powers of physicians increased as reliance on
charitable donations became less necessary. 194 Table 1-7 summarizes the key people, places,
and events of the nineteenth century in medical history.

187 “A History of Medicine” By Arturo Castiglioni, Second Edition, New York, NY: Alfred A. Knopf, Inc., 1947, p. 895-899.
188 Ibid., p. 701-11.
189 “Biomarket Trends: Pharmaceutical Industry Undergoing Transformation” By Steve Arlington and Anthony Farino, Genetic Engineering
and Biotechnology News, Vol. 27, No. 15 (September 1, 2007); “Cancer Molecular Diagnostics Take the Stage: CMDS Are at the Forefront
of Evolving Healthcare Practices” Genetic Engineering and Biotechnology News, Vol. 29, No. 7 (April 1, 2009),
http://www.genengnews.com/articles/chitem_print.aspx?aid=2852&chid=0 (Accessed 7/6/09).
190 “The Cambridge Illustrated History of Medicine” Edited By Roy Porter, Cambridge, England: Cambridge University Press, 1996, p. 214;
“In the Beginning: The Story of the Creation of the Nation’s First Hospital” University of Pennsylvania, http://www.uphs.upenn.
edu/paharc/features/creation.html (Accessed 8/21/12).
191 “Two Centuries of American Medicine: 1776-1976” By James Bordley III and A. McGehee Harvey, Philadelphia, PA: W.B. Saunders
Company, 1976, p. 62.
192 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY, Basic Books, Inc., 1982, p. 154.
193 Ibid., p. 160.
194 Ibid., p. 160-162.
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Table 1-7: Influential Figures, Key Places, and Important Events During the
Nineteenth Century
Name

Influential Figures*,**,†,††,‡,‡‡
Birth/Death
Location

Sir Thomas Watson

1792–1882

Devonshire,
England

Sir William Osler

1849–1919

Montreal, Canada

American Medical Association

1847–Present

U.S.

Oliver Wendell Holmes

1809–1894

U.S.

Andrew Taylor Still

1828–1917

U.S.

Louis Pasteur

1822–1896

Paris, France

Wilhelm Conrad Roentgen

1845–1923

Germany

Antoine Béclère

1856–1939

Paris, France

Claim to Fame
Authored Practice, a premier medical text
published in 1843
Authored The Principles and Practice of
Medicine, a premier medical text published in
1892
A group of predominantly allopathic physicians
that lobbies for physicians rights and supremacy
Prominent physician who coined the term
anesthesia
Founder of osteopathic medicine, the practice of
treating patients based on symptoms and overall
health
Pioneered bacteriology, a subfield of
microbiology; also discovered pasteurization
Discovered x-rays in 1895
Implemented the first x-ray treatment of
glandular tuberculosis

Places‡‡
Place

Location

Role in Medical History

American School of Osteopathy

Kirksville,
MO, U.S.

First osteopathic school, founded by Andrew Taylor Still in 1892

Events*,**,‡,§,§§

*
**
†
††
‡
‡‡
§
§§

Name

Definition

Anesthesia
American Journal of Medical
Science
New England Journal of
Medicine and Surgery
Fermentation
Pathogenic Bacteria
Pasteurization
Antirabic Treatment
Anthrax
Chicken Cholera
Staphylococci
Streptococci
Asepsis
X-ray

A numbing agent
Began printing in 1838 to help the spread of medical information
Began printing in 1812 and to facilitate the growth of medical knowledge
The enzymatic decomposition of an organic substance in the absence of oxygen
Bacteria that causes disease
A process which involves the strategic application of heat to kill microbes
A treatment for rabies developed at the Pasteur Institute
A fatal bacterial infection of warm-blooded animals
Pasteur’s work with the disease led him to discover vaccinations
A set of spherical bacteria
Used to make Streptomycin, an antibiotic
The state of being free from disease-causing germs
Discovered in 1895, promulgated the rapid advancement of quantum physics

“A History of Medicine” By Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“The Greatest Benefit to Mankind: A Medical History of Humanity” By Roy Porter, New York: NY: HarperCollins Publishers Ltd., 1997.
“The Life of Sir William Osler” By Harvey Cushing, Oxford, 1925.
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“Dr. Holmes at 200—The Spirit of Skepticism” By Charles S. Bryan, MD, and Scott H. Podolsky, MD, New England Journal of Medicine, Vol. 361,
No. 9 (August 27, 2009), p. 846.
“An Osteopathic Approach to Diagnosis and Treatment” By Eileen L. DiGiovanna and Stanley Schiowitz, 1997.
“Early History of X Rays” By Alexi Assmus, Beamline Publication, Stanford University, Summer 1995.
“Two Centuries of American Medicine” By James Bordley III, MD and A. McGehee Harvey, MD, W.B. Saunders Company, 1976.
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As hospitals’ reliance on physicians for revenue increased, healthcare professional practitioners
became viewed not only as healers but also as businessmen. Within that context, demand for
more sophisticated management technologies to enhance practice efficiency and reliability
increased significantly.195 As the demand for increasingly expensive medical technology grew,
the old adage, “No Buck, No Buck Rogers,” was often cited to define the cyclical relationship
between technological demand and business capital investment.

TWENTIETH AND TWENTY-FIRST CENTURIES: THE
TRANSFORMATION OF MODERN HEALTHCARE
The twentieth century will be remembered chiefly, not as an age of political
conflicts and technical inventions, but as an age in which human society
dared to think of the health of the whole human race as a practical
objective.
Arnold Toynbee, 1931
By the twentieth and twenty-first centuries, healthcare professionals had earned credibility, and
continuing developments in modern medicine only fortified the perpetual growth of their medical
authority.196 Starr noted:
The rise of the professionals was the outcome of a struggle for cultural authority as well
as for social mobility. It needs to be understood not only in terms of the knowledge and
ambitions of the medical profession, but also in the context of broader changes in the
culture and society that explains why Americans became willing to acknowledge and
institutionalize their dependence on the professions. The acceptance of professional
authority was, in a sense America’s cultural revolution.197

THE INTRODUCTION OF HEALTH INSURANCE
It is possible to trace aspects of the current U.S. health insurance system to practices arising from
large post-Industrial Revolution era mining and railroad companies, which provided medical
treatment for employment-related injuries. Accident or casualty insurance, which would replace
income in the case of an illness or accident, was available for individuals in that era,198 but
coverage of non-casualty related medical services was not offered. In 1847, the first insurance
company began offering casualty insurance for rail and steamboat accidents and by the close of
the 19th century, 47 insurance companies offering accident insurance existed in the U.S.199
195 “Studies Show Electronic Medical Records Make Financial Sense” By Stacy Lawrence, Posted on CIO Insight, September 14, 2005,
http://www.cioinsight.com/c/a/Health-Care/Studies-Show-Electronic-Medical-Records-Make-Financial-Sense/ (Accessed 8/17/12).
196 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, Inc., 1982, p. 17.
197 Ibid.
198 “The U.S. Health System: Origins and Functions” By Marshall W. Raffel, New York, NY: John Wiley & Sons, 1980, p. 394.
199 Ibid.
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The delineation between medical care for work-related injuries and worked-acquired diseases
(industrial medicine, as it came to be known) began to fade as company-employed physicians
eventually became more involved in general employee health, with companies beginning to
compete for employees through the perceived value of their intra-company medical services.200
At its core, the multi-goal purpose of these programs was to create goodwill toward the company
from their employees and the public by establishing an employee-employer connection and,
perhaps most importantly, to reduce tort liability from work-related injuries and accidents. 201
Ultimately, upon employers realizing the potential benefits associated with providing employee
health services, the movement evolved toward programs more closely resembling contemporary
health insurance. Despite positive reception, the early industrial health programs were one of the
first casualties of the massive unemployment of the Great Depression as major industries
perceived in-house medical services as an unnecessary expenditure.202 However, during the
Great Depression one of today’s largest and most highly publicized insurance conglomerates,
Blue Cross Blue Shield, began operation.
The Blue Cross Blue Shield Association (BCBSA) started as two separate entities, with Blue
Cross covering hospital services and Blue Shield providing coverage for physician services.203
The first nonprofit, prepaid hospital plan, which would eventually become the Blue Cross
Organization, was first created in 1929 and developed by Justin Ford Kimball, a vice-president
of the University Hospital at Baylor University, for Dallas area teachers.204 The plan initially
covered 1,500 teachers who paid $6 per year for 21 days of hospital care at the University
Hospital.205 At that time, the Great Depression resulted in a growing number of patients who
could not afford to pay their bills, and prepaid plans similar to the Baylor Plan quickly began to
develop at hospitals across the country.206 These plans, known as Blue Cross, gained formal
recognition in 1934 when the American Hospital Association (AHA) and the American College
of Surgeons (ACS) expressed their approval of hospital group plans.207
Blue Shield developed in response to the public’s desire to have prepaid coverage for physician
services comparable to what Blue Cross offered for hospital services. Beginning in 1933, Dr.
Sidney Garfield offered prepaid physician services to 5,000 aqueduct workers in California, each
of whom paid a nickel per day.208 Admiring this success, Henry J. Kaiser adopted Dr. Garfield’s
approach in the late 1930s to provide his employees with physician services. The Kaiser
Foundation Health Plan prospered and thrives today as the Kaiser-Permanente plan.209 Since
200 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, Inc., p. 200-209.
201 Ibid., p. 200-201.
202 Ibid., p. 203-204.
203 “The Blues: A History of the Blue Cross and Blue Shield System” By Robert Cunningham III and Robert M. Cunningham Jr., DeKalb, IL:
Northern Illinois University Press, 1997, p. viii.
204 Ibid., p. 4.
205 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, Inc., 1982, p. 295.
206 Ibid., p. 295-296.
207 “The Blues: A History of the Blue Cross and Blue Shield System” By Robert Cunningham III and Robert M. Cunningham Jr., DeKalb, IL:
Northern Illinois University Press, 1997, p. 19.
208 Ibid., p. 39.
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their formation, Blue Cross and Blue Shield have remained strong forces in the insurance market
as the Blue Cross Blue Shield Association (the two companies combined on October 17,
1977).210 The expansion of the insurance and other healthcare markets increased the need for
regulation related to competition.

THE INCEPTION OF MEDICARE AND MEDICAID SERVICES
The economic devastation that plagued a weary middle- and working-class at the dawn of the
Great Depression gave rise to the concept of health security in the newly urbanized and
industrialized United States.211 Despite resistance from conservative stakeholders, that is, the
AMA, the Progressive movement emerged in hopes of relinquishing “inequities and poverty in
America.”212 President Franklin D. Roosevelt (FDR) attempted to implement a national health
insurance program, first in 1935 through the Social Security Bill, a part of The New Deal, and
again through the National Health Act of 1939.213

The Passage of the Social Security Act
President Roosevelt’s action to establish social security in the U.S. began June 8, 1934, and led
to the passage of the Social Security Act (SSA) on August 14, 1935, absent a national healthcare
program,214 but providing many of the recommendations of the Committee on Economic
Security, and those benefits Roosevelt enumerated in his address to Congress in January,
1935.215 The SSA has been amended numerous times, with the establishment of Medicare and
Medicaid (a part of President Lyndon B. Johnson’s Great Society initiatives during the 1960s)
being the most significant change concerning healthcare.
The National Health Act of 1939, President Roosevelt’s second attempt at the establishment of a
national health insurance program, met with similar disappointment. The National Health Act of
1939 purported to support a national health program funded by federal grants to states and
administered by the states themselves.216 However, after the conservative revival in the 1938
election, further innovations in public policy stalled.217
Accordingly, both of FDR’s attempts were in vain, and his sudden, tragic death in 1945 left
health reform in the hands of his successor, Harry S. Truman.218
210 Ibid., p. 197.
211 “Harry S. Truman Versus the Medical Lobby: The Genesis of Medicine” By Monte M. Poen, Columbia, MO: University of Missouri Press,
1979, p. 2, 14-15.
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Harry Truman’s Efforts to Establish Universal,
Comprehensive Coverage
Truman was a zealous proponent of “universal, comprehensive coverage,” and actively sought
enactment of a program for the entirety of his presidency.219 However, he faced opposition from
the AMA, perceived to be “the country’s richest and most influential post-World War II
lobby.”220 His stance on healthcare was viewed by the AMA and other conservative stakeholders
as “socialistic” and “un-American.”221 Although his vehement support for health reform did not
result in the implementation of a national health program during his presidency, Truman did live
to see the inception of a program that, though not as ambitious as the ones he or FDR proposed,
represented significant progress in the direction of change.222

Post-War Technologies
Following World War II (WWII), the U.S. healthcare delivery system saw the rapid advent of
new medical technologies, resulting in higher levels of health and an increased life expectancy,
accompanied by a significant increase in medical costs. Associated with these rising costs has
been a decline in infant and child mortality and increased longevity, which, in turn, led to an
increase in the overall population and the number of individuals needing care and treatment.223
Post-war discoveries of new medical therapies, such as sulfa drugs and penicillin, quickly
reduced infectious disease rates, with these rates decreasing to current levels within two
decades.224 Similarly, longer lifespans resulted in a more aged population, and shifted the focus
of medicine toward expensive treatments for degenerative age-related diseases, e.g., heart
disease; stroke; cancer; and senile dementia, treatment of which increased overall costs due to
the long-term nature of the care.225

The Hill-Burton Act of 1946
After World War II, the regulation of healthcare resources began with the passage of the Hospital
Survey and Construction Act, commonly referred to as the Hill-Burton Act. 226 The passage of
the Hill-Burton Act marked the beginning of over four decades of federally funded health policy
planning.227 The Act’s federal funding was intended to correct the perceived shortage of
healthcare facilities following the Great Depression and World War II by encouraging states to
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develop hospitals in rural areas.228 To receive federal funding for hospital construction under the
Act, states had to institute health policy planning.229 In addition to publishing a healthcare plan
outlining their healthcare needs, states were required to inventory existing healthcare facilities
and designate a single agency that would be responsible for health policy planning.230 Over the
course of three decades, the Act provided financial assistance to nearly 60 percent of all U.S.
hospital,231 while also prohibiting discrimination against the provision of hospital services based
on race and religion, and mandating hospitals to provide a reasonable amount of charitable
care.232

John F. Kennedy, Lyndon Johnson, and the Establishment
of Medicare
In the late 1950s and early 1960s, preparations began for the enactment of Medicare and
Medicaid. As employer-based health insurance coverage increased, private insurance plans
began to set premiums based on previous health costs, and those individuals who were retired
and/or disabled found it more and more difficult to obtain affordable coverage. Consequently,
health reformers refocused their efforts toward the elderly. In the 1960s, John F. Kennedy’s
presidential campaign once again targeted the recession, unemployment, and stagnant economy
introduced by World War II.233 Author Paul Starr stated that “[t]he triumph of the liberal agenda
in the mid-1960s brought a new generation of programs and policies in health care.”234 Starr also
recognized that the need for an increase in health manpower would result in an expansion of
education programs and initiatives.235
Introduced by President Kennedy, Medicare is solely managed by the federal government, and
attempts to alleviate the economic hardships of the elderly who encounter rising medical costs,
while at the same time experiencing a diminishing income, frequently resulting in dire financial
conditions. In the aftermath of President Kennedy’s assassination, and following legendary
political debates, President Johnson guided the passage of Medicare and signed House
Resolution 6675 on July 30, 1965.236 The bill amended the Social Security Act (SSA) of 1935
and was comprised of two components: Medicare Parts A and B. Medicare Part A is “a hospital
insurance plan providing protection against the costs of hospital and related care.” Medicare Part
B involves “a supplementary medical insurance plan covering payments for physicians’ services
and other medical and health services to cover certain areas not covered by the hospital insurance
228 “Health and Politics: The Impact of Certificate of Need Regulation” By Andrew B. Dunham, Chicago, IL: National Center for Health
Service Research, 1981, p. 141.
229 “Cost, Quality, and Access in Health Care: New Rolls for Health Planning in a Competitive Environment” By Frank A. Sloan, et al., San
Francisco, CA: Josey-Bass Publishers, 1988, p. 30.
230 “Health and Politics: The Impact of Certificate of Need Regulation” By Andrew B. Dunham, Chicago, IL: National Center for Health
Service Research, 1981, p. 141.
231 “Special Analyses: Budget of the United States Government: Fiscal Year 1978” United States Office of Management and Budget,
Washington, DC: Government Printing Office, 1978, p. 215.
232 “Timeline: History of Health Reform in the U.S.” Kaiser Family Foundation, http://healthreform.kff.org/flash/health-reform-new.html
(Accessed 8/20/12).
233 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, Inc., 1982, p. 363.
234 Ibid.
235 Ibid., p. 364.
236 “History of SSA During the Johnson Administration 1963-1968, The Development of Medicare” Social Security Administration,
http://www.ssa.gov/history/ssa/lbjmedicare1.html (Accessed 4/27/12).
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plan.”237 Part A, which provides hospital insurance, is funded through the Medicare Hospital
Insurance (HI) Trust Fund, which is comprised of payroll taxes paid by both employers and
employees; enrollees who have not met the requisite requirements for automatic enrollment; a
Social Security benefits tax; interest on Federal securities; and government credits. 238 Medicare
Part B is funded through the Supplementary Medical Insurance (SMI) Trust Fund and draws the
bulk of its resources from premiums paid by Medicare Part B enrollees; general revenue; and
payments from the disabled enrollees with chronic renal disease. 239
Although the passage of Medicare was the result of a longtime congressional interest in social
health insurance for elderly Americans, discontent at Medicare’s original suggestion ultimately
prompted a central figure in the law’s passage, Representative Wilbur Mills, a member of the
House Ways and Means Committee, to combine the original proposal with two additional
components.240 The AMA lobbied for increased coverage of physician services under the
program and even went as far to suggest an Eldercare program, their own version of what
eventually became Medicare. Representative Mills placated all involved parties by integrating
portions of each program into the final legislative package.241 The original Medicare proposal
(i.e., Part A), coupled with the Republican suggestion to cover physician services, was eventually
supplemented by an additional program, prompting some commentators to classify the program
as a “three-layer cake” containing Medicare Parts A and B, as well as a social insurance for the
healthcare of impoverished Americans – Medicaid.242

Creation of Medicaid
The SSA amendment passed in 1965 (which is discussed above) also included the establishment
of the Medicaid program. Medicaid, which was part of President Lyndon B. Johnson’s Great
Society initiative, delivered healthcare insurance coverage for poor individuals who met the
requirements of their states of residence. Unlike Medicare, which is a federal initiative, Medicaid
is a collaborative program between both the federal and state governments, with individual states
setting the criteria for eligible residents. Compared to Medicare, Medicaid was seen as a welfare
program and did not enjoy the widespread acclaim and admiration as its oft-cited companion.243

237 Ibid.
238 “Section 2 - Medicare” U.S. House Ways and Means Committee, “WMCP 108-6 - Background Material and Data on Programs Within the
Jurisdiction of the Committee on Ways and Means (Green Book)” Washington, DC: U.S. Government Printing Office, 2004, p. 2-10.
239 Ibid., p. 2-14.
240 “The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry” By Paul Starr,
New York, NY: Basic Books, p. 368-371.
241 Ibid.
242 Ibid.
243 “Annual Statistical Supplement, 2011: Medicaid Program Description and Legislative History” U.S. Social Security Administration, Office
of Retirement and Disability Policy, 2011, https://www.socialsecurity.gov/policy/docs/statcomps/supplement/2011/medicaid.html
(Accessed 4/27/12).

57

Adviser's Guide to Healthcare

THE RISING COSTS OF HEALTHCARE
Since the 1970s, in response to the establishment of Medicare and Medicaid and the federal
funding that sustains those programs, health expenditures have been rising steadily. Policy
considerations addressing the rising cost of healthcare became a priority of the administration of
President Jimmy Carter and presented barriers for national reform efforts.244 Concerns regarding
the cost of healthcare continue today as healthcare costs have continued to increase. A visual
depiction of the rising trend of national health expenditures is set forth below in Figure 1-2,
National Health Expenditures per Capita 1960-2013.
Figure 1-2: National Health Expenditures per Capita, 1960-2013245
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In the decade from 2003 to 2013, national health expenditures have increased more than 64
percent.246 However, as illustrated below in Figure 1-3: Average Annual Change in National
Health Expenditures, 1960-2013, the rate of increase in National Health Expenditures has
recently begun to slow.

244 “Timeline: History of Health Reform in the U.S.” Kaiser Family Foundation, http://healthreform.kff.org/flash/health-reform-new.html
(Accessed 8/20/12).
245 “Table 1 - National Health Expenditures; Aggregate and Per Capita Amounts, Annual Percent Change and Percent Distribution: Selected
Calendar Years 1960-2013” from “NHE Tables” located at “NHE Fact Sheet” Centers for Medicare & Medicaid Services,
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-FactSheet.html (Accessed 2/18/15).
246 Ibid.
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Figure 1-3: Average Annual Change in National Health Expenditures, 1960-2013247
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RESPONSES TO RISING COSTS OF HEALTHCARE
Diagnostic Related Groups (DRG), Prospective Payment Systems
(PPS), and the Inception of the Resource Based Relative Value
System (RBRVS)
Diagnostic Related Groups
In response to the growing costs of medical care, myriad payment reforms were proposed. One
of the payment reforms, the Diagnostic Related Group (DRG), was implemented in New Jersey
in 1980. This reimbursement reform aimed to realign incentives within hospitals to
simultaneously increase efficiency and decrease healthcare expenditures. Despite limited
evaluation of the DRG program, many states followed suit, and in 1983 the federal government
under President Ronald Reagan adopted the DRG system and integrated it into the Medicare
program.248 Under Medicare Part A, hospitals are reimbursed using DRGs, which classify
patients based on the average per discharge cost of caring for their diagnosis.249 Each DRG is
assigned a relative rate based on its average cost, which rate is then multiplied by the input-price
level of each market to determine the payment rate for the DRG.250

247 Ibid.
248 “Lessons of the New Jersey DRG Payment System” By W.C. Hsiao, et al., Health Affairs, Vol. 5, No. 2 (1986), p. 33.
249 “Hospital Acute Inpatient Services Payment System” MedPAC Payment Basics, October 2008,
http://www.medpac.gov/documents/MedPAC_Payment_Basics_08_hospital.pdf (Accessed 9/24/09), p. 1.
250 Ibid.
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Prospective Payment Systems
Historically, Medicare and Medicaid reimbursed hospital services using a cost plus method, in
which hospitals received reimbursement in excess of all of their costs.251 In 1982, the federal
government introduced a prospective payment system (PPS) as an attempt to remedy rising
healthcare costs.252 Under the PPS, hospitals are reimbursed an average, qualified, and
predetermined fee for every recognized DRG (discussed above).253 The government has also
developed a PPS for hospital outpatient services; ambulatory surgery centers (ASCs); skilled
nursing facilities (SNFs); rehabilitation facilities; and home healthcare.254 Applying
microeconomic theory, the PPS was proposed at the pinnacle of the Reagan Administration’s
revolution of domestic policy. The U.S. Department of Health and Human Services (HHS)
considered PPS to be a self-maintaining system, and it was viewed by some to be “a critical step
in the ‘deregulation’ of American hospitals” to enhance marketplace competition by utilizing
incentives versus legislative controls.255
In 1982, the federal government introduced a prospective payment system (PPS) in an effort to remedy the
rising healthcare costs.
Report to the Congress: Medicare Payment Policy, March 2005.

Inception of the Resource Based Relative Value System
In 1989, the Resource Based Relative Value System (RBRVS) was presented as a mechanism to
control the cost of physician services borne by the Medicare program,256 although it was not
implemented until January 1, 1992, along with the Medicare Fee Schedule.257 In 1986, in
response to the increase in Medicare spending and concerns regarding assertions of inequity in
reimbursement rates for procedural services over cognitive clinical services, the Physician
Payment Review Commission (PPRC), the precursor to the Medicare Payment Advisory
Commission (MedPAC), mandated that the new resource-based physician fee schedule be
developed.258 William C. Hsiao, Ph.D., a professor at the Harvard School of Public Health, was
engaged to develop the RBRVS, which was derived from the results of a 1988 study entitled, A
National Study of Resource-Based Relative Value Scales for Physician Service.259

251 “Medicare Hospital Prospective Payment System: How DRG Rates Are Calculated and Updated” Office of Inspector General, Office of
Evaluation and Inspections, Region IX, OEI-09-00-00200, August 2001, p. 1.
252 “Medicare Hospital Prospective Payment System: How DRG Rates Are Calculated and Updated” Office of Inspector General, Office of
Evaluation and Inspections, Region IX, OEI-09-00-00200, August 2001, p. 1.
253 Ibid.
254 “Assessing payment adequacy and updating payment in fee-for-service Medicare” in Report to the Congress: Medicare Payment Policy,
March 2005, p. 27-32.
255 “Medicare’s Prospective Payment System at Age Eight: Mature Success or Midlife Crisis” By Bruce C. Vladeck, University of Puget Sound
Law Review, Vol. 14, No. 3 (Spring 1991), p. 453.
256 “Health Care USA: Understanding its Organization and Delivery” By Harry A. Sultz and Kristina M. Young, Sixth Edition, Boston, MA:
Jones and Bartlett Publishers, 2009, p. 261.
257 “An Overview of the Development and Refinement of the Resource-Based Relative Value Scale: The Foundation for Reform of U.S.
Physician Payment” By William C. Hsiao, et al., Medical Care, Vol. 30, No. 11, Supp. (November 1992), p. NS1-NS2.
258 “Resource-Based Relative Value Units: A Primer for Academic Family Physicians” By Sarah E. Johnson, MD, and Warren P. Newton,
MD, MPH, Family Medicine, March 2002, p 172.
259 Ibid., p 172-73.
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The study was commissioned and funded by the Health Care Financing Administration
(HCFA),260 currently known as Centers for Medicare & Medicaid Services (CMS), and was
supported by the AMA, various specialty groups, and the PPRC. Based on earlier work by Hsiao
and others that examined the inconsistencies, inadequacies, and ambiguities in the measurement
of the relative value of physician work input and the coding system that was utilized,261 the 1988
study apportioned physician services into distinct fungible units comprised of work, practice
cost, and malpractice cost inputs known as Relative Value Units (RVUs).262 Phase I of the study
examined over 200 practicing physicians performing over 400 services in 18 medical and
surgical specialties relying on the Current Procedural Terminology (CPT-4).263 The process of
allocating physician services into distinct, fungible units of defined commodities (i.e., RVUs)
embraced the concept that establishing a standard per unit of care across physician services and
specialties could augment initiatives to ensure more equitable and reasonable reimbursement
rates, while additionally serving as an effective cost containment measure.
The 1989 legislative decision to include the RBRVS was passed on Phase I of the 1988 Hsiao
study, which was performed between 1986 and 1988. Following the acceptance of the RBRVS
system, but prior to its 1992 implementation through the Omnibus Budget Reconciliation Act of
1990,264 Hsiao and his peers completed both Phase II (1988-1990) and Phase III (1990-1992) of
the study to further refine and expand the scope of the RBRVS system.265
The system was intended to replace the previous Customary Prevailing and Reasonable (CPR)
charge system by aligning payments for medical practice with a prospective payment system,
under which reimbursement is based on a predetermined, fixed amount, and on estimates of
resource costs incurred in an efficient medical practice.266 The RBRVS was intended to place
greater emphasis on the time a physician spent with a patient when assessing health, diagnosing
conditions, and listening to patient complaints, thereby distributing Medicare payments more
heavily to primary care physicians and reducing the traditionally higher reimbursement payments
to specialists and surgeons.267
In 1989, the resource-based relative value system (RBRVS) was introduced as a mechanism to control the costs
of physicians’ services borne by the Medicare program.
Robert James Cimasi 2009.

260 HCFA was established in 1977 to manage the Medicare and Medicaid programs. The agency changed its name in 2001. “History” Centers
for Medicare & Medicaid Services, https://www.cms.gov/About-CMS/Agency-Information/History/index.html?redirect=/history/
(Accessed 4/7/15).
261 “An Overview of the Development and Refinement of the Resource-Based Relative Value Scale: The Foundation for Reform of U.S.
Physician Payment” By William C. Hsiao, et al., Medical Care, Vol. 30, No. 11, Supp., November 1992, p. NS1-NS2; “Toward Developing
a Relative Value Scale for Medical and Surgical Services” By William C. Hsiao and William B. Stason, Health Care Financing Review,
Fall 1979, p. 23.
262 “A National Study of Resource-Based Relative Value Scales for Physician Services” By William C. Hsiao, et al., Cambridge, MA, 1988,
p. 1-25.
263 “An Overview of the Development and Refinement of the Resource-Based Relative Value Scale: The Foundation for Reform of U.S.
Physician Payment” By William C. Hsiao, et al., Medical Care, Vol. 30, No. 11, Supp. (November 1992), p. NS1-NS3.
264 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Ninth Edition,
Clifton, NY: Delmar Cengage Learning, 2008, p. 23.
265 “An Overview of the Development and Refinement of the Resource-Based Relative Value Scale: The Foundation for Reform of U.S.
Physician Payment” By William C. Hsiao, et al., Medical Care, Vol. 30, No. 11, Supp. (November 1992), p. NS2.
266 "Health Care USA: Understanding Its Organization and Delivery" By Harry A. Sultz and Kristina M. Young, Sixth Edition, Sudbury, MA,
Jones and Bartlett Publishers, 2009, p. 261.
267 “RBRVS: How New Physician Fee Schedule Will Work - Resource-Based Relative Value Scale Payment System” By Paul L. Grimaldi,
Healthcare Financial Management, Sept 1991.
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The Establishment of the Sustainable Growth Rate
The Medicare physician fee schedule is updated by CMS each year based on a formula entailed
in the Balanced Budget Act of 1997, which includes application of the Sustainable Growth Rate
(SGR).268 The SGR represents a spending target set for total annual expenditures under Medicare
on Part B services and provides a calculation for annual adjustments to the Medicare physician
fee schedule based on whether actual spending came in above or below the target.269 Since its
inception, and especially since 2002, intense debate has surrounded the need and benefit of the
SGR, which, since 2002, has required annual Congressional intervention to prevent calculated
decreases to physician payments. For more information of the SGR and the debates concerning
its longevity see Chapter 2, Reimbursement Environment in An Era of Reform: The Four Pillars.

The Rise and Fall of Managed Care
In response to ever increasing healthcare costs, employers began relying more heavily on prepaid
health insurance models, e.g., Health Maintenance Organizations (HMO), a name coined by Paul
Ellwood Jr. in 1970. Even as employers began to utilize HMOs, fewer than four million
Americans were enrolled in these health plans in 1971.270
Congress passed the Health Maintenance Organization Act of 1973 to fund the development and
spread of HMOs, which are prepaid health plans that utilize primary care physicians as
gatekeepers to provider networks and capitated provider reimbursement, which incentivizes the
reduction of health service utilization and increases in the efficiency of care for HMO members.
HMOs and a similar type of prepaid health plan, preferred provider organizations (PPOs), seek to
combine the roles of insurance companies, utilization review organizations, and medical services
providers in order to offer prepaid medical plans to subscribers that control costs by integrating
operational and financial functions.271
One of the inevitable goals of the shift to managed care and capitation, from a fee-for-service
medical system, was the managed competition between large, consolidated provider.272 The
adoption of managed care at the state and federal levels led to the expeditious consolidation of
healthcare entities in both public and private sectors into emerging healthcare organizations.273
The adoption of managed care promulgated the aforementioned increase in integration of
healthcare organizations.274 Unfortunately, the managed care movement did not provide the
quality and efficiency outcomes that the industry expected.275 Most organizations only
268 “The Sustainable Growth Rate Formula and Health Reform” By Paul N. Van de Water, Center on Budget and Policy Priorities, April 21,
2010, http://www.cbpp.org/cms/?fa=view&id=3166 (Accessed 2/19/15).
269 “The Sustainable Growth Rate Formula for Setting Medicare’s Physician Payment Rates” Congressional Budget Office, Economic and
Budget Issue Brief, Sept. 6, 2006, http://www.cbo.gov/ftpdocs/75xx/doc7542/09-07-SGR-brief.pdf (Accessed 10/9/09), p. 2, 4-5.
270 “The Rise of HMOs” By Martin Markovich, Santa Monica, CA: RAND Corporation, 2003, p. 3.
271 “Health Care USA: Understanding its Organization and Delivery” By Harry A. Sultz and Kristina M. Young, Sixth Edition, Boston, MA:
Jones and Bartlett Publishers, 2009, p. 240-242.
272 Ibid., p. 242.
273 Ibid., p. 240-242.
274 “Unhealthy Trends: The Future of Physician Services” By Hoangmai H. Pham and Paul B. Ginsburg, Health Affairs, Vol. 26, No. 6
(November/December 2007), p. 1586, 1589-1592.
275 Ibid.
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consolidated in order to survive the backlash of managed care. This consolidation to date has, in
some aspects, deviated from the original goals of the managed care movement: the fluid delivery
of healthcare services along the continuum of care. In light of this misalignment, increased
integration has only furthered the fragmentation of healthcare delivery, creating a façade of
increased consolidation in a healthcare system that remains, inherently, a “cottage industry.”276
Although managed care was, at one time, believed to be the Pied Piper of cottage healthcare,
transformation into postindustrial care is also contingent upon the standardization of care,
accounting for performance measures, and employed transparent reporting practices.277
The stated goals and original promises of the HMO Act, lower costs and higher quality outcomes
for patients (similar to the goals of modern accountable care organizations) due to the fluid
delivery of healthcare services along the continuum of care, were not met. Similarly, the
projected increases in the number of HMO plans appeared to be woefully optimistic, as the goals
of increasing the number of HMO plans from 30 in 1970 to 1,700 by 1976 and covering 90
percent of the population by 1980, were not achieved. Nonetheless, throughout the 1970s and
1980s, the number of HMO plans did increase, and other models of managed care plans
flourished, maintaining prominence into 1990s. There were over 600 HMOs in operation by
1996 with almost 65 million enrollees- almost one fourth of the U.S. population at the time.278
The capitation form of payment utilized in many managed care plans, which was originally
thought to incentivize efficiency and reduce waste in the healthcare delivery system, instead
caused physicians and hospitals to underprovide services for fear of sustaining continual
financial losses. Patients accused HMO gatekeeper providers and insurers of being of focusing
on their own financial benefit, rather than the medical interests of their patients.279 By 1997, 52
percent of U.S. citizens were in favor of the government stepping in to regulate managed care
companies, even if it resulted in increased cost. Further, 54 percent believed the continued use of
capitated payment models and gatekeeping functions of managed care plans would harm the
quality of medical care.280
Despite overall satisfaction with the level of medical care received from HMO providers, the
public discontent with managed care plans was heavily publicized, and further encouraged the
eventual consumer backlash.281 Since the 1990s, HMOs have seen continued use in the U.S.
healthcare delivery system; however, reports suggest that restrictions on provider preferences
have been significantly relaxed.282

276 “Cottage Industry to Postindustrical Care—The Revolution in Health Care Delivery” By Stephen J. Swensen, et al., New England Journal
of Medicine, January 20, 2010, p. e12(1); “Unhealthy Trends: The Future of Physician Services” By Hoangmai H. Pham and Paul B.
Ginsburg, Health Affairs, Vol. 26, No. 6 (November/December 2007), p. 1586, 1589-1592.
277 “Cottage Industry to Postindustrical Care—The Revolution in Health Care Delivery” By Stephen J. Swensen, et al., New England Journal
of Medicine, January 20, 2010, p. e12(3).
278 “A Brief History of Managed Care” Tufts Managed Care Institute, 1998, http://www.thci.org/downloads/briefhist.pdf (Accessed 12/28/11).
279 “The Public, Managed Care, and Consumer Protections” Kaiser Family Foundation, Kaiser Public Opinion Spotlight, January 2006, p. 1;
“Understanding the Managed Care Backlash” By Robert J. Blendon, et al., Health Affairs, Vol. 17, No. 4 (July/August 1998), p. 87- 88.
280 “Understanding the Managed Care Backlash” By Robert J. Blendon, et al., Health Affairs, Vol. 17, No. 4 (July/August 1998), p. 83-84.
281 Ibid., p. 90-91.
282 “The Managed Care Backlash: Did Consumers Vote With Their Feet?” By Susan Marquis, et al., Inquiry, Vol. 41 (Winter 2004/2005),
p. 387.
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The Resulting Erosion of Physician Independence
Although most professions saw an increase in compensation since the 1990s, physician
compensation has been fairly stagnant.283 Physicians have invested in ancillary services
providers not only in an effort to counter reductions in professional fee reimbursement revenue,
but also to exercise control over their practice environment and ability to provide technologically
advanced, high-quality care to their patients.284 The realignment of the Inpatient PPS (IPPS) with
the introduction of severely adjusted DRGs, as well as heightened initiatives aimed at restricting
physician ownership of ancillary services and technical component revenue streams have raised
some investor concerns.285
The overall impact of this and other attacks on physician ownership appears to be aimed at
consigning physicians to nothing more than sharecroppers. This perceived diminution of the
professional standing and investor interest of physicians is further exacerbated by widespread
acceptance among even the most ardent proponents of physician independence, such as Arnold
Relman, MD, Harvard professor and former editor of the New England Journal of Medicine,
who, by neglecting to condone physician ownership and advocating for a U.S. healthcare system
where the majority of physicians would be employed by not-for-profit group practices, may have
redefined his stance on physician “independence.”286
“From the perspective of many, the inevitable outcome of these efforts at placing
additional restrictions on physician independence will be to relegate these professionals
and their practice of medicine, to the status of, at best, the healthcare equivalent of
sharecropping, and, at worst (per Relman), the status of hired help.”287

CLINTON ERA HEALTHCARE REFORMS
Healthcare reform was a key policy initiative from the beginning of the Clinton administration’s
campaign in 1992 and throughout his term. The political landscape during his first term in office
seemed to support his efforts: Democrats controlled both the Senate and the House of
Representatives; bipartisan concessions were offered; the public supported reform; and many
influential industry organizations approved sweeping changes.288 The bill was primarily

283 “A Guide to Consulting Services for Emerging Healthcare Organizations” By Robert J. Cimasi, New York, NY: John Wiley & Sons, Inc.,
1999, p. 5; “Health Care USA: Understanding its Organization and Delivery” By Harry A. Sultz and Kristina M. Young, Sixth Edition,
Boston, MA: Jones and Bartlett Publishers, 2009, p. 245-246.
284 “A Guide to Consulting Services for Emerging Healthcare Organizations” By Robert James Cimasi, New York, NY: John Wiley & Sons,
Inc., 1999, p. 4; “Enhancing the Bottom Line—Considerations in Developing Ancillary Services” By Darrell L. Schryver and Bruce A
Johnson, Directions Newsletter, Vol. 5, No. 2 (2003), http://www.mgma.com/article.aspx?id=1142 (Accessed 2/3/10).
285 “Health Care USA: Understanding its Organization and Delivery” By Harry A. Sultz and Kristina M. Young, Sixth Edition, Boston, MA:
Jones and Bartlett Publishers, 2009, p. 240, 257-260; “Specialty Hospitals, Ambulatory Surgery Centers, and General Hospitals: Charting a
Wise Policy Course” By David Shactman, Health Affairs, Vol. 24, No. 3 (2005), p. 24.
286 “A Second Opinion: Rescuing America’s Health Care: A Plan for Universal Coverage Serving Patients Over Profit” By Arnold S. Relman,
New York, NY: PublicAffairs, 2007.
287 “Down on the Farm: The Attack on Physician Ownership” By Robert James Cimasi, SurgiStrategies, May 1, 2008,
http://www.surgistrategies.com/articles/physician-ownership-law-asc-cimasi.html# (Accessed 10/08/09), p. 4.
288 “What Happened to Health Care Reform?” By Paul Starr, The American Prospect, No. 20 (Winter 1995), p. 20-31.; “Learning from Failure
in Health Care Reform” By Jonathan Oberlander, Ph.D., The New England Journal of Medicine, Vol. 357, No. 17 (October 25, 2007),
p. 1677-1679.
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championed by First Lady, Hilary Rodham Clinton,289 who served as Chair of the Task Force on
National Health Care Reform, established by President Clinton on January 25, 1993, at the
beginning of his term.290 The healthcare reform proposal, H.R. 3600, The Health Security Act,
which was submitted to Congress on November 20, 1993,291 attempted to institute universal
coverage; regulate the private insurance market; change healthcare financing through the
implementation of an employer mandate; control costs to levels enforced by a national health
board; and transform the healthcare delivery system through managed care.292 The plan
combined the liberal ends of universal coverage with the conservative means of managed
competition.293
Several factors contributed to the sharp change in sentiment toward healthcare between 1993 and
1994 when the Clinton healthcare reform bill was being debated. President Clinton could not
muster the requisite political capital to finish his push for reform, expending much of his political
clout on other issues, such as the federal budget and the North American Free Trade Agreement
(NAFTA), as well as the political fallout from the Whitewater scandal.294 In the face of the
approaching midterm elections, Republicans stopped making concessions and instead touted the
bill’s defeat as a means to humiliate President Clinton.295 Further, the economy had started to
improve and, as a result, constituents were less concerned with reforming healthcare.296 President
Clinton reduced the scope of his envisioned reform by focusing on universal coverage and
threatening to veto any bill that did not include it.297 In the end, no compromise was found, and
the Clinton plan died in Congress.298

MEDICARE PART C AND THE CHILDREN’S HEALTH INSURANCE
PROGRAM (CHIP)
Medicare Part C, or Medicare Advantage, and the State Children’s Health Insurance Program
(SCHIP) were established as part of the Balanced Budget Act of 1997. In addition, as set forth
below, the Act added civil monetary penalty provisions to the Anti-Kickback Statute in an
amount of $50,000, in addition to three times the amount of illegal remuneration, or treble
damages.299
289 Hillary Clinton was a member of the Jackson Hole Group, a group of healthcare experts consisting of approximately 100 academics,
insurance executives, hospital and pharmaceutical executives, physicians, and associated business and policy makers. Meeting at the home
of Dr. Paul M. Ellwood (a main proponent of managed competition), in Jackson Hole WY, the group was one of the driving forces behind
the formation of the Health Security Act based on their publication, “The 21st Century American Health System – Managed Competition: A
Proposal for Public and Private Health Care Reform.” Alan Enthoven (founder of the concept of managed competition) participated in the
group stating, “What was valuable is that we brought together people from many perspectives. We learned from each other.” “Hillary
Clinton’s Potent Brain Trust on Health Reform” By Robin Toner, The New York Times, February 28, 1993.
290 “President's Task Force on National Health Care Reform” Federal Register Daily Journal, https://www.federalregister.gov/agencies/
president-s-task-force-on-national-health-care-reform (Accessed 8/23/12).
291 “The Health Security Act” H.R. 3600 (November 20, 1993).
292 “Learning from Failure in Health Care Reform” By Jonathan Oberlander, PhD, The New England Journal of Medicine, Vol. 357, No. 17
(October 25, 2007), p. 1677-1679.
293 “What Happened to Health Care Reform?” By Paul Starr, The American Prospect, No. 20 (Winter 1995), p. 20-31; “The Rationale Behind
the Clinton Health Care Reform Plan” By W. A. Zelman, Health Affairs, Vol. 13, No. 1 (Spring 1994), p. 9-29.
294 “What Happened to Health Care Reform?” By Paul Starr, The American Prospect, No. 20 (Winter 1995), p. 20-31.
295 Ibid.
296 Ibid.
297 Ibid.
298 Ibid.
299 “The Balanced Budget Act of 1997” Pub. L. No. 105-33, § 4304, 111 Stat. 251, 383 (August 5, 1997).
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Medicare Part C offers a managed care alternative to Medicare Parts A and B, which allowed
private insurance coverage to offer plans that include hospital coverage (Part A), medical
coverage (Part B), and other services without the need to purchase a Medigap plan (a private
plan that aids the elderly in meeting the expenses that Medicare Parts A and B leave
uncovered).300
The State Children’s Health Insurance Program (SCHIP) (currently known as the Children’s
Health Insurance Program (CHIP)) is a federal partnership with the states that provides health
insurance to children and pregnant women in families whose income is above the threshold for
regular Medicaid.301 The Patient Protection and Affordable Care Act (ACA) extended the
authorization of federal CHIP funding through September 30, 2015.302

MEDICARE PART D
In response to the increase in utilization, demand, and price of prescription drugs, Congress
enacted the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003
during the George W. Bush Administration, which resulted in some of the most significant
changes to the Medicare Program in the 38 years since its enactment, including Medicare Part
D, an entitlement benefit for prescription drugs, which had seen drastically increased
utilization.303 As part of the MMA, Medicare Advantage plans were altered to allow insurers the
ability to offer Medicare Part D coverage, and to restrict patient access and prescription drug
choice.304 The MMA also replaced and expanded medical savings accounts, by establishing the
regulatory scheme for health savings accounts (HSA).305

FEDERAL FRAUD AND ABUSE STATUTES
After the implementation of Medicare and Medicaid, it quickly became apparent that, with the
massive amount of federal and state funding at stake, regulation to protect these important public
coffers was required. These statutes and regulations, first implemented in the 1970s, are
constantly changing, resulting in the rapidly evolving healthcare regulatory environment.

300 “Part C – Medicare+Choice Program: Eligibility, Election, and Enrollment” Social Security Act § 1851 (42 U.S.C. § 1395w-21); “Medigap
(Medicare Supplement Health Insurance)” Centers for Medicare & Medicaid Services, March 26, 2012, http://www.cms.gov/Medicare/
Health-Plans/Medigap/index.html?redirect=/Medigap/ (Accessed 5/14/12).
301 “Medicaid & CHIP Coverage” Centers for Medicare and Medicaid Services, https://www.healthcare.gov/medicaid-chip/ (Accessed
2/19/15).
302 “Children’s Health Insurance Program Overview” National Conference of State Legislatures, August 1, 2011, http://www.ncsl.org/
research/health/childrens-health-insurance-program-overview.aspx (Accessed 2/19/15); “Financing” Centers for Medicare and Medicaid
Services, http://medicaid.gov/chip/financing/financing.html (Accessed 2/19/15).
303 “Fact Sheet: Medicare Prescription Drug, Improvement, and Modernization Act of 2003” The White House Press Release, December 8,
2003, http://georgewbush-whitehouse.archives.gov/news/releases/2003/12/20031208-3.html (Accessed 2/19/15).
304 “Medicare Prescription Drug, Improvement, and Modernization Act of 2003” Pub. L. No. 108-173, § 101, 117 Stat. 2017-2081
(December 8, 2003).
305 “Medicare Prescription Drug, Improvement, and Modernization Act of 2003” Pub. L. No. 108-173, § 1201, 117 Stat. 2017, 2066, 24692478 (December 8, 2003).
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The Anti-Kickback Statute
The Medicare Anti-kickback Statute (AKS) was enacted in 1972 and subsequently amended to
provide felony criminal penalties for knowingly and willfully offering, paying, soliciting, or
receiving remuneration in order to induce business reimbursed under the Medicare or state
healthcare programs.306 In 1987, the Office of Inspector General (OIG) was given authority to
issue civil penalties, including exclusion from the Medicare Program.307 These civil penalties
were believed to be a more effective way of enforcing the statute, as they did not require the
government to prove violation of the statute beyond a reasonable doubt, but merely by the lesser
standard of preponderance of the evidence.308
Given the relatively broad scope of the AKS, the statute also includes several safe harbors
(exceptions to the statute) to protect legitimate business arrangements.309 It was the intent of
Congress that the rules evolve and be updated to reflect changes within the healthcare industry
and in technologies affecting the industry.310 As intended, the safe harbors have continuously
developed and changed since their enactment, the most recent of which include the addition of
waivers for:
(1) Cost sharing for financially needy Medicare Part D beneficiaries;
(2) Cost sharing for emergency ambulance services furnished by state or municipality owned
ambulance services; and
(3) Protection for free or discounted local transportation services, among others.311

The Stark Law
More commonly known as the Stark Law, after the legislation’s chief supporter, Congressman
Fortney “Pete” Stark (D-CA), the Ethics in Patient Referral Act of 1989 originally prohibited
physicians from making referrals to clinical laboratories if the physician, or an immediate family
member of the physician, had an ownership or investment interest in the lab.312 Further, the lab
was prohibited from billing for those services.313 Congressman Stark supported the legislation

306 “Anti-Kickback Statute” By Terri Sabella, American Health Lawyers Association, Health Law Resources, https://www.healthlawyers.org/
hlresources/Health%20Law%20Wiki/Anti-Kickback%20Statute.aspx (Accessed 2/19/15).
307 “Anti-Kickback Statute” By Terri Sabella, American Health Lawyers Association, Health Law Resources, https://www.healthlawyers.org/
hlresources/Health%20Law%20Wiki/Anti-Kickback%20Statute.aspx (Accessed 2/19/15); “Exclusion of entities owned or controlled by a
sanctioned person” 42 C.F.R. § 1001.1001 (October 1, 2011).
308 “Institute on Medicare and Medicaid Payment Issues: Fraud and Abuse Primer” By John T. Brennan, American Health Lawyers
Association, March 16-18, 2005, http://www.crowell.com/documents/DOCASSOCFKTYPE_PRESENTATIONS_721.pdf (Accessed
2/19/15), p. 12.
309 “Exceptions” 42 C.F.R. § 1001.952 (March 18, 2002).
310 “Medicare and State Health Care Programs: Fraud and Abuse; Clarification of the Initial OIG Safe Harbor Provisions and Establishment of
Additional Safe Harbor Provisions Under the Anti-Kickback Statute; Final Rule” Federal Register Vol. 64, No. 223 (November 19, 1999),
p. 63518.
311 “Exceptions” 42 C.F.R. § 1001.952 (March 18, 2002); “Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe
Harbors under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing” Federal
Register Vol. 79, No. 192 (October 3, 2014), p. 59718.
312 “Medicare Program; Physician Financial Relationships With, and Referrals to, Health Care Entities That Furnish Clinical Laboratory
Services and Financial Relationship Reporting Requirements: Final Rule with Comment Period” Federal Register Vol. 60, No. 156
(August 14, 1995), p.41915.
313 Ibid.
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based on studies indicating that despite the broad scope of the Anti-Kickback Statute, selfreferrals were prevalent in the healthcare industry.314
This act marked the beginning of the stream of numerous restrictive amendments to the Stark
Law, which have significantly impacted the ways in which physicians and healthcare enterprises
interact. Currently, the Stark Law prohibits a physician from making a referral to an entity for
designated health services (a list of 12 services, including inpatient and outpatient hospital
services), if that physician has a financial relationship with the entity.315
Similar to the Anti-Kickback Statute, there are a variety of exceptions to the Stark Law that
permit narrowly defined financial agreements between physicians and designated health service
entities.316

The False Claims Act
The False Claims Act (FCA) is a longstanding statute that was established by President Abraham
Lincoln to address fraudulent bills submitted by defense contractors to the United States
Army.317 The statute imposes civil monetary penalties upon violators in an amount between
$5,000 to $10,000 per claim, as well as three times the amount of damages that the Government
sustains,318 if a person performs any of the following actions:
(1) Knowingly presents, or causes to be presented, a false or fraudulent claim for payment or
approval;
(2) Knowingly makes, uses, or causes to be made or used, a false record or statement
material to a false or fraudulent claim;
(3) Conspires to commit a violation of the FCA; or
(4) Knowingly makes, uses, or causes to be made or used, a false record or statement
material to an obligation to pay or transmit money or property to the Government, or
knowingly conceals or knowingly and improperly avoids or decreases an obligation to
pay or transmit money or property to the Government.319
The FCA is a potent fraud and abuse enforcement tool, as it allows private individuals, also
known as qui tam relators or whistleblowers, to bring suits on behalf of the Government.320
314 “Health Care Fraud and Abuse: Practical Perspectives” Edited By Linda A. Baumann, Washington, DC: American Bar Association, 2002,
p. 52.
315 “Physician Self-Referral” Centers for Medicare and Medicaid Services, January 5, 2015, https://www.cms.gov/Medicare/Fraud-andAbuse/PhysicianSelfReferral/index.html?redirect=/physicianselfreferral/ (Accessed 2/19/15); “Limitation on Certain Physician Referrals”
42 U.S.C. § 1395nn(a)(1) (January 7, 2011).
316 “Limitation on Certain Physician Referrals” 42 U.S.C. § 1395nn(b)-(e) (January 7, 2011); “General exceptions to the referral prohibition
related to both ownership/investment and compensation” 42 C.F.R. § 411.355(a)-(i) (October 1, 2011); “Exceptions to the referral
prohibition related to ownership or investment interests” 42 C.F.R. § 411.356(a)-(c) (October 1, 2010); “Exceptions to the referral
prohibition related to compensation arrangements” 42 C.F.R. § 411.357(a)-(p) (October 1, 2011).
317 “False Claims Act” The American Health Lawyers Association, Health Law Resources, https://www.healthlawyers.org/hlresources/
Health%20Law%20Wiki/False%20Claims%20Act.aspx (Accessed 2/19/15).
318 “False Claims” 31 U.S.C. § 3729(a) (January 3, 2012).
319 Ibid.
320 “False Claims Act” The American Health Lawyers Association, Health Law Resources, https://www.healthlawyers.org/hlresources/
Health%20Law%20Wiki/False%20Claims%20Act.aspx (Accessed 2/19/15); “Qui Tam: The False Claims Act and Related Federal
Statutes” By Charles Doyle, Congressional Research Service, August 6, 2009, https://www.fas.org/sgp/crs/misc/R40785.pdf (Accessed
2/19/15), Summary, p. 1.
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Further still, the FCA allows these private individuals to share in the Government’s recovery, as
recompense for their assistance.321 In the context of healthcare, violations the Stark Law and
AKS serve as predicate actions that may be enforced through the FCA.322

THE PATIENT PROTECTION AND AFFORDABLE CARE ACT (ACA)
Perhaps the most significant transformation of the delivery of healthcare in the U.S., the Patient
Protection and Affordable Care Act (ACA) was signed into law by President Barack Obama on
March 23, 2010, following a period of divisive political debate which has continued nearly five
years after the ACA’s enactment. The regulation contains many provisions affecting the triple
aim of healthcare reform (access, quality, and cost of healthcare), including ACA §3022, which
establishes the Medicare Shared Savings Program (MSSP), regulations that govern Federal
Accountable Care Organizations (ACOs).323 Its provisions include: the implementation of risk
adjustment, reinsurance, and risk corridors;324 increased transparency through publication of
physician payments from industry;325 expanded access to affordable insurance;326 and expanded
access to care (especially to primary care providers).327

Challenges to the ACA
Challenges to the Individual Mandate and Medicaid
On June 28, 2012, the Supreme Court of the United States (SCOTUS) handed down its highly
anticipated decision upholding most of the 2010 healthcare reform. A national controversy was
ignited upon the passage of the ACA,328 and the individual mandate was challenged in court by
certain States’ Attorneys General, who challenged Congress’s ability to mandate the purchase of
health insurance, invoking both the Supremacy and Commerce Clauses.329 Similarly, the
National Federation of Independent Business filed a suit challenging the constitutionality of the
ACA’s Medicaid expansion provisions, which would require states to expand their Medicaid
coverage to certain low-income individuals, or face revocation of all Federal Medicaid
funding.330
321 “False Claims Act” The American Health Lawyers Association, Health Law Resources, https://www.healthlawyers.org/hlresources/
Health%20Law%20Wiki/False%20Claims%20Act.aspx (Accessed 2/19/15); “Qui Tam: The False Claims Act and Related Federal
Statutes” By Charles Doyle, Congressional Research Service, August 6, 2009, https://www.fas.org/sgp/crs/misc/R40785.pdf (Accessed
2/19/15), p 1.
322 “A Public Policy Discussion: Taking the Measure of the Stark Law” American Health Lawyers Association, https://www.healthlawyers.org/
hlresources/PI/ConvenerSessions/Documents/Stark%20White%20Paper.pdf (Accessed 2/19/15), p. 8.
323 “Patient Protection and Affordable Care Act,” Pub. L. No 111-148, § 3022, 124 Stat. 119, 395 (2010).
324 “Explaining Health Care Reform: Risk Adjustment, Reinsurance, and Risk Corridors” The Henry J. Kaiser Family Foundation, January
2014, https://kaiserfamilyfoundation.files.wordpress.com/2014/01/8544-explaining-health-care-reform-risk-adjustment-reinsurance-andrisk-corridors1.pdf (Accessed 2/19/15), p. 1.
325 “Open Payments (Physician Payments Sunshine Act)” Centers for Medicare and Medicaid Services, http://www.cms.gov/Regulations-andGuidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Physician-fact-sheet.pdf (Accessed 2/19/15), p. 1.
326 “Summary of Coverage Provisions in the Affordable Care Act” The Henry J. Kaiser Family Foundation, July 17, 2012,
https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8023-r.pdf (Accessed 2/19/15), p. 1.
327 “How the Affordable Care Act will Strengthen the Nation’s Primary Care Foundation” By Karen Davis, et al., Journal of General Internal
Medicine, Vol. 26, No. 10 (April 27, 2011), p. 1.
328 “National Federation of Independent Business v. Sebelius” 132 S. Ct. 2566, 2572 (SCOTUS 2012).
329 “Showdown gets a head start” By Rich Daly and Jessica Zigmond, Modern Healthcare, March 26, 2012,
http://www.modernhealthcare.com/article/20120324/MAGAZINE/303249947 (Accessed 8/17/12).
330 “National Federation of Independent Business v. Sebelius” 132 S. Ct. 2566, 2580 (SCOTUS 2012).
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Despite agreeing with the argument that the individual mandate violated the Constitution’s
Commerce clause, SCOTUS chose to uphold the provision, and the ACA, as an exercise of the
federal taxing power. SCOTUS also upheld the provision mandating the expansion of the
Medicaid program, although the Court did limit Congress’s attempt to pressure states into
participating.331 SCOTUS found that Congress can offer new funding to entice Medicaid
expansion by the States, but cannot withdraw existing funds.
Touted as the one of the most significant SCOTUS decisions of this century, the Court’s 5 to 4
ruling to uphold the ACA has caused repercussions throughout the U.S. healthcare delivery
system and the businesses and professionals that operate therein. 332
Challenging the ACA’s Tax Subsidies
Recently, the permissibility of making subsidies available to low income individuals and families
in the form of tax credits, which assist millions in affording health insurance via the state and
federally run health insurance exchanges established by the ACA,333 has come under siege.334
The petitioners alleged that, on its face, the ACA only allowed the U.S. Treasury to distribute
subsidies in the form of tax credits for health insurance that is purchased through a state
established exchange, but not for health insurance that is purchased through the HHS established
exchange.335 The respondents, in turn, argued that this reading of the statute is inappropriate,
declaring such an interpretation to be “…contrary to the [ACA]’s text and structure and would
render the Act unrecognizable to the Congress that passed it.”336 Ultimately, the Supreme Court
upheld the Government’s interpretation of the statute, noting that the petitioner’s interpretation
would result in serious damage to the health insurance markets that the ACA was designed to
reform.337
If the Supreme Court found in favor of the petitioners and limited distribution of tax subsidies to
only those individuals who purchase insurance through state established exchanges, an estimated
8.2 million additional people would have become uninsured.338 Further still, few of the newly
uninsured would be required to obtain coverage or pay a penalty as required by the individual
mandate, because the cost of health insurance would exceed 8% of income.339 This would likely
have resulted in an older and less healthy mix of individuals enrolling in nongroup insurance,
thereby increasing average premiums in the nongroup insurance market by an estimated 35%.340

331 “National Federation of Independent Business v. Sebelius” 132 S. Ct. 2566, 2604 (SCOTUS 2012).
332 “National Federation of Independent Business v. Sebelius” 132 S. Ct. 2566, 2566 (SCOTUS 2012).
333 “Affordable Care Act Tax Provisions” Internal Revenue Service, February 18, 2015, http://www.irs.gov/Affordable-Care-Act/AffordableCare-Act-Tax-Provisions (Accessed 2/19/15).
334 “Halbig, et al. v. Burwell” Appeal from the United States District Court for the District of Columbia, Opinion, No. 14-5018, July 22, 2014,
p. 1; “King, et al. v. Burwell” Appeal from the United States District Court for the Eastern District of Virginia, at Richmond, No. 14-1158,
July 22, 2014, p. 5; “King, et al. v. Burwell” Brief for the Respondents, No. 14-114, January 21, 2015, p. I.
335 “King, et al. v. Burwell” Brief for the Petitioners, No. 14-114, December 22, 2014, p. 3, 5-6.
336 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2015), Brief for the Respondents in Opposition, p. 12.
337 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 21.
338 “The Implications of a Supreme Court Finding for the Plaintiff in King vs. Burwell: 8.2 Million More Uninsured and 35% Higher
Premiums” Robert Wood Johnson Foundation, January 2015, http://www.urban.org/UploadedPDF/2000062-The-Implications-King-vsBurwell.pdf (Accessed 2/19/15), p. 1.
339 Ibid.
340 Ibid.
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THE SHIFT FROM INPATIENT TO OUTPATIENT TREATMENT
The idea that medical care is delivered on an inpatient basis is continually being eroded as
reforms associated with the ACA reverberate throughout the healthcare industry and new
technologies continue to evolve, allowing patients to be treated for increasingly complicated
diagnoses on an outpatient basis.341 Inpatient admissions have only increased from over 31
million, in 1992, to approximately 34 million admissions, in 2012,342 while, over the same
period, outpatient visits increased from 347 million to 674 million.343 Conversely, the number of
inpatient surgeries has decreased, from just over 10 million, in 1992, to 9.5 million, in 2012,344
while the number of outpatient surgeries has increased from 12 million to over 17 million over
the same period.345
Compounding the mass migration to delivery of healthcare on an outpatient basis, the United
States Census predicted that between 2015 and 2060, the U.S. population would increase from
320 million to over 416 million.346 Further still, the number of people aged sixty-five and older,
the segment of the population that utilizes a greater proportion of medical services relative to the
rest of the general population,347 is expected to more than double, increasing from 41 to 86
million between 2010 and 2050.348 The continuing increases in healthcare cost containment
pressures, coupled with improvements in technology and exploding growth in the over age sixtyfive population, should preserve growth in outpatient demand.
U.S. outpatient visits have increased from 347 million to 674 million between 1992 and 2012.
American Hospital Association, 2014.

THE HEALTHCARE MANPOWER SHORTAGE: A BARRIER TO
MANAGED CARE
In 1980, the Graduate Medical Education National Advisory Committee projected a surplus of
70,000 physicians in the year 2000. As a result of this estimate, a cap on medical school

341 “The Great Migration” By Rebecca Vesely, Hospitals and Health Networks, March 11, 2014, http://www.hhnmag.com/display/HHN-newsarticle.dhtml?dcrPath=/templatedata/HF_Common/NewsArticle/data/HHN/Magazine/2014/Mar/cover-story-great-migration (Accessed
2/19/15); “The New Normal? Shift to put patient care, payer pressure hit hospitals” By Beth Kutscher and Melanie Evans, Modern
Healthcare, August 10, 2013, http://www.modernhealthcare.com/article/20130810/MAGAZINE/308109974 (Accessed 2/19/15).
342 “Trendwatch Chartbook 2014: Trends Affecting Hospitals and Health Systems” American Hospital Association, 2014,
http://www.aha.org/research/reports/tw/chartbook/2014/14chartbook.pdf (Accessed 1/15/15), A-26.
343 “Trendwatch Chartbook 2014: Trends Affecting Hospitals and Health Systems” American Hospital Association, 2014,
http://www.aha.org/research/reports/tw/chartbook/2014/14chartbook.pdf (Accessed 1/15/15), A-29.
344 Ibid., A-26.
345 Ibid., A-29.
346 “U.S. Population Projections: 2015 to 2060” United States Census Bureau, December 10, 2014,
http://www.census.gov/population/projections/data/national/2014/summarytables.html (Accessed 1/15/15).
347 “US Health Spending Trends by Age and Gender: Selected Years 2002-10” By David Lassman et al., Health Affairs, Vol. 33, No. 5 (May
2014), p. 830.
348 “10 Projections for the Global Population in 2050” By Rakesh Kochhar, Pew Research Center, February 3, 2014,
http://www.pewresearch.org/fact-tank/2014/02/03/10-projections-for-the-global-population-in-2050/ (Accessed 1/15/15).
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enrollment was put in place to control supply of physicians to the market.349 Due to “tightly
controlled” managed care in the 1990s, the projections of a physician surplus in the next decade
were reaffirmed, and the number of graduates per year remained unchanged for nearly twentyfive years.350 However, in 2006, foreseeing a physician shortage, the Association of American
Medical Colleges (AAMC) recommended a 30 percent increase in U.S. medical school
enrollment by 2015 in hopes of alleviating the shortage.351
The supply of physicians in the U.S. has not kept pace with the demand for healthcare services.
In fact, the gap between supply and demand may increase, as the sources of physician supply
remain insufficient and the drivers of demand (e.g., the aging population and the increase in the
number of insured under the ACA’s individual mandate) intensify.352 However, new models of
care delivery, as well as advances in medical technology, may reduce the risk of potential future
shortages. Given the demographic shift towards an older population, primary care is an area of
particular concern.
Various organizations have constructed forecasts regarding the potential shortage of physicians
over the next several years. For example, in June 2010, the Association of American Medical
Colleges (AAMC) projected that by 2025, the U.S. would have a shortage of 130,000 physicians,
over half of whom would be primary care physicians.353 More recently, in November 2013, the
Health Resources and Services Administration (HRSA) projected that by 2020, the U.S. would
need an additional 20,000 primary care physicians in order to meet demand.354 The same HRSA
projection also forecasted an increase in the supply of nurse practitioners (NPs) and physician
assistants (PAs), which reduced the projected shortage to 6,400 full-time equivalent (FTE)
physicians.355 However, it should be noted that these findings are restricted to primary care.
Increased assistance from NPs and PAs may do little to help a shortage in certain areas of care
that require the advanced training of a specialized physician.

The Association of American Medical Colleges (AAMC) projected a physician shortage of 130,000 physicians
by the year 2025.
Association of American Medical Colleges, 2010.

As suggested by the inclusion of NPs and PAs in the HRSA forecast, projections of a physician
shortage may be overstated. Research by the Research and Development (RAND) Corporation
349 “The Complexities of Physician Supply and Demand: Projections Through 2025” By Michael J. Dill and Edward S. Salsberg, Association
of American Medical Colleges, November 2008, p. 12.
350 “Looming Shortage of Physicians Raises Concerns About Access to Care” By Mike Mitka, Journal of the American Medical Association,
Vol. 297, No. 10 (March 14, 2007), p. 1045-1046.
351 “The Complexities of Physician Supply and Demand: Projections Through 2025” By Michael J. Dill and Edward S. Salsberg, Association
of American Medical Colleges, November 2008, p. 12.
352 “The Impact of Health Care Reform on the Future Supply and Demand for Physicians: Updated Projections Through 2025” Association of
American Medical Colleges, June 2010, https://www.aamc.org/download/158076/data/updated_projections_through_2025.pdf (Accessed
5/22/14).
353 Ibid.
354 “Projecting the Supply and Demand for Primary Care Practitioners Through 2020” Health Resources and Services Administration,
November 2013, http://bhpr.hrsa.gov/healthworkforce/supplydemand/usworkforce/primarycare/projectingprimarycare.pdf (Accessed
5/21/14), p. 1-3.
355 Ibid.
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found that the potential shortage of primary care physicians may be lessened not only by the
inclusion of NPs and PAs, but also by modifying how primary care is delivered.356 Specifically,
the RAND research found that if (1) the use of Patient Centered Medical Homes (PCMHs) grew
from 15% to 45%; (2) the use of Nurse-managed Health Centers (NMHCs) grew from 0.5% to
5%; and (3) medical homes could use improvements in technology and techniques to handle 20%
more patients, then the projected shortage of primary care physicians could be virtually
eliminated by 2025.357 In the event that a physician shortage does occur, such a shortage may
interrupt the efficient delivery of healthcare, which could cause deterioration in the cost and
quality of healthcare services.358
In addition to the shortage of physicians across all specialties, there is a growing shortage of
physicians seeking to practice in primary care medicine as compared to specialty practitioners.359
Possibly the largest factor contributing to the shortage is the disparity in pay, as specialists often
earn twice the pay of primary care physicians and work more predictable hours.360 Given that
medical students graduate with a significant amount of debt (the class of 2014 had an average
debt load of $176,348, which was an increase of 4% compared to the following year361), many
young practitioners are drawn to the more lucrative specialty practices.362
“Primary care physicians (PCPs) believe they treat the conditions that patients have, while specialists and
surgeons believe their patients have the conditions they treat.”

Old Medical Adage
“Specialists and surgeons relegate the complaints of primary care physicians as ‘the revenge of the
C student.’!”

356 “Research Highlight: New Approaches for Delivering Primary Care could Reduce Predicted Physician Shortage” RAND Corporation, 2013,
http://www.rand.org/content/dam/rand/pubs/research_briefs/RB9700/RB9752/RAND_RB9752.pdf (Accessed 12/3/14); “Nurse Managed
Health Centers and Patient-Centered Medical Homes Could Mitigate Expected Primary Care Physician Shortage” By David I. Auerbach, et
al., Health Affairs, Vol. 32, No. 11 (November 2013), p. 1933-1941.
357 Ibid.
358 “Physician Supply and the Affordable Care Act” By Elayne J. Heisler, Congressional Research Service, January 15, 2013,
http://op.bna.com/hl.nsf/id/myon-93zpre/$File/crsdoctor.pdf (Accessed 5/22/14), p. 1.
359 “Can’t find a Doctor? You’re Not Alone” By Nancy Shute, U.S. News and World Report, March 19, 2008,
http://health.usnews.com/articles/health/living-well-usn/2008/03/19/cant-find-a-doctor-youre-not-alone.html (Accessed 10/05/09).; “Match
Day: High-Paid Specialties Still IN, Primary Care Still Out” By Jacob Goldstein, Wall Street Journal Blogs, (March 19, 2009),
http://blogs.wsj.com/health/2009/03/19/match-day-high-paid-specialties-still-in-primary-care-still-out/ (Accessed 3/27/09); “Will Generalist
Physician Supply Meet Demands of an Increasing Aging Population” By Jack M. Colwill, James M. Cultice, and Robin L. Kruse, Health
Affairs, Web Exclusive, Vol. 27, No. 3 (April 29, 2008), p. w232-w241.
360 “Can’t find a Doctor? You’re Not Alone” By Nancy Shute, U.S. News and World Report, March 19, 2008,
http://health.usnews.com/articles/health/living-well-usn/2008/03/19/cant-find-a-doctor-youre-not-alone.html (Accessed 10/05/09).; “Match
Day: High-Paid Specialties Still IN, Primary Care Still Out” By Jacob Goldstein, Wall Street Journal Blogs, March 19, 2009,
http://blogs.wsj.com/health/2009/03/19/match-day-high-paid-specialties-still-in-primary-care-still-out/ (Accessed 03/27/09).
361 “Medical Student Education: Debt, Costs, and Loan Repayment Fact Card” Association of American Medical Colleges, October 2014,
https://www.aamc.org/download/152968/data/debtfactcard.pdf (Accessed 1/30/15).
362 “Can’t find a Doctor? You’re Not Alone” By Nancy Shute, U.S. News and World Report, March 19, 2008,
http://health.usnews.com/articles/health/living-well-usn/2008/03/19/cant-find-a-doctor-youre-not-alone.html (Accessed 10/05/09).; “Match
Day: High-Paid Specialties Still IN, Primary Care Still Out” By Jacob Goldstein, Wall Street Journal Blogs (March 19, 2009),
http://blogs.wsj.com/health/2009/03/19/match-day-high-paid-specialties-still-in-primary-care-still-out/ (Accessed 03/27/09).
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Table 1-8 outlines several of the most important twentieth century figures and events as they
relate to the healthcare profession.
Table 1-8: Influential Figures, Key Places, and Important Events During the Twentieth
Century
Name

Birth/Death

Influential Figures*,**,†,††
Location
Washington, D.C.,
U.S.

Franklin D.
Roosevelt

1882–1945

Harry S. Truman

1884–1972

John F. Kennedy

1917–63

Lyndon B. Johnson

1908–73

Washington, D.C.,
U.S.

Paul Starr

1949–present

Princeton, N.J., U.S.

Washington, D.C.,
U.S.
Washington, D.C.,
U.S.

Claim to Fame

U.S. President from 1932–45, who attempted to implement
a national health insurance program in 1935 and again in
1939
U.S. President from 1945–53, who attempted to implement
a national health insurance program
U.S. President from 1961–63, whose term was plagued by a
recession, unemployment, and a stagnant economy
U.S. President from 1963–69, who, with assistance from a
democratic sweep, passed Medicare parts A and B, and
Medicaid
Renowned sociologist who won the Pulitzer Prize for his
book, The Social Transformation of American Medicine

Events‡
Name

Definition

Bureau of Health Professions

Part of HHS, deals with grants, studies, and designations of the health workforce

* “Harry S. Truman Versus the Medical Lobby” By Monte M. Poen, University of Missouri Press, 1979.
** “A Brief History: Universal Health Care Efforts in the U.S.” By Karen S. Palmer, MPH, MS, Physicians for a National Health Program, Spring 2009,
www.pnhp.org/facts/a_brief_history_universal_health_care_efforts_in_the_us.php?page=all (Accessed 2/17/10)
† “The Social Transformation of American medicine,” By Paul Star, New York, NY: Basic Books, Inc., 1982.
†† “Paul Starr: Biographical Sketch”, Princeton University, October 19, 2008, www.princeton.edu/~starr/starrbio.html (Accessed 2/24/10)
‡ “Projected supply, demand, and shortages of registered nurses: 2000–2020” United States Department of Health and Human Services, Health Resources and
Services Administration, Bureau of Health Professions, National Center for Health Workforce Analysis, July 2002,
www.ahcancal.org/research_data/staffing/Documents/Registered_Nurse_Supply_Demand.pdf (Accessed 4/10/09).

THE HEALTHCARE PROFESSIONAL’S DUTY TO
THE STATE
The practice of medicine began as hypothetical thought and transformed over time into a
scientific industry in growing demand. Ultimately, a company’s success is a function of market
control and profit. However, market competition within the healthcare industry is ultimately
driven by the ethical duties unique to the medical profession. In addition to the duty to primum
non nocere—first (or above all) do no harm—healthcare professionals are also expected to
exhibit “[q]ualities such as wisdom, compassion, human concern, and service.”363 However,
business objectives built around these ethical values may conflict with the entrepreneurial
objectives that take priority in most industries.364 Further, due to the community-based nature of
many healthcare services, industry trends are driven largely by public opinion on matters related
to health status.365 As such, the healthcare professional’s ethical duties are rooted deeply in
363 “’Primum Non Nocere’ and the Principle of Non-Maleficence” By Raanan Gillon, British Journal of Medicine, Vol. 21 (July 13, 1985)
p.130; “Medical Ethics: Common Ground for Understanding” By K.D. O’Rourke and D. Brodeur, St. Louis, MO: The Catholic Health
Association of the United States, 1986, p. 36.
364 “Medical Ethics: Common Ground for Understanding” By K.D. O’Rourke and D. Brodeur, St. Louis, MO: The Catholic Health Association
of the United States, 1986, p. 36-39.
365 “No Margin, No Mission: Health-Care Organizations and the Quest for Ethical Excellence” By S.D. Pearson, J.E. Sabin and E.J. Emanuel,
New York, NY: Oxford University Press, 2003, p. vii- viii.
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community benefit.366 Healthcare delivery is subject to a unique sixth force of the competitive
equation: the requirement that community benefit maintain weighted significance in the
decisions that impact the provision of care.367
According to the AMA’s 1908 publication, The Doctor’s Duty to the State:
“The doctor’s highest duty is to be honest and to fight for honesty in his profession and
the state...He, as others, sees in history the same process exhibited in the remote effects of
corporate and governmental vice...To whom then shall the state look for preservation of
its health, to whom shall the state call for help in time of trouble, in whom shall the state
place its hope for deliverance...The honest citizen; and the honest doctor is his best
representative.”368

Unfortunately, the public’s perception of healthcare providers has gradually eroded during the
past decade, with patients becoming increasingly distrustful of hospitals, doctors, and drug
companies and with a growing perception that there has been a lapse in attention to the
healthcare professional’s highest ethical duty.369 The ACA has implemented a tool to combat the
growing distrust of healthcare professionals among patients, the Open Payments database.370 The
Open Payments database is a federally run program that collects the information about financial
relationships between doctors and hospitals and other third parties to make these transactions
public information.371 This availability will add a level of transparency between the patient and
physician in attempts to rebuild trust.372
In the face of rapidly accelerating changes in the healthcare industry, it is an ever-present
challenge for healthcare professionals to maintain their professional obligations as well as their
financial solvency. Notwithstanding this duality of objective, medical ethics remain a market
driver that distinguishes healthcare from all other industries.

366 “Medical Ethics: Common Ground for Understanding” By K.D. O’Rourke and D. Brodeur, St. Louis, MO: The Catholic Health Association
of the United States, 1986, p. 41-42.
367 Ibid., p. 36-39.
368 “The Doctor’s duty to the State: Essays on the Public Relations of Physicians” By J. B. Roberts, Chicago, IL: American Medical
Association, 1908, p. 9, 31.
369 “Futurescan: A Forecast of Healthcare Trends, 2003-2007” By R. Coile, Chicago, IL: Health Administration Press, 2003, p. 33.
370 “Open Payments (Physician Payments Sunshine Act)” Centers for Medicare and Medicaid Services, http://www.cms.gov/Regulations-andGuidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Physician-fact-sheet.pdf (Accessed 2/19/15), p. 1.
371 “Open Payments” Centers for Medicare and Medicaid Services, http://www.cms.gov/openpayments/ (Accessed 1/30/15).
372 “Open Payments (Physician Payments Sunshine Act)” Centers for Medicare and Medicaid Services, http://www.cms.gov/Regulations-andGuidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Physician-fact-sheet.pdf (Accessed 2/19/15), p. 1.
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THE HISTORY YOU DON’T KNOW
The only thing new in the world is the history you don’t know.
Harry S. Truman (1974), in Plain Speaking:
An Oral Biography of Harry S. Truman
Discussed in subsequent chapters of this Guide, and as mentioned in the introduction, the
healthcare industry’s four pillars, the reimbursement, regulatory, competitive, and technology
environments, are founded in the historical development of medicine and science. These
historical foundations have played a significant role in influencing the development of several
other aspects of the healthcare delivery system, for example, the organizational structure and
emerging models of healthcare, and they also have had an impact on the practice of the
healthcare consulting, both of which are discussed in more herein.
Key Sources
Key Source

Description

The Social
Transformation of
American Medicine

Paul Starr’s work
discussing the evolution
of American Medicine.

Oath of Hippocrates

An oath taken by
physicians that was
originally
written by Hippocrates
but has been revised
multiple times to date.

Centers for Medicare
and Medicaid

“The US federal agency
which administers
Medicare, Medicaid, and
the Children’s Health
Insurance Program.”

The Doctor’s Duty to
the State

Roberts’ work
discussing the healthcare
professional’s state and
federal responsibility to
community benefit.
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Citation
“The Social Transformation of
American Medicine: The Rise of a
Sovereign Profession and the
Making of a Vast Industry”
By Paul Starr, New York, NY:
Basic Books Inc., 1982.
Original: “The Hippocratic Oath:
Text, Translation, and Interpretation”
By Ludwig Edelstein, Baltimore, MD:
Johns Hopkins Press, 1943.
Modern: “The Hippocratic Oath and
the Ethics of Medicine” By Steven H.
Miles, Oxford University Press, 2004.
"Guidelines for Ensuring the Quality
of Information Disseminated to the
Public: E. Centers for Medicare &
Medicaid Services" Centers for
Medicare and Medicaid,
http://aspe.hhs.gov/infoquality/
Guidelines/CMS-9-20.shtml
(Accessed 4/2/15).
“The Doctor’s Duty to the State:
essays on the Public Relations of
Physicians” By John Bigham Roberts,
Chicago, IL: American Medical
Association, 1908.

Website

n/a

Original:
http://guides.library.jhu.edu/co
ntent.php?pid=23699&sid=190
555
Modern:
http://guides.library.jhu.edu/co
ntent.php?pid=23699&sid=190
964

www.cms.hhs.gov

n/a
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Associations
Type of
Association

National

National

Professional
Association

Description

Citation

Contact Information

American
Medical
Association

The American Medical
Association "promote[s] the
art and science of medicine
and the betterment of public
health" through several
guiding principles.

“AMA Mission & Guiding
Principles,” American
Medical Association,
www.amaassn.org/ama/pub/aboutama/our-mission.shtml
(Accessed 4/2/15).

Association of
American
Medical
Colleges
(AAMC)

The AAMC represents all 141
accredited U.S. and 17
accredited Canadian medical
schools; approximately 400
major teaching hospitals and
health systems, including 51
Department of Veterans
Affairs medical centers; and
90 academic and scientific
societies. Through these
institutions and organizations,
the AAMC represents
148,000 faculty members,
83,000 medical students, and
115,000 resident physicians.

American Medical Association
AMA Plaza
330 North Wabash Avenue
Suite 39300
Chicago, IL 60611-5885
Phone: 800-621-5885
Fax: n/a
E-mail: n/a
www.ama-assn.org

“About the AAMC,” the
Association of American
Medical Colleges,
https://www.aamc.org/about
/ (Accessed 4/2/15).

Association of American
Medical Colleges
2450 N Street, NW
Washington, DC 20037-1126
Phone: 202-828-0400
E-mail: n/a
Fax: 202-828-1125
www.aamc.org
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Reimbursement
Environment

Trust not to the omnipotency of gold, or say not
unto it, thou art my confidence.
Thomas Browne, 1643

KEY TERMS
BlueCross BlueShield
Bundling
Capitation
Charge Capture
Children’s Health Insurance Program
Civilian Health and Medical Program of the Department of
Veteran Affairs
Civilian Health and Medical Program of the Uniformed
Services
Disproportionate Share Hospital (DSH) Payments
Fee Schedule
Fee-for-Service
Health Maintenance Organization (HMO)
Health Savings Accounts
Independent Practice Association

International Classification of Diseases, Ninth Revision
(ICD-9)
International Classification of Diseases, Tenth Revision
(ICD-10)
Lockboxes
Managed Care
Medicaid
Medicare
Nonparticipating Provider
Participating Provider
Point-of-Service Plans (POS)
Preferred Provider Organization (PPO)
Revenue Cycle
Self-Insurance
TRICARE
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Key Concept

Mentioned
on Page #

Definition

Citation

Reimbursement

Payment for provider services made by
patients and third-party payors. Unlike
most businesses, healthcare providers
may have hundreds of different contracts
with payors, each with varying terms and
rates for the same services.

84

Pay-forPerformance
(P4P)

A remuneration system in which part of
the payment is dependent on performance
as measured against a defined set of
criteria. Although a P4P system can be
structured in several ways, the common
elements to all systems are (1) a set of
targets or objectives that define what will
be evaluated; (2) measures and
performance standards for establishing
the target criteria; and (3) rewards—
typically financial incentives—that are at
risk, including the amount and the
method for allocating the payments
among those who meet or exceed the
reward threshold.

“Reimbursements” in “Medical Practice
Management System” By Linda Nadeau,
Clifton Park, NY: Thomson Delmar
Learning, 2007, p. 198; “Financial
Environment of Health Care
Organizations” in “Essentials of Health
Care Finance” By William O. Cleverley
and Andrew E. Cameron, Sixth Edition,
Sudbury, MA: Jones and Bartlett
Publishers, Inc., 2007, p. 36–37.

“Pay-for-Performance in Health Care”
By Jim Hahn, CRS Report for Congress,
December 12, 2006,
http://www.allhealth.
org/briefingmaterials/crsreportingforcong
ress-pay-for-performanceinhealthcare501.pdf (Accessed 2/23/15), p. i.

169

Medical Home

A patient-centered model of healthcare
delivery and payment reform that focuses
on improving the quality of care and
reducing costs through its emphasis on
the role of primary care.

Resource Based
Relative Value
System
(RBRVS)

The scale on which Medicare bases its
standardized physician payment
schedule. The RBRVS determines
payments based on the value of the
resources necessary to provide a
particular service.

Relative Value
Unit (RVU)

The RBRVS assigns each procedure a
relative value unit, or RVU. Three types
of RVUs exist: one for physician work
(wRVU), one for practice expense (PE),
and one for malpractice costs. The three
components of the RVU can be broken
down as follows:
1. Work. The estimated value of the time,
effort, expertise, and intensity of the
service, approximately 55 percent of the
RVU value.
2. Professional Liability Insurance (PLI).
The estimated value of malpractice cost
for the service—approximately 3 percent
of RVU value.
3. Practice expense. The estimated value
of overhead and other expenses necessary
to run the practice, approximately 42
percent of the RVU value.
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“Medical Home Models: Improving Care
and Reducing Costs in Healthcare” By
Laura M. Greene, Healthcare Intelligence
Network, May 2009, www.hin.com/cgilocal/link/ news/pl.cgi?pcmh09
(Accessed 5/24/10).
“Overview of the RBRVS” American
Medical Association, http://www.
ama-assn.org/ama/pub/physicianresources/solutions-managing-yourpractice/coding-billing-insurance/
medicare/the-resource-based-relativevalue-scale/overview-of-rbrvs.shtml
(Accessed 10/5/09).

“Gauging Emergency Physician
Productivity: Are RVUs the Answer” By
John Proctor, American College of
Emergency Physicians, www.acep.
org/practres.aspx?id=30306 (Accessed
4/1/09).
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Mentioned
on Page #

Key Concept

Definition

Citation

Healthcare
Common
Procedure
Coding System
(HCPCS)

A coding system that provides the payor
information in regard to the procedures
performed in the treatment of patients.
The system does not relay diagnosis
information. HCPCS codes are used by
hospitals to report information on
procedures performed for outpatient
services and by physicians to report
information in connection with the
performance of procedures in both the
inpatient and outpatient settings. Two
HCPCS levels exist: Level I codes are
referred to as Current Procedural
Terminology (CPT) codes, and Level II
codes are temporary codes used to
represent services, supplies, and
procedures for which CPT codes do not
yet exist.

“Billing and Coding for Health Services”
in “Essentials of Health Care Finance”
By William O. Cleverley and Andrew E.
Cameron, Sixth Edition, Sudbury, MA:
Jones and Bartlett Publishers, Inc., 2007,
p. 18.

91

“Understanding Health Insurance: A
Guide to Billing and Reimbursement” By
Michelle A. Green and JoAnn C. Rowell,
Twelfth Edition, Stamford, CT: Cengage
Learning, 2013, p. 218-219.: A Guide to
Billing and Reimbursement” By
Michelle A. Green and JoAnn C. Rowell,
Twelfth Edition, Stamford, CT: Cengage
Learning, 2013, p. 218.

91

“Diagnosis-related group (DRG),” By
Charlyn Stanberry, American Health
Lawyers Association, 8/10/2012, p. 1,
http://www.healthlawyers.org/hlresource
s/Health%20Law%20Wiki/Diagnosisrelated% 20group%20(DRG).aspx
(Accessed 6/3/14).

115

“Understanding Health Insurance: A
Guide to Billing and Reimbursement” By
Michelle A. Green and JoAnn C. Rowell,
Twelfth Edition, Stamford, CT: Cengage
Learning, 2013, p. 600.

151

“Indian Health Service Introduction” By
Indian Health Services, I.gov, June 2009,
http://www.ihs.gov/PublicInfo/PublicAff
airs/Welcome_Info/IHSintro.asp
(Accessed 8/10/09).

153

Current
Procedural
Terminology
(CPT)

DiagnosisRelated Group
(DRG)

Workers’
Compensation

Indian Health
Services (IHS)

A system developed by the American
Medical Association that is used by
providers to report information to
patients and insurers about services and
procedures provided to patients.
A way to categorize patients in hospitals
based on the relative intensity of services
related to that diagnosis. Patients
typically are classified based on their
admitting diagnosis, which is grouped
with other diagnoses into a DRG so that
the hospital can identify groups of
patients that require roughly the same
amount of resources.
Laws that provide healthcare coverage
and monetary payments to employees
injured at work or suffering from an
occupational disease and monetary
benefits for the dependents of employees
killed on the job. In addition, the laws
limit the financial liability of employers,
and they nearly eliminate the financial
liability of co-workers for most accidents.
An agency located within the United
States Department of Health and Human
Services. It provides healthcare services
to approximately 1.9 million American
Indians and Alaska Natives directly
through tribal healthcare programs and
indirectly through purchases from private
providers.

(continued)
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Mentioned
on Page #

Key Concept

Definition

Citation

Commercial
Insurers

Plans that are offered by life insurance
companies, casualty insurance
companies, and companies that were
formed for the sole purpose of offering
health insurance.

“The Financial Environment” in
“Healthcare Finance: An Introduction to
Accounting and Financial Management”
By Louis C. Gapenski, Third Edition,
Chicago, IL: Health Administration
Press, 2004, p. 35.

154

“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 140–41.

170

“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 140–41.
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“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 181.

170

“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 186.

170

“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 186.

170

Fee Allowance
Schedule

Relative Value
Scale (RVS)

Performance
Based Fee-ForService

Retainer

Hourly & Salary
Reimbursement

82

A managed care reimbursement scheme
by which the fees for procedures are
explicitly laid out and the physician
agrees to accept those fees as full
payment, unless the discounted charges
are less than the fee schedule in which
case the plan pays the lesser of the two.
The reimbursement scheme by which
each procedure is assigned a relative
value which is multiplied by a negotiated
factor (the multiplier), usually a discount,
to arrive at a payment.
A managed care reimbursement scheme
using a scale that adjusts fees based on
individual medical specialties. In this
approach, each specialty has a permember-per-month budget (for example,
$2 per member per month for OB/GYN),
and actual costs are measured against that
budget. If costs exceed the budget, then
fees are lowered but only for that
specialty and vice versa if costs are better
than budget. This system requires a
highly sophisticated tracking system and
a large enough patient base to make the
analysis statistically significant, which
makes it well suited for independent
practice associations.
A managed care reimbursement scheme
that involves a set monthly payment
amount for each physician, reconciled at
periodic intervals based on actual
utilization, either as a pre-negotiated
discount on charges or on some other
objective measure. This ensures the
availability of physicians to members and
provides for the steady income desired by
physicians, while still allowing payment
on the basis of actual utilization.
A way to pay physicians at an hourly rate
or a salary for performing services. This
type of arrangement is common in
emergency departments or other settings
in which a physician needs to be
available for a defined period of time.
This arrangement also works when
buying on-call coverage to back up an inhouse physician.
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Key Concept

Single Fee
Reimbursement

Bundled Case
Rates or Package
Pricing

Periodic Interim
Payments (PIPs)
and Cash
Advances

Definition
A scheme under which fees are paid for a
procedure no matter how much time and
effort is required. Two applications of
this method exist:
1. Case rates or flat rates. The same rate
is paid for a procedure no matter what
choice of treatment used; for example, a
physician is reimbursed the same amount
for delivering a baby regardless of
whether it was a vaginal birth or delivery
by way of a cesarean section surgery.
2. Global fees. A flat rate encompassing
more than a single type of service. For
example, a global fee for surgery may
include all preoperative and postoperative
care as well as one or two follow-up
office visits. A global fee for obstetrics
may include all prenatal and postnatal
care.
A form of reimbursement that combines
institutional and professional charges into
a single payment; for example, a plan
may negotiate a bundled case rate of
$20,000 for cardiac bypass surgery,
which covers all staff for preoperative
and postoperative care. Usually outlier
provisions exist for cases that become
catastrophic.
A managed care reimbursement plan that
advances the provider a set amount of
cash equivalent to a defined time period’s
expected reimbursable charges. As claims
come in from a physician, the claims are
subtracted from the PIP, which is
routinely replenished. In this way, the
physician has a positive cash flow, as
well as the use of the plan’s money,
interest free. This method may be
employed in a plan with a heavy POS
enrollment.

Citation

Mentioned
on Page #

“The Managed Health Care Handbook,
Third Edition,” by Peter R. Kongstvedt,
Ernst & Young, 1996, p. 186–87.

170

“The Managed Health Care Handbook,
Third Edition,” by Peter R. Kongstvedt,
Ernst & Young, 1996, p. 187.

170

“The Managed Health Care Handbook,
Third Edition” By Peter R. Kongstvedt,
Ernst & Young, 1996, p. 187.

170
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OVERVIEW
Healthcare reimbursement is the payment received by providers for the services they render to
patients.1 Most providers will be reimbursed for their services by patients and by third-party
payors, including, but not limited to, employers, insurance companies, and government
agencies.2 Unlike most businesses, which bill their customers based on a fixed-price per unit set
by the business and multiplied by the quantity sold, healthcare providers may have hundreds of
different contracts with payors, each with varying terms and rates for the same services.3 These
payments may take a variety of forms, including payment at a fee set by the provider, a
discounted fee negotiated by the parties, a fee schedule set by the payor, a relative value scale
that takes into consideration various costs incurred by the provider rendering the service in a
particular geographic locale, capitation based on the number of individuals enrolled in a plan,
bundled payments which pay providers on a per-diem or per-case rate multiplied by the length of
stay, or a prospective payment system (PPS), which reimburses providers a set amount in
accordance with a patient’s diagnosis or treatment.4
In 2013, U.S. healthcare expenditures totaled $2.9 trillion, or 17.4 percent of the gross domestic
product (GDP).5 U.S. healthcare costs have exceeded general inflation for twenty years.6 To
combat these rising costs, private payors, state governments, and the federal government have
implemented PPSs, fee schedules, selective contracting agreements, and managed care
principles, but, until recently, this continued growth has yet to slow.7 In addition, healthcare
reform has taken center stage in federal and state politics, with reform efforts aimed at reducing
the cost of care and improving healthcare by tying provider reimbursement to patient outcomes
and the quality of care, allowing providers to receive a share of the savings attributable to their
cost-cutting efforts, increasing the coordination of care, increasing the reliance on capitated
payments and bundling provider payments.

HEALTHCARE REVENUE CYCLE
The revenue cycle describes the process by which a provider practice schedules patients,
diagnoses conditions, documents and codes the diagnoses, bills payors, complete claims
resolutions, and collects billable charges from the payor and the patient to recover revenue for
the services provided.8 See Figure 2-1 for a pictorial description of the revenue cycle in
healthcare.
1
2
3
4
5
6
7
8
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“Healthcare Valuation: The Financial Appraisal of Enterprises, Assets, and Services in an Era of Reform” By Robert James Cimasi,
Volume I, New York, NY: John Wiley & Sons, 2014, p. 85.
“Medical Practice Management System” By Linda Nadeau, Clifton Park, NY: Thomson Delmar Learning, 2007, p. 198.
“Essentials of Heath Care Finance” By William O. Cleverley and Andrew E. Cameron, 6th Edition, Sudbury, MA: Jones and Bartlett
Publishers, Inc., 2007, p. 36-37.
“Essentials of Heath Care Finance” By William O. Cleverley and Andrew E. Cameron, 6th Edition, Sudbury, MA: Jones and Bartlett
Publishers, Inc., 2007, p. 36-45.
“NHE Fact Sheet” Centers For Medicare & Medicaid Services, December 3, 2014, http://www.cms.gov/ Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html (Accessed 1/29/15).
“IT Investments for Naught Unless They Cut Healthcare Costs, Says Greenspan” By Neil Versel, Healthcare IT News, April 9, 2009,
http://www.healthcareitnews.com/news/it-investments-naught-unless-they-cut-healthcare-costs-says-greenspan (Accessed 8/25/09).
“Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 106.
“Financial Management of the Medical Practice” By Max Reiboldt, Second Edition, The Coker Group, American Medical Association,
2002, p. 12-14.
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ELEMENTS OF THE REVENUE CYCLE
Figure 2-1: The Healthcare Revenue Cycle

2. Patient Encounter
Forms
(For Providers to Note
What Diagnoses and
Services Occurred)

1. Scheduling &
Registration

3. Diagnostic
& Procedural
Coding

(Of Patients to
Maintain Appropriate
Patient Volume)

(Using ICD-9[10],
HCPCS & CPT
Codes)

Healthcare
Revenue
Cycle

4. Charge Entry
(Capturing the
Charge by Charge
Entry Procedures
Performed
for Billing)

5. Primary Billing
(To Primary Public &
Private Payors)

7. Claims Resolution
(Account Follow-Up on
Past-Due Accounts)

6. Secondary Billing
(To Secondary Public
& Private Payors)

Step 1: Scheduling and Registration
The revenue cycle typically begins when a patient schedules his or her appointment.9 The
importance of a practice’s scheduling system should not be underestimated, as patient-physician
relationships and a healthy revenue cycle depend on it.10 Although a system that overbooks
appointments may lead to a stressful office environment that could negatively affect revenue, a
steady flow of patients is what brings in revenue to the practice.11 Therefore, to maximize

9
10
11

“Financial Management of the Medical Practice” By Max Reiboldt, Second Edition, The Coker Group, American Medical Association,
2002, p. 11.
“Medical Practice Management System” By Linda Nadeau, Clifton Park, NY: Thomson Delmar Learning, 2007, p. 96.
Ibid.
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revenue, when developing a scheduling system, private practices should give sufficient thought
to the type of patients to be seen, their medical conditions, provider tasks that need to be
completed throughout the day (for example, chart review and dictation), the provider’s
scheduling preferences, and the likelihood of walk-ins and no-shows.12
A key element of the revenue cycle is an effective registration system that accurately collects
patient information. This is especially important when dealing with claims that are paid by thirdparty payors, because erroneous or omitted information may delay reimbursement.13 To ensure
revenue maximization, a patient’s demographic information should be verified every time the
patient sees a provider.14 In addition, staff should check the patient’s eligibility status and satisfy
any pre-authorization requirements before the patient receives services in order to avoid the
denial of a claim.15
Volume Management
Volume management is critical to a successful practice because the main objective of an
appointment scheduling system is to have a continuous succession of patients each day.16 Too
often, healthcare practices use off-the-shelf software or appointment books, and they proceed to
schedule patients in the predetermined time slots without considering whether this schedule
realistically accommodates the needs of the practice.17 To better manage patient volume, an
appointment scheduling system should be set according to the amount of time each provider
prefers to spend per patient type and appointment type, the maximum number of patients to
schedule per day, and the amount of time required per appointment type for every provider in the
practice.18 An appointment system based on these criteria will ensure a workable schedule that
maximizes patient satisfaction and physician efficiency.19

Step 2: Patient Encounter Forms
Before services are coded for the billing process, providers must note the principal and related
diagnoses and must document, with specificity, the nature and scope of services rendered during
a patient encounter.20 Providers document patient history and responses, diagnoses, procedures
performed, and follow-up information on either a paper or an electronic form, known as a patient
encounter form, superbill, or charge ticket. This information may be incorporated into a patient’s
electronic medical record (EMR).21
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Step 3: Diagnostic and Procedural Coding
Accurate coding and documentation are necessary to ensure proper payment, as treatment
information in a patient’s medical record is used to trigger payment in the billing process.22 The
proper education of the provider and staff, and the regular review of coding procedures, can help
ensure accuracy and the legitimate maximization of practice revenue.23
Providers typically bill for a professional component (PC), technical component (TC), or the global diagnostic
code (PC + TC) when billing for diagnostic services.
Federal Register, 2009.

In the case of diagnostic services, providers typically bill for both a professional fee component
and a technical component24 or they may report a global diagnostic code, which is a combination
of both the professional fee and technical components.25 If reporting is done with a global
diagnostic code, reimbursement is equal to the sum of the professional fee and technical
components that could have been billed separately for the services.26
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) requires providers to
classify (1) diagnoses and (2) clinical procedures by using several coding systems (see chapter 3,
Health Insurance Portability and Accountability Act of 1996 (HIPAA)).27
The most commonly implemented coding systems include: ICD-9, HCPCS, ICD-10, CPT-4, CDT, and the
NDC.
Centers for Medicare and Medicaid, 2014.

The most commonly implemented coding systems include the International Classification of
Diseases, Ninth Revision (ICD-9), the Healthcare Common Procedure Coding System (HCPCS),
for classifying ancillary services and procedures, the imminent ICD-10 (as of October 1, 2015),
the Current Procedural Terminology (CPT-4) for physician procedures in both inpatient and
outpatient settings, the Current Dental Terminology for dental procedures (CDT), and the
National Drug Code (NDC) system.28 For diagnosis reporting, all healthcare providers, including
both physician professional practices and other facilities (for example, hospitals), use the ICD-9,
Clinical Modification (ICD-9-CM). The ICD-9 Procedure Coding System (ICD-9-PCS) is used
for procedure reporting for hospital inpatients. Despite the fact that ICD-9 is used universally for
classifying diagnoses, procedural reporting is not as simple. Procedural coding depends on
22
23
24
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26
27
28

“Essentials of Health Care Finance” By William O. Cleverley and Andrew E. Cameron, Sixth Edition, Sudbury, MA: Jones and Bartlett
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(1) whether the designated provider is a physician or a facility and (2) in the circumstance of a
facility provider, whether the procedure was performed within an inpatient or outpatient system.
Procedures and services submitted on a claim must be linked, by way of appropriate CPT,
HCPCS Level II, or ICD-9 codes, to the ICD-9-CM code that corresponds to the diagnostic
reasoning behind the claim.29 Table 2-1 illustrates the coding systems used for services provided
by each provider type within each setting.30
Table 2-1: HIPAA-Designated Coding31
Inpatient

Outpatient

Provider
Type

Diagnosis

Procedure

Diagnosis

Procedure

Physician

ICD-9-CM

CPT

ICD-9-CM

Facility

ICD-9-CM

ICD-9-CM

ICD-9-CM

CPT
HCPCS (CPT and
HCPCS Level II)

International Classification of Diseases 9th Revision—Clinical Modification
The ICD-9 system has codes that supply a payor with information regarding both the patient
diagnosis and the procedures performed in treating the diagnosis.32 HIPAA requires all
healthcare providers to use the ICD-9 codes when reporting diagnosis information to payors.33 In
addition, HIPAA requires that hospitals use the ICD-9 procedural codes when reporting
information to payors detailing the treatment of hospital inpatients.34
Shift from ICD-9 to ICD-10 Coding
In early 2009, the United States Department of Health and Human Services (HHS) announced a
final rule that called for the replacement of the current ICD-9 code set used to report healthcare
diagnoses and procedures with the International Classification of Diseases, Tenth Revision (ICD10) set by October 1, 2013.35 This date was delayed twice, most recently as a part of the
Protecting Access to Medicare Act of 2014, which set the compliance date for October 1, 2015.36
The delays of implementation have been the result of concerns among many in the industry that
adopting ICD-10 will require substantial capital spending and require complete I
implementation. However, the adoption of the new system will offer several benefits to help
enhance the quality and efficiency of care. These include the facilitation of quality data
reporting, support for pay for performance payment methodologies, improved billing accuracy,
and the ability for international comparison of the incidence and spread of disease.37
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Even with the calls for further delays, many in the industry are preparing for the October 1, 2015
date to take effect. In 2014, an HIMSS survey of healthcare IT professionals found that while
only 69% of respondents felt the conversion to ICD-10 was a top IT priority, 92% of the
respondents indicated their conversion would be complete by October 2014.38 Additionally, as of
2013, 64% of hospital respondents began the process of re-training their coding staff and 68%
began updating their document improvement education for the conversion to ICD-10.39
Differences between ICD-9 and ICD-10
Note the several major differences between the current ICD-9 code set and the new ICD-10 code
set:
(1) Size. The ICD-9 code set contains 13,000 codes and parts of the code set are running out
of space, whereas the ICD-10 code set contains more than 68,000 codes and has ample
room for the addition of new diagnoses and procedures.40
(2) Specificity. The new ICD-10 code set provides for greater specificity when diagnosing
conditions to allow for a greater amount of detailed and specific information to be
documented in an episode of care. For example, under the new system, 1,170 codes
describe angioplasty, whereas the ICD-9 code set has only one. This allows the episode
of care to document the precise location of the blockage and what instruments were used
to expand the vessel.41
(3) Basic information. It is anticipated that the ICD-10 system will improve the quality of
care provided through the communication of basic information the ICD-9 code does not
provide, such as informing providers about which side of a patient’s body the condition
occurred.42
Financial Impact of the Shift
The switch to the ICD-10 code set will not be without costs. According to a 2008 study,
physicians will incur significant expenditures associated with the change in six key areas:
(1)
(2)
(3)
(4)
(5)
(6)
38
39
40
41
42
43

employee education and training;
business processes;
billing documents;
information technology systems;
documentation; and
disruptions in cash flow.43
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Although the extent of these expenditures will vary by practice, the study estimates that they will
range from slightly more than $83,000 for a “small” practice, consisting of three physicians and
two administrative employees, to slightly more than $2.7 million for a “large” practice,
consisting of one hundred providers, ten full time coders, and fifty-four medical records
employees.44 This study was recreated in 2014, and the researchers found the updated expenses
to range between approximately $56,639 for a small practice to $8,018,364 for a large practice.45
The variation of costs is categorized and detailed in Table 2-2 below.
Table 2-2: ICD-10 Increased Cost Estimates from the American Medical Association
2014 Study46
Type of Cost

Typical Small Practice

Typical Medium Practice

Typical Large Practice

Training

$2,700–$3,000

$4,800–$7,900

$75,100

Assessment

$4,300–$7,000

$6,535–$9,600

$19,320

Vendor/Software Upgrades

$0–$60,000

$0–$200,000

$0–$2,000,000

Process Remediation

$3,312–$6,701

$6,211–$12,990

$14,874–$31,821

Testing

$15,248–$28,805

$47,906–$93,098

$428,740–$880,660

Productivity Loss

$8,500–$20,250

$72,649–$166,649

$726,487–$1,666,487

Payment Disruption

$22,579–$100,349

$75,263–$334,498

$752,630–$3,344,976

Total Costs

$56,639–$226,105

$213,364–$824,735

$2,017,151–$8,018,364

In 2008, expenditures for the shift from ICD-9 to ICD-10 were estimated to cost anywhere from $83,000 to
$2.7 million, depending on the size of the practice. As of 2014, these costs are predicted to range between
approximately $56,639 for a small practice with minimum expenses to $8,018,364 for a large practice with
maximum expenses.
Nachimson Advisors, LLC, 2008; American Medical Association, 2014.

Procedural Coding
Procedure codes are used to identify and classify medical services including surgical procedures
and diagnostic tests, evaluation and management codes for patient visits and examinations, and
to evaluate medical necessity of report charges.47 Specifically, this type of coding depends on
whether the designated provider is a physician or a facility; and in the circumstances of the
facility provider, whether the services were performed as an inpatient or an outpatient
procedure.48 Any service that is submitted on a claim for payment must be linked through its
appropriate procedure code, corresponding to the diagnostic reasoning behind the claim.49
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Healthcare Common Procedure Coding System (HCPCS)
The Healthcare Common Procedure Coding System (HCPCS) provides the payor information
regarding the procedures performed in the treatment of patients.50 The system does not relay
diagnosis information.51 Hospitals use HCPCS codes to report information on procedures
performed for outpatient services, while physicians use them to report information in connection
with the performance of procedures in both the inpatient and outpatient settings.52 There are two
HCPCS levels: Level I codes are referred to as Current Procedural Terminology (CPT) codes,
and Level II codes are temporary codes used to represent services, supplies, and procedures for
those CPT codes that do not yet exist.53
Current Procedural Terminology (CPT)
Current Procedural Terminology (CPT) is a system developed by the American Medical
Association (AMA) that providers use to report information to patients and to insurers about
services and procedures provided to patients.54 In response to the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA), the Centers for Medicare and Medicaid
Services (CMS) adopted regulations that require “new, revised, and deleted CPT codes be
implemented” on the first day of January each year.55 Currently, the system divides the
established codes between six sections that will differentiate among the various types of
procedures. These six sections include:
(1)
(2)
(3)
(4)
(5)
(6)

Evaluation and management (E/M);
Anesthesiology;
Surgery;
Radiology, including nuclear medicine and diagnostic ultrasound;
Pathology and laboratory; and
Medicine, excluding anesthesiology.56

The E/M section is used to describe the type of service, place of service, and patient’s status.57
Figure 2-2 displays the subdivisions between E/M codes.
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Figure 2-2: EM Code Subdivisions58

Determining coding for each E/M service requires the provider to determine a level of
complexity, establish a diagnosis, or select a care management option. A code’s complexity level
is determined by the number of options available, the amount of and complexity of a patient’s
medical record and history, and the risk of complications, morbidity, mortality, and/or
comorbidity with the patient’s current condition. The third determinant may also include the
diagnosis or the selected care management option. Table 2-3 below displays the various
categorical classifications that are associated with each level of complexity.
Table 2-3: Assignment of Complexity Level for E/M Services59
Level of Complexity

Number of Options Available

Amount of, and Complexity
of, the Data to be Reviewed

Risks Associated with a
Particular Case

Straightforward

Minimal

None-Minimal

Minimal

Low Complexity

Limited

Limited

Low

Moderate Complexity

Multiple

Moderate

Moderate

High Complexity

Extensive

Extensive

High

In addition to the Category I CPT codes above, there are also Category II and III CPT codes that
are considered supplementary. Category II codes are optional and account for performance
assessment and quality improvement activities. They use a four digit numerical code to describe
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the activity and use a fifth character letter to describe the patient’s characteristics.60 Currently the
sections of Category II codes are as follows:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)

Composite measures;
Patient Management;
Patient History;
Physical Examination;
Diagnostic/Screening Processes or Results;
Therapeutic, Preventative, or Other Interventions;
Follow-up or Other Outcomes;
Patient Safety; and
Structural Measures.61

Category III CPT codes are temporary and are assigned to emerging medical technologies,
services, and procedures as needed.62
Additionally, there are often occasions where multiple combinations of HCPCS and CPT codes
apply to a particular procedure.63 Despite the many ways providers may code for a procedure,
they are not permitted to separate, or unbundle, codes for different components of a
comprehensive procedure if a code exists for the entire procedure.64 CMS developed the National
Correct Coding Initiative (NCCI) in an effort to prevent improper coding (for example,
unbundling CPT codes in an effort to receive higher payments) and standardize national coding
procedures.65 The NCCI policy manual lists HCPCS and CPT codes that cannot be reported
together unless a NCCI-associated modifier is used in a clinically appropriate manner.66 NCCI
denies claims when certain pairs of codes are reported together because one of the two codes
may represent a component procedure to the procedure described by the other code, or because
the two described procedures cannot possibly be performed together.67 Additionally, some
procedures that are integral to more comprehensive procedures (for example, wound irrigation is
essential to the comprehensive treatment of all wounds) do not have CPT codes at all, and,
therefore, should not be reported separately.68
Other Commonly Used Procedural Coding System: National Drug Codes (NDC)
and Current Dental Terminology (CDT)
The National Drug Codes (NDC) is a coding system that provides a list of all the pharmaceutical
products that are considered to be final marketed drugs and have been submitted to the Food and
Drug Administration (FDA) in the electronic listing format by a labeler. Published and
60
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maintained by the FDA, the codes use a unique ten digit, three-segment number as the universal
identifier for each product.69 The identifier provides information about the labeler (first
segment), product information (second segment), and trade package size and type (third
segment). Originally the NDC was updated twice a month; however as of February 1, 2013, the
FDA began updating the NDC daily.70
The Current Dental Terminology (CDT) is a coding system used to achieve uniformity,
consistency, and specificity in the reporting of all dental procedures in order to properly process
claims.71 The CDT is revised annually by the American Dental Association’s Code Maintenance
Committee (CMC) to ensure that the code accurately reflects the most current procedures for
reimbursement and liability purposes.72
Modifiers
Modifiers are two-digit codes added to five-digit CPT codes to clarify the services and
procedures performed.73 Modifiers may be added to CPT codes for a number of reasons,
including that the procedure was performed more than once, performed by more than one
physician, or discontinued because of threats to a patient’s health.74 The AMA updates the list of
modifiers on a continuous basis.75 The expansion of modifiers presents the potential for some of
the same operational and financial challenges as does the expansion of CPT codes.76 A
provider’s costs may increase if billing time increases and the need for staff training arises.77
However, as with expansions to the CPT coding system, an increase in the number of modifiers
may lead to increased revenue because the added modifiers may lead to reimbursement for
procedures and services not previously covered.78

Step 4: Documentation to Capture the Charge
Upon completion of the coding and documentation process, “the revenue cycle moves from the
clinical side to the business side.”79 Capturing the charge entails the transfer of a provider’s
coding and documentation to the actual bill.80 Providers are tasked with recording the appropriate
procedure and diagnosis codes on an encounter form, and their business staff is responsible for
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ensuring that the encounter form is accurate before using it to bill patients and third-party
insurers.81
Electronic Charge Capture
To improve charge capture and revenue generation, the more technologically advanced practices
have begun using personal digital assistants to capture charges.82 The electronic capture systems
are then tied into the practice’s practice management system, a computer system designed to
collect registration and insurance information, facilitate billing and collections, and perform
other operational functions so that charges can be downloaded and posted electronically.83 These
systems help reduce errors that may occur in the capture process, and they reduce the time
between service and charge entry.84
Capturing Revenue for Office- and Hospital-Based Professional Practices
Office-based professional practices can capture inpatient charges in a variety of ways. Typically,
if a practice has not adopted an electronic charge capture system as described previously, it may
rely on the older method of charge capture, which requires the physician to actually note every
consult or procedure he or she performs on a paper form.85 Other practices hire staff to review
hospital charts onsite for all patients seen by the practice’s physicians.86 In addition, to capture
charges when the office-based practice is closed, some providers have set up a phone message
system to which the physician can call, order to record the relevant patient information, and from
which the staff performs the relevant billing actions when the office reopens.87
Hospital-based professionals typically capture charges in much the same way as their officebased counterparts, using either paper forms or electronic charge capture devices, although their
bills are then submitted to the hospital’s billing department.88

Steps 5 & 6: Patient and Insurance Billing
Once a provider has properly coded and documented the services provided, its staff must ensure
the accuracy of the charge captures in order to facilitate accurate and timely billing of patients
and third-party insurers.89 Many providers implement practice management systems, process
81
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claims electronically, work to maintain relationships with payors, develop internal information
system processes, and develop other steps to ensure the effectiveness of the billing process.90
Without an effective billing process, the revenue cycle will breakdown, money will be lost, and
the full financial potential of the practice will not be realized.91
Primary Insurance Billing
A provider may submit a bill of exchange, a written document drafted by a party ordering
payment from a third party, through their central billing department to the primary insurer. These
bills are almost always submitted electronically.92 Notably, as of 2005, Medicare began refusing
to accept paper claims for any physician practice with more than 9 FTEs and any institution with
more than 24 FTEs. As a result, many providers began utilizing clearinghouses or electronic data
interchanges. These two types of entities assess each claim for errors and securely forward the
bill to the correct payor. Clearinghouses also offer a service where they transform paper claims
into the appropriate electronic format.93
Secondary Insurance Billing & Patient Responsibility
Once copayments and deductibles have been paid by the patient and primary payors have been
billed, any remaining amount owed can be billed to a secondary payor. Some patients may have
secondary insurance from their spouse or parent, an alternative public payor system for which
the patient is eligible, or through supplemental insurance that covers any gaps left from the
primary insurance coverage. The procedures and scope of coverage and benefits differ based on
the secondary insurance party. After the copayment has been deducted and the insurers have
determined their coverage, any amount left may be billed to the patient.94 It is important to note
that when a patient is covered by a participating public payor, the provider may not bill a person
the amount to close the gap between what the provider was charged and what the payor was
allowed to bill for that service.95

Step 7: Account Follow-Up, Claims Resolutions, and Collections
Submitting claims to third-party payors and sending bills to patients are not always sufficient to
ensure timely payment, and follow-up on overdue accounts is often necessary to correct billing
errors or to encourage payment by those who refuse to pay or cannot pay in a timely manner.96
Thus, the revenue cycle is complete with the successful performance of the account follow-up
and collection process.97 A practice’s past due accounts should be continually monitored, and
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“Healthcare Valuation: The Four Pillars of Healthcare” By Robert James Cimasi, MHA, ASA, FRICS, MCBA, AVA, CM&AA, Vol. I,
Hoboken, NJ: Wiley & Sons, Inc., 2014, p. 103.
“Say Goodbye to Paper: Noncompliant Medicare Claims Oct. 1” By Joyce Frieden, Family Practice News, September 1, 2005, p. 6.
“Healthcare Valuation: The Four Pillars of Healthcare” By Robert James Cimasi, MHA, ASA, FRICS, MCBA, AVA, CM&AA, Vol. I,
Hoboken, NJ: Wiley & Sons, Inc., 2014, p. 104.
“State Plans for Medical Assistance,” Social Security Act, Section 1902(n)(3)(B) (1997) (modified by “Balanced Budget Act of 1997” Pub.
L. No. 105-33, § 4714, 111 Stat. 251, 509 (1997)).
“Prohibition on Balance Billing Qualified Medicare Beneficiaries (QMBs)” Centers for Medicare & Medicaid Services, MLN Matters
Number: SE1128, Revised, July 25, 2012, p. 2.
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when attempting to collect payment, it should use frequent phone calls, e-mails, and collection
letters and other forms of communication, as needed.98
Use of Lockboxes
Instead of handling the collection and processing of payments themselves, providers may decide
to use a lockbox service. For a fee, lockbox services open a provider’s mail, collect payments,
and deposit payments into the provider’s account.99 A lockbox service is convenient in that it
saves the practice the time and resources of performing these procedures themselves. However,
if the lockbox service is slow to process the payments, a payor who has properly paid its bill may
receive another statement from the provider requesting payment, thereby creating more work for
the provider and frustration for the patient.100
Accounting for Bad Debt
Regardless of the amount of effort a provider puts into the collection process, some account
balances may never be collected. In these instances, providers will likely write the “balance off
the accounts receivable as bad debt.”101 At this time, the provider must then decide whether to
send the account to an outside collection agency, which will attempt to recover the balance for a
fee, or give up all attempts at recovery because it may cost more to further pursue payment than
to receive the outstanding amount.102

CHANGING NATURE OF THE REVENUE CYCLE
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle
management regulations, will force providers to assess their revenue cycle management systems,
resulting in system upgrades and the purchase of new systems over the next several years.103
Since payment flows and the calculations of reimbursements and balances after insurance will
make the revenue cycle more complicated,104 providers with older revenue cycle management
systems may need to upgrade these systems in order to improve patient satisfaction and
convenience and to allow providers to more efficiently manage their revenue cycles.105 Patient
satisfaction, convenience, and increased efficiency will result from, among other things, the
patient’s ability to pre-register, schedule, and pay for their services by way of their provider’s
website.106 Similarly, providers will benefit from new systems that improve efficiency by way of
checking the payor’s rules to ensure that the services to be performed are covered by the payor,
automatically creating bills from the electronic medical record, bypassing clearinghouses and
98
99
100
101
102
103
104
105
106

“The Revenue Cycle,” By Max Reiboldt and the Coker Group, in Financial Management of the Medical Practice, 2nd ed., Chicago, IL:
American Medical Association, 2002, p. 14.
“The Physician Billing Process: Avoiding Potholes in the Road to Getting Paid” By Deborah L. Walker, Sara M. Larch, and Elizabeth W.
Woodcock, Englewood, CO: Medical Group Management Association, 2004, p. 80.
Ibid.
Ibid, p. 137.
Ibid, p. 137.
“Essentials of the U. S. Hospital IT Market” By HIMSS Analytics, Fourth Edition, 2009, http://www.himssanalytics.org/docs/
4thEditionEssentialsNGRCMfinal.pdf (Accessed 8/21/09); “Revenue Cycle Management-Storm Clouds on the Horizon” By Mike Davis,
Future Healthcare, 2007, http://www.futurehealthcareus.com/?mc=revenue-cycle&page=fin-viewresearch (Accessed 8/21/09).
“Hospital Revenue Cycle Operations: Opportunities Created by the ACA” By Mathew Bayley, et al., McKinsey Healthcare Systems and
Services Practice (May 2013), p. 51.
“Essentials of the U. S. Hospital IT Market” By HIMSS Analytics, Fourth Edition, 2009, http://www.himssanalytics.org/docs/
4thEditionEssentialsNGRCMfinal.pdf (Accessed 8/21/09).
“Revenue Cycle Management-Storm Clouds on the Horizon” By Mike Davis, Future Healthcare, 2007, http://www.futurehealthcareus.com/
?mc=revenue-cycle&page=fin-viewresearch (Accessed 8/21/09).
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submitting claims directly to payors, enabling providers to receive electronic funds transferred
directly from the payor to the provider’s bank, and allowing providers to integrate their financial
and clinical data.107

CURRENT REIMBURSEMENT ENVIRONMENT
The Healthcare reimbursement environment is composed of an elaborate set of relationships
between healthcare providers, payors, and patients. The nature of any particular relationship
between these entities is characterized by:
(1)
(2)
(3)
(4)

The type of service provided;
The location where that service is provided;
The type of payor for the service; and
The type of reimbursement model utilized.

The most recent breakdown of national health expenditures by type of service is illustrated in
Figure 2-3: Allocation of Healthcare Expenditures by Type of Service, below.
Figure 2-3: Allocation of Healthcare Expenditures by Type of Service108

107 “Revenue Cycle Management-Storm Clouds on the Horizon” By Mike Davis, Future Healthcare, 2007, http://www.futurehealthcareus.com/
?mc=revenue-cycle&page=fin-viewresearch (Accessed 8/21/09).
108 “National Health Expenditures by Type of Service and Source of Funds, CY 1960-2013” Centers for Medicare & Medicaid Services,
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports/NationalHealthExpendData/Downloads/NHE2013.zip (Accessed 2/24/2015). Other Personal Health Care includes dental and other
professional health services, as well as durable and non-durable medical equipment. Other Health Spending includes administration and net
cost of health insurance, public health activity, research, as well as structures and equipment.
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A variety of payors are responsible for organizing the payment of these various healthcare
services. The most recent breakdown of National Health Consumption Expenditures by type of
payor is illustrated in Table 2-4: Allocation of National Health Consumption Expenditures by
Payor, below.
Table 2-4: Allocation of National Health Consumption Expenditures by Payor109
Payor

Percentage of National Health
Consumption Expenditures

Private Insurance

35%

Medicare

21%

Medicaid

16%

Other Health Insurance Programs

4%

Other Third Party Payors, Programs,
and Public Health Activity

11%

Out of Pocket

12%

Total

100%

These healthcare payors are discussed in detail, below.

PUBLIC PAYORS
As the baby boomer generation becomes eligible for Medicare, public payor spending is
expected to grow at a greater rate than private payor spending. From 2016 to 2023, Medicare
spending is projected to grow over 7% per year compared to 5.4% for private payors.110
Spending by public payors already represents a significant portion of the healthcare industry,
with estimated payments by public programs surpassing 40% of all national health expenditures
(NHE) in 2014.111 This prevalence of public payors in the healthcare marketplace typically tends
to set the benchmark for private reimbursement rates.112 Among these influential public payors
are Medicare, Medicaid, State Children’s Health Insurance Program (SCHIP), TRICARE,
Civilian Health and Medical Program of the Department of Veteran Affairs (CHAMPVA),
workers’ compensation, and Indian Health Services (IHS).
109 “Table 03 National Health Expenditures; Levels and Annual Percent Change, by Source of Funds: Selected calendar Years 1960-2013” in
“NHE Tables” Centers for Medicare & Medicaid Services, December 9, 2014, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Tables.zip (Accessed 2/25/15). Note that other health
insurance Programs include Children's Health Insurance Program (Titles XIX and XXI), Department of Defense, and Department of
Veterans Affairs. Further, Other Third Party Payors, Programs, and Public Health Activity includes worksite health care, other private
revenues, Indian Health Service, workers' compensation, general assistance, maternal and child health, vocational rehabilitation, other
federal programs, Substance Abuse and Mental Health Services Administration, other state and local programs, and school health.
110 “National Health Expenditure Projections 2013-2023: Forecast Summary” Centers for Medicare & Medicaid Services, September 17, 2014,
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports/NationalHealthExpendData/NationalHealthAccountsProjected.html (Accessed 1/27/15).
111 “Table 3: National Health Expenditures; Aggregate and per Capita Amounts, Percent Distribution and Annual Percent Change by Source of
Funds: Calendar Years 2007-2023”in “National Health Expenditure Projections 2013-2023” Centers for Medicare & Medicaid Services,
September 17, 2014, http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports/NationalHealthExpendData/NationalHealthAccountsProjected.html (Accessed 1/27/15).
112 “Bargaining in the Shadow of a Giant: Medicare’s Influence on Private Payment Systems” by Jeffrey Clemens and Joshua D. Gottlieb,
National Bureau of Economic Research, October 2013, p. 3.

99

Adviser's Guide to Healthcare

Medicare
Overview
Medicare was created in 1965 as Title XVIII of the Social Security Act (SSA).113 The program,
originally known as the Health Insurance for the Aged and Disabled Act, is an entitlement
program available to individuals over the age of sixty-five.114 During the 1970s, benefits were
extended to include the disabled and individuals with end-stage renal disease (ESRD).115
Medicare is divided into four parts, as described in Table 2-5: The Four Parts of Medicare,
below:
Table 2-5: The Four Parts of Medicare116
Medicare Part
Part A
Part B
Part C
Part D

Statutory Reference
42 U.S.C. § 1395c,
et seq. (2013)
42 U.S.C. § 1395j,
et seq. (2013)
42 U.S.C. § 1395w-21,
et seq. (2013)
42 U.S.C. § 1395w-101,
et seq. (2013)

Description
Covers inpatient care
Covers outpatient visits
Managed Care replacement of Parts A and B
Covers prescription drug benefits

Medicare Part A
Medicare Part A, also known as Medicare Hospital insurance, pays for institutional inpatient
services in acute care hospitals, critical access hospitals (CAHs), and skilled nursing facilities
(SNFs), as well as some hospice and home health services, although physician services that are
provided in a hospital are covered under Medicare part B.117 For those individuals aged 65 or
older who paid (or whose spouse paid) Medicare taxes while they were working, Medicare Part
A does not have a monthly premium. However, there is a deductible associated with hospital
stays, which increases with the duration of the hospital stay according to the following
schedule:118
(1) $1,184 (total) for the first 60 days;
(2) $296 per day for days 61-90;
(3) Patient pays all charges for days 91-150, or can elect to use lifetime reserve days (of
which each beneficiary receives 60 to be used once in their life) at $592 per day; and
(4) Patient pays all charges for days past the 150th continuous day of hospitalization.

113 “Compilation of the Social Security Laws” Social Security Administration, 2009, http://www.socialsecurity.gov/OP_Home/ssact/
title18/1800.htm (Accessed 6/19/09).
114 Ibid.
115 Ibid.
116 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 487; “The Medicare Part D Prescription Drug Benefit” The Henry J. Kaiser Family Foundation,
September 2014, p. 1, http://files.kff.org/attachment/medicare-prescription-drug-benefit-fact-sheet (Accessed 3/2/15).
117 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 490.
118 Ibid, p. 488, 491.
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Medicare Part B
Medicare Part B pays for institutional outpatient services, physician services, and some other
services that are not covered by Medicare Part A.119 Beneficiaries of Medicare Part B are
responsible for the following costs:120
(1) A monthly premium of $104.90 (which may increase, based on the beneficiary’s
income);
(2) An annual deductible of $147;
(3) Co-insurance of 20% after the deductible is met (except on recommended preventive
services);
(4) Co-insurance of 20% on all occupational, physical, and speech-language therapy
services;
(5) Co-insurance of 20% of the Medicare-approved amount for durable medical equipment
(DME); and
(6) Co-insurance of 50% of most outpatient mental health services.
Medigap
Medicare Supplementary Insurance (MSI, also known as Medigap) is a type of health plan that is
offered by private insurance companies.121 Medigap plans cover the out-of-pocket expenses paid
by beneficiaries of Medicare Parts A and B (e.g., costs for services not covered by Medicare,
normal deductible, or co-insurance costs).122 These plans (of which there are 12) require
beneficiaries to pay a monthly premium, which is determined by the private payor.123 Some
Medigap plans, known as Medicare SELECT, require beneficiaries to use a network of providers
in order to receive the benefits of the plan. Due to this restriction, Medicare SELECT plans
typically have lower monthly premiums than other Medigap plans.124
Medicare Part C
In general, Medicare Part C plans (also known as Medicare Advantage, or MA) are paid a
capitated amount to provide all Part A and B Medicare benefits.125 In order to determine the
plan’s reimbursement, MA plans submit bids based on their estimated costs per enrollee, and
these bids are compared to geographic benchmark amounts that are set by a formula established
by statute. The geographic benchmarks represent the maximum amount Medicare will pay a plan
in any geographic area.126 If the plan’s bid is higher than the benchmark, then the enrollees must
pay a premium to participate in that particular plan. If the plan’s bid is lower than the
119 “Medicare Primer” by Patricia A. Davis et al., Congressional Research Service, July 12, 2011, p. 9, http://greenbook.waysandmeans.
house.gov/sites/greenbook.waysandmeans.house.gov/files/2011/documents/R40425_gb.pdf (Accessed 3/2/15).
120 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 492.
121 “What’s Medicare Supplement Insurance (Medigap)?” Centers for Medicare & Medicaid Services, http://www.medicare.gov/supplementother-insurance/medigap/whats-medigap.html (Accessed 3/2/15).
122 Ibid.
123 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 496.
124 Ibid.
125 “Medicare Advantage Fact Sheet” The Henry J. Kaiser Family Foundation, November 25, 2013, http://kff.org/medicare/factsheet/medicare-advantage-fact-sheet/ (Accessed 4/22/14).
126 Ibid.
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benchmark, then the plan receives a rebate which must be used to provide supplement benefits to
enrollees.127 Subsequently, payments to plans are adjusted based upon the risk profile of the
plan’s enrollees, which is determined according to the CMS Hierarchical Condition Category
(CMS-HCC) methodology.128 The individual’s risk score is determined by assessing the
individual enrollee’s diagnoses, disability status, age, sex, and Medicaid status, which are
provided to CMS by the insurer.129 All diagnoses for risk adjustment purposes must be
documented in a medical record, coded in accordance with guidelines, and assigned based on
dates of service within the data collection period.130 In 2014, the average monthly MA plan
premium was $49. 131
MA plan beneficiaries may choose among the following plan types:132
(1) A Medicare health maintenance organization (HMO);
(2) A Medicare medical savings account (MSA), wherein Medicare pays into an account that
the beneficiary draws upon to pay for covered healthcare services until a (relatively high)
deductible has been met, after which point the private insurer pays for the cost of
healthcare services;
(3) A Medicare special needs plan, which is designed for individuals who need advanced
chronic care management services;
(4) A preferred provider organization (PPO); and
(5) A private fee-for-service (PFFS) plan.
Medicare Part D
Medicare Part D provides optional coverage for prescription drugs, and can be added on to other
Medicare health insurance plans.133 Medicare beneficiaries who opt into Medicare Part D
coverage pay a monthly premium (on top of any monthly premium associated with their base
Medicare plan), which is based on the beneficiary’s annual income and ranges from $0 to
$66.60.134 Currently, Medicare Part D beneficiaries may fall into the Medicare Part D coverage
gap, which is the difference between the Medicare Part D plan’s initial coverage limit and the
threshold for catastrophic coverage.135 Between these two values, Medicare Part D beneficiaries
are responsible for a greater share of the cost of prescription drugs. The Patient Protection and
Affordable Care Act (ACA) gradually closes the coverage gap, requiring Medicare Part D plans
127 Ibid.
128 “Medicare Managed Care Manual – Chapter 7” Centers for Medicare & Medicaid Services, June 7, 2013, http://www.cms.gov/Regulationsand-Guidance/Guidance/Manuals/downloads/mc86c07.pdf (Accessed 4/29/14), § 50.
129 “Medicare Advantage Fact Sheet” The Henry J. Kaiser Family Foundation, November 25, 2013, http://kff.org/medicare/factsheet/medicare-advantage-fact-sheet/ (Accessed 4/22/2014); “Medicare Managed Care Manual – Chapter 7” Centers for Medicare &
Medicaid Services, June 7, 2013, http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/mc86c07.pdf (Accessed
4/29/214), §§ 70.2.3, 70.2.4, 110, 120.
130 “Medicare Managed Care Manual – Chapter 7” Centers for Medicare & Medicaid Services, June 7, 2013, http://www.cms.gov/Regulationsand-Guidance/Guidance/Manuals/downloads/mc86c07.pdf (Accessed 4/29/14), § 40.
131 “Medicare Advantage 2014 Spotlight: Plan Availability and Premiums” By Marsha Gold et al., Kaiser Family Foundation, November 25,
2013, p. 4, http://kff.org/medicare/issue-brief/medicare-advantage-2014-spotlight-plan-availability-and-premiums/ (Accessed 5/29/14).
132 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 493-494.
133 “The Medicare Part D Prescription Drug Benefit” The Henry J. Kaiser Family Foundation, September 2014,
http://files.kff.org/attachment/medicare-prescription-drug-benefit-fact-sheet (Accessed 3/2/15), p. 1.
134 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 494-495.
135 “The Medicare Part D Prescription Drug Benefit” The Henry J. Kaiser Family Foundation, September 2014, http://files.kff.org/attachment/
medicare-prescription-drug-benefit-fact-sheet (Accessed 3/2/15), p. 2.
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to cover 50% of said costs in 2011, and growing to total coverage of costs associated with the
coverage gap, in 2020.136
Reimbursement and Billing
Medicare reimburses providers using a combination of fee-for-service (FFS), managed care
arrangements, and payments from health savings accounts (HSA).137 Medicare does not process
or pay claims directly, but contracts with insurance companies to perform these services for
them, instead.138 Fiscal intermediaries are insurance companies that handle claims for hospitals,
skilled nursing facilities, intermediate care facilities, long-term care facilities, and home health
agencies.139 By contrast, carriers process claims for physicians, providers, and suppliers.140 In
addition, private companies provide medical and hospital coverage to enrollees of MA
(Part C).141
Under federal law, all providers and suppliers must submit claims if they provide a Medicarecovered service to a beneficiary enrolled in Medicare Part B.142 Medicare should be billed as the
primary payor when:
(1) An employee has chosen not to enroll in, or has recently dropped, his or her coverage in a
group health plan;
(2) An employee is not yet eligible for group health plan coverage or has depleted his or her
benefits under the plan;
(3) The insurance plan only covers the self-employed;
(4) The insurance plan is an individual plan and was not obtained through a group;
(5) The patient has coverage through TRICARE;
(6) The patient is younger than sixty-five, is covered by Medicare due to a disability or
ESRD, and does not have employer-sponsored health insurance;
(7) The patient is younger than sixty-five, has ESRD, and is covered by an employer
sponsored health insurance plan, but the patient has been eligible for Medicare for more
than thirty months;
(8) The patient has left a company through which they were covered under a group health
plan and has coverage under federal Consolidated Omnibus Budget Reconciliation Act
(COBRA); or
(9) The patient has both Medicare and Medicaid.143

136 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 495.
137 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, Ohio:
Glencoe/McGraw-Hill, 2002, p. 141-142.
138 Ibid, p. 140.
139 Ibid, p. 140.
140 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, Ohio:
Glencoe/McGraw-Hill, 2002, p. 140.
141 “Medicare Advantage Fact Sheet” The Henry J. Kaiser Family Foundation, November 25, 2013, http://kff.org/medicare/factsheet/medicare-advantage-fact-sheet/ (Accessed 4/22/14).
142 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 500.
143 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 505.
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Medicare administrative contractors are required to pay clean claims, i.e., those with the
requisite data needed to process and pay the claim, within thirty days from receipt, and must pay
interest on those clean claims paid after thirty days.144 Federal regulation also mandates that MA
organizations pay 95 percent of clean claims submitted by nonparticipating providers in thirty
days and pay interest on clean claims that are not paid prior to this deadline.145 In addition, MA
organizations must include a prompt payment provision in their contracts with participating
providers, although the organization and the participating provider are free to agree upon its
terms.146 Typically, if an electronic claim is submitted, providers can receive Medicare
reimbursement in fourteen days.147
As mentioned previously, Medicare pays for services provided by physicians, allied health
professionals, nurse practitioners, and other paraprofessionals, with few exceptions.148 In
particular, Medicare makes certain distinctions for reimbursement based on the site of service of
particular allied health practices.
A unique aspect of the Medicare reimbursement system is the participating physician program,
which originated with the 1984 Deficit Reduction Act.149 Under the program, Medicare and
physicians enter into participating provider (PAR) agreements by which the providers agree to
accept the reimbursement amount set by the Medicare physician fee schedule (MPFS), as
payment in full for every claim.150 The physician may bill the patient for the patient’s share of
the co-insurance and the patient’s deductible, but it cannot balance bill the patient, that is,
attempt to collect the difference between its usual fee and Medicare’s lower allowed charge.151
Like any other third-party payor system, Medicare beneficiaries may be subject to premiums,
deductibles, and co-insurance, all of which vary according to their coverage, income, and
services sought.152
Participating Providers (PARs)—Medicare Allowable Charge
Medicare reimburses providers at different rates depending on whether or not they agree to
become participating providers (PARs). In 2011, approximately 96% of all physicians billing

144
145
146
147
148
149
150
151
152

Ibid, p. 88.
“Prompt Payment by MA Organization” Vol. 42 CFR. Section 422.520 (October 1, 2014).
Ibid.
“80.2.1.2 – Payment Floor Standards” in “Medicare Claims Processing Manual: Chapter 1 – General Billing Requirements” Centers for
Medicare & Medicaid Services, August 1, 2014, http://www.cms.gov/Regulations-andGuidance/Guidance/Manuals/Downloads/clm104c01.pdf (Accessed 1/28/15).
“Medicare Benefit Policy Manual” Centers For Medicare & Medicaid Services, Department of Health and Human Services, August 7,
2009, Accessed at http://www.cms.hhs.gov/manuals/Downloads/bp102c15.pdf (Accessed 9/21/09), p. 150-250.
“Paying a Visit to the Doctor: Current Financial Protections for Medicare Patients When Receiving Physician Services” by Cristina Boccuti,
The Henry J. Kaiser Family Foundation, April 2014, p. 5, https://kaiserfamilyfoundation.files.wordpress.com/2014/04/8573-paying-to-seeyour-doctor.pdf (Accessed 2/3/2015).
“From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, Ohio:
Glencoe/McGraw-Hill, 2002, p. 142.
“Medicare Enrollment and Claim Submission Guidelines” Centers for Medicare & Medicaid Services, August 2014, p. 5,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNProducts/downloads/MedicareClaimSubmissionGuidelines-ICN906764.pdf (Accessed 2/3/2015).
“Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 492-495.
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Medicare were PARs.153 In order to enroll in Medicare, providers must be assigned a specific
National Provider Identifier (NPI) by the National Plan and Provider Enumeration System
(NPPES), and enter into a PAR agreement through a CMS-855 form.154 By entering a PAR
agreement, a physician agrees to accept the MPFS reimbursement as payment in full for a given
service, which ensures that after a Medicare beneficiary meets their deductible, their coinsurance
will not exceed 20% of the Medicare charge for their services.155 To encourage physicians to
enter into PAR agreements, Congress has developed special incentives including: 156
(1)
(2)
(3)
(4)

Direct payment of all claims;
A 5% higher fee schedule than for non-participating providers (non-PARs);
Inclusion in Medicare provider directories; and
Electronic access to Medicare beneficiaries' supplemental insurance status.

In 2011, 96 percent of all physicians billing Medicare were participating providers.
Centers for Medicare and Medicaid Services, December 2011.

Nonparticipating Providers (non-PARs)
Nonparticipating providers (non-PARs) are providers that have not agreed to accept the
Medicare reimbursement amount for every claim. Still, non-PARs are allowed to accept
Medicare assignment on a claim-by-claim basis,157 subject to a limiting charge requirement.158
When a non-PAR provides services to a Medicare beneficiary, the beneficiary is usually
responsible for full charge of the service. The non-PAR must then file a claim with Medicare,
which reimburses the beneficiary for Medicare's share of the charge.159
Nonparticipating Providers Accepting Medicare Assignment on a Claim-by-Claim
Basis—95 Percent of Medicare Allowable Charge (80 Percent Medicare,
20 Percent Patient)
Non-PARs that accept assignment on a claim-by-claim basis are subject to an allowable fee that
is 5 percent less than the allowable fee that PARs are paid for similar services.160 For example, if
the Medicare allowable fee schedule for a PAR pays $100 for a service, Medicare would pay the
PAR 80 percent of the allowable fee, or $80, and the patient would be responsible for paying the
153 “Table VII.20: Medicare Part B Participating Physicians and Other Practitioners by State Selected Years” in “Data Compendium 2011”
Centers For Medicare & Medicaid Services, December 2011, https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trendsand-Reports/DataCompendium/2011_Data_Compendium.html (Accessed 2/3/15).
154 “Difference between the Medicare Provider Numbers” WPS Medicare j5 MAC Part B, August 16, 2012,
http://www.wpsmedicare.com/j5macpartb/resources/new_providers/providernumber.shtml (Accessed 9/18/213).
155 “Paying a Visit to the Doctor: Current Financial Protections for Medicare Patients When Receiving Physician Services” by Cristina Boccuti,
The Henry J. Kaiser Family Foundation, April 2014, https://kaiserfamilyfoundation.files.wordpress.com/2014/04/8573-paying-to-see-yourdoctor.pdf (Accessed 2/3/15), p. 5.
156 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 497-498.
157 See the Nonparticipating Providers Accepting Medicare Assignment on a Claim-by-Claim Basis section.
158 “Paying a Visit to the Doctor: Current Financial Protections for Medicare Patients When Receiving Physician Services” by Cristina Boccuti,
The Henry J. Kaiser Family Foundation, April 2014, 6, https://kaiserfamilyfoundation.files.wordpress.com/2014/04/8573-paying-to-seeyour-doctor.pdf (Accessed 2/3/15), p. 6.
159 Ibid.
160 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 498.
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PAR the remaining 20 percent, or $20.161 However, a non-PAR accepting assignment on the
same claim will have an allowable fee of 5 percent less, or $95 for the same service.162 Then,
Medicare would pay the non-PAR 80 percent of the non-PAR fee schedule of $95, or a payment
of $76 and the patient would be responsible for paying the non-PAR the remaining 20 percent, or
$19.163
Although Medicare reimbursement differences can lead to a non-PAR being reimbursed more for
a service than a PAR, a non-PAR’s prices are decreased by limiting charges and increasing costs
for patients, which may decrease a non-PAR’s competitive advantage.164
Nonparticipating Providers Rejecting Medicare Assignment—115 Percent of 95
Percent of Medicare Allowable Charge (100 Percent from Patient)
A non-PAR may also treat Medicare patients without accepting the claim for assignment. When
a non-PAR decides not to accept assignment on a particular claim, he or she may only charge a
maximum of 15 percent above the non-PAR fee.165 For example, if the Medicare allowable fee
schedule for a PAR pays $100 for a particular service, Medicare would pay a non-PAR accepting
assignment on a claim for the same type of service an allowable fee of 5 percent less, or $95.
However, a non-PAR that chooses to submit a Medicare claim for the same type of service but
chooses not to accept assignment may bill the patient an amount equal to 115 percent of the
allowable fee for non-PARs.166 Thus, the provider could charge a fee equal to 115 percent of
$95, or $109.25. The ability to charge more than the Medicare allowable fee is offset by the
increased risk that the provider faces from fact that he or she must collect the entire billable
amount from the patient.
Physician Reimbursement and Billing: The Resource Based Relative Value
Scale (RBRVS)
Medicare reimbursement is based on a standardized physician payment schedule based on a
resource-based relative value scale (RBRVS), which determines payments based on the value of
the resources necessary to provide a particular service.167
History and Background
The RBRVS was introduced in 1988 as a mechanism to control the cost of physicians’ services
borne by the Medicare program. William C. Hsiao from the Harvard School of Public Health
161 “Medicare Enrollment and Claim Submission Guidelines” Centers for Medicare & Medicaid Services, August 2014, http://www.cms.gov/
Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/MedicareClaimSubmissionGuidelinesICN906764.pdf (Accessed 2/3/15), p. 6-7.
162 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 498.
163 “Medicare Enrollment and Claim Submission Guidelines” Centers for Medicare & Medicaid Services, August 2014, http://www.cms.gov/
Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/MedicareClaimSubmissionGuidelinesICN906764.pdf (Accessed 2/3/215), p. 6-7.
164 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 497-498.
165 “CCH Medicare Explained” By Pamela K. Carron and Nicole T. Stone, Chicago, IL: CCH, 2012, p. 413.
166 “CCH Medicare Explained” By Pamela K. Carron and Nicole T. Stone, Chicago, IL: CCH, 2012, p. 413.
167 “Overview of the RBRVS” American Medical Association, http://www.ama-assn.org/ama/pub/physician-resources/solutions-managingyour-practice/coding-billing-insurance/medicare/the-resource-based-relative-value-scale/overview-of-rbrvs.shtml (Accessed 10/5/09).
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developed it from the results of a 1988 study that was conducted in order to address the growing
inequity between reimbursement rates for procedural services and those for cognitive clinical
services, as well as the rapid increase in Medicare spending.168 The system also was intended to
bring medical practice payment more in line with a PPS, whereby reimbursement is based on a
predetermined, fixed amount, and away from a purely FFS system.169 The RBRVS system was
implemented in 1992, and it is updated annually by the CMS.170
The RBRVS was created by William C. Hsiao in 1988 in order to (1) address the growing inequity of
reimbursement rates for procedural services for cognitive clinical services and (2) address the rapid increases in
Medicare spending.
Sarah E. Johnson, MD, and Warren P. Newton, MD, MPH, March 2002.

Hsiao’s Research
Dr. Hsiao’s research consisted of examining components of providing care, such as physician
work, practice costs, and the opportunity costs associated with training.171 Through a series of
surveys, the Hsiao study determined the relative value of the service-specific work component by
establishing ways of quantifying work, including the time spent before, during, and after a
procedure, as well as measuring the intensity of the work.172 By conducting interviews with
physicians, Hsiao and his team were able to develop a common scale describing and quantifying
the resource costs needed to provide physician services across all fields of medicine.173
Transition from Customary Prevailing and Reasonable (CPR) to Prospective
Payment System with Resource-Based Relative Value Scale
The Omnibus Reconciliation Acts of 1989 and 1990 implemented a new fixed-fee schedule for Medicare
services.174 The MPFS became effective January 1, 1992, and replaced the previous customary prevailing
and reasonable (CPR) charge system with the RBRVS.175 CPR payments were based on fees charged by
providers by specialty within particular regions of the country, whereas the RBRVS fee schedule is a list
of predetermined payments for healthcare services provided to patients.176 The RBRVS was intended to
place greater emphasis on time spent with a patient when assessing health, diagnosing conditions, and
listening to complaints, thereby distributing Medicare payments more equitably among specialists, who
traditionally received higher payments, and primary care physicians.177
168 “Resource-based Relative Value Units: A Primer for Academic Family Physicians” By Sarah E. Johnson, and Warren P. Newton, Family
Medicine, Vol. 34, No. 3 (March 2002), p. 172-173.
169 “Overview: Prospective Payment Systems, General Information” Centers For Medicare & Medicaid Services, Aug. 17, 2009,
http://www.cms.hhs.gov/prospmedicarefeesvcpmtgen/ (Accessed 10/2/09).
170 “Medicare Physician Payment Updates and the Sustainable Growth Rate (SGR) System” by Jim Hahn, Congressional Research Service,
June 12, 2014, http://greenbook.waysandmeans.house.gov/sites/greenbook.waysandmeans.house.gov/files/R40907_gb.pdf (Accessed
3/2/15), p. 1-2.
171 “Resource-based Relative Value Units: A Primer for Academic Family Physicians” By Sarah E. Johnson, and Warren P. Newton, Family
Medicine, Vol. 34, No. 3 (March 2002), p. 172-173.
172 Ibid.
173 Ibid.
174 “Medicare Physician Payment Updates and the Sustainable Growth Rate (SGR) System” by Jim Hahn, Congressional Research Service,
June 12, 2014, p. 1-2, http://greenbook.waysandmeans.house.gov/sites/greenbook.waysandmeans.house.gov/files/R40907_gb.pdf (Accessed
3/2/215).
175 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 333.
176 Ibid.
177 “RBRVS: How New Physician Fee Schedule Will Work -Resource-Based Relative Value Scale Payment System” By Paul L. Grimaldi,
Healthcare Financial Management, Vol. 45, No. 9 (Sept 1991), p. 15.
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Utilizing Relative Value Units (RVU) When Determining Fees and Costs
The MPFS constitutes a list of payment rates for different services based on their particular
HCPCS codes.178 The MPFS bases its payments on a single cross-specialty RBRVS with
payment determined by a procedure’s relative value units (RVUs).179
There are three RVU components: one for physician work, one for practice expense, and one for
malpractice costs. These components can be broken down as follows:
(1) Work. The estimated value of the time, effort, expertise, and intensity of the service—
approximately 55 percent of the RVU value.
(2) Practice expense. The estimated value of overhead and other expenses necessary to run
the practice—approximately 42 percent of the RVU value.
(3) Professional liability insurance. The estimated value of malpractice cost for the
service—approximately 3 percent of RVU value.180
These RVU components, as well as total RVU, are often adjusted using modifiers. Local
geographic differences are accounted for by multiplying each RVU component by its
corresponding geographic practice cost index (GPCI). By multiplying total RVU (the sum of
geographically adjusted components) by a conversion factor (CF), the dollar amount of
governmental reimbursement may be determined.181
The formula for calculating the Medicare physician reimbursement amount for a specific
procedure and location is as follows:182
Payment =

[(wRVU * GPCI work) + (RVU PE * GPCI PE) +
(RVU malpractice * GPCI malpractice)] * CF

RVUs are updated annually by committees from the AMA, as described in the RVU Updates
section below. The three RVU components, GPCI, and CF are discussed further in the following
sections.
Work Component
The work RVU component represents a physician’s contribution of time and effort to the
completion of a procedure. For example, a colonoscopy will have a higher work RVU than an
intermediate office visit because the colonoscopy requires more time and skill.183 The higher the
value of the code, the more skill, time, and work it takes to complete.
178 “Physician Services Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/MedPAC_Payment_
Basics_08_Physician.pdf (Accessed 9/24/09).
179 Ibid.
180 “Gauging Emergency Physician Productivity: Are RVUs the Answer” By John Proctor, American College of Emergency Physicians,
www.acep. org/practres.aspx?id=30306 (Accessed 4/1/09).
181 “Physician Services Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/MedPAC_Payment_
Basics_08_Physician.pdf (Accessed 9/24/09).
182 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2006 and Certain Provisions
Related to the Competitive Acquisition Program of Outpatient Drugs and Biological Under Part B; Final Rule” Federal Register Vol. 70,
No. 223 (November 21, 2005), p. 70120.
183 “The Basics: Relative Value Units (RVUS)” National Health Policy Forum, The George Washington University, February 2009,
http://www.nhpf.org/library/the-basics/Basics_RVUs_02-12-09.pdf (Accessed 4/1/09).
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Practice Expense Component
The practice expense RVU component is based on numerous expenses that are incurred as a cost
of providing the service or overhead of the practice, including the costs associated with office
space, supplies, equipment, and non-administrative staff.184 The practice expense RVU
component is calculated using a bottom-up methodology in which direct costs (for example,
costs that can be assigned, such as the cost of supplies) are calculated and indirect costs (for
example, costs that cannot be assigned but are the costs of owning a practice, such as the cost of
having a waiting room) are allocated.185
The practice expense RVU component may calculated differently, depending on whether
services were provided in a facility setting (for example, a hospital), or in a non-facility setting
(for example, a freestanding center) because of differences in the cost of operation.186 The
formula discussed previously can therefore be rewritten as:
Facility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Facility PE RVU * PE
GPCI) + (MP RVU * MP GPCI)] * [Conversion Factor
adjusted for budget neutrality]
Nonfacility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Nonfacility PE RVU * PE
GPCI) + (MP RVU * MP GPCI)] * [Conversion Factor
adjusted for budget neutrality]187

Services that are billed by a non-facility receive a higher practice expense RVU component than
services billed by a facility because the practice expenses are higher for a physician office than
for a hospital.188 When a service is billed by a non-facility, the practice expense RVU component
compensates the physician’s practice for the costs of owning and operating a practice (i.e.,
clinical personnel, equipment, and supplies).189 However, when the service is billed by a facility,
the practice does not incur these costs, and as such the practice expense RVU component is
reduced.190

184 “Gauging Emergency Physician Productivity: Are RVUs the Answer” By John Proctor, American College of Emergency Physicians,
www.acep. org/practres.aspx?id=30306 (Accessed 4/1/09); “Introduction to Relative Value Units (RVUs) and How Medicare
Reimbursement is Calculated” American College of Radiation Oncology, 2009, http://www.acro.org/washington/RVU.pdf (Accessed
04/01/09); “Physician Services Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/
MedPAC_Payment_Basics_08_Physician.pdf (Accessed 9/24/09).
185 “Introduction to Relative Value Units (RVUs) and How Medicare Reimbursement is Calculated” American College of Radiation Oncology,
2009, http://www.acro.org/washington/RVU.pdf (Accessed 04/01/09).
186 “Introduction to Relative Value Units (RVUs) and How Medicare Reimbursement is Calculated” American College of Radiation Oncology,
2009, http://www.acro.org/washington/RVU.pdf (Accessed 04/01/09).
187 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to
Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015; Final Rule”
Federal Register Vol. 79, No. 219, p. 67552; “Physician Fee Schedule” Centers for Medicare & Medicaid Services, February 4, 2015,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/ (Accessed 2/27/2015).
188 “The Basics: Relative Value Units (RVUS)” National Health Policy Forum, The George Washington University, February 2009,
http://www.nhpf.org/library/the-basics/Basics_RVUs_02-12-09.pdf (Accessed 4/1/09).
189 Ibid.
190 “Resource-based Relative Value Units: A Primer for Academic Family Physicians” By Sarah E. Johnson, and Warren P. Newton, Family
Medicine, Vol. 34, No. 3, (March 2002), p. 172-173; “The Basics: Relative Value Units (RVUS)” National Health Policy Forum, The
George Washington University, February 2009, http://www.nhpf.org/library/the-basics/Basics_RVUs_02-12-09.pdf (Accessed 4/1/09).
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Malpractice Expense Component
Section 1848(c) of the SSA, “Payment for Physician Services,” requires CMS to develop
resource-based malpractice RVU components as part of the method for physician
reimbursement.191 These RVUs correspond to the relative malpractice practice expense for
medical procedures.192 These values are updated at least every five years and typically comprise
the smallest component of the RVU.193 Due to the variation in malpractice costs among states
and specialties, the malpractice component must be weighted geographically and across
specialties.194
Geographic Practice Cost Index
The Geographic Practice Cost Index (GPCI) accounts for the geographic differences in the cost
of maintaining a practice. Every Medicare payment locality has a GPCI for the work, practice,
and malpractice component.195 A locality’s GPCI is determined by taking into consideration
median hourly earnings of workers in the area and the average cost of office rental, medical
equipment and supplies, and other miscellaneous expenses.196 There were eighty-nine GPCI
payment localities in the 2014 PFS final rule.197
Conversion Factor
The conversion factor (CF) is a monetary amount that is multiplied by the RVU from a locality
to determine the payment amount for a given service.198 This conversion factor is updated yearly
by a formula that takes into account: (1) the previous year’s conversion factor; (2) the estimated
percentage increase in the Medicare Economic Index for the year (which accounts for
inflationary changes in office expenses and physician earnings); and (3) an update adjustment
factor.199 All physician services, except anesthesia services, use a single conversion factor.200

191 “Interim Report on Malpractice RVUs for the CY 2010 Medicare Physician Fee Schedule Proposed Rule” By Margaret O’Brien-Strain,
Sean McClellan, and Steve Frances Acumen LLC, June 2009, http://www.cms.gov/PhysicianFeeSched/05_Malpractice_Report.asp
(Accessed 07/30/09), p.1.
192 Ibid.
193 “Interim Report on Malpractice RVUs for the CY 2010 Medicare Physician Fee Schedule Proposed Rule” By Margaret O’Brien-Strain,
Sean McClellan, and Steve Frances Acumen LLC, June 2009, http://www.cms.gov/PhysicianFeeSched/05_Malpractice_Report.asp
(Accessed 07/30/09), p. 1; “Introduction to Relative Value Units (RVUs) and How Medicare Reimbursement is Calculated” American
College of Radiation Oncology, 2009, http://www.acro.org/washington/RVU.pdf (Accessed 04/01/09).
194 “Interim Report on Malpractice RVUs for the CY 2010 Medicare Physician Fee Schedule Proposed Rule” By Margaret O’Brien-Strain,
Sean McClellan, and Steve Frances Acumen LLC, June 2009, http://www.cms.gov/PhysicianFeeSched/05_Malpractice_Report.asp
(Accessed 07/30/09), p. 11.
195 “Physician Fee Schedule Look-Up, Overview” Centers For Medicare & Medicaid, January 7, 2009, http://www.cms.hhs.gov/PFSLookup/
(Accessed 7/30/09); “Physician Reimbursement Under Medicare” By Alan M. Scarrow, Neurosurgical Focus, Vol. 12, No. 4 (April, 2002),
p. 2.
196 “Physician Reimbursement Under Medicare” By Alan M. Scarrow, Neurosurgical Focus, Vol. 12, No. 4 (April, 2002), p. 2.
197 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other
Revisions to Part B for CY 2014; Final Rule” Fed. Reg. Vol. 78, No. 237 (December 10, 2013), p. 74384.
198 “Physician Reimbursement Under Medicare” By Alan M. Scarrow, Neurosurgical Focus, Vol. 12, No. 4 (April, 2002), p. 2.
199 “2009 Master Medicare Guide” CCH Health Editorial, Chicago, IL: Wolters Kluwer, 2009, p. 901.
200 Ibid, p. 900.
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The CF is part of an annual update made to the MPFS by CMS based on an updated formula
mandated in the Balanced Budget Act of 1997, which, until recently, included application of the
sustainable growth rate (SGR) when determining MPFS rates.201 Based on inflation, Medicare
enrollment, growth of GDP, and regulatory developments, the SGR represented a spending target
set for total annual expenditures under Medicare on Part B services, and annual adjustments were
made to the MPFS based on whether actual spending came in above or below the target.202 If
actual spending was above the target, payment update rates were adjusted down; likewise, if
actual spending was below the target, payment update rates were adjusted up.203
The SGR formula indicated downward adjustments to the MPFS every year since 2002; however,
CMS averted the adjustment in 2003, and the United States Congress intervened and overrode the
MPFS decreases to the CF for the past several years, sometimes replacing scheduled cuts with
increases in payment.204 On April 1, 2014, President Obama signed the Protecting Access to
Medicare Act of 2014, which prevented a 24.4% cut to reimbursement for physicians’ services to
Medicare beneficiaries, replacing the cut with a 0.5% increase.205 The law also provides for a 0%
update to the 2015 MPFS through March 31, 2015.206 The trends of CF and SGR updates, as
compared to the actual physician fee schedule update, are represented below in Table 2-6: Annual
Updates to the MPFS CF (CMS Final Rule v Congressional Action), 2002–2015.
Table 2-6: Annual Updates to the MPFS CF (CMS Final Rule v Congressional Action), 2002–2015
Year

Physician Fee Schedule Update Under
CMS Final Rule

Physician Fee Schedule Update
After Congressional Actions

2002

-4.8%207

N/A

2003

-4.4%

208

2004

-4.5%210

1.5%211

2005

1.5%212

1.5%213

1.6%*209

(continued)

201 “CMS Proposes Payment, Policy Changes for Physicians Services to Medicare Beneficiaries in 2010” Centers For Medicare & Medicaid
Services, Press Release (July 1, 2009), http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=3469 (Accessed 10/09/09).
202 “The Sustainable Growth Rate Formula for Setting Medicare’s Physician Payment Rates” Congressional Budget Office, Economic and
Budget Issue Brief, September 6, 2006, http://www.cbo.gov/ftpdocs/75xx/doc7542/09-07-SGR-brief.pdf (Accessed 10/09/09).
203 Ibid.
204 “CMS Proposes Payment, Policy Changes for Physicians Services to Medicare Beneficiaries in 2010” Centers For Medicare & Medicaid
Services, Press Release (July 1, 2009), p. 1, http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=3469 (Accessed 10/09/09).
205 “President Obama Signs the Protecting Access to Medicare Act of 2014” Centers for Medicare & Medicaid Services, April 2, 2014,
http://www.cms.gov/outreach-and-education/outreach/ffsprovpartprog/downloads/2014-04-02-standalone.pdf (Accessed 11/17/14).
206 Ibid.
207 “Medicare Program; Revisions to Payment Policies and Five-Year Review of and Adjustments to the Relative Value Units Under the
Physician Fee Schedule for Calendar Year 2002: Final Rule with Comment Period” Federal Register Vol. 66, No. 212 (November 1, 2001),
p. 55312.
208 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2003 and Inclusion of Registered
Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote
Locations” Federal Register, Vol. 67, No. 251 (December 31, 2002), p. 80018.
209 “Medicare Program; Physician Fee Schedule Update for Calendar Year 2003: Final Rule” Federal Register Vol. 68, No. 40 (February 28,
2003), p. 9567; [The revision of the SGR calculation is permitted due to the passage of the Consolidated Appropriations Resolution of 2003,
section 402] “Consolidated Appropriations Resolution, 2003” Pub. L. No. 108-7, § 402, 117 Stat. 548 (February 20, 2003).
210 “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule for Calendar Year 2004” Federal Register Vol. 68,
No. 216 (November 7, 2003), p. 63196.
211 “Medicare Program; Changes to Medicare Payment for Drugs and Physician Fee Schedule Payments for Calendar Year 2004: Interim Final
Rule with Comment Period” Federal Register Vol. 69, No. 4 (January 7, 2004), p. 1095; “Medicare Prescription Drug, Improvement, and
Modernization Act of 2003” Pub. L. No. 108-173, § 601, 117 Stat. 2300 (December 8, 2003).
212 “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule for Calendar Year 2005” Federal Register Vol. 69,
No. 219 (November 15, 2004), p. 66236.
213 “Medicare Prescription Drug, Improvement, and Modernization Act of 2003” Pub. L. No. 108-173, § 601, 117 Stat. 2300 (December 8,
2003).
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Year

Physician Fee Schedule Update Under
CMS Final Rule

Physician Fee Schedule Update
After Congressional Actions

2006

-4.4%214

0.0%215

2007

-5.0%216

0.0%217

2008

-10.1%218

0.5%219

2009

1.1%220

1.1%221

2010 (Jan - May)
2010 (June-Dec)

-21.2%222

0.0%223
2.2%224

2011

-24.9%225

0.0%226

2012

-27.4%227

0.0%228

2013

-26.5%229

0.0%230

2014

-20.1%231

0.5%232

233

0.0%234

2015 (Jan-March)

-21.2%

*Enacted for March 1, 2003 - December 1, 2003
214 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2006 and Certain Provisions
Related to the Competitive Acquisition Program of Outpatient Drugs and Biologicals Under Part B” Federal Register Vol. 70, No. 223
(November 21, 2005), p. 70116.
215 “Deficit Reduction Act of 2005” Pub. L. No. 109-171, § 5104, 120 Stat. 40-41 (February 8, 2006).
216 “Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense
Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of
Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance Inflation Factor Update for CY 2007” Federal
Register Vol. 71, No. 231 (December 1, 2006), p. 69624.
217 “Tax Relief and Health Care Act of 2006” Pub. L. No. 109-432, § 101, 120 Stat. 2975 (December 20, 2006).
218 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008;
Revisions to the Payment Policies of Ambulance Services Under the Ambulance Fee Schedule for CY 2008; and the Amendment of the
E-Prescribing Exemption for Computer Generated Facsimile Transmissions” Federal Register Vol. 72, No. 227 (November 27, 2007),
p. 66222.
219 “Medicare, Medicaid, and SCHIP Extension Act of 2007” Pub. L. No. 110-173, § 101, 121 Stat. 2493 (December 29, 2007).
220 “Medicare Program; Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2009” Centers for Medicare
and Medicaid Services, Federal Register Vol. 73, No. 224 (November 19, 2008), p. 69726.
221 “Medicare Improvements for Patients and Providers Act of 2008” Pub. L. No. 110-275, § 131, 122 Stat. 2520 (July 15, 2008).
222 “Medicare Program; Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2010” Federal Register Vol.
74, No. 226 (November 25, 2009), p. 61738.
223 “Department of Defense Appropriations Act, 2010” Pub. L. No. 111-118, § 1011, 123 Stat. 3473-3474.
224 “Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010” Pub. L. No. 111-192, § 101, 124 Stat. 1280
(June 25, 2010).
225 “Medicare Program; Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule” Federal
Register Vol. 75, No. 228 (November 29, 2010), p. 73283.
226 “Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Corrections:
Correction on Final Rule with Comment Period” Federal Register Vol. 76, No. 7 (January 11, 2011), p. 1670; “Medicare and Medicaid
Extenders Act of 2010” Pub. L. No. 111-309, § 101, 124 Stat. 3285-3286.
227 “Medicare Program; Payment Policies Under the Physician Fee Schedule, Five-Year Review of Work Relative Value Units, Clinical
Laboratory Fee Schedule: Signature on Requisition, and Other Revisions to Part B for CY 2012; Final Rule” Federal Register Vol. 76,
No. 228 (November 28, 2011), p. 73277.
228 “Temporary Payroll Tax Cut Continuation Act of 2011” Pub. L. No. 112-78, § 301, 125 Stat. 1283-1284 (December 23, 2011); extended by
“Middle Class Tax Relief and Job Creation Act” Pub. L. No. 112-96, § 3003, 126 Stat. 186-187 (February 22, 2012).
229 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the
Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013; Final
Rule” Federal Register Vol. 77, No. 222 (November 16, 2012), p. 69138.
230 “American Taxpayer Relief Act of 2012” Pub. L. No. 112-240, § 601, 126 Stat. 2345 (January 2, 2013).
231 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other
Revisions to Part B for CY 2014; Final Rule” Federal Register Vol. 78, No. 237 (December 10, 2013), p. 74398.
232 “Pathway for SGR Reform Act of 2013” Pub. L. No. 113-67, § 1101, 127 Stat. 1165, 1196 (December 26, 2013); “Protecting Access to
Medicare Act of 2014” Pub. L. No. 113-93, § 101, 128 Stat. 1041 (April 1, 2014).
233 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to
Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015; Final Rule”
Federal Register Vol. 79, No. 219 (November 13, 2014), p. 67742.
234 “Protecting Access to Medicare Act of 2014” Pub. L. No. 113-93, § 101, 128 Stat. 1041 (April 1, 2014).
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In April of 2015, Congress passed the Medicare Access and CHIP Reauthorization Act of 2015
(MACRA), the first section of which is dedicated to repealing the SGR.235 In place of the SGR,
Congress enacted a series of pre-determined updates, which vary based on the payment model
used by the provider.236 MACRA mandates an annual conversion factor update of 0.5%,
beginning in July 2015 and ending in December 2019, followed by a 0.0% annual update from
2020 to 2025, followed by a 0.25% annual update from 2026 forward.237 However, for providers
who qualify as participants in an alternative payment model (APM), the annual update to the
conversion factor for 2026 forward is 0.75%.238
Chronic Care Management
As noted in the Reimbursement and Billing section above, Medicare uses a fee-for-service (FFS)
system when reimbursing providers. In the 2015 MPFS, CMS finalized a rule that allows
primary care providers to bill for chronic care management (CCM), effectively opening a new
category of services to be reimbursed under Medicare's FFS system. CCM, as defined by CMS,
includes the following services:239
(1) The provision of 24/7 access to a provider who will address a patient’s acute chronic care
needs;
(2) Continuity of care with a designated provider with whom the patient is able to get
successive routine appointments;
(3) Systematic assessment of a patient’s medical, functional, and psychological needs;
(4) Ensuring the timely receipt of all recommended preventive care services;
(5) Medication reconciliation with review of adherence and potential interactions;
(6) Oversight of patient self-management of medications;
(7) Management of care transitions between providers of healthcare services;
(8) Coordination with home and community based clinical service providers required to
support a patient’s psychosocial needs and functional deficits; and
(9) Enhanced opportunities to communicate with the provider regarding the patient’s care.
In order to bill for CCM, these services must be furnished to patients with multiple chronic
conditions that (1) are expected to last at least one year (or until the death of the patient) and
(2) put the patient at significant risk of death, acute decompensation, or functional decline.240
The provider must spend at least 20 minutes on the services listed above in order to bill for
CCM, and the services can only be billed once per patient, per month.241 Providers will be able to
bill, on average, $40.39 per Medicare beneficiary, per month for CCM services in the first
quarter of 2015 (after this point, changes in the SGR and Congressional action will dictate the

235 “Medicare Access and CHIP Reauthorization Act of 2015” H.R. 2, January 6, 2015, p. 1-2; “Summary: H.R.2—114th Congress (20152016)” Congress.gov, April 16, 2015, https://www.congress.gov/bill/114th-congress/house-bill/2 (Accessed 4/22/2015).
236 Ibid.
237 “Medicare Access and CHIP Reauthorization Act of 2015” H.R. 2, January 6, 2015, p. 3-4.
238 Ibid; For more information about MACRA, see Chapter 6: Healthcare Reform, of Volume 1: An Era of Reform.
239 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other
Revisions to Part B for CY 2014; Final Rule” Federal Register Vol. 78, No. 237 (December 10, 2013), p. 74417-74418.
240 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to
Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015; Final Rule”
Federal Register Vol. 79, No. 219 (November 14, 2014), p. 67716.
241 Ibid.
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reimbursement rates).242 A 2014 analysis showed that, at $40.39 per Medicare beneficiary, per
month, a family physician with an average number of patients that qualify for CCM services
could generate nearly $240,000 in annual revenue by billing for CCM services.243 As such, the
introduction of Medicare reimbursement for CCM services may blend traditional FFS
reimbursement with elements of value-based purchasing (VBP), by incentivizing physicians to
provide for a patient's overall level of health.244
Chapter Appendix A, found at the end of this chapter, shows historic changes in Medicare
payments charged by various physician specialties.
RVU Updates
RVUs are updated annually by CMS, with significant input and advice from the AMA/Specialty
Society Relative Value Scale Update Committee (RUC).245 The RUC is a somewhat controversial
panel of 31 physicians from different specialties who recommend updates to the values of
various RVU’s under the Physician Fee Schedule.246 Of the 31 physicians comprising the RUC,
21 physicians represent major medical specialties. Four additional seats are reserved for internal
medicine subspecialty practitioners, one primary care practitioner, and one for any other
specialty.247 The remaining six slots are occupied by:
(1)
(2)
(3)
(4)
(5)
(6)

The RUC Chair;
The Co-Chair of the RUC Health Care Professionals Advisory Committee Review Board;
The chair of the Practice Expense Review Board;
A representative of the AMA;
A representative of the American Osteopathic Association; and
Current Procedural Terminology (CPT) Editorial Panel.248

The panel convenes three times per year to discuss and make recommendations regarding a
multitude of medical and surgical procedures.249 There has been significant controversy
surrounding the RUC’s level of impartiality and the extent to which CMS’s relies on their
recommendations.250 Critics of the RUC process have suggested that CMS gives the RUC too
much influence in the RBRVS decision-making process. Historically, CMS has followed

242 “Providing and Billing Medicare for Chronic Care Management: 2015 Medicare Physician Fee Schedule Final Rule” Pershing Yoakley &
Associates, PC, November 2014, p. 4.
243 Ibid.
244 Ibid.
245 “Gauging Emergency Physician Productivity: Are RVUs the Answer?” By John Proctor, ACEP Reimbursement Committee, Posted on
American College of Emergency Physicians, www.acep.org/practres.aspx?id=30306 (Accessed 08/14/12).
246 “AMA/Specialty Society RVU Update Committee: The RUC is… The RUC is Not…” American Medical Association, June 16, 2007; “The
RVS Update Committee” American Medical Association, December 8, 2014, http://www.ama-assn.org/ama/pub/physicianresources/solutions-managing-your-practice/coding-billing-insurance/medicare/the-resource-based-relative-value-scale/the-rvs-updatecommittee.page? (Accessed 2/23/15).
247 “The RVS Update Committee” American Medical Association, December 8, 2014, http://www.ama-assn.org/ama/pub/physicianresources/solutions-managing-your-practice/coding-billing-insurance/medicare/the-resource-based-relative-value-scale/the-rvs-updatecommittee.page? (Accessed 2/23/215).
248 Ibid.
249 “AMA/Specialty Society RVS Update Committee (RUC)” By Barbara S. Levy, AMA/Specialty Society RVS Committee Chair, American
Medical Association, March 5, 2010, p.4.
250 “Letter From AAFP to CMS Regarding the RUC” By Lori Heim, American Academy of Family Physicians, To Donald Berwick, Centers
For Medicare & Medicaid Administrator, October 8, 2010.

114

Chapter 2: Reimbursement Environment

90 percent of the recommendations provided by the RUC regarding physician reimbursements,
basing at least 20 percent of physician payments on RUC recommendations.251
RUC challengers have also alleged that, as the majority of RUC members are selected by
medical-specialty trade groups, the RUC has facilitated disparities between specialty and primary
reimbursement rates.252 The American Academy of Family Physicians (AAFP), the most vocal
opponent to the RUC, wrote to CMS urging them to follow a 2006 Medicare Payment Advisory
Commision (MedPac) Report to Congress, which suggested lowering reliance on the RUC by
forming a group of less financially invested experts to identify over-valued services and work
with the RUC to increase transparency and encourage provider efficiency.253
Professional Component Versus Ancillary Services and Technical Component
The MPFS differentiates between two distinct revenue streams: the professional services
component and the ancillary services and technical component (ASTC).254 To use the
performance of diagnostic services as an example, a provider performs the technical component
when he or she executes functions such as taking an x-ray or administering an
electrocardiogram.255 Providers then perform the professional component when they interpret the
results of those tests or write reports.256 Providers must use the appropriate procedure code
modifiers on submitted claims to distinguish between the services they performed and those
performed by others, such as the hospital, technicians, or other staff, because a provider may
only bill for services he or she provides.257
Imaging Reimbursement
Reimbursement for diagnostic imaging services is often split into a professional component
(PC), representing the physician’s efforts in interpreting a test, and a technical component (TC),
representing the use of an imaging device itself (e.g. an MRI machine).258 Adding another layer
of complexity, the reimbursement methodology changes depending on where the diagnostic
imaging services are performed. For example, if the imaging services are performed in a
physician practice, both the PC and the TC are billed using the MPFS.259 However, if the

251 “A Small Group of Physicians has a Big Say in What you Get Paid: What Every Physician Should Know about the RUC” By Kent J,
Moore, et al., Family Practice Management, February 2008; “AMA/Specialty Society RVU Update Committee: The RUC is… The RUC is
Not…” American Medical Association, June 16, 2007.
252 “Missing Productivity Gains in Medicare Physician Fee Schedule: Where are They?” By Jerry Cromwell, et al., Medical Research and
Review, June 16, 2010, p.2-3; “RUC Physician Fee Lawsuit Dismissed” By Andis Robeznieks, Modern Healthcare, May 11, 2012,
http://www.modernhealthcare.com/article/20120511/MODERNPHYSICIAN/305119989 (Accessed 2/23/15).
253 “Letter From AAFP to CMS Regarding the RUC” By Lori Heim, American Academy of Family Physicians, To Donald Berwick, Centers
For Medicare & Medicaid Administrator, October 8, 2010; “Missing Productivity Gains in Medicare Physician Fee Schedule: Where are
They?” By Jerry Cromwell, et al., Medical Research and Review, June 16, 2010, p. 3, 15.
254 “2009 CCH Medicare Explained” Edited By Pam Carron et al., Chicago, IL: Wolters Kluwer, 2009, p. 306.
255 Ibid.
256 “Professional and Technical Component Modifiers” By Donna Tyler, The American College of Obstetricians and Gynecologists, 2009,
http://www.acog.org/departments/dept_notice.cfm?recno=6&bulletin=4672 (Accessed 8/19/09).
257 “2009 CCH Medicare Explained” Edited By Pam Carron et al., Chicago, IL: Wolters Kluwer, 2009, p. 306; “2009 Master Medicare Guide”
CCH Health Editorial, Chicago, IL: Wolters Kluwer, 2009, p. 917.
258 “Medicare Coverage of Imaging Services” Medicare Learning Network, Centers for Medicare & Medicaid Services, June 2013,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/Radiology_FactSheet_
ICN907164.pdf (Accessed 11/11/2014), p.1.
259 Ibid, p. 2.

115

Adviser's Guide to Healthcare

imaging services are performed in a hospital, the PC is billed using the MPFS, while the TC is
billed using the appropriate hospital PPS, depending on whether the patient had been admitted.260
Over the last several years, reimbursement for many diagnostic imaging procedures has suffered
drastic cuts, many of which particularly target imaging services delivered in a “non-facility”
setting (e.g. services delivered in a physician practice).261 One source of payment reduction for
imaging services is the equipment utilization rate. CMS uses the utilization rate to calculate PE
RVUs, reasoning that the more often a fixed piece of equipment is used, the lower the expense
per use (and therefore, lower reimbursement for the use of that equipment). For most equipment,
CMS assumes a utilization rate of 50% (i.e. the equipment is in use 50% of the time the provider
is open for business).262 However, the American Taxpayer Relief Act mandated that CMS assume
a utilization rate of 90% for imaging equipment that costs more than $1 million.263 With this
higher utilization rate, imaging services receive less reimbursement per use of the equipment.
Radiologists have argued that 90% utilization is nearly unattainable, citing surveys which place
average utilization rates for imaging equipment much closer to CMS’s original assumption of
50%.264 In response, CMS has stated that the agency now lacks the authority to change the
assumed utilization rate, due to the American Taxpayer Relief Act.265
In addition to the 90% utilization rate assumption for equipment that costs more than $1 million
(effectively reducing payments for imaging services that utilize such equipment), Medicare also
reduces reimbursement for certain repeated imaging services delivered by the same physician to
the same patient on the same day (coded using modifier 51), known as the Multiple Procedure
Payment Reduction (MPPR).266 Aside from the highest paying service (which receives the
normal Medicare payment), further services delivered to the same patient in the same session on
the same day by the same physician are reimbursed at 75% of the normal Medicare payment.267
CMS Anti-Markup Rule
If a provider orders a diagnostic test from another supplier, he or she may bill Medicare for the
technical component of that diagnostic test, even though he or she didn’t perform the technical
component.268 However, that provider may not mark-up the bill he or she submits for Medicare
260 “Medicare Claims Processing Manual: Chapter 13 – Radiology Services and Other Diagnostic Procedures” Centers For Medicare &
Medicaid Services, April 18, 2014, p. 5-8.
261 “Medicare Cuts Imaging Reimbursement Again – But There is Good News Too” by Jon Geise, 3d health, Inc., February 24, 2014, p. 2,
http://www.3dhealthinc.com/blog/medicare-cuts-imaging-reimbursement-again-but-there-is-good-news-too (Accessed 11/11/14).
262 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to
Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015; Proposed Rule”
Federal Register Vol. 79, No. 133 (July 11, 2014), p. 40327.
263 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other
Revisions to Part B for CY 2014; Final Rule” Federal Register Vol. 78, No. 237 (December 10, 2013), p. 74238-74239; “Equipment
Utilization Rate Changes Adversely Affect Patients and Radiologists” American College of Radiologists, 2013,
http://www.acr.org/~/media/ACR/Documents/PDF/Advocacy/Fed%20Relations/EquipmentUtilizationAssumptionRateIssueBrief.pdf
(Accessed 11/12/14).
264 “Equipment Utilization Rate Changes Adversely Affect Patients and Radiologists” American College of Radiologists, 2013,
http://www.acr.org/~/media/ACR/Documents/PDF/Advocacy/Fed%20Relations/EquipmentUtilizationAssumptionRateIssueBrief.pdf
(Accessed 11/12/14) , p. 2.
265 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other
Revisions to Part B for CY 2014; Final Rule” Federal Register Vol. 78, No. 237 (December 10, 2013), p. 74238-74239.
266 “Pub 100-04 Medicare Claims Processing: Transmittal 2395” Centers for Medicare & Medicaid Services, January 26, 2012,
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R2395CP.pdf (Accessed 11/21/2014), p. 3.
267 Ibid.
268 “CMS 2008 Rulemaking Focuses on Curbing Self-Referred Imaging” By Thomas W. Greeson & Heather M. Zimmerman, American
Journal of Roentgenology, Vol. 190 (February 2008), http://www.ajronline.org/cgi/reprint/190/2/275.pdf (Accessed 09/15/09), p. 277.
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reimbursement above the amount he or she paid for the test to reflect additional professional
component costs associated with reading and interpreting the test.269 Additionally, the 2008
MPFS expanded this anti-markup provision to both professional and technical component
revenue generated by tests performed outside the office of the billing physician.270 There are two
exceptions that allow the billing physician to avoid the anti-markup rule: 271
(1) The technical component is supervised by a physician who performs substantially all
(that is, 75 percent or more) of his or her professional services for the billing physician,
physician organization, or supplier; and,
(2) The technical component is conducted and supervised in the same building as the medical
office of the ordering physician or authorized non-physician provider is located.
Therefore, even in a group practice, the technical component must be performed in the same
building where the ordering physician provides services, rather than the technical component
being performed at a separate diagnostic testing facility, in order to avoid the anti-markup
rule.272
Incidentally, an increasingly volatile regulatory environment surrounding physician ownership is
being driven by competition over who should benefit from ASTC revenues. Federal legislators
consistently have advocated against physicians earning profits, which compounds the problem of
declining reimbursement under the MPFS for the professional component of diagnostic imaging
services, which has not kept up with inflation indices and has resulted in consistent decreases in
physician professional component fee reimbursement yield.273 To attempt to counteract this
trend, physicians have attempted to invest in ASTC revenue stream enterprises, for example,
ASCs; independent diagnostic testing facilities, surgical hospitals, physical therapy, etc.274
However, there have been incessant legislative and regulatory efforts undertaken at the federal
and state levels, in large part due to massive lobbying initiatives by oligopoly hospitals and their
trade associations, to prevent this trend by restricting physician investment in ASTC revenue
stream enterprises.275 These measures have served to relegate independent physicians in private
practice to receiving only professional fee component revenues or to acquiesce by accepting
employee status under the substantial control of hospital systems or large corporate players.276 In
cases in which physicians receive only the professional fee component, many physician owners
269 Ibid.
270 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008;
Revision to the Payment Policies of Ambulance Services under the Ambulance Fee Schedule for CY 2008; and the Amendment of the
E-Prescribing Exemption for Computer Generated Facsimile Transmissions” Federal Register Vol. 72 No. 227(November 27, 2007),
p. 66307.
271 “30.2.9—Payment to Physician or Other Supplier for Diagnostic Tests Subject to the Anti-Markup Payment Limitation—Claims Submitted
to A/B MACs (B)” in “Medicare Claims Processing Manual: Chapter 1 – General Billing Requirements” Centers for Medicare & Medicaid
Services, February 20, 2015, http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c01.pdf (Accessed
3/2/2015).
272 Ibid.
273 “Down on the Farm: The Attack on Physician Ownership” By Robert James Cimasi, SurgiStrategies, May 1, 2008,
http://www.surgistrategies.com/articles/physician-ownership-law-asc-cimasi.html# (Accessed 10/08/09); “Specialty Hospitals, Ambulatory
Surgery Centers, and General Hospitals: Charting a Wise Policy Course” By Michael D. Maves, American Medical Association, The
Council on Health Care Economics and Policy: Sept. 10, 2004, http://content.healthaffairs.org/content/24/3/868.full.pdf (Accessed
5/20/2010), p. 24.
274 “Down on the Farm: The Attack on Physician Ownership” By Robert James Cimasi, SurgiStrategies, May 1, 2008,
http://www.surgistrategies.com/articles/physician-ownership-law-asc-cimasi.html# (Accessed 10/08/09).
275 “Down on the Farm: The Attack on Physician Ownership” By Robert James Cimasi, SurgiStrategies, May 1, 2008,
http://www.surgistrategies.com/articles/physician-ownership-law-asc-cimasi.html# (Accessed 10/08/09).
276 Ibid.
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are finding it very difficult to recover both the operating and capital expenses associated with
running a practice.
Facility-Based Reimbursement Rates
Medicare reimburses providers at different rates depending on whether payments are being made
under Part A or Part B (that is, inpatient or outpatient), and reimburses outpatient procedures at
different rates based on the site of service.
Hospital Inpatient Services
CMS reimburses hospitals under Medicare Part A for two different payments, the operating
payment and the capital payment.277 The operating payment covers operating expenses, such as
the cost of radiological isotopes, supplies, nurse salaries, etc., while the capital payment covers
costs for depreciation, interest, rent, and property-related insurance and taxes.278 The hospital
submits the bill for all inpatient services, and any associated outpatient services, to a Medicare
Claims Administration Contractor, who then categorizes the bill into a Medicare Severity
Diagnosis Related Group (MS-DRG) classification.279 The MS-DRG classification system
divides possible diagnoses into approximately 500 groups depending on the patient’s diagnosis,
the resources used to treat the condition, and the severity of the condition.280 In order to calculate
the operating payment, each MS-DRG is assigned a specific DRG weight, which is then
multiplied by the base payment rate. The base payment rate is comprised of a labor-related
portion, and a non-labor related portion. The labor-related portion is adjusted by a wage index
to reflect geographic differences in cost of labor, while the non-labor related portion is adjusted
by a cost-of-living adjustment.281 The DRG-adjusted base payment rate is then modified by
certain policy adjustments, including:282
(1)
(2)
(3)
(4)
(5)

Indirect costs of graduate medical education (IME) payments;
Disproportionate share hospital (DSH) payments;
Hospital value based purchasing payments (VBP) or penalties;
Hospital readmissions reduction program penalties (HRR); and
High cost outlier payments, among others.

277 “Acute Care Hospital Inpatient Prospective Payment System; Payment System Fact Sheet Series” Medicare Learning Network, Centers for
Medicare & Medicaid Services, April 2013, http://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNProducts/downloads/AcutePaymtSysfctsht.pdf (Accessed 6/3/14), p. 5.
278 Ibid.
279 Ibid, p. 2.
280 “Diagnosis-related group (DRG),” By Charlyn Stanberry, American Health Lawyers Association, 8/10/2012, p. 1,
http://www.healthlawyers.org/hlresources/Health%20Law%20Wiki/Diagnosis-related%20group%20(DRG).aspx (Accessed 6/3/14).
281 “Acute Inpatient PPS” Centers for Medicare & Medicaid Services, August 4, 2014, http://www.cms.gov/Medicare/Medicare-Fee-forService-Payment/AcuteInpatientPPS/index.html (Accessed 3/2/15).
282 “Acute Care Hospital Inpatient Prospective Payment System; Payment System Fact Sheet Series,” Medicare Learning Network, Centers for
Medicare & Medicaid Services, April 2013, http://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNProducts/downloads/AcutePaymtSysfctsht.pdf (Accessed 6/3/14), p. 4.
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The formulas for calculating the operating and capital cost components of the IPPS payment are
as follows:
Operating Cost Payment = DRG Relative Weight x [(Wage Index
x Labor Related Portion) + Nonlabor
Related Portion x Cost of Living
Adjustment] x (1 + IME + DSH ±
VBP - HRR)283
Capital Cost Payment =

DRG Relative Weight x (Capital Base
Rate x Capital Wage Index x Cost of
Living Adjustment) x (1 + DSH +
IME)284

Hospital Outpatient Departments
When physicians provide services and perform procedures in their offices, they are reimbursed
under the MPFS for both their professional services as well as the technical component of those
services. When procedures are provided in hospital outpatient departments (HOPDs) or
ambulatory surgery centers (ASCs), however, they are reimbursed under both the MPFS (for the
physician services) and the associated payment schedule, which reimburses for the cost of
facilities, equipment, supplies, and staff for services provided in a HOPD or ASC.285 For services
provided in a HOPD, Outpatient Prospective Payment System (OPPS) payments are classified by
service groups called Ambulatory Payment Classifications (APC), each of which includes
services that are clinically similar to one another and require similar resources.286 Each APC has
a relative weight that reflects the geometric mean cost of services in that group.287 These APCs
are multiplied by a conversion factor (CF) and adjusted for geographic variance in order to arrive
at the HOPD payment. The formula for calculating the HOPD payment is as follows:
HOPD Payment = (CF x APC relative weight) x [Labor Related
Portion (60%) Adjusted by Hospital Wage
Index + Non labor Related Portion (40%)
288
Unadjusted] + (Special Exception Payments)

283 “Acute Care Hospital Inpatient Prospective Payment System” Centers for Medicare & Medicaid Services, Medicare Learning Network,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/AcutePaymtSysfctsht.pdf
(Accessed 2/21/2015), p. 4. Note that outlier payments and adjustments for transfers are not included in the displayed formula.
284 Ibid.
285 “Ambulatory Surgical Centers Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/
MedPAC_Payment_Basics_08_ASC.pdf (Accessed 09/24/09), p. 1.
286 “Final 2009 Policy, Payment Changes for Hospital Outpatient Departments and Ambulatory Surgery Centers,” Centers For Medicare &
Medicaid Services, October 30, 2008, http://www.cms.gov/apps/media/press/factsheet.asp?Counter= 3335&intNumPerPage=10&check
Date=&checkKey=&srchType=1&numDays= 3500&srchOpt=0&srchData=&keywordType=All&chkNewsType=6&intPage=
&showAll=&pYear=&year=&desc=false&cboOrder=date (Accessed 9/24/09).
287 “Hospital Outpatient Prospective Payment System” Payment Fact Sheet Series, Centers for Medicare & Medicaid Services, January 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/HospitalOutpaysysfctsht.pdf
(Accessed 1/28/15), p. 4.
288 Ibid, p. 4-6.
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Ambulatory Surgery Centers
For services performed in an ASC, Medicare pays the lower of: (1) the actual charge or (2) the
ASC payment rate, according to the Ambulatory Surgical Center Fee Schedule (ASCFS).289 ASC
payment rates are calculated by multiplying the ASC conversion factor (CF) by the ASC relative
payment weights, which are based on the relative weights assigned to procedures under the
OPPS for HOPDs.290 CMS implemented this payment methodology for ASCs in 2008. Due to
the need to ensure budget neutrality between the old ASC payment system and the revised
system, CMS reduces the OPPS relative payment weights before applying them to the ASCFS.
In 2014, the ASC relative weights were 7.7% lower than those used in the OPPS.291 In addition
to the reduction of the payment weights, the ASCFS and the OPPS use different methodologies
to update their respective CFs, resulting in the ASC CF generally having smaller updates than the
OPPS CF.292 As a result of these discrepancies, payments for most ambulatory procedures are,
according to MedPac, overall 81% higher in HOPDs than in freestanding ASCs.293
In order to take advantage of this increased reimbursement to HOPDs, physician offices and
physician-owned ASCs may wish to integrate with hospitals, and apply for provider-based
status.294 There are separate requirements for provider-based billing, i.e., the ability to charge a
HOPD rate and a physician professional component, based upon the site of the entity seeking
provider based status (on and off the hospital’s campus), as well as the type of contract for which
provider based status is sought (joint ventures and management contracts).295 However, all of
these sites and contracts have the following requirements in common:
(1) The provider applying for provider based status must be operated under the same license
as the main facility, except for certain circumstances;
(2) The provider applying for provider based status and the main facility must be clinically
integrated;
(3) The provider applying for provider based status and the main facility must be financially
integrated; and
(4) The entities must make their affiliation known to the public.296
However, there have been various suggestions and rules regarding the repeal of this payment
discrepancy. The OIG stated in its 2015 Work Plan that it would review the “appropriateness of
Medicare’s methodology for setting ambulatory surgical center payment rates under the revised
payment system,” and that it would determine if a payment disparity exists between ASCs and
289 “Ambulatory Surgical Center Fee Schedule: Payment System Fact Sheet Series” Centers for Medicare & Medicaid Service, April 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNProducts/downloads/AmbSurgCtrFeepymtfctsht508-09.pdf (Accessed 8/6/14), p. 5.
290 “Ambulatory Surgical Center Fee Schedule: Payment System Fact Sheet Series” Centers for Medicare & Medicaid Service, April 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNProducts/downloads/AmbSurgCtrFeepymtfctsht508-09.pdf (Accessed 8/6/14), p. 5.
291 “Chapter 5—Ambulatory Surgery Center Services” in “Report to the Congress: Medicare Payment Policy” Medicare Payment Advisory
Commission, March 2014, p. 123.
292 “Payment Disparities Persist, but ASCs Gain Some Ground under Medicare’s Proposed 2015 Payment Rule” Ambulatory Surgery Center
Association, July 22, 2014, http://www.ascassociation.org/ASCsGainGroundin2015ProposedRule (Accessed 1/28/15).
293 “Chapter 5—Ambulatory Surgery Center Services” in “Report to the Congress: Medicare Payment Policy” Medicare Payment Advisory
Commission, March 2014, p. 121-122.
294 “Requirements for a Determination that a Facility or an Organization has Provider-Based Status” 42 C.F.R. § 413.65(d)-(h) (November 6,
2014).
295 Ibid.
296 Ibid.
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HOPDs for similar surgical procedures.297 Similarly, MedPac has recommended that CMS
collect ASC cost data to determine whether the utilization of alternative price indices would be
more accurate in determining an appropriate proxy for ASC costs.298 Despite these suggestions,
in its final payment rule for 2015, CMS stated that it would not use the hospital market basket as
the inflation index for ASCs, but it would consider collecting ASC cost data to assist in
determining the appropriate inflation index to use; however, CMS does not believe the collection
of such data would be productive.299
There are a few procedures performed in ASCs that are not reimbursed through the standard
payment methodology. CMS began paying ASCs for “new, office-based procedures” (which are
generally performed in physician offices) in 2008.300 In an effort to prevent physicians from
moving their practices out of their offices and into ASCs, CMS determined that it would
reimburse for these services performed in an ASC at a rate that is the lower of the ASC rates
(that is, the percentage of the OPPS rate) or the practice expense portion of the MPFS payment
rate that would apply to the procedure if it had been performed in a physician’s office.301 Based
on the same objective of discouraging shifting procedures to ASCs, CMS also excludes from the
revised ASC payment rates reimbursement for separately payable radiology services and
reimbursement for drugs, instead applying the same reimbursement policy as for office-based
procedures.302
Critical Access Hospitals
Outpatient services that are delivered at a Critical Access Hospital (CAH) are reimbursed under a
methodology that is separate from the reimbursement for outpatient services delivered at a
normal hospital, which are reimbursed under the OPPS. The CAH designation was created to
ensure that Medicare beneficiaries in remote areas would have access to healthcare services, by
providing hospitals that receive the designation with improved reimbursements.303 When paying
for outpatient services delivered at a CAH, instead of using the OPPS payment rates, Medicare
pays the CAH 101% of their reasonable costs.304 In addition, the Medicare beneficiary is
responsible for a coinsurance payment in the amount of 20% of the CAH's charge for the service,
regardless of what Medicare will eventually pay.305 An investigation by the Office of the
Inspector General (OIG) in October of 2014 found that, due to this discrepancy, Medicare
beneficiaries were paying, on average, 47% of the cost of outpatient services delivered at
297 "Work Plan: Fiscal Year 2015" Office of Inspector General - U.S. Department of Health and Human Services, October, 2014,
https://oig.hhs.gov/reports-and-publications/workplan/#current (Accessed 11/6/2014) p. 27.
298 "Report to the Congress: Medicare Payment Policy" Medicare Payment Advisory Commission, March, 2014, http://www.medpac.gov/
-documents-/reports (Accessed 11/6/2014) p. 123.
299 “Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and
Quality Reporting Programs; Physician-Owned Hospitals; Data Sources for Expansion Exception; Physician Certification of Inpatient
Hospital Services; Medicare Advantage Organizations and Part D Sponsors; CMS-Identified Overpayments Associated with Submitted
Payment Data; Final Rule” Federal Register Vol. 79, No. 217 (November 10, 2014), p. 66939.
300 “Ambulatory Surgical Centers Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/
MedPAC_Payment_Basics_08_ASC.pdf (Accessed 09/24/09), p. 2.
301 Ibid.
302 Ibid.
303 “Medicare Beneficiaries Paid Nearly Half of the Costs for Outpatient Services at Critical Access Hospitals” by Daniel R. Levinson,
Inspector General, Office of the Inspector General, U.S. Department of Health and Human Services, October 2014, p. 1.
304 “Critical Access Hospital: Rural Health Fact Sheet Series” Centers for Medicare and Medicaid Services, September 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/CritAccessHospfctsht.pdf
(Accessed 3/2/15) , p. 2.
305 Ibid.
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CAHs.306 The OIG concluded that CMS should seek legislative authority to change how
coinsurance payments for outpatient services at CAHs are calculated.307
Inpatient vs. Outpatient Reimbursement
Depending on whether a hospital admits a patient or provides treatment to the patient without
admitting them (i.e., providing services in observation), a hospital may bill Medicare for services
using the IPPS or the OPPS. As described above, the IPPS calculates payment based on the
average cost of a patient with a specific diagnosis, while the OPPS calculates payment based on
the services provided to a specific beneficiary.
Because of these differing methodologies, hospitals may have an incentive to admit patients or
leave them in observation status based on the patient’s complexity, rather than the duration of
their hospital stay.308 If a patient will require relatively few services (and a correspondingly short
stay), the hospital may seek to admit them, then bill Medicare for services using the IPPS. Thus
the hospital still receives the standard IPPS payment for an average patient with a given
diagnosis, while incurring comparatively low costs. Alternatively, if a patient will require a
relatively high number of services (and a correspondingly longer stay), the hospital may not
admit them, leaving the patient in observation status for a prolonged period. Because the OPPS
pays for beneficiaries on a per-service basis, and because patients in observation are billed using
the OPPS, hospitals could receive significantly higher payments by performing as many services
as possible on patients in observation.309
In July of 2013, the Office of the Inspector General (OIG) published research that reinforced the
idea that a hospital could reap significant financial rewards by admitting patients who required
relatively short stays. The OIG found that in 2012, Medicare paid an average of $5,142 per
inpatient stay lasting one night or fewer (which the report defined as a short inpatient stay).310
Conversely, Medicare paid an average of $1,741 per observation stay.311 Furthermore, the OIG
found that when patients were treated for the same medical problems, Medicare still paid more
for short inpatient stays than for observation stays.312
The Two Midnight Rule
In order to standardize how hospitals classify their patients (thus addressing the issue of hospitals
admitting patients based on revenue projections rather than medical necessity, as described
above), CMS issued the final version of the two-midnight rule in August of 2013, which states:313
306 “Medicare Beneficiaries Paid Nearly Half of the Costs for Outpatient Services at Critical Access Hospitals” by Daniel R. Levinson,
Inspector General, Office of the Inspector General, U.S. Department of Health and Human Services, October 2014, p. 7.
307 Ibid, p. 13.
308 “Two-midnight rule a double-edged sword” by Tammy Worth, Healthcare Finance News, October 22, 2013,
http://www.healthcarefinancenews.com/news/two-midnight-rule-double-edged-sword?single-page=true (Accessed 8/12/14).
309 “Memorandum Report: Hospitals’ Use of Observation Stays and Short Inpatient stays for Medicare Beneficiaries” by Stuart Wright, Office
of Inspector General, To Marilyn Tavenner, Centers for Medicare & Medicaid Services, https://oig.hhs.gov/oei/reports/oei-02-12-00040.pdf
(Accessed 8/12/14) , p. 2.
310 Ibid, p. 12.
311 Ibid, p. 12.
312 “Memorandum Report: Hospitals’ Use of Observation Stays and Short Inpatient stays for Medicare Beneficiaries” by Stuart Wright, Office
of Inspector General, To Marilyn Tavenner, Centers for Medicare & Medicaid Services, https://oig.hhs.gov/oei/reports/oei-02-12-00040.pdf
(Accessed 8/12/14) , p. 12-13.
313 “Admissions” 42 CFR § 412.3(e)(1) (October 1, 2013).
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“[if a] physician expects to keep the patient in the hospital for only a limited period
of time that does not cross 2 midnights, the services are generally inappropriate for
inpatient admission and inpatient payment under Medicare Part A…”
Similarly, the rule states that admission, and the corresponding payment under the IPPS, is
appropriate for patients that could be expected to stay in the hospital for a period of time
spanning more than two midnights.314 As of October 1, 2013, claims for services that do not
comply with this rule could be denied, if the claim were reviewed.315 Therefore, as a result of this
rule, hospitals may stand to lose significant revenue.316 Some hospital groups have spoken out
against the two-midnight rule, leading CMS to enact a Probe and Educate program through
March 2015, during which CMS auditors will attempt to educate hospitals.317 Auditors will deny
claims that do not comply with the two-midnight rule, but auditors will not conduct postpayment reviews of claims for admissions between October 1, 2013 and March 31, 2015.318
Skilled Nursing Facility Reimbursement
Medicare only covers about 22 percent of all nursing home expenditures,319 as neither Medicare
Parts A or B cover custodial care, i.e., care that helps residents with daily activities.320
Reimbursement for nursing home expenditures are further restricted because Medicare Part A
(the primary payor for covered skilled nursing services) only pays for daily skilled nursing or
rehabilitation services when they fall under following scenario: (1) the patient had a prior stay in
a general acute care hospital for three consecutive days; (2) admission to a skilled nursing
facility was within a short time period after hospital discharge; (3) the patient is receiving
treatment for the same condition that was being treated in the hospital; and (4) a medical
professional certified the need for daily skilled nursing or rehabilitative care.321 Even with these
limitations, Medicare still paid skilled nursing facilities about $26.4 billion in 2010.322
In the interest of controlling program costs, Medicare Part A limits the amount of skilled nursing
days covered to 100 days per benefit period. While Medicare covers the first 20 days at 100
percent of costs, a co-payment of $144.50 per day is required for days 21 through 100.323 After
the 100-day benefit is exhausted, the patient’s Medicare Part B benefits will continue to
reimburse for any physician services; however, the beneficiary will also be liable for all other

314 “Admissions” 42 CFR § 412.3(e)(1) (October 1, 2013).
315 “Selecting Hospital Claims for Patient Status Reviews: Admissions On or After October 1, 2013” Centers for Medicare & Medicaid
Services, November 4, 2013, http://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/MedicalReview/Downloads/SelectingHospitalClaimsforAdmissionsonorafterOctober1st2013forReviewForWebPostingCLEAN.pdf (Accessed
8/12/14).
316 “Two-midnight rule a double-edged sword” by Tammy Worth, Healthcare Finance News, October 22, 2013,
http://www.healthcarefinancenews.com/news/two-midnight-rule-double-edged-sword?single-page=true (Accessed 8/12/14).
317 “Inpatient Hospital Reviews” Centers for Medicare & Medicaid Services, November 25, 2014, http://www.cms.gov/Research-StatisticsData-and-Systems/Monitoring-Programs/Medicare-FFS-Compliance-Programs/Medical-Review/InpatientHospitalReviews.html (Accessed
2/18/15).
318 Ibid.
319 “Health Care Spending and the Medicare Program” Medicare Payment Advisory Commission, Data Book, June 2012, p. 6.
320 "CCH Medicare Explained: §244" Editor Pamela K. Carron and Nicole T. Stone, Chicago, IL: CCH, 2012, p. 60.
321 "CCH Medicare Explained: §230, §625" Editor Pamela K. Carron and Nicole T. Stone, Chicago, IL: CCH, 2012, p. 50-52, 301
322 “Skilled nursing facility services payment system” MedPAC, October 2011, http://www.medpac.gov/documents/MedPAC_Payment_
Basics_11_SNF_v2.pdf (Accessed 8/17/12).
323 “Medicare & You 2012” Centers For Medicare & Medicaid Services, 2012, http://www.medicare.gov/publications/pubs/pdf/10050.pdf
(Accessed 8/21/12), p. 35.
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costs.324 The costs of nursing home care, without the assistance of insurance coverage, are often
prohibitive for many patients, as these costs range between $39,600 and $81,030.325
Medicare reimbursed skilled nursing facility services under a cost-based payment system prior to
the July 1, 1998 implementation of the PPS. Under the PPS reimbursement system, skilled
nursing facilities are reimbursed through:
“…prospective, case-mix adjusted per diem payments that cover routine, ancillary, and
capital-related costs, including most items and services for which payment was
previously made under Medicare Part B. The per diem payment is based on Fiscal Year
1995 Part A & B costs adjusted using the [skilled nursing facility] market basket index,
the case mix from resident assessments, and geographical wage variations.”326
The case-mix index accounts for the different levels of care required by individual patients while
the market basket index serves as an adjustment factor made for inflation.327 In order to
determine an appropriate case-mix, skilled nursing facilities assign patients into one of the 66
Resource Utilization Groups (RUGs),328 and then divide patients into the following six major
categories:
(1)
(2)
(3)
(4)
(5)
(6)

Special rehabilitation;
Extensive services;
Special care;
Clinically complex;
Impaired cognition; and
Reduced physical function.329

In order to address concerns that reimbursement payments for skilled nursing services were
reduced by the implementation of the PPS, Congress enacted the Balanced Budget Refinement
Act (BBRA) on November 29, 1999. As a result, Congress implemented a four percent acrossthe-board increase in payments to skilled nursing facilities for Fiscal Years 2001 and 2002, with
a temporary 20 percent increase in payments for 15 RUGs that represented medically complex
conditions, on April 1, 2001.330 Congress then enacted additional legislation to further increase
reimbursement rates to skilled nursing facilities. Under the Benefits Improvement and Protection
Act of 2000 (BIPA), the inflation update was increased to the full market basket in Fiscal Year

324 “Medicare & You 2012” Centers For Medicare & Medicaid Services, 2012, http://www.medicare.gov/publications/pubs/pdf/10050.pdf
(Accessed 8/21/12), p. 35; “Medicare Beneficiary Access to Skilled Nursing Facilities, 2001,” Report OEI-02-01-00160, U.S. Office of
Inspector General, July 2001, p.1; “Prospective Payment for Post-Acute Care: Current Issues and Long-Term Agenda,” Report to the
Congress: Medicare Payment Policy, MedPAC, March 2001, p. 91.
325 “Genworth 2012 Cost of Care Survey: Home Care Providers, Adult Day Health Care Facilities, Assisted Living Facilities and Nursing
Homes” Genworth Financial, LLC and National Eldercare Referral Systems, LLC, 2012, p. 9.
326 “Medicare Beneficiary Access to Skilled Nursing Facilities, 2001,” Report OEI-02-01-00160, U.S. Office of Inspector General, July 2001,
p.2; “Prospective Payment for Post-Acute Care: Current Issues and Long-Term Agenda” Medicare Payment Advisory Commission, Report
to the Congress: Medicare Payment Policy, 2001 Washington, D.C., March 2010, p. 90-92.
327 “Medicare Beneficiary Access to Skilled Nursing Facilities, 2001,” Report OEI-02-01-00160, U.S. Office of Inspector General, July 2001,
p. 2.
328 Resource Utilization Groups are based on patient characteristics, including services used, that estimate what resources a particular patient
with similar characteristics may utilize. RUGs are used to adjust the daily rate for skilled nursing payments. “Skilled Nursing Facility
Services Payment System” Medicare Payment Advisory Commission, Payment Basics, October 2011, p. 1-2.
329 “Skilled Nursing Facility Services Payment System” Medicare Payment Advisory Commission, Payment Basics, October 2011, p. 1-2.
330 “Balanced Budget Refinement Act of 1999” Pub. L. 106-113, § 101, 113 Stat. 1501, 1501A-324 (November 29, 1999).
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2001, and the nursing component of the RUGs were increased by 16.6 percent.331 Additionally,
BIPA adjusted BBRA’s 20 percent increase in payment for three of the fifteen RUGs (those for
rehabilitation) to a 6.7 percent increase across 14 additional rehabilitation RUGs.332
Home Health Reimbursement
Home health services are reimbursed through Medicare Part A as directed by Section 1861 of the
SSA. Specifically, Medicare Part A will reimburse for home healthcare for a patient only when:
(1) A physician has certified that home healthcare is necessary;
(2) The beneficiary has been confined to their home; and,
(3) The beneficiary requires services covered by Medicare, specifically:
(a) Physical and occupational therapy;
(b) Speech language pathology services;
(c) Medical social services; and,
(d) Home health aide services for personal care related to the treatment of the
beneficiary’s illness or injury.
Additionally, Medicare Part B covers the cost of medical supplies and durable medical
equipment (DME).333
When Congress drafted this section of the Social Security Act, they intended to limit the
coverage of care strictly to the skilled treatment of a specific illness or injury.334 As a result, the
SSA’s coverage of home health services was constructed similarly to the reimbursement
methodology for skilled nursing facilities by specifically denying coverage for custodial care
and personal comfort items.
Originally, Medicare Part A benefits were limited to 100 home healthcare visits for Medicare
beneficiaries discharged from a minimum three day stay at the hospital. If these visits were
exhausted under Medicare Part A, the beneficiary gained additional coverage under Medicare
Part B. Specifically, Medicare Part B provided coverage for an additional 100 home healthcare
visits yearly, but required the beneficiary to pay a deductible. However, the Omnibus Budget
Reconciliation Act of 1980 eliminated the 100 visit limits for both Part A and Part B, removed
the deductible requirement for Part B home health services, and waived the three day prior
hospitalization requirement under Part A. This essentially transformed the Medicare home health
benefits into an unlimited benefit serving both the short-term recuperative care after a hospital
stay and the long-term chronic needs of patients.335

331 “Medicare Program; Provisions of the Benefits Improvement and Protection Act of 2000; Inpatient Payments and Rates and Costs of
Graduate Medical Education: Interim Final Rule with Comment Period” Federal Register Vol. 66, No. 144 (June 13, 2001)., p. 32175.
332 “Medicare Beneficiary Access to Skilled Nursing Facilities, 2001,” Report OEI-02-01-00160, U.S. Office of Inspector General, July 2001,
p.3.
333 “What Part B covers,” Medicare.gov, http://www.medicare.gov/what-medicare-covers/part-b/what-medicare-part-b-covers.html (Accessed
4/1/15).
334 “Testimony on the Balanced Budget Act Home Health Provisions by Nancy-Ann Min DeParle” Assistant Secretary for Legislation
Department of Health and Human Services, March 31, 1998.
335 “Medicare from the Start to Today” By Tom Dowdal, National Bipartisan Commission of the Future of Medicare, http://rs9.loc.gov/
medicare/history.htm (Accessed 8/29/12).
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The 1983 implementation of the Medicare PPS for inpatient hospital services resulted in a large
transition of healthcare services that once were provided in an inpatient setting instead being
provided through an outpatient setting. The result of this was evident through the first half of the
1980’s, as the percentage of Medicare patients discharged to home health facilities increased
from 9.1 percent in 1981 to 17.9 percent in 1985.336 In order to slow the surging home health
costs, the Balanced Budget Act of 1997 implemented a PPS for home health services, as well as
aggregate, per patient cost caps, on the amount agencies were reimbursed for home healthcare
patients.337
On October 1, 2000, the PPS for home health was implemented,338 causing home health agencies
to be paid a pre-determined pay rate for each 60-day episode of care. This rate is based upon
several elements, including:
(1)
(2)
(3)
(4)

Patients’ conditions and service usage;
Geographic area;
Case mix; and
Number of visits.

If there were fewer than five visits within the 60-day episode of care period, the home health
agency is paid instead by the type of visit.339 The episode of care is then categorized by labor and
non-labor portions. The labor portion of the pay rate is adjusted to account for geographic
differences in labor inputs to home health services.340 Any remaining elements in the episode of
care are categorized as non-labor portions.341 In addition to these established CMS payment
rates, the ACA provided an additional three percent payment for episodes of care in rural areas
between April 2010 and April 2015.342
Independent Diagnostic Testing Facilities (IDTF) Reimbursement
Independent Diagnostic Testing Facilities (IDTF), also known as Freestanding Diagnostic
Imaging Facilities, offer diagnostic services that are independently performed outside of a
physician’s office or hospital. Medicare Part B reimburses IDTFs according the MPFS. Notably,
the Deficit Reduction Act of 2005 (DRA), signed into law on February 8, 2006, placed a cap on
the technical component (which includes the technical component of the global fee, i.e., when
the technical and professional components are reimbursed as one amount—globally) for various
336 “Basic Statistics About Home Care” National Association for Home Care and Hospice, November 2001, www.nahc.org/Consumer/
hcstats.html (Accessed 6/5/2003), p. 6.
337 “Medicare Home Health Care: Prospective Payment System Could Reverse Recent Declines in Spending” GAO Report to the Chairman,
Subcommittee on Health, Committee on Ways and Means, House of Representatives, September 2000,
http://www.gao.gov/new.items/he00176.pdf (Accessed 7/13/07), p. 23.
338 “Home Health Prospective Payment System” Centers For Medicare & Medicaid Services, Payment System Fact Sheet Series, ICN 006816,
December 2012, http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/
HomeHlthProsPaymt.pdf (Accessed 3/3/2015), p. 2.
339 Type of Visit is characterized as skilled nursing care; physical, occupational, and speech therapy; medical social work; or, home health aide
services. “Home Health Care Services Payment System” MedPAC, October 2014, Payment Basics, http://www.medpac.gov/documents/
payment-basics/home-health-care-services-payment-system-14.pdf?sfvrsn=0 (Accessed 3/3/2015), p. 1.
340 “Balanced Budget Act of 1997” Pub. L. 105-33, § 4603, 111 Stat. 251, 467 (August 5, 1997); “Home Health Care Services Payment
System” MedPAC, October 2014, Payment Basics, http://www.medpac.gov/documents/payment-basics/home-health-care-servicespayment-system-14.pdf?sfvrsn=0 (Accessed 3/3/2015), p. 3.
341 Ibid.
342 “Home Health Care Services Payment System” MedPAC, October 2014, Payment Basics, http://www.medpac.gov/documents/paymentbasics/home-health-care-services-payment-system-14.pdf?sfvrsn=0 (Accessed 3/3/2015), p. 3.
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imaging services provided in either a physician’s office or IDTF. Importantly, these services may
also be provided in a hospital outpatient setting at the OPPS rate.343 This cap on the technical
component in physician office or IDTF settings, established by the DRA, which went into effect
on or after January 1, 2007, applies to imaging services including:
(1)
(2)
(3)
(4)
(5)
(6)

X-ray;
Ultrasound;
Nuclear medicine;
Magnetic resonance imaging (MRI);
Computed tomography (CT); and
Fluoroscopy. 344

Notably, the DRA-established cap does not include imaging services that are classified as
diagnostic and screening mammography.345
Reimbursement to IDTFs has historically been perceived as more vulnerable to abuse than other
services by health policy regulators. A 2012 Office of the Inspector General (OIG) study found
that, despite accounting for only 2.2 percent of the Medicare beneficiaries receiving IDTF services,
90.1 percent of all IDTF services were provided by 9 percent of the IDTFs in the 20 highest
CBSAs. Additionally, these 20 CBSAs allegedly submitted twice as many claims to Medicare that
were marked as having at least two questionable characteristics.346 As a result, CMS has increased
the monitoring of IDTF billing; however, CMS postponed any further judgment regarding the
imposition of a temporary moratorium on new IDTF Medicare enrollment.347
ESRD Reimbursement
Medicare has reimbursed providers of dialysis services for end stage renal disease (ESRD)
based on a composite rate (CR), which is comprised of a predetermined prospective payment for
each dialysis treatment they conduct, since 1983.348 The CR covers the costs associated with a
single dialysis treatment, which includes:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)

Nursing;
Diet counseling;
Other clinical services;
Social services;
Supplies;
Equipment;
Certain laboratory tests; and
Drugs.349

343
344
345
346

“Deficit Reduction Act of 2005” Pub. L. 109-171, § 5102, 120 STAT 4, 39 (February 8, 2006).
“Deficit Reduction Act of 2005” Pub. L. 109-171, § 5102, 120 STAT 4, 40 (February 8, 2006).
Ibid.
“Questionable Billing for Medicare Independent Diagnostic Testing Facility Services” By Timothy S. Brady, et al., Office of the Inspector
General, OEI-09-09-00380, March 2012, http://oig.hhs.gov/oei/reports/oei-09-09-00380.pdf (Accessed 3/3/2015), p. 9-11.
347 Ibid, p. 14.
348 “Outpatient Dialysis Services Payment System” Payment Basics, Medicare Payment Advisory Committee, October 2014,
http://www.medpac.gov/documents/payment-basics/outpatient-dialysis-services-payment-system.pdf?sfvrsn=0 (Accessed 3/3/2015), p. 1.
349 “Outpatient Dialysis Services Payment System” Payment Basics, Medicare Payment Advisory Committee, October 2014,
http://www.medpac.gov/documents/payment-basics/outpatient-dialysis-services-payment-system.pdf?sfvrsn=0 (Accessed 3/3/2015), p. 1;
“Outpatient Dialysis Services” Medicare Payment Advisory Commission, Report to the Congress: Medicare Payment Policy, 2006
Washington, D.C., March 2006, p. 105-129.
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Additionally, the CR is adjusted to account for geographic differences in prices and case-mix.350
As of January 1, 2011, the basic composite payment system was replaced with a bundled ESRD
prospective payment system (ESRD PPS) for Medicare outpatient ESRD facilities by §153(b) of
the Medicare Improvements for Patients and Providers Act (MIPPA).351 The new reimbursement
model was fully implemented on January 1, 2014, having been transitioned in over a four-year
period.352 Providers were given the option to either: (1) fully implement the new reimbursement
system on January 1, 2011 or (2) transition to the new reimbursement system under the four year
transition model.353 If the provider elected to transition under the four year model, they received
a blended payment rate comprised of the initial case-mixed adjusted composite payment rate and
the new ESRD PPS payment.354
The ESRD PPS bundled payment system includes services that were included in the CR as of
2010, such as erythropoiesis stimulating agents and any oral form of such agents; injectable
biologicals used to treat anemia; laboratory tests and other items and services provided to
beneficiaries for ESRD treatment; and other injectable medications that are furnished to ESRD
beneficiaries and separately paid for under Medicare Part B.355 Similar to other forms of
payment, the bundled payment rate is adjusted for patient case-mix, high cost patients, and low
volume facilities.356 Various factors that adjust the ESRD PPS base rate are described and set
forth below, in Table 2-7: Factors Used to Adjust ESRD PPS Base Rate Payments.
Table 2-7: Factors Used to Adjust ESRD PPS Base Rate Payments357
Adjustment Factor

Description

Patient-Level Adjustments for Case-Mix

Based on demographics that play a role in the cost of providing care,
including: patient age; body surface area; low body mass index; onset of
dialysis; and the following six specified co-morbidities: (1) Hereditary
Hemolytic and Sickle Cell Anemia; (2) Monoclonal Gammopathy (in the
absence of multiple Myeloma); (3) Myelodysplastic Syndrome; (4) Bacterial
Pneumonia; (5) Gastrointestinal Bleeding; and (6) Pericarditis.

Facility-Level Adjustments

Facilities that are certified to furnish home or self-care dialysis training
services will receive a training add-on payment. This adjustment applies to
both peritoneal dialysis and hemodialysis training treatments.

350 “Outpatient Dialysis Services Payment System” Payment Basics, Medicare Payment Advisory Committee, October 2014,
http://www.medpac.gov/documents/payment-basics/outpatient-dialysis-services-payment-system.pdf?sfvrsn=0 (Accessed 3/3/2015), p.2.
351 “ESRD Prospective Payment System (PPS) Overview” Centers for Medicare & Medicaid Services, August 19, 2014,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ESRDpayment/index.html?redirect=/ESRDPayment (Accessed 3/2/15).
352 “Medicare: ESRD Payment" Centers For Medicare & Medicaid Services, March 23, 2012, http://www.cms.gov/ESRDPayment (Accessed
2/18/10).
353 This option was not available to providers that began offering dialysis services on or after January 1, 2011, instead these providers were
reimbursed at 100 percent of the ESRD PPS. “Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and
Proposed Rule,” Centers For Medicare & Medicaid Services, Federal Register Vol. 75, No. 155 (August 12, 2010), p. 49033-49034;
354 “Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule,” Centers For Medicare &
Medicaid Services, Federal Register Vol. 75, No. 155 (August 12, 2010), p. 49083.
355 “Outpatient Dialysis Services Payment System” By The Medicare Payment Advisory Commission, October 2009, http://www.amcp.org/
WorkArea/DownloadAsset.aspx?id=11180 (Accessed 3/2/15), p. 3.
356 Ibid.
357 “Medicare Program; End-Stage Renal Disease Prospective Payment System and Quality Incentive Program; Ambulance Fee Schedule;
Durable Medical Equipment; and Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies;
Final Rule,” Centers For Medicare & Medicaid Services, Federal Register Vol. 76, No. 218 (November 10, 2011), p. 70230.

128

Chapter 2: Reimbursement Environment

Adjustment Factor
Adjustments for Pediatric Patients

Outlier Adjustments

Description
Treatments provided to pediatric patients (i.e., individuals under the age of
18) are subject to a payment adjustment to reflect the higher total payments
for pediatric composite rate and separately billable services compared to
adult patients.
An additional outlier payment is applied when a beneficiary's payment per
treatment for outlier services exceeds the predicted payment amount per
treatment for the outlier services plus a fixed dollar amount. Outlier services
include drugs, laboratory testing, and other items that facilities separately
billed under the old payment system, such as ESRD-related medical and
surgical supplies.

A pay-for-performance program was also implemented into the payment bundle system under
MIPPA.358
Durable Medical Equipment Reimbursement
Medicare Part B reimburses approximately 28 percent of all spending on durable medical
equipment, prosthetics, orthotics, and other medical supplies (DMEPOS) that is medically
necessary and physician prescribed. CMS reimbursement varies based on the distinctions in the
definition of DMEPOS. Durable medical equipment (DME) and prosthetics and orthotics (PO)
have the largest scope of Medicare reimbursement. DME includes any equipment that: “(1) can
withstand repeated use, (2) is used to serve a medical purpose, (3) generally is not useful in the
absence of an illness or injury, and (4) is appropriate for use in the home.”359 PO are more
limited to those devices that replace all or part of an internal body organ or body part, e.g.,
colostomy bags, artificial parts, and leg braces. Additionally, Medicare covers some supplies (S)
that are not including in DME or PO, such as disposable surgical dressings.360
Medicare’s reimbursement fee schedule for DMEPOS is developed from previous charges
submitted to Medicare by suppliers. Medicare typically pays 80 percent of either (1) the
supplier’s actual charge or (2) the Medicare fee schedule for an item or service, whichever is
less. The remaining 20 percent of the charge is covered through beneficiary coinsurance
accounts. There are four specific Medicare Administrative Contractors that manage the payment
of claims for DMEPOS Medicare billing.361
President Ronald Reagan signed The National Association of Medical Equipment Services’ SixPoint Plan into law as a part of the Omnibus Budget Act of 1987. Taking effect in 1989, the SixPoint Plan’s purpose was to stabilize Medicare reimbursements for DMEPOS and to increase the
rent/purchase cap362 from $120 to $150.363 The Six-Point Plan classified DMEPOS into six
categories, as follows:
358 “Outpatient Dialysis Services Payment System” By The Medicare Payment Advisory Commission, October 2009, http://www.amcp.org/
WorkArea/DownloadAsset.aspx?id=11180 (Accessed 3/2/15), p. 3.
359 “Medicare Durable Medical Equipment: The Competitive Bidding Program” By Paulette C. Morgan, Congressional Research Service,
Report to Congress, R41211, August 6, 2010, p. 1
360 Ibid.
361 “Medicare: Review of the First Year of CMS’s Durable Medical Equipment Competitive Bidding Program’s Round 1 Rebid” Government
Accountability Office, GAO-12-693, May 2012, p. 6.
362 The maximum cost of DME of which Medicare will reimburse.
363 “The Home Care Evolution” Home Care Magazine, January 1, 2003, http://homecaremag.com/mag/medical_home_care_evolution/
(Accessed 5/29/07); “Reimbursement Challenges Hit Home” By David Gourley, RT for Decision Makers in Respiratory Care, (2006),
p. 1-4.
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(1) Inexpensive or Other Routinely purchased DME (Rent or Purchase). Defined as
DME that does not exceed $150 or is acquired by purchase as least 75 percent of the
time;
(2) Items Requiring Frequent and Substantial Servicing (Rental Only). Defined as DME
items that require frequent and substantial servicing to avoid a risk to a patient’s health,
such as ventilators and aspirators;
(3) General Prosthetic and Orthotic Devices and Supplies, Miscellaneous Supplies and
Other Items (Purchase Only). Where prosthetics are defined as devices that replace all
or part of an internal body organ or its function, orthotic devices are defined as items
used for the correction or prevention of skeletal deformities, and miscellaneous supplies
include items such as sterile saline or water and blood glucose test strips;
(4) Capped Rental Items (Rent or Purchase). Defined as items that cost more than $150;
are not routinely purchased; are not service intensive; are not customized; and are not
oxygen or oxygen-related;
(5) Oxygen (Rental Only) and Oxygen Equipment. With oxygen equipment defined as
stationary or portable gaseous and liquid systems; and
(6) Customized Equipment (Including Customized Prosthetic and Orthotic Devices)
(Purchase Only). Defined as equipment uniquely constructed or modified to meet the
needs of a specific patient.364
To this day, CMS still uses all of these six basic categories for DMEPOS reimbursement.365
The terms of beneficiary ownership of certain DMEPOS, including those defined in the Six-Point
Plan, were altered under the Deficit Reduction Act (DRA) of 2005. Payments must be made on a
monthly basis, not exceeding 13 months of continuous use, in order to be considered a rental
item. In the event that the rental item is used for more than 13 continuous months, the title will
be transferred from the supplier to the individual. An exception to this rule is made if the item is
a power-driven wheelchair. Instead, power-driven wheelchairs are required to be offered for
purchase at a lump sum price when the supplier furnishes the item. The DRA also changed the
rules for maintenance and servicing of DME after the title is transferred to the individual, by
stating that reasonable and necessary maintenance and servicing for capped rental items and
certain oxygen-generating equipment is the responsibility of the supplier.366
The process of competitive bidding, whereby certain DMEPOS manufacturers (i.e., patient safety
items, ambulatory aids, wheelchairs, and hospital beds) submit competing bids to Medicare
based on the charge per unit and the lowest of which is granted a government DMEPOS
contract, provides the DMEPOS provider with a unique opportunity to be a Medicare provider in
one of ten different metropolitan areas.367 CMS chooses two, sometimes more, suppliers from
each metropolitan statistical area (MSA), until patient need is satisfied and CMS caps the
number of winning bidders. Competitive bidding, mandated under §302 of the Medicare

364 “Region C DMERC: DMEPOS Supplier Manual” Palmetto GBA and Centers For Medicare & Medicaid Services, Spring 2007, p. 8.2-8.7.
365 “30 – General Payment Rules” in “Medicare Claims Processing Manual: Chapter 20 – Durable Medical Equipment, Prosthetics, Orthotics,
and Supplies (DMEPOS)” Centers for Medicare & Medicaid Services, June 20, 2014, http://www.cms.gov/Regulations-andGuidance/Guidance/Manuals/Downloads/clm104c20.pdf (Accessed 3/3/2015)..
366 “Deficit Reduction Act of 2005” Pub. L. 109-171, § 5101, 120 STAT 4, 37 (February 8, 2006).
367 “Medicare DME Bidding Program Set to Relaunch in 2010,” By Chris Silva, American Medical News, May 4, 2009,
http://www.ama-assn.org/amednews/2009/05/04/gvsd0504 (Accessed 11/10/09).
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Prescription Drug, Improvement, and Modernization Act of 2003 (MMA),368 was designed to
reduce out-of-pocket costs to patients, as well as costs incurred by Medicare, by combatting
provider fraud.369 Identical products must be priced the same within an individual MSAs,
however prices may vary between MSAs.
In general, all DME contract suppliers for Medicare must be licensed and accredited by an
approved agency370 before their bid is considered.371 CMS requires any potential DME supplier
to meet seven criteria:
(1) Be in good standing with the Medicare program and not under any current sanctions by
Medicare or any governmental agency or accreditation or licensing organization;
(2) Have an active National Supplier Clearinghouse (NSC) number372;
(3) Meet any local or state licensure requirements for the item being bid;
(4) Submit a bid as a prerequisite to becoming a winning supplier;
(5) Be accredited or have an application for accreditation pending in order to participate in
bidding;
(6) Provide capacity estimates of the number of units for each item included in the product
category that the supplier would be capable of furnishing under the program; and
(7) Agree to service the entire competitive bidding area (CBA) regardless of where the
beneficiary is located, although the supplier will not be required to be capable of
servicing 100 percent of the beneficiaries in that geographic area.373
Approximately 85 percent of DMEPOS suppliers enrolled in the Medicare program are small
suppliers that generate gross revenue of $3.5 million or less in annual receipts.374 CMS published
their final rule on the DMEPOS competitive bidding program April 10, 2007, ensuring that small
suppliers would be able to participate in, and access the competitive bidding market through
368 “Medicare Prescription Drug, Improvement, and Modernization Act of 2003” Pub. L. 108-173, § 302, 117 STAT. 2066, 2223 (December 8,
2003).
369 “Medicare Announces Competitive Acquisition Program for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies”
Centers For Medicare & Medicaid Services, April 2, 2007, http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=2097
&intNumPerPage=10&checkDate=&checkKey=&srchType=&numDays=3500&srchOpt=0&srchData=&keywordType=All&chkNewsTyp
e=1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll=&pYear=&year=&desc=&cboOrder=date (Accessed 08/16/12).
370 To obtain a CMS contract to supply DME, suppliers must meet quality standards established by CMS and be accredited by a CMSapproved independent national Accreditation Organization (AO), of which there are ten (approved by CMS in November 2006), including:
(1) Accreditation Commission for Health Care, Inc.; (2) American Board for Certification in Orthotics & Prosthetics, Inc.; (3) Board of
Certification/Accreditation International; (4) Commission on Accreditation of Rehabilitation Facilities; (5) Community Health
Accreditation Program; (6) HealthCare Quality Association on Accreditation; (7) National Association of Boards of Pharmacy; (8) The
Compliance Team, Inc.; (9) The Joint Commission; and, (10) The National Board of Accreditation for Orthotic Suppliers. “Medicare New
Deemed Accreditation Organizations for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS)”
Centers for Medicare & Medicaid Services, March 2013, http://www.cms.gov/Medicare/Provider-Enrollment-andCertification/MedicareProviderSupEnroll/Downloads/DeemedAccreditationOrganizationsCMB.pdf (Accessed 3/3/2015).
371 “Shaping Up for NCB,” Miram Lieber, HomeCare, April 1, 2007, http://www.homecaremag.com/mag/medical_shaping_ncb/index.html,
(May 8, 2007).
372 The National Supplier Clearinghouse (NSC) is the organization that enrolls and monitors the business information for DMEPOS suppliers
in the Medicare program. NSC issues Medicare supplier numbers based on a suppliers single tax reporting or employee identification
number and uses modifiers to identify geographic office locations. Although NSC is not directly involved in billing and claims, they supply
DME Medicare Administrative Contractors with the overall NSC Master File to facilitate supplier eligibility for claims payment. “Durable
Medicare Equipment Medicare Administrative Contractor: Workload Implementation Handbook” Centers For Medicare & Medicaid and
the Medicare Contractor Management Group, March 1, 2007, p. 7-3.
373 “Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and
Other Issues” Federal Register Vol. 72, No. 68 (April 10, 2007), p. 18035-18039.
374 “Fact Sheet: Competitive Bidding Program for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies: Final Rule (CMS
1270-F)” Centers for Medicare & Medicaid Services, April 02, 2007, http://www.cms.hhs.gov/apps/media/press/factsheet.asp?
Counter=2098&int NumPerPage=10&checkDate=&checkKey=&srchType=&numDays=3500&srchOpt=0&srchData=
&keywordType=All&chkNewsType=6&intPage=&showAll=&pYear=&year=&desc=&cboOrder=date, (Accessed 8/16/12).
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several provisions. First, the final rule set that winning bidders representing small supplier
participation must meet the target percentage of 30 percent for each category. If this percentage
is not met during a competitive bidding cycle, CMS must offer DMEPOS supplier contracts to
those small suppliers that submitted bids higher than the winning bids, and represent the highest
of the small supplier bids until either: (1) the 30 percent goal is met or (2) there are no additional
small supplier bidders.375 Additionally, the rule also facilitated participation in the bidding
process by permitting small suppliers to form networks in order to “lower bidding costs, expand
service options, or attain more favorable purchasing terms,”376 so long as they comply with all
federal and state laws, including antitrust laws.377
The first round of competitive bidding began in 2007, and the first round of contracts that were
awarded took effect on July 1, 2008. This process successfully achieved an approximate 26
percent in savings as compared to prior Medicare expenditures on specific DMEPOS items.378
However, partially due to problems with the implementation of the automatic bid submission
system, MIPPA rescinded the contracts awarded in the first round of bidding; delayed the second
round of bidding, which was scheduled for 2009; and made several other changes to the
program.379
MIPPA made changes to the fee schedule in order to offset the cost of the implementation
delays. Any item selected for competitive bidding before July 1, 2008 had their 2009 fee
schedule payment amount reduced by 9.5 percent.380 Beginning in October 2009, the Round One
Rebid resulted in 1,217 new contracts, which became effective in January 2011, in nine MSAs
for nine product categories.381 Approximately 51 percent of the contracts were with small
businesses, vastly exceeding the required target minimum of 30 percent (discussed above).382
The competitive bidding program achieved a 35 percent savings in its first round, significantly
reducing prices for beneficiaries in select areas.383 Due to the competitive bidding process of
MSAs included in the Round One Rebid, CMS has estimated that DMEPOS expenditures were
reduced by $202.1 million (42 percent).384 Additionally, their real-time monitoring also indicated
significantly fewer instances of inappropriate mail-order claims.385

375 "Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and
Other Issues" Federal Register Vol. 72, No. 68 (April 10, 2007), p. 18058.
376 Ibid, p. 18058-18059.
377 Ibid, p. 18058-18059.
378 “Durable Medical Equipment Payment System” Medicare Payment Advisory Commission, October 2014, http://www.medpac.gov/
documents/payment-basics/durable-medical-equipment-payment-system-14.pdf?sfvrsn=0 (Accessed 3/2/15), p. 2.
379 Ibid.
380 Ibid.
381 “DMEPOS Competitive Bidding” Centers For Medicare & Medicaid Services, April 18, 2012, http://www.cms.gov/Medicare/MedicareFee-for-Service-Payment/DMEPOSCompetitiveBid/index.html?redirect=/DMEPOSCompetitiveBid/ (Accessed 8/9/12); “Competitive
Bidding Update – One Year Implementation Update” Centers For Medicare & Medicaid Services, April 17, 2012,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSCompetitiveBid/Downloads/Competitive-Bidding-UpdateOne-Year-Implementation.pdf (Accessed 8/9/12), p. 2.
382 “Review of the First Year of CMS’s Durable Medical Equipment Competitive Bidding Program’s Round 1 Rebid” U.S. Government
Accountability Office, May 2012, p. 19, http://www.gao.gov/assets/600/590712.pdf (Accessed 3/2/15).
383 “Durable Medical Equipment Payment System” Medicare Payment Advisory Commission, October 2014, p. 2,
http://www.medpac.gov/documents/payment-basics/durable-medical-equipment-payment-system-14.pdf?sfvrsn=0 (Accessed 3/2/15).
384 “Review of the First Year of CMS’s Durable Medical Equipment Competitive Bidding Program’s Round 1 Rebid” U.S.Government
Accountability Office, May 2012, http://www.gao.gov/assets/600/590712.pdf (Accessed 3/2/15), p. 55.
385 “Competitive Bidding Update – One Year Implementation Update” Centers For Medicare & Medicaid Services, April 17, 2012,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSCompetitiveBid/Downloads/Competitive-Bidding-UpdateOne-Year-Implementation.pdf (Accessed 8/9/12), p. 7.

132

Chapter 2: Reimbursement Environment

CMS, which is required to re-complete DMEPOS contracts every three years, set an expiration
date on the Round One Rebid contracts (except for mail order diabetes products) of December
31, 2013. Additionally, they began conducting the Round One Re-compete in the spring of 2012
in the same geographic areas (MSAs) included in the Round One Rebid.386
The implementation of the ACA expanded the Round Two MSAs from 70 to 91 and required
further expansion in subsequent re-competes, including the requirement that the entire country be
eligible for competitive bidding by 2016.387 Mail order items were also included as a product
category for Round Two competitive bidding.388 Absent any negative effects on access to
supplies or beneficiary health indicators, the Round Two competitive bidding process mirrors the
process used during Round One. The Office of the Actuary (OACT)389 has predicted that
competitive bidding may save the Medicare program about $25.7 billion and may save
beneficiaries an additional $17.1 billion between 2013 and 2022.390
Medicare Shared Savings Program
The ACA, §3022, formally introduced the Federal Accountable Care Organization (ACO)
model, i.e., the Medicare Shared Savings Program (MSSP), which amends Title XVIII of the
SSA by adding §1899 to the end of the Title.391 Federal ACOs are discussed more fully in this
section, while Commercial ACOs are more fully described in the Commercial ACOs section of
this chapter. ACOs are a healthcare organizations in which a set of providers, usually a
combination of primary care physicians, nurse practitioners, specialists, and allied health
practitioners, as well as hospitals, nursing homes, ASCs, or any other entity in the patient’s
continuum of care,392 are held accountable under an ACO contract with a payor for the cost and
quality of care delivered to a specific population. This differs from the medical home model,
discussed in the Medical Home Model section below, because a separate entity focuses on
coordinating all of a patient’s healthcare providers, rather than placing this responsibility on the
physicians of the medical home and their staff.393
The MSSP allows for the creation of Federal ACOs, and “promotes accountability for a patient
population and coordinates items and services under parts A and B, and encourages investment
in infrastructure and redesigned care processes for high quality and efficient service delivery.”394
386 “DMEPOS Competitive Bidding Program Round 1 Recompete Announced” Centers For Medicare & Medicaid Services, April 17, 2012,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOS-Round-1-Recompete/index.html (Accessed 8/9/12).
387 “DMEPOS Competitive Bidding” Centers For Medicare & Medicaid Services, April 18, 2012, http://www.cms.gov/Medicare/MedicareFee-for-Service-Payment/DMEPOSCompetitiveBid/index.html?redirect=/DMEPOSCompetitiveBid/ (Accessed 8/9/12).
388 “DMEPOS Competitive Bidding” Centers For Medicare & Medicaid Services, April 18, 2012, http://www.cms.gov/Medicare/MedicareFee-for-Service-Payment/DMEPOSCompetitiveBid/index.html?redirect=/DMEPOSCompetitiveBid/ (Accessed 8/9/12).
389 The Office of the Actuary (OACT) is a department within CMS that, “[c]onducts and directs the actuarial program for CMS and directs the
development of and methodologies for macroeconomic analysis of health care financing issues.” “Office of the Actuary” Centers For
Medicare & Medicaid Services, June 28, 2012, http://www.cms.gov/About-CMS/Agency-Information/CMSLeadership/Office_OACT.html
(Accessed 9/11/12).
390 “Competitive Bidding Update – One Year Implementation Update” Centers For Medicare & Medicaid Services, April 17, 2012, p. 7,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSCompetitiveBid/Downloads/Competitive-Bidding-UpdateOne-Year-Implementation.pdf (Accessed 8/9/12).
391 "Shared Savings Program" 42.U.S.C. §1395jjj(a) (March 23, 2010); “Patient Protection and Affordable Care Act: Pub. L. No 111-148,
§3022, 124 Stat. 119, 395 (2010).
392 “Health Care Reform Requires Accountable Care Systems” By Stephen Shortell and Lawrence Casalino, Journal of the American Medical
Association, Vol. 300 No. 1 (July 2, 2008), p. 95.
393 “Creating Accountable Care Organizations: The Extended Hospital Medical Staff” By Elliot Fisher et al, Health Affairs Vol. 26, No. 1
(December 5, 2006) http://content.healthaffairs.org/cgi/reprint/26/1/w44 (Accessed 05/20/10), p. w53.
394 "Shared Savings Program" 42 U.S.C. §1395jjj(a) (March 23, 2010).
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Section 1899(d)(1)(A) of the SSA, provides that ACOs will be reimbursed under a FFS model as
previously established for Medicare Part A and Part B.395 While FFS reimbursement places little
risk on providers, providers in an ACO have some discretion as to the amount of risk to assume
in regard to incentive bonuses, i.e., shared savings payments.396
Under the MSSP, a participating ACO may receive bonuses for achieving resource use and
quality targets over the course of a year, as well as potentially being subject to penalties, i.e.,
shared losses, for failing to meet these requirements.397 Originally, there were two risk models
for ACOs to receive shared savings payments or pay shared losses: (1) the one-sided risk model
(Track 1) and (2) the two-sided risk model (Track 2). In December of 2014, CMS released a
proposed rule for a third ACO risk model (Track 3), similar to the two-sided risk model.398
The one-sided risk model allows federal ACOs to avoid risk (i.e., no shared losses) during their
initial three-year contract in exchange for a smaller percentage of the achieved shared savings
distributed to the ACO.399 The two-sided risk model offsets the additional risk of possible shared
losses by allowing the ACO to partake in a greater percentage of the shared savings (i.e., patient
expenditure reductions) they can demonstrate and document have been achieved.400
Under all risk models, CMS sets a spending benchmark for each ACO based upon the most
recently available three years of Medicare Parts A and B expenditure data for the population of
beneficiaries assigned to the ACO.401 Then, CMS establishes a minimum savings rate (MSR) for
each ACO, which is the minimal amount of savings the ACO must achieve in order to receive
shared savings, akin to a corridor around the ACO’s benchmark.402 Under the December 2014
proposed rule, both Track 1 and Track 2 ACOs will have MSRs established based upon the size
of their assigned populations, and this amount will vary between 2.0% and 3.9%, while Track 3
ACOs will have a fixed MSR of 2.0%.403
Similarly, CMS establishes a minimum loss rate (MLR) for each Track 2 ACO, which is the
maximum amount of losses that an ACO may incur before becoming liable for sharing in its

395 “Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations” Federal Register Vol. 76 No. 212 (November 2,
2011), p. 67904.
396 “Accountable Care Organizations: A new model for sustainable innovation” By Paul H. Keckley and Michelle Hoffman, Deloitte Center for
Health Solutions, 2010, http://www.deloitte.com/assets/dcom-unitedstates/local%20assets/documents/us_Chs_accountable
Careorganizations_041910.pdf (Accessed 2/24/15), p. 11.
397 “Methodology for Determining Shared Savings and Losses under the Medicare Share Savings Program” Medicare Learning Network,
Centers for Medicare and Medicaid Services, April 2014, http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/sharedsavingsprogram/Downloads/ACO_Methodology_Factsheet_ICN907405.pdf (Accessed 2/24/15), p. 2.
398 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No.
235 (December 8, 2014) p. 72808-72809; “CMS ACO Proposed Rule to Extend One-Sided Risk Track While Incentivizing PerformanceBased Risk” McDermott Will & Emery, December 19, 2014, http://www.mwe.com/CMS-ACO-Proposed-Rule-to-Extend-One-Sided-RiskTrack-While-Incentivizing-Performance-Based-Risk-12-19-2014/ (Accessed 2/18/15).
399 "Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations” Federal Register Vol. 76, No. 212 (November 2,
2011), p. 67985-67986.
400 Ibid, p. 67986-67987.
401 “Methodology for Determining Shared Savings and Losses under the Medicare Share Savings Program” Medicare Learning Network,
Centers for Medicare and Medicaid Services, April 2014, http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/sharedsavingsprogram/Downloads/ACO_Methodology_Factsheet_ICN907405.pdf (Accessed 2/24/15), p. 3-4.
402 Ibid, p. 5-6.
403 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79,
No. 235 (December 8, 2014), p. 72807-72808, 72844-72845.
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losses.404 The MLR for each Track 2 ACO is established using the same methodology outlined
above, while Track 3 ACOs will have a fixed MLR of 2.0%.405
The amount of shared savings, if any, is determined by comparing an ACO’s quality
performance to a specified set of metrics.406 In Track 1, an ACO may earn up to 50% of its
shared savings, based upon its performance as compared with these quality measure
benchmarks, with a shared savings cap of 10% of the ACO’s benchmark in that year.407 Under
the December 2014 proposed rule, ACOs may be able to participate in the MSSP under Track 1
for more than one three-year agreement period; however, Track 1 ACOs may only earn up to
40% of their shared savings in its second agreement period.408
Under Track 2, an ACO may earn up to 60% of its shared savings, based upon its performance
as compared with quality measure benchmarks, with a shared savings cap of 15% of the ACO’s
benchmark in that year.409 In addition, under Track 2, an ACO may share in up to 60% of the
losses between the MLR and the actual amount of losses, with the actual percentage varying
based upon the ACOs performance as compared with the same quality measure benchmarks.410
The maximum amount of losses for which Track 2 ACOs will be required to share in will vary
based upon the ACO’s year in the MSSP. Track 2 ACOs will be required to share in losses up to
5% of the ACO’s benchmark in their first year, 7.5% of the ACO’s benchmark in their second
year, and 10% of the ACO’s benchmark in their third year.411
The third risk model proposed by CMS in December 2014 works in a similar fashion to the twosided risk model, but differs in the amount of shared savings and losses allocated toward the
ACO. Specifically, Track 3 ACOS may earn up to 75% of the savings that they generate, based
upon quality performance as compared with quality measure benchmarks, with a cap of 20% of
the ACO’s benchmark.412 Similarly, Track 3 ACOs will be required to share between 45% and
404 “Methodology for Determining Shared Savings and Losses under the Medicare Share Savings Program” Medicare Learning Network,
Centers for Medicare and Medicaid Services, April 2014, http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/sharedsavingsprogram/Downloads/ACO_Methodology_Factsheet_ICN907405.pdf (Accessed 2/24/15), p. 5.
405 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No.
235 (December 8, 2014), p. 72807-72808, 72844-72845.
406 “Methodology for Determining Shared Savings and Losses under the Medicare Share Savings Program” Medicare Learning Network,
Centers for Medicare and Medicaid Services, April 2014, http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/sharedsavingsprogram/Downloads/ACO_Methodology_Factsheet_ICN907405.pdf (Accessed 2/24/15), p. 6; “Medicare Shared
Savings Program Quality measure Benchmarks for the 2014 and 2015 Reporting Years” Centers for Medicare & Medicaid Services,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf
(Accessed 2/24/15), p. 1.
407 “Methodology for Determining Shared Savings and Losses under the Medicare Share Savings Program” Medicare Learning Network,
Centers for Medicare and Medicaid Services, April 2014, http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/sharedsavingsprogram/Downloads/ACO_Methodology_Factsheet_ICN907405.pdf (Accessed 2/24/15), p. 6; “Medicare Program;
Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No. 235 (December 8,
2014), p. 72844-72845.
408 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No.
235 (December 8, 2014), p. 72807-72805.
409 “Medicare Shared Savings Program: Shared Savings and Losses and Assignment Methodology – Specifications” Centers for Medicare and
Medicaid Services, December 2014, p. 42, http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/
Downloads/Shared-Savings-Losses-Assignment-Spec-v2.pdf (Accessed 3/2/15); “Medicare Program; Medicare Shared Savings Program;
Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No. 235 (December 8, 2014), p. 72844-72845.
410 Ibid.
411 Ibid.
412 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No.
235 (December 8, 2014), p. 72808-72809, 72844-72845; “CMS ACO Proposed Rule to Extend One-Sided Risk Track While Incentivizing
Performance-Based Risk” McDermott Will & Emery, December 19, 2014, http://www.mwe.com/CMS-ACO-Proposed-Rule-to-ExtendOne-Sided-Risk-Track-While-Incentivizing-Performance-Based-Risk-12-19-2014/ (Accessed 2/18/15).
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75% of the losses between the MLR and the actual amount of losses, with the actual percentage
varying upon the ACOs performance as compared with the quality measure benchmarks.413 The
maximum amount of losses for which Track 3 ACOs will be required to share in will be fixed at
15% of the ACO’s benchmark.414 Therefore, the one-sided model may be most appropriate for
entities that are smaller and less mature in terms of their level of integration and coordination of
care, while the two-sided models may be more attractive for more experienced ACOs that are
willing to take on higher risks for potentially higher rewards.
Modifications to Medicare Resulting from the Affordable Care Act
The ACA, signed into law on March 23, 2010, included a number of modifications (some
temporary, others permanent), to the Medicare program.
Modifications to Medicare Advantage
Among the most significant changes to Medicare in the 2010 healthcare reform legislation are
the changes to the Medicare Advantage (MA) Program. The ACA implements provisions to
bring MA spending back in line with Medicare FFS spending. These changes include altering the
benchmark rates used in each county; altering the amount of money that may be paid as rebates
to insurers; and utilizing quality measures to adjust benchmarks that determine MA rebate
payment rate.
Benchmark rates were frozen in 2011 at 2010 levels, and are now being adjusted downward
pursuant to the ACA’s new benchmark policy.415 Under the new ACA benchmark policy, all
counties in the U.S. will be ranked according to their estimated per capita spending in the
traditional Medicare program, as well as health plan quality indicators.416 As stated above, MA
plans submit bids that are then compared to these benchmarks, and MA plans with high quality
scores (i.e., star rankings, discussed below) may have their benchmark values increased.
In addition, prior to the passage of the ACA, insurers received a rebate payment calculated at
75% of the difference between the plan’s bid and the geographic area benchmark rate. However,
the new ACA rebate policy reduces the rebate payment to between 50% and 70% of the
difference between the plan’s bid and the geographic area benchmark rate, depending upon the
plan’s star rankings.417

413 “Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations; Proposed Rule” Federal Register Vol. 79, No.
235 (December 8, 2014), p. 72844-72845.
414 Ibid, p. 72814, 72844-72845.
415 “Medicare Advantage Fact Sheet” The Henry J. Kaiser Family Foundation, May 2014, http://kaiserfamilyfoundation.files.wordpress.com/
2013/06/8448.pdf (Accessed 2/25/15), p. 3.
416 “Medicare Advantage Program Payment System” Medicare Payment Advisory Council, October 2014, http://medpac.gov/documents/
payment-basics/medicare-advantage-program-payment-system-14.pdf?sfvrsn=0 (Accessed 2/25/14), p. 1; “Realizing Health Reform’s
Potential: The Impact of Health Reform on the Medicare Advantage Program: Realigning Payment with Performance” By Brian Biles et al.,
The Commonwealth Fund, October 2012, http://www.commonwealthfund.org/~/media/Files/Publications/Issue%20Brief/2012/Oct/
1637_Biles_impact_hlt_reform_Medicare_Advantage_rb.pdf (Accessed 4/28/14), p. 3-4.
417 “Realizing Health Reform’s Potential: The Impact of Health Reform on the Medicare Advantage Program: Realigning Payment with
Performance,” By Brian Biles et al., The Commonwealth Fund, October 2012,
http://www.commonwealthfund.org/~/media/Files/Publications/Issue%20Brief/2012/Oct/1637_Biles_impact_hlt_reform_Medicare_Advant
age_rb.pdf (Accessed 4/28/14), p. 5; “Medicare Advantage Program Payment System” Medicare Payment Advisory Council, October 2014,
http://medpac.gov/documents/payment-basics/medicare-advantage-program-payment-system-14.pdf?sfvrsn=0 (Accessed 2/25/14), p. 3.
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Further, the ACA established a method by which MA plans were rewarded with bonus payments
for performing well on the new MA star scale. CMS uses information from satisfaction surveys,
plans, and healthcare providers to rate plans on overall performance, or star rankings. A plan
may receive between 1 and 5 stars.418 In general, higher star plans get percentage bonuses to their
geographic benchmarks, thereby increasing the amount of rebate payments to those plans.419
Further, the percentage amount that the plan receives as a rebate is altered by their star-score,
with higher star plans receiving larger percentage payments.420 The additional amount that the
plan receives in rebates with the bonus payment adjustments, over the original rebate amount, is
called the bonus payment. The ACA awards bonus payments to MA plans that receive 4 or more
stars. As such, due to the combined effects outlined above, MA plans will likely experience
reduced reimbursement.
Bonus Payments for Primary Care Services
The ACA provides for a 10% bonus payment for primary care services that are delivered by a
variety of providers, including:421
(1)
(2)
(3)
(4)

Primary care physicians;
Certain nurse practitioners;
Clinical nurse specialists; and
Physician assistants.

In order to qualify for these bonus payments, primary care services must account for at least 60%
of these providers’ Medicare allowed charges.422 Furthermore, the ACA also provides for a 10%
increase in payments to general surgeons operating in health professional shortage areas
(HPSAs).423 These bonus payments are effective from 2011-2015.424
Medicare Disproportionate Share Hospital Payments
The Medicare Disproportionate Share Hospital (DSH) payments are meant to assist hospitals in
providing care to low income Medicare beneficiaries, the uninsured, and the underinsured.425
The 2010 healthcare reform reduces the DSH payments to 25% of the amount that otherwise
418 “5-Star special Enrollment Period,” Centers for Medicare and Medicaid Services, http://www.medicare.gov/sign-up-change-plans/whencan-i-join-a-health-or-drug-plan/five-star-enrollment/5-star-enrollment-period.html (Accessed 4/30/14); “5-Star Plan Rankings,” Centers for
Medicare and Medicaid Services, http://www.cms.gov/Outreach-and-Education/Training/CMSNationalTrainingProgram/Downloads/20135-Star-Enrollment-Period-Job-Aid.pdf (Accessed 4/29/14).
419 “Realizing Health Reform’s Potential: The Impact of Health Reform on the Medicare Advantage Program: Realigning Payment with
Performance” By Brian Biles et al., The Commonwealth Fund, October 2012, http://www.commonwealthfund.org/~/media/Files/
Publications/Issue%20Brief/2012/Oct/1637_Biles_impact_hlt_reform_Medicare_Advantage_rb.pdf (Accessed 4/28/14), p. 6; “Medicare
Advantage Program Payment System” Medicare Payment Advisory Council, October 2014, http://medpac.gov/documents/paymentbasics/medicare-advantage-program-payment-system-14.pdf?sfvrsn=0 (Accessed 2/25/14), p. 2-3.
420 Ibid.
421 “Pub 100-04 Medicare Claims Processing: Transmittal 2161” Centers for Medicare and Medicaid Services, February 25, 2011,
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R2161CP.pdf (Accessed 3/2/15), p. 1, 3.
422 “Summary of Key changes to Medicare in 2010 Health Reform Law” Kaiser Family Foundation, http://www.kff.org/healthreform/upload/
7948-02.pdf (Accessed 8/24/10), p. 4.
423 Ibid.
424 “Pub 100-04 Medicare Claims Processing: Transmittal 2161” Centers for Medicare and Medicaid Services, February 25, 2011,
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R2161CP.pdf (Accessed 3/2/15), p. 1, 3.
425 “Medicare DSH Factsheet” American Hospital Association, January 10, 2014, https://www.google.com/url?sa=t&rct=j&q=&esrc=s
&source=web&cd=2&ved=0CCQQFjAB&url=http%3A%2F%2Fwww.aha.org%2Fcontent%2F13%2Ffs-dsh.pdf&ei=oNvbU9CdBY1yASd6ILICw&usg=AFQjCNFQXlF8OOU43lo4bDCE0mCldeZfZA&bvm=bv.72197243,d.aWw&cad=rja (Accessed 8/1/14), p. 1.
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would be made beginning in 2014.426 The remaining 75% of the DSH payments are reduced
based on the reduction in the percent of individuals under the age of 65 who are uninsured, and
then reallocated to hospitals based on the amount of uncompensated care that each hospital
provides, relative to the total amount of uncompensated care for all DSHs.427 Congress passed
this payment reduction in part because of the theory that hospitals would have fewer uninsured
or underinsured patients when the ACA was implemented, due to the ACA’s provisions aimed at
expanding health insurance coverage. Although a bill has been proposed to postpone the DSH
payment reductions, in their current format, DSH payments will be reduced by over $22 billion
between 2014 and 2019.428
Value Based Purchasing Programs
In an attempt to address the predicted rapid growth rate for the U.S. healthcare system, the
Institute for Healthcare Improvement developed an innovative framework called the Triple Aim
that focused on simultaneously improving the patient’s experience of care, improving the health
of populations, and reducing the per capita cost of care.429 By addressing the payment structure
and implementing concepts such as value based purchasing programs, CMS is able to link the
quality of care to the Medicare payment system and address some of the suggested triple aim
improvements that are needed to control the growing cost of care.430
Hospitals
The ACA provides for a variety of programs that alter Medicare payments to hospitals based on
the quality of care that those hospitals provide. These include:431
(1) The Hospital Readmissions Reduction Program;
(2) The Hospital-Acquired Condition (HAC) Reduction Program; and
(3) The Hospital Value-Based Purchasing Program.
The Hospital Readmissions Reduction Program is intended to reduce the number of unintended
readmissions for conditions such as acute myocardial infarction, heart failure, and pneumonia.432
This program reduces DRG payment rates based on a hospital’s ratio of expected readmissions to
actual readmissions, with reductions of:
426 “Summary of Key changes to Medicare in 2010 Health Reform Law” Kaiser Family Foundation, http://www.kff.org/healthreform/
upload/7948-02.pdf (Accessed 8/24/10), p. 4.
427 “Disproportionate Share Hospital (DSH)” Centers for Medicare and Medicaid Services, August 4, 2014, http://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/dsh.html (Accessed 2/4/15).
428 “Medicare DSH Factsheet” American Hospital Association, January 10, 2014, https://www.google.com/url?sa=t&rct=j&q=
&esrc=s&source=web&cd=2&ved=0CCQQFjAB&url=http%3A%2F%2Fwww.aha.org%2Fcontent%2F13%2Ffsdsh.pdf&ei=oNvbU9CdBY-1yASd6ILICw&usg=AFQjCNFQXlF8OOU43lo4bDCE0mCldeZfZA&bvm=bv.72197243,d.aWw&cad=rja
(Accessed 8/1/14), p. 1.
429 “IHI Triple Aim Initiative,” Institute for Healthcare Improvement, 2015, http://www.ihi.org/Engage/Initiatives/TripleAim/Pages/
default.aspx (Accessed 2/27/15).
430 “Hospital Value Based Purchasing,” Centers for Medicare and Medicaid Services, December 18, 2014, https://www.cms.gov/Medicare/
Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html?redirect=/hospital-value-based-purchasing/
(Accessed 2/27/15); “IHI Triple Aim Initiative,” Institute for Healthcare Improvement, 2015, http://www.ihi.org/Engage/Initiatives/
TripleAim/Pages/default.aspx (Accessed 2/27/15).
431 “Selected Medicare Hospital Quality Provisions Under the ACA” Association of American Medical Colleges, https://www.aamc.org/
advocacy/medicare/153882/selected_medicare_hospital_quality_provisions_under_the_aca.html (Accessed 2/4/15).
432 “Readmissions Reduction Program” Centers for Medicare and Medicaid Services, August 4, 2014,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html (Accessed
2/4/15).
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(1) 1% in fiscal year (FY) 2013;
(2) 2% in FY 2014; and
(3) 3% in FY 2015 and beyond.
Furthermore, as the severity of payment reductions increases, the program also scrutinizes a
wider variety of conditions beginning in FY 2015.433
The HAC reduction program uses not only payment reductions, but also public reporting of
quality measures to incentivize hospitals to improve patient safety. The HAC reduction program
focuses on preventable conditions (e.g., infections) that patients develop while staying at an
inpatient hospital (i.e., HACs), as well as general patient safety.434 This program imposes a 1%
payment reduction for hospitals in the top 25% for HACs, beginning in 2015.435
Contrary to the preceding two programs, which incentivize hospitals to improve patient wellbeing through payment reductions for poor performance, the Hospital Value-Based Purchasing
(HVBP) Program provides hospitals with incentive payments in order to encourage improvement
in four major areas:436
(1)
(2)
(3)
(4)

Clinical process of care;
Patient experience and satisfaction;
Clinical outcomes (e.g., mortality measures for specified conditions); and
Efficiency (e.g., spending per beneficiary).

Based on their performance in these domains, hospitals are given a Total Performance Score
(TPS). The TPS has a direct, linear relationship with the hospital’s value-based incentive
payments.437 However, these incentive payments are funded by a reduction in the base payment
rate for all DRGs, which starts at a 1% reduction in FY 2013 and gradually increases to a 2%
reduction by FY 2017.438
In addition to those value based programs implemented by the ACA, in 2008, Medicare ceased
paying the extra costs associated with treating never events, particularly shocking medical errors
that should never occur, such as wrong site surgery.439
433 “Selected Medicare Hospital Quality Provisions Under the ACA” Association of American Medical Colleges, https://www.aamc.org/
advocacy/medicare/153882/selected_medicare_hospital_quality_provisions_under_the_aca.html (Accessed 2/4/15); “Readmissions
Reduction Program” Centers for Medicare and Medicaid Services, August 4, 2014, http://www.cms.gov/Medicare/Medicare-Fee-forService-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html (Accessed 2/4/15).
434 “Fact sheets: Fiscal Year 2015 Results for the CMS Hospital-Acquired Condition Reduction Program and Hospital Value-Based Purchasing
Program” Centers for Medicare and Medicaid Services, December 18, 2014, http://www.cms.gov/Newsroom/MediaReleaseDatabase/Factsheets/2014-Fact-sheets-items/2014-12-18-2.html?DLPage=1&DLSort=0&DLSortDir=descending (Accessed 2/27/15).
435 “Selected Medicare Hospital Quality Provisions Under the ACA” Association of American Medical Colleges,
https://www.aamc.org/advocacy/medicare/153882/selected_medicare_hospital_quality_provisions_under_the_aca.html (Accessed 2/4/15);
“Hospital-Acquired Condition (HAC) Reduction Program” Centers for Medicare & Medicaid Services, December 18, 2014,
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/HAC-Reduction-Program.html (Accessed 2/4/15).
436 “Fact sheets: Fiscal Year 2015 Results for the CMS Hospital-Acquired Condition Reduction Program and Hospital Value-Based Purchasing
Program” Centers for Medicare & Medicaid Services, December 18, 2014, http://www.cms.gov/Newsroom/MediaReleaseDatabase/Factsheets/2014-Fact-sheets-items/2014-12-18-2.html?DLPage=1&DLSort=0&DLSortDir=descending (Accessed 2/27/15).
437 Ibid.
438 “Selected Medicare Hospital Quality Provisions Under the ACA” Association of American Medical Colleges, https://www.aamc.org/
advocacy/medicare/153882/selected_medicare_hospital_quality_provisions_under_the_aca.html (Accessed 2/4/15).
439 “Letter From CMS to State Medicaid Director” By Herb Kuhn, Centers for Medicare & Medicaid Services, July 31, 2008,
http://downloads.cms.gov/cmsgov/archived-downloads/SMDL/downloads/SMD073108.pdf (Accessed 2/23/15); “Never Events” Agency
for Healthcare Research and Quality, October 2012, http://psnet.ahrq.gov/primer.aspx?primerID=3 (Accessed 2/23/15).

139

Adviser's Guide to Healthcare

Physicians
The ACA also instructed CMS to create a value based purchasing program for physicians, which
resulted in the Physician Value-Based Payment Modifier (PVBM). This program scores
providers on measures of cost and quality of the care that they deliver, and adjust the payments
these providers receive from Medicare accordingly, rewarding the providers with the best value
care and punishing the providers with the worst.440
The PVBM is primarily based on the Physician Quality Reporting System (PQRS).441 The PQRS
is a program that CMS uses to encourage providers to report data on the quality of care which
they provide, using incentive payments and payment reductions.442 2014 is the last year for
physicians to receive a bonus payment for participating in the PQRS, consisting of a 0.5%
increase in the physician’s reimbursement.443 After 2014, physicians who do not report quality
measures via the PQRS will be penalized by a reduction in their Medicare payments. In 2015,
this penalty is a 1.5% reduction of the physician’s reimbursement, and from 2016 forward this
penalty is a 2% reduction of the physician’s reimbursement.444
After physician practices report data on the cost and quality of the care which they deliver
through the PQRS, CMS grades each practice in terms of cost and quality in order to determine
their payment modifier under the PVBM.445 Groups are assigned a payment adjustment based on
their cost and quality designations according to Table 2-8: Physician Value Based Payment
Modifier Adjustments, shown below.
Table 2-8: Physician Value Based Payment Modifier Adjustments446
Level of Quality

Low Cost

Average Cost

High Cost

High Quality

+2.0x

+1.0x

0%

Average Quality

+1.0x

0%

-0.50%

Low Quality

0%

-0.50%

-1%

Note that downward adjustments are given percentage penalties, while upward adjustments are
not. CMS first calculates the aggregate downward adjustments by combining the penalties to
low-scoring groups with the penalties to groups that did not report performance metrics.447 The
savings generated by these aggregate reduced payments constitute a pool of funds which is
divided among the high-scoring provider groups. To do this, CMS calculates the number of
440 “Medicare’s Physician Value-Based Payment Modifier – Will the Tectonic Shift Create Waves?” By Alyna T. Chien, M.D. and Meredith B.
Rosenthal, Ph.D., The New England Journal of Medicine, November 28, 2013, http://www.nejm.org/doi/full/10.1056/NEJMp1311957
(Accessed 5/19/14), p. 1.
441 “Summary of 2015 Physician Value-based Payment Modifier Policies” Centers for Medicare & Medicaid Services, January 24, 2014,
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeedbackProgram/Downloads/CY2015Value
ModifierPolicies.pdf (Accessed 6/20/14), p. 3.
442 “Physician Quality Reporting System” Centers for Medicare & Medicaid Services, June 9, 2014, http://www.cms.gov/Medicare/QualityInitiatives-Patient-Assessment-Instruments/PQRS/Index.html (Accessed 6/20/14), p. 1.
443 “Physician Quality Reporting System,” 42 C.F.R. §414.90(c)(3) (December 10, 2013).
444 “Physician Quality Reporting System,” 42 C.F.R. §414.90(e)(1) (December 10, 2013).
445 “The Physician Value-Based Payment Modifier under the 2014 Medicare Physician Fee Schedule” Centers for Medicare & Medicaid
Services, December 3, 2013, http://www.cms.gov/Outreach-and-Education/Outreach/NPC/Downloads/NPC-PFS-VBP-12-03-13-Slides.pdf
(Accessed 3/2/15), p. 15.
446 “Summary of 2015 Physician Value-based Payment Modifier Policies,” Centers for Medicare & Medicaid Services, January 24, 2014,
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeedbackProgram/Downloads/CY2015ValueModifier
Policies.pdf (Accessed 6/20/14), p. 14.
447 Ibid.
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shares to be awarded to the high value provider groups, with one share going to some groups,
and two shares going to those groups that scored high in both cost and quality (see Table 2-7).
The pool of funds derived from reduced payments to low scoring groups is then divided equally
among these shares. Thus, when receiving their shares, provider groups that scored above
average in overall value receive a bonus payment, provider groups that scored above average in
both cost and quality (making them well above average in overall value) receive a double bonus
payment, and the payments are funded by the forfeits of the low-scoring provider groups. Using
this methodology, CMS ensures that the PVBM payment adjustments are budget neutral.448

Medicaid and State Children’s Health Insurance Program
Overview
Medicaid is a state-administered health insurance program for low-income individuals and
certain federally recognized eligibility groups.449 Medicaid is funded by participating state
governments that receive federal matching funds as long as they operate their Medicaid
programs within parameters set by the federal government.450
These parameters determine mandatory eligibility groups and mandatory services (i.e., the
groups and services the state must cover to receive federal Medicaid money).451 The mandatory
eligibility groups are as follows:452
(1) Families who meet their states’ eligibility requirements for Temporary Assistance for
Needy Families (TANF);
(2) Pregnant women and children under the age of 6 whose income is at or below 133% of
the federal poverty level (FPL);
(3) Relatives or legal guardians who care for children under the age of 18 (i.e., caretakers);
(4) Those who receive Supplemental Security Income (SSI), or the aged, blind, and disabled
who meet more restrictive requirements than those of the SSI program, depending on the
state; and
(5) Individuals and couples living in medical institutions whose monthly income is up to
300% of the SSI.

448 “Summary of 2015 Physician Value-based Payment Modifier Policies,” Centers for Medicare & Medicaid Services, January 24, 2014,
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeedbackProgram/Downloads/CY2015ValueModifier
Policies.pdf (Accessed 6/20/14), p. 14.
449 “Federal Core Requirements and State Options in Medicaid: Current Policies and Key Issues” The Henry J. Kaiser Family Foundation,
April 2011, https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8174.pdf (Accessed 2/5/15), p. 1.
450 Ibid.
451 Ibid.
452 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 535.
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Table 2-9: 2015 Federal Poverty Guidelines for the 48 Contiguous States 453
Persons in
family/household

Poverty Guideline

1
$11,770
2
$15,930
3
$20,090
4
$24,250
5
$28,410
6
$32,570
7
$36,730
8
$40,890
For each additional person over 8, add $4,160

In addition to mandatory groups and services, states may also receive federal funds for covering
other optional groups and services.454 States have significant discretion regarding to whom they
extend Medicaid benefits beyond the mandatory groups, and many states opt to extend benefits
to individuals who are above the income cutoffs found in the mandatory groups.455 For example,
many states offer Medicaid coverage for children well above the mandatory federal minimum.456
Although the federal government determines the medical services that will be covered and paid
for by the federal portion of the program, Medicaid programs vary widely from state to state, as
state governments are free to add additional services or expand eligibility to additional groups.457
The mandatory services that state Medicaid programs must provide in order to receive federal
matching funds include the following:458
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)

Inpatient and outpatient hospital services;
Outpatient hospital services and, depending on the state, rural health clinic and other
ambulatory services;
Other laboratory and x-ray services;
Certified pediatric and family nurse practitioners’ services;
Nursing facility services for those aged 21 and over;
Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) for children under
the age of 21;
Family planning services and supplies;
Physicians’ services;
Medical and surgical services of a dentist;
Home health services for those who qualify for nursing facility services according to
the state’s Medicaid plan;
Intermittent or part-time nursing services;
Nurse midwife services;
Pregnancy related services;
Home health aides; and
Medical supplies and appliances for use in the home.

453 “Annual Update of the HHS Poverty Guidelines” Federal Register Vol. 80, No. 14 (January 22, 2015), p. 3237. Note that the Poverty
Guidelines in Alaska and Hawaii deviate from those of the 48 contiguous states.
454 “Medicaid Enrollment and Expenditures by Federal Core Requirements and State Options” By Brigette Courtot et al., The Henry J. Kaiser
Family Foundation, January 2012, https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8239.pdf (Accessed 2/5/15), p. 1.
455 Ibid..
456 Ibid, p. 4.
457 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 132.
458 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 537-538.
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Optional services, by contrast, may include prescription drugs, dental services, durable medical
equipment, personal care services, and home and community-based services.459 It is important to
look at a particular state’s Medicaid coverage manual to determine which optional groups and
services that state covers.
Medicaid Expansion
One of the central elements of the ACA was the expansion of Medicaid to cover a larger share of
low income individuals. In general, the ACA’s expansion extended Medicaid coverage to the
majority of adults with incomes at or below 138% of the FPL.460 Originally intended to be a
nationwide change, a June 2012 Supreme Court decision made the Medicaid expansion optional
for individual states.461 As of January 27, 2015, 29 states, as well as the District of Columbia,
had opted to expand Medicaid coverage under the ACA.462 The federal government funds 100%
of the expansion (i.e., the cost associated with the newly eligible individuals) through 2016,
gradually decreasing to 90% in 2020 and beyond, for those states that opt to expand Medicaid.463
In addition, it was thought that the expansion of Medicaid would change the basis for the
supplemental payments to hospitals accepting Medicaid patients, known as disproportionate
share payments, discussed more fully in the Medicaid Disproportionate Share Hospital (DSH)
Payments section below.
Section 1115 Waivers
Before the passage of the ACA, the only way to obtain federal funds for Medicaid coverage of
childless adults was through the use of a Section 1115 waiver.464 Using these waivers, states
could offer Medicaid coverage to childless adults, albeit with restrictions. Section 1115 waivers
are required to be budget neutral for the federal government, and as such, the coverage that they
provide often has limited benefits and higher cost-sharing for the beneficiaries.465 Since the ACA
has been passed, states that opt into the Medicaid expansion have been able to offer Medicaid
coverage to childless adults without the use of a Section 1115 waiver.
However, some states (Arkansas, Iowa, Michigan, and Pennsylvania, as of November 2014),
have effectively expanded Medicaid without meeting the federal rules under the ACA, instead
implementing the expansion through the use of Section 1115 waivers.466 In these states, this
alternative approach to Medicaid expansion is perceived by some as being more politically
viable than opting into the ACA Medicaid expansion, due to the partisan contention surrounding

459 “Medicaid Moving Forward” The Henry J. Kaiser Family Foundation, January 2015, http://files.kff.org/attachment/fact-sheet-medicaidmoving-forward (Accessed 2/5/15), p. 4.
460 “Status of State Action on the Medicaid Expansion Decision” The Henry J. Kaiser Family Foundation, January 27, 2015,
http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ (Accessed 3/2/15).
461 “Medicaid Moving Forward” The Henry J. Kaiser Family Foundation, January 2015, http://files.kff.org/attachment/fact-sheet-medicaidmoving-forward (Accessed 2/5/15), p. 1.
462 “Status of State Action on the Medicaid Expansion Decision” The Henry J. Kaiser Family Foundation, January 27, 2015,
http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ (Accessed 3/2/15).
463 “Medicaid Moving Forward” The Henry J. Kaiser Family Foundation, January 2015, http://files.kff.org/attachment/fact-sheet-medicaidmoving-forward (Accessed 2/5/15), p. 1.
464 “The ACA and Recent Section 1115 Medicaid Demonstration Waivers” The Henry J. Kaiser Family Foundation, November 2014,
http://files.kff.org/attachment/the-aca-and-recent-section-1115-medicaid-demonstration-issue-brief (Accessed 2/5/15), p. 1.
465 Ibid.
466 “The ACA and Recent Section 1115 Medicaid Demonstration Waivers” The Henry J. Kaiser Family Foundation, November 2014,
http://files.kff.org/attachment/the-aca-and-recent-section-1115-medicaid-demonstration-issue-brief (Accessed 2/5/15), p. 2.
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the ACA.467 As such, the 23 states which have not yet opted into the ACA’s Medicaid Expansion
have put a significant stress on hospitals that, heretofore, had received more significant amounts
of Medicaid disproportionate share payments than would be available under the ACA. This topic
is discussed more fully in the Medicaid Disproportionate Share Hospital (DSH) Payments
section of this chapter.
Children’s Health Insurance Program (CHIP)
In addition to Medicaid, each state, territory, and the District of Columbia have implemented the
Children’s Health Insurance Program (CHIP), a state-federal partnership that provides
assistance to children and pregnant women in families whose income is above the threshold for
Medicaid.468 Enacted under the Balanced Budget Act of 1997, and formerly known as SCHIP,
CHIP covered approximately 5.7 million children in June 2013, which is in addition to the
number of children already covered under Medicaid (28 million in June 2013).469
CHIP covered approximately 5.7 million children in June 2013 which is in addition to the number of children
already covered under Medicaid (28 million in June 2013).
Robin Rudowitz et al, March 2014.

CHIP programs vary among states, which determine, within federal parameters, who may be
eligible for CHIP funds, as well as other details such as benefits, payment levels, and
administration.470 As part of their autonomy over CHIP programs, states are free to set premiums
and co-payment rates on a sliding scale based on income; funds are then matched by the federal
government up to a certain capped amount.471
After temporary reauthorizations of the program in 2007 and 2009, the ACA most recently
reauthorized federal CHIP funding through fiscal year 2015, leaving the long term life of the
program open to debate.472 If the program is extended beyond fiscal year 2015, the ACA
mandates that the federal matching rate for CHIP financing increase by 23% (up to 100%) for
fiscal years 2016-2019.
Billing and Reimbursement
Reimbursement for services provided to Medicaid patients are paid by states on either an FFS
basis or under a pre-paid managed care arrangement.473 The Medicaid program requires the use
467 Ibid, p. 1.
468 “The Children’s Health Insurance Program (CHIP): Overview” Centers for Medicare & Medicaid Services, http://www.cms.hhs.gov/
LowCostHealthInsFamChild/ (Accessed 10/6/09).
469 “Children’s Health Coverage: Medicaid, CHIP and the ACA” by Robin Rudowitz et al, The Henry J. Kaiser Family Foundation, March
2014, p. 1, https://kaiserfamilyfoundation.files.wordpress.com/2014/03/8570-children_s-health-coverage-medicaid-chip-and-the-aca1.pdf
(Accessed 2/5/15).
470 “The Children’s Health Insurance Program (CHIP): Overview” Centers for Medicare & Medicaid Services, http://www.cms.hhs.gov/
LowCostHealthInsFamChild/ (Accessed 10/6/09).
471 “Health Coverage of Children: The Role of Medicaid and SCHIP” By the Kaiser Commission on Medicaid and the Uninsured, November
2008, http://www.kff.org/uninsured/upload/7698_02.pdf (Accessed 10/6/09).
472 “Report to the Congress on Medicaid and CHIP” Medicaid and CHIP Payment and Access Commission, June 2014,
http://www.macpac.gov/reports (Accessed 1/5/15), p. 6-7.
473 “Delivery Systems” Centers for Medicare & Medicaid Services, http://medicaid.gov/medicaid-chip-program-information/bytopics/delivery-systems/delivery-systems.html (Accessed 3/2/15).
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of the CMS-1500 claim form when seeking FFS reimbursement.474 Providers should consult
their state’s Medicaid managed care organization (MCO) billing manual in order to determine
how to bill for non-capitated managed care services, as these procedures may vary by state.475
Deadlines for filing a Medicaid claim range from two months to one year from the date of
treatment.476 Thus, it is important for providers to be familiar with their particular state’s rules
and deadlines for claim submission. Federal regulation requires states to promptly pay
practitioners for clean claims submitted for services rendered to Medicaid recipients.477 Under
the regulation, states must pay 90 percent of clean claims in thirty days, 99 percent of clean
claims within ninety days, and all other claims within twelve months of receipt unless limited
exception apply.478
Each state is free to develop its own reimbursement process and payment rates, with three
exceptions:
(1) For institutional services, payment may not exceed amounts that would be paid under
Medicare payment rates;
(2) For DSH, hospitals that treat a disproportionate number of Medicaid patients, different
limits apply; and
(3) For hospice care services, rates cannot be lower than Medicare rates.479
Accordingly, states may impose deductibles, co-insurance, or co-payments on certain recipients
for particular services.480 PARs in the Medicaid program must accept direct payments from
Medicaid for services rendered as payment in full, and they may not bill patients the difference
between their usual fee and the Medicaid reimbursement rate for covered benefits.481 Medicaid
reimburses on a lump-sum basis, meaning providers will receive one payment for several
submitted claims.482
Medicaid is considered by many to be the payor of last resort.483 As such, for Medicaid patients
who also are covered by an insurance plan or another government program, including Medicare,
TRICARE, CHAMPVA, or IHS, these plans or programs must be billed first.484 Claims should
only be submitted to Medicaid if one of the other payors denies responsibility for payment or

474 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Ninth Edition,
Clifton Park, NY: Delmar Cengage Learning, 2008, p. 483.
475 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 545.
476 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 135.
477 “Timely Claims Payment” 42 C.F.R. § 447.45(d) (October 1, 2013).
478 Ibid.
479 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 541.
480 “Medicaid Information by Topic” Centers for Medicare & Medicaid Services, http://medicaid.gov/medicaid-chip-program-information/bytopics/by-topic.html (Accessed 3/2/15).
481 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 542.
482 Ibid., p. 544.
483 “Deficit Reduction Act Important Facts for State Policymakers” Centers for Medicare & Medicaid Services, December 11, 2007,
http://www.cms.gov/Regulations-and-Guidance/Legislation/DeficitReductionAct/downloads/tpl.pdf (Accessed 3/2/15), p. 1.
484 “Deficit Reduction Act Important Facts for State Policymakers” Centers for Medicare & Medicaid Services, December 11, 2007,
http://www.cms.gov/Regulations-and-Guidance/Legislation/DeficitReductionAct/downloads/tpl.pdf (Accessed 3/2/15), p. 1.
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reimburses at a rate that is less than Medicaid’s fee schedule, or if Medicaid reimburses for
procedures that are not covered by the other plans or programs.485
Medicaid Disproportionate Share Hospital (DSH) Payments
Similar to the Medicare DSH program, Medicaid Disproportionate Share Hospital (DSH)
payments are a form of additional reimbursement under Medicaid for hospitals that care for a
large number of Medicaid and uninsured patients (these hospitals are sometimes referred to as
safety-net hospitals).486 DSH payments are allotments from the federal government that augment
basic Medicaid reimbursement, and under federal law, states are required to supplement DSHs in
order to receive this additional Medicaid funding.487 DSH payments are intended to supplement
hospitals when costs are not adequately covered by traditional Medicaid and Medicare payments,
by CHIP payments, or by other health insurance.488
Each state has its own methodology for calculating DSH payments, subject to two federal caps:
(1) the federal funds that a state may spend on DSH payments may not exceed that state's annual
DSH allotment and (2) Medicaid DSH payments to a particular facility may not exceed 100% of
the costs incurred by the facility in serving Medicaid and uninsured patients for which the
facility has not been otherwise compensated by Medicaid.489
Typically, a state's annual allotment of federal DSH funds is calculated using the state's federal
DSH funds from the previous year, increased to account for inflation, and is capped at 12% of
the state's total Medicaid medical assistance expenditures.490 In order to receive its DSH
allotment, a state must submit an annual report and a certified audit documenting payments made
to DSHs, though the state has discretion over the hospitals to which it distributes DSH
payments.491 The only limits on this discretion are that: (1) a state may not distribute DSH
payments to any hospital with a Medicaid utilization rate less than 1 percent; (2) the state must
distribute DSH payments to all hospitals that have either a Medicaid inpatient utilization rate
exceeding one standard deviation or more above the mean for all hospitals in the state, or a lowincome utilization rate of more than 25 percent; and (3) all DSHs must retain at least two
obstetricians with staff privileges who are willing to serve Medicaid patients.492 If a state wants
to distribute DSH payments to additional hospitals, it is free to do so; however, the state must

485 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 542.
486 “Disproportionate-Share Hospital Payment Reductions May Threaten The Financial Stability Of Safety-Net Hospitals” by Katherine
Neuhausen et al., Health Affairs, June 2014, http://content.healthaffairs.org/content/33/6/988.full.pdf (Accessed 2/5/15), p. 1; “Medicaid
Disproportionate Share Hospital (DSH) Payments: The Basics” National Health Policy Forum, The George Washington University,
June 15, 2009, http://www.nhpf.org/library/the-basics/Basics_DSH_06-15-09.pdf (Accessed 10/05/09), p. 1.
487 “Medicaid Disproportionate Share Hospital (DSH) Payments: The Basics” National Health Policy Forum, The George Washington
University, June 15, 2009, http://www.nhpf.org/library/the-basics/Basics_DSH_06-15-09.pdf (Accessed 10/05/09), p. 1
488 Ibid.
489 “How Do Medicaid Disproportionate Share Hospital (DSH) Payments Change Under the ACA?” The Henry J. Kaiser Family Foundation,
November 2013, p. 1, https://kaiserfamilyfoundation.files.wordpress.com/2013/11/8513-how-do-medicaid-dsh-payments-change-under-theaca.pdf (Accessed 2/5/15).
490 “Medicaid Program; Preliminary Disproportionate Share Hospital Allotments (DSH) for Fiscal Year (FY) 2014 and the Preliminary
Institutions for Mental Diseases Disproportionate Share Hospital Limits for FY 2014” Federal Register Vol. 79, No. 40 (February 28,
2014), p. 11436.
491 “Medicaid Disproportionate Share Hospital Payments” by Alison Mitchell, Congressional Research Service, December 2, 2013,
https://www.fas.org/sgp/crs/misc/R42865.pdf (Accessed 2/5/15), p. 23-24, 33.
492 “How Do Medicaid Disproportionate Share Hospital (DSH) Payments Change Under the ACA?” The Henry J. Kaiser Family Foundation,
November 2013, https://kaiserfamilyfoundation.files.wordpress.com/2013/11/8513-how-do-medicaid-dsh-payments-change-under-theaca.pdf (Accessed 2/5/15), p. 7.
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distribute payments at a rate in line with the Medicaid DSH payment methodology or based on
the hospital’s low-income utilization rate.493
The ACA included a significant alteration to the Medicaid DSH program. The ACA mandated
that aggregate federal Medicaid DSH funds be reduced each year from fiscal year 2014-2020,
under the assumption that the ACA's other provisions would reduce the number of uninsured
individuals in the U.S., and, as a result, there would be less need for DSH payments.494
Furthermore, the Middle Class Tax Relief and Job Creation Act of 2012 and the American
Taxpayer Relief Act of 2012 extended the DSH reductions through fiscal years 2021 and 2022.495
The federal Medicaid DSH funds reduction starts at $500 million in fiscal year 2014, peaks at
$5.6 billion in fiscal year 2019, and stays at $4 billion for fiscal years 2020-2022.496 A
preliminary analysis of the impact of the federal Medicaid DSH funds reduction in June 2014
found that the reduction increased the amount of uncompensated care that safety-net hospitals
provided, potentially threatening their financial stability.497
Dual Eligibility
Some individuals who receive healthcare coverage from Medicare may also meet the eligibility
criteria for Medicaid coverage. These individuals may utilize Medicaid to pay for additional
services that are not covered by Medicare, e.g., nursing facility care beyond Medicare’s 100 day
limit.498 Furthermore, dual eligible beneficiaries may utilize Medicaid to help cover Medicare’s
out-of-pocket expenses.499 The individuals who are dually eligible for both Medicare and
Medicaid (of which there are over 9 million) typically represent the poorest, sickest
beneficiaries, and most expensive beneficiaries in either program.500
Any services that are covered by both Medicare and Medicaid are paid first by Medicare, after
which point Medicaid coverage may apply to any remaining charges. This is due to the fact that
Medicaid is always the payor of last resort.501 Thus, if a Medicaid beneficiary has coverage
through any other means, (e.g. Medicare, TRICARE, CHAMPVA, etc.), those other sources of
coverage must be billed before Medicaid may be utilized.

493 “Medicaid Disproportionate Share Hospital (DSH) Payments: The Basics” National Health Policy Forum, The George Washington
University, June 15, 2009, http://www.nhpf.org/library/the-basics/Basics_DSH_06-15-09.pdf (Accessed 10/05/09), p. 3.
494 “Medicaid Disproportionate Share Hospital Payments” by Alison Mitchell, Congressional Research Service, December 2, 2013,
https://www.fas.org/sgp/crs/misc/R42865.pdf (Accessed 2/5/15), p. ii.
495 Ibid.
496 “How Do Medicaid Disproportionate Share Hospital (DSH) Payments Change Under the ACA?” The Henry J. Kaiser Family Foundation,
November 2013, https://kaiserfamilyfoundation.files.wordpress.com/2013/11/8513-how-do-medicaid-dsh-payments-change-under-theaca.pdf (Accessed 2/5/15), p. 2.
497 “Disproportionate-Share Hospital Payment Reductions May Threaten The Financial Stability Of Safety-Net Hospitals” by Katherine
Neuhausen et al., Health Affairs, June 2014, http://content.healthaffairs.org/content/33/6/988.full.pdf (Accessed 2/5/15), p. 1.
498 See the Long Term Care section below.
499 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 541.
500 “State Demonstration Proposals to Integrate Care and Align Financing and/or Administration for Dual Eligible Beneficiaries” The Henry J.
Kaiser Family Foundation, February 6, 2015, http://kff.org/medicaid/fact-sheet/state-demonstration-proposals-to-integrate-care-and-alignfinancing-for-dual-eligible-beneficiaries/ (Accessed 2/24/15).
501 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 542.
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Long Term Care
Despite the fact that Medicaid is designed to be the payor of last resort, it is the United States’
primary payor for long-term services and supports (LTSS), representing over 40% of the
payments for long-term care services in 2009.502 This is due, in part, to the fact that many long
term services are not covered by Medicare or private insurance. Eligibility for Medicaid longterm care coverage for the elderly and disabled is often tied to the Supplemental Security Income
(SSI) program, but states may set higher thresholds.503 Furthermore, the elderly and disabled
must have assets below a pre-determined threshold (some states use $2,000 for an individual) in
order to be eligible for Medicaid long-term care coverage (similar to the eligibility criteria tied to
the SSI, this threshold also varies by state).504

TRICARE (CHAMPUS)
Overview
TRICARE, formerly known as the Civilian Health and Medical Program of the Uniformed
Services (CHAMPUS), is the Department of Defense’s healthcare program for active duty
military personnel; members of the National Guard and Reserves; retirees, their dependents, and
survivors; and certain former spouses.505 The program uses military healthcare as the main
provider of services, and supplements it with civilian healthcare providers, facilities, pharmacies,
and suppliers.506 TRICARE covers approximately 9.5 million beneficiaries worldwide through a
variety of plans, including FFS and managed care plans.507
Billing and Reimbursement
TRICARE reimburses providers for services rendered to beneficiaries using both FFS and
managed care arrangements.508 The allowable fee is determined using Medicare’s RBRVS
system, except TRICARE uses a slightly higher conversion factor and has made minimal
modifications to the geographic regions.509 TRICARE only renders payment for services
provided by authorized providers, those providers that meet licensing and certification
requirements, and those who have been certified to treat beneficiaries.510 Providers seeking
reimbursement must submit claims using the CMS-1500 claim form within one year from the
date the services were rendered.511

502 “Medicaid and Long-Term Care Services and Supports” The Henry J. Kaiser Family Foundation, June 2012, https://kaiserfamilyfoundation.
files.wordpress.com/2013/01/2186-09.pdf (Accessed 2/24/15), p. 1.
503 Ibid.
504 Ibid.
505 “Welcome” U.S. Department of Defense, http://www.tricare.mil/welcome.aspx (Accessed 3/2/15).
506 “Evaluation of the TRICARE Program: Fiscal Year 2014 Report to Congress” U.S. Department of Defense, February 25, 2014, p. 5
507 Ibid.
508 Ibid.
509 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 580.
510 “TRICARE Prime Fact Sheet,” U.S. Department of Defense, February 2015, p. 2.
511 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 579-580.
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TRICARE offers a variety of programs with different beneficiary cost-sharing requirements,
including co-insurance, annual enrollment fees, co-pays, catastrophic caps, and deductibles.512
PARs must accept the allowable fee as payment in full, which prohibits them from billing the
patient for more than the allowable charge for covered services.513 Nonparticipating, authorized
providers may accept the allowable fee on a case-by-case basis, or they can refuse to accept the
fee, and bill the patient an amount not exceeding 15 percent above the TRICARE fee
schedule.514 Excluded from the 15 percent limiting charge are claims from independent
laboratory and diagnostic laboratory companies, claims for durable medical equipment, and
claims from medical supply companies.515 In order to be reimbursed by TRICARE, the
beneficiary files a claim using DD Form 2642.516 TRICARE is typically very efficient in its
claims processing, with an average processing time under 26 days in fiscal year 2013.517
However, providers that do not accept TRICARE’s allowable fee schedule must attempt to
collect the entire bill from the beneficiary.
TRICARE is a primary payor if a beneficiary qualifies for Medicaid coverage, but it assumes
secondary payor status if a patient is covered by another primary health plan.518 In addition,
TRICARE will not pay for occupational injuries or diseases covered by workers’ compensation
laws unless these benefits have been exhausted.519 As such, to ensure prompt payment, providers
must understand the relationship among TRICARE and other insurance or health plans.

Civilian Health and Medical Program of the Department of Veteran
Affairs (CHAMPVA)
Overview
The Civilian Health and Medical Program of the Department of Veteran Affairs (CHAMPVA) is
the Department of Veterans Affairs’ (VA) healthcare program for the spouses and children of
veterans who meet certain eligibility requirements. The CHAMPVA program and the
beneficiaries are both responsible for a portion of the beneficiaries’ healthcare costs.520 To be
eligible for the program, a beneficiary must be the spouse or child of a veteran who was declared
to have a permanent service connected disability; the surviving spouse or child of a veteran who
died as a result of his or her service related disability; the surviving spouse or child of a veteran
who, at the time of his or her death, was determined to be permanently or totally disabled due to
a service connected disability; or in certain instances, the surviving spouse or child of a service
member who died in the line of duty.521
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514
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“Evaluation of the TRICARE Program: Fiscal Year 2014 Report to Congress” U.S. Department of Defense, February 25, 2014, p. 5.
“TRICARE Standard and TRICARE Extra” U.S. Department of Defense, February 2015, p. 1.
Ibid.
“Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 581.
“TRICARE Prime Fact Sheet,” U.S. Department of Defense, February 2015, p. 4.
“Evaluation of the TRICARE Program: Fiscal Year 2014 Report to Congress” U.S. Department of Defense, February 25, 2014, p. 41.
“Using Other Health Insurance” U.S. Department of Defense, January 16, 2015, http://www.tricare.mil/Plans/OHI.aspx (Accessed 3/2/215).
“Double Coverage” 32 C.F.R. § 199.8(d)(ix)(3) (2015).
“Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 573.
Ibid.
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Billing and Reimbursement
The CHAMPVA program reimburses providers for services rendered on a FFS basis up to the
CHAMPVA allowable amount, which is equal to Medicare and TRICARE’s allowable amount
for similar services.522 All claims for reimbursement must be accompanied by the proper claim
form and submitted to CHAMPVA Claims within one year from the date of service.523 Claims
submitted by providers should use the CMS 1500 or the UB-04 (institutional providers, i.e.
hospitals, skilled nursing facilities, end stage renal disease providers, home health agencies,
hospices, outpatient rehabilitation clinics, comprehensive outpatient rehabilitation facilities,
community mental health centers, critical access hospitals, federally qualified health centers,
histocompatibility laboratories, Indian Health Service facilities, organ procurement
organizations, religious non-medical health care institutions, and rural health clinics) forms, and
an itemized list of charges for each service must accompany every claim.524
CHAMPVA typically does not sign contracts with providers. Instead, providers elect to
participate in the program by either submitting a claim or agreeing to treat a beneficiary.525
Providers choosing to treat CHAMPVA beneficiaries must accept the allowable rate as payment
in full; they cannot bill the patient for the difference between their usual fee for the service and
the VA allowable amount.526 A provider is free to refuse to accept the CHAMPVA allowable
rate if he or she makes this fact clear to the patient before treatment is rendered, in which case
the patient is responsible for paying the entire bill and submitting a claim to CHAMPVA for
reimbursement up to the allowable amount.527 CHAMPVA typically reimburses 95 percent of
their claims within thirty days.528
It is important for providers to understand the relationship among payors, because CHAMPVA
assumes the role of both primary and secondary payer.529 If a beneficiary is eligible for
Medicaid, has a Medicaid or CHAMPVA supplemental insurance policy, or is eligible for a
state’s Victims of Crime Compensation Program, CHAMPVA assumes the role of primary payer
and all claims should be filed with CHAMPVA first.530 However, some CHAMPVA members
may be enrolled in Medicare, covered by a workers’ compensation policy, or have other health
insurance. In these instances, Medicare, the relevant workers’ compensation program, or the
other health insurance plan should be billed first and CHAMPVA will assume the role of
secondary payor.531

522 “Fact Sheet 01-11, Payment Methodology” Department of Veterans Affairs Health Administration Center, VA.gov, July 2008,
http://www.va.gov/PURCHASEDCARE/docs/pubfiles/factsheets/FactSheet_01-11.pdf (Accessed 2/27/15), p. 1.
523 “How to File a CHAMPVA Claim” U.S. Department of Veterans Affairs, http://www.va.gov/PURCHASEDCARE/docs/pubfiles/
brochures/HowToFileACHAMPVAClaim.pdf (Accessed 3/2/15), p. 3.
524 Ibid, p. 2.
525 “Fact Sheet 01-15, Participating Providers” Department of Veterans Affairs Health Administration Center, VA.gov, July 2009,
http://www.va.gov/PURCHASEDCARE/docs/pubfiles/factsheets/FactSheet_01-15.pdf (Accessed 2/27/15), p. 1.
526 Ibid.
527 Ibid.
528 “Fact Sheet 01-16, For Outpatient Providers and Office Managers” Department of Veterans Affairs Health Administration Center, October
2010, http://www.va.gov/PURCHASEDCARE/docs/pubfiles/factsheets/FactSheet_01-16.pdf (Accessed 2/5/15).
529 “A Guide for the CHAMPVA Program” U.S. Department of Veterans Affairs, 2014, http://www.va.gov/PURCHASEDCARE/
docs/pubfiles/programguides/champva_guide.pdf (Accessed 2/27/15), p. 64-65.
530 Ibid, p. 64.
531 Ibid, p. 65.
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Other Public Payors
Workers’ Compensation
Federal and state laws mandate that employers provide workers’ compensation coverage for their
employees.532 Workers’ compensation provides healthcare coverage and monetary payments to
employees injured at work or suffering from an occupational disease. They also provide
monetary benefits for the dependents of employees killed on the job.533 In addition, the Workers’
Compensation Laws limit the financial liability of employers, and they nearly eliminate the
financial liability of co-workers for most accidents.534
The Department of Labor’s Office of Workers’ Compensation Programs (OWCP) oversees four
workers’ compensation programs covering federal employees: The Energy Employees
Occupational Illness Compensation Program, the Federal Employees’ Compensation Program,
the Longshore and Harbor Workers’ Compensation Program, and the Black Lung Benefits
Program.535
In addition, each state establishes a workers’ compensation board or commission, tasked with
administering workers’ compensation programs that cover employees of private companies and
state and local governments.536 Depending on the state, employers can comply with workers’
compensation laws by obtaining coverage through:537
(1) State insurance (or compensation) funds. Agencies that provide workers’
compensation insurance coverage to both public and private employers.
(2) Self-insurance plans - Plans under which employers set aside a percentage of capital
funds to cover expenses that may arise.
(3) Commercial workers’ compensation insurance. Policies purchased from commercial
insurance companies.
(4) Combination programs. Programs under which employers cover their workers through
a combination of any of the aforementioned methods.
Billing and Reimbursement
Providers treating ill or injured employees covered under one of the four federal workers’
compensation acts are reimbursed according to the Department of Labor’s OWCP fee schedule
for the Federal Employees’ Compensation Program Act, the Longshore and Harbor Workers’
Compensation Program Act, and the Energy Employees Occupational Illness Compensation

532 “Workers’ Compensation: Benefits, Coverage, and Costs, 2010” By Ishita Sengupta, et al., Washington, DC: National Academy of Social
Insurance, August 2012, p. 2.
533 “Workers Compensation” Cornell University Law School, https://www.law.cornell.edu/wex/workers_compensation (Accessed 3/2/15).
534 Ibid.
535 “Workers’ Compensation” United States Department of Labor, DOL.gov, http://www.dol.gov/dol/topic/workcomp/ (Accessed 8/10/09).
536 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 602; “Workers’ Compensation” United States Department of Labor, DOL.gov,
http://www.dol.gov/dol/topic/workcomp/ (Accessed 8/10/09).
537 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 602-603.
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Program Act.538 A modified version of the fee schedule is used to reimburse providers treating
patients covered under the Federal Black Lung Benefits Act.539 The OWCP’s schedule is based in
part on the fee schedule developed by CMS with some program specific adjustments.540 Claims
for reimbursement should be submitted to the Department of Labor using the UB-04 form for
inpatient hospital charges and the CMS-1500 form for physician services.541 In addition, various
forms, progress reports, and supplemental reports may be required as well.542 Bills must be
submitted to OWCP by December 31 of the year following the year in which services were
provided, or by December 31 of the year following the year when the condition was first
accepted as covered by the workers’ compensation program, whichever is later.543
Medicare claims for physician services must be submitted using the CMS-1500 claim form, whereas
institutional providers (i.e. hospitals, skilled nursing facilities, end stage renal disease providers, home health
agencies, hospices, outpatient rehabilitation clinics, comprehensive outpatient rehabilitation facilities,
community mental health centers, critical access hospitals, federally qualified health centers, histocompatibility
laboratories, Indian Health Service facilities, organ procurement organizations, religious non-medical health
care institutions, and rural health clinics) must submit the UB-04 claim form. Medicare claims must be filed
within one calendar year of the date of service.
U.S. Department of Veterans Affairs; United States Department of Labor, 2009.

Although some state workers’ compensation programs reimburse providers using a fee schedule
based on RVUs established by the state compensation board or commission, many states have
developed managed care plans, in an effort to improve quality of care and control costs.544 The
claims forms, progress reports, and supplemental reports used, as well as the filing deadlines for
them, vary from state to state.545
Providers treating patients eligible for coverage under workers’ compensation programs must
accept assignment, meaning they must accept the compensation as payment in full.546 Patients
covered by workers’ compensation programs are charged no fees at the time of treatment; they
pay no deductible and no co-payment.547 In addition, the patient’s employer pays all
premiums.548

538 “Workers’ Compensation: Benefits, Coverage, and Costs, 2010” By Ishita Sengupta, et al., Washington, DC: National Academy of Social
Insurance, August 2012, p. 80, 83.
539 “Office of Workers’ Compensation Program Medical Fee Schedule 2009” United States Department of Labor, May 12, 2009,
http://www.dol.gov/esa/owcp/regs/feeschedule/fee/fee09/fs09instructions.htm (Accessed 8/19/09).
540 Ibid.
541 Ibid.
542 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 612.
543 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 132.
544 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 621.
545 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 132.
546 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 621.
547 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Ninth Edition,
Clifton Park, NY: Delmar Cengage Learning, 2008, p. 543-544.
548 Ibid, p. 544.
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Indian Health Services (IHS)
The Indian Health Services (IHS) Agency is located within HHS.549 The agency provides
healthcare services to approximately 2.2 million American Indians and Alaskan Natives through
IHS direct healthcare services, tribally operated healthcare services, and Urban Indian healthcare
services and resource centers.550 Most of the agency’s resources fund the care of American
Indians or Native Alaskans living on or near reservations or Alaskan villages.551 However,
Congress has provided some funding for programs for eligible individuals in urban areas as
well.552
Billing and Reimbursement
On occasion, IHS needs to purchase healthcare services from private providers.553 In these
instances, IHS contracts with non-IHS facilities and providers to deliver healthcare services
when:
(1) No IHS facility exists;
(2) The direct care element is incapable of providing the required emergency or specialty
care;
(3) The direct care element has an overflow of medical care workload; or
(4) Supplementary alternate resources are needed.554
Typically, IHS pays providers for these services in accordance with the terms of the negotiated
contract.555 When these services are purchased from hospitals participating in the Medicare
program, the MMA provides IHS with the authority to limit the reimbursement amount to rates
similar to those paid by the Medicare program.556 Providers should submit their claims to the
IHS fiscal intermediary, Blue Cross Blue Shield (BCBS) of New Mexico, using the appropriate
claim form.557
IHS is considered a payor of last resort, so if a patient has other insurance, providers should
submit claims to the patient’s insurance provider first “notwithstanding any state or local law or
regulation to the contrary.”558 The contract standards between IHS and BCBS of New Mexico

549 “Indian Health Service Introduction” By Indian Health Services, IHS.gov, June 2009, http://www.ihs.gov/PublicInfo/PublicAffairs/
Welcome_Info/IHSintro.asp (Accessed 8/10/09).
550 “Indian Health Service Year 2015 Profile” Indian Health Service, January 2015, http://www.ihs.gov/newsroom/factsheets/
ihsyear2015profile/ (Accessed 2/5/15), p. 1.
551 “Indian Health Service: A Quick Look” Indian Health Service, June 2009, http://info.ihs.gov/QuickLook09.asp (Accessed 8/10/09).
552 Ibid.
553 Ibid.
554 “CHS 101” Contract Health Services Data Quality Work Group, http://www.ihs.gov/NonMedicalPrograms/dqwg/dqwg-section1-home.asp
(Accessed 08/27/09).
555 “Contract Health Services” Indian Health Services, IHS.gov, June 2009, http://info.ihs.gov/CHS.asp (Accessed 08/26/09).
556 “Section 506 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003—Limitation on Charges for Services
Furnished by Medicare Participating Inpatient Hospitals to Individuals Eligible for Care Purchased by Indian Health Programs” Federal
Register Vol. 72 No. 106 (June 4, 2007), p. 30706.
557 “About the Fiscal Intermediary (FI)” BlueCross BlueShield of New Mexico, 2015, http://www.bcbsnm.com/ihsfi/about_fi.html (Accessed
2/5/15), p. 1.
558 “CHS 101” Contract Health Services Data Quality Work Group, http://www.ihs.gov/NonMedicalPrograms/dqwg/dqwg-section1-home.asp
(Accessed 08/27/09).
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call for 97 percent of clean claims submitted to the IHS fiscal intermediary to be completed
within 30 days of receiving the claim from the provider.559

PRIVATE PAYORS
Private health insurance consists of commercial insurers, BCBS plans, MCOs, and self-funded
plans. In 2012, private health insurance financed 34 percent of the amount spent on personal
healthcare.560

For Profit Commercial Insurers
Commercial health insurers entered the health insurance market in the 1940s.561 Commercial
health insurance refers to plans that are offered by life insurance companies, casualty insurance
companies, and companies that were formed for the sole purpose of offering health insurance.562
Commercial insurers are taxable entities organized as either mutual or stock insurers.563 Mutual
insurance companies are owned by their policyholders, whereas stock insurance companies are
owned by their stockholders.564 Commercial insurers typically offer a variety of health insurance
plans, which offer varying trade-offs between cost, the variety of the services covered, and the
flexibility to select providers.
To compete in today’s health insurance market, many commercial insurers offer a variety of plan
options. As such, it can be hard to generalize patient and insurance billing requirements for
commercial insurers, because co-pay and deductible amounts, reimbursement methods, claim
form requirements, claims submission deadlines, remittance schedules, policies, and the claim
submittal process will vary by plan. Further complicating matters, it is uncommon for
commercial insurers to publish their billing manuals or inform providers of changes to their
claims process.565 Accordingly, to avoid claim denials and to ensure maximum reimbursement, it
may be important for providers to routinely contact commercial insurers with whom they
frequently work in order to stay informed of any changes to the claims process.

559 “Indian Health Service: Opportunities May Exist to Improve the Contract Health Services Program” U.S. Government Accountability
Office, December 2013, http://www.gao.gov/assets/660/659602.pdf (Accessed 2/5/15), p. 18.
560 “Table 5: Personal Health Care Expenditures; Aggregate and per Capita Amounts, Percent Distribution and Annual Percent Change by
Source of Funds: Calendar Years 2007-2023” in “National Health Expenditure Projections 2013-2023” Centers for Medicare & Medicaid
Services, September 17, 2014, http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealth
ExpendData/NationalHealthAccountsProjected.html (Accessed 1/27/15).
561 “Health Care Economics, Sixth Edition” By Paul J. Feldstein, Clifton Park, NY: Thomson Delmar Learning, 2005, p. 184.
562 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 35.
563 Ibid.
564 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 114.
565 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 438.
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Managed Care
Overview
Managed care plans integrate the financing (that is, insurance) and provision of health services
under the administration of one managed care organization (MCO) in an effort to contain
costs.566 Because managed care plans assume risk, they focus on managing care as well as
managing costs. Under managed care, costs are contained by holding providers accountable to
offer quality services at predetermined levels of reimbursement. Managed care plans hold
providers accountable for providing care to a population through:
(1)
(2)
(3)
(4)
(5)

Clinical practice standardization;
Selective contracting;
Low-cost settings;
Reduced discretionary hospital admissions; and
Effective staff use.567

These mechanisms ensure that financial risk is shared by the managed care plan and the
providers, forcing them both to be accountable for the delivery, cost, and quality of services.
Typically, managed care plans are created by an insurer that owns its own provider network or
by an insurer that creates a network by way of contracts with independent providers.568 Managed
care plans are structured in a variety of ways, each with their own unique characteristics.
However, three of the more popular forms of managed care plans are health maintenance
organizations (HMO), preferred provider organizations (PPO), and point-of-service plans (POS).
Health Maintenance Organizations (HMOs)
Health maintenance organizations (HMOs) are healthcare financing and delivery systems that
provide comprehensive healthcare services for enrollees in a particular geographic area through
its network of providers.569 The HMO structure benefits health plans, enrollees, and providers.570
Health plans benefit because they are able to limit their financial risk by contracting with
providers to care for the enrolled population for a fixed amount per member per month,
regardless of the amount of services provided to any given beneficiary (this system of
reimbursement is known as capitation).571 Enrollees receive the benefit of little or no deductibles

566 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 37.
567 “A Guide to Consulting Services for Emerging Healthcare Organizations” By Robert J. Cimasi, New York, NY: John Wiley & Sons, Inc.,
1999, p. 24-25.
568 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 37.
569 “Managed Care Health Plans in Wisconsin” State of Wisconsin: Office of the Commissioner of Insurance, July 2013, http://oci.wi.gov/
pub_list/pi-044.pdf (Accessed 4/18/14), p. 6; “Medicare Advantage in Wisconsin,” State of Wisconsin, Office of the Commissioner of
Insurance, March 2012, http://oci.wi.gov/pub_list/pi-099.pdf (Accessed 4/27/14), p. 6.
570 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 126.
571 “Paying Physicians by Capitation: Is the Past Now Prologue?” By Samuel Zuvekas and Joel Cohen, Health Affairs, Vol. 29, No. 9,
http://content.healthaffairs.org/content/29/9/1661.full (Accessed 4/28/14), p. 1661.
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and nominal or no co-payments for the care they receive; providers benefit from a steady stream
of income regardless of how often enrollees seek care.572
The HMO came into existence in Los Angeles in 1923 with the founding of the Ross-Loos Clinic. The clinic,
founded by two physicians, Donald E. Ross and H. Clifford Loos, provided medical and hospital care to Los
Angeles Department of Water and Power employees and their families in exchange for monthly payments. 573

HMOs are more restrictive than other health plans, as they generally operate on a closed panel
basis, i.e., enrollees must receive all of their care from the plan’s provider network.574 In serious
emergencies, however, HMOs will generally allow their enrollees to receive care from providers
outside of the HMO’s network.575 Under some HMO models, enrollees must select a primary
care physician to oversee and coordinate their healthcare. This physician also helps to control
costs by limiting which providers the enrollee has access to; by acting as a gatekeeper, the
physician’s authorization is required before the plan will pay for specialized or referral
services.576 In addition, because enrollees are typically limited to seeking care from the plan’s
network of providers, HMOs do assume responsibility for quality assurance and are able to
transfer some of the financial risk to their preferred providers.577
HMOs may be classified by the methods by which they contract with their physicians and other
providers. The following are common forms of HMOs:
(1) Staff model HMOs. The HMO employs its physicians and care is usually provided in a
facility owned by the HMO. There is a high degree of control over the care that is
delivered. Costs are often lower in this type of structure due to the HMO’s ownership of
the treatment facility.578
(2) Group model HMOs. The HMO plan is structured around a multi-specialty medical
group that may include internists; obstetricians; gynecologists; cardiac and oncology
specialists; and surgeons, contracting exclusively with the HMO to provide services. Care
may be delivered in facilities owned by the physician group, e.g., clinics, or in facilities
owned by the HMO, e.g., hospitals.579
(3) Network model HMOs. The HMO plan contracts with many different independent
practice associations (IPA) or other provider groups to form a physician network. Care
can be provided in a larger geographic service area than would be possible with only one
physician group. This model offers the patient choice of physicians and managed costs.580

572 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 126.
573 “Private Health Insurance and Managed Care” in “Introduction to Health Services, Seventh Edition” by Alma Koch., Thomson Delmar
Learning, 2008, p. 115; www.economicexpert.com/a/Ross:Loos:Medical:Group.htm.
574 “Health Maintenance Organization (HMO) Plan” Centers for Medicare & Medicaid Services, http://www.medicare.gov/sign-up-changeplans/medicare-health-plans/medicare-advantage-plans/hmo-plans.html (Accessed 3/3/2015).
575 Ibid.
576 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 38.
577 “Fundamentals of Health Law” By Daniel J. Schwartz, Fourth Edition, Washington, DC: American Health Lawyers Association, 2008, p.
248-250.
578 “HMO Organizational Models,” Patient Advocate Foundation, 2012, http://www.patientadvocate.org/index.php?p=383 (Accessed 4/18/14).
579 Ibid.
580 Ibid.
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(4) Independent Practice Association (IPA) HMOs. The HMO plan contracts with an
association of physicians who are members of a separate legal entity, i.e. an IPA, but who
practice as solo practitioners or in a group practice. Most physicians in an IPA model are
in solo practice and typically have a significant number of patients who are not members
of the HMO plan.581
(5) Direct Contract Model HMOs. The HMO plan delivers healthcare services to
beneficiaries using individual physicians in the community.582
Preferred Provider Organizations (PPOs)
A preferred provider organization (PPO), a hybrid of an HMO and traditional health insurance
plan, is a managed care plan that allows members to choose from an array of healthcare
providers that have contracted with the plan to provide services on a discounted basis.583 The
health plan, the members, and the providers all benefit when the member chooses to receive
services from a provider on the preferred provider list.584 Health plans benefit through increased
purchasing power, which allows them to negotiate lower prices; members benefit because they
are charged lower co-insurance and deductibles when they see in-network providers; and
providers benefit because being a preferred provider status may make plan members more likely
to choose them when seeking medical treatment.585
The PPO evolved in California in 1982 in response to the legislature’s desire to have a system that “would
allow selective contracting for Medicaid through private insurers.”586

PPO members are not required to have a gatekeeper physician authorize the care they receive,
nor are PPO members required to use the preferred providers on their plan’s list, although going
outside the network will result in higher co-insurance rates and deductibles.587 However, because
members are not limited to seeking care from the list of preferred providers, PPOs do not usually
cover preventative care because they do not undertake the same responsibility for quality
assurance as HMOs.588 Also different from HMOs, PPOs do not transfer financial risk to their
preferred providers.589
581 “What is the Difference Between Health maintenance Organization (HMO) and a Preferred Provider Organization (PPO)?” City of Pomona,
California, http://www.ci.pomona.ca.us/mm/humres/pdf/BENEFIT/Pg2_Diff_HMO_PPO.doc (Accessed 4/18/14); “Are there different
types of HMOs?” Archdiocese of Cincinnati, https://pcms.plansource.com/entities/18315/pub_nodes/16066 (Accessed 4/18/2014);
“Managed Care Glossary,” Patient-Physician Network, 2001, http://www.drppg.com/managed_care.asp (Accessed 4/18/14).
582 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 55.
583 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 37; “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton
Park, NY: Thomson Delmar Learning, 2008, p. 124.
584 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 124.
585 Ibid, p. 124-125.
586 “Understanding Health Insurance and the PPO” Sheila Guilloton, Examiner, June 15, 2009, www.examiner.com/x-11804-Health-CareExaminer~y2009m6d15-Understanding-health-insurance-and-the-PPO, (accessed July 10, 2009).
587 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 37; “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton
Park, NY: Thomson Delmar Learning, 2008, p. 125.
588 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 37.
589 “Fundamentals of Health Law” By Daniel J. Schwartz, Fourth Edition, Washington, DC: American Health Lawyers Association, 2008,
p. 245.
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Exclusive Provider Organizations (EPOs)
A subset of the PPO model, the exclusive provider organization (EPO) utilizes the PPO preferred
provider list, but does not allow the insured to obtain services from an out-of-network physician
except in the case of an emergency. Although EPOs have a small market footprint, they have
become increasingly popular as a means to control costs for self-funded employer plans.590
Point-of-Service (POS) Plans
Point-of-service (POS) plans combine many of the elements of HMOs and PPOs.591 POS plans
are usually an addition to an HMO product that allows members the benefit of seeking care from
non-PARs.592 As with an HMO, when members seek care from in-network providers they
typically pay no deductible or coinsurance.593 However, similar to a PPO, members are free to
seek services outside the network subject to higher cost sharing in the form of deductibles and
coinsurance.594 Although the cost is higher, this freedom of choice is why many consider POS
plans to be the least restrictive form of managed care.595
Like members of an HMO, POS enrollees must choose a primary care physician from the list of
in-network providers to oversee the provision of healthcare services.596 This primary care
physician is also responsible for referrals to specialists and hospitals.597 Should a POS member
choose not to seek a referral from his or her primary care physician before undergoing treatment,
his or her expenses associated with this treatment typically will be higher.598
Billing Managed Care Organizations
To ensure timely payment and maximum reimbursement, it is important that a provider’s staff be
aware of the managed care contracts in effect in their practice, the rules of the various plans, and
how these contracts affect the claims process.599 Providers should be aware of the co-pay and
deductible amounts, plan requirements, policies, and if applicable, the length of time it takes a
plan to remit payment for the practice’s various contracts, as they will usually vary by plan.
HMO Billing
Patients in HMOs typically pay a fixed premium to enroll in the plan and co-payments at the
time of treatment ranging from $1 to $35, unless the co-pay is waived because a co-insurance
590 “Essentials of Managed Health Care” By Peter R. Kongstvedt, 6th Edition, Burlington, MA: Jones and Bartlett Learning, LLC, 2013, p. 29.
591 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 127.
592 “Fundamentals of Health Law” By Daniel J. Schwartz, Fourth Edition, Washington, DC: American Health Lawyers Association, 2008,
p. 258.
593 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 55.
594 Ibid.
595 “Point of Service (POS)” All Insurance Info, AllInsuranceInfo.org, 2007, http://allinsuranceinfo.org/health/pos.html (Accessed 7/13/09).
596 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 55.
597 “Point of Service (POS)” All Insurance Info, AllInsuranceInfo.org, 2007, http://allinsuranceinfo.org/health/pos.html (Accessed 7/13/09).
598 Ibid.
599 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 112.
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payment, a fixed percentage of the bill the patient is required to pay after meeting their
deductible, is required instead.600 It should be noted that providers are often required to file
claims with procedure codes for all services rendered, even those directly employed by the HMO
and those compensated on a capitated basis.601 In turn, HMOs use these claims to adjust rates and
track the quality of care.602
PPO Billing
PPOs contract with providers to render services to the plan’s enrollees on a reduced fee basis.603
Patients in most PPOs have the freedom to receive care from providers outside the plan, with the
trade-off being higher out-of-pocket expenses.604 Members of a PPO usually pay higher
premiums, deductibles, and co-payments than those paid by members of HMOs, but these
payments are generally lower than FFS plans.605
POS Plan Billing
Providers in POS plans generally are reimbursed according to the terms of the contract, except
that specialty services typically are paid on a FFS basis.606 Patients in a POS plan pay only small
co-pays or charges, no co-insurance, and no deductibles for care received from network
providers and out-of-network providers to whom they have a referral to see.607 However, when a
patient sees a non-network specialist without first obtaining a referral from his or her primary
care physician, the patient usually will be subject to higher out-of-pocket expenses in the form of
a larger deductible and 20 - 25 percent coinsurance charges.608

Not For Profit Insurers
Not for profit health plans include many of the largest health insurance providers in the United
States. In 2012, approximately 45% of enrollees in the 154 largest health plans in the United
States belonged to nonprofit health plans.609 Similar to for profit insurers, nonprofit health
insurers plans offer a variety of types of health plans, including HMOs, PPOs, and POS plans.

600 “Health Maintenance Organizations” Texas Department of Insurance, November 2014, http://www.tdi.texas.gov/pubs/consumer/cb069.html
(Accessed 2/17/15), p. 2; “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C.
Rowell, Twelfth Edition, Stamford, CT: Cengage Learning, 2013, p. 54; “Definitions of Health Insurance Terms,” Bureau of Labor
Statistics, http://webcache.googleusercontent.com/search?q=cache:orHxVTPXSEwJ:www.bls.gov/ncs/ebs/sp/healthterms.pdf+&cd=
1&hl=en&ct=clnk&gl=us (Accessed 4/29/14).
601 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 113.
602 Ibid.
603 “Essentials of Managed Health Care” By Peter Kongstvedt, Sixth Edition, Burlington, MA: Jones & Bartlett Learning, 2013, p. 9.
604 Ibid.
605 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 56.
606 “From Patient to Payment: Insurance Procedures for the Medical Office, Third Edition” By Cynthia Newby, Columbus, OH:
Glencoe/McGraw-Hill, 2002, p. 112.
607 “Point of Service (POS)” All Insurance Info, AllInsuranceInfo.org, 2007, http://allinsuranceinfo.org/health/pos.html (Accessed 7/13/09).
608 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 55.
609 “Basic Facts & Figures: Nonprofit Health Plans” Alliance for Advancing Nonprofit Health Care, http://www.nonprofithealthcare.org/
resources/BasicFacts-NonprofitHealthPlans.pdf (Accessed 2/24/15), p. 1.
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Blue Cross Blue Shield
Overview
Blue Cross began providing private health insurance in 1929 by offering coverage for hospital
expenses.610 Blue Shield began providing insurance to cover expenses associated with
physicians’ services in 1939.611 In 1986, the independent boards of directors of the national Blue
Cross and Blue Shield (BCBS) accrediting associations merged to form a single nonprofit BCBS
Association (BCBSA).612 Today, the BCBSA consists of thirty-seven independent BCBS
companies, in addition to a Federal Employee Program and an Association that serves the
collective needs of the BCBS plans.613 The BCBSA works to coordinate the nationwide plans by
establishing standards for new plans and programs; assisting local plans with enrollment
activities, national advertising, public education, professional relations, and statistical and
research activities; and serving as the primary contractor for processing Medicare hospital,
hospice, and home health claims.614
During the 1990s, many nonprofit BCBS plans were in need of additional capital in order to
compete with for-profit insurers and requested permission from their respective state
governments to convert to for-profit corporations. In the instances in which the plans were
allowed to convert to for-profit status, the transitions were closely watched to ensure that the
plans’ charitable assets were preserved.615
BCBS plans offer a variety of health insurance options, including FFS coverage, indemnity
plans, managed care plans, a federal employee program, Medicare supplemental plans, and
Healthcare Anywhere, an option that allows enrollees of independently owned and operated
plans to receive the benefits of their plan from other BCBS plans worldwide.616 As of 2013,
BCBS plans provide healthcare coverage to over 80 million Americans.617
Billing and Reimbursement
BCBS plans include a variety of managed care plans (e.g. health maintenance organization
[HMO] programs, preferred provider organization [PPO] programs, and point-of-service [POS]
plans and traditional FFS coverage, among others).618 BCBS FFS plans are typically divided into
two types of coverage: (1) basic coverage, which covers a variety of minimum benefits and (2)
major medical (MM) coverage, which is usually subject to patient deductible and copayment

610 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 114.
611 Ibid.
612 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 459.
613 “BlueCross BlueShield” BlueCross BlueShield Association, 2015, http://www.bcbs.com/ (Accessed 2/16/15), p. 2.
614 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 459.
615 Ibid, p. 460.
616 Ibid, p. 462-466.
617 “About Blue Cross blue Shield Association” BlueCross BlueShield, http://www.bcbs.com/about-the-association/ (Accessed 3/2/15).
618 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 462; For more information on managed care plans, see the Managed Care section above.

160

Chapter 2: Reimbursement Environment

requirements.619 Similar to the Medicare participating provider program, providers can enter into
contracts with BCBS in order to become PARs. BCBS PARs agree to: (1) write off the
difference between the amount charged by the provider to the patient and the approved fee
established by the insurer and (2) only bill patients for the deductible and copay amounts that are
based on BCBS allowed fees for covered services.620 In return, BCBS corporations make direct
payments to PARs and publish the name, location, and specialty of all PARs in a directory that is
distributed to all BCBS subscribers.621 Providers that do not sign such agreements (i.e., nonPARs) can bill patients for the full charge for any given service, who in turn may be reimbursed
by BCBS for the allowed fee for the service, minus deductible and copay obligations, assuming
that the service is covered by the patient's BCBS plan.622
Depending on the enrollee’s coverage and the services sought, patients usually are subject to
deductible, coinsurance, and co-pay requirements, with coinsurance amounts commonly ranging
from 20 percent to 25 percent.623 The CMS-1500 claim form is accepted by most BCBS plans,
and it typically must be filed within one year from the date of service unless the provider’s
contract states otherwise.624
Health System Plans (HSPs)
A health system plan (HSP) is a type of health plan that acts as a payor and also manages the
delivery of medical services. These plans serve as the primary payor for services offered at the
health system’s own facilities, enabling the health plan to streamline billing, and limit the
complexity of their payment systems. Although most HSPs have a modest national footprint,625
their ability to attract and retain individuals and small groups in their geographic regions make
PHSPs highly competitive.626 Examples of HSPs include Kaiser Permanente and Geisinger
Health Plan, among others. As of 2011, approximately 13% of U.S. hospitals reported having an
equity position in an HMO.627
With the advent of the ACA and its focus on ACOs, health systems are showing renewed interest
in operating their own insurance plans.628 Health systems with internal health plans may be able
to better align financial incentives and clinical operations in an ACO arrangement by having one
entity represent both the provider and the payor. Further, entities where the ACO and payor are
under the same overall organizational structure may be more apt to implement pay-for619 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 462-463.
620 “Anthem Blue Cross and Blue Shield Provider Agreement” Blue Cross Blue Shield, http://www.anthem.com/provider/va/f4/s0/t0/
pw_e188276.pdf (Accessed 3/2/15), p. 6.
621 “Understanding Health Insurance: A Guide to Billing and Reimbursement” By Michelle A. Green and JoAnn C. Rowell, Twelfth Edition,
Stamford, CT: Cengage Learning, 2013, p. 461.
622 Ibid, p. 461-462.
623 Ibid, p. 467.
624 Ibid, p. 467.
625 “Provider Sponsored health Plans: Past, Present and Future” By Chris Myers, http://www.navigant.com/insights/library/healthcare/2013/
pulse-providers-sponsored-healthplans/?page=2 (Accessed 4/29/14).
626 “Provider Sponsored Health Plans” By James Smith et al., First Illinois Speaks, January 2014, http://firstillinoishfma.org/january-2014newsletter/ (Accessed 4/29/2014); “Deciding Whether to Enter Provider-Sponsored Health Plans Requires Careful Up-Front Analysis” By
Michael Finnerty, HFMA, May 29, 2013, https://www.hfma.org/Content.aspx?id=17327 (Accessed 4/29/2014); “Provider Sponsored
Health Plans as a new Accountable Care Entity” By Phil Kamp, Accountable Care News, Vol. 4, No. 5, May 2013,
http://valencehealth.com/uploads/files/Accountable_Care_News_Reprint_Phil_Kamp_byline_May_2013.pdf. (Accessed 4/29/14), p. 1.
627 “Provider Sponsored health Plans: Past, Present and Future” By Chris Myers, http://www.navigant.com/insights/library/healthcare/
2013/pulse-providers-sponsored-healthplans/?page=2 (Accessed 4/29/14).
628 Ibid.
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performance (P4P) initiatives to improve cost and quality outcomes, since they are more able to
monitor and influence the performance of individual providers by incorporating physician
compensation into incentive programs.
Consumer Driven Health Plans—The Shift From Defined Benefits to Defined
Contributions
To combat the problem of ever increasing premiums for employee health insurance, many
employers have implemented defined contribution health insurance plans instead of the
traditional defined benefit plans.629 The goal is to model health insurance programs after defined
contribution pension programs, such as 401(k)s.630 Unlike a defined benefit system, in which an
employer has the obligation to contribute the necessary premium for a certain health insurance
benefit package, a defined contribution system allows an employer to contribute a designated
amount of money and give the employee the freedom to do with it what he or she chooses.631
The shift toward defined contribution health insurance plans has directed the focus from the
employer to the employee when it comes to making healthcare decisions.632 Many forms of
defined contribution leave substantial decisions to employee (that is, the consumer of the
healthcare services), putting the employee in the driver’s seat when it comes to deciding which
services are worth purchasing and from whom to purchase them.633 To accomplish this,
employers occasionally will present employees with what amounts to a voucher to purchase
insurance on their own, but more often, employers will create an account for each employee into
which the employer, the employee, or both will contribute funds, and from which the employee
will be able to draw to purchase health services.634
Health Savings Accounts (HSAs)
One of the most common models of defined contribution health insurance is the establishment of
a health savings account (HSA), coupled with enrollment in a high-deductible health plan
(HDHP), whereby employers and employees both contribute to a special account from which the
employee can draw funds to pay for health services.635 HSAs were first introduced in the MMA.
An individual, an employee, or his or her employer may make contributions to an HSA. If the
employer contributes, the value of those contributions is not taxable to the employee. Similarly,
if the employee makes contributions, they count as above-the-line deductions.636
Individuals excluded from HSA eligibility are those not covered by a HDHP, those with health
coverage other than a HDHP, those who can be claimed as a dependent on someone else’s tax
629 “Defined Contribution Health Insurance” By Greg Scandlen, National Center for Policy Analysis, October 26, 2000, http://www.ncpa.org/
pdfs/bg154.pdf (Accessed 09/10/09).
630 Ibid.
631 “Defined Contribution: From Managed Care to Patient-Managed Care” By E. Haavi Morreim, Cato Journal, Vol. 22, No. 1 (Spring/Summer
2002), p. 110-111.
632 “Defined-Contribution Health Insurance Products: Development and Prospects” By Jon B. Christianson, Stephen T. Parente, and Ruth
Taylor, Health Affairs, Vol. 21, No. 1 (January/February 2002), p. 51.
633 “Defined Contribution: From Managed Care to Patient-Managed Care” By E. Haavi Morreim, Cato Journal, Vol. 22, No. 1 (Spring/Summer
2002), p. 112.
634 Ibid, p. 111.
635 “All About HSAs” U.S. Treasury Department, July 22, 2007, http://www.treas.gov/offices/public-affairs/hsa/pdf/all-aboutHSAs_072208.pdf (Accessed 07/01/09), p. 2.
636 Ibid, p. 14.
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return, and Medicare recipients.637 However, enrollees are allowed to have non HDHP insurance
coverage for the following reasons: (1) a specific disease or illness; (2) a fixed amount per period
of hospitalization; and (3) liabilities incurred under workers' compensation laws, tort liabilities,
or liabilities related to the ownership or use of property.638 Furthermore, coverage for
(1) accidents; (2) disability; (3) dental care; (4) vision care; or (5) long-term care does not
preclude an individual from HSA eligibility.639 No requirement exists that an individual have
earned income, nor are there any upper-end limits on income, that would restrict an individual’s
ability to contribute to an HSA.640
Legislative Impacts
In 2006, President George W. Bush signed into law the Health Opportunity Patient
Empowerment Act of 2006, which provided new opportunities for HSA participants to build their
funds. Included among the provisions of the act was an allowance for employers to transfer funds
from flexible spending arrangements (FSAs) or health reimbursement arrangements (HRAs) to
an HSA plan for those employees wishing to switch. The new act also increased the maximum
HSA contribution amount to a statutorily defined amount (indexed for inflation), eliminated the
system of prorating HSA contributions based on the number of months that an individual was
eligible and replaced it with a system allowing individuals who enrolled in a month other than
January to make a contribution equal to a full year’s enrollment. Additionally, the act allowed for
a one-time transfer from an individual retirement arrangement (IRA) to an HSA, which avoided
early withdrawal and income taxes, eliminated FSA coverage previously deemed as disregarded
coverage which reduced HSA contribution for a given year, set an earlier date for cost-of-living
index adjustments, and allowed greater employer contributions for lower-paid employees.641
More recently, the ACA may pose a threat to HSAs for three reasons: (1) the law contains a
provision that prohibits the use of HSA funds to pay for over-the-counter pharmaceuticals, unless
they are obtained with a prescription or doctor's orders;642 (2) the law contains a provision that
increases the penalty for early withdrawal of HSA funds from 10% to 20%;643 and (3) the ACA
requires that health insurance plans pay at least 60% of the actuarial value of covered benefits.644
Due to the fact that HDHPs generally have lower actuarial values than traditional health
insurance plans, supporters of HSAs feared that HDHPs may have difficulty reaching this
threshold, thus reducing access to HSAs.645 However, a 2014 analysis found that HSA-eligible
637 “Publication 969 – Main Content” Internal Revenue Service, 2013, http://www.irs.gov/publications/p969/ar02.html (Accessed 2/17/15),
p. 1.
638 Ibid.
639 Ibid, p. 3.
640 “All About HSAs” U.S. Treasury Department, July 22, 2007, http://www.treas.gov/offices/public-affairs/hsa/pdf/all-aboutHSAs_072208.pdf (Accessed 07/01/09), p. 4.
641 “President Bush Signs Bill to Make Health Care More Affordable, Accessible” U.S. Treasury Department, Press Release, Dec. 20, 2006,
http://www.treas.gov/press/releases/hp209.htm (Accessed 7/1/09).
642 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 9003, 124 STAT 119, 854 (March 23, 2010); “State Legislation and
Actions on Health Savings Accounts (HSAs) and Consumer-Directed Health Plans, 2004-2015” National Conference of State Legislatures,
January 2015, http://www.ncsl.org/research/health/hsas-health-savings-accounts.aspx (Accessed 2/17/15), p. 2.
643 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 9003, 124 STAT 119, 854 (March 23, 2010) ; “State Legislation and
Actions on Health Savings Accounts (HSAs) and Consumer-Directed Health Plans, 2004-2015” National Conference of State Legislatures,
January 2015, http://www.ncsl.org/research/health/hsas-health-savings-accounts.aspx (Accessed 2/17/15), p. 2.
644 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1302, 124 STAT 119, 167 (March 23, 2010); “State Legislation and
Actions on Health Savings Accounts (HSAs) and Consumer-Directed Health Plans, 2004-2015” National Conference of State Legislatures,
January 2015, http://www.ncsl.org/research/health/hsas-health-savings-accounts.aspx (Accessed 2/17/15), p. 2.
645 “State Legislation and Actions on Health Savings Accounts (HSAs) and Consumer-Directed Health Plans, 2004-2015” National Conference
of State Legislatures, January 2015, http://www.ncsl.org/research/health/hsas-health-savings-accounts.aspx (Accessed 2/17/15), p. 2.
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plans made up about 25% of the plans offered on the ACA's exchanges.646 Accordingly, although
the ACA may inhibit the access to and use of HSAs in some ways, they are still available.
Prevalence and Growth of HSAs
According to a 2014 census conducted by America’s Health Insurance Plans (AHIP), the number
of individuals covered by HSAs and HDHPs has increased by an annual average of 15% since
2011, with over than 17 million individuals covered as of January 2014.647
According to a 2014 census conducted by America’s Health Insurance Plans (AHIP), the number of individuals
covered by HSAs or HDHPs has increased by an annual average of 15% since 2011, with over 17 million
individuals covered as of January 2014.
America’s Health Insurance Plans, July 2014.

Reimbursement with HSAs and HDHPs
Providers may receive reimbursement from an individual with an HSA in a variety of forms,
including debit card, checks, and automatic claims forwarding.648 The fact that an individual has
an HSA does not mean that a provider will be paid the day the services are provided, because
some HSAs encourage their patients not to pay for the provider’s services until the plan informs
the patient of the amount.649 To combat this issue, providers should insist on payment at the time
of service, always check their patient’s insurance eligibility to determine how much of the
deductible has been met, and, if the entire deductible has been met, whether the service is
covered by their HDHP and whether the patient has co-insurance requirements.650 Performing
these tasks at the time of service can ensure the provider receives the appropriate payment in a
timely manner, without having to go through the costly and time consuming process of seeking
payment from the patient at a later date or reimbursing the patient due to an overpayment.651
Self Insurance
Self-insurance plans, often referred to as self-funded plans, have been one of the leading trends in
the health insurance industry since the late 1970s.652 Self-insuring employers make a conscious
choice to undertake the risks associated with the cost of healthcare and set aside money to pay

646 “Health Savings Accounts Under the Affordable Care Act: Challenges and Opportunities for Consumer-Directed Health Plans” By Paul
Howard and Yevgeniy Feyman, Center for Medical Progress, Manhattan Institute for Policy Research, October 2014,
http://www.manhattan-institute.org/pdf/mpr_18.pdf (Accessed 2/17/15), p. 5.
647 “January 2014 Census Shows 17.4 Million Enrollees in Health Savings Account-Eligible High Deductible Health Plans (HSA/HDHPs)”
America’s Health Insurance Plans, July 2014, http://www.ahip.org/News/Press-Room/2014/New-Census-Survey-Shows-ContinuedGrowth-in-HSA-Enrollment.aspx (Accessed 2/17/15), p. 1.
648 “CIGNA Choice Fund Health Savings Account: Frequently Asked Questions About a Health Savings Account” CIGNA, CIGNA.com,
2009, http://www.cigna.com/our_plans/medical/hsa/for_you.html#3a (Accessed 08/28/09).
649 “Healthonomics: How to Handle Health Savings Accounts” By Suz Redfearn, physicianspractice.com, February 2008,
http://www.physicianspractice.com/index/fuseaction/articles.details/articleID/1115/page/1.htm (Accessed 08/28/09).
650 Ibid.
651 Ibid.
652 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 113; “Self Insurance In Times Of Growing And Retreating Managed Care” By Jon R. Gabel et al., Health Affairs, Vol.
22, No. 3 (March/April 2003), p. 203.
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these costs as they arise.653 Often, a self-insurer will hire a commercial insurer or third-party
administrator to run its medical benefits program and adjudicate claims.654
Self-insurance plans vary by the amount of risk an employer is willing to assume.655 In a fully
self-funded plan, the employer undertakes the responsibility for 100 percent of the healthcare
expenses submitted for reimbursement.656 Typically, this type of funding is limited to employers
or groups of 5,000 or more, as medical expenses for large groups can be reasonably predicted.657
However, employers with fewer than 5,000 employees often are unwilling to assume the risk of
funding their entire health insurance program.658 Accordingly, these employers may opt for a
partially self-funded plan.659 The most common type of partially self-funded plans is the
minimum premium plan.660 Under a minimum premium plan, the employer covers claims up to a
predetermined amount, and an insurance policy assumes liability for claims thereafter.661
Another popular form of partially self-funded plans involves combining self-funding with stoploss insurance. Under these plans, the employer covers employee claims up to a predetermined
amount per employee, at which time stop-loss insurance covers any employee who exceeds his
or her out-of-pocket maximum.662
Employers choose to self-insure as an alternative to purchasing health insurance policies for
several reasons. First, self-insurers avoid the charges, fees, and profits that insurance companies
build into the price of insurance premiums.663 In addition, because self-insurance is not
technically insurance, state taxes assessed on premium revenue can be avoided.664 Perhaps the
most important benefit of self-insurance is the fact that the Employee Retirement Income Security
Act of 1974 exempts self-insured plans from state regulation.665 This exemption provides the
self-insured considerable flexibility to design benefit programs as they see fit, and it provides
them with the opportunity to save considerable money by avoiding state mandates requiring the
coverage of particular services.666
Self-insured employers contract directly with providers and reimburse them according to the
terms of the contract. Employers have designed self-insurance programs to provide coverage for
their employees using a variety of plans, including indemnity, HMOs, PPOs, and POSs.667
However, some states may prohibit a self-insured employer from signing capitated contracts with
653 “Healthcare Finance: An Introduction to Accounting and Financial Management” By Louis C. Gapenski, Third Edition, Chicago, IL: Health
Administration Press, 2004, p. 36.
654 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 113.
655 “Self-Insured Group Health Plans” Self-Insurance Institute of America, Inc., http://www.siia.org/i4a/pages/Index.cfm?pageID=4546
(Accessed 3/2/15).
656 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 113.
657 Ibid.
658 Ibid.
659 Ibid.
660 Ibid.
661 Ibid.
662 “When You’re Considering Self-Funding” The Alliance, August 2014, p. 7, http://www.the-alliance.org/uploadedFiles/Downloads/
WhenYoureConsideringSelfFunding.pdf (Accessed 3/2/15).
663 “Introduction to Health Services” By Stephen J. Williams and Paul R. Torrens, Seventh Edition, Clifton Park, NY: Thomson Delmar
Learning, 2008, p. 113.
664 Ibid.
665 Ibid.
666 Ibid.
667 “Self Insurance In Times Of Growing And Retreating Managed Care” By Jon R. Gabel et al., Health Affairs, Vol. 22, No. 3 (March/April
2003), p. 203.
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physicians.668 The forms used and the claims process likely will vary by employer, as will the
coverage, co-insurance amount, and length of time for remittance, as the employer will design its
plan in accordance with its particular needs.
It should be noted that, although the ACA makes significant changes to the small-group
insurance market, self-insured group plans are exempted from these reforms, regardless of the
size of the employer.669 As a result, beginning in 2014, firms with relatively low-cost workers
may be able to save money by self-insuring.670
Self-Pay
Individuals may pay out-of-pocket for their own healthcare costs for a number of reasons,
including a lack of health insurance, a desire to keep a medical condition from their health
insurer, or due to the conscious decision not to purchase health insurance.
Having decided to treat a self-pay patient, a provider must determine what form of payment to
accept for these medical services, what to charge for these services, and how to collect the
payment due.
Most public insurers, like Medicare, set their reimbursement rates independently of a provider’s
actual charges.671 In addition, most private insurers have the bargaining power to negotiate
discounts.672 However, most self-pay patients will lack the ability to set their payment amount or
negotiate lower charges, and, as a result, they may pay more than the amount an insurer would
pay for the same service. Charges for services vary widely, but the 2010 average full-charge
hospital bill was 3.6 times the hospital's costs.673 This billing practice has led to multiple class
action lawsuits against providers, and it has resulted in settlements by which the providers offer
both prospective and retrospective discounts to their self-pay patients.674 Thus, to avoid costly
litigation at a later date, a provider may choose to offer all self-pay patients discounts similar to
those negotiated by other payors.
Once a provider has determined what form of payment to accept and what to charge self-pay
patients, he or she must face the question of how to collect payment. Staff training and a
requirement that the bill be paid in full before the patient leaves can help reduce the chance that

668 Ibid.
669 “Small Firm Self-Insurance Under the Affordable Care Act” By Matthew Buettgens and Linda J. Blumberg, The Commonwealth Fund,
November 2012, http://www.commonwealthfund.org/~/media/files/publications/issue-brief/2012/nov/1647_buettgens_small_firm_
self_insurance_under_aca_ib.pdf (Accessed 2/17/15), p. 2.
670 Ibid, p. 5.
671 “From ‘Soak The Rich’ To ‘Soak The Poor’: Recent Trends In Hospital Pricing” By Gerard F. Anderson, Health Affairs, Vol. 26, No. 3
(May/June 2007), p. 784.
672 “From ‘Soak The Rich’ To ‘Soak The Poor’: Recent Trends In Hospital Pricing” By Gerard F. Anderson, Health Affairs, Vol. 26, No. 3
(May/June 2007), p. 784.
673 “Uninsured Americans Get Hit With Biggest Hospital Bills: Markups Vary” By Charles Babcock, Bloomberg Business, March 10, 2013,
http://www.bloomberg.com/news/articles/2013-03-11/uninsured-americans-get-hit-with-biggest-hospital-bills (Accessed 2/18/15).
674 “Settlement in Uninsured Billing Lawsuit” BJC HealthCare, BJC.org, http://www.bjc.org/?id=5557&sid=1, March 03, 2008 (Accessed
7/31/09); Healthcare system and uninsured patients reached a settlement in a class action suit that called for a “Self-Pay Discount Policy” to
be implemented at the system’s hospitals. The discount is to apply prospectively for at least four years for all self-pay patients regardless of
income level. In addition, upon request, the discount is to be available retroactively to all uninsured patients with bills dating back to
January 1, 1999.
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the provider will have to write off the visit as bad debt.675 In addition, some providers require
self-pay patients to give both their driver’s license and Social Security numbers to ensure they
are more readily pursuable should collection become an issue.676

Commercial ACOs
Since the advent of the MSSP, commercial insurers have been experimenting with commercial
ACOs. In contrast to federal ACOs, which contract with CMS through the MSSP, commercial
ACOs assume risk and realize financial incentives by means of contractual ACO arrangements
made with private payors. Similar to the Federal market, Commercial ACOs accept the
accountability and responsibility for the health outcomes and cost containment of an established
patient population by offering coordinated, high quality care.677 In the absence of the type of
regulatory guidelines imposed on Federal ACOs, Commercial ACOs may develop any number
of operational and governance structures depending on the nature and terms of the contract
negotiated with the chosen private payor, as well as the resources available to the ACO based on
its scale. Although Commercial ACOs and Federal ACOs share a common policy goal, i.e.,
higher quality of care at lower costs, these commercial ACOs generally contract with private
payors utilizing one of three payment arrangements:
(1) Shared Savings Arrangements, in which the ACO is reimbursed under a fee-for-service
model, and, at the end of the year, any savings generated by the ACO are shared between
the payor and ACO, based upon the ACO’s quality performance;
(2) Global Budget Arrangements, in which the ACO has a predetermined global budget for
their assigned patient population, which is reconciled at the end of the year, and where
the ACO is awarded bonuses above their global budget for achieving quality benchmarks;
or
(3) Capitated Arrangements, in which the ACO are paid a set amount per assigned ACO
patient, and where a portion of this capitated payment is withheld until the end of the year
and then returned to the ACO if the ACO meets certain quality benchmarks.678
The most common form of commercial ACO arrangement is the shared savings model, and the
majority of commercial ACOs have some form of downside risk associated with their
commercial contracts, unlike the one-sided risk model of the MSSP described above.679

METHODS OF REIMBURSEMENT
Insurers use a variety of methodologies to negotiate and calculate reimbursement for their
contracted healthcare providers. The most commonly utilized reimbursement methods for both
primary and specialty care physicians are risk-based reimbursement methods like capitation or
675 “Pay Up, Self-Payor: Getting the Most From Patients Who Pay Out-of-Pocket” By Suz Redfearn, PhysicianPractice.com, March/April
2002, http://www.physicianspractice.com/index/fuseaction/articles.details/articleID/293.htm (Accessed 7/31/09).
676 “Pay Up, Self-Payor: Getting the Most From Patients Who Pay Out-of-Pocket” By Suz Redfearn, PhysicianPractice.com, March/April
2002, http://www.physicianspractice.com/index/fuseaction/articles.details/articleID/293.htm (Accessed 7/31/09).
677 “ACO Results: What We Know So Far” by Matthew Petersen and David Muhlestein, Health Affairs, May 30, 2014,
http://healthaffairs.org/blog/2014/05/30/aco-results-what-we-know-so-far/ (Accessed 3/3/2015).
678 “ACO Contracting with Private and Public Payers: A Baseline Comparative Analysis” By Valerie A. Lewis, et al., American Journal of
Managed Care, Vol. 20, No. 12 (December 2014), p. 1009.
679 Ibid, p. 1010.
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FFS.680 Figure 2-4: Methods of Reimbursement, below, displays the various options for
reimbursement in the U.S. Healthcare system.
Figure 2-4: Methods of Reimbursement

Capitation
In order to reduce healthcare service utilization, insurers have passed some of their risk to
providers in the form of capitation.681 Capitation is a pre-paid reimbursement method that pays a
provider a set price for providing medical services to a defined population for a defined set of
services, regardless of service utilization.682 Providers must manage the financial risk of
providing adequate care by calculating the expected volume of referrals, the average cost, and
their ability to control utilization.683 Capitated payments are often based on actuarial or historical
data that may help to determine an appropriate and acceptable amount of risk to the
organization.684
Capitated contracts allow providers to budget for expected medical costs while accepting both
the financial risk and potential rewards, and they provide providers with financial incentives that
encourage them to become more active participants in controlling (and accepting responsibility
for) utilization.685
Full Risk Capitation
Full risk capitation occurs when a healthcare plan, facility, or provider accepts the entire
financial risk for a plan’s members.686 However, due to the significant risk involved, any medical
680 “The Managed Health Care Handbook” By Peter R. Kongstvedt, Third Edition, Gaithersburg, MD: Aspen Publishers, Inc., 1996, p. 120.
681 “A Guide to Consulting Services for Emerging Healthcare Organizations” By Robert J. Cimasi, New York, NY: John Wiley & Sons, Inc.,
1999, p. 11, 16.
682 “Overview of Alternative Payment Models” Massachusetts Medical Society, Department of Health Policy and Health Systems, March
2009, http://www.massmed.org/advocacy/key-issues/health-care-reform/mms-overview-of-alternative-payment-models-(pdf)/ (Accessed
2/13/15) p. 1.
683 “The Complete Capitation Handbook: How to Design and Implement At-Risk Contracts for Behavioral Healthcare” By Gayle L. Zieman,
Tiburon, CA: CentraLink Publications, 1995, p. 30, 294.
684 “Capitation Models” Health Care Incentives Improvement Institute, 2012, http://www.hci3.org/content/capitation-models (Accessed
2/17/15).
685 “Overview of Alternative Payment Models” Massachusetts Medical Society, Department of Health Policy and Health Systems, March
2009, http://www.massmed.org/advocacy/key-issues/health-care-reform/mms-overview-of-alternative-payment-models-(pdf)/ (Accessed
2/13/15), p. 2.
686 Ibid.
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group undertaking full risk capitation must have strong financial management skills and
management information systems.687 In absence of such safeguards, many insurers will refuse
such arrangements in order to avoid the risk of failure.688 Usually, large groups or an organized
system of providers are best suited to support full risk capitation.689
Blended Capitation
Blended capitation is a payment method that combines per-member-per-month rates and FFS
remuneration to pay for physician services as a way to counterbalance the faults identified with a
purely capitated or a purely FFS payment system. In the healthcare context, the FFS payment
method encourages providers to see many patients and perform difficult and unpleasant
procedures.690 However, a purely FFS system does not provide the physician with an incentive to
reduce costs associated with his or her practice style, nor does it encourage cooperation among
physicians.691 Similarly, capitation rewards provider activities that strive for high clinical quality
and customer service.692 However, without adjustments, a purely capitated form of remuneration
may lead a physician to withhold preventative services, narrow his or her scope of practice, and
refuse to treat patients that are in need of a greater amount of care due to the fear of financial
burden.693 Therefore, organizations may utilize a blended system that combines elements of both
capitation and FFS payments, in order to address the weaknesses of a given payment method.694
Furthermore, a blended system can be organized such that the payments incentivize providers to
achieve specific policy targets, such as promoting preventative services while controlling overall
healthcare costs.695

Fee-for-Service (FFS)
Fee-for-service (FFS) health coverage occurs when healthcare providers receive separate
compensation for each service they provide (for example, an office visit, procedure, etc.).696
Critics condemn FFS systems, stating that physicians tend to over-treat patients, up-code, and
unbundle services in order to receive higher reimbursement.697 Nonetheless, FFS systems are
often used as an incentive for healthcare providers in markets where managed care penetration is
low.698
687 “The Capitation Sourcebook: A Practical Guide to Managing At-Risk Arrangements” By Peter Boland, Berkeley, CA: Boland Healthcare,
Inc., 1996, p. 107.
688 “The Capitation Sourcebook: A Practical Guide to Managing At-Risk Arrangements” By Peter Boland, Berkeley, CA: Boland Healthcare,
Inc., 1996, p. 107.
689 Ibid.
690 “Amid Tough Times With Capitation, Doctors Struggle To Balance Risk” By Phyllis Maguire, American College of Physicians-American
Society of Internal Medicine, May 2000, http://www.acpinternist.org/archives/2000/05/capitation.htm (Accessed 7/31/09); “Blended
Payment Methods in Physician Organizations Under Managed Care” By James C. Robinson, The Journal of the American Medical
Association, Vol. 282, No. 13 (October 6, 1999), p. 1259.
691 “Blended Payment Methods in Physician Organizations Under Managed Care” By James C. Robinson, The Journal of the American
Medical Association, Vol. 282, No. 13 (October 6, 1999), p. 1262.
692 Ibid, p. 1259.
693 Ibid, p. 1262.
694 “Overview of Alternative Payment Models” Massachusetts Medical Society, Department of Health Policy and Health Systems, March
2009, http://www.massmed.org/advocacy/key-issues/health-care-reform/mms-overview-of-alternative-payment-models-(pdf)/ (Accessed
2/14/15), p. 1.
695 Ibid.
696 “Insurance Programs: Glossary” U.S. Office of Personnel Management, http://www.opm.gov/insure/glossary/index.asp (Accessed
10/05/09).
697 “The Managed Health Care Handbook” By Peter R. Kongstvedt, Third Edition, Gaithersburg, MD: Aspens Publishers, Inc., 1996, p. 139,
143.
698 Ibid.
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Insurers can sometimes negotiate discounts with providers, based either directly on charges or
based on volume:
(1) Straight discount on charges. Discounting a specific amount off the reimbursement rate
for every procedure code.
(2) Discount based on volume or a sliding scale. The degree of discount is based upon a
pre-agreed set of procedural volume ranges. For example, if the provider performs five or
less of a specific procedure per month, he or she earns a 10 percent discount. However,
should the provider perform six to ten procedures per month, he or she earns a 15 percent
discount. Many plans combine a discount arrangement with a fee maximum. The fee
maximum is a fee schedule; the plan pays the lesser of the discounted charges or the fee
maximum.699

Pay for Performance (P4P)
Pay for performance (P4P) is a method of reimbursement in which part of the payment is
dependent upon the quality of services delivered.700 Common elements of all P4P systems
include a set of targets or objectives that define what will be evaluated, measures and
performance standards for establishing specific physician target criteria, and rewards for meeting
those criteria.701 Generally, these payment systems also include a portion of the payment that is
independent of any quality metrics.702 Examples of P4P programs include Medicare’s Value
Based Purchasing Programs,703 as set forth in the Value Based Purchasing Programs section
above.

Specialty Care Reimbursement
The most commonly utilized reimbursement methods for specialty care physicians (SCPs) are
risk-based models: FFS and capitation.704 However, SCPs are reimbursed by way of additional
methods including: (1) relative value scales or fee allowance schedules, (2) performance-based
FFS, (3) retainers, (4) hourly and salary wages, (5) single fees, (6) bundled case rates or package
pricing plans, (7) DRGs, and (8) periodic interim payments and cash advances.705

Payment Bundling
Bundling is a method of reimbursement that combines institutional and professional charges into
a single payment.706 A bundled payment or episode-based payment occurs when payments for
multiple related procedures or diagnoses are combined to reimburse for the entirety of one
699 “The Managed Health Care Handbook” By Peter R. Kongstvedt, Third Edition, Gaithersburg, MD: Aspens Publishers, Inc., 1996, p. 207208.
700 “Pay-for-Performance in Health Care” By Jim Hahn, CRS Report for Congress, December 12, 2006, http://www.allhealth.org/briefing
materials/crsreportingforcongress-pay-for-performanceinhealthcare-501.pdf (Accessed 2/23/15), p. i.
701 Ibid.
702 Ibid.
703 “Linking Quality to Payment” Centers for Medicare & Medicaid Services, http://www.medicare.gov/hospitalcompare/linking-quality-topayment.html (Accessed 2/23/15).
704 “The Managed Health Care Handbook” By Peter R. Kongstvedt, Third Edition, Gaithersburg, MD: Aspens Publishers, Inc., 1996, p. 181.
705 Ibid, p. 179-187.
706 “The Managed Health Care Handbook” By Peter R. Kongstvedt, Third Edition, Gaithersburg, MD: Aspens Publishers, Inc., 1996, p. 187.
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episode of care.707 During the healthcare reform debate, several proposals were advanced by
legislators to reduce Medicare costs by various methods of bundling payments to hospitals and
physicians for services provided over the course of a patient’s treatment plan. The trend was
validated by the United States Senate Finance Committee’s Proposals to Improve Patient Care
and Reduce Health Care Costs, whereby it released a plan to use the bundling of payments for
inpatient and post-discharge care to save $16 billion.708 Further, CMS has also created a pilot
program to examine the benefits of bundling Part A and Part B Medicare payments.709
The Senate Finance Committee proposed to bundle payments for acute inpatient care and postacute care occurring or initiating up to thirty days following a patient’s discharge, including
home health, skilled nursing, rehabilitation, and long-term hospital services. This bundled
payment included the inpatient Medicare Severity Diagnosis-Related Group (MS-DRG) amount
plus post-acute care costs for the treatment of patients in that MS-DRG, including any expected
or planned readmissions within the thirty-day window. Although the hospital would receive the
bundled payment even if no post-discharge care was given, the bundled amount will have
already been adjusted to “capture savings from the expected efficiencies gained from improving
patient care and provider coordination within the bundled payment system.”710 Further, Medicare
is establishing DRG bundling for certain services, whereby if two or more procedures are
inextricably linked, then reimbursement cannot be claimed for each procedure separately, but
rather for one episode of care.711
Proponents of bundled payments assert that the move toward bundled payments could provide
higher coordination between providers and more efficient levels of care.712 However, critics
articulate concern regarding the level of savings and patient care improvement that a blanket
bundling of payments will actually generate. For example, the AMA expressed concern that such
bundling proposals could result in the withholding or limiting of appropriate post-discharge or
inpatient services.713 The AMA also called for the appropriate distribution of the payments to
individual providers, risk-adjustment for patients whose care exceeds the amount accounted for
in the bundled payment, and safeguards to ensure that patient care decisions remain in the hands
of the individual providers.714 Similarly, in a letter to the Senate Finance Committee, the
American Hospital Association stated that the administration’s approach to bundling payments
was “problematic” and would require a “paradigm shift in health service delivery” resulting in
the revision or withdrawal of numerous regulations promulgated to manage the current

707 “Accountable Care Organizations: Value Metrics and Capital Formation” By Robert James Cimasi, Taylor & Francis Group, Boca Raton:
FL, 2013, p. 90.
708 “President Obama’s Budget Request Includes $828B for HHS” Kaisernetwork.org., May 8, 2009. http://www.kaisernetwork.org/
daily_reports/print_report.cfm?DR_ID=58379&dr_cat=3 (Accessed 5/14/09).
709 “Acute Care Episode Demonstration Fact Sheet” Centers for Medicare & Medicaid Services, March 20, 2009, http://www.cms.hhs.gov/
DemoProjectsEvalRpts/downloads/ACEFactSheet.pdf (Accessed 06/01/09).
710 “Transforming the Health Care Delivery System: Proposals to Improve Patient Care and Reduce Health Care Costs” By the Senate Finance
Committee, April 29, 2009,
http://www.abanet.org/health/04_government_sub/media/Transforming_the_Health_Care_Delivery_System.pdf (Accessed 05/24/10), p. 15.
711 “End Stage Renal Disease Drugs: Facility Acquisition Costs and Future Medicare Payment Concerns,” Statement by Daniel R. Levinson,
the HHS Office of Inspector General, September 2010, p. i-iv.
712 “Effects of Bundled Payment Policy Options” RAND, 2009, http://www.randcompare.org/analysis/mechanism/bundled_payment (Accessed
11/12/09).
713 “Reforming Medicare’s Physician Payment System” By Nancy H. Nielsen, Statement of the American Medical Association to the
Committee on Ways and Means, September 11, 2008, p. 6.
714 “Reforming Medicare’s Physician Payment System” By Nancy H. Nielsen, Statement of the American Medical Association to the
Committee on Ways and Means, September 11, 2008, p. 6.
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healthcare delivery and payment system.715 Finally, the Association of American Medical
Colleges, which supports the concept of care coordination provided through bundling, criticized
Medicare’s ACE program for not ensuring that payments are made directly to all parties (that is,
physicians) who provide the services.716
While many expressed their concerns, on August 23, 2011, pursuant to the ACA mandate, CMS
announced the Bundled Payments for Care Improvement Initiative (Bundled Payments
Initiative); which included four approaches to the payment model consisting of three
retrospective payment system models that set a target cost for an established episode of care and
one single prospective payment model for all services during a patient's single inpatient stay.717
The table below compares the specific features of the 4 models to each other.
Table 2-10: Key Features of Bundled Payment Models Compared718
Model 1

Model 2
Inpatient Stay plus PostDischarge Services

Model 3
Post-Discharge
Services Only

Physician group
practices; Acute care
hospitals paid under the
IPPS; Health systems

Physician group practices;
Acute care hospitals paid
under the IPPS; Health
systems

Physician-hospital
organizations; and
Conveners of
participating health care
providers

Physician-hospital
organizations; Post-acute
providers; and Conveners of
participating health care
providers

Physician group
practices; Acute
care hospitals paid
under the IPPS;
Health systems

Payment of Bundle
and Target Price

Discounted IPPS
payment; no separate
target price

Retrospective comparison of
target price and actual FFS
payment

Clinical Conditions
Targeted

All MS-DRGs

Applicants to propose based
on MS-DRG for inpatient
hospital stay

Model Feature

Inpatient Stay Only

Eligible Awardees

Long-term care
hospitals
Inpatient
rehabilitation
facilities; Skilled
nursing facilities
Home health
agency; Physicianowned hospital
organizations; and
Conveners of
participating
healthcare
providers
Retrospective
comparison of
target price and
actual FFS
payment
Applicants to
propose based on
MS-DRG for
inpatient hospital
stay

Model 4
Inpatient Stay Only

Physician group
practices; Acute care
hospitals paid under
the IPPS; Health
systems; Physicianhospital organizations;
and Conveners of
participating health
care providers

Prospectively set
payment

Applicants to propose
based on MS-DRG for
inpatient hospital stay

715 “Statement of the American Hospital Association to the Senate Finance Committee” American Hospital Association, Roundtable on Health
Care Delivery System Reform: Washington, DC, April 21, 2009.
716 “Transforming the Health Care Delivery System: Proposals to Improve Patient Care and Reduce Health Care Costs” By the Senate Finance
Committee, April 29, 2009, http://www.abanet.org/health/04_government_sub/media/Transforming_the_Health_Care_Delivery_
System.pdf (Accessed 5/24/10), p. 5.
717 “Bundled Payments for Care Improvement Initiative” Centers for Medicare & Medicaid Services, August 23, 2011,
http://www.innovations.cms.gov/areas-of-focus/patient-care-models/bundled-payments-for-care-improvement.html (Accessed 2/20/2015).
718 Ibid, p. 5-6.
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Model 1
Model Feature

Types of Services
Included in Bundle

Expected Discount
Provided to
Medicare

Payment from CMS
to Providers

Quality Measures

Inpatient Stay Only

Inpatient hospital
services

To be proposed by
applicant CMS requires
minimum discounts
increasing from 0% in
first 6 mos. to 2% in
Year 3
Acute care hospital:
IPPS payment less predetermined discount;
and, Physician:
Traditional fee schedule
payment (not included in
episode or subject to
discount)
All Hospital IQR
measures and additional
measures to be proposed
by applicants

Model 2
Inpatient Stay plus PostDischarge Services

Model 3
Post-Discharge
Services Only

Inpatient hospital and
physician services; Related
post-acute care services;
Related readmissions; and
Other services defined in the
bundle

Post-acute care
services
Related
readmissions; and
Other services
defined in the
bundle

Model 4
Inpatient Stay Only

Inpatient hospital and
physician services; and
Related admissions

To be proposed by applicant;
CMS requires minimum
discount of 3% for 30-89
days post-discharge episode;
2% for 90 days or longer
episode

To be proposed by
applicant

To be proposed by
applicant; subject to
minimum discount of
3%; larger discount for
MS-DRGs in ACE
Demonstration

Traditional fee-for-service
payment to all providers and
suppliers, subject to
reconciliation with
predetermined target price

Traditional fee-forservice payment to
all providers and
suppliers, subject
to reconciliation
with predetermined
target price

Prospectively
established and
bundled payment to
admitting hospital;
hospitals distribute
payments from
bundled payment

To be proposed by applicants, but CMS will ultimately establish a
standardized set of measures that will be aligned to the greatest extent
possible with measures in other CMS programs

All four of these models were designed to incentivize care coordination and the reduction of
costs while, at the same time, using a patient centered approach to provide the patient with high
quality care.

PAYOR MIX AND THE EFFECT ON THE REVENUE CYCLE
It is important to realize that a healthcare provider’s payor mix can have a profound impact on
their practice’s financial performance. Today, many providers are reimbursed for treating
patients through an array of payment sources using a variety of payment methods, FFS,
capitation, and self-pay, all of which can affect financial performance.719
When determining the appropriate payor mix to ensure financial viability, providers must be
aware that it is not uncommon for Medicare, Medicaid, and major health plans to reimburse at
levels that are less than the full or average cost of providing the services.720 In addition, providers
must take into account the discounts they offer on billed charges to health plans and the
uninsured, and they should consider the likelihood that they may not collect a large portion of the
charges billed to the uninsured patients they treat.721 Thus, to remain viable, a provider may need
to offset the losses incurred on these patients by increasing the prices charged to other patients,
specifically marketing their services to attract payors that traditionally reimburse at a more
719 “Basics of Financial Management for the Medical Practice” By Marcel Frenkel, Phoenix, MD: Greenbranch Publishing, 2003, p. 24.
720 “Essentials of Heath Care Finance” By William O. Cleverley and Andrew E. Cameron, 6th Edition, Sudbury, MA: Jones and Bartlett
Publishers, Inc., 2007, p. 106.
721 “Essentials of Heath Care Finance” By William O. Cleverley and Andrew E. Cameron, 6th Edition, Sudbury, MA: Jones and Bartlett
Publishers, Inc., 2007, p. 106.
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favorable level, or limiting the number of patients they will accept from lower reimbursing
payors.
In addition to having an appropriate payor mix, financial viability also may depend on a
provider’s mix of payment methods; having too many or too few of one type of method may
negatively affect a practice’s revenue. When providers are reimbursed on an FFS basis, practice
revenues increase as patient visits and the intensity of the services provided increase.722
However, under a capitation payment method a provider’s profits are higher if its patients
require minimal medical services and have few, if any, chronic conditions.723 The provider’s mix
of self-pay and uninsured patients and their effect on a provider’s practice is dependent on the
patients’ abilities to pay their bills and the effort expended by the practice to collect the
payments. If a majority of the self-pay and uninsured patients are affluent and have no trouble
paying their bills at the time of service, a provider’s revenue may increase, as they can avoid the
billing and collection process altogether. However, if these patients are not affluent or have
trouble paying their bills, it is likely that the practice’s revenue will decrease because it may now
have to make multiple attempts to receive payment through the billing and collection process or
write off the debt altogether. A provider’s awareness of his or her practice’s reimbursement mix
and its effect on financial performance may help ensure financial viability by providing useful
insight when considering new contracts, renegotiating existing contracts, or dropping less
lucrative contracts.724

EMERGING REIMBURSEMENT TRENDS
The ACA includes many provisions that aim to utilize financial incentives and policies to
address the triple aim of healthcare.725 Federal policy debates, e.g., disallowing tax rebates for
health plans bought on the federal health insurance exchange and the repeal of the SGR, also
have the potential to change the way reimbursement is provided and impacts provider
compensation. Many of these reimbursement initiatives share the common trend of shifting away
from traditional FFS models.

HEALTHCARE REFORM EFFORTS
Although healthcare reform has been a recurring policy theme throughout the past few decades,
reform efforts took center stage with the 2008 presidential election, the subsequent leadership
under the Obama administration, and the passage of the Affordable Care Act in 2010. Twentyfirst century reform efforts share many common themes, all aimed at combating the problems of
uninsured individuals and the rising cost of services.726

722
723
724
725

“Basics of Financial Management for the Medical Practice” By Marcel Frenkel, Phoenix, MD: Greenbranch Publishing, 2003, p. 24.
Ibid.
Ibid.
“The IHI Triple Aim” Institute for Healthcare Improvement, 2015, http://www.ihi.org/Engage/Initiatives/TripleAim/pages/default.aspx
(Accessed 2/25/15).
726 “Comparing the Three Main Health Reform Bills” By John Commins and Janice Simmons, Health Leaders Media, August 4, 2009,
http://www.healthleadersmedia.com/content/236931/topic/WS_HLM2_LED/Comparing-the-Three-Main-Health-Reform-Bills.html
(Accessed 8/06/09).
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Many common elements to the reform proposals exist. Among these elements are:
(1)
(2)
(3)

The creation of standardized health insurance benefits packages;
Reforms of state insurance markets for small and nongroup health insurance;
Limits on an insurer’s ability to charge higher premiums based on health status, gender,
and other factors;
(4) The elimination of insurance coverage denials due to pre-existing conditions;
(5) Prohibitions on cost sharing for preventative treatments;
(6) Credits to make premiums affordable;
(7) Limits on out-of-pocket expenses;
(8) Coverage of preventative services;
(9) The promotion of quality healthcare by the use of provider incentives;
(10) The elimination of lifetime and annual limits on dollar value for individual and group
policies; and
(11) Requirements that employers must either provide health insurance for their employees
or contribute to a fund on their behalf.727
A significant amount of reform rhetoric was defined by proposals of a public insurance option
and a healthcare exchange that would provide consumers with a choice between private
insurance and the government-run plan.728 Another plan proposed to include the possibility of
creating a nonprofit consumer owned and operated health insurance plan instead of a public
option.729 While both the public option and the nonprofit consumer owned health insurance
organization did not make the final draft of the legislation in 2010, the Affordable Care Act did
include provisions to penalize individuals who fail to obtain health insurance coverage and to
provide subsidies for the purchase of health insurance with tax credits.730 Additionally, the
Affordable Care Act also utilized cost controlling mechanisms including ACOs, bundling
provider payments for acute and post-acute care, and establishing mechanisms to simplify
paperwork.731

MOVE FROM FEE FOR SERVICE
The current trend toward value based reimbursement, discussed in the Value Based Purchasing
Programs section above, and pay for performance measures, discussed in the Increased Emphasis
on Quality: Pay-for-Performance (P4P) section below, are not new developments. Originally
viewed as a cost saving alternative to FFS arrangements, many capitation contracts actually have
been replaced by FFS arrangements because the risk can be difficult for physicians to manage

727 Ibid.
728 Ibid.
729 “Side-by-Side Analysis of Key Provisions of the Senate HELP Bill, H.R. 3200, and the Senate Finance Draft Proposal” Rand Corporation,
randcompare.org, July 17, 2009, http://www.randcompare.org/downloads/hot/07/SidebySide_071709.pdf (Accessed 8/6/09).
730 “America’s Affordable Health Choices Act: Quality Affordable Health Care” House Committees on Ways and Means, Energy and
Commerce, and Education and Labor, July 14, 2009, http://edlabor.house.gov/documents/111/pdf/publications/AAHCA-BILLSUMMARY071409.pdf (Accessed 8/06/09); “Comparing the Three Main Health Reform Bills” By John Commins and Janice Simmons, Health Leaders
Media, August 04, 2009, http://www.healthleadersmedia.com/content/236931/topic/WS_HLM2_LED/Comparing-the-Three-Main-HealthReform-Bills.html (Accessed 8/06/09); “Side-by-Side Analysis of Key Provisions of the Senate HELP Bill, H.R. 3200, and the Senate
Finance Draft Proposal” By Rand Corporation, randcompare.org, July 17, 2009, http://www.randcompare.org/downloads/hot/07/
SidebySide_071709.pdf (Accessed 8/6/09).
731 “Patient Protection and Affordable Care Act: Pub. L. No 111-148, §§ 1561, 3022, 3023, 124 Stat. 119, 262, 395, 399 (March 23, 2010).
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without the requisite economic and actuarial skills.732 A study released by the Center for
Studying Health System Change, shows that the shift from FFS remuneration toward capitation
as a method of physician reimbursement has waned from the mid-1990s.733 According to the
data, the number of physicians accepting capitated payments fell 9.5 percent, from 54.2 percent
in 1996-97, to 44.7 percent in 2004-05.734
However, in 2008, the pendulum began to swing back to greater utilization of capitation. The
resurgence was led, at least in part, by BCBS of Massachusetts and its Alternative Quality
Contract (AQC).735 Unlike previous generation capitation plans designed by insurance
companies to place the risk on providers while offering little or no rewards for improved quality
of care, the AQC offered providers the opportunity to earn substantial rewards for quality.736 The
new contract reimbursed providers on a per-member-per-month basis, with increases yearly for
inflation, combined with incentive payments for meeting national standards in quality,
effectiveness, and patient experience.737
In addition, in 2008 the Massachusetts state legislature established the Special Commission on
the Health Care Payment System to recommend improvements to the state’s current payment
system that would “motivate and reward effective, efficient, and patient centered care.”738 The
commission concluded that the state should transition to a global payment model used by all
payors, including the state and federal government, within five years.739 The commission
recommended that the payment model include, in addition to other features, accountable care
organizations (ACOs),740 consisting of hospitals, physicians or other clinicians, and nonclinicians, to manage and coordinate care to meet patient needs, patient-centered care, pay-forperformance (P4P) incentives, and financial risk sharing among ACOs and carriers.741
As a result of the ACA, many of the reimbursement models that shift risk to the providers in
exchange for potential financial gains may be gaining traction, such as accountable care
organizations (ACOs);742 bundled payments;743 and, value based reimbursement agreements.744
Some commentators have suggested that the most recent trend toward reimbursement contracts

732 “Can the Massachusetts Blues Revive Capitation? New Twist Includes Quality Bonus” By Emily Berry, American Medical News, February
11, 2008, http://www.ama-assn.org/amednews/2008/02/11/bil10211.htm (Accessed 08/04/09).
733 “CTSonline Physician Survey Results” Center for Studying Health System Change, 2009, http://ctsonline.s-3.com/displaytable.asp?
xtopic=18!4&xrow=4&xYrSel=&xpcp=&xother= (Accessed 08/09/09).
734 Ibid.
735 “Can the Massachusetts Blues Revive Capitation? New Twist Includes Quality Bonus” By Emily Berry, American Medical News, February
11, 2008, http://www.ama-assn.org/amednews/2008/02/11/bil10211.htm (Accessed 08/04/09).
736 Ibid.
737 “Alternative Quality Contract” BlueCross BlueShield Massachusetts, 2009, http://www.qualityaffordability.com/solutions/alternativequality-contract.html (Accessed 08/04/09).
738 “Recommendations of the Special Commission on the Health Care Payment System” By Leslie A. Kirwan and Sarah Iselin, Division of
Health Care Finance and Policy, July 16, 2009, http://www.mass.gov/Eeohhs2/docs/dhcfp/pc/Final_Report/Final_Report.pdf (Accessed
8/4/09), p. 5.
739 Ibid, p. 10.
740 “Can Accountable Care Organizations Improve the Value of Health Care by Solving the Cost and Quality Quandaries?” by Kelly Devers
and Robert Berenson, Robert Wood Johnson Foundation, Urban Institute, October 2009, http://www.rwjf.org/files/research/
acosummaryfinal.pdf (Accessed 1/19/2012), p. 1.
741 “Can Accountable Care Organizations Improve the Value of Health Care by Solving the Cost and Quality Quandaries?” by Kelly Devers
and Robert Berenson, Robert Wood Johnson Foundation, Urban Institute, October 2009, http://www.rwjf.org/files/research/
acosummaryfinal.pdf (Accessed 1/19/12), p. 1.
742 Discussed in the Medicare Shared Savings Program section and the Commercial ACOs section above.
743 Discussed in the Payment Bundling section above.
744 Discussed in the Value Based Purchasing Programs section above.

176

Chapter 2: Reimbursement Environment

which more appropriately shift risk to providers, may persist, in contrast to the failures of many
capitation plans in the past.745

INCREASED EMPHASIS ON QUALITY: PAY-FOR-PERFORMANCE
(P4P)
In the wake of an ongoing national controversy with several recent studies finding that medical
errors are a leading cause of death in the United States, demands have been waged by both
private and public payors regarding the accountability of providers. After a 1999 study from the
Institute of Medicine reported that as many as 44,000 – 98,000 deaths annually may be linked
directly to medical errors, increased focus has been placed on paying physicians based on the
quality of their services, as a way of improving quality and lowering costs.746 However, since
there has never been an actual count of how many patients experience preventable harm, there is
no way to know for sure whether or not the 98,000 number is accurate or not. More recent
studies have claimed that the deaths linked to medical errors ranges between 210,000 and
440,000 patients annually.747
A 1999 study from the Institute of Medicine (IOM) reported that as many as 44,000–98,000 deaths annually
may be linked directly to medical errors. More recent studies suggest this number is much closer to 210,000
and 440,000 patients annually.
Linda T. Kohn, Janet M. Corrigan and Molla S. Donaldson, 2000; John T. James, September 2013.

Pay-for-performance (P4P) is a remuneration system in which part of the payment is dependent
on performance as measured against a defined set of criteria.748 Although a P4P system can be
structured in several ways, the common elements to all systems are (1) a set of targets or
objectives that define what will be evaluated; (2) measures and performance standards for
establishing the target criteria; and (3) rewards, typically financial incentives, that are at risk,
including the amount and the method for allocating the payments among those who meet or
exceed the reward threshold.749 Proponents of P4P remuneration systems argue that they have
the potential to improve the quality of care and slow the growth in healthcare costs through
improvements in quality and provider efficiency.750

745 “The Return of Capitation: Preparing for Population-Based Health Care” By Jonathan W. Pearce, Healthcare Financial Management
Association, July 2, 2012, http://www.hfma.org/Content.aspx?id=3234 (Accessed 3/3/2015).
746 “Pay-for-Performance in Health Care” By Jim Hahn, CRS Report for Congress, Washington, DC: Congressional Research Service,
November 2, 2006, p. CRS-1; “To Err is Human: Building a Safer Health System” By Linda T. Kohn, Janet M. Corrigan and Molla S.
Donaldson, Washington, DC: National Academy Press, 2003, p. 26.
747 “A New, Evidence-Based Estimate of Patient Harms Associated with Hospital Care” By John T. James, Journal of Patient Safety, Vol. 9,
No. 3 (September 2013) p. 122-128.
748 “Pay-for-Performance: New payment systems reward doctors and hospitals for improving the quality of care, but studies to date show
mixed results” Robert Wood Johnson Foundation, Health Affairs, Health Policy Brief, October 11, 2012, http://healthaffairs.org/
healthpolicybriefs/brief_pdfs/healthpolicybrief_78.pdf (Accessed 3/3/2015), p. 1.
749 “Pay-for-Performance in Health Care” By Jim Hahn, CRS Report for Congress, Washington, DC: Congressional Research Service,
November 2, 2006, p. CRS-4.
750 Ibid., p. CRS-1, 13.
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P4P’s Impact on Provider Revenue
The impact of P4P on quality outcomes has been measured in multiple studies but has had
varying results. While some studies have demonstrated that P4P reduced costs and improved
quality, other studies have had different results and conclusions.
Some studies have indicated that P4P has had a significant impact on controlling hospital costs.
A 2008 report of a study conducted by CMS and Premier, Inc., measured cost and quality
improvements among P4P providers for five different patient populations and determined that
the median hospital cost per patient declined over $1,000.751 The study concluded that “if all
hospitals nationally were to achieve the three-year cost and mortality improvements found
among the [study] project participants for [the five different patient populations], they could save
an estimated 70,000 lives per year and reduce hospital costs by more than $4.5 billion
annually.”752 However, this study did not compare any findings to a control group of hospitals
not utilizing the P4P guidelines, which limited its ability to assess any trends for casual
conclusions.753 A review of the literature on P4P programs determined that “…P4P has the
potential to be cost-effective, but that convincing evidence is lacking.”754
Contrary to the CMS and Premier study above, multiple other studies have found that P4P has
no significant or very minimal impact on improving revenue. Specifically, a 2009 report
documented a study that reviewed CMS records in a hospital demonstration project to assess
whether P4P had a significant impact on cost changes from the Medicare perspective. While it
found that there was no evidence to show that P4P had a significant effect, the study did not
include all payments associated with hospitalization, but instead only examined inpatient costs
on a few conditions for the first 60 days after hospitalization.755 Notably, in a more recent study
published in 2012, investigators were able to demonstrate that P4P had only a minimal impact on
hospital financials and payments to providers.756 Additionally, another 2012 study released
through the Harvard School of Public Health found that there was little evidence to show that
participation in P4P has meaningfully improved patient outcomes and could not demonstrate any
significant difference in the mortality trends of those conditions with outcomes linked to
payment incentives and those conditions without outcomes linked to payment incentives.757
Efficacy and revenue are not the only concern providers have when it comes to transitioning
between a FFS and P4P payment system. Specifically, providers are worried that the transition
could have a profound impact on their practice's incurred costs. Providers may have to undertake
the time consuming process of hand collecting and reviewing the data needed to satisfy reporting
751 “Hospital Quality Improving, Cost, Mortality Rate Trends Declining for Participants in Medicare Pay-For-Performance Project” Premier
Inc., Press Release (January 31, 2008), http://premierinc.com/about/news/08-jan/performance-pays-2.jsp (Accessed 04/25/08).
752 Ibid.
753 “The Impact of Hospital pay-for-Performance on Hospital and Medicare Costs” By Gregory B. Kruse, Daniel Polsky, et al., HSR: Health
Services Research, Vol. 47, No. 6 (December 2012), p. 2120.
754 “Effects of pay for performance in health care: A systematic review of systematic reviews” by Frank Eijkenaar et al., Health Policy, Vol.
110 (January 2013), p. 115-130.
755 “Effects of the Premier Hospital Quality Incentive Demonstration on Medicare Patient Mortality Cost” By A. M. Ryan, HSR: Health
Services Research, Vol. 44, No. 3 (2009), p. 821-42.
756 “The Impact of Hospital pay-for-Performance on Hospital and Medicare Costs” By Gregory B. Kruse, Daniel Polsky, Elizabeth A. Stuart,
and Rachel M. Werner,, HSR: Health Services Research, Vol. 47, No. 6 (December 2012), p. 2120.
757 “The Long-Term Effect of Premier Pay for Performance on Patient Outcomes” By K. Jha Ashish, et al., New England Journal of Medicine
(March 28, 2012), p. 9.
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requirements or make a significant capital investment in an electronic health records system.758
Regardless of the collection method used, the bonuses for achieving the requisite reporting
standards may not be sufficient to offset the costs associated with the data collection process.759
In addition, providers who practice in low-income minority communities may see their revenue
fall, as it is likely that these providers will miss out on incentive pay because of lower quality
scores due to their treating patients who may be less likely to obtain preventative care, follow
treatment recommendations, and return for further investigation into abnormal test results than
their wealthier counterparts.760
While some have used these studies and the rapid rise of healthcare costs to conclude that no
impact on hospital financials suggests hospital quality-improvement investment decisions are
paying off and that they are not negatively impacting costs and margins,761 other providers are
worried that the transition from a FFS payment system to a P4P model could have a profound
impact on practice revenue. While these varying study results have not helped the efficacy
concerns with P4P initiatives, the final assessment and widespread acceptance of the P4P model
are still unknown.

INCREASED REIMBURSEMENT TO ENCOURAGE IMPLEMENTATION
OF ELECTRONIC HEALTH RECORDS (EHR) THROUGH
MEANINGFUL USE
With the passage of the American Recovery and Reinvestment Act of 2009 (ARRA), the
government adopted, as part of the overarching economic stimulus package, a stimulus plan to
promote the universal implementation of electronic health records (EHR).762 Through the Health
Information Technology for Economic and Clinical Health (HITECH) Act, incorporated into the
ARRA, providers are incentivized with increased reimbursement rates to implement EHR
systems.763 As part of this process, the HITECH Act officially established the Office of the
National Coordinator for Health Information Technology (ONCHIT) and Health Information
Technology (HIT) Policy and Standards Committees to recommend, develop, and promote a
national HIT infrastructure.764
In particular, the HITECH Act permitted the secretary of HHS to appropriate funds each year,
beginning 2009 through 2013, to promote the implementation of EHR.765 Under the act,
nonhospital-based physicians will receive financial incentives or penalties through Medicare and
Medicaid for use or nonuse of EHRs. Originally, if a provider began the program in 2011, the
758 “Paying for Performance-Risks and Recommendations” By Elliot S. Fisher, The New England Journal of Medicine, Vol. 355, No. 18
(November 2, 2006), p. 1846.
759 Ibid.
760 “Will Pay-For-Performance And Quality Reporting Affect Health Care Disparities?” By Lawrence P. Casalino and Arthur Elster, Health
Affairs 26, No. 3 (April 2007), http://content.healthaffairs.org/cgi/content/abstract/hlthaff.26.3.w405 (Accessed 5/25/10), p. 406-407.
761 “The Impact of Hospital pay-for-Performance on Hospital and Medicare Costs” By Gregory B. Kruse, Daniel Polsky, et al., HSR: Health
Services Research, Vol. 47, No. 6 (December 2012), p. 2132.
762 “American Recovery and Reinvestment Act of 2009” Pub. L. No. 111-5, § 4101, 123 Stat. 115, 467 (February 17, 2009).
763 “American Recovery and Reinvestment Act of 2009” Pub. L. No. 111-5, § 13001, 123 Stat. 115, 226 (February 17, 2009).
764 “Health Information Technology for Economic and Clinical Health Act or HITECH Act” Committee on Ways and Means, January 16,
2009, http://waysandmeans.house.gov/media/pdf/110/hit2.pdf (Accessed 6/17/09); “Health Information Technology for Economic and
Clinical Health Act or HITECH Act” Committee on Ways and Means, January 16, 2009, http://waysandmeans.house.gov/media/pdf
/110/hit2.pdf (Accessed 6/17/09).
765 “American Recovery and Reinvestment Act of 2009” Pub. L. No. 111-5, § 3018, 123 Stat. 115, 258 (February 17, 2009).
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provider would be eligible to receive incentive payments up to a maximum of $44,000 under
Medicare over a five-year period, if meaningful use of an EHR system begins by 2012.766
However, the Medicare amounts were adjusted by 2% in 2013 due to the sequestration order.767
As a result, total payments under Medicare equaled $43,720 for having begun in 2011, $43,480
for having begun in 2012, $38,220 for having begun in 2013, and $23,520 for having begun in
2014.768 In 2015, if practitioners do not adopt meaningful EHR use, they will receive a
percentage reduction in their MPFS payment that increases yearly until 2019.769 The table below
displays the possible penalties and incentives for a provider under Medicare's meaningful use
EHR program.
Table 2-11: Meaningful Use EHR Incentive Payments and Payment Reductions Under
Medicare770
Year

Maximum
Incentive Payment
for Provider Using
Meaningful Use
EHR if Program
Began in 2011

Maximum Incentive
Payment for Provider
Using Meaningful
Use EHR if Program
Began in 2012

Maximum Incentive
Payment for
Provider Using
Meaningful Use
EHR if Program
Began in 2013

Maximum Incentive
Payment for
Provider Using
Meaningful Use
EHR if Program
Began in 2014

Total MPFS
Payment
Reduction for Not
Using Meaningful
Use EHR

2011
2012
2013
2014
2015
2016
2017
Beyond 2017

$18,000
$12,000
$7,840
$3,920
$1,960
$0
$0
$0

$0
$18,000
$11,760
$7,840
$3,920
$1,960
$0
$0

$0
$0
$14,700
$11,760
$7,840
$3,920
$0
$0

$0
$0
$0
$11,760
$7,840
$3,920
$0
$0

0%
0%
0%
0%
1%
2%
3%
3% - 5%

Those who qualify for Medicaid payments are eligible for up to 6 years of payments, totaling
$63,750, and may begin participation as late as 2016.771 Additionally, those who are only eligible
for the Medicaid program are not subject to payment adjustments resulting from the sequester
order. If a provider qualifies for meaningful use reimbursement under both EHR incentive
programs, the provider must choose to participate in one or the other, as they are not allowed to
participate in both.772 Additionally, hospitals will receive millions of dollars in increased
reimbursement under Medicare and Medicaid for successfully implementing HIT and certified
EHR systems.773 Rural health clinics, federally qualified health centers, and other providers other

766 “Incentives and Beyond: Maximizing the Opportunities from Moving to Meaningful Use of HER” PNC, PNC Healthcare Whitepapers,
https://content.pncmc.com/live/pnc/microsite/CFO/pdf/pnc_healthcare_whitepaper.pdf (Accessed 2/15/15); “American Recovery and
Reinvestment Act of 2009” Pub. L. No. 111-5, § 4101(a), 123 Stat. 115, 467 (February 17, 2009).
767 “Medicare & Medicaid EHR Incentive Program Basics” by Centers for Medicare & Medicaid Services, 2015, http://www.cms.gov/
Regulations-and- Guidance/Legislation/EHRIncentivePrograms/Basics.html (Accessed 2/15/15).
768 Ibid.
769 “Incentives and Beyond: Maximizing the Opportunities from Moving to Meaningful Use of HER” PNC, PNC Healthcare Whitepapers,
https://content.pncmc.com/live/pnc/microsite/CFO/pdf/pnc_healthcare_whitepaper.pdf (Accessed 2/15/15).
770 “Medicare & Medicaid EHR Incentive Program Basics” Centers for Medicare & Medicaid Services, 2015,
http://www.cms.gov/Regulations-and- Guidance/Legislation/EHRIncentivePrograms/Basics.html (Accessed 2/25/2015), p.1; “Incentives
and Beyond: Maximizing the Opportunities from Moving to Meaningful Use of EHR” PNC Healthcare Whitepapers,
https://content.pncmc.com/live/pnc/microsite/CFO/pdf/pnc_healthcare_whitepaper.pdf (Accessed 2/25/2015), p. 3.
771 “Medicare & Medicaid EHR Incentive Program Basics” Centers for Medicare & Medicaid Services, 2015, http://www.cms.gov/
Regulations-and- Guidance/Legislation/EHRIncentivePrograms/Basics.html (Accessed 2/25/15).
772 “Medicare & Medicaid EHR Incentive Program Basics” Centers for Medicare & Medicaid Services, 2015, http://www.cms.gov/
Regulations-and- Guidance/Legislation/EHRIncentivePrograms/Basics.html (Accessed 2/25/15).
773 “Health Information Technology for Economic and Clinical Health Act or HITECH Act” Committee on Ways and Means, January 16,
2009, http://waysandmeans.house.gov/media/pdf/110/hit2.pdf (Accessed 6/17/09).
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than physicians and hospitals will be eligible for increased incentive funding under Medicaid or
through grants offered for the implementation of EHR systems.774
Although the term “meaningful use” has yet to be defined, the ARRA specified three specific
components that make up the context of meaningful use, including the use of a certified EHR in a
meaningful manner, the electronic exchange of health information to improve quality of care,
and the use of certified EHR technology to submit clinical quality and other measure.775
HITECH's incentive program, which aims to gain meaningful and effective use from EHR
systems, focuses on five specific goals including:
(1)
(2)
(3)
(4)
(5)

Improving the quality, safety, and efficiency of care while reducing disparities;
Engaging patients and families in their care;
Promoting public and population health;
Improving care coordination; and
Promoting the privacy and security of patient information.776

In order to demonstrate meaningful use, a system must include a function for electronic
prescribing, information exchanges between systems, qualitative reporting methods, and
additional coding of the use of and the ability to complete survey responses in the system.777
Initially, CMS and the Office of the National Coordinator of Health Information Technology
(ONC) published Stage 1 of the meaningful use requirement, consisting of two complimentary
rules that enumerated: (1) the criteria for eligible hospitals and providers to meaningfully use
health information technology778 and (2) the certification criteria and standards for EHR
technology.779 In order to meet Stage 1 meaningful use standards, providers must meet at least 18
of 22 objectives, which include: (1) using e-prescriptions; (2) demographics record keeping; and
(3) providing patients with an electronic copy of their health information.780 On September 4,
2012, CMS released the Final Rule for Stage 2 of the meaningful use requirement of the
Medicare and Medicaid EHR Incentive Program,781 which stated that in order to continue
receiving EMR incentive payments, providers who have met Stage 1 standards for two years
must meet new Stage 2 standards in their third year.782 These providers must meet a total of
20 Stage 2 objectives, which include similar objectives as Stage 1, but at increasingly difficult
levels of compliance.783 Preliminary requirements for Stage 3 meaningful use objectives were
774 Ibid.
775 “What is Meaningful Use?” Health Resources and Services Administration, U.S. Department of Health and Human Services, 2015,
http://www.hrsa.gov/healthit/meaningfuluse/stage1clinicalquality/whatis.html (Accessed 2/25/15).
776 Ibid.
777 “American Recovery and Reinvestment Act of 2009” Pub. L. No. 111-5 (February 17, 2009), Section 4101(a)(2).
778 “Fact Sheets: CMS and ONC Final Regulations Define Meaningful Use and Set Standards for Electronic Health Record Incentive Program”
Centers for Medicare & Medicaid Services, July 13, 2010, http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-Sheets/2010-FactSheets-Items/2010-07-13.html (Accessed 2/26/15).
779 “Establishment of the Temporary Certification Program for Health Information Technology” Federal Register Vol. 75, No. 121 (July 24,
2010), p. 36158.
780 “Eligible Professional Meaningful Use Table of Contents Core and Menu Set Objectives” EHR Incentive Program, http://www.cms.gov/
Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/EP-MU-TOC.pdf (Accessed 4/25/14); “Meaningful Use”
Centers for Medicare & Medicaid Services, 4/15/2014, http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentive
Programs/Meaningful_Use.html (Accessed 4/25/14).
781 “Medicare and Medicaid Programs; Electronic Health Record Incentive Program-Stage 2” Federal Register, Vol. 77, No. 171 (September 4,
2012), p. 53968.
782 “Stage 2,” Centers for Medicare & Medicaid Services, 4/11/2014, http://www.cms.gov/Regulations-and-Guidance/Legislation/
EHRIncentivePrograms/Stage_2.html (Accessed 4/25/14).
783 “Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals,” EHR Incentive Program, August 2012, https://www.cms.gov/
Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/stage1vsStage2CompTablesforEP.pdf (Accessed 4/25/14).
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later issued on March 11, 2014, the majority of which consisted of updates to the Stage 2
objectives.784
While HIT may enhance patient care and make the healthcare delivery system more efficient,
there is a high cost associated with the technology necessary to meet these goals. As a result,
reimbursement programs are considered necessary to help offset the expense of transitioning to
new technology. Overall, a total of roughly $1.5 billion will go toward federal grants for the
implementation of EHR systems and capital improvements of EHR systems.785

REIMBURSEMENT OF AESTHETIC AND RECONSTRUCTIVE
PROCEDURES
As technological advances in recent years have increased the accessibility of plastic surgery, the
number of many procedures has increased despite downswings in the economy. In 2013, there
were 20.8 million plastic surgery procedures performed in the United States, up roughly 3
percent from the previous year.786 Of these, 15.1 million were cosmetic procedures, divided
between surgical (1.6 million) and minimally-invasive (13.4 million), while 5.7 million were
reconstructive procedures.787
Despite this increased prevalence, however, reimbursement for elective cosmetic procedures has
remained minimal. In the field of plastic surgery, the two types of procedures are treated
differently by payors. Aesthetic, or cosmetic, procedures typically are performed at the election
of the patient to reshape a normal part of the body to the patient’s satisfaction and, since they
normally are elective surgeries, they are not generally covered by health insurance plans.788 By
contrast, reconstructive procedures are necessary for the correction of physical disfigurement or
function or to restore a normal appearance following trauma or disease.789 Examples include skin
grafts and the rebuilding of bones for burn and accident victims.790 These procedures generally
are covered by most health insurance policies, though specific coverage may vary by procedure,
as well as the degree to which the procedures are covered.791
When procedures that typically are classified as cosmetic are medically necessary to correct a
problem or relieve symptoms, insurance carriers may treat that procedure as reconstructive and

784 “Preliminary Stage 3 Meaningful Use Recommendations Released” By Chris Dimick, Journal of American Health Information
Management Association, March 11, 2014, http://journal.ahima.org/2014/03/11/preliminary-stage-3-meaningful-use-recommendationsreleased/ (Accessed 12/8/14).
785 “Health Information Technology for Economic and Clinical Health Act or HITECH Act” Committee on Ways and Means, January 16,
2009, http://waysandmeans.house.gov/media/pdf/110/hit2.pdf (Accessed 6/17/09).
786 “2013 Plastic Surgery Statistics Report” The American Society of Plastic Surgeons, 2014, http://www.plasticsurgery.org/Documents/newsresources/statistics/2013-statistics/plastic-surgery-statistics-full-report-2013.pdf (Accessed 2/20/15), p. 5.
787 Ibid.
788 “Insurance Coverage: A Patient’s Guide: Staying Informed About Your Healthcare Costs” American Society of Plastic Surgeons, 2009,
http://www.plasticsurgery.org/Patients_and_Consumers/Planning_Your_Surgery/Insurance_Coverage_A_Patients_Guide.html (Accessed
9/28/09).
789 Ibid.
790 “Cosmetic and Reconstructive Surgery Procedures” Priority Health, September 1, 2007, http://www.priorityhealth.com/
provider/manual/policies/91535.pdf (Accessed 10/05/09).
791 “Insurance Coverage: A Patient’s Guide: Staying Informed About Your Healthcare Costs” American Society of Plastic Surgeons, 2009,
http://www.plasticsurgery.org/Patients_and_Consumers/Planning_Your_Surgery/Insurance_Coverage_A_Patients_Guide.html (Accessed
9/28/09).
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cover part or all of the cost of the surgery.792An example of this is a nasal surgery called
rhinoplasty. Typically, nasal surgeries are cosmetic however, a rhinoplasty can be a
reconstructive surgical procedure that changes the shape of the nose to correct a broad range of
nasal defects and return an abnormal or damaged nasal structure to a more normal state.793 In
such cases, the payor will generally require verification of the true reason for the surgery (that is,
whether it was truly reconstructive or merely cosmetic), as well as require that the physician
obtain prior approval and then supply post-procedure documentation from which the payor can
determine how much it will reimburse.794
Like most private payors, Medicare and Medicaid do not cover cosmetic procedures that are not
medically necessary.795

CONCIERGE MEDICINE
Recent years have seen the emergence of the practice of concierge, or boutique, medicine. In
terms of reimbursement, it is important to understand that boutique medicine is not a substitution
for traditional insurance. Patients will typically keep their traditional health insurance to pay for
any tests or scans ordered by their physician. Medicare beneficiaries cannot be charged more
than 115 percent of the rate for services, and many politicians have said that the annual fees
patients pay is a lot more than the Medicare rate and, thus, is illegal billing.796

MEDICAL HOME MODEL
The term “medical home” was coined in 1967 and originally was used by the American
Academy of Pediatrics “to describe a single source of medical information about a patient.”797
The term evolved overtime and is now used to describe a patient centered model of healthcare
delivery and payment reform, which focuses on improving the quality of care and reducing costs
through its emphasis on the role of primary care.798

792 Ibid.
793 “ASPS Recommended Insurance Coverage Criteria for Third Party Payers: Nasal Surgery” American Society of Plastic Surgeons,
http://www.plasticsurgery.org/Documents/medical-professionals/health-policy/insurance/Nasal-Surgery-Insurance-Coverage.pdf (Accessed
2/20/2015), p. 1.
794 “Insurance Coverage: A Patient’s Guide” American Society of Plastic Surgeons, http://www.plasticsurgery.org/Patients_and_Consumers/
Planning_Your_Surgery/Insurance_Coverage_A_Patients_Guide.html (Accessed 10/05/09).
795 “Medicare and You 2009” Centers for Medicare & Medicaid Services, 2009, http://www.medicare.gov/Publications/Pubs/pdf/10050.pdf
(Accessed 10/05/09).; “Reconstructive and Cosmetic Surgery Clinical Coverage Policy No.: 1-O-1,” Division of Medical Assistance, North
Carolina Department of Health and Human Services, January. 1, 1985, http://www.ncdhhs.gov/dma/mp/1-O-1.pdf (Accessed 10/5/09).
796 “Paying a Visit to the Doctor: Current Financial Protections for Medicare Patients When Receiving Physician Services” By Cristina
Boccuti, The Henry J. Kaiser Family Foundation, Issue Brief, April 2014, https://kaiserfamilyfoundation.files.wordpress.com/
2014/04/8573-paying-to-see-your-doctor.pdf (Accessed 2/6/15).
797 “The Patient Centered Medical Home: History, Seven Core Features, Evidence and Transformational Change” By Robert Graham Center,
Center for Policy Studies in Family Medicine and Primary Care, adfammed.org, November 2007, http://www.adfammed.org/
documents/grahamcentermedicalhome.pdf (Accessed 8/10/09).
798 “Measuring The Medical Home Infrastructure In Large Medical Groups” By Diane R. Rittenhouse et al., Health Affairs, Vol. 27, No. 5
(September/October 2008), p. 1246-1247; “Medical Home Models: Improving Care and Reducing Costs in Healthcare” By Laura M.
Greene, Healthcare Intelligence Network, May 2009, www.hin.com/cgi-local/link/news/pl.cgi?pcmh09 (Accessed 5/24/10).
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The medical home is comprised of seven components:
(1) A personal physician who provides a patient with ongoing, comprehensive care;
(2) Physician-directed medical practices in which the physician and his or her team
members assume responsibility for the ongoing care of their patients;
(3) Whole person orientation which tasks the physician with the responsibility to ensure
that the patient receives all necessary care, including care provided by other qualified
healthcare professionals;
(4) Coordinated or integrated care calls for the use of information technology, registries,
and health information exchanges to coordinate and integrate patient care within the
community;
(5) Quality and safety improvements through the use of a variety of quality improvement
activities, feedback, and evidence based decision support systems;
(6) Improved access is sought through the timely access to care and improved
communication with patients; and
(7) Payment methods that reimburse physicians for direct patient interaction, coordinating
patient care, adopting information technology for quality improvement, and achieving
quality improvement goals, which allows physicians to share in the savings attributed to
reduced hospitalizations.799
In addition to being endorsed by various medical associations, the medical home model has
gained the attention of the federal government. Notably, the Tax Relief and Health Care Act of
2006 mandated a Medicare medical home demonstration project to measure the effectiveness of
the model.800 The two-year project was designed to examine the efficacy of “targeted, accessible,
continuous, and coordinated care to Medicare beneficiaries with chronic or prolonged illnesses,"
which requires "regular medical monitoring, advising, or treatment.”801 While this demonstration
was planned to run between 2010 and 2012, it never came to life after being delayed by the
Medicare Improvements for Patients and Providers Act of 2008,802 and eventually replaced by
the Centers for Medicare and Medicaid Innovation Center that was established by the ACA.803
The Center for Medicare and Medicaid Innovation (CMMI) tests payment and service delivery
models to determine their effect on program expenditures and the quality of care received. The
CMMI is currently running two studies, the Federally Qualified Health Center Advanced
Primary Care Practice Demonstration and the Multi-Payer Advanced Primary Care Practice

799 “Measuring The Medical Home Infrastructure In Large Medical Groups” By Diane R. Rittenhouse et al., Health Affairs, Vol. 27, No. 5
(September/October 2008), p. 1247.
800 “Medicare Demonstrations: Details for Medicare Medical Home Demonstration” Centers For Medicare & Medicaid Services, March 31,
2009, http://www.cms.hhs.gov/demoprojectsevalrpts/md/itemdetail.asp?filterType=none&filterByDID=0&sortByDID=2&
sortOrder=ascending&itemID=CMS1199247&intNumPerPage=10 (Accessed 8/10/09); “The Patient Centered Medical Home: History,
Seven Core Features, Evidence and Transformational Change” By Robert Graham Center, Center for Policy Studies in Family Medicine
and Primary Care, adfammed.org, November 2007, http://www.adfammed.org/documents/grahamcentermedicalhome.pdf (Accessed
8/10/09).
801 “Fact Sheet: Medical Home Demonstration Fact Sheet” Centers For Medicare & Medicaid Services, January 09, 2009,
http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/MedHome_FactSheet.pdf (Accessed 8/10/09); “Medicare Demonstrations:
Details for Medicare Medical Home Demonstration” Centers For Medicare & Medicaid Services, March 31, 2009,
http://www.cms.hhs.gov/demoprojectsevalrpts/md/itemdetail.asp?filterType=none&filterByDID=0&sortByDID=2&sortOrder=ascending&i
temID=CMS1199247&intNumPerPage=10 (Accessed 8/10/09).
802 “Medicare Improvements for Patients and Providers Act of 2008” Pub. L. 110-275, § 133(a)(2), 122 Stat. 2494, 2531 (July 15, 2008).
803 “Center for Medicare and Medicaid Innovation” 42 U.S.C. § 1315a (2010).
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Demonstration, both of which encompass the main points of the original medical home model
demonstration.804
Specifically, the Multi-Payer Advanced Primary Care Practice Demonstration is centered on the
patient-centered medical home model developed in the 1967 as a means of achieving efficient
management and delivery of quality healthcare services through prevention, health information
technology, care coordination, and shared decision making among patients and providers.805 The
project pays a monthly care management fee for patients receiving care from advanced primary
care practices, and the fee covers care coordination, patient education, and other services to
support chronically ill patients.806 The demonstration will allow CMS to evaluate whether
advanced primary care practice will reduce medical expenditures, improve the safety of
healthcare, and increase the availability of care in underserved areas.807
The Federally Qualified Health Center Advanced Primary Care Practice Demonstration was
designed to operate for three years, from November 1, 2011 to October 31, 2014, to determine
the impact of providing financial and technical resources to help federally qualified health
centers make the transition to a patient-centered medical home or advanced primary care
practice. It is hoped that through this demonstration, CMS will be able to determine what factors
and resources are required for this transition across the country in order to meet its ultimate goal
of providing better healthcare for the population at a lower cost.808
Regardless of the type of the organization formed, whether it is an ACO or medical home (as
described above) all models will likely rely on a clinically integrated network to provide care.
These clinically integrated networks consist of independent or employed physicians that share
information and work together to provide increased value to patients through improved patient
care and reduced costs.809 These networks generally implement “…evidence-based medicine and
align incentives between [their] providers and insurance payers.”810 On February 13, 2013, the
FTC released its first approval of a clinically integrated network, with its advisory opinion
regarding the Norman Physician Hospital Organization (Norman PHO), a network of 280
physicians and the Norman Regional Health System.811

804 “Details for Title Medicare Medical Home Demonstration” Centers for Medicare and Medicaid Services, April 14, 2011,
http://www.cms.gov/Medicare/Demonstration-Projects/DemoProjectsEvalRpts/Medicare-Demonstrations-Items/CMS1199247.html
(Accessed 2/12/15).
805 “Multi-Payer Advanced Primary Care Practice” Centers for Medicare and Medicaid Services, http://innovation.cms.gov/initiatives/MultiPayer-Advanced-Primary-Care-Practice/ (Accessed 3/1/15).
806 Ibid.
807 Ibid.
808 “Federally Qualified Health Center Advanced Primary Care Practice Demonstration Details” Centers for Medicare and Medicaid Services,
2011, http://www.cms.gov/Medicare/Demonstration-Projects/DemoProjectsEvalRpts/Downloads/FQHC_DemoDetails.pdf (Accessed
2/12/15).
809 “Going Further: Value-Based Insights and Opportunities” Valence Health, 2013,
http://valencehealth.com/uploads/files/Valence_Health_Further_2013_White_Paper.pdf (Accessed 3/2/2015), p. 2: “Creating a Clinically
Integrated Network” McKesson, 2015, http://www.mckesson.com/population-health-management/solutions/create-a-clinically-integratednetwork/ (Accessed 3/2/2015).
810 “Going Further: Value-Based Insights and Opportunities” Valence Health, 2013, http://valencehealth.com/uploads/files/Valence_Health_
Further_2013_White_Paper.pdf (Accessed 3/2/2015), p. 2.
811 “RE: Norman PHO Advisory Opinion” By Markus H. Meier, Federal Trade Commission, February 13, 2013, http://www.ftc.gov/
sites/default/files/documents/advisory-opinions/norman-physician-hospital-organization/130213normanphoadvltr_0.pdf (Accessed
3/2/2015), p. 1-5.
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Under the Norman PHO advisory opinion, the FTC engaged in a rule of reason analysis,
discussed more thoroughly in Chapter 3, Regulatory Environment, to evaluate whether the
186recompetitive effects of the Norman PHO outweighed any potential anticompetitive
effects.812 Among the potential benefits cited in the Norman PHO advisory opinion, the FTC
identified benefits to:
(1) Patients—through reduced medical errors; earlier disease detection; more timely
communication and scheduling; and elimination of unnecessary and duplicative
paperwork and tests;
(2) Payers—through centralized administrative work; elimination of duplication of services;
avoidance of preventable hospitalization; and, lower costs of care; and
(3) Providers—through more timely receipt of public health information (PHI) and
scheduling of services; more streamlined referrals; and reduced paperwork, among
others.813
Further, the Norman PHO stated that it would engage in efforts to reduce any potentially
anticompetitive effects arising from the clinically integrated network, such as ensuring that
information such as pricing and negotiating strategy would not be improperly shared among
participants.814 Accordingly, the FTC determined that these potential recompetitive benefits
arising from the Norman PHO outweighed the associated, potential anticompetitive effects, i.e.,
the improper leveraging of market power associated with network participation in order to drive
non-network contract reimbursement rates.815 However, despite the tentative approval of the
Norman PHO, the FTC explicitly reserved the right to revoke approval of future implementation
if the program, “…results in substantial anticompetitive effects, if…used for improper purposes,
if facts change significantly, or if it otherwise would be in the public interest to do so.”816
Accordingly, the Norman PHO Advisory Opinion requires, in essence, that the Norman PHO
maintain a non-exclusive structure, and avoid vertical arrangements that may prevent
collaboration between Norman PHO and non-network providers.817 Despite the scrutiny to which
clinically integrated networks may be subject, their ability efficiently coordinate the treatment of
patients may make them a worthwhile investment.

CONCLUSION
As discussed above, there continues to be a major paradigm shift taking place in the Healthcare
reimbursement environment. As healthcare reform efforts that focus on reducing costs have
begun to gain traction, providers have felt even more presedbetween the cost of providing
services and the value of the reimbursement/collections they receive for providing them.
However, as more emphasis is placed on the shift from quantity to quality, providers who
survive to be those which exhibit increased efficiency and reductions in the cost of service.
While these trends will be most likely driven by federal and state government payors, their role
812
813
814
815
816
817
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as the gold standard benchmarks for all healthcare reimbursement, will lead any future
developments in the commercial reimbursement environment, as well.
Key Sources
Key Source

Description

Citation

Website

“About HHS,”
Department of Health
and Human Services,
www.hhs.gov/about/
(Accessed 4/1/15).

www.hhs.gov

United States
Department
of Health and
Human
Services
(HHS)

“The Department of Health and Human Services
(HHS) is the United States government’s
principal agency for protecting the health of all
Americans and providing essential human
services.” HHS has eleven agencies, among
which are the Centers for Medicare and Medicaid
Services (CMS), Indian Health Services (IHS),
the Office of the Inspector General (OIG), and the
National Institutes of Health (NIH).

Centers for
Medicare and
Medicaid
Services
(CMS)

CMS administers the Medicare, Medicaid, and
CHIP programs. CMS is responsible for setting
reimbursement rates under Medicare and
Medicaid. The CMS website contains important
information for beneficiaries of these programs,
as well as for guidelines for providers.

www.cms.hhs.gov

United States
Department
of Health
And Human
Services
(HHS) Office
of Inspector
General
(OIG)

“Centers for Medicare
and Medicaid Services”
Centers for Medicare and
Medicaid Services, U.S.
Department of Health
and Human Services,
http://www.cms.gov/
(Accessed 4/1/15).

The OIG of HHS oversees all of the department’s
programs in order to protect the integrity of the
programs and the health and welfare of
beneficiaries.

“Office of the Inspector
General,” U.S.
Department of Health
and Human Services,
http://oig.hhs.gov/
(Accessed 4/1/15).

http://oig.hhs.gov

TRICARE

The TRICARE website provides useful
information to program beneficiaries.

Civilian
Health and
Medical
Program of
the
Department
of Veteran
Affairs
(CHAMPVA)

The CHAMPVA page of the U.S. Department of
Veterans Affairs website provides useful
enrollment and benefit information for
CHAMPVA enrollees.

Indian Health
Services
(IHS)
BlueCross
BlueShield
(BCBS)

Department
of Labor
(DOL)

IHS is a division of HHS, and the website
provides comprehensive information on the
activities of IHS, as well as useful information on
health programs for Native Americans and Alaska
Natives.
The website of the BlueCross BlueShield
Association contains information on regional
BCBS carriers, as well as up-to-date news
affecting the U.S. healthcare and health insurance
industries.
The DOL website includes information regarding
employer sponsored health insurance plans and
the laws that govern them, such as the
Employment Retirement Income Security Act.

“TRICARE,”
http://www.tricare.mil/
(Accessed 4/1/15).
“Department of Veterans
Affairs Health
Administration Center:
CHAMPVA,” United
States Department of
Veterans Affairs
http://www.va.gov/
purchasedcare/
(Accessed 4/1/15).
“Indian Health Service,”
www.ihs.gov (Accessed
4/1/15).
“BlueCross BlueShield
Association,”
www.bcbs.com
(accessed February 20,
2015).
“Health Plans and
Benefits,” United States
Department of Labor,
http://www.dol.gov/dol/
topic/healthplans/index.htm
(Accessed 4/1/15).

www.tricare.mil/

http://www.va.gov/
purchasedcare/

www.ihs.gov

www.bcbs.com

www.dol.gov
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Type of
Practice

Primary
Care

20042005818
2%
2%
2%
1%

Specialty

General Practice

Internal
Medicine

General Surgery

Orthopedic
Surgery
-0.40%

0.20%

-0.10%

0.20%

20052006819

-1%

0%

5%

3%

20062007820

-1%

-1%

0%

0%

20072008821

0%

0%

0%

0%

20082009822

1%

1%

3%

3%

20092010823

3%

1%

1%

1%

20102011824

-1%

0%

1%

1%

20112012825

0%

0%

4%

1%

20122013826

-2%

0%

1%

0%

20132014827

-1%

0%

1%

0%

20142015828

818 “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule for Calendar Year 2005; Final Rule”, Federal Register, Vol. 69, No. 219 (November 15, 2004), p. 66401
819 “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule for Calendar Year 2006; Proposed Rule” Federal Register, Vol. 70, No. 151 (August 8, 2005), p. 45860.
820 “Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other
Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance Inflation Factor Update for CY
2007,” U.S. Department of Health and Human Services: Centers For Medicare & Medicaid Services, Federal Register, Vol. 71, No. 231, December 1, 2006, p. 69766.
821 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008”, Federal Register, Vol. 72, No. 227 (November 27, 2007),
p. 66390.
822 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2009”, Federal Register, Vol. 73, No. 130 (July 7, 2008), p.
38595
823 “Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Corrections; Final Rule” Federal Register, Vol. 75, No. 90 (May 11, 2010),
p. 26358.
824 “Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule” Federal Register, Vol. 75, No. 228, (November 29, 2010),
p. 73595.
825 “Medicare Program; Payment Policies under the Physician Fee Schedule, Five-year Review of Work Relative Value Units, Clinical Laboratory Fee Schedule: Signature on Requisition, and Other
Revisions to Part B for CY 2012; Final Rule” Federal Register, Vol. 76, No. 228 (November 28, 2011), p. 73454.
826 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the requirement for Termination of Non-Random
Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013; Final Rule” Federal Register, Vol. 77, No. 222, (November 16, 2012), p. 69344.
827 “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other Revisions to Part B for CY 2014; Final Rule” Federal Register,
Vol. 78, No. 237, (December 10, 2013), p. 74800.
828 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid
Innovation Models & Other Revisions to Part B for CY 2015; Final Rule” Federal Register Vol. 79, No. 219, (November 13, 2014) p. 67988.
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Suppliers

Mid-level
Providers

Allied Health
Practitioners

Medical
Specialties

Type of
Practice
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Chiropractor

Podiatrist

Nurse Anesthetist

Physical or
Occupational
Therapist
3%
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Radiology

Diagnostic Testing
Facility
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20042005818
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Specialty
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-11%

0%

3%

-1%

12%

-2%
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Chapter 3

Regulatory Environment

“In all science, error precedes the truth, and it is
better it should go first than last.”
Hugh Walpole, 1801

KEY TERMS

Accreditation
Ambulatory Surgery Center
Antitrust
Civil Monetary Penalty
Commercial Reasonableness
Cream Skimming
Designated Health Service
Electronic Health Record (EHR)
Fair Market Value (FMV)
Financial Relationship

Gainsharing
Kickback
Licensure
National Committee on Quality Assurance (NCQA)
Physician-Owned Facilities
Protected Health Information (PHI)
Qui Tam Action
Self-Referral
The Joint Commission
Treble Damages
Upcoding
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Key Concept

Corporate
Practice of
Medicine

Health Insurance
Portability and
Accountability
Act of 1996
(HIPAA)

False Claims Act
(FCA)

Covered Entities
Under HIPAA

192

Definition
The corporate practice of medicine doctrine was
created by the American Medical Association (AMA)
to protect the public as well as the profession of
medical doctors. The doctrine essentially bans
unlicensed individuals and entities from engaging in
the practice of medicine by restricting them from
employing licensed physicians. The intent of the
doctrine was to ensure that only licensed
professionals delivered medical care and that lay
persons and entities not influence treatment
decisions. The premise underlying the doctrine was
that it would protect patients from potential abuses
because commercialized medicine would ultimately
divide a physician’s loyalty between profits and the
delivery of quality patient care.
The HIPAA Privacy Rule provides standards for the
use and disclosure of “protected health information”
(PHI) to safeguard patient privacy. PHI is anything
that relates to a patient’s past, present, or future
physical or mental health condition and the provision
of healthcare services to the patient and the past,
present, or future payment for the provision of
healthcare to the individual. The Privacy Rule
governs health plans, healthcare clearinghouses, and
any healthcare provider that transmits health
information in electronic form in connection with a
transaction for which the secretary of Department of
Health and Human Services (HHS) has adopted
HIPPA standards (“covered entities”). The act was
updated by the Health Information Technology for
Economic Clinical Health (HITECH) Act, located
within the Recovery and Reinvestment Act of 2009,
and allows patients to request an audit trail that
shows all disclosures of their PHI, prohibiting the
sale of a patient’s PHI without his or her
authorization, and requiring individuals to be notified
if there is an unauthorized disclosure or use of their
PHI.
Creates civil liability for knowingly presenting false
or fraudulent claims for reimbursement to the federal
government. Amended in 1986, it has become one of
the primary weapons used to combat healthcare
fraud. Under the statute’s qui tam (whistleblower)
provisions, any private citizen can enforce the FCA
by filing a complaint alleging fraud against the
federal government. The incentive is the potential to
share in the recovery of any ill-gotten funds. In 1998,
the Office of Inspector General (OIG) and the
Department of Justice issued guidelines limiting
enforcement actions.
“Health plans, healthcare clearinghouses, and any
health care provider who transmits health information
in electronic form in connection with a transaction
for which the Secretary of HHS [Department of
Health and Human Services] has adopted [HIPAA]
standards.”

Citation

Key Concept
Mentioned
on Page #

“Corporate Medicine in 21st
Century Health Care” By John W.
Jones, Physician’s News Digest,
June 2007, http://www.physicians
news.com/law/607jones.html
(Accessed 7/09/09); “The People
of the State of Illinois v. United
Medical Service, Inc.” 362 Ill.
442, 455 (1936).

198-200

“Definitions” 45 C.F.R. § 160.103
(October 1, 2008); “Summary of
the HIPAA Privacy Rule” Office
of Civil Rights, Department of
Health and Human Services, May
2003, http://www.hhs.gov/ocr/
privacy/hipaa/understanding/summ
ary/privacysummary.pdf
(Accessed 3/6/15), p. 1.

211-214

“Civil Actions for False Claims”
31 U.S.C. § 3729(a) (1994);
“Health Care Fraud Report: Fiscal
Year 1998,” Department of
Justice, justice.gov, 1998,
www.justice.gov/dag/pubdoc/healt
h98.htm#national (Accessed
4/1/15); “Civil Actions for False
Claims” 31 U.S.C. § 3730(d)(1)
(1994).

217-220

“Summary of the HIPAA Privacy
Rule,” OCR Privacy Brief, United
States Department of Health and
Human Services, May 2003, p. 2,
www.hhs.gov/ocr/privacy/hipaa/un
derstanding/summary/privacysum
mary.pdf (Accessed 4/1/15).

213, 215
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Definition

Citation

Key Concept
Mentioned
on Page #
217, 219,
222-23, 22526, 229, 23538, 241, 246,
250-52, 256
201, 206-7,
212-15, 220,
226-29, 23233, 235, 24041, 252, 257,
276, 281

Office of the
Inspector General
(OIG)

“Office of Inspector General's (OIG) mission is to
protect the integrity of Department of Health &
Human Services (HHS) programs as well as the
health and welfare of program beneficiaries.”

“Mission” U.S Department of
Health Services, Office of the
Inspector General, http://oig.
hhs.gov/ (Accessed 4/1/15).

The Department
of Health and
Human Services
(HHS)

“The Department of Health and Human Services
(HHS) is the United States government’s principal
agency for protecting the health of all Americans and
providing essential human services, especially for
those who are least able to help themselves.”

“About HHS,” U.S Department of
Health and Human Services,
www.hhs.gov/about/ (Accessed
4/1/15).

Fraud
Enforcement and
Recovery Act of
2009 (FERA)

Expands government resources to combat fraud in
the housing and mortgage arena and expands the
scope of the FCA by clarifying the term knowingly to
mean; a person who, “1) has actual knowledge of the
information; 2) acts in deliberate ignorance of the
truth or falsity of the information; or 3) acts in
reckless disregard of the truth or falsity of the
information.” FERA also reduces the government’s
burden of proof, no longer requiring it to provide
“proof of specific intent to defraud,” and expanded
the definition of claim.

Health Care
Quality
Improvement Act
of 1986

“Fraud Enforcement and Recovery
Act” Pub. L. No. 111-21, § 4, 123
Stat. 1617, 1622 (January 6, 2009);
“Concerns with Proposed
Amendments to the Fraud
Enforcement and Recovery Act of
2009” By American Hospital
Association et al., To the Members
of the United States Senate, April
21, 2009, http://www.aha.org/aha/
letter/2009/090421-FCA-Senltr.pdf (Accessed 05/05/09), p. 1.

Among other things, established the National
Practitioner Data Bank to improve the availability of
information obtained during the peer review process.

“Health Care Quality
Improvement Act of 1986,” 42
U.S.C. § 11111 et seq. (2012).

201

Medicare and
Medicaid Patient
& Program
Protection Act of
1987 (MMPPPA)

Amended the 1987 Anti-Kickback statute by
including an alternative civil remedy to violation:
exclusion from the Medicare Program.

222

National Health
Planning and
Resources
Development Act
of 1974

Legislation that pushed Certificate of Need
regulations to the forefront of government healthcare
cost containment efforts. The act required that federal
agencies pass health policy planning guidelines and
establish “a statement of ‘national health planning
goals’!”.

“Medicare and Medicaid Patient &
Program Protection Act of 1987”
Pub. L. 100-93 § 2, 101 Stat. 680,
680-684 (August 18, 1987);
“Medicare and State Health Care
Programs: Fraud and Abuse OIG
Safe Harbor Provisions” Federal
Register Vol. 56 (July 29, 1991),
p. 35952.
“The National Health Planning and
Resources Development Act of
1974” Pub. L. No. 93-641, 88 Stat.
2225 (January 4, 1975).

208

Balanced Budget
Act of 1997

Added a civil monetary penalty of treble damages, or
three times the illegal remuneration, plus $50,000 per
violation of the Anti-Kickback statute.

Patient Safety and
Quality Act
(PSQIA)
Health
Information
Technology for
Economic
Clinical Health
(HITECH) Act

Legislation that established a voluntary reporting
system for medical errors to increase the availability
of such and more efficiently address issues related to
patient care and quality.
Legislation used to promote widespread adoption of
health information technology, particularly electronic
health records (EHRs). Also used to protect the
privacy and security of PHI by allowing patients to
request an audit trail that shows all disclosures of
their PHI, prohibiting the sale of a patient’s PHI
without his or her authorization, and requiring
individuals to be notified if there is an unauthorized
disclosure or use of their PHI.

“The Balanced Budget Act of
1997,” Pub. L. No. 105-33, §
4304(b)(2)(A), 111 Stat. 251, 383384 (August 5, 1997).
“Patient Safety and Quality
Improvement; Final Rule” Federal
Register Vol. 73, No. 226
(November 21, 2008), p. 70732.
“Health Information Technology
for Economic and Clinical
Health,” in “American Recovery
and Reinvestment Act of 2009,”
Pub. L. No. 111-5, 123 Stat. 115
(February 17, 2009).

220

222

216-217

214-215
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Definition

Citation

Key Concept
Mentioned
on Page #

Stark Law

The federal physician self-referral law, or Stark law,
prohibits physicians from referring Medicare or
Medicaid patients to an entity for designated health
services (defined by HHS) if the physician, or an
immediate family member, has a financial
relationship with that entity. It began in 1989 and has
been revised many times.
Stark I (1989)—The Ethics in Patient Referrals
Act—physicians can’t refer to family members.
Stark II Phase I (2002) and Phase II (2004)—
physicians can’t refer if they have an ownership
interest.
Stark II Phase III (2007)—any financial arrangement
is a direct compensation arrangement.
Stark IV (2009)—physician with any ownership is
considered part of the whole physician organization.
There are many specified exceptions to Stark law.

228-35

Anti-Kickback
Statute

Enacted in 1972, the federal Anti-Kickback statute
makes it a felony for any person to “knowingly and
willfully” solicit or receive or to offer or pay, any
“remuneration” directly or indirectly in exchange for
the referral of a patient for a healthcare service paid
for by a federal healthcare program. Penalties were
amended by Medicare and Medicaid Patient and
Program Protection Act of 1987 and the Balanced
Budget Act of 1997. Congress enacted “safe
harbors,” which detail specific regulatory criteria that
must be met to shield an arrangement from liability
and are meant to protect practices unlikely to result in
fraud or abuse.

“Limitation on Certain Physician
Referrals” 42 U.S.C.
1395nn(a)(1)(A) (2012);
"Medicare Program; Physician
Financial Relationships With, and
Referrals to, Health Care Entities
That Furnish Clinical Laboratory
Services and Financial
Relationship Reporting
Requirements," Federal Register
Vol. 60, No. 156 (August 14,
1995), p. 41914; “Phase III
Regulations Result in Dramatic
Changes to Stark Law” By J. Kelly
Barnes, et al., BNA Health Law
Reporter, Vol. 16, No. 40, October
11, 2007, p. 1220-1221; "Medicare
Program; Physicians’ Referrals to
Health Care Entities With Which
They Have Financial Relationships
(Phase III)" Federal Register Vol.
72, No. 171 (September 5, 2007),
p. 51012, 51028.

“Criminal Penalties for Acts
Involving Federal Health Care
Programs” 42 U.S.C. § 1320a7b(b) (1997).

221-28

Key Concept

Centers for
Medicare and
Medicaid
Services (CMS)

"…administers the Medicare program, providing
health care security and choice for aged and disabled
people in this country."

Osteopath

“Osteopathic medicine is dedicated to treating and
healing the patient as a whole, rather than focusing
on one system or body part. An osteopathic physician
will often use a treatment method called osteopathic
manipulative treatment (also called OMT or
manipulation)—a hands-on approach to make sure
that the body is moving freely. This free motion
ensures that all of your body’s natural healing
systems are able to work unhindered. A doctor of
osteopathic medicine (D.O.) is a physician licensed
to practice medicine, perform surgery, and prescribe
medication.”

194

“Guidelines for Ensuring the
Quality of Information
Disseminated to the Public: E.
Centers for Medicare & Medicaid
Services,” Department of Health
and Human Services,
http://aspe.hhs.gov/infoquality/Gui
delines/CMS-9-20.shtml
(Accessed 4/1/15).

202, 207,
213, 219,
227, 230-31,
233-41, 256,
278, 281-82

“Doctor of Osteopathy” Medical
Encyclopedia, National Library of
Medicine, www.nlm.nih.gov/
medlineplus/ency/article/002020.h
tm (Accessed 4/1/15).

205-6
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Citation
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Medicare
Prescription
Drug,
Modernization,
and Improvement
Act of 2003
(MMA)

Implemented an eighteen-month moratorium on the
development of new specialty hospitals, which
represented a compromise between the idea that the
“whole hospital” exception should be removed for all
hospitals and the position of removing it only for
specialty hospitals. The moratorium officially ended
on June 8, 2005.

234, 236

Emergency
Medical
Treatment and
Active Labor Act
(EMTALA)

Enacted by Congress in 1986 “to ensure public
access to emergency services regardless of ability to
pay. Section 1867 of the Social Security Act imposes
specific obligations on Medicare-participating
hospitals that offer emergency services to provide a
medical screening examination (MSE) when a
request is made for examination or treatment for an
emergency medical condition (EMC), including
active labor, regardless of an individual’s ability to
pay. Hospitals are then required to provide stabilizing
treatment for patients with EMCs. If a hospital is
unable to stabilize a patient within its capability, or if
the patient requests, an appropriate transfer should be
implemented.”

“The Medicare Prescription Drug,
Modernization, and Improvement
Act of 2003” Pub. L. No. 108-173,
§ 507, 117 Stat. 2066, 2295
(December 8, 2003); “Valuation of
Healthcare Ancillary Service
Providers,” Robert James Cimasi
ASA, CBA, AVA, FCBI, CM&A,
CMP, President, Health Capital
Consultants, National Association
of Certified Valuation Analysts:
Consultants’ Training Institute
2007, September 13, 2007, p. 10.

“EMTALA Overview”
Department of Health and Human
Services, Centers for Medicare and
Medicaid, www.cms.hhs.
gov/emtala/ (Accessed 4/1/15).

279

Key Concept

Certificate of
Need (CON)

Requires that healthcare providers obtain state
approval before either developing new services, or
expanding existing services.

Sherman
Antitrust Act

Prohibits any “contract, combination...or conspiracy,
in restraint of trade or commerce to combat unfair
competition and abuse of monopolistic power.” Used
by federal government to combat kickbacks and selfreferral joint ventures.

Racketeer
Influenced and
Corrupt
Organizations
Act

Federal laws which carry both criminal and civil
penalties with the aim of protecting the public from,
“parties who conduct organizations affecting
interstate commerce through a pattern of criminal
activity.” Makes it illegal for any person to use or
invest any income derived from a “pattern of
racketeering activity” in an enterprise, to acquire or
maintain control of any enterprise through a pattern
of racketeering activity, and for any person employed
by or associated with any enterprise to conduct the
affairs of the enterprise through a pattern of
racketeering activity.

The Occupational
Safety and Health
Act of 1970

Established standards for occupational health and
safety, and requires states to enact legislation
implementing standards and procedures developed by
the Department of Labor.

“Certificate-of-Need Law in
Illinois Slammed by Feds, AMA”
By Amy Lynn Sorrel, American
Medical News, October 6, 2008,
www.ama-assn.org/amednews/
2008/10/06/gvsb1006.htm
(Accessed 4/1/15).
“Sherman Antitrust Act” 15
U.S.C. § 1 (2013); “Health Care
Fraud: Enforcement and
Compliance” By Robert Fabrikant,
et al., New York, NY: Law
Journal Press, 2007, p. 2-60.

207-11

257-58

“Health Care Fraud: Enforcement
and Compliance,” By Robert
Fabrikant et al., New York, NY:
Law Journal Press, 2007, p. 3-8384, quoting 115 Cong. Rec. 9566,
9568 (April 18, 1969), statement
of Sen. McClellan.

256

“Problems in Health Care Law”
By Robert D. Miller, Ninth
Edition, Sudbury, MA: Jones
and Bartlett Publishers, 2006,
p. 184–85.

277
(continued)

195

Adviser's Guide to Healthcare

Key Concept

Definition

Citation
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Clinical
Laboratory
Improvement Act
(CLIA)

Requires laboratories to regulate all laboratory testing
performed on humans, except the testing performed
for research purposes, in order to improve the
accuracy, reliability, and timeliness of test results.
Requires that healthcare providers that perform
laboratory testing on specimens derived from humans
to obtain a certificate and abide by established
standards in order to operate these services. Overseen
by CMS.

“Clinical Laboratory Improvement
Amendments: Overview” Centers
for Medicare & Medicaid
Services, http://www.cms.hhs.
gov/clia/ (Accessed 09/01/09).

278

The United States
Nuclear
Regulatory
Commission
(NRC)

An independent agency created by Congress in 1974
to ensure the safe use of radioactive material
(including those used in medical facilities) for
civilian purposes through a combination of regulatory
requirements, licensing, safety oversight, operational
evaluation, and support activities. Under section 274
of the Atomic Energy Act of 1954, the NRC is
authorized to delegate its authority to oversee certain
licensees to state regulatory commissions, or
agreement states.

278

Medical Injury
Compensation
Reform Act

“Medical, Industrial, and
Academic Uses of Nuclear
Material” United States Nuclear
Regulatory Commission, February
10, 2015, http://www.nrc.gov/
materials/medical.html (Accessed
3/5/15); “Governing Legislation”
United States Nuclear Regulatory
Commission, September 30, 2014,
http://www.nrc.gov/aboutnrc/governing-laws.html#top
(Accessed 3/5/15).

California legislation that caps pain and suffering and
malpractice damages.

“Damages for Wrongs” Cal. Civ.
Code § 3333.2 (1975).

280

“Help Efficient, Accessible, LowCost, Timely Healthcare
(HEALTH) Act of 2009” H.R.
1086 (February 13, 2009).

281

“Sherman Antitrust Act” 15
U.S.C. § 1 (2013).

257

“Deficit Reduction Act of 2005”
Pub. L. 109-171, § 6031, 120 Stat.
4, 72-73 (February 8, 2006);
“Health Law Update - The Deficit
Reduction Act of 2005: New
Medicaid Fraud and Abuse
Provisions” Bass, Berry & Sims,
May 31, 2006, www.bassberry.
com/.../Health%20Law%20Update
%20May%2031%202006.pdf
(Accessed 05/10/10).

251

Help Efficient,
Accessible, LowCost, Timely
Healthcare Act of
2009
Federal Trade
Commission
(FTC) Act

Deficit Reduction
Act (DRA)

196

Introduced before the U.S. House of Representatives
in February 2009 as a new attempt to pass a federal
cap on noneconomic damages in medical malpractice
suits, which has been a continuing congressional goal
since the same bill was first introduced in the House
in 2002.
Prohibits “unfair methods of competition in or
affecting commerce...” One of the federal
government’s primary means of combating unfair
competition and abuse of monopolistic power.

Enacted February 8, 2006, and continued the
suspension of CMS’s enrollment of new specialty
hospitals (from MMA) for about six months, until the
release of the CMS’s final report on specialty
hospitals as required by the DRA.

Chapter 3: Regulatory Environment

OVERVIEW
The U.S. healthcare industry is replete with overlapping state and federal regulations that shape
the practice of medicine and delivery of healthcare services in the twenty-first century. A
significant number of regulations apply to both physician and non-physician practitioners. While
regulation has traditionally been directed at physicians and allied health professionals, regulation
of mid-level providers has increased, resulting from the expanding scope of services provided
under their own Medicare or Medicaid provider numbers. This chapter discusses the general
provisions of federal and state regulations, noting whether they apply solely to medical
professionals or to allied health professionals and mid-level providers as well. The regulatory
environment surrounding these specific professions will be examined in further detail in the
chapters dedicated to each profession.

HEALTHCARE LIABILITY
Generally speaking, liability is a measure of responsibility and accountability under the law.1
Liability within healthcare is uniquely allocated, as practitioners and practices cannot completely
shelter each other from all the various laws governing medicine. Historically, healthcare
professionals were liable solely for their professional actions, i.e., the provision of medical care
to patients. As healthcare grew in complexity, from the practice of medicine to the business of
medicine, practitioners began to face liability as industry entrepreneurs as well. As such, liability
in healthcare can be classified, as it affects both practice and practitioner, into three distinct
categories: civil liability, financial liability, and tax liability.2 Hospitals and practices, as business
enterprises, are held liable for the way in which they file their taxes; depending on the affiliation,
ownership, and arrangement structure, a practitioner can be held liable for tax purposes as well.3
Practitioners with ownership interest may be financially liable for any violations related to
business practices and, as a result, may suffer personal losses.4 Lastly, each practitioner
shoulders a certain amount of professional liability for services rendered based on their scope of
practice and supervision or supervisory status.5 As healthcare grows in complexity, both
medically and entrepreneurially, the liability that practitioners and practices face likely will
increase in complexity as well.

1
2
3
4
5

“Black’s Law Dictionary: Liability” By Bryan A. Garner, 10th Edition, Thomson West, 2014, http://www.next.westlaw.com (Accessed
3/4/15).
“When Starting Your Own Practice, Be Savvy About Successful Business Structure Basics” Rehab Regs, April 8, 2004,
http://www.hcpro.com/RHB-37280-882/When-starting-your-own-practice-be-savvy-about-successful-business-structure-basics.html
(Accessed 2/9/10).
“S Corp, C Corp, LLC, LLP—Which is Best?” By Dennis Murray, Medical Economics, March 5, 2004, http://www.modernmedicine.com/
modernmedicine/article/articleDetail.jsp?id=108814 (Accessed 7/30/09); see the IRS Tax Status section below.
“When Starting Your Own Practice, Be Savvy About Successful Business Structure Basics” Rehab Regs, April 8, 2004,
http://www.hcpro.com/RHB-37280-882/When-starting-your-own-practice-be-savvy-about-successful-business-structure-basics.html
(Accessed 2/9/10); see the Fraud and Abuse Laws section below.
“S Corp, C Corp, LLC, LLP—Which is Best?” By Dennis Murray, Medical Economics, March 5, 2004, http://www.modernmedicine.com/
modernmedicine/article/articleDetail.jsp?id=108814 (Accessed 7/30/09); see the Tort Reform section below.
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THE SHIFT FROM COTTAGE INDUSTRY TO CORPORATE PRACTICE
OF MEDICINE
Historically, the practice of medicine has been a cottage industry with little crossover seen
between specialties and practices.6 The gradual corporatization of medicine necessitates the
regulation of emerging entrepreneurial concerns, that is, business arrangements, fraud and abuse,
tax compliance, and practitioner compensation. The Corporate Practice of Medicine doctrine is
the most fundamental legislative manifestation of the healthcare transition from a cottage
industry to, effectively, the corporate practice of medicine.

CORPORATE PRACTICE OF MEDICINE (CPOM)
The American Medical Association promulgated the Corporate Practice of Medicine (CPOM) to
prohibit unlicensed individuals from engaging in the practice of medicine by employing licensed
physicians.7 CPOM was intended to ensure that licensed physicians could provide medical care
without pressure from lay persons whose goals may not be in the best interest of the patient, as
medicine should not be “subject to commercialization or exploitation.”8
The CPOM is regulated by the states.9 Although restrictions vary by jurisdiction, forty-eight
states and the District of Columbia have some form of regulation that follows a CPOM
standard.10 However, the method by which states regulate COPM varies widely from state-tostate.11 Some states, such as Colorado, expressly prohibit the corporate practice of medicine by
statute.12 Others have developed the prohibition based on applications of licensure statutes that
prevent corporations from becoming licensed as physicians.13 A separate group of states have
developed CPOM doctrine by case law or attorney general actions.14 Because the regulations
vary significantly, it is important to understand restrictions regarding the CPOM on a state-bystate basis.
Certain healthcare organizations are generally exempt from the application of the CPOM
doctrine. In all states, physicians are allowed to incorporate as professional corporations. In some
states, the organization of health maintenance organizations (HMOs) and contracts between
HMOs and professionals for the provision of services are exempted specifically from the
6
7
8
9
10
11
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14

See Chapter 1, The Rise and Fall of Managed Care.
“Corporate Medicine in 21st Century Health Care” By John W. Jones, Physician’s News Digest, June 2007, http://www.physiciansnews.
com/law/607jones.html (Accessed 07/09/09); “Corporate Practice of Medicine: A Fifty State Survey” By Stuart Silverman et al., American
Health Lawyers Association, Washington, D.C., 2014, p. v.
“The People of the State of Illinois v. United Medical Service, Inc.” 362 Ill. 442, 455 (1936).
“Corporate Medicine in 21st Century Health Care” By John W. Jones, Physician’s News Digest, June 2007, http://www.physiciansnews.
com/law/607jones.html (Accessed 07/09/09).
See generally “Corporate Practice of Medicine: A Fifty State Survey” By Stuart Silverman et al., American Health Lawyers Association,
Washington, D.C., 2014.
“Corporate Practice of Medicine: A Fifty State Survey” By Stuart Silverman et al., American Health Lawyers Association, Washington,
D.C., 2014, p. v.
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doctrine.15 Further, some states exempt nonprofit healthcare entities under the rationale that the
lack of profit incentive eliminates the dangers associated with the CPOM.16
As a result of CPOM, new practice areas have surfaced that may be prone to running afoul of
current statutes. A growing practice area that may violate existing CPOM restrictions is the
growth in quick clinics, or physician offices generally found in large retail stores or
pharmacies.17 Although retailers in states with CPOM restrictions typically cannot open in-store
clinics and staff physicians, CPOM laws generally allow corporations to rent or lease space to
providers.18 With the growth of accountable care organizations (ACOs) and their increased
emphasis on cost-saving measures through improved primary care, the fate of the quick clinic
market may rest, in part, on the ability of ACOs to successfully navigate CPOM restrictions.19
Another growing trend in CPOM violation is the practice of non-physician-owned spas offering
Botox injections and other medical procedures with physicians staffed as medical directors.20
Under this arrangement, unlicensed spa owners may be involved in the unlicensed practice of
medicine and the physician may be aiding and abetting.21 Various states, such as California and
Idaho, have taken affirmative steps to prohibit this practice.22
CPOM also has been influenced by the creation of new enforcement strategies and regulations
that aid in the prevention of fraud. In 2005, the New York Court of Appeals held that no-fault
insurance carriers could refuse payment for medical services provided by fraudulently
incorporated medical businesses.23 The court based its holding on two premises: (1) a business
corporation law that prohibits individuals from owning a share in a professional service
corporation if they are not licensed to practice in the same profession as the corporation and
(2) an insurance regulation that excludes payments made to unlicensed or fraudulently licensed
providers.24 The defendant corporation argued that it should be reimbursed because all of its
patients received care from licensed providers.25 However, because the corporation was owned
by non-physicians, the court found the organization to be in clear violation of state law.26
Despite these regulations, CPOM has found its way into the marketplace through new entities
that utilize technology to address patient concerns while bypassing traditional methods of patient
15
16
17
18
19
20
21
22
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Ibid.

199

Adviser's Guide to Healthcare

consultation. Medical consultation services by phone or e-mail and quick clinic stores may
promote efficiency and access for patients, but such acts may implicate state CPOM laws. These
particular types of entities should be cognizant of the most recent CPOM in their states to avoid
running afoul of restrictions.

HEALTHCARE REGULATION AT FEDERAL AND
STATE LEVELS
For many actors, the regulatory environment surrounding healthcare takes place at both the state
and federal levels. In fact, state legislative and regulatory enforcement measures may actually
stem from federally elicited incentives or compliance standards, e.g., those federal regulations
governing Medicaid eligibility and reimbursement. Conversely, there are matters that are
federally regulated, which in turn constitutionally bind states to comply, i.e., federal edicts are
preserved, but tailored through supplemental state laws to meet state-specific needs. Identifying
the matters that are affected by a particular level of healthcare regulation as well as the interplay
between different levels of healthcare regulation is essential to properly advise clients who face
issues surrounding healthcare matters.

LICENSURE
State laws typically control the licensure of healthcare providers under the state’s police powers.
Through these laws states can regulate entry into the field, restrict professional scope of practice,
and hold professionals accountable accordingly. State licensing laws specify the minimum level
of qualification needed to practice in a field. It is argued that licensure is intended to ensure the
public’s safety by providing a standard for the evaluation of provider expertise and accurate
assessment of the risks of substandard care.27 However, the domination of professional licensure
boards by the professionals themselves has also been criticized as serving the interests of the
profession more than the interests of the public.28 Licensure of the various provider types is
discussed in the corresponding Chapters of Consulting with Professional Practices (Volume 2).

INDIVIDUAL PROFESSIONAL LICENSURE
Every state and the District of Columbia require licensure of all allopathic (M.D.) and
osteopathic (D.O.) physicians.29 Although the specific criteria for licensure vary by state, each
state requires candidates to submit proof of completion of the requisite number of years of
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“U.S. Health Law and Policy 2001: A Guide To The Current Literature” By Donald H. Caldwell Jr., San Francisco, CA: Jossey-Bass, 2001,
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graduate medical education and passage of examinations verifying that “the physician is ready
and able to practice competently and safely in an independent setting.”30
A physician applying for licensure is typically found to be of “good moral character” absent his
or her involvement in illegal activities.31 Most physicians satisfy the exam requirement by
submitting proof of their successful completion of the United States Medical Licensing
Examination (USMLE) or the Comprehensive Osteopathic Medical Licensing Examination
(COMLEX-USA) to the licensure board.32 However, as some practicing physicians may have
been licensed under a previously administered exam, certain state licensing boards may consider
a combination of other examinations as sufficient to meet licensure requirements, so long as
those exams were completed prior to 2000.33
As part of the Health Care Quality Improvement Act of 1986, Congress established the National
Practitioner Data Bank to improve the availability of information obtained during the peer
review process.34 The Department of Health and Human Services (HHS) is responsible for
overseeing the National Practitioner Data Bank system, and requires state medical and dental
licensing boards to report disciplinary action taken against a licensed professional in regards to
his or her professional competence and professional conduct.35 Hospitals are also required to
periodically check the status of the database for each member of their medical staff.36 The
general public does not currently have access to the data bank.37
In addition to physicians, all states require the licensure of dentists, registered nurses, practical
nurses, dental hygienists, pharmacists, optometrists, physical therapists, podiatrists,
chiropractors, and administrators of nursing homes.38 Frequently, physician assistants, midwives,
psychologists, social workers, opticians, physical therapy assistants, audiologists, and speech
pathologists also are subject to state licensure laws.39 As with physician licensing, state rules
vary on licensure requirements for these professions.

PHYSICIAN VERSUS NON-PHYSICIAN SCOPES OF PRACTICE
Recent physician shortages coupled with declining reimbursement rates have led to increased
calls for physician manpower relief.40 To satisfy these calls, the healthcare workforce has
diversified in ways beyond the traditional physician realms. Instead of healthcare workforce
evolution limited to the horizontal expansion of medical specialty and subspecialty areas, current
30
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trends demonstrate a vertical expansion in the role of the non-physician workforce to provide
services that support, supplement, and parallel physician services, particularly for primary
care.41
Traditionally, non-physician providers (NPPs) were referred to, collectively, as “allied health
professionals.”42 However, NPPs have assumed multiple roles in the provision of healthcare
services that may implicate their licensed scope of practice. Because the licenses issued to nonphysician practitioners are limited in scope, so as not to run afoul of the prohibition against the
unlicensed practice of medicine, these professionals must be careful to only practice within the
limits set forth by relevant statutes. This has led nurses and allied health professionals to lobby
legislatures and seek judicial rulings to expand the practice limits placed on their licenses.43
Recent changes in technology, better education for nurses and allied health professionals,
physician shortages, and the government’s and third party payor’s insistence on controlling
healthcare costs have led to expanded roles for non-physician professionals.44
Practitioners are liable for violation of state laws that regulate the range of services they are
permitted to provide. Additionally, Medicare fee schedules indirectly influence professionals by
navigating the degree and magnitude of reimbursement rates from public and private payors, as
well as which services are covered.45 Overseen by the Centers for Medicare and Medicaid
Services (CMS), Medicare reimbursement rates vary based on the level of specialization of each
type of practitioner. For non-physician practitioners, reimbursement rates are dictated by policies
related to incident-to billing, which state the percentage of a service cost that a non-practitioner
may be reimbursed through Medicare.46 These rates vary based on the level of supervision
required (if at all) and the type of services provided.47 CMS has periodically revised the
supervision requirements for non-physician practitioners since the passage of the Patient
Protection and Affordable Care Act (ACA)—particularly for hospital outpatient therapeutic
services—with its most recent revision effective July 1, 2014.48
In some cases, Medicare rules and state laws overlap, which may be cause for controversy. For
example, Certified Registered Nurse Anesthetists (CRNA) are authorized to administer
anesthesia without supervision to Medicare patients if a state’s governor petitions CMS on the
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basis of state need.49 As of September 2014, seventeen states have opted-out of CRNA physician
supervision requirements.50 Contention between physicians and mid-level providers has led to
several lawsuits regarding this topic by physician groups interested in protecting physician
provision of certain services.51
As the overlap between the scope of practice for physicians and non-physicians increases,
malpractice liability, which jeopardizes the licenses of both the supervising physician and the
non-physician professional, may increase as well.52 For more information on mid-level provider
competition with physicians.53

SPECIALTY LICENSURE AND CERTIFICATION
Technological advances during the past forty years have led to an increase in the specialization
of healthcare personnel.54 Physicians can seek specialty certification through the American
Board of Medical Specialties (ABMS), an organization of 24 approved medical specialty
boards.55 As specialization took hold in the early and mid-1900s (ophthalmology being the first
established specialty in 1917), medical professionals, began to self-regulate the profession by
forming boards to establish standards of practice.56 Established in 1933, the ABMS certifies
physicians in over 150 general specialties and subspecialties, ensuring that they have completed
the requisite training programs necessary for their areas of expertise and that they can
demonstrate competence in their specialties or sub-specialties through a board-executed
evaluation.57 While board certification is not required of U.S. physicians in order to practice their
chosen specialty, it has become the gold standard for demonstrating expertise and commitment in
their field to patients, providers, insurance companies, and quality organizations across the
nation.58 Unlike a state licensure board, a professional association cannot bar a licensed
physician from practicing in a particular specialty for failing to obtain board certification,
although board certification is viewed favorably by hospitals and healthcare service providers as
an indicator of competence.59
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Advances in technology have also led to the development of new categories of healthcare
providers, including radiological technologists and telemedicine provisions, as well as the state
licensing programs and private certifying agencies governing these providers.60

HEALTHCARE FACILITY AND PRACTICE LICENSURE
Although the licensing of healthcare entities is typically handled by state governments,
significant interplay exists between state and federal government regulations. Most states require
entities to meet practice standards set forth by Medicare as a condition of licensure, and
Medicare requires state licensure as a condition of reimbursement.61 As with other types of
professional licensure, the licensure of healthcare facilities is intended to ensure that patients
receive quality healthcare.
State regulation designates the healthcare facilities that must be licensed. All states require
hospitals and nursing homes to be licensed.62 Many states require further licensure of specialized
areas within an already-licensed facility, including clinical laboratories and hospital-based
ambulatory surgery centers (ASCs).63 In order to maintain licensure, facilities may need to meet
certain building requirements, as well as comply with limits on the number of beds allowed in a
given facility.
Physicians are not typically required to license their solo or group practices, because the state
exercises control over these facilities through control of each physician’s license.64 However, as
the provision of medical care continues to shift to the outpatient setting, more states have
expanded the scope of their licensing regulations to require the licensure of facilities performing
outpatient procedures similar to those performed in inpatient facilities for which a license is
ordinarily required.65

ACCREDITATION
Accreditation is the process by which private organizations assess participating institutions and
programs and issue accreditation certificates to institutions that meet their requirements.
Ensuring the quality and safety of services is the focus of most accreditation standards; however,
many also include documentation requirements, among others.66 If a participating institution or
program fails to maintain the requisite standards, they may not incur penalties other than the loss
60
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of their accreditation. In most states, there is no link between accreditation and institutional
licensure, although, some states will forego further inspection and accept accreditation by
organizations, such as The Joint Commission, as the basis for the state licensure of certain
providers.67
Accreditation can be beneficial to organizations for purposes of federal compliance. Medicare
grants deemed status to hospitals accredited by The Joint Commission (TJC)68 or the American
Osteopathic Association (AOA).69 Deemed status allows providers to participate in the Medicare
program unless a later Medicare validation survey finds noncompliance with the conditions of
participation requirements set forth in federal regulations.70 Accreditation is also important
because some payors will only contract with accredited providers.71
Major accrediting bodies in the United States include the TJC, the AOA, and the National
Committee for Quality Assurance (NCQA).

THE JOINT COMMISSION
TJC is a nongovernmental organization that strives to ensure the safety and quality of healthcare
services provided to the public.72 TJC pursues this goal by conducting on-site reviews and setting
standards for institutional governance, support services, and patient care.73 Facilities seek TJC
accreditation because it helps to: (1) ensure the provision of quality services; (2) attract quality
staff; (3) become qualified to receive Medicare reimbursement; and (4) in some states, TJC
accreditation is a requirement for licensure.74 TJC provides accreditation for ambulatory care
centers, including group practices and office-based surgery practices, behavioral health centers,
home health services, various types of hospitals—such as general, children’s, psychiatric, critical
access, and rehabilitation—laboratory services, long-term care facilities, and international
healthcare providers.75

AMERICAN OSTEOPATHIC ASSOCIATION
The AOA is the main board certifying entity for osteopathic physicians (D.O.), and it is the
accrediting body for every osteopathic healthcare facility and medical college.76 The AOA
strives to promote the practice of osteopathic medicine by ensuring quality in education,
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research, and the delivery of healthcare services. Much like TJC, Medicare grants deemed status
to those facilities accredited by the AOA.77

NATIONAL COMMITTEE ON QUALITY ASSURANCE
The NCQA is a not-for-profit organization that works with employers, physicians, policymakers,
patients, and health plans to improve the quality of healthcare through the accreditation of
managed care plans.78 NCQA functions much like other accrediting bodies through the setting of
standards and the collection of outcome and performance data.79 In 1991, the NCQA accredited
its first MCO, and focused its accreditation efforts throughout the 1990s primarily on the
development of quality metrics for managed care organizations.80 These efforts led to the
development of the Health Employer Data Information Set (HEDIS), which measured essential
elements of clinical care.81 By 1998, 75 percent of all HMO enrollees were enrolled in plans that
were subject to NCQA accreditation.82 HEDIS was formally integrated into NCQA’s
accreditation procedures in 1999, with an emphasis on establishing preventive services (e.g.,
immunizations and screening tests) in the primary care setting. Since that time, HEDIS has
grown to include additional programs related to disease management and protection of human
research test subjects.83

MEDICARE AND MEDICAID CERTIFICATION
In order to receive reimbursement for services provided to patients that are Medicare or
Medicaid beneficiaries, healthcare provider organizations must become a certified participant in
the Medicare and Medicaid programs. Certification for participation in these federal programs is
contingent upon the organization being “deemed” to have satisfied the health and safety
standards components of the Medicare certification process.84 Providers can achieve “deemed
status” by earning a certificate of compliance with the Conditions of Participation established in
federal regulations, which can be accomplished in one of two ways.85 First, under Section
1864(a) of the Social Security Act, the Secretary of HHS is required to grant state health agencies
the authority to approve, disapprove, or terminate the Medicare and Medicaid participation of
certified providers86 based on whether providers have met the Conditions of Participation.87 In
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“Health Care Regulation in America: Complexity, Confrontation, and Compromise” By Robert I. Field, New York, NY: Oxford University
Press, 2007, p. 84.
Ibid, p. 83-84.
“Accreditation and its Impact on Various Survey and Certification Scenarios” By Thomas E. Hamilton, Director, Survey and Certification
Group, Centers for Medicare & Medicaid Services, To State Survey Agency Directors, October 17, 2008.
“Facts about federal deemed status and state recognition” The Joint Commission, June 19, 2012, http://www.jointcommission.org/assets
/1/18/Facts_about_Federal_Deemed_Status.pdf (Accessed 9/14/12).
“Use of state agencies to determine compliance by providers of services with conditions of participation” 42 U.S.C. § 1395aa(a) (2012).
“Facts about federal deemed status and state recognition” The Joint Commission, June 19, 2012, http://www.jointcommission.org/
assets/1/18/Facts_about_Federal_Deemed_Status.pdf (Accessed 9/14/12); “State Operations Manual” Centers for Medicare & Medicaid
Services, May 21, 2004, http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/som107c01.pdf (Accessed
09/14/12), §§ 1008A, 1008B.
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the alternative, a healthcare provider can achieve Medicare certification by obtaining
accreditation through an HHS-approved national accreditation organization (AO), as specified
in the Accreditation section above. As of March 2015, CMS utilizes nine AOs for the purpose of
overseeing the health and safety compliance of accredited program participants.88 An AO may
obtain CMS “deeming” authority if it enforces standards that meet or exceed the Conditions of
Participation.89 Additional information on Medicare and Medicaid reimbursement can be found
in Reimbursement Environment.

CERTIFICATE OF NEED (CON)
A Certificate of Need (CON) program is one in which government determines where, when, and
how capital expenditures will be made for public healthcare facilities and major equipment.90
CON is based on the theory that, in an unregulated market, healthcare providers will expand their
services regardless of duplication or need.91 However, the validity of CON programs is now
contested by agencies such as the Antitrust Division of the U.S. Department of Justice (DOJ),
which stated that “CON laws tend to create barriers to entry for health care providers…but they
do not, on balance, tend to suppress health care spending.”92

OVERVIEW: THE FEDERAL CERTIFICATE OF NEED PROGRAM
CON statutes and regulations specify those healthcare facilities, medical equipment, and services
that require applications and approval to operate. The enactment of federal CON laws was the
product of federally mandated health policy planning efforts that dated back to the post-World
War II era.93 However, program development and implementation generally takes place at the
state or local level today.94
The enactment of federally mandated CON laws was the product of government mandated health policy
planning efforts that dated back to the post–World War II era.
Patrick John McGinley, 1995.

88
89
90
91
92
93
94

“CMS-Approved Accreditation Organizations: Contact Information for Prospective Clients” Centers for Medicare & Medicaid Services,
January 8, 2015, http://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertificationGenInfo/Downloads/Accrediting-Organization-Contacts-for-Prospective-Clients-.pdf (Accessed 3/6/15).
“Facts about federal deemed status and state recognition” The Joint Commission, June 19, 2012, http://www.jointcommission.org/
assets/1/18/Facts_about_Federal_Deemed_Status.pdf (Accessed 9/14/12).
“Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, April 30, 2009, http://www.ncsl.org/
IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (Accessed 1/13/10).
“Improving Health Care: A Dose of Competition” Report by the Federal Trade Commission and The Department of Justice, July 2004,
Ch. 8, p. 2.
“Competition in Health Care and Certificates of Need: Joint Statement of the Antitrust Division of the U.S. Department of Justice and the
Federal Trade Commission Before the Illinois Task Force on Health Planning Reform” U.S. Department of Justice, September 15, 2008,
http://www.justice.gov/atr/public/comments/237351.htm (Accessed 2/21/15).
“Beyond Health Care Reform: Reconsidering Certificate of Need Laws in a ‘Managed Competition’ System” By Patrick John McGinley,
|23 Fla. St. U. L. Rev. 141, 145 (1995).
“Beyond Health Care Reform: Reconsidering Certificate of Need Laws in a ‘Managed Competition’ System” By Patrick John McGinley,
23 Fla. St. U. L. Rev. 141, 145-148 (1995); “Certificate of Need: State Health Laws and Programs” National Conference of State
Legislature, July 2014, http://www.ncsl.org/research/health/con-certificate-of-need-state-laws.aspx#Program (Accessed 2/21/15).
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The National Health Planning and Resources Development Act of 1974 pushed CON regulations
to the forefront of government healthcare cost containment efforts.95 The act required that federal
agencies pass health policy planning guidelines and establish “a statement of national health
planning goals.”96 It prompted states to enact CON programs by guaranteeing federal funding for
state CON review programs and conditioning the receipt of certain healthcare funding on
enacting CON programs.97 It also specified that state CON programs must meet federal
guidelines in order to receive federal funding.98 In response to the act, all fifty states developed
some form of CON review program.99
In 1987, Congress repealed the 1974 legislation, which caused fourteen states to discontinue
their CON programs.100 Despite the discontinuation of a formal CON program, all fourteen states
retain certain regulatory mechanisms intended to prevent duplication of services.101
CON laws were modeled after federal legislation, but current CON regulation is based on
various state statutes, rules, and regulations that designate an agency or board to administer the
approval process.102 State CON programs generally have two functions: (1) to develop a health
plan promoting equitable access to healthcare services and (2) to review CON applications
submitted by healthcare providers.103 State CON programs are administered according to statutes
and regulations controlling market entry for regulated facilities, services, and equipment. As of
July 2014, at least 50% of U.S. states subject the following healthcare services and/or providers
to CON laws:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)

95
96
97
98
99

100
101
102
103
104

Acute Hospital Beds;
ASCs;
Cardiac Catheterization Services;
Long-Term Acute Care Facilities;
Nursing Home/ Long-Term Care Beds;
Open Heart Surgery;
Psychiatric Services; and
Rehabilitation Services.104

“The National Health Planning and Resources Development Act of 1974” Pub. L. No. 93-641,§ 1523(a)(4)(B), 88 Stat. 2225, 2246 (January
4, 1975).
“The National Health Planning and Resources Development Act of 1974” Pub. L. No. 93-641,§ 1501, 88 Stat. 2225, 2227
(January 4, 1975).
“Beyond Health Care Reform: Reconsidering Certificate of Need Laws in a ‘Managed Competition’ System” By Patrick John McGinley,
23 Fla. St. U. L. Rev. 141, 141, 147-148, (1995).
“Excess Capacity: Markets, Regulation, and Values” By Carolyn W. Madden, Health Services Research, Vol. 33, No. 6 (February 1999),
p. 1658, 1662
“Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, April 30, 2009, http://www.ncsl.org/
IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (Accessed 1/13/10); “The Effect of Certificate-of-Need
Laws on Hospital Beds and Healthcare Expenditures: An Empirical Analysis” By Fred Hellinger, American Journal of Medical Care, Vol.
15 No. 10, October 8, 2009, p. 738.
“Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, April 30, 2009, http://www.ncsl.org/
IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (Accessed 1/13/10)
“Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, July 2014, http://www.ncsl.org/
research/health/con-certificate-of-need-state-laws.aspx#Program (Accessed 2/21/15).
“The U.S. Healthcare Certificate of Need Sourcebook” By Robert James Cimasi, Washington, DC: BeardBooks, 2005, p. 30-33.
Ibid, p. 8.
“Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, July 2014, http://www.ncsl.org/
research/health/con-certificate-of-need-state-laws.aspx#Program (Accessed 2/21/15).
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CON also often applies to the purchase of medical equipment and new technology, e.g.,
ultrasounds and positron emission tomography (PET) scanners.
CON regulatory policy has been highly contentious in the state legislative arenas since its
widespread adoption four decades ago, and it has been the subject of significant administrative
agency study and review. Beyond these activities, the grant or denial of a CON application
frequently has resulted in complex and costly litigation.105 During this period, CON also has
been the subject of numerous academic and governmental scientific research studies, as well as
the subject of thousands of news and journal articles.
Opponents of CON programs argue that its intervention into the healthcare industry disrupts
natural market forces and limits competition.106 Seeking to preserve competition in healthcare
markets, the Federal Trade Commission (FTC) consistently has criticized CON as a failing, outof-date regulatory policy that creates barriers to market entry for new players, preventing price
competition.107

THE FEDERAL TRADE COMMISSION AND CON
The FTC has evaluated the impact of CON on competition for many years. A 1988 FTC study
estimated that total hospital costs might decline by 1.4 percent, or $1.3 billion per year, if all
states with CON laws doubled the dollar thresholds at which they require CON review of
hospital expenditures.108 Since this initial estimation, the FTC has embarked on a steady
campaign against state CON programs and their anti-competitive nature.
A 1988 FTC study estimated that total hospital costs might decline by 1.4 percent, or $1.3 billion per year, if
all states with CON laws doubled the dollar thresholds at which they require CON review of hospital
expenditures.
Daniel Sherman, Jan. 1988.

105 Through 2005, state courts issued over 800 reported opinions regarding certificate of need programs and decisions. “The U.S. Healthcare
Certificate of Need Sourcebook” By Robert James Cimasi, Washington, DC: BeardBooks, 2005, p. 1, 168. For examples of more current
decisions, see, e.g., “Good Hope Health System, L.L.C. v. North Carolina Department of Health and Human Services” 659 S.E.2d 456
(2008); “Mainland Manor Nursing & Rehabilitation Center v. New Jersey Department of Health and Senior Services” 959 A.2d 885 (2008);
“In re Certificate of Need Application of OPRS Communities” Case No. 13AP-46, (Ohio Ct. App. January 14, 2014) Decision.
106 “State Commission on the Efficacy of the Certificate of Need Program and its Effect on Cost, Quality, and Access in Georgia” Testimony
of S. Houston Payne: Georgia Hand & Microsurgery, Before the Georgia Department of Community Health (August 8, 2005),
http://dch.georgia.gov/sites/dch.georgia.gov/files/imported/vgn/images/portal/cit_1210/38/49/178516440-Testimony-Georgia-Society-ofAmbulatory-Surgery-Centers.pdf (Accessed 3/5/15).
107 “Improving Health Care: A Dose of Competition” Report by the Federal Trade Commission and The Department of Justice, July 2004, p.
23; “Federal Trade Commission, Department of Justice Issue Joint Statement on Certificate-of-Need Laws in Illinois” The Federal Trade
Commission, September 12, 2008, https://www.ftc.gov/news-events/press-releases/2008/09/federal-trade-commission-department-justiceissue-joint-statement (Accessed 3/11/15).
108 “The Effect of State Certificate-of-Need Laws on Hospital Costs: An Economic Policy Analysis” By Daniel Sherman, Report for Bureau of
Economics, Federal Trade Commission, Jan. 1988, http://www.ftc.gov/be/econrpt/232120.pdf (Accessed 10/29/09), p. vi.
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In November 2002, FTC Chairman Timothy J. Muris announced that the FTC would hold joint
hearings with the DOJ on competition in healthcare in the following year.109 On July 23, 2004,
following the conclusion of the hearings, the FTC and DOJ issued a joint report in which the
agencies recommended that states decrease barriers to entry into provider markets.110 Following
the testimony, the agencies suggested that instead of reducing costs, there is evidence that CON
programs actually drive up costs by “fostering anticompetitive barriers to entry.”111 In addition to
raising prices, the FTC has stated that CON regulation may cause “lower quality… and reduced
innovation in healthcare markets.”112
The creation of ASCs has become a focal point surrounding CON regulation. In the opinion of
the FTC and DOJ, ASCs are beneficial for consumers and state CON laws pose an
anticompetitive barrier to entry. In response to ASC provider allegations that general hospitals
attempted to use CON laws to prevent ASCs from entering the healthcare market, the FTC and
DOJ have aggressively pursued activities of anticompetitive conduct against ASC facilities.113
However, both agencies acknowledged that antitrust laws do not prevent individual hospitals
from unilaterally approaching state governments in connection with CON proceedings, calling
into question the effectiveness of their efforts encourage ASC creation in spite of CON
programs.114
Currently, thirty-six states, the District of Columbia, and Puerto Rico retain some sort of CON
program.115 See Exhibit 3-1 for a complete list of states with CON legislation.

THE APPLICATION PROCESS
Every state has its own unique CON application process. However, general procedures tend to
guide the application process in all states with CON programs. The typical application process
involves submission of an application for review, agency review for consistency with planning
criteria, and a public hearing and decision by the granting authority.116 If an application is
approved, the project must typically begin within a specified amount of time.117 If a CON holder
fails to fulfill the requirements of the CON, the state may retain the right to revoke it.118
Additionally, each state has its own unique criteria and thresholds related to what type of CON
109 “FTC Chairman Announces Public Hearings on Health Care and Competition Law and Policy to Begin in February 2003” U.S. Federal
Trade Commission, Press Release, November 7, 2002, http://www.ftc.gov/news-events/press-releases/2002/11/ftc-chairman-announcespublic-hearings-health-care-and (Accessed 2/21/15).
110 “Improving Health Care: A Dose of Competition” Report by the Federal Trade Commission and The Department of Justice, July 2004,
cover page.
111 Ibid, p. 22.
112 “Comment on Senate Bill 398” By Paul K. Davis: Federal Trade Commission, Letter To Senator Culver Kidd (March 4, 1988),
http://www.ftc.gov/opp/advocacy/1988/V880021.PDF (Accessed 10/29/09). “Prepared Statement of the Federal Trade Commission Before
the Florida State Senate” Federal Trade Commission, Statement to Florida Senate (April 2, 2008),
https://www.ftc.gov/sites/default/files/documents/advocacy_documents/ftc-prepared-statement-florida-senate-concerning-florida-certificateneed-laws/v080009florida.pdf (Accessed 3/5/15), p. 2.
113 “Improving Health Care: A Dose of Competition” Report by the Federal Trade Commission and The Department of Justice, July 2004,
Executive Summary p. 28, Chapter 3 p. 27, 28.
114 “Improving Health Care: A Dose of Competition” Report by the Federal Trade Commission and The Department of Justice, July 2004,
Chapter 3 p. 2, 27, 28.
115 “Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, July 2014, http://www.ncsl.org/
research/health/con-certificate-of-need-state-laws.aspx#Program (Accessed 2/21/15).
116 “Corporate Law for the Healthcare Provider: Organization, Operation, Merger and Bankruptcy” By Ann Huckstep, James C. Wilson, Jr.,
and Richard P. Carmody, National Health Lawyers Association: Washington, D.C. 1993, p. 120-22.
117 Ibid, p. 122.
118 Ibid, p. 122.
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review is required, particularly when it comes to examinations regarding utilization by a
population. These standards include, for example, (1) Full Review: thresholds related to both
utilization and population must be met; (2) Expedited Review: utilization threshold standards are
not used, but rather “questions” related to “quality of care” and “technological advancements”
must be answered; and (3) Non-Substantive Review: no formal application is required.119 In some
states, a CON may be transferable, but laws governing such rights differ from state to state.
Exhibit 3-1: States with Certificate of Need Legislation120
Alabama
Alaska
Arkansas
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Illinois
Iowa
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Mississippi
Missouri

Montana
Nebraska
Nevada
New Hampshire
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Puerto Rico
Rhode Island
South Carolina
Tennessee
Vermont
Virginia
Washington
West Virginia
Wisconsin

THE APPEAL PROCESS
Because CON is an administrative process, an appeal of a negative application decision would
first go through the proper administrative channels, which could then be appealed to the
appropriate state court.121

PRIVACY LAWS
The handling of confidential healthcare information is regulated in order to protect patients and
ensure that their privacy is secure, a concern of particular importance because practitioners,
providers, and organizations have regular access to patient medical records. Specifically, the
Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulates access to
medical information, and the Red Flags Rule regulates access to financial information. With
119 “The US Healthcare Certificate of Need Sourcebook” By Robert James Cimasi, Washington, D.C.: Beard Books, 2005, p. 506-509.
120 “Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, July 2014,
http://www.ncsl.org/research/health/con-certificate-of-need-state-laws.aspx#Program (Accessed 2/21/15).
121 “Health Care Certificate-of-Need Laws: Policy or Politics?” By Tracy Yee, Lucy B. Stark, Amelia M. Bond , and Emily Carrier, National
Institute for Health Care Reform, Research Brief No. 4, May 2011, http://www.nihcr.org/CON_Laws (Accessed 3/6/15), p. 2.
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healthcare organizations typically managing both patient medical information and billing for
services, practices with varying degrees of complexity and size are expected to comply with both
laws.

HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY
ACT OF 1996
HIPAA is designed to serve many purposes, though the most widely recognized purpose is to
safeguard the privacy of protected health information (PHI), which is health information that can
be individually identifiable.122 HIPAA protection extends to information relating to the “past,
present or future physical or mental health condition of an individual; the provision of healthcare
services to an individual; or the past, present or future payment for the provision of healthcare to
an individual.”123 The HIPAA Privacy Rule provides standards for the use and disclosure of PHI
by entities covered by HIPAA as well as rights for individuals to control how their PHI is
used.124
Under the privacy rule, a “covered entity” includes “health plans, healthcare clearinghouses, and
any health care provider who transmits health information in electronic form in connection with
a transaction for which the Secretary of HHS [U.S. Department of Health and Human Services]
has adopted [HIPAA] standards.”125 Transactions by healthcare providers falling under the
HIPAA Privacy Rule include claims for reimbursement, benefit eligibility inquiries, referral
authorization requests, and other transactions for which HHS has established particular
standards.126 These transactions are covered regardless of whether they are performed by the
healthcare provider themselves, a billing service, or any other third party under contract with the
provider.127 Consequently, when a covered entity contracts with a third-party entity to perform
billing or other business associate activities, including claims processing, data analysis, and
utilization review, the covered entity must impose specific safeguards protect PHI, and the
business associate agreement between the covered entity and third-party entity cannot authorize
the third party to use PHI in a way that would violate the privacy rule.128
Information that has been de-identified, however, is not covered by HIPAA. De-identification
can occur either by: “(1) … a formal determination by a qualified statistician; or (2) the removal
of specified identifiers of the individual and of the individual’s relatives, household members,

122 “Definitions” 45 C.F.R. § 160.103 (October 1, 2008); “Health Information Privacy: The Privacy Rule” U.S. Department of Health and
Human Services, 2014, http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/ (Accessed 3/6/15).
123 “Definitions” 45 C.F.R. § 160.103 (October 1, 2008).
124 “Summary of the HIPAA Privacy Rule” Office of Civil Rights, Department of Health and Human Services, May 2003, http://www.hhs.gov/
ocr/privacy/hipaa/understanding/summary/privacysummary.pdf (Accessed 3/6/15), p. 1.
125 “Entities Covered by the HIPAA Privacy Rule” Department of Health and Human Services, May 2003, http://www.hhs.gov/ocr/privacy/
hipaa/understanding/training/coveredentities.pdfpdf (Accessed 3/6/15), p. 2.
126 Ibid, p. 5.
127 Ibid, p. 4.
128 “Standards for Privacy of Individually Identifiable Health Information” Federal Register Vol. 65, No. 250, (December 28, 2000), p. 82470,
82494-95.
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and employers,” but only as long as the covered entity that performed the de-identification “has
no actual knowledge that the remaining information could be used to identify the individual.”129
It is paramount that entities abide by HIPAA regulations in order to avoid penalties. If a party
violates HIPAA regulations unintentionally, it can receive fines of $100-$50,000 or more per
violation and up to $1.5 million per year, depending on whether the violation occurred before
February 18, 2009 or after.130 If an entity intentionally violates HIPAA, it can receive criminal
penalties including fines of up to $250,000 and 10 years in prison.131
As the healthcare industry transitions to electronic transactions, HHS has implemented updated
versions of HIPAA standards that regulate the transmission of specific health care information.
The first of these updates was known as the Accredited Standards Committee X12 Version
4010/4010AI, but became increasingly less functional for the coding and transactional updates
providers were required to accommodate (i.e., the coming ICD-10 transition). Then HHS
approved ASC X12 Version 5010, which included technical, structural, and data content
requirements; transactional business standardization; data transmission specifications, and
delineation of various patient codes.132 The transition to HIPAA Version 5010 affected many
healthcare industry stakeholders, including providers, health plans, healthcare clearinghouses,
and business associates that participate in electronic transactions, such as billing/service agents
and vendors.133 According to a 2011 Medical Group Management Association report, 45 percent
of practices would have to replace their practice management systems completely to manage
Version 5010, and 50.3 percent of practices would need to install upgrades to accommodate
Version 5010.134
Despite the fact that, according to the 2011 MGMA report, only 34.5 percent of private physician
practices did not utilize practice management vendors that planned to upgrade the practice’s
current system, 42.5 percent of practices had not started implementation of Version 5010.135 One
barrier to implementation is the cost of new HIPAA Version 5010 software, hardware, and staff
training, which may total approximately $16,575 per practice.136 Although the HIPAA rule
introducing the changes was published on January 16, 2009, the CMS Office of E-Health

129 “Summary of the Privacy Rule: What Information is Protected” Department of Health and Human Services,
http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/ (Accessed 2/21/15).
130 “General Penalty for Failure to Comply with Requirements and Standards” 42 U.S.C. § 1320d-5(a) (2010); “Summary of the Privacy Rule:
Enforcement and Penalties for Noncompliance” Department of Health and Human Services, 2015, http://www.hhs.gov/ocr/privacy/
hipaa/understanding/summary/ (Accessed 2/21/15).
131 “General Penalty for Failure to Comply with Requirements and Standards” 42 U.S.C. § 1320d-5(a) (2010).
132 “Is Your Practice Ready for Version 5010” MGMA Government Affairs Department, October 2011,
http://www.mgma.com/Libraries/Assets/Practice%20Resources/Publications/MGMA%20Connexion/2011/HIPAA-Version-5010-and-thefuture-of-administrative-simplification---MGMA-Connexion-magazine-October-2011.pdf (Accessed 3/11/15), p. 10.
133 “New Health Care Electronic Transactions Standards: Versions 5010, D.0, and 3.0” Centers for Medicare & Medicaid Services, January
2010, http://www.cms.gov/ICD10/Downloads/w5010 BasicsFctSht.pdf (Accessed 11/29/11).
134 “Statement of the Medical Group Management Association to the National Committee on Vital and Health Statistics Subcommittee on
Standards: RE: HIPAA Version 5010 ” Medical Group Management Association, June 17, 2011, Englewood, CO: Medical Group
Management Association, p. 5.
135 Ibid, p. 6, 8.
136 Ibid, p. 6.
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Standards and Services (OESS), responsible for enforcement of compliance with electronic
transaction standards, delayed enforcement until July 1, 2012,137 partially due to industry
feedback suggesting that many covered entities would be unable to comply with the new
transaction standards by the original January 1, 2012 deadline.138
Since that final rule went into effect, HHS has begun working on another updated version,
known as HIPAA Transaction Standard 6020, which includes revisions that satisfy a significant
number of business needs and requests.139 This update is near completion but will not be
considered by HHS for adoption until it believes the industry is ready to begin another
transition.140

HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND
CLINICAL HEALTH (HITECH) ACT
The American Recovery and Reinvestment Act of 2009 (ARRA) made changes to HIPAA’s
health information privacy and security provisions.141 The ARRA used the HITECH Act in order
to promote widespread adoption of health information technology, particularly electronic health
records (EHR).142 Provisions in the HITECH Act also protect the privacy and security of PHI by
allowing patients to request an audit trail that shows all disclosures of their PHI, prohibiting the
sale of a patient’s PHI without his or her authorization, and requiring individuals to be notified if
there is an unauthorized disclosure or use of their PHI.143 This latter provision also requires
practices to publicly post information about security breaches affecting ten or more patients who
cannot be directly contacted, and it requires public notification to the HHS website, prominent
media outlets, and the secretary of HHS of breaches affecting 500 patients or more.144 There are
various general exceptions to the HITECH Act for PHI, including:
(1) Unintentional access to, acquisition of, or use of PHI by a worker of the covered entity,
acting in good faith, within the scope and course of duties, as long as act does not lead to
disclosure under HIPAA;

137 “Version 5010” Centers for Medicare & Medicaid Services, June 14, 2012, http://www.cms.gov/Regulations-and-Guidance/HIPAAAdministrative-Simplification/Versions5010andD0/Version_5010.html (Accessed 3/11/15).
138 “Centers for Medicare & Medicaid Services’ Office of E-Health Standards and Services Announces 90-Day Period of Enforcement
Discretion for Compliance with New HIPAA Transaction Standards.” Centers for Medicare & Medicaid Services, Nov 17, 2011,
http://www.cms.gov/ICD10/Downloads/CMSStatement5010EnforcementDiscretion111711.pdf (Accessed 11/28/11); “Health Insurance
Reform; Modifications to the Health Insurance Portability and Accountability Act (HIPAA); Final Rules,” 74 Fed. Reg. 3302 (January 16,
2009).
139 “ASC X12: Electronic Health Data Interchange Standards” American Society of Anesthesiologists, December 2014,
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0CC0QFjAA&url=https%3A%2F%2Fw
ww.asahq.org%2F~%2Fmedia%2Fsites%2Fasahq%2Ffiles%2Fpublic%2Fresources%2Fpractice%2520management%2F2014-12-17-ascx12-timely-topic.pdf%3Fla%3Den&ei=tI30VKCAK8zCggT4moTgCQ&usg=AFQjCNEy9a5vZK8FXnO9Xxrxp6TLAte1iw (Accessed
3/2/15) p. 2.
140 Ibid.
141 “American Recovery and Reinvestment Act of 2009” Pub. L.111-5, § 3009, 123 Stat. 115, 242 (February 17, 2009); “Stimulus Package
Includes New HIPAA Security Rules: Small Practices Face Greatest Financial Impact” By Sheri Porter, AAFP News Now, March 18, 2009,
http://www.aafp.org/online/en/home/publications/news/news-now/government-medicine/20090318hipaa-security-rules.html (Accessed
5/10/10).
142 “American Recovery and Reinvestment Act of 2009” Pub. L.111-5, § 13001 et seq., 123 Stat. 115, 226 (February 17, 2009).
143 “Health Information Technology for Economic and Clinical Health Act” Pub. L. 111-5, § 13405, 123 Stat. 115, 264 (February 17, 2009).
144 “Health Information Technology for Economic and Clinical Health Act” Pub. L. 111-5, § 13402, 123 Stat. 115, 260 (February 17, 2009).
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(2) Inadvertent disclosure from one worker of the covered entity to another, when both
workers were authorized to access information and no future disclosure occurs; and
(3) Unauthorized disclosure to an unauthorized person, when there is reasonable belief that
the recipient would not retain information.145
In 2013, HHS issued its final omnibus rule modifying HIPAA, with the rule amending the
HITECH Act to “strengthen the privacy and security protection for individuals’ health
information; modify the rule for Breach Notification for unsecured [PHI] under the HITECH
Act[;]” “modify [HIPAA] to strengthen privacy protections for genetic information […]; and
make certain other modifications to the [HIPAA Rules] to improve their workability and
effectiveness and to increase flexibility for and decrease burden on the regulated entities.”146
Essentially, this updated final rule provides greater privacy protections for patients, provides
patients with more rights to their own information, and strengthens enforceability by the
government while affirming proposed or interim rules from 2009.147 The rule amended the
requirements of business associates, which have been responsible for many large breaches, to
include security and privacy obligations and imposed direct liability on these business associates
for compliance with certain HIPAA requirements.148
The definition of a business associate now includes vendors that deal with PHI on behalf of a
covered entity; businesses that perform patient safety activities, health information organizations,
e-prescribing gateways, data transmission services that access PHI regularly, personal health
record providers for covered entities, and subcontractors of business associates.149 Under the new
rule, individual patients have the right to request electronic copies of their health information and
to restrict disclosures to a health plan regarding treatment that they paid for out of pocket.150
HHS also adopted additional HITECH improvements that were not included in the 2009
adoption, including enforcement of noncompliance with HIPAA rules due to willful neglect.151
The HITECH Act’s goal was to incorporate electronic health records into the healthcare industry,
and it attempted to do this by providing incentives to organizations that complied with its
requirements. These incentives reimburse organizations through Medicare and Medicaid as long
as the organization follows the meaningful use standards.152

145 “Investigating Privacy Breaches Under HITECH and HIPAA” By Barry Herrin and Allyson Jones Labban, Smith Moore Leatherwood,
2008, p. 17, 22, 25.
146 “Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for
Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules” Federal
Register Vol. 78, No. 17 (January 25, 2013), p. 5566.
147 “New Rule Protects Patient Privacy, Secures Health Information” U.S. Department of Health and Humans Services, January 17, 2013,
http://www.hhs.gov/news/press/2013pres/01/20130117b.html (Accessed 2/21/15).
148 Ibid.
149 “Deadline Ahead: Last-Minute HIPAA Business Associate Compliance” By Steven Wu, Journal of AHIMA, September 11, 2013,
http://journal.ahima.org/2013/09/11/deadline-ahead-last-minute-hipaa-business-associate-compliance/ (Accessed 2/21/15).
150 “New Rule Protects Patient Privacy, Secures Health Information” Department of Health and Humans Services, January 17, 2013,
http://www.hhs.gov/news/press/2013pres/01/20130117b.html (Accessed 2/21/15).
151 “Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for
Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules” Federal
Register Vol. 78, No. 17 (January 25, 2013), p. 5566.
152 See the Increased Reimbursement to Encourage Implementation of Electronic Health Records (EHR) Through Meaningful Use section of
Chapter 2, Reimbursement Environment, for more information on the application of HITECH with the meaningful use EHR program.
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RED FLAGS RULE
On November 9, 2007, the FTC and other agencies published the Red Flags Rule, which listed
red flags, or warnings, that indicated the possibility of identity theft and mandated the
implementation of an identity theft prevention program.153 In 2013, the FTC issued a guide to
help organizations and businesses determine whether they were subject to the rule and comply
with it.154 The rule applies to financial institutions including creditors, which are defined as “any
person who regularly extends, renews, or continues credit; any person who regularly arranges for
the extension, renewal, or continuation of credit; or any assignee of any original creditor who
participates in the decision to extend, renew, or continue credit” and covered accounts, which
include:
(1) “Consumer account you offer customers that’s primarily for personal, family or
household purposes that involves or is designed to permit multiple payments or
transactions; or
(2) Any other account that a financial institution or creditor offers or maintains for which
there is a reasonably foreseeable risk to customers or to the safety and soundness of the
financial institution or creditor from identity theft, including financial, operational,
compliance, reputation, or litigation risks.”155
Healthcare institutions will have to (1) review their billing practices and payment procedures and
(2) create a program to ensure compliance.156 Written compliance programs must include
strategies and procedures for identifying existing red flags, avoiding future red flags violations,
preventing and mitigating identity theft, and developing and implementing a procedure for reevaluating and updating program protocols.157 Although varying degrees of detail are required
depending on organizational complexity, all enterprises, healthcare and otherwise, may be
subject to regulation under the Red Flags Rules.158
The Red Flags Rules were updated in 2013 to include four elements that create the framework
for dealing with the possibility of identity theft. These elements require that:
(1) A program must include reasonable policies and procedures to identify the red flags of
identity theft that may occur in an organization’s day-to-day operations;
(2) A program must be designed to detect the red flags the organization has identified;
A program must spell out appropriate actions an organization will take when it detects
red flags; and
(3) A program must detail how an organization will keep its red flag program current to
reflect new threats.159

153 “Identify Theft Red Flags and Address Discrepancies Under the Fair and Accurate Credit Transactions Act of 2003; Final Rule” Federal
Register Vol. 72, No. 217 (November 9, 2007), p. 63718.
154 “Fighting Identity Theft with the Red Flags Rule: A How-to Guide for Business” Federal Trade Commission, May 2013,
http://www.ftc.gov/tips-advice/business-center/guidance/fighting-identity-theft-red-flags-rule-how-guide-business (Accessed 2/21/15).
155 Ibid.
156 Ibid.
157 Ibid.
158 Ibid.
159 “Identity Theft Red Flag Rules; Final Rule” Federal Register Vol. 78, No. 76 (April 19, 2013), p. 23645-46.
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Compliance with the Red Flags Rule is critical to ensure that patient information is protected
from identity theft and other potential fraud. Utilizing the various processes outlined by the FTC
will help health businesses and organizations avoid threats against their protected information.

THE PATIENT SAFETY AND QUALITY IMPROVEMENT ACT OF 2005
The Patient Safety and Quality Improvement Act (PSQIA) of 2005, which became effective on
January 19, 2009, established a voluntary reporting system for medical errors to increase the
availability of such quality reporting and to more efficiently address issues related to patient care
and quality.160 Under PSQIA, confidentiality provisions to protect “patient safety work product”
were established such that reporting organizations may maintain compliance with HIPAA and
other regulations, guidelines, and rules.161 Patient safety work product includes any information
that is collected while reporting and analyzing patient safety events.162 Under PSQIA, Patient
Safety Organizations are charged with collecting and analyzing data under the supervision of the
Agency for Healthcare Research and Quality.163

FRAUD AND ABUSE LAWS
With the increase in the corporatization of medicine, governmental authorities have engaged in
heightened regulatory scrutiny of healthcare transactions to prevent fraud and abuse within the
healthcare industry. These fraud and abuse enforcement regulations have enabled the
government to recover billions of dollars. In December 2014, the Office of the Inspector General
(OIG) released a statement announcing that approximately $4.9 billion would be returned to
federal coffers as a result of fraud and abuse enforcement in FY2014.164 See the table below for a
more extensive list of total indictments, convictions, civil suits, and monetary collections from
fraud and abuse legal proceedings from 1997-2014.

FALSE CLAIMS ACT (FCA)
The False Claims Act (FCA) is a federal statute that creates civil liability for any person who
“knowingly presents, or causes to be presented, to an officer or employee of the United States
government or a member of the Armed Forces of the United States a false or fraudulent claim for

160 “Patient Safety and Quality Improvement; Final Rule” Federal Register Vol. 73, No. 226 (November 21, 2008), p. 70732; “Health
Information Privacy: Understanding Patient Safety Confidentiality” Department of Health and Human Services, 2010,
http://www.hhs.gov/ocr/privacy/psa/understanding/index.html (Accessed 2/4/10).
161 “Patient Safety and Quality Improvement; Final Rule” Federal Register Vol. 73, No. 226 (November 21, 2008), p. 70734; “Patient Safety
and Quality Improvement Act of 2005” Agency for Healthcare Research and Quality, December 2012, http://archive.ahrq.gov/news/
newsroom/press-releases/2008/psoact.html (Accessed 3/16/15).
162 “Patient Safety and Quality Improvement; Final Rule” Federal Register Vol. 73, No. 226 (November 21, 2008), p. 70739.
163 “Health Information Privacy: Understanding Patient Safety Confidentiality” Department of Health and Human Services, 2010,
http://www.hhs.gov/ocr/privacy/psa/understanding/index.html (Accessed 2/4/10).
164 “Nearly $5 Billion to be Returned to Taxpayers as a Result of OIG Work in FY 2014” Office of Inspector General, News Release,
December 10, 2014, http://oig.hhs.gov/newsroom/news-releases/2014/sar14fall.asp (Accessed 2/25/15).
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Table 3-1: Total Indictments, Convictions, Civil Suits, and Monetary Collections From Fraud
and Abuse Legal Proceedings, 1997-2014165
Year

Total Criminal
Indictments

Total
Convictions

1997166
1998167
1999168
2000169
2001170
2002171
2003172
2004173
2005174
2006175
2007176
2008177
2009178
2010179
2011180
2012181
2013182
2014183
Total

Total Civil
Matters
Pending

Monetary
Collections
(Millions)

282
322
371
457
445
361
362
1,002
935
836
878
957
1,014
1,116
1,110
1,131
1,013
849
13,441

363
326
396
467
465
480
437
459
523
547
560
588
583
726
743
826
718
760
9,967

4,010
3,741
2,278
1,995
1,746
1,529
1,277
1,362
1,334
2,016
743
1,311
1,155
1,290
1,069
1,023
1,079
2,771
31,729

$1,200
$480
$524
$1,200
$1,700
$1,800
$1,800
$605
$1,470
$2,200
$1,800
$1,000
$1,630
$2,500
$2,400
$3,000
$2,600
$3,311
$31,220

165 “Health Care Fraud and Abuse Control Program Report” Office of Inspector General, 2014, http://oig.hhs.gov/reports-andpublications/hcfac/index.asp (Accessed 2/25/15).
166 “Health Care Fraud and Abuse Control Program Annual Report For FY 1997” Department of Health and Human Services and Department
of Justice, January 1998, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport1997.PDF (Accessed 3/6/15), p. 1.
167 “Health Care Fraud and Abuse Control Program Annual Report For FY 1998” Department of Health and Human Services and Department
of Justice, February 1999, http://oig.hhs.gov/publications/docs/hcfac/HCFAC%20Annual%20Report%20FY%201998.htm (Accessed
3/6/15).
168 “Health Care Fraud and Abuse Control Program Annual Report For FY 1999” Department of Health and Human Services and Department
of Justice, January 2000, http://oig.hhs.gov/publications/docs/hcfac/HCFAC%20Annual%20Report%20FY%201999.htm (Accessed
3/6/15).
169 “Health Care Fraud and Abuse Control Program Annual Report For FY 2000” Department of Health and Human Services and Department
of Justice, January 2001, http://oig.hhs.gov/publications/docs/hcfac/HCFAC%20Annual%20Report%20FY%202000.htm (Accessed
3/6/15).
170 “Health Care Fraud and Abuse Control Program Annual Report For FY 2001” Department of Health and Human Services and Department
of Justice, April 2002, http://oig.hhs.gov/publications/docs/hcfac/HCFAC%20Annual%20Report%20FY%202001.htm (Accessed 3/6/15).
171 “Health Care Fraud and Abuse Control Program Annual Report For FY 2002” Department of Health and Human Services and Department of
Justice, September 2003, http://oig.hhs.gov/publications/docs/hcfac/HCFAC%20Annual%20Report%20FY%202002.htm (Accessed 3/6/15).
172 “Health Care Fraud and Abuse Control Program Annual Report For FY 2003” Department of Health and Human Services and Department
of Justice, December 2004, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2003A.htm (Accessed 3/6/15).
173 “Health Care Fraud and Abuse Control Program Annual Report For FY 2004” Department of Health and Human Services and Department
of Justice, September 2005, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2004.htm (Accessed 3/6/15).
174 “Health Care Fraud and Abuse Control Program Annual Report For FY 2005” Department of Health and Human Services and Department
of Justice, August 2006, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2005.pdf (Accessed 3/6/15), p. 1.
175 “Health Care Fraud and Abuse Control Program Annual Report For FY 2006” Department of Health and Human Services and Department
of Justice, November 2007, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2006.pdf (Accessed 3/6/15), p. 1.
176 “Health Care Fraud and Abuse Control Program Annual Report For FY 2007” Department of Health and Human Services and Department
of Justice, November 2008, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2007.pdf (Accessed 3/6/15), p. 1.
177 “Health Care Fraud and Abuse Control Program Annual Report For FY 2008” Department of Health and Human Services and Department
of Justice, September 2009, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2008.pdf (Accessed 3/6/15), p. 1.
178 “Health Care Fraud and Abuse Control Program Annual Report For FY 2009” Department of Health and Human Services and Department
of Justice, May 2010, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2009.pdf (Accessed 3/6/15), p. 1.
179 “Health Care Fraud and Abuse Control Program Annual Report For FY 2010” Department of Health and Human Services and Department
of Justice, January 2011, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2010.pdf (Accessed 3/6/15), p. 1.
180 “Health Care Fraud and Abuse Control Program Annual Report For FY 2011” Department of Health and Human Services and Department
of Justice, February 2012, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2011.pdf (Accessed 3/6/15), p. 1.
181 “Health Care Fraud and Abuse Control Program Annual Report For FY 2012” Department of Health and Human Services and Department
of Justice, February 2013, http://oig.hhs.gov/publications/docs/hcfac/hcfacreport2012.pdf (Accessed 3/6/2015), p. 1.
182 “Health Care Fraud and Abuse Control Program Annual Report For FY 2013” Department of Health and Human Services and Department
of Justice, February 2014, http://oig.hhs.gov/publications/docs/hcfac/FY2013-hcfac.pdf (Accessed 3/6/15), p. 1.
183 “Health Care Fraud and Abuse Control Program Annual Report For FY 2014” Department of Health and Human Services and Department
of Justice, March 2015, http://oig.hhs.gov/publications/docs/hcfac/FY2013-hcfac.pdf (Accessed 3/6/15), p. 1.
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payment or approval.”184 Since Congress substantially amended the FCA in 1986, it has
developed into one of the most important enforcement methods used by the government
to combat healthcare fraud, particularly when used in conjunction with the federal physician
self-referral (Stark) law and the federal Anti-Kickback statute.185 In particular, physician
acceptance of kickbacks (that is, monetary bribes, free travel, and various other prerequisites)
from pharmaceutical and medical device manufacturers, as well as health systems, has come
under increased scrutiny as violations of the FCA.186 The 1986 amendments strengthened the
statute’s qui tam, or whistleblower, provision,187 allowing any private citizen to enforce the FCA
by filing a complaint against a party alleging fraud against the federal government.188 Qui tam
actions are often brought by former employees, but they can also be brought by competitors.189
The DOJ assumes primary responsibility for prosecuting the claim if it intervenes,190 and the
whistleblower is entitled to a portion of any recovery the government obtains.191 Potential
liability can be significant since the FCA provides for treble damages plus an additional penalty
for each false claim.192
One of the primary provisions contained in the FCA is the prohibition against provider upcoding,
defined as the “practice of improperly assigning a diagnosis code to a patient discharge that is
not supported by the medical record for the purpose of obtaining a higher level of reimbursement
from Medicare for that hospital discharge than the hospital would otherwise receive.”193
Another critical FCA provision is the prohibition against submitting claims to the federal
government for outlier payments. The outlier and stop-loss payments refer to the remuneration
providers receive for complicated or/or costly procedures that are not sufficiently covered by the
Diagnostic Related Groups (DRG) formula used for hospital inpatient reimbursement.194
Specifically, outlier payments consist of remunerations from Medicare, while stop-loss payments
consist of reimbursements from managed care organizations.
In 2013, the OIG investigated outlier payments to hospitals following a 2003 policy change from
CMS to ensure better accuracy of outlier payments.195 The investigation, published in a 2013
study, found that the majority of hospitals received outlier payments and some received
significantly higher proportions of reimbursements from these outlier payments. Specifically,
these payments averaged 12.8% of Medicare inpatient prospective payment system
reimbursements in 158 hospitals, compared to only 2.2% for all other hospitals. The study found
184 “Civil Actions for False Claims” 31 U.S.C. § 3729(a) (1994).
185 “Health Care Fraud and Abuse: Practical Perspectives” By Linda A. Baumann, Health Law Section of the American Bar Association,
Washington, DC: BNA Books, 2002, p. 112-113.
186 “Anti-Kickback Enforcement and Legislation Developments: What Drug, Medical Device and Biologics Companies Must Know” By Karen
Gibbs, BNA Pharmaceutical Law & Industry Report, Vol. 6, No. 10 (March 7, 2008), http://www.crowell.com/documents/Anti-KickbackEnforcement-and-Legislation-Developments_Pharmaceutical-Law_Gibbs.pdf (Accessed 9/02/09), p. 1-2.
187 “The 1986 False Claims Act Amendments: A Retrospective Look at Twenty Years of Effective Fraud Fighting In America” Taxpayers
Against Fraud, 2006, http://www.taf.org/retrospective.pdf (Accessed 9/2/09), p. 5.
188 “Civil Actions for False Claims” 31 U.S.C. § 3730(b) (1994).
189 “Qui Tam Actions Under the False Claims Act” By James G. Gumbert, Medical Journal-Houston, July 2003, p. 1.
190 “Civil Actions for False Claims” 31 U.S.C. § 3730(c)(1) (1994).
191 “Civil Actions for False Claims” 31 U.S.C. § 3730(d)(1) (1994).
192 “Civil Actions for False Claims” 31 U.S.C. § 3729(a) (1994).
193 “Five Tenet Hospitals in Florida Pay United States $4.3 Million for Allegedly Violating False Claims Act” Department of Justice, February
10, 2003, http://www.justice.gov/archive/opa/pr/2003/February/03_civ_085.htm (Accessed 2/23/15).
194 See Chapter 2, Reimbursement Environment.
195 “Medicare Hospital Outlier Payments Warrant Increased Scrutiny” Office of Inspector General, November 13, 2013, http://oig.hhs.gov/oei/
reports/oei-06-10-00520.pdf (Accessed 2/23/15), p. ii.

219

Adviser's Guide to Healthcare

that the high-outlier hospitals charged substantially more to Medicare for the same DRGs than
did all others.
As detailed below, the federal government has utilized and modified the FCA as a basis for
increasing enforcement of fraud and abuse laws and heightened scrutiny of healthcare
arrangements.

Fraud Enforcement and Recovery Act of 2009 (FERA)
In 2009, the federal government enacted the Fraud Enforcement and Recovery Act of 2009
(FERA), which changes what the United States Supreme Court has interpreted to be the FCA’s
definition of “knowingly” to ensure the designation is more in line with the intent of the law.196
Under the new definition the government need only prove by a preponderance of the evidence
that a person who acts “knowingly,” “(1) has actual knowledge of the information; (2) acts in
deliberate ignorance of the truth or falsity of the information; or (3) acts in reckless disregard of
the truth or falsity of the information,”197 thereby reducing the government’s burden of proof by
removing the requirement of showing specific intent to defraud.198
FERA also expanded the definition of “claim” to include any request for money or property
offered to a government employee or official.199 The definition now includes any attempt to
defraud the government regardless of whether the government currently has title to the money,
and the government need not prove any specific intent to defraud the government.200 Further,
organizations are only liable if they “knowingly” retain improper payments.201
Another FERA amendment to the FCA was related to civil investigative demands (CIDs).202
Similar to a subpoena, the U.S. Attorney General can use CIDs to gather evidence without court
approval prior to filing an official complaint against parties suspected of violating the FCA.203
The amendment also expands the definition of “official use” to allow the government to use the
information obtained through CID communications with other government departments.204

Health Care Fraud Prevention and Enforcement Action Team (HEAT)
In May 2009, HHS Secretary Kathleen Sebelius and Attorney General Eric Holder announced
the establishment of HHS’s Healthcare Fraud Prevention and Enforcement Action Team
(HEAT), a group comprised of both HHS and DOJ investigators.205 Funded through the Health
Care Fraud and Abuse Control (HCFAC) Program, HEAT focuses on fraud prevention and
196 “Fraud Recovery Bill Has Healthcare Implications” By Ben Amirault, Health Leaders Media, April 29, 2009, http://www.healthleaders
media.com/content/PHY-232249/Fraud-Recovery-Bill-Has-Healthcare-Implications.html (Accessed 5/6/10).
197 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1622 (January 6, 2009).
198 “Fraud Recovery Bill Has Healthcare Implications” By Ben Amirault, Health Leaders Media, April 29, 2009, http://www.healthleaders
media.com/content/PHY-232249/Fraud-Recovery-Bill-Has-Healthcare-Implications.html (Accessed 5/6/10).
199 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1622 (January 6, 2009).
200 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1622 (January 6, 2009).
201 “Concerns with Proposed Amendments to the Fraud Enforcement and Recovery Act of 2009” By American Hospital Association et al., To
the Members of the United States Senate, April 21, 2009, http://www.aha.org/aha/letter/2009/090421-FCA-Sen-ltr.pdf (Accessed 05/05/09),
p. 1.
202 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1623 (January 6, 2009).
203 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1623-24 (January 6, 2009).
204 “Fraud Enforcement and Recovery Act” Pub. L. No. 111-21, § 4, 123 Stat. 1617, 1624 (January 6, 2009).
205 “HEAT Task Force” Stop Medicare Fraud, http://www.stopmedicarefraud.gov/aboutfraud/heattaskforce/ (Accessed 2/25/15).
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elimination by identifying patterns of suspected fraudulent activity, and acts through the
Medicare Fraud Strike Force, which was established in 2007 to combat Medicare fraud through
Medicare data analysis techniques focusing on community policing.206 Between 2008 and 2011,
HEAT was able to increase its criminal healthcare fraud charges 75%,207 and in 2012, HEAT’s
Medicare Fraud Strike Force coordinated the largest healthcare fraud takedown across seven
cities that involved $452 million in fraudulent billing by 107 individuals.208 As of December 31,
2014, the Medicare Fraud Strike Force has teams operating in nine cities that have accumulated
1,227 criminal actions, 1,773 indictments, and $1.579 billion in recovered fraudulent charges.209

Dodd-Frank Act
Signed into law on July 21, 2010, the Dodd-Frank Act expanded the scope of the FCA’s
protections from employer retaliation and created additional protections and financial incentives
for whistle-blowing employees who disclose violations of federal securities and consumer
protection laws.210 In addition, the Dodd-Frank Act expands the scope of potential
whistleblowers under the FCA to include both current and former employees, vendors, and
independent contractors.211 Furthermore, Dodd-Frank provides employees with a three-year
statute of limitations to bring an FCA civil claim against the employer for retaliatory actions.212
Dodd-Frank applies to any type of financial fraud by a company under the jurisdiction of the
Securities and Exchange Commission (SEC) or the Commodities Futures Trading Commission
(CFTC), whereas the FCA applies only to financial fraud against the government.213 For
example, under Dodd-Frank, the government can bring claims against an employer for off-label
pharmaceutical marketing, defective pricing, or falsely charging for goods or services that it did
not provide (similar to filing false Medicare claims).214

ANTI-KICKBACK STATUTE
Enacted in 1972, the federal Anti-Kickback statute makes it a felony for any person (including a
physician, allied health professional, or paraprofessional with a Medicare provider number) to
“knowingly and willfully” solicit or receive or to offer or pay any “remuneration” directly or
indirectly in exchange for the referral of a patient for a healthcare service paid for by a federal

206 “Statement of William Corr on Efforts to Combat Health Care Fraud and Abuse Before Committee on Appropriations Subcommittee on
Labor, Health and Human Services, Education, and Related Agencies” Department of Health and Human Services, March 4, 2010,
http://www.hhs.gov/asl/testify/2010/03/t20100304a.html (Accessed 3/11/2015).
207 “HEAT Task Force” Stop Medicare Fraud, http://www.stopmedicarefraud.gov/aboutfraud/heattaskforce/ (Accessed 2/25/15).
208 “Historic Medicare Fraud Strike Force Takedown” Federal Bureau of Investigation, U.S. Department of Justice, Posted on FBI News Blog,
May 2, 2012, http://www.fbi.gov/news/news_blog/strike-force-takedown-050212 (Accessed 2/25/15).
209 “Medicare Fraud Strike Force” Office of Inspector General, December 31, 2014, http://oig.hhs.gov/fraud/strike-force/ (Accessed 2/25/15).
210 “Dodd-Frank Wall Street Reform and Consumer Protection Act” Pub. L. 111-203, § 1079A(c), 124 Stat. 1376, 2079-2080 (July 21, 2010);
(July 21, 2010); “Dodd-Frank: The Spillover Impact on Nonprofit Healthcare” By Michael Peregrine and Timothy Cotter, American Health
Lawyers Association, American Health Lawyers Weekly, Vol. VIII, No. 29, July 30, 2010,
http://www.mwe.com/info/pubs/The_Spillover_Impact_On_Nonprofit_Healthcare.pdf (Accessed 3/11/2015), p. 3.
211 “Dodd-Frank Wall Street Reform and Consumer Protection Act” Pub. L. 111-203, §§ 929F, 1079A, 124 Stat. 1376, 1854, 2079 (July 21,
2010).
212 “Dodd-Frank Wall Street Reform and Consumer Protection Act” Pub. L. 111-203, § 1079A, 124 Stat. 1376, 2079 (July 21, 2010).
213 “Dodd-Frank: Picking Up Where SOX Fell Short” By Lynne Ann Anderson and Meredith R. Murphy, New Jersey Labor and Employment
Law, New Jersey State Bar Association, Spring 2012, p. 19.
214 Ibid.
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healthcare program.215 Violations of the Anti-Kickback statute are punishable by either a prison
sentence up to five years, criminal fines up to $25,000, or both.216
In 1987, Congress amended the original 1972 version of the Anti-Kickback statute with the
passage of the Medicare and Medicaid Patient and Program Protection Act of 1987 (MMPPPA),
which allows for exclusion from the Medicare and Medicaid program as an alternative civil
remedy to criminal penalties.217 Also, under the MMPPPA, the “intent” requirement under the
Anti-Kickback statute changed from a party who "knows or has reason to know" that a particular
billing or referral action might be considered fraud, to any party who "knows or should know."218
The Balanced Budget Act of 1997 added a civil monetary penalty of treble damages, or three
times the illegal remuneration, plus $50,000 per violation. Civil monetary penalties may be a
more effective way of enforcing the statute’s prohibition, as the government need not prove the
Anti-Kickback violation by the criminal standard of beyond a reasonable doubt.219
The ACA made additional changes to the intent standard for the Anti-Kickback Statute. First, the
ACA amended the statute to specify that a person need not have actual knowledge of the statute
or a specific intent to commit a violation of the statute in order for the government to prove a
violation of the statute occurred.220 Second, the ACA added that a “claim that includes items or
services resulting from a violation [of the statute] constitutes a false or fraudulent claim for
purposes” of the FCA.221

Regulatory and Court Interpretations of Statute
The OIG periodically issues Special Fraud Alerts, which are public announcements that provide
insight into how the OIG believes the statute should be applied to particular business
arrangements and which arrangements will violate the statute. The OIG has issued Special Fraud
Alerts on a number of topics, including joint venture arrangements, clinical laboratory services,
and rental agreements for space in physician offices.222
Beyond the issuance of Special Fraud Alerts, the OIG has adopted and advocated for expansive
interpretations of the statute, such as the one purpose test, which has been followed by multiple
federal appellate courts.223 Because of these expansive interpretations, detailed below, as well as
215 “Criminal Penalties for Acts Involving Federal Health Care Programs” 42 U.S.C. § 1320a-7b(b) (1997).
216 Ibid.
217 “Medicare and Medicaid Patient & Program Protection Act of 1987” Pub. L. 100-93 § 2, 101 Stat. 680, 680-684 (August 18, 1987);
“Medicare and State Health Care Programs: Fraud and Abuse OIG Safe Harbor Provisions” Federal Register Vol. 56 (July 29, 1991),
p. 35952.
218 “The Criminalization of American Medicine: 1965-1993” By Madeleine P. Cosman, The Kaiser Papers, September 11, 2000,
http://businesspractices.kaiserpapers.org/criminalizationofamericanmedicine.html (Accessed 08/17/12).
219 “Federal Anti-Kickback Statute Primer” By Robert G. Homchick, American Health Lawyers Association,
https://www.healthlawyers.org/Events/Programs/Materials/Documents/FC12/101_homchick_williams.pdf (Accessed 3/11/2015), p. 9;
“Teaching the Anti-Kickback Statute: How to Advise Clients” By Robert Miller, American Health Lawyers Association,
https://www.healthlawyers.org/hlresources/Academics/LawProfessors/AdviceColumns/Pages/Teaching_the_Anti-Kickback_Statute.aspx
(Accessed 3/11/2015).
220 “Health Care Reform: Substantial Fraud and Abuse and Program Integrity measures Enacted” McDermott Will & Emery, April 12, 2010,
http://www.mwe.com/info/news/wp0410a.pdf (Accessed 3/2/15) p. 3; “Patient Protection and the Affordable Care Act,” Pub. L. 111-148, §
6402, 124 Stat. 119, 759, (March 23, 2010).
221 Ibid.
222 “Special Fraud Alerts” Office of Inspector General, https://oig.hhs.gov/compliance/alerts/index.asp (Accessed 2/12/15).
223 “U.S. v. Greber” 760 F.2d 68, 72 (3d Cir. 1985); “Medicare and Medicaid Programs; Fraud and Abuse OIG Anti-Kickback Provisions”
Federal Register Vol. 74 (January 23, 1989), p. 3088.
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heightened regulatory scrutiny, healthcare industry actors and their advisors should be highly
cognizant that many financial relationships could violate the Anti-Kickback statute.224
Thornton Letter—Office of the Inspector General
The increased OIG review and overall heightened amount of regulatory scrutiny of the U.S.
healthcare industry has coincided with recent surges in exempt hospital/physician practice
transactions. While issues surround the legal permissibility of the payment of consideration for
intangible assets in exempt hospital/physician practice transactions is not new, the concern as to
when payments of consideration for physician practice intangible assets would be legally
permissible under the Anti-Kickback statute225 and the Internal Revenue Code (IRC)226 has
gained less attention since the 1990s. This regulatory scrutiny was particularly prevalent during
the period immediately following the much-publicized December 22, 1992 letter from D.
McCarty Thornton, Esq. to T. J. Sullivan, Esq.,227 the history and evolution of which is
instructive. That December 22, 1992 letter stated that, “accordingly, when attempting to assess
the fair market value attributable to a physician’s practice, it may be necessary to exclude from
consideration any amounts which reflect, facilitate or otherwise relate to the continuing treatment
of the former practice’s patients.”228 Thornton further stated that, “specific items that we believe
would raise a question as to whether payment was being made for the value of a referral stream
would include, among other things: payment for goodwill.”229
At the time of its issuance, many asserted that Thornton’s statements should be interpreted to
mean that hospitals could legally pay only for the tangible assets of a physician practice.
However, the letter did not constitute, in and of itself, a regulatory ruling regarding the legal
permissibility of including payment of consideration for intangibles in the transaction price.
Rather, it was simply an advisory admonition that payments for these items “may,” or “would
likely,” be held to a higher level of scrutiny, which provides insight into OIG enforcement trends
but is not binding authority.230 Subsequent to the December 1992 letter, in a November 2, 1993
letter responding to John E. Steiner, Esq.,231 Thornton further explained his position regarding
the payment for intangibles, “clarifying” that:

224 “OIG Advisory Opinion No. 04-08” Office of Inspector General, Advisory Opinion, June 30, 2004, http://oig.hhs.gov/fraud/docs/
advisoryopinions/2004/AdvOp04-08B.pdf (Accessed 5/10/10), p. 3.
225 "Criminal Penalties for Acts Involving Federal Healthcare Programs” 42 U.S.C. § 1320a-7b (2010).
226 "Taxes on Excess Benefit Transactions" 26 U.S.C. § 4958 (2011).
227 “The Application of the Medicare and Medicaid Anti-Kickback Statute” By D. McCarty Thornton, Associate General Counsel, Inspector
General Division, U.S. Department of Health and Human Services, To T.J. Sullivan, Technical Assistant, office of the Associate Chief
Counsel, Internal Revenue Service, December 22, 1992, http://oig.hhs.gov/fraud/docs/safeharborregulations/acquisition122292.htm
(Accessed 4/18/12), p. 1.
228 “The Application of the Medicare and Medicaid Anti-Kickback Statute” By D. McCarty Thornton, Associate General Counsel, Inspector
General Division, U.S. Department of Health and Human Services, To T.J. Sullivan, Technical Assistant, office of the Associate Chief
Counsel, Internal Revenue Service, December 22, 1992, http://oig.hhs.gov/fraud/docs/safeharborregulations/acquisition122292.htm
(Accessed 4/18/12), p. 3.
229 Ibid.
230 “Fraud and Abuse Considerations in Establishing Integrated Delivery Systems” By Carrie Valiant, AHLA Seminar Materials, 1993, p. 6-7.
231 “RE: Requesting Assistance in Interpreting the Scope of Prohibited Referrals under the Medicare and Medicaid Anti-Kickback Statute with
Respect to the Acquisition of Physician Practices” by D. McCarty Thornton, Associate General Counsel, Inspector General Division, U.S.
Department of Health and Human Services, To John E. Steiner, Jr., Esq., Assistant General Counsel, American Hospital Association,
November 2, 1993, http://oig.hhs.gov/fraud/docs/safeharborregulations/acquisition110293.htm (Accessed 5/10/12), p. 1.
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“I would like to emphasize that the position I articulated in the December 22,
1992 letter to T. J. Sullivan remains the same. I did not state that payments for
intangible assets are illegal per se. Nor have I indicated approval of any
particular acquisition practices or valuation methodologies. Since payments for
items other than the hard assets of a physician practice could be a payment to
induce referrals or could be in return for future referrals, any such payments are
subject to scrutiny to determine whether they violate the Anti-Kickback statute.
The fact that the parties may identify the purpose of the payment as something
other than a payment for referrals is not determinative.”232 [Emphasis added].
Thereafter, in the seminar materials for Thornton’s 1994 presentation before the American
Health Lawyers Association (AHLA), he continued to “clarify” that:
“Often times, what the hospital is really interested in is the future flow of
business from the practice to the hospital. When the CEO of the hospital sits
down to think about doing such an acquisition, and calculating the price that he
or she is willing to pay, what they are really thinking about is what the flow of
business is going to look like from the group practice to the hospital over the
next 15, 20, 25 years, however long they figure the doctors are going to be
around to refer business. What is it worth to the hospital to lock in the stream of
business? It is illegal under the Anti-Kickback statute to pay doctors now for the
flow of business that you expect from them in the next 15 to 20 years. Everyone
knows this, at least everyone experienced in the health care bar, so you never see
payments allocated to the value of the future referral stream. What we have seen
is that the value of the future referral stream sometimes is disguised as things like
goodwill of the patients to the group practice, the value of patient records, the
value of an ongoing business, etc. These are all intangibles. I am not saying that
it is unlawful to pay for intangibles, but we see the valuation of these intangibles
puffed up through creative accounting games to disguise payment for what is
often one of the primary intentions of the hospital, that is, to lock in the referral
stream from the practice to the hospital.”233 [Emphasis added].
It is important to note that the matter of the recipient of the economic benefit derived from the
intangible asset in question is the often overlooked and misunderstood gravamen of the entire
issue as to the legal permissibility regarding the payment of consideration for goodwill and
intangible assets. With careful consideration of the fact that the intangible asset being valued
does not constitute a disguised payment to physicians for future referrals to the hospital, which
would constitute remuneration under the Anti-Kickback statute, and instead reflects only the
current Fair Market Value of those intangible assets typically found to exist in physician practice
enterprises, it would comport with the statements made in Thornton’s continued “clarification”
in his 1994 AHLA presentation, which stated that exempt hospital organizations can, in fact, pay
for the intangible assets of a physician practice, to wit:

232 Ibid, p. 2.
233 “Impact of the Anti-Kickback Statute and the Stark Amendment on Vertically Integrated Delivery Systems in the Health Care Industry” By
D. McCarty Thornton, American Health Lawyers Association Seminar Materials, 1994, p. 3.
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“In December 1992 I wrote a letter to the IRS that has gotten a fair amount of
publicity in the trade press. There has been somewhat of an overreaction to this
letter, because I am not saying you can never pay for goodwill, that you can never
pay for the value of an ongoing business unit, etc. Our concern is where the
payment for intangibles is used as a disguise for the intention of the parties to
recompensate the practice for the future flow of patients from the practice to the
hospital. That would be illegal.”234 [Emphasis added].
The evolving nature of Thornton’s comments demonstrates misinterpretations of the December
1992 letter by some in the valuation community immediately following its initial issuance.
“One Purpose” Test
The one purpose test, established in United States v. Greber, is a prominent example of courts
adopting an expansive interpretation of the Anti-Kickback statute. Under the one purpose test,
healthcare providers violate the Anti-Kickback statute if even one purpose of the arrangement in
question is to offer illegal remuneration.235 Subsequently adopted by the OIG, under the one
purpose test providers can reasonably expect referrals to result from a business arrangement, but
will such arrangements survive regulatory scrutiny if the expectation must not be a reason for
entering into the arrangement?236 Critics of the one purpose test claim that it treats a legitimate
relationship with a referral component in the same manner as an arrangement primarily intended
to violate the statute and increase the potential for fraud.237 Opponents also argue that it is
impossible for providers to expect referrals while also not considering referrals when entering
into a business arrangement.238
Special Fraud Alert: Physician-Owned Distributorships
In 2013, the OIG issued a Special Fraud Alert regarding Physician-Owned Distributorships
(PODs) that gain revenue from selling or arranging the sale of medical devices ordered and used
by physician-owners on their own patients.239 The OIG is concerned that such POD
arrangements contain questionable features including, but not limited to:
(1) Selecting investors because they are in a position to generate substantial business for the
entity;
(2) Requiring investors who cease practicing in the service area to divest their ownership
interests; and
(3) Distributing returns on investment compared to the level of risk involved.240
234 Ibid, p. 4.
235 “The Hypocrisy of the One Purpose Test in Anti-Kickback Enforcement Law” By Eugene E. Elder, BNA Health Care Fraud Report, Vol. 4,
No. 15 (July 26, 2000), http://www.akingump.com/files/Publication/ef37d179-30e2-4266-b4f8-a8481641073c/Presentation/Publication
Attachment/eada4c55-dae7-498d-befa-adefb6d82b9d/445.html (Accessed 10/06/09), p. 3; “U.S. v. Greber” 760 F.2d 68, 72 (3d Cir. 1985).
236 “Medicare and Medicaid Programs; Fraud and Abuse OIG Anti-Kickback Provisions” Federal Register Vol. 54 (January 23, 1989), p. 3088.
237 “United States v. Dan Anderson” American Hospital Association et al., Brief Amici Curiae, June 6, 2000, www.hospitalconnect.com/
aha/advocacy-grassroots/advocacy/legal/anderson200066.html (Accessed 02/27/05), p. 1.
238 “The Hypocrisy of the One Purpose Test in Anti-Kickback Enforcement Law” By Eugene E. Elder, BNA Health Care Fraud Report, Vol. 4,
No. 15 (July 26, 2000), http://www.akingump.com/files/Publication/ef37d179-30e2-4266-b4f8a8481641073c/Presentation/PublicationAttachment/eada4c55-dae7-498d-befa-adefb6d82b9d/445.html (Accessed 10/06/09), p. 546.
239 “Special Fraud Alert: Physician-Owned Entities” Office of Inspector General, Department of Health and Human Services, March 26, 2013,
p. 1.
240 Ibid, p. 2.
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If a POD displays questionable features, OIG is usually concerned that medical judgment is
corrupt, medical devices are over-utilized, Federal healthcare programs or beneficiaries are
overcharged, or competition is unfair.241 The Fraud Alert contains a non-exhaustive list of
suspicious characteristics that could be cause for investigation into a POD and reiterates the
OIG’s position that it is “inherently suspect” of PODs under the federal Anti-Kickback
Statute.242 Furthermore, the Fraud Alert notes that OIG considers the intent of both parties,
regardless of whether the party contracting with the POD is a physician, hospital, or ambulatory
service center.243 Physicians and their advisers may find it beneficial for outside counsel to
examine any potential PODs to determine whether or not their arrangement may implicate many
of the concerns noted by the OIG.

Safe Harbors
Due to the broadness of the Anti-Kickback statute, legitimate business arrangements by
healthcare providers may be prohibited. For example, under a literal interpretation of the statute,
a physician would not be allowed to receive dividend payments from a publicly traded
pharmaceutical company if the physician prescribed products produced by the company.244 In
response to these and other harmless arrangements, Congress created a number of statutory
exceptions and gave HHS authority to protect other business arrangements through safe
harbors.245 Safe harbors detail specific regulatory criteria that must be met to shield the parties
to a business arrangement from liability, and they are meant to protect practices unlikely to result
in fraud or abuse.246 The failure to comply with every requirement of a safe harbor does not
mean that the arrangement is illegal,247 so long as there is a low risk of fraud and abuse.248
The MMPPPA directed HHS to promulgate regulations specifying payment practices that did not
violate the Anti-Kickback statute. Congress created the following statutory exemptions from the
statute to protect legitimate business arrangements, including:
(1)
(2)
(3)
(4)

241
242
243
244
245
246
247
248
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Properly disclosed discounts;
Payments to bona fide employees for employment;
Certain payments to group purchasing organizations;
Co-insurance waivers to Medicare services for patients qualifying for certain public
health service programs;

Ibid, p. 2.
Ibid, p. 3-4.
Ibid, p. 4.
“Medicare and Medicaid Programs; Fraud and Abuse OIG Anti-Kickback Provisions: Supplementary Information; II. Provisions of the
Proposed Rule” Federal Register Vol. 54 (July 23, 1989), p. 3088
“Exceptions” 42 C.F.R. § 1001.952 (June 11, 2009).
“Medicare and State Health Care Programs: Fraud and Abuse; Clarification of the Initial OIG Safe Harbor Provisions and Establishment of
Additional Safe Harbor Provisions. Under the Anti-Kickback Statute; Final Rule” Federal Register Vol. 64, No. 223 (November 19, 1999),
p. 63518.
Ibid, p. 63519
“OIG Letter Re: Malpractice Insurance Assistance” By Lewis Morris, Office of the Inspector General, January 15, 2003,
http://oig.hhs.gov/fraud/docs/alertsandbulletins/MalpracticeProgram.pdf (Accessed 3/11/2015); “OIG Advisory Opinion 07-10” Office of
the Inspector General, Advisory Opinion, https://oig.hhs.gov/fraud/docs/advisoryopinions/2007/AdvOpn07-10A.pdf (Accessed 3/11/2015),
p. 1-2; “OIG Advisory Opinion 08-14” Office of the Inspector general, Advisory Opinion (October 2, 2008) http://oig.hhs.gov/fraud/
docs/advisoryopinions/2008/AdvOpn08-14.pdf (Accessed 3/11/2015), p. 5; “OIG Advisory Opinion 09-07” Office of the Inspector General,
Advisory Opinion (June 30, 2009), http://oig.hhs.gov/fraud/docs/advisoryopinions/2009/AdvOpn09-07.pdf (Accessed 5/7/10), p. 6.
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(5) Payment practices specified by the HHS secretary in regulations promulgated under the
MMPPPA or nonmonetary remuneration necessary and used solely to receive and
transmit electronic prescription information in accordance with the standards
promulgated under 42 U.S.C. 1395w-104;
(6) Certain risk-sharing and arrangements with managed care organizations;
(7) Waiver or reduction by pharmacies of any cost-sharing imposed under Medicare Part D
which has met certain conditions under 42 U.S.C. 1320a-7a(i)(6)(A);
(8) Any remuneration between a federally qualified health center and a Medicare Advantage
organization pursuant to a written agreement; and
(9) Any remuneration between a healthcare center entity and any entity providing goods,
items, services, donations, loans, or a combination thereof to that entity pursuant to a
contract, lease, grant, loan, or other agreement if such agreement contributes to the ability
of the healthcare center to serve an underserved population.249
The safe harbors to the Anti-Kickback statute were intended to “permit individuals and entities
to freely engage in business practices and arrangements that encourage competition, innovation
and economy.”250 Since 1989, HHS has created a number of safe harbors, and it also clarified
existing safe harbors in 1999. The 1991 safe harbors included promulgations protecting
investments in large publicly-held healthcare companies and investments in small healthcare
joint ventures.251 In 1999, HHS added safe harbors protecting investments in healthcare entities
located in underserved areas, investments in ASCs, and investments in group practices.252 In
2007, HHS promulgated a safe harbor related to arrangements related to federally qualified
health centers (FQHC), which serves as the most recent safe harbor added to the Anti-Kickback
statute.253 However, new safe harbors may be on the horizon. On October 3, 2014, HHS
proposed new safe harbors related to emergency ambulance services, Medicare Part D costsharing waivers and gap discounts, local transportation provided to federal healthcare program
beneficiaries, and limited arrangements between FQHCs and Medicare Advantage
organizations.254
The most important safe harbors for the purposes of physician/hospital integration protect
certain physician investment interests, which Congress intended to safeguard because “[it] did
not intend to bar all investments by physicians in other health care entities,”255 and certain
business investments “represent the extension of a physician’s office space and not a means to
profit from referrals.”256 Further, CMS believed that the risk of improper referrals was relatively
249 “Criminal Penalties for Acts Involving Federal Health Care Programs” 42 U.S.C. § 1320a-7b(b)(3) (1997).
250 “Medicare and Medicaid Programs; Fraud and Abuse OIG Anti-Kickback Provisions: Supplementary Information; II. Provisions of the
Proposed Rule” Federal Register Vol. 54 (July 23, 1989), p. 3088.
251 “Medicare and State Health Care Programs: Fraud and Abuse OIG Safe Harbor Provisions” Federal Register Vol. 56 (July 29, 1991),
p. 35952.
252 “Medicare and State Health Care Programs: Fraud and Abuse; Clarification of the Initial OIG Safe Harbor Provisions and Establishment of
Additional Safe Harbor Provisions Under the Anti-Kickback Statute; Final Rule” Federal Register Vol. 64 (November 19, 1999), p. 63532,
63534, 63540.
253 “Safe Harbor Regulations” Office of Inspector General, U.S. Department of Health and Human Services, 2015, https://oig.hhs.gov/
compliance/safe-harbor-regulations/ (Accessed 3/6/15).
254 “Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil
Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing” Federal Register, Vol. 79, No. 192, (October 3, 2014),
p. 59718.
255 “Medicare and Medicaid Programs; Fraud and Abuse OIG Anti-Kickback Provisions” Federal Register, Vol. 54 (January 23, 1989), p. 3088
256 “Medicare and State Health Care Programs: Fraud and Abuse; Clarification of the Initial OIG Safe Harbor Provisions and Establishment of
Additional Safe Harbor Provisions Under the Anti-Kickback Statute; Final Rule” Federal Register, Vol. 64, No. 223 (November 19, 1999),
p. 63535-63536.
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low when the physician personally performed services at his or her own facility, such as an ASC,
and on his or her own patients.257 Additionally, the investment safe harbors were enacted with
the intent of protecting arrangements that “[could] significantly reduce costs for Federal health
care programs, while simultaneously benefiting patients.”258 In particular, HHS wanted to avoid
“chill[ing] group practice integration that [was] crucial in an increasingly managed care
environment.”259
There are a total of twenty-five safe harbors under the Anti-Kickback statute. Many of these safe
harbors focus on the traditional concept of FMV and the separate and distinct threshold of
commercial reasonableness. These thresholds are discussed in-depth in the Physician
Compensation Restrictions section below, and in Financial Valuation of Enterprises, Assets, and
Services in Consulting with Professional Practices.
While the above exemptions allow federally funded healthcare programs to reduce their potential
liability under the Anti-Kickback statute, many healthcare transactional arrangements business
interactions may still be suspect under the Stark Law.

STARK LAW
The federal physician self-referral, or Stark law, prohibits physicians from referring Medicare or
Medicaid patients to an entity for designated health services if the physician, or an immediate
family member, has a financial relationship with that entity.260 Since its promulgation in 1989,
the Stark law has gone through multiple revisions that have both increased the scope of its
provisions and added exceptions to what kind of transactions the prohibitions apply. This
continued evolution of the Stark Law has coincided with increasing regulatory scrutiny under the
Stark Law, making compliance with this scheme an increasingly pressing issue for healthcare
providers.
Whether an arrangement is subject to the Stark Law rests in part on whether the arrangement fits
within the definition of the core terms constituting the Stark prohibition. HHS defines physician
under Stark law as a “doctor of medicine or osteopathy, a doctor of dental surgery or dental
medicine, a doctor of podiatric medicine, a doctor of optometry, or a chiropractor, as defined in
section 1861(r) of the [Social Security] Act.”261 HHS defines designated health services (DHS)
as “any of the following services…payable, in whole or in part, by Medicare…
(1)
(2)
(3)
(4)
(5)

Clinical Laboratory Services;
Physical Therapy, Occupational Therapy, and Outpatient Speech-Language
Pathology Services;
Radiology and Certain Other Imaging Services;
Radiation Therapy Services and Supplies;
Durable Medical Equipment and Supplies;

257 Ibid.
258 Ibid, p. 63536.
259 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities With Which They Have Financial Relationships; Final
Rule” Federal Register, Vol. 66, No. 3 (Jan 4. 2001), p. 895.
260 “Limitation on Certain Physician Referrals” 42 U.S.C. 1395nn(a)(1)(A) (2012).
261 “Definitions” 42 C.F.R. § 411.351 (October 1, 2014).
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(6)
(7)
(8)
(9)
(10)

Parenteral and Enteral Nutrients, Equipment, and Supplies;
Prosthetics, Orthotics, and Prosthetic Devices and Supplies;
Home Health Services;
Outpatient Prescription Drugs; and
Inpatient & Outpatient Hospital Services.”262

Of particular note under Stark is that services provided at an ASC and billed as part of the ACS’s
facility fee do not constitute DHS—and therefore do not fall under the scope of the Stark law—
unless that service falls within the ten types listed above.263
HHS defines financial relationship as either: (1) a “direct or indirect ownership or investment
interest” in an entity furnishing DHS or (2) a “direct or indirect compensation arrangement” with
an entity furnishing DHS.264
Prohibitions of physician self-referral are similar to the Anti-Kickback legislation, in that both
laws prohibit conduct that induces physicians and other healthcare providers to profit from
referring patients to healthcare entities based on financial motives. The difference between the
two statutes is that the self-referral prohibition addresses the financial incentives of the physician
who makes the referral, and the Anti-Kickback statute is concerned with the financial
relationship between healthcare providers and individuals other than physicians.265 The other
important difference between the regulations is that the self-referral prohibitions apply only to
Medicare and Medicaid, but the Anti-Kickback legislation applies to all federally-funded
healthcare programs.266

Regulatory Evolution of the Stark Law
The physician self-referral prohibitions are named after the legislation’s chief supporter,
Congressman Fortney “Pete” Stark (D-CA). Congressman Stark supported the legislation based
on studies indicating that despite the broad scope of the Anti-Kickback statute, self-referrals
were prevalent in the healthcare industry.267 One such study, published by the OIG in 1989,
reported on physician investments in healthcare facilities and found that patients at physicianowned laboratories received more services than other Medicare patients.268 Since then, the Stark
law has undergone numerous revisions that have both expanded the scope of the law as well as
the exceptions to the law. Of note in this evolution is the Stark IV rule, which refers to the

262 Ibid.
263 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships” Federal
Register, Vol. 66, No. 3, (January 4, 2001), p. 923; “Regulatory Issues in Ambulatory Surgery Center Acquisitions” By Patricia O. Powers
& Nora L. Liggett, Waller Lansden Dortch & Davis, LLP, ABA Health eSource, Vol. 9, No. 8, (April 2013), http://www.americanbar.org/
content/newsletter/publications/aba_health_esource_home/aba_health_law_esource_1304_powers.html (Accessed 3/10/15).
264 “Financial Relationship, Compensation, and Ownership or Investment Interest” 42 C.F.R. § 411.354(a)(1) (January 1, 2014).
265 “Limitation on Certain Physician Referrals” 42 U.S.C. § 1395nn (2012); “Criminal Penalties for Acts Involving Federal Health Care
Programs” 42 U.S.C. § 1320a-7b(b) (2012).
266 Ibid.
267 “Health Care Fraud and Abuse: Practical Perspectives” By Linda A. Baumann, Health Law Section of the American Bar Association,
Washington, DC: BNA Books, 2002, p. 52.
268 “Financial Arrangements Between Physicians and Health Care Businesses” By Richard P. Kusserow, Office of Inspector General, May
1989, https://oig.hhs.gov/oei/reports/oai-12-88-01410.pdf (Accessed 3/6/2015), p. iii.

229

Adviser's Guide to Healthcare

changes made to the Stark law in the 2009 Inpatient Prospective Payment System.269 Most
notably, Stark IV modified the stand in the shoes provision, changed the definition of entity and
prohibited per-click leasing under four of the exceptions to the Stark law.
Stand in the Shoes
The first stand in the shoes provisions were implemented on September 5, 2007, when CMS
issued the final rule establishing the Stark II Phase III regulations, which contained many
changes that were predicted to have a significant impact on healthcare provider relationships.270
One requirement, as set out in the Phase I regulations, stipulated that at least two financial
relationships between the physician and the DHS entity must exist in order for an indirect
compensation arrangement to exist.271 The Phase III regulations changed the definition of an
indirect compensation arrangement so that physician members, employees, and contractors of the
physician organization were now deemed to stand in the shoes of the physician organization, that
is, they would have the same direct compensation arrangement as the physician organization
itself.272 As a result, a hospital that had a contract for professional services with a physician
group, which was considered to be an indirect relationship under the Phase I regulations, would
now be considered to have a direct compensation arrangement.273 Under this revision of the rule,
a physician organization would no longer be considered an intervening entity for purposes of
establishing an indirect compensation arrangement, and arrangements between providers and
DHS entities would need to be structured differently to avoid Stark liability.274 This change
applied to physician-owners, physician-employees, and physician-contractors of a physician
organization.275 However, other arrangements, such as an arrangement between a DHS entity, a
leasing company, and a physician, would still be analyzed as an indirect compensation
arrangement under the Stark Law.276
In Stark IV, CMS modified the stand in the shoes provision first introduced in Stark II, Phase III
for situations in which a physician organization employs both physician owners and
nonphysician owners. In these circumstances, DHS entities are permitted to treat the
nonphysician owners as standing in the shoes of the physician organization so that two different

269 “Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Payments for Graduate
Medical Education in Certain Emergency Situations; Changes to Disclosure of Physician Ownership in Hospitals and Physician SelfReferral Rules; Updates to the Long-Term Care Prospective Payment System; Updates to Certain IPPS-Excluded Hospitals; and Collection
of Information Regarding Financial Relationships Between Hospitals” Federal Register Vol. 73, No. 161 (August 19, 2008), p. 48434.
270 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase III); Final Rule”
Federal Register Vol.72, No. 171, (September 5, 2007), p. 51012.
271 “Phase III Regulations Result in Dramatic Changes to Stark Law” By J. Kelly Barnes, et al., BNA Health Law Reporter, Vol. 16, No. 40,
October 11, 2007, p. 1220-1221.
272 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase III); Final Rule”
Federal Register Vol.72, No. 171, (September 5, 2007), p. 51028.
273 “Phase III Regulations Result in Dramatic Changes to Stark Law” By J. Kelly Barnes, et al., BNA Health Law Reporter, Vol. 16, No. 40,
October 11, 2007, p. 1221.
274 “Phase III Regulations Result in Dramatic Changes to Stark Law” By J. Kelly Barnes, et al., BNA Health Law Reporter, Vol. 16, No. 40,
October 11, 2007, p. 1221.
275 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase III); Final Rule”
Federal Register Vol.72, No. 171, (September 5, 2007), p. 51028.
276 Ibid, p. 51028-51029.
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compensation analyses are not required.277 Exempted from the Stark IV provisions are
arrangements that meet the requirements of the academic medical centers exception.278
Expansion of “Entity” to Include Under Arrangement Service Providers
Stark IV also modified the legal permissibility of under arrangement transactions such that both
the physician-owned entity that provides the service, as well as the enterprise (typically the
hospital) that bills for the service, are considered DHS entities for purposes of Stark Law.279 This
provision precludes physician-owned entities from performing services under arrangement with
the hospital unless the physician-owned entity can satisfy one of the ownership exceptions under
Stark. Specifically, any physician-owned entity that performs a service under arrangement for a
hospital that is then billed by that hospital is considered a DHS entity, even if that physicianowned entity would not have been considered a DHS entity if the service was performed outside
of the hospital setting. The only exception to the Stark IV prohibitions against under
arrangements is for lithotripsy services, a procedure to break up stones in urinary organs.280
Additionally, those physician-owned entities that fall within the Stark rural provider exception
will generally survive scrutiny.
Prohibition of “Per-Click” Arrangements and Percentage-Based Rent
Stark IV also modified the exceptions for space and equipment leases, fair market value
compensation, and indirect compensation arrangements to prohibit basing the charge for rented
space and equipment on a per-click, or per-unit basis.281 Accordingly, physicians and DHS entity
lessors may not charge physician lessees rent based on the number of services provided by the
lessees that are referred to them by the lessors. CMS concluded that on-demand time-based
rental arrangements were also considered per-click arrangements for purposes of the Stark IV
prohibitions.282
Similarly, Stark IV also prohibited calculating rental charges based on a percentage of revenues
earned in the rented space or with the rented equipment, regardless of whether the services were
referred from the lessor.283 Excluded from this prohibition are arrangements in which physicians
pay on a percentage basis for management and billing services.284 CMS also stated that the rule
would not prohibit gainsharing arrangements as long as they are properly structured incentive
payment and shared saving programs.285

277 “Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Payments for Graduate
Medical Education in Certain Emergency Situations; Changes to Disclosure of Physician Ownership in Hospitals and Physician SelfReferral Rules; Updates to the Long-Term Care Prospective Payment System; Updates to Certain IPPS-Excluded Hospitals; and Collection
of Information Regarding Financial Relationships Between Hospitals” Federal Register, Vol.73, No.161 (August 19, 2008), p. 48693.
278 Ibid.
279 Ibid, p. 48731.
280 “Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Final Rule,” Federal
Register Vol. 73, No. 161 (Aug. 19, 2008), p. 48729; ”Lithotripsy” Medline Plus Medical Encyclopedia, U.S. National Library of Medicine,
National Institutes of Health December 18, 2009, http://www.nlm.nih.gov/medlineplus/ency/article/007113.htm (Accessed 8/17/12).
281 “Stark Rule Proposals Finalized” By Cathy Dunlay and Kevin Hilvert, Schottenstein Zox & Dunn, August 13, 2008,
http://www.szd.com/resources.php?NewsID=1184&method=unique (Accessed 8/14/08), p. 2-3.
282 “Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Final Rule,” Federal
Register Vol. 73, No. 161 (Aug. 19, 2008), p. 48719.
283 Ibid, p. 48709.
284 Ibid, p. 48710.
285 Ibid, p. 48711.
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Exceptions to Stark Law
The very broad prohibition of physician self-referrals is limited by a number of statutory
exceptions. The exceptions are intended to promote practice integration and to protect
arrangements in which there is little risk of abuse.286 Similar to concerns on the restrictive nature
of the Anti-Kickback statute, Congress intended to protect group practices to avoid loss of
integration.287 There are thirty-six total exceptions to the Stark law, and the statute gives the
secretary of HHS the authority to promulgate additional exceptions.288 A significant difference
between the Anti-Kickback legislation and Stark is that, under Stark, any financial relationship
between a healthcare entity and a physician must fall within one of the statutory or regulatory
exceptions in order to avoid scrutiny.289
The thirty-six exceptions to the Stark law are divided into smaller subsets based on certain
categories of applicability, to wit: (1) exceptions that apply to both ownership/investment
interests and compensation arrangements;290 (2) exceptions that apply to only ownership/
investment interests;291 and (3) exceptions that apply to only compensation arrangements.292
Exceptions that apply to both ownership/investment interests and compensation agreements
include exceptions for:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(10)

Physician services;
In-office ancillary services;
Services furnished by organization to enrollee of health plan;
Academic medical centers;
Implants furnished by an ASC;
EPO and other dialysis-related drugs;
Preventative screening tests, immunizations, and vaccines;
Eyeglasses and contact lenses following cataract surgery; and
Intra-family rural referrals.293

Exceptions that apply to only ownership or investment interests include exceptions for:
(1) Publicly traded securities;
(2) Mutual funds; and
(3) Specific providers (for example, rural providers, hospitals located in Puerto Rico, and
whole hospital ownership).294

286 “Health Law: Cases, Materials and Problems” By Barry R. Furrow et al., Seventh Edition, St. Paul, MN: West Publishing, 2013, p. 1146.
287 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities With Which They Have Financial Relationships; Final
Rule” Federal Register Vol. 66, No. 3 (January 4. 2001), p. 895.
288 “General Exceptions to the Referral Prohibition Related to both Ownership/Investment and Compensation” 42 C.F.R. §§ 411.355-411.357
(October 1, 2014); “Limitation on Certain Physician Referrals” 42 U.S.C. § 1395nn (2012).
289 “Health Care Fraud and Abuse: Practical Perspectives” By Linda A. Baumann, Health Law Section of the American Bar Association,
Washington, DC: BNA Books, 2002, p. 106.
290 “General Exceptions to the Referral Prohibition Related to both Ownership/Investment and Compensation” 42 C.F.R. § 411.355 (October 1,
2014).
291 “Exceptions to the Referral Prohibition Related to Ownership or Investment Interests” 42 C.F.R. § 411.356 (October 1, 2014).
292 “Exceptions to the Referral Prohibition Related to Compensation Arrangements” 42 C.F.R. § 411.357 (October 1, 2014).
293 “General Exceptions to the Referral Prohibition Related to both Ownership/Investment and Compensation” 42 C.F.R. § 411.355 (October 1,
2014).
294 “Exceptions to the Referral Prohibition Related to Ownership or Investment Interests” 42 C.F.R. § 411.356 (October 1, 2014).
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There are a total of thirty-six exceptions to the Stark law, and the secretary of HHS has the authority to
promulgate additional exceptions.
42 C.F.R. §§ 411.355-411.357; 42 U.S.C. § 1395nn.

Exceptions that apply to only compensation relationships include exceptions for the following
situations, described in Exhibit 3-2, below:
Exhibit 3-2: Stark Exceptions relating to Compensation Relationships295
Rental of office space
Rental of equipment
Bona fide employment relationships
Personal service arrangements
Physician recruitment
Isolated transactions
Certain arrangements with hospitals
Group practice arrangements with a hospital
Payments by a physician
Charitable donations by a physician
Nonmonetary compensation
Fair market value compensation

Medical staff incidental benefits
Risk sharing arrangements
Compliance training
Indirect compensation arrangements
Referral services
Obstetrical malpractice insurance subsidies
Professional courtesy
Retention payments in underserved areas
Community-wide health information systems
Electronic prescribing items and services
Electronic health records and services

Further, the whole hospital exception allowed physicians to refer patients to hospitals in which
they have an ownership interest so long as the physicians are authorized to perform services at
the hospital and the ownership or investment interest is in the entire hospital.296 Like the AntiKickback statute, many of these exceptions under the Stark law incorporate the traditional
concept of FMV and the separate and distinct threshold of commercial reasonableness. These
concepts and thresholds are discussed more thoroughly in the Physician Compensation
Restrictions section below.

ACA Restrictions on Stark “Whole Hospital” Exception
The ACA included a set of requirements that significantly narrowed the applicability of the
whole hospital exception and rural hospital exception for most hospitals.297 In response to this
statutory mandate, CMS released two Final Rules to implement the ACA provisions. CMS’s first
Final Rule, which was published on November 24, 2010, promulgated restrictions for the use of
the whole hospital exception as well as the requirements for obtaining grandfather status.298
CMS’s second Final Rule, which was published November 30, 2011,299 established the
exemption application process for physician-owned hospitals in existence prior December 31,
295 “Exceptions to the Referral Prohibition Related to Compensation Arrangements” 42 C.F.R. § 411.357 (October 1, 2014).
296 “Limitation on Certain Physician Referrals” 42 U.S.C. § 1395nn(d)(3) (2009).
297 “A Guide to Complying with Stark Physician Self-Referral Rules” By Frances R. Fernald, Washington, D.C.: Atlantic Information Services,
Inc., 2010, p. 400:216-400:218.
298 “Medicare Program: Hospital Outpatient Prospective Payment System and CY 2011 Payment Rates; Ambulatory Surgical Center Payment
System and CY 2011 Payment Rates; Payments to Hospitals for Graduate Medical Education Costs; Physician Self-Referral Rules and
Related Changes to Provider Agreement Regulations; Payment for Certified Registered Nurse Anesthetist Services Furnished in Rural
Hospitals and Critical Access Hospitals; Final Rule” Federal Register, Vol. 75, No. 226 (November 24, 2010) p. 72240-72241.
299 “Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment; Hospital Value-Based
Purchasing Program; Physician Self-Referral; and Patient Notification Requirements in Provider Agreements; Final Rule” Federal Register,
Vol. 76, No. 230 (November 30, 2011) p. 74523.
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2010 that were considering facility expansion.300 However, CMS’s second Final Rule stated that
expansions may only be granted for a facility’s main campus and that reviews are subject to
community input as mandated by the ACA.301 Prior to the ACA’s restriction on physician
ownership and investment in hospitals, the Medicare Prescription Drug, Modernization, and
Improvement Act of 2003 (MMA) placed a temporary 18-month moratorium on the development
of new physician-owned specialty/surgical hospitals, which officially ended on June 8, 2005.302
By narrowing both the whole hospital and rural provider exceptions, the ACA indirectly
prohibits the establishment of physician-owned hospitals that were not Medicare-certified by
December 31, 2010.303 To avoid this prohibition, hospitals with a Medicare Provider Agreement
prior to December 31, 2010, can be granted grandfather status and allowed to continue to
participate in Medicare if the following five criteria are met:
(1) The hospital is located in a county with a population growth rate of at least 150 percent of
the state’s population growth over the last five years;
(2) The hospital has a Medicaid inpatient admission percentage of at least the average of all
hospitals in the county;
(3) The hospital does not discriminate against beneficiaries of Federal health care programs;
(4) The hospital is located in a state with below-national-average bed capacity; and
(5) The hospital has a bed occupancy rate greater than state average.304
Even if physician-owned hospitals are granted grandfather status, these hospitals are
nevertheless subject to further restrictions contained in the final rules. In particular, physicianowned hospitals that are granted grandfather status are restricted on the total percentage in
which individual physicians may own or invest in a hospital, while its existing, invested
physicians are limited to their individual ownership or investment percentages as of March 23,
2010.305 Additionally, if a grandfathered physician-owned hospital is approved for an exception
to the expansion limits, the physician-owned hospital may not grow more than 200 percent from
its baseline number of operating rooms, procedure rooms, and beds.306

300 Ibid, p. 74518-74525.
301 “Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment; Hospital Value-Based
Purchasing Program; Physician Self-Referral; and Patient Notification Requirements in Provider Agreements; Final Rule” Federal Register
Vol. 76, No. 230 (November 30, 2011), p. 74523-74524; “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 6001, 124
Stat. 119, 687-688 (March 23, 2010).
302 “The Medicare Prescription Drug, Modernization, and Improvement Act of 2003” Pub. L. No. 108-173, § 507, 117 Stat. 2066, 2295
(December 8, 2003).
303 “Patient Protection and Affordable Care Act, Sec. 6001” Pub. Law 111-148, 124 Stat. 119,684-89 (March 23, 2010), as amended by "Health
Care and Education Reconciliation Act, Sec.1106" Pub. Law 111-152, § 1106, 124 Stat. 1029, 1049-50 (March 30, 2010). [The HCERA
changes the effective date to December 31, 2010.] “Physician Ownership of Hospitals Significantly Impacted by Health Care Reform
Legislation” By Craig A. Conway, J.D., LL.M., Health Law & Policy Institute, University of Houston Law Center, http://www.law.uh.edu/
healthlaw/perspectives/2010/%28CC%29%20Stark.pdf (Accessed 3/11/15) p. 2.
304 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 6001, 124 Stat. 119, 684-689 (March 23, 2010), as amended by
“Health Care and Education Reconciliation Act” Pub. L. No. 111-152, § 1106, 124 Stat. 1029, 1049-1050 (March 30, 2010).
305 “Medicare Program: Hospital Outpatient Prospective Payment System and CY 2011 Payment Rates; Ambulatory Surgical Center Payment
System and CY 2011 Payment Rates; Payments to Hospitals for Graduate Medical Education Costs; Physician Self-Referral Rules and
Related Changes to Provider Agreement Regulations; Payment for Certified Registered Nurse Anesthetist Services Furnished in Rural
Hospitals and Critical Access Hospitals; Final Rule” Federal Register Vol. 75, No. 226 (November 24, 2010), p. 72242.
306 “Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment; Hospital Value-Based
Purchasing Program; Physician Self-Referral; and Patient Notification Requirements in Provider Agreements; Final Rule” Federal Register
Vol. 76, No. 230 (November 30, 2011), p. 74524.
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Stark Self-Referral Disclosure Protocol
In recent years, CMS has increased both its level of enforcement and its auditing efforts for
federal fraud and abuse laws, which has led to the recovery of billions of dollars in civil and
criminal penalties.307 As part of its increasing levels of fraud and abuse scrutiny, CMS has
shifted away from its traditional pay and chase auditing method, instead implementing new
technology and programs to recover additional funds, e.g., using predictive modeling software,
and identify fraudulent billings before payments are disbursed.308 CMS has also established a
method for providers to voluntarily report their own violations in exchange for lesser sanctions.
Promulgated by the ACA, the Self-Referral Disclosure Protocol (SRDP) serves as a reporting
mechanism for providers who suspect that they may be in violation of the Stark Law to
voluntarily disclose their conduct in exchange for reduced financial liability.309 As of March
2015, 69 SDRP settlements have been published, with several of the voluntary disclosing
providers having been assessed a mere fraction of their potential Stark liability.310
In addition to the federal Stark Law prohibitions, forty-two states and the District of Columbia
have laws prohibiting limiting self-referrals.311

CIVIL MONETARY PENALTIES
The Social Security Act (SSA) § 1128 gives the Secretary of HHS authorization to seek civil
monetary penalties (CMPs) against physicians, hospitals, and other healthcare providers that
violate any fraud and abuse laws related to the Federal healthcare programs. According to the
SSA, HHS’s OIG can seek different amounts and types of CMPs depending on the type and
severity of the violation. Most CMP cases are settled without a final judgment; otherwise, an
administrative law judge will issue a decision that is appealable.312 Furthermore, OIG encourages
self-disclosure of potential fraudulent behavior, and any self-disclosures and cooperation are
taken into account when determining CMPs against a party.313

Gainsharing
The gainsharing component of the CMP regulation provides civil penalties against a hospital if
the hospital knowingly makes a payment, directly or indirectly, to a physician as an inducement
to reduce or limit services provided with respect to individuals who are entitled to Medicare or
307 “Inspector General: Audits, Legal Actions May Net Up to $3.4 Billion” Office of Inspector General, June 1, 2011, http://oig.hhs.gov/
newsroom/news-releases/2011/sar_release.asp (Accessed 11/18/11).
308 “Is There A Statistician In The House?” By Allyson Jones Labban, Smith Moore Leatherwood, Health Care Law Note, July 2011,
http://www.healthcarelawnote.com/articles/2011/201107.asp (Accessed 8/8/12); “From ‘Pay and Chase’ to ‘Catch and Keep:’ CMS to
Introduce Anti-Fraud Predictive Modeling July 1” Bradley Arant Boult Cummings LLP, June 28, 2011,
http://www.babc.com/files/Uploads/Documents/Health%20Care%20Alert_June%2028%202011.pdf (Accessed 8/8/12).
309 “Patient Protection and Affordable Care Act" Pub. L. No. 111-148, § 6409. 124 Stat. 119, 772-773 (March 23, 2010); “Self-Referral
Disclosure Protocol” Centers for Medicare & Medicaid Services, December 27, 2011 https://www.cms.gov/PhysicianSelfReferral/
98_Self_Referral_Disclosure_Protocol.asp#TopOfPage (Accessed 02/10/12).
310 “Self-Referral Disclosure Protocol Settlements” Centers for Medicare & Medicaid Services, http://www.cms.gov/Medicare/Fraud-andAbuse/PhysicianSelfReferral/Self-Referral-Disclosure-Protocol-Settlements.html# (Accessed 3/6/15).
311 For an in-depth discussion of state self-referral prohibitions, see the Anti-Kickback and Self-Referral Laws section below.
312 “Civil Monetary Penalties and Affirmative Exclusions” Office of Inspector General, U.S. Department of Health and Human Services,
http://oig.hhs.gov/fraud/enforcement/cmp/background.asp (Accessed 2/26/2015).
313 Ibid.
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Medicaid or are under the direct care of the physician.314 Furthermore, it provides civil penalties
against a physician if the physician knowingly accepts receipt of any payments described
above.315 Recently, the statute was amended such that only payments to limit or reduce medically
necessary services would result in civil penalties, effective April 16, 2015.316

Beneficiary Inducement
The beneficiary inducement component of the CMP regulation provides civil penalties in
instances where an individual or entity transfers compensation to an individual eligible for
Medicare or Medicaid that the transferring individual or entity knows or should know is likely to
influence the eligible individual to order or receive from a particular provider any item or service
for which payment may be made under Medicare or Medicaid.317 Together, these regulations
expand hospital and physician fraud and abuse liability beyond what may typically be enforced
through the Anti-Kickback Statute and Stark law, and, as such, physicians and hospitals should
attempt to structure arrangements so as to comply with CMP provisions.

CMS REIMBURSEMENT MONITORING PROGRAMS
Within the past ten years, CMS has instituted several fraud and abuse monitoring programs that
review, or audit, reimbursements to providers for submitted Medicare and Medicaid claims.
CMS initiated Medicare and Medicaid payment audits to identify fraudulent billing practices and
recoup claim reimbursements based on fraud; once uncovered, providers may be subject to
repayment, regulatory sanctions, and civil fines. Most allegations are resolved through
negotiation and settlement with the OIG before a formal hearing occurs; however, providers have
the right to appeal determinations made by OIG.318 The Medicare recovery audit programs have
recovered $7.4 billion in improper payments made by the Medicare program between 2010 and
the first quarter of 2014.319

Recovery Audit Contractors (RACs)
Promulgated by the Medicare Modernization Act of 2003 (MMA) as a three-year demonstration
project beginning in 2005, the RAC program is now a permanent monitoring program within
CMS that is tasked with improving payment accuracy and increasing program transparency.
RACs perform this function by identifying improper Medicare overpayments and underpayments
to providers based on three categories of errors: (1) payment for medically unnecessary services;
(2) payment for incorrectly coded services; and (3) payment for services not supported by

314 “Civil Monetary Penalties” 42 U.S.C. § 1320a-7a(b)(1) (2014).
315 “Civil Monetary Penalties” 42 U.S.C. § 1320a-7a(b)(2) (2014).
316 “Medicare Access and CHIP Reauthorization Act of 2015” H.R. 2, 114th Congress, § 512 (January 6, 2015); “Summary: H.R.2—114th
Congress (2015-2016)” Library of Congress, 2015, https://www.congress.gov/bill/114thcongress/housebill/2 (Accessed 4/22/2015). The
revision applies to payments made on or after the date of the enactment of the act, which was signed into law on April 16, 2015.
317 “Civil Monetary Penalties” 42 U.S.C. § 1320a-7a(a)(5) (2014).
318 “Civil Monetary Penalties and Affirmative Exclusions” Office of Inspector General, http://oig.hhs.gov/fraud/enforcement/cmp/index.asp
(Accessed 11/18/2011).
319 “CMS Efforts to Reduce Improper Payments in the Medicare Program” By Shantanu Agrawal, M.D., To Subcommittee on Energy Policy,
Health Care and Entitlements, Committee on Oversight and Government Reform, House of Representatives, Washington, D.C.: Department
of Health & Human Services, May 20, 2014, p. 7.
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sufficient documentation.320 An overpayment occurs when CMS reimburses a provider an excess
amount for a given claim, resulting in a provider owing Medicare the overpaid amount.
Conversely, an underpayment occurs when the Medicare reimbursement received by a provider
is less than the cost of providing care, resulting in Medicare owing the provider additional
reimbursement funds.321 RAC reviews are becoming increasingly common for providers. A
recent report from the Government Accountability Office (GAO) noted that, on a national level,
RACs reviews increased from 1,358,097, in fiscal year 2011, to 2,107,455, in fiscal year 2012,
representing an increase of 55%.322 Further, RACs are required to refer potential cases of
healthcare fraud to CMS, which serves as another method for federal authorities to identify fraud
and abuse.323 Because of the increasing prevalence of RAC audits and their use to identify fraud
and abuse, physicians and other providers should be aware of their potential impact on the
revenue cycle.

Audit Medicaid Integrity Contractors (Audit MICs)
In a March 2012 report titled “Early Assessment of Audit Medicaid Integrity Contractors, the
OIG assessed the efforts of the Medicaid Integrity Contractors (MICs), which conduct “postpayment audits” on reimbursements to providers in the Medicaid program, as part of its
examination of the effectiveness of the Medicaid Integrity Program.324 Of the 370 identified
audits conducted through March 2012 (i.e., identifying a potential of $80 million in
overpayments), 81 percent of those audits were unable, or unlikely, to discover overpayments to
Medicaid providers.325 The remaining 11 percent of the 370 audits accounted for $6.9 million in
overpayments, $6.2 million of which were attributed to program areas that had previously been
identified as vulnerable to overpayments.326 The OIG concluded that the MICs’ audits were
hindered by CMS’s selection of poorly identified audit targets, as MICs are not contracted to
identify targets for potential fraud, but to audit targets provided to them by CMS.327 The March
2012 Report further indicated that audit targets were mistakenly selected, due either to incorrect
data or the improper application of state policies for identifying audit targets.328 As CMS refines
its MIC program, physicians may expect an increase in audits from these contractors in ways
similar to the increase in RAC audits.

320 “Implementation of Recovery Auditing at the Centers for Medicare and Medicaid Services: FY 2010 Report to Congress” By Centers For
Medicare & Medicaid Services, To U.S. Congress, Washington, D.C., 2011, p. 2.
321 “Implementation of Recovery Auditing at the Centers for Medicare and Medicaid Services: FY 2010 Report to Congress” By Centers For
Medicare & Medicaid Services, To U.S. Congress, Washington, D.C., 2011, p. 2; “Underpayment By Medicare and Medicaid Factsheet”
American Hospital Association, December 2010, http://www.aha.org/content/00-10/10medunderpayment.pdf (Accessed 12/1/11).
322 “Medicare: Further Action Could Improve Improper Payment Prevention and Recoupment Efforts” By Kathleen M. King, To
Subcommittee on Energy Policy, Health Care and Entitlements, Committee on Oversight and Government Reform, House of
Representatives, Washington, D.C.: United States Government Accountability Office, May 20, 2014, p. 13.
323 “Statement of Work for the Recovery Audit Program” Centers for Medicare & Medicaid Services, https://www.cms.gov/ResearchStatistics-Data-and-Systems/Monitoring-Programs/recovery-audit-program/downloads/090111RACFinSOW.pdf (Accessed 3/10/15) p. 29.
324 “National Medicaid Audit Program” Centers for Medicare & Medicaid Services, November 2012, http://www.cms.gov/medicare-medicaidcoordination/fraud-prevention/provider-audits/downloads/mip-audit-fact-sheet.pdf (Accessed 3/6/15); “Early Assessment of Audit
Medicaid Integrity Contractors” By Daniel R. Levinson, Office of the Inspector General, March 2012, OEI-05-10-00210, p. 1.
325 “Early Assessment of Audit Medicaid Integrity Contractors” By Daniel R. Levinson, Office of the Inspector General, March 2012,
OEI-05-10-00210, p. 17.
326 “Early Assessment of Audit Medicaid Integrity Contractors” By Daniel R. Levinson, Office of the Inspector General, March 2012,
OEI-05-10-00210, p. 17.
327 Ibid, p. 11-12.
328 Ibid, p. 11-12.
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Comprehensive Error Rate Testing (CERT) Program
CMS created the Comprehensive Error Rate Testing (CERT) program to determine improper
Medicare fee-for-service payments, a critical step in identifying the scope of fraud and abuse in
the Medicare program.329 CMS provides data obtained through the CERT program to Congress,
giving Congress an estimate of the annual amount of improper Medicare payments made to
providers during a given year. However, a March 2012 OIG report entitled, Review of CERT
Errors Overturned Through the Appeals Process for Fiscal Years 2009 and 2010, suggested that
this estimate did not account for any payment errors that were overturned through the appeals
process and may, therefore, have inflated the number of improper payments made in a given
year.330 Error rate data discovered by the CERT program, particularly data relating to claims or
providers with a “high propensity for error,” can provide insight into claim types likely to be
reviewed by RACs in the future.331

Medicare-Medicaid (Medi-Medi) Data Match Program
CMS operates the Medicare-Medicaid (Medi-Medi) Data Match Program to allow state and
federal collaboration to identify areas of potential fraud, abuse, and waste in Medicare and
Medicaid billing.332 The Medi-Medi program initially started in 2001 as a pilot program in one
state and expanded significantly over the course of a decade, garnering annual funding of $60
million over the past several years.333 The goal of the program is to analyze Medicare and
Medicaid claims data collectively to better identify potentially fraudulent billing activities that
may be missed when analyzing Medicare and Medicaid claims data separately.334 State
participation in the Medi-Medi program is voluntary, and states must fund their own program.335
Physicians should note if their state of licensure participates in this program and, if so, may find
it beneficial to use program data to examine its own billing practices.

PHYSICIAN COMPENSATION RESTRICTIONS
Generally
Many different healthcare transactions, e.g., physician compensation arrangements, medical
directorships, and lease agreements, are scrutinized under the traditional concept of FMV and the

329 “Comprehensive Error Rate Testing (CERT)” Centers for Medicare & Medicaid Services, May 15, 2012, http://www.cms.gov/ResearchStatistics-Data-and-Systems/Monitoring-Programs/CERT/index.html?redirect=/CERT/ (Accessed 5/23/12); “Review of CERT Errors
Overturned Through the Appeals Process for Fiscal Years 2009 and 2010” By Daniel R. Levinson, Office of the Inspector General, March
2012, A-01-11-00504, p. 1.
330 “Review of CERT Errors Overturned Through the Appeals Process for Fiscal Years 2009 and 2010” By Daniel R. Levinson, Office of the
Inspector General, March 2012, A-01-11-00504, p. 1.
331 “Statement of Work for the Recovery Audit Program” Centers for Medicare & Medicaid Services, https://www.cms.gov/ResearchStatistics-Data-and-Systems/Monitoring-Programs/recovery-audit-program/downloads/090111RACFinSOW.pdf (Accessed 3/10/15) p. 1.
332 “The Medicare-Medicaid (Medi-Medi) Data Match Program” By Daniel R. Levinson, Office of the Inspector General, April 2012, OEI-0908-00370, p. 1, citing; “Medicare Program Integrity Manual, Chapter 4, Section 4.2” Centers for Medicare & Medicaid Services,
September 30, 2011.
333 “The Medicare-Medicaid (Medi-Medi) Data Match Program” By Daniel R. Levinson, Office of the Inspector General, April 2012, OEI-0908-00370, p. 1-2.
334 Ibid, p. 1.
335 Ibid, p. 17.
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separate and distinct threshold of commercial reasonableness.336 Under federal fraud and abuse
laws, healthcare transactions must be simultaneously at FMV and also commercially reasonable
in order to be deemed legally permissible. A failure to meet these two thresholds may result in
Stark or Anti-Kickback violations and may also lead to FCA violations if the healthcare provider
knowingly submits a claim for reimbursement to a government entity for services under
impermissible compensation arrangements.337
Compensation arrangements for physician and executive services must be both at FMV and commercially
reasonable to avoid liability under the Stark law, the Anti-Kickback statute, and the FCA.
Lewis Lefko, Jan. 24, 2008.

The test for commercial reasonableness is a threshold that is related but distinct from that of the
standard of FMV. FMV looks to the reasonableness of the “range of dollars” paid for a product
or service; the standard of commercial reasonableness looks to the reasonableness of the
business arrangement generally.338

Definitions of Fair Market Value
Federal fraud laws define fair market value somewhat differently than it is defined by traditional
business valuation principles. Under Stark II Phase I, the Health Care Financing Administration
(HCFA; now CMS) defined FMV as “the value in arm’s-length transactions, consistent with the
general market value.”339
General market value is defined as:
“[T]he price that an asset would bring as a result of bona fide bargaining between wellinformed buyers and sellers who are not otherwise in a position to generate business for
the other party, or the compensation that would be included in a service agreement as a
result of bona fide bargaining between well-informed parties to the agreement who are
not otherwise in a position to generate business for the other party, on the date of
acquisition or the asset or at the time of the service agreement.”340 [Emphasis added].

Elaborating on that definition in 2001, HCFA provided the following guidance for determining
when a payment for services provided is at FMV:
“We believe the relevant comparison is aggregate compensation paid to physicians
practicing in similar academic settings located in similar environments. Relevant factors
include geographic location, size of the academic institutions, scope of clinical and
academic programs offered, and the nature of the local health care marketplace... we
336 “All Eyes on Physician-Hospital Arrangements,” By Lewis Lefko, HealthLeaders Media, Jan. 24, 2008, www.healthleadersmedia.com

(Accessed September 18, 2008).
337 “False Claims” 31 U.S.C. § 3729(a) (2009); “United States of America v. Peter Rogan” 459 F.Supp. 2d 692, 717 (N.D. Ill. 2006); the
impact of fraud and abuse regulation on structuring physician compensation plans is discussed further in Compensation and Income
Distribution in Consulting with Professional Practices.
338 “Tread Carefully When Setting Fair Market Value: Stark Law Must Be Considered” By Joyce Frieden, OB/GYN News, Vol. 38, No. 2
(November 1, 2003), p. 26, http://findarticles.com/p/articles/mi_m0CYD/is_21_38/ai_110804605/ (Accessed 05/17/10).
339 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships, Federal
Register, Vol. 66, No. 3 (January 4, 2001), p. 944.
340 “Financial Relationships Between Physicians and Entities Furnishing Designated Health Services; Definitions” 42 C.F.R § 411.351 (2014).
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intend to accept any method [for establishing FMV] that is commercially reasonable and
provides us with evidence that the compensation is comparable to what is ordinarily paid
for an item or service in the location at issue, by parties in arm’s-length transactions who
are not in a position to refer to one another... The amount of documentation that will be
sufficient to confirm FMV... will vary depending on the circumstances in any given case;
that is, there is no rule of thumb that will suffice for all situations.”341

In 2004, CMS noted that valuation methods under Stark law, “must exclude valuation where the
parties to the transaction are at arm’s-length but in a position to refer each other.”342 Because
FMV under Stark law does not “necessarily comport with the usage of the term in standard
valuation techniques and methodologies,” a purely market-driven determination of FMV may not
always be considered commercially reasonable for the purposes of federal fraud laws.343 For
example, even if an arrangement meets traditional FMV standards, if it does not meet
commercial reasonableness standards, it may not withstand scrutiny under Stark.
In the Stark II Phase II legislation, dated March 2004, CMS stated that it “will consider a range
of methods of determining [FMV] and that the appropriate method will depend on the nature of
the transaction, its location, and other factors.”344 Additionally in the Stark II Phase II legislation,
CMS created a voluntary safe harbor provision within the regulatory definition of FMV for
hourly payments to physicians for their personal services, which could have been used with
regard to any hourly compensation paid by any DHS entity.345 Under the FMV safe harbor, there
were two methodologies that would result in an hourly arrangement being considered to be at
FMV: (1) when the physician’s hourly rate is less than or equal to the hourly rate for emergency
room physician services in the relevant geographic market (provided there are at least three
hospitals with emergency rooms) or (2) when the physician’s hourly rate is calculated by
averaging the 50th percentile of the national compensation level for physicians with the same
specialty (or general practice if specialty is not identified) in at least four of six listed salary
surveys, then dividing that figure by 2,000 hours.346 Subsequently, the United States Appellate
Court for the D.C. Circuit discerned in Renal Physicians Association v. HHS that these two safe
harbor tests would also result in the consideration of an agreement being presumptively
reasonable.347
Concerns about the impracticality and infeasibility of the CMS FMV voluntary safe harbor
forced CMS to eliminate that provision in the September 2007 Stark II Phase III rule. At that
time, however, CMS emphasized that it planned to continue to scrutinize the FMV of
arrangements and indicated that “[p]arties to a transaction may calculate FMV ‘using any
341 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships, Federal
Register, Vol. 66, No. 3 (January 4, 2001), p.916, 944.
342 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16107.
343 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16107; “Successful Medical Practice Valuation” By Reed Tinsley, Physician’s News Digest,
July 2008, http://www.physiciansnews.com/business/708tinsley.html (Accessed 9/19/2008).
344 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16107.
345 “Financial Relationships Between Physicians and Entities Furnishing Designated Health Services; Definitions” 42 C.F.R § 411.351 (2014);
“Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16092.
346 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16092.
347 “Renal Physicians Association v. U.S. Department of Health and Human Services et al.” 489 F.3d 1267, 1269-1270 (D.C. Cir. 2007).
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commercially reasonable methodology that is appropriate under the circumstances and otherwise
fits [within] the definition’ of FMV for purposes of Stark.”348
Further, in the Stark II Phase III provisions, CMS stated, in response to a request for
confirmation as to whether a FMV hourly rate could be used to compensate physicians for both
physician clinical and administrative services and whether that hourly rate could be used to
determine an annual salary, that:
“A fair market value hourly rate may be used to compensate physicians for both
administrative and clinical work, provided that the rate paid for clinical work is
fair market value for the clinical work performed and the rate paid for
administrative work is fair market value for the administrative work performed
We note that the fair market value of administrative services may differ from
the…value of clinical services. A fair market value hourly rate may be used to
determine an annual salary, provided that the multiplier used to calculate the
annual salary accurately reflects the number of hours actually worked by the
physician.”349
FMV is also an important requirement under several Anti-Kickback safe harbors.350 Although
FMV is not specifically defined within the Anti-Kickback statute,351 the OIG has provided
guidance on this issue and stated in Thornton’s widely circulated 1992 letter (see the Thornton
Letter—Office of the Inspector General section above).

Definitions of Commercial Reasonableness
HHS has interpreted commercially reasonable to mean that an arrangement appears to be “a
sensible, prudent business agreement, from the perspective of the particular parties involved,
even in the absence of any potential referrals.”352 The Stark II Phase II commentary also suggests
that, “an arrangement will be considered ‘commercially reasonable’ in the absence of referrals if
the arrangement would make commercial sense if entered into by a reasonable entity of similar
type and size and a reasonable physician of similar scope and specialty, even if there were no
potential DHS referrals.”353
When determining the commercial reasonableness of a compensation arrangement, one should
consider: (1) if it is necessary to have a physician perform a certain service and (2) if it is
necessary to have a physician of that specialty perform a certain service. For example, the FMV
compensation for more specialized physicians and surgeons generally is higher than that of
general practitioners and nonphysician practitioners. As a result, if a specialized physician is
348 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase III); Final Rule”
Federal Register, Vol. 72, No. 171 (September 5, 2007) p. 51015.
349 Ibid, p. 51016.
350 “Exceptions” 42 C.F.R. § 1001.952 (2013); “Health Care Compliance Forum” Fair Market Value: The Lawyer’s Perspective, By Kimberley
Elting, et. al., Jones Day, Arizona, October 25-27, 2006.
351 “Health Care Compliance Forum” Fair Market Value: The Lawyer’s Perspective, By Kimberley Elting, et. al., Jones Day, Arizona,
October 25-27, 2006.
352 “Medicare and Medicaid Programs; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships” Federal
Register, Vol. 63, No. 6 (January 9, 1998) p. 1700.
353 “Medicare Program; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships (Phase II) Federal
Register, Vol. 69, No. 59 (March 26, 2004) p. 16093.
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receiving compensation within the higher range of FMV to perform duties that a less skilled
practitioner could perform for less compensation, the arrangement may not be deemed to be
commercially reasonable despite the fact that it is within the range of FMV for that specialist. In
such situations, there tends to be a presumption of fraud unless the healthcare provider can
demonstrate that using the physician specialist was reasonably necessary for specified reasons
(for example, experience) or that the position’s requirements could not have been done
sufficiently by a less-skilled practitioner.
The IRS has listed several specific factors to weigh in determining the commercial
reasonableness of a physician compensation arrangement:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)

Specialized training and experience of the physician;
The nature of duties performed and the amount of responsibility;
Time spent performing duties;
Size of the organization;
The physician’s contribution to profits;
National and local economic conditions;
Time of year when compensation is determined;
Whether the compensation is in part or in whole payment for a business or assets; and
Salary ranges for equally qualified physicians in comparable organizations.354

The IRS also will examine the independence of the board or committee that establishes a
physician’s compensation arrangement.355

Specific Application of Fraud Laws to Hospital-Physician
Relationships
As discussed in the Recovery Audit Contractors section above, the increased regulatory scrutiny
of healthcare transactions often implicates numerous hospital-physician relationships, including
physician compensation practices and lease agreements. With regard to FMV under Stark Law
and the Anti-Kickback Statute, a 2002 Federal District court stated, “payments exceeding FMV
are in effect deemed ‘payment for referrals.’”356 Later courts have evolved from this rigid
framework and developed more analytical approaches to determining whether or not a particular
hospital-physician relationship will survive fraud and abuse scrutiny. In particular, courts are
evaluating, under Stark and the Anti-Kickback Statute, whether physicians are actually
performing the services outlined in the agreement. In circumstances where the physicians are not
actually performing required services or obligated under their agreement, courts have found that
the arrangement does not satisfy the commercial reasonableness threshold.357 For this reason, a
typical medical director or physician executive agreement requires that contemporaneous logs
are kept documenting the number of actual hours worked, as well as the physician’s fulfillment
354 “Physician Compensation Arrangements: Management and Legal Trends” By Daniel K. Zismer, Gaithersburg, MD: Aspen Publishers, Inc.,
1999, p. 204; “Reasonable Compensation” By Jean Wright and Jay H. Rotz, in Exempt Organizations Continuing Professional Education,
1993, http://www.irs.gov/pub/irs-tege/eotopici93.pdf (Accessed 3/10/15).
355 “Reasonable Compensation” By Jean Wright and Jay H. Rotz, in Exempt Organizations Continuing Professional Education, 1993,
http://www.irs.gov/pub/irs-tege/eotopici93.pdf (Accessed 3/10/15).
356 “American Lithotripsy Society v. Thompson,” 215 F.Supp.2d 23, 27 (D.D.C. July 12, 2002).
357 “U.S. ex rel. Roberts v. Aging Care Home Health, Inc., et al.,” 474 F.Supp. 2d 810, 818 (W.D. La. Feb. 16, 2007); see also “United States
of America v. Peter Rogan” 459 F.Supp. 2d 692, 722 (N.D. Ill. 2006).
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of the tasks, duties, responsibilities, and accountabilities which are set forth in the compensation
agreement for the given position.358
McLeod Regional Medical Center
One of the earliest and most widely circulated qui tam actions regarding the applicability of the
fraud and abuse laws relating to physician compensation is the 1998 case United States ex rel.
Richard Raugh v. McLeod Regional Medical Center of the Pee Dee, Inc., McLeod Physician
Services, Inc., D. Laurenece McIntosh, and Ernst and Young, LLP. Raugh, an individual
whistleblower under the FCA, and the previous head of the physician network development at
McLeod, filed suit against McLeod Regional Medical Center, a tax exempt organization, alleging
that McLeod submitted false claims to Medicare in violation of the Stark Law and the AntiKickback statute related to its purchase of several physician practices and the execution of
subsequent employment arrangements. Additionally, the relator alleged that McLeod’s purchase
of the physician practices exceeded FMV, stating that the compensation paid to the physicians
under the terms of the physician employment agreements evidenced intent to buy future referrals,
an unlawful practice under the Anti-Kickback statute.359 Specifically, as the DOJ explained:
“[t]he claims for services referred, ordered or arranged by those physicians were
alleged to be false in three respects: First, Section 1877 of the Social Security Act,
42 USC 139nn (also known as Stark II) prohibited McLeod from billing Medicare
for items or services referred or ordered by physicians with whom it had such
financial relationships. Second, McLeod forfeited its right to submit those claims
to the federal health care programs by paying remuneration intended to induce
those and other referrals in violation of the Anti-Kickback Statute, 42 USC
1320a-7(b). And third, McLeod certified falsely on Medicare cost reports that the
services identified or summarized were not provided or procured through payment
directly or indirectly of a kickback or billed in violation of federal law.”360
The case settled for $15,485,000 in October 2002.361 It is of particular note that although the
relator was released from criminal and civil liability stemming from his previous role as head of
physician network development, he received no financial share of the settlement paid by
McLeod.362
U.S. v. SCCI Hospital Houston
Another key milestone in the development of the commercial reasonableness threshold for
purposes of the Stark Law is the U.S. v. SCCI Hospital Houston case, wherein the government’s
358 "Fair Market Valuation Report - United States v. SCCI" In "US ex rel. Kaczmarczyk, et. al v. SCCI Hospital Ventures, Inc." Civ. No. H-991031, (July 12, 2005), p. 4, 6.
359 “Spotlight on Compensation Practices: Where We Have Been and Where Are We Going?” By Bernadette M. Broccolo, Esq., presented at
“Hospitals and Health Systems Law Institute” February 10-11, 2005, Tucson, AZ, p.70.
360 “McLeod Regional Medical Center to Pay U.S. Over $15 Million to Resolve False Claims Act Allegations,” Department of Justice, Press
Release, November 1, 2002, http://www.justice.gov/opa/pr/2002/November/02_civ_634.htm (Accessed 9/19/2012).
361 “McLeod Regional Medical Center to Pay U.S. Over $15 Million to Resolve False Claims Act Allegations” Department of Justice, News
Release, November 1, 2002, http://www.justice.gov/opa/pr/2002/November/02_civ_634.htm (Accessed 9/19/12); “Spotlight on
Compensation Practices: Where We Have Been and Where Are We Going?” By Bernadette M. Broccolo, Esq., presented at “Hospitals and
Health Systems Law Institute” February 10-11, 2005, Tucson, AZ,, p.70.
362 Ibid.
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expert proposed a more detailed analysis for determining whether a given compensation
arrangement was commercially reasonable. In SCCI Hospital Houston, the U.S. challenged the
commercial reasonableness of the compensation paid by the hospital to three physician medical
directors.363 The government’s financial expert stated that commercial reasonableness of a
medical director arrangement depended upon the agreement being “essential to the functioning
of the hospital,”364 and emphasized that there had to be “sound business reasons for paying
medical director fees to referring physicians.”365 To examine these thresholds, the government’s
expert analyzed several factors in assessing the commercial reasonableness of the compensation,
including:
(1)
(2)
(3)
(4)

The size of the hospital, number of patients, patient acuity levels, and patient needs;
The quality of activities and involvement of medical staff in need of medical direction;
The number of regular committees and meetings requiring physician involvement; and
The quality of hospital management and interdisciplinary coordination of patient
services.366

While medical director compensation may be based on either (1) an hourly payment, with the
maximum number of hours specified in the contract or (2) an annual payment that is determined
by a projected number of hours multiplied by a hourly rate consistent with FMV, it may be
critical to surviving regulatory scrutiny for the employer to track and document the actual
number of hours the medical director spends performing the services, i.e., “[j]ustifying the need
for...medical director services goes hand-in-hand with showing that the services are actually
furnished. Any situation with more than one medical director for a single department is likely to
be viewed with suspicion. If such arrangements exist, hospitals should be especially thorough in
demonstrating the necessity for the arrangements.”367
U.S. v. Covenant Medical Center
Hospitals and physicians face significant liability for violating the regulatory thresholds of
commercial reasonableness and FMV, as illustrated by the 2009 case, U.S. v. Covenant Medical
Center. In U.S. v. Covenant Medical Center, which settled for $4.5 million, the DOJ alleged that
Iowa’s Covenant Medical Center compensated five referring physicians at rates far exceeding
FMV.368 The DOJ alleged that the five referring physicians—specifically, two orthopedic
surgeons, two neurosurgeons, and a gastroenterologist—were among the highest-paid physicians
in the entire U.S., making as much as $2.1 million despite the hospital’s tax exempt status.369
363 "U.S. ex rel. Kaczmarczyk, et al. v. SCCI Hospital Ventures, Inc.," Civ. No. H-99-1031, (July 12, 2005), Fair Market Valuation Report—
Kathy McNamara, p. 4.
364 Ibid.
365 "U.S. ex rel. Kaczmarczyk, et al. v. SCCI Hospital Ventures, Inc.," Civ. No. H-99-1031, (July 12, 2005), Fair Market Valuation Report—
Kathy McNamara, p. 4; “Fair Market Value in Health Care Transactions,” By Lewis Lefko, Haynes and Boone, LLP, July 20, 2007,
http://www.worldservicesgroup.com/publications.asp?action=article&artid=2086 (Accessed 10/9/2009).
366 Fair Market Valuation Report - United States v. SCCI, In "U.S. ex rel. Kaczmarczyk, et al. v. SCCI Hospital Ventures, Inc.," Civ. No. H-991031, (July 12, 2005), p. 4.
367 “Health Care Fraud and Abuse: Practical Perspectives” By Linda A. Baumann, Washington, D.C.: American Bar Association Health Law
Section & The Bureau of National Affairs, Inc., 2002, p. 281.
368 “Covenant Medical Center to Pay U.S. $4.5 Million to Resolve False Claims Act Allegations,” Press Release, Department of Justice,
August 25, 2009, http://www.usdoj.gov/opa/pr/2009/August/09-civ-849.html (Accessed 8/31/09).
369 “Covenant Medical Center to Pay U.S. $4.5 Million to Resolve False Claims Act Allegations,” Press Release, Department of Justice,
August 25, 2009, http://www.usdoj.gov/opa/pr/2009/August/09-civ-849.html (Accessed 8/31/09).; “Covenant to Pay Feds $4.5M to Settle
Fraud Allegations” Waterloo Cedar Falls Courier, August 25, 2009, http://www.wcfcourier.com/articles/2009/08/25/news/breaking_news/
doc4a94156271f78380125347.txt (Accessed 8/31/09).
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The DOJ cited significant discrepancies between the compensation paid to the five Covenant
physicians in comparison to the compensation paid to physicians in the region and around the
country, leading the DOJ to conclude that the hospital was paying the physicians for referrals in
violation of the Stark Law.370
U.S. v. Bradford Regional Medical Center
In addition to hospital-physician compensation arrangements facing increased scrutiny for
potential Stark Law and Anti-Kickback statute violations, hospital-physician lease arrangements
have also come under heightened scrutiny for Stark and Anti-Kickback violations in recent years.
Perhaps the most widely publicized case involving such an arrangement is the 2010 case U.S. v
Bradford Regional Medical Center, a qui tam action in which the Court found that a noncompete clause of a lease agreement between two physicians and Bradford Regional Medical
Center constituted an indirect financial relationship, whereby the consideration provided under
the sublease explicitly took into account anticipated referral volumes, in violation of the Stark
Law.371
The Court analyzed the legal permissibility of the lease arrangement, and applied Stark’s
definition of FMV and the value or volume standard (i.e., if the consideration takes into account
the value or volume of referrals, then the arrangement is not consistent with FMV) to determine
whether the agreement accounted for anticipated referrals.372 Although the Court did not
conclude as a matter of law that the defendants “knowingly or willfully” paid and received
remuneration under the arrangement, in violation of the Anti-Kickback statute, the Court did find
that the arrangement considered value or volume of referrals to determine the amount of
compensation received by the physicians.373 Significantly, when applying a Bradford analysis to
future hospital/physician lease arrangements, advisers should note that in making its
determination that the financial relationship at issue in Bradford did not fall within the FMV
exception to the Stark Law, the district court looked to the Defendant’s expert report, which
specifically stated that referrals were taken into account when valuing the consideration paid for
the nuclear camera sublease:
“When modified to reflect the aforementioned incremental/variable costs for
providing the MRI and CT services the following table shows the expected
quantitative revenues (000’s omitted) that would accrue to the Hospital with the
non-competition agreement in place and a comparison of those benefits to the
amounts payable under the non-competition agreement. This is based on the
assumption that the Physicians would likely refer this business to the Hospital in
the absence of a financial interest in their own facilities or services, although they

370 “Covenant Medical Center to Pay U.S. $4.5 Million to Resolve False Claims Act Allegations,” Press Release, Department of Justice, Aug.
25, 2009, http://www.usdoj.gov/opa/pr/2009/August/09-civ-849.html (Accessed 9/4/09); “Iowa Hospital Pays $4.5 Million in Fraud Case,”
By Nigel Duara, Associated Press, August 25, 2009(Accessed 8/31/09).
371 Report of Charles T. Day, CPA, in “U.S. ex rel. Singh v. Bradford Regional Medical Center,” Civ. No. 1:04-cv-00186-MBC, (W.D. Pa.
September 10, 2008), p. 17.
372 "U.S. ex rel. Singh v. Bradford Regional Medical Center" 752 F.Supp.2d 602, 634-635 (W.D. Pa. 2010).
373 "U.S. ex rel. Singh v. Bradford Regional Medical Center" 752 F.Supp.2d 602, 634-635, 640 (W.D. Pa. 2010).
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are not required to do so by virtue of any of the covenants contained in the
Agreements or otherwise.”374
U.S. ex rel. Drakeford v. Tuomey
In United States ex rel. Drakeford v. Tuomey Healthcare System, Inc. (Tuomey), Michael
Drakeford, M.D. alleged that Tuomey, a private, non-profit community hospital in South
Carolina, violated Stark when it entered into more than fifteen employment agreements, all of
which were designed to induce and maintain referral relationships.375 Tuomey entered into
compensation contracts with area physicians, conferring salary and benefits to those physicians
in excess of the net collections received from their professional practices.376 Tuomey would then
generate two billings to Medicare, one for the professional services rendered and a second
“facility fee” assessed because Tuomey provided the space, nurses, equipment, and other items
for the physicians’ practices.377 The court found that the facility component of the physicians’
personally performed services and the resulting fee constituted a “referral” as defined by Stark
and its regulations.378 In doing so, the court relied on the OIG’s official commentary, which
stated:
“We have concluded that when a physician initiates a designated health service
and personally performs it him or herself, that action would not constitute a
referral of the service to an entity…However, in the context of inpatient and
outpatient hospital services, there would still be a referral of any hospital service,
technical component, or facility fee billed by the hospital in connection with the
personally performed service. Thus, for example, in the case of an inpatient
surgery, there would be a referral of the technical component of the surgical
service, even though the referring physician personally performs the service.”379
Accordingly, failure by a physician (with whom the hospital has a financial relationship) to
personally perform the technical (facility) components of treating a patient for which Medicare is
subsequently billed constitutes a non-compliant referral under the Personal Services
Arrangement (PSA) exception to Stark, because “the personal services exception does not extend
to a facility fee a hospital bills for a facility component resulting from a personal performed
service.”380
This lawsuit also demonstrates the OIG and DOJ’s increased focus regarding the benchmark
salary rates utilized in determining the fair market value of physician compensation. The court in
Tuomey established physician compensation in the 75th percentile as the benchmark for Stark
scrutiny, likely responding to the case’s expert reports, which noted that that the 75th percentile

374 Report of Charles T. Day, CPA, in “U.S. ex rel. Singh v. Bradford Regional Medical Center,” Civ. No. 1:04-cv-00186-MBC, (W.D. Pa.
September 10, 2008), p. 17.
375 “United States ex rel. Drakeford v. Tuomey Healthcare Systems, Inc.” 675 F.3d 394, 399 (4th Cir. 2012).
376 Ibid.
377 Ibid.
378 “United States ex rel. Drakeford v. Tuomey Healthcare Systems, Inc.” 675 F.3d 394, 406-407 (4th Cir. 2012).
379 “United States ex rel. Drakeford v. Tuomey Healthcare Systems, Inc.” 675 F.3d 394, 406-07 (4th Cir. 2012); “Medicare and Medicaid
Programs; Physicians’ Referrals to Health Care Entities with Which They Have Financial Relationships, Federal Register, Vol. 66, No. 3
(January 4, 2001), p. 941.
380 “United States ex rel. Drakeford v. Tuomey,” 675 F.3d 394, 406 (4th Cir. 2012).
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was at the high end of what was considered to be FMV for physician compensation.381
Nevertheless, the government’s expert witness, Kathy McNamara, actually stated that annual
compensation may exceed the 75th percentile and survive Stark scrutiny. Her report stated:
“…[A]n employer is not categorically prevented from paying above the 75th
percentile in total compensation. Applying the ‘supportable rate’ to very high
production (either collections or Work RVUs) will result in defendable and FMV
compensation, sometimes even above the 90th percentile total cash
compensation.”382
Together, these two elements significantly expand the scope of physician contracts that could be
subject to Stark scrutiny.
U.S. v. Campbell
Like Tuomey, the 2011 case, U.S. v. Campbell, explores the possibility of Stark violations arising
through referrals for DHS services by physicians to healthcare enterprises with which they have
a fixed compensation arrangement.383 In Campbell, the University of Medicine and Dentistry of
New Jersey (UMDNJ) operated a university hospital accredited and licensed as a Level 1 Trauma
Center, requiring the hospital to perform a requisite number of cardiac procedures each year to
maintain its accreditation level. In an effort to increase the number of cardiac procedures that
were both referred to, and performed at, the hospital, UMDNJ engaged in a recruitment
initiative, which included “enter[ing] into part-time employment contracts with local community
cardiologists in private practices, who had patients they could refer to University Hospital for
cardiac-related procedures.”384 One cardiologist, Dr. Joseph Campbell, entered into an
employment contract with UMDNJ, which contained a compensation provision of $75,000
annually to Dr. Campbell for his part-time services.385 These services included: teaching and
lecturing for hospital fellows and medical students; interpreting hospital electrocardiograms;
attending weekly cardiology conferences; supporting research efforts; and completing Medicare
time studies.
Stemming from a federal investigation into UMDNJ’s employment and referral practices,
UMNDJ entered into a settlement with the federal government, paying approximately $8.33
million in FCA damages for knowingly submitting claims to Medicare in violation of the Stark
Law.386 After settling with UMNDJ, the U.S. brought an action against Campbell individually,
alleging that: (1) Campbell’s primary service for UMDNJ was referring cardiology patients to
the hospital from his private cardiology practice and (2) Campbell failed to perform the majority
of the services identified in his employment agreement with UMDNJ, receiving compensation of

381 U.S. ex rel. Drakeford v. Tuomey Healthcare Systems, Inc., Kathleen McNamara Expert Report, In “United States ex rel. Drakeford v.
Tuomey Healthcare Systems, Inc.,” No. 3:05-cv-02858 (D. S.C. 2010), ECF No. 358-3, p. 9; U.S. ex rel. Drakeford v. Tuomey Healthcare
Systems, Inc., Steve Rice Expert Report, In “United States ex rel. Drakeford v. Tuomey Healthcare Systems, Inc.,” No. 3:05-cv-02858
(D. S.C. 2010), ECF No. 302-47, p. 31.
382 U.S. ex rel. Drakeford v. Tuomey Healthcare Systems, Inc., Kathleen McNamara Expert Report, In “United States ex rel. Drakeford v.
Tuomey Healthcare Systems, Inc.,” No. 3:05-cv-02858 (D. S.C. 2010), ECF No. 358-3, p. 10.
383 “U.S. v. Campbell et al.” 2011 U.S. Dist. LEXIS 1207 (D. N.J. January 4, 2011) p. 5.
384 Ibid, p. 2.
385 Ibid, p. 2.
386 Ibid, p. 3.
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$70,000.387 This case stands for the proposition that healthcare providers, including individual
physicians, may open themselves up to potential Stark liability by referring patients to healthcare
entities with which they have a financial relationship if a fixed compensation amount can be seen
as remuneration for patient referrals in the absence of services performed by the physician as
called for in the employment agreement.
U.S. ex rel. Baklid-Kunz v. Halifax
In U.S. ex. rel. Baklid-Kunz v. Halifax, a 2012 qui tam case involving Stark and the FCA,388 the
U.S. government alleged that Halifax violated the FCA by submitting, and causing others to
submit, false and fraudulent Medicaid claims arising from improper referrals.389 In the Halifax
case, certain oncologists were paid incentive bonuses from an incentive pool, which comprised
15% of the operating margin of the medical oncology program.390 The bonus pool was then
divided between the oncologists based upon each oncologist’s personally performed services.391
On the government’s motion for summary judgment, Halifax contended that this incentive bonus
complied with the productivity bonus provisions of the bona fide employee exception to the
Stark law, which requires that a productivity bonus be based on services personally performed by
a physician.392 However, the Court disagreed with Halifax, and held that the bonus pool was
comprised of certain revenues from services that the oncologists did not personally perform, such
as outpatient prescription drugs and other outpatient services not personally performed by the
oncologists.393 Accordingly, the Court found that Halifax did, in fact, violate the Stark law and
the FCA.394 Similarly, the Court denied Halifax’s motion for summary judgment related to three
neurosurgeons that, in certain years, were paid more than twice as much as neurosurgeons at the
90th percentile of their specialty, despite the fact that the neurosurgeons’ collections fell below
that measure.395
Shortly thereafter, in March 2014, Halifax agreed to settle with the US government for $85
million to resolve remaining allegations of violations of the FCA and Stark Law.396 Accordingly,
hospitals and providers should be careful to ensure that any bonus pool from which physicians
are compensated contains only revenues derived from services that were personally performed
by the physicians receiving productivity bonus compensation.

387 Ibid, p. 3.
388 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31DAB (M.D. Fla. March 19, 2012), Order on
Motion to Dismiss the Complaint in Intervention, p. 2.
389 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31DAB (M.D. Fla. February 18, 2011),
Plaintiff’s Second Amended Complaint, p. 1-2.
390 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31TBS (M.D. Fla. November 13, 2013), Order
on Motion for Partial Summary Judgment, p. 4.
391 Ibid, p. 4, 16.
392 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31TBS (M.D. Fla. November 13, 2013), Order
on Motion for Partial Summary Judgment, p. 16; “Bona Fide Employment Relationships” 42 U.S.C. § 1395nn(e)(2) (2013).
393 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31TBS (M.D. Fla. November 13, 2013), Order
on Motion for Partial Summary Judgment, p. 15-16.
394 Ibid, p. 17.
395 “U.S. ex. rel. Baklid-Kunz v. Halifax Hospital Medical Center” Case No. 6:09-cv-1002-Orl-31TBS (M.D. Fla. November 18, 2013), Order
on Motion for Summary Judgment, p. 10-11.
396 “Florida Hospital System Agrees to Pay the Government $85 Million to Settle Allegations of Improper Financial Relationships with
Referring Physicians” Department of Justice, March 11, 2014, http://www.justice.gov/opa/pr/florida-hospital-system-agrees-paygovernment-85-million-settle-allegations-improper (Accessed 3/4/15).
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U.S. ex rel. Heesch v. Diagnostic Physicians Group
In the 2013 case U.S. ex rel. Heesch v. Diagnostic Physicians Group, the U.S. and a relator
challenged the legality of a physician/clinic relationship whereby a diagnostic clinic’s
compensation to a physician group allegedly included a percentage of the money collected from
Medicare for tests and procedures the providers referred to the clinic.397 Specifically, the U.S.
alleged that the physicians “were aware that they received a financial benefit from ordering tests
at [the clinic] that they did not receive from referring tests to other clinics and hospitals.”398 In
July 2014, the parties settled the matter out of court, with the defendant physicians and the clinic
paying $24.5 million and entering into a corporate integrity agreement with the government for a
five-year period.399
U.S. ex rel. Parikh v. Citizens Medical Center
The U.S. ex rel. Parikh v. Citizens Medical Center case involved physician relators that alleged
Citizens Medical Center (CMC) had a kickback scheme with a group of five cardiologists.400
Specifically, the relators alleged that the cardiologists were hired at CMC with salaries that more
than doubled from the time when the cardiologists were employed privately, as well as with
insurance coverage, malpractice coverage, dictation services, and rental of office space at belowmarket rates.401 The relators alleged that CMC provided these services and salaries to the
cardiologists in an effort to induce the cardiologists to refer patients to CMC, and explained that
CMC reaped enormous profits from the cardiologists’ referrals.402
Importantly, the relators specifically alleged that the cardiologists’ practice have systematically
lost money, as much as $400,00 in 2008 and $1,000,000 in 2010, while CMC prospered as a
result of the increased referrals.403 Importantly, the Court stated:
“Relators have made several allegations that, if true, provide a strong inference of
the existence of a kickback scheme. Particularly, the Court notes Relators’
allegations that the cardiologists’ income more than doubled after they joined
Citizens, even while their own practices were costing Citizens between $400,000
and $1,000,000 per year in net losses. Even if the cardiologists were making less
than the national median salary for their profession, the allegations that they
began making substantially more money once they were employed by Citizens
[are] sufficient to allow an inference that they were receiving improper
remuneration. This inference is particularly strong given that it would make little
apparent economic sense for Citizens to employ the cardiologists at a loss unless

397 “U.S. ex rel. Heesch v. Diagnostic Physicians Group” Civil Action No. 11-364-KD-B (S.D. Ala. August 8, 2013), U.S. Complaint in
Intervention, p. 2.
398 “U.S. ex rel. Heesch v. Diagnostic Physicians Group” Civil Action No. 11-364-KD-B (S.D. Ala. August 8, 2013), U.S. Complaint in
Intervention, p. 29.
399 “Alabama Hospital System and Physician Group Agree to Pay $24.5 Million to Settle Lawsuit Alleging False Claims for Illegal Medicare
Referrals” Department of Justice, July 21, 2014, http://www.justice.gov/opa/pr/alabama-hospital-system-and-physician-group-agree-pay245-million-settle-lawsuit-alleging (Accessed 3/10/15).
400 “U.S. ex rel. Parikh v. Citizens Medical Center” Case No. 6:10-cv-00064, (S.D. TX. September 20, 2013), Memorandum and Order, p. 25.
401 Ibid.
402 Ibid
403 Ibid, p. 26-27.
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it was doing so for some ulterior motive—a motive Relators identify as a desire to
induce referrals.”404
After the defendants’ failed appeal to the 5th Circuit Court of Appeals on their qualified
immunity defense, the parties settled their claims on February 27, 2015.405
U.S. ex rel. Williams v. Banks-Jackson-Commerce Hospital &
Nursing Home Authority
Not only hospitals, but also individual physicians have become targets of federal fraud and abuse
enforcement agencies. In United States ex rel. Williams v. Banks-Jackson-Commerce Hospital &
Nursing Home Authority, an individual physician agreed to pay $200,000 to the U.S. to settle
allegations regarding improper kickbacks and billing practices, in violation of the FCA, Stark
law, and Anti-Kickback statute.406 The physician involved in the Banks-Jackson case, Dr.
Narasimhulu Neelargaru, allegedly over-read electrocardiogram tests, and billed Medicare for
these over-readings.407 Although the hospital involved in the lawsuit settled the claims against it
in 2010, Dr. Neelargaru and the federal government engaged in litigation for nearly four years
until the parties settled their claims on September 22, 2014.408 Accordingly, physicians should be
aware that hospitals are not the only entities that federal fraud and abuse authorities are pursuing.
OIG Guidance Relating to Physician Compensation
The OIG has also issued pronouncements relating to scrutiny of physician compensation
arrangements. On September 20, 2007, the OIG issued Advisory Opinion No. 07-10, regarding
the compensation paid for physician services related to on-call coverage.409 The opinion stated
that the key inquiry for determining whether the compensation arrangement for providing
emergency on-call coverage violates the Anti-Kickback statute, “is whether compensation is: (i)
[at] fair market value in an arm’s length transaction for actual and necessary items or services;
and, (ii) not determined in any manner that takes into account the volume or value of referrals or
other business generated between the parties.”410
Although the OIG found that the subject arrangement did not “fit squarely into the terms of the
safe harbor” for personal services and management contracts, because the amount of
compensation was not set in advance and varied monthly, the compensation arrangement was
nevertheless deemed low risk because:

404 Ibid, p. 27-28.
405 “U.S. ex rel. Parikh v. Citizens Medical Center” Case No. 13-41088, (5th Cir. October 1, 2014), Appeal from the United States District
Court for the Southern District of Texas, p. 9; “U.S. ex rel. Parikh v. Citizens Medical Center” Case No. 6:10-cv-00064, (S.D. TX.
September 20, 2013), Order of Dismissal on Settlement Announcement, p. 1.
406 “Hospital and Cardiologist Settle False Claims Act Case” The United States Attorney’s Office: Northern District of Georgia, Sept. 22, 2014,
http://www.justice.gov/usao/gan/press/2014/09-22-14.html (Accessed 10/10/14).
407 “U.S. ex rel. Ralph D. Williams v. Banks-Jackson-Commerce Hosp. & Nursing Home Auth. et al.” Case No. 1:08-CV-3235-TWT (N.D.
Ga. October 16, 2008) Qui Tam Complaint, p. 17-18.
408 “U.S. ex rel. Ralph D. Williams v. Banks-Jackson-Commerce Hosp. & Nursing Home Auth. et al.” Case No. 1:08-CV-3235-TWT (N.D.
Ga. September 29, 2014) Order, p. 2.
409 “OIG Advisory Opinion No. 07-10” Office of Inspector General, Advisory Opinion, September 27, 2007, oig.hhs.gov/fraud/docs/
advisoryopinions/2007/AdvOpn07-10A.pdf (Accessed 5/10/10) p. 1.
410 Ibid, p. 6-7.
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(1) The per diem rates were at FMV without regard to referrals;
(2) The physicians were required to treat any patient who entered the emergency department
until discharge with no additional compensation;
(3) The physicians provided certain volunteer (uncompensated) services;
(4) The emergency department was understaffed prior to on-call compensation being paid,
therefore, the likelihood that the arrangement was instituted to provide remuneration to
physicians for referrals was minimized; and
(5) All physicians were given a chance to participate in the on-call program on equal ground,
and the program was not being used to reward physicians for referrals.411
Providers and their advisers may consider utilizing OIG Advisory Opinion 07-10 and the
rationales behind the favorable ruling in crafting physician compensation arrangements that work
to minimize the risk of fraud and abuse enforcement action.

STATE FRAUD AND ABUSE STATUTES
To better control healthcare fraud and abuse, and to take advantage of potential federal
incentives, many states have implemented laws modeled after the federal False Claims Act, Stark
Law, and Anti-Kickback Statute. These state laws range in level of severity and similarity to
these federal laws, with some states having lenient laws that do not rise to the level of the federal
standards and others with equal or greater standards than federal laws.

State False Claims Acts
Violations of state false claims acts can result in fines from $1,000 to $15,000 per false claim.412
Although the state statutes commonly mirror the federal FCA, some differences can include
expanded liability provisions, jurisdictional bars and scope of employment limitations for
whistleblowers, and damage and penalty provisions.413 Violation of these state statutes may carry
significant penalties, as illustrated by the HCA, Inc. settlement, wherein the DOJ and the State of
Tennessee settled a qui tam lawsuit for $16.5 million against HCA, Inc. after allegations that
HCA entered into improper financial transaction where it traded office space rental payments in
excess of FMV to induce physician referrals to its facilities.414
Following the passage of the Deficit Reduction Act (DRA) by Congress in 2005, the number of
state false claims acts was expected to increase, because the act incentivized state governments
to enact state false claims acts similar in scope to the federal FCA by promising to return 10
percent of the funds recovered from Medicaid enforcement actions to the state.415 Prior to the
DRA’s enactment, all recovered money only went to the federal government.416 The DRA also
required entities receiving more than $5 million annually from Medicaid establish an employee
411
412
413
414

Ibid, p. 8-10.
“Health Care Fraud: Enforcement and Compliance” By Robert Fabrikant et al., New York, NY: Law Journal Press, 2007, p. 4-72.4.
Ibid, p. 4-72.4-72.6.
“Hospital Chain HCA Inc. Pays $16.5 Million to Settle False Claims Act Allegations Regarding Chattanooga, Tenn., Hospital,” Department
of Justice, September 19, 2012, http://www.justice.gov/opa/pr/2012/September/12-civ-1133.html (Accessed 9/21/12).
415 “Deficit Reduction Act of 2005” Pub. L. 109-171, § 6031, 120 Stat. 4, 72-73 (February 8, 2006).
416 “Health Law Update - The Deficit Reduction Act of 2005: New Medicaid Fraud and Abuse Provisions” Bass, Berry & Sims, May 31, 2006,
www.bassberry.com/.../Health%20Law%20Update%20May%2031%202006.pdf (Accessed 05/10/10).
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education plan regarding state and federal false claims acts and whistleblower protections.417 The
required education plan must offer information to employees regarding the federal FCA,
administrative remedies for false claims and statements, any civil or criminal penalties under
state false claims acts, and any whistleblower protections under federal and state law.418 Since its
implementation in January 2007, many states have strengthened their existing false claims laws
to make match the incentive requirements, and more states have developed their own false
claims acts.419
The OIG for HHS is charged with reviewing state false claims laws to ensure they meet the
criteria related to the DRA incentive program. Programs must:420
(1) Establish liability to the state for false or fraudulent claims described in the FCA with
respect to any expenditures related to the state Medicaid plans described in section
1903(a) of SSA;
(2) Contain provisions that are at least as effective in rewarding and facilitating qui tam
actions for false or fraudulent claims as those described in the FCA;
(3) Contain a requirement for filing an action under seal for sixty days with review by the
state attorney general; and
(4) Contain a civil penalty that is not less than the amount of the civil penalty authorized
under the FCA.421
Thirty states, including the District of Columbia, have enacted some form of a false claims act
under the encouragement of the federal FCA to create state laws to better monitor potential false
claims.422 The FCA has been amended many times by various legislative acts since 1986,
including the Fraud Enforcement and Recovery Act of 2009 (FERA), the ACA, and the DoddFrank Wall Street Reform and Consumer Protection Act of 2010 (the Dodd-Frank Act).423
However, in 2013 OIG declared that any previously approved state false claims acts had to be
amended and resubmitted to the OIG for review.424 Of the thirty states with laws, twenty-eight
have submitted their laws for OIG review, and only eighteen have been approved as meeting all
the necessary requirements to qualify for incentives.425 For the complete list of states with False
Claims Act Legislation, see Exhibit 3-3, below.

417 “Deficit Reduction Act of 2005” Pub. L. 109-171, § 6032, 120 Stat. 4, 73-74 (February 8, 2006).
418 Ibid.
419 “Health Law Update - The Deficit Reduction Act of 2005: New Medicaid Fraud and Abuse Provisions” Bass, Berry & Sims, May 31, 2006,
www.bassberry.com/.../Health%20Law%20Update%20May%2031%202006.pdf (Accessed 05/10/10).
420 “State False Claims Act Reviews” Office of Inspector General, 2015, http://oig.hhs.gov/fraud/state-false-claims-act-reviews/index.asp
(Accessed 2/23/15).
421 Ibid.
422 “States with False Claims Acts” Taxpayers Against Fraud Education Fund, 2015, http://www.taf.org/states-false-claims-acts (Accessed
2/23/15).
423 “State False Claims Act Reviews” Office of Inspector General, 2015, http://oig.hhs.gov/fraud/state-false-claims-act-reviews/index.asp
(Accessed 2/23/15).
424 Ibid.
425 “State False Claims Act Reviews” Office of Inspector General, http://oig.hhs.gov/fraud/state-false-claims-act-reviews/index.asp (Accessed
2/23/15).
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Exhibit 3-3: States With False Claims Act Legislation426
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii

Minnesota
Montana
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina

Illinois
Indiana
Iowa
Louisiana
Maryland
Massachusetts
Michigan

Oklahoma
Rhode Island
Tennessee
Texas
Virginia
Washington
Wisconsin

State Anti-Kickback and Self-Referral Laws
Forty-two states and the District of Columbia have laws prohibiting kickbacks and limiting selfreferrals. For the complete list, see Exhibit 3-4, below.
Exhibit 3-4: States with Self-Referral and Anti-Kickback Legislation427
Alabama (Anti-Kickback)
Arizona
Arkansas
California
Colorado
Connecticut
Delaware (Anti-Kickback)
Florida

Montana
Nevada
New Hampshire
New Jersey
New Mexico (Anti-Kickback)
New York
North Carolina
Ohio

Georgia (self-referral)
Hawaii (self-referral)
Illinois
Indiana
Kansas

Oklahoma
Pennsylvania
Rhode Island (Anti-Kickback)
South Carolina
South Dakota

Kentucky
Louisiana
Maine (self-referral)
Maryland (self-referral)
Massachusetts
Michigan
Minnesota (self-referral)
Mississippi (Anti-Kickback)
Missouri

Tennessee (self-referral)
Texas (Anti-Kickback)
Utah
Virginia
Washington
Washington DC (Anti-Kickback)
West Virginia
Wisconsin

426 “State False Claims Acts” The False Claims Act Legal Center, Taxpayers Against Fraud Education Fund, http://www.taf.org/states-falseclaims-acts (Accessed 2/23/15).
427 “Health Cost Containment and Efficiencies: Combating Health Care Fraud and Abuse” NCSL Briefs for State Legislators, September 2010,
http://www.ncsl.org/portals/1/documents/health/Fraud-2010.pdf (Accessed 2/21/15) p. 3.
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Updates to State Self-Referral Laws
Many states have their own version of the federal self-referral law (Stark Law). These state selfreferral laws vary in degree of coverage; some mirror the federal language in prohibiting the
majority of self-referrals, some prohibit all self-referrals, some prohibit any physician ownership
in care facilities, some only require disclosure of financial interests to patients, and some states
have no self-referral laws. Over the past few years, many states have expanded or updated their
self-referral laws to accommodate ACA initiatives and further control potential fraud and abuse.
When claims arise in states that have their own self-referral laws, both the federal and state
governments are able to prosecute and collect from the offending party.
New Jersey Update to “Codey Act”
After the 2007 decision in Health Net of New Jersey, Inc. v. Wayne Surgical Center, LLC,
physicians in New Jersey who referred patients to an ASC in which they had an ownership
interest were suddenly at risk of being in violation of New Jersey’s anti-self-referral law, the
Codey Law.428 Most unexpectedly, the Health Net decision rejected a widely relied upon 1997
New Jersey Board of Medical Examiners (BME) advisory opinion, which held that an ASC
constitutes an “extension of the physician’s medical office,” such that the arrangement did not
violate the Codey Law.429
After the ruling in Health Net, the BME adopted emergency rules declaring that doctors who
referred patients to physician-owned ASCs were not in danger of violating the law.430 In
response, legislators in New Jersey, led by Senate President Richard Codey (the namesake of the
original law), proposed an amendment to the Codey Law that would allow self-referral to
physician-owned ASCs.431
In 2009, the New Jersey legislature amended the Codey Law to permit physician referrals to
ASCs in which they have a financial interest, on the following conditions:
(1) The physicians personally perform the procedure;
(2) The physicians’ remuneration as an owner is directly proportional to their ownership
interest (rather than the amount of the physician’s referrals);
(3) All patient-related decisions at facilities with non-physician owners are made by
physicians; and
(4) The physicians inform the patients of their ownership share at the time of referral.432

428 “New Jersey Court Rules that Physician Referrals to Ambulatory Surgical Center in Which They Own an Interest Violates Codey Act” By
Flaster Greenberg, Health Care Alert Newsletter, December 2007, http://www.flastergreenberg.com/Uploads/FileManager/client%20alerts/
healthcarealertdec07.pdf (Accessed 4/18/08); “New Jersey Codey Act” N.J. Stat. Ann. § 45:9-22.4 et seq. (1992).
429 “New Jersey Court Rules that Physician Referrals to Ambulatory Surgical Center in Which They Own an Interest Violates Codey Act” By
Flaster Greenberg, Health Care Alert Newsletter, December 2007, http://www.flastergreenberg.com/Uploads/FileManager/client%20alerts/
healthcarealertdec07.pdf (Accessed 4/18/08).
430 “New Jersey Codey Law Update: New Jersey BME Provides ‘Emergency Rules’ for State’s Centers, Says Referrals are Not in Violation”
Surgi Strategies, January 9, 2008, http://www.surgistrategies.com/hotnews/7ch14111940.html (Accessed 2/10/10).
431 “Doctors Battle Hospitals Over ASC Ownership Restrictions” By Gregg Blesch, Modern Physician, December 8, 2008,
http://www.modernphysician.com/article/20081208/MODERNPHYSICIAN/311309995/1110 (Accessed 2/10/10).
432 “New Jersey Senate Bill” No. 787, 213th Legislature, November 24, 2008.
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In addition, the statute also prohibits the issuance of new registrations for surgical practices and
ambulatory care facilities unless one of the limited exceptions applies.433 Most recently in 2014,
the New Jersey legislature extended the Codey Law to expand the scope of referable facilities for
lithotripsy procedures.434

State Fraud and Abuse Cases
In 2013, Cooper Health System, a New Jersey hospital, settled allegations of inappropriate
kickbacks and referrals with the U.S. and state of New Jersey after paying outside physicians
$18,000 per year to sit on an advisory board and attend meetings.435 The lawsuit against Cooper
Health was brought by both federal and state attorneys because New Jersey has similar
legislation to the federal Stark and Anti-Kickback laws. The original claim was brought as a qui
tam action against the hospital by a physician that alleged the hospital used consulting and
compensation agreements to induce referrals and hid them under the guise of advisory board
compensation.436 Additionally, the $18,000 payment to each physician-board member was found
to exceed the FMV of the services rendered. The resulting $12.6 million settlement was allocated
to the federal government, state government, and the initial whistle-blower physician.437
Similarly, in California, a health system and its affiliated hospital, Adventist Health System and
White Memorial Medical Center, settled claims with the U.S. and state of California over
allegations they violated the False Claims Act, Anti-Kickback Statute, and Stark Law, as well as
the state law counterparts.438 The plaintiffs alleged that Adventist improperly referred patients to
White Memorial by transferring medical and non-medical supplies and inventory below FMV.439
White Memorial was also accused of paying compensation above FMV to physicians that
referred patients to the medical center.440 The settlement between parties totaled $14.1 million,
with $11.5 million paid to the U.S. government, with most of that benefiting the Medicare Trust
Fund, and $2.6 million paid to the state of California’s Department of Health Care Services.441
Like the Cooper case, this case also originated with a qui tam suit, with the whistle blower
receiving $2.8 million from the settlement.442
When advising providers regarding compliance for particular physician arrangements, advisers
should note the subtle differences between federal and state fraud and abuse laws and how it may
influence the legality of the arrangement.

433 Ibid.
434 “Legislature Expands Codey Law Exception for Lithotripsy Referrals” By Beth Christian, Posted on New Jersey Healthcare Blog, March
24, 2014, http://www.njhealthcareblog.com/2014/03/legislature-expands-codey-law-exception-for-lithotripsy-referrals/ (Accessed 2/26/15).
435 “Cooper Health System Pays $12.6 Million Over Kickback Case” By David Voreacos, Bloomberg Business, January 24, 2013,
http://www.bloomberg.com/news/articles/2013-01-24/cooper-health-system-pays-12-6-million-to-settle-kickback-case (Accessed 2/26/15).
436 Ibid.
437 “Cooper Health System Pays $12.6 Million Over Kickback Case” By David Voreacos, Bloomberg Business, January 24, 2013,
http://www.bloomberg.com/news/articles/2013-01-24/cooper-health-system-pays-12-6-million-to-settle-kickback-case (Accessed 2/26/15).
438 “Adventist Health Pays United States and State of California $14.1 Million to Resolve False Claims Act Allegations” Department of
Justice, May 3, 2013, http://www.justice.gov/opa/pr/adventist-health-pays-united-states-and-state-california-141-million-resolve-falseclaims-act (Accessed 2/26/15).
439 Ibid.
440 Ibid.
441 Ibid.
442 Ibid.
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RACKETEER INFLUENCED AND CORRUPT ORGANIZATIONS ACT
(RICO)
The Racketeer Influenced and Corrupt Organizations Act (RICO)443 is a federal law that carries
both criminal and civil penalties with the aim of protecting the public from, “parties who conduct
organizations affecting interstate commerce through a pattern of criminal activity.”444 The
general prohibition of RICO is against using a business to commit a crime. When applied to
healthcare, RICO makes it illegal for any person to:
(1) Use or invest any income derived from a pattern of racketeering activity in an enterprise;
(2) Acquire or maintain control of any enterprise through a pattern of racketeering activity;
or
(3) For any person employed by, or associated with, any enterprise to conduct the affairs of
the enterprise through a pattern of racketeering activity.445
It is also a violation of RICO to conspire to engage in any of these three activities.446 A pattern of
racketeering activity involves committing at least two acts of racketeering activity.
RICO has been used to prosecute physicians, attorneys, and patients who conspire to defraud
payors by filing false claims related to fictitious automobile accidents, billing for services not
actually rendered, and unnecessarily prescribing controlled substances.447

ACOS AND FRAUD AND ABUSE
The Affordable Care Act initiated the development of accountable care organizations (ACOs) to
enable more coordinated care for beneficiaries. In response, regulatory agencies have issued
statements and proposed rules to accommodate the unique nature of these ACOs. Specific to
fraud and abuse, CMS and OIG issued a joint interim final rule in October 2014, extending the
waivers for Stark Law, the Anti-Kickback Statute, and certain CMP provisions related to the
Medicare Shared Savings Program (MSSP) that were originally proposed in 2011.448 These
waivers are designed to ensure that the development of beneficial ACOs is not hindered by fraud
and abuse laws and are MSSP specific, i.e., they do not apply to state fraud and abuse laws. The
proposed waivers give the Secretary of HHS the authority to waive the federal fraud and abuse
laws, even if the behavior would normally violate these laws.
There are five types of ACO fraud and abuse waivers; however, the ACO Participation waivers
is likely the broadest in scope, as it waives the effects of the Stark Law, the Anti-Kickback
statute, and CMP provisions for ACOs:
443 “Racketeer Influenced and Corrupt Organizations Act; Definitions” 18 U.S.C. § 1961 (2009).
444 “Health Care Fraud: Enforcement and Compliance,” By Robert Fabrikant et al., New York, NY: Law Journal Press, 2007, p. 3-83-84,
quoting 115 Cong. Rec. 9566, 9568 (April 18, 1969), statement of Sen. McClellan.
445 “Racketeer Influenced and Corrupt Organizations Act; Prohibited Activities”18 U.S.C. § 1962(a)-(c) (2009).
446 “Racketeer Influenced and Corrupt Organizations Act; Prohibited Activities”18 U.S.C. § 1962(d) (2009).
447 “Health Care Fraud: Enforcement and Compliance” By Robert Fabrikant et al., New York, NY: Law Journal Press, 2007, p. 3-90.
448 “Medicare Program; Final Waivers in Connection with the Shared Savings Program; Continuation of Effectiveness and Extension of
Timeline for Publication of Final Rule” Federal Register, Vol. 79, No. 201 (October 17, 2014) p. 62357.

256

Chapter 3: Regulatory Environment

(1) That have entered into a participation agreement with the MSSP and remain in good
standing;
(2) That meet certain governance, leadership, and management requirements;
(3) The ACO’s governing body has made an authorized, bona fide determination that the
proposed arrangement is reasonably related to the purposes of the MSSP;
(4) The proposed arrangement and its authorization by the governing body are documented;
and
(5) A description of the proposed arrangement is publicly disclosed at a time and in a place
and manner established in guidance issued by the Secretary of HHS.449
The remaining four ACO fraud and abuse waivers contain different requirements, waive
different fraud and abuse laws, and are named after the certain enumerated situations to which
they apply, to wit:
(1)
(2)
(3)
(4)

ACO Pre-Participation Waiver;
Shared Savings Distributions Waiver;
Compliance with Stark Waiver; and
Patient Incentive Waiver.450

Accordingly, for participants in certain ACOs, if the requirements of the ACO fraud and abuse
waivers are met, certain provider-ACO arrangements may not be required to fit in within the
exceptions or safe harbors to the aforementioned fraud and abuse laws. However, it should be
noted that these fraud and abuse waivers were extended only through November 2, 2015, unless
a final waiver rule becomes effective on an earlier date.451 As such, ACOs may be well served by
ensuring that any arrangements entered into under an ACO fraud and abuse waiver may be
unwound, or, alternatively, fit within the exceptions or safe harbors to the aforementioned fraud
and abuse laws.

FEDERAL ANTITRUST LAWS
STATUTORY BACKGROUND AND GENERAL APPLICATION
Antitrust laws aim to combat anticompetitive behavior conducted by businesses. The Sherman
Antitrust Act (Sherman Act), which prohibits any “contract, combination...or conspiracy, in
restraint of trade or commerce;”452 Section 5 of the Federal Trade Commission Act, which
prohibits “unfair methods of competition in or affecting commerce;”453 and Section 7 of the
Clayton Act, which prohibits acquisitions which are likely to “substantially lessen competition,
or tend to create a monopoly,”454 are the federal government’s three primary means of
combating unfair competition and abuse of monopolistic power. Further, Section 2 of the
449 “Medicare Program; Final Waivers in Connection with the Shared Savings Program; Interim Final Rule” Federal Register Vol. 76, No. 212,
(November 2, 2011), p. 68001.
450 Ibid, p. 68000-68001.
451 “Medicare Program; Final Waivers in Connection with the Shared Savings Program; Continuation of Effectiveness and Extension of
Timeline for Publication of Final Rule” Federal Register, Vol. 79, No. 201, (October 17, 2014), p. 62357.
452 “Sherman Antitrust Act” 15 U.S.C. § 1 (2013).
453 “Federal Trade Commission Act” 15 U.S.C. § 45 (2013).
454 “Clayton Act” 15 U.S.C. § 18 (2013).
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Sherman Act prohibits the abuse of monopoly power across states and establishes the act as a
felony.455 In the healthcare context, these statutes have also been used to combat kickbacks and
self-referral joint ventures, which have been recognized as an impediment to competition by
providers outside the self-referral or kickback network,456 as well as other anticompetitive
healthcare arrangements including: physician integration under physician hospital organization
models, independent practice associations (IPAs), and healthcare organizations negotiating on
behalf of their physician members.457

Tests for Anticompetitive Effects
The FTC typically examines healthcare arrangements under a rule of reason analysis, balancing
procompetitive and anticompetitive effects of the integration arrangement on the market.458 The
rule of reason test is used by antitrust authorities when the examined conduct has some level of
procompetitive justification.459 Under this test, courts analyze the whole agreement to determine
whether procompetitive benefits outweigh anticompetitive effects.460 If the court finds that the
“procompetitive benefits outweigh the harm to competition,” the agreement is acceptable and
reasonable.461 This test usually applies to activities such as “information exchanges, blanket
licenses, and vertical … price fixing.”462
In contrast, when an agreement is inherently anticompetitive and restrictive on trade, courts find
it per se illegal.463 A per se analysis enables the government to avoid costly investigations
without having to show potential anticompetitive effects.464 Examples of per se illegal
agreements include horizontal price fixing and market allocation, tying arrangements, and some
boycotts.465 Authorities have begun to use the rule of reason test more often than the per se
analysis when determining the legality of a healthcare agreement.466

ANTITRUST CASE LAW
Independent Practice Associations
In 2008, the FTC’s finding of illegal price fixing by a Texas IPA was upheld by a federal
appellate court.467 The court held that negotiation (on behalf of physician members) that doesn’t
involve risk sharing with payors or any form of improved efficiency from clinical integration
runs afoul of antitrust laws.468 Similarly, in a separate case, the FTC also approved a final order
455 “Sherman Antitrust Act” 15 U.S.C. § 2 (2013).
456 “Health Care Fraud: Enforcement and Compliance” By Robert Fabrikant, et al., New York, NY: Law Journal Press, 2007, p. 2-60.
457 “Health Care Fraud and Abuse: Practical Perspectives, 2003 Supplement” By Linda A. Baumann, Washington, DC: BNA Books, 2003,
p. 61.
458 “Greater Rochester Independent Practice Association, Inc., Advisory Opinion” By Markus H. Meier, To Christi J. Braun and John J. Miles,
September 17, 2007, http://www.ftc.gov/bc/adops/gripa.pdf (Accessed 3/6/15), p. 10.
459 “Antitrust Violations” By Bahadur Khan and Nickolas Barber, American Criminal Law Review, Vol. 50, (Fall 2013) p. 642-43.
460 “Chicago Board of Trade v. United States” 246 U.S. 231, 238 (1918).
461 “Antitrust Violations” By Bahadur Khan and Nickolas Barber, American Criminal Law Review, Vol. 50, (Fall 2013) p. 643.
462 Ibid.
463 “State Oil Co. v. Khan” 522 U.S. 3, 10 (1997).
464 “Antitrust Violations” By Bahadur Khan and Nickolas Barber, American Criminal Law Review, Vol. 50, (Fall 2013) p. 644-45.
465 “Antitrust Violations” By Bahadur Khan and Nickolas Barber, American Criminal Law Review, Vol. 50, (Fall 2013) p. 646.
466 Ibid, p. 647.
467 “North Texas Specialty Physicians v. Federal Trade Commission” 528 F.3d 346, 346 (5th Cir. 2008).
468 “North Texas Specialty Physicians v. Federal Trade Commission” 528 F.3d 346, 357 (5th Cir. 2008).
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that barred Minnesota Rural Health Cooperative from using “coercive tactics or refusals to deal”
including negotiating fixed pricing, threatening contract termination with payors who refuse to
deal on its terms, and refraining from individual negotiations with payors to ensure better terms
and rates from insurance plans.469 The order also forced the healthcare system to renegotiate all
existing contracts with insurers and to seek approval of them from the state.470
Similarly, in 2009, the FTC settled a price fixing charge against Alta Bates Medical Group, a 600
physician IPA in San Francisco, CA.471 The FTC found that Alta Bates arranged collective
negotiations for fee-for-service contracts with health insurers on behalf of all its physicians.472
Instead of consulting with the physicians to discuss pricing individually, the IPA would arrange
the negotiations as a group, and then offer the negotiated contracts to the individual physicians.
The FTC also charged the IPA with unlawful concerted refusal to deal when it tried to
contractually exclude its physicians from providing services to a third party network of its
competitor,473 even though it the FTC was ultimately unsuccessful in this endeavor.474 The FTC
found that the IPA did not demonstrate efficiencies through clinical or financial integration in
order to counter the complaint alleged against it, and, therefore, Alta Bates was prohibited “from
collectively negotiating fee-for-service reimbursements and engaging in related anticompetitive
conduct.”475 In order to avoid agency investigations or complaints, IPAs should consider serving
as a messenger between the physicians and insurers while giving each physician the ability to
accept or reject the terms.476
Traditionally, IPAs have only been able to negotiate on behalf of their members if the jointcontracting agreement has an element of risk-sharing built into it or if the IPA has embarked on a
clinical integration scheme to improve efficiency among its members.477 For example, the
Greater Rochester Independent Physician Association (GRIPA) sought out an advisory opinion
from the FTC staff regarding its planned agreement that involved enhanced coordinated care for
patients and joint-contracting on behalf of its physicians.478 GRIPA argued that the jointcontracting was necessary in order to achieve its quality and efficiency goals of clinical
integration and get total involvement from physicians.479 The FTC Advisory Opinion explained
that the staff would not refer the agreement to the Commission, finding that enough
469 “FTC Approves Final Order Settling Charges that the Minnesota Rural Health Cooperative Fixed Healthcare Reimbursement Rates”
Federal Trade Commission, January 2011, http://www.ftc.gov/news-events/press-releases/2011/01/ftc-approves-final-order-settlingcharges-minnesota-rural-health (Accessed 3/6/15); “In the Matter of Minnesota Rural Health Cooperative” Federal Trade Commission
Docket No. C-4311 (Dec. 28, 2010), Decision and Order, p. 3.
470 Ibid.
471 “FTC Settles Price-Fixing Charges against San Francisco Bay Area Doctors Group” Federal Trade Commission, June 4, 2009,
http://www.ftc.gov/news-events/press-releases/2009/06/ftc-settles-price-fixing-charges-against-san-francisco-bay-area (Accessed 2/11/15).
472 Ibid.
473 “In the Matter of Alta Bates Medical Group, Inc.” Federal Trade Commission Docket No. C-4260 (July 2009) Complaint, p. 5-6.
474 “FTC Settles Price-Fixing Charges against San Francisco Bay Area Doctors Group” Federal Trade Commission, June 4, 2009,
http://www.ftc.gov/news-events/press-releases/2009/06/ftc-settles-price-fixing-charges-against-san-francisco-bay-area (Accessed 2/11/15).
475 Ibid.
476 “How Antitrust Affects Your Health: The Antitrust Laws’ Impact on the Delivery of Healthcare Services in America” By Colin Kass and
Ryan Blaney, Proskauer Rose LLP, Posted on Bloomberg Law, March , 2012, https://www.bloomberglaw.com/home/
cd2313f81aecd63445f910ad8c22dcab/document/X7TK38O#0x0x0x2_ref (Accessed 2/4/15).
477 “Greater Rochester Independent Practice Association, Inc., Advisory Opinion” By Markus H. Meier, Letter to Christi J. Braun and John J.
Miles, September 17, 2007, http://www.ftc.gov/bc/adops/gripa.pdf (Accessed 04/18/08), p. 1, 11-12; “Health Care Fraud and Abuse:
Practical Perspectives, 2003 Supplement” By Linda A. Baumann, Health Law Section of the American Bar Association, Washington, DC:
BNA Books, 2003, p. 61-62.
478 “FTC Staff Advise Rochester Physician Organization That It Will Not Recommend Antitrust Challenge to Proposal to Provide Member
Physicians’ Services Through ‘Clinical Integration’ Program” Federal Trade Commission , 2007, http://www.ftc.gov/news-events/pressreleases/2007/09/ftc-staff-advises-rochester-physician-organization-it-will-not (Accessed 2/4/15).
479 Ibid.
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procompetitive effects existed so as to not challenge the program, “unless it became apparent
that GRIPA in fact was able to exercise market power or otherwise have an anticompetitive
effect in the relevant market.”480 However, in the matter of Southwest Health Alliances, Inc., the
FTC ruled against an IPA representing 900 physicians in Texas because the IPA’s jointcontracting negotiations were not “reasonably related to any efficiency-enhancing integration
among … physicians.”481

Physician-Owned Facilities
Antitrust authorities have investigated many community hospitals for engaging in exclusionary
practices in an effort to respond to the negative financial impact of physician-owned facilities
(POFs).482 Many hospitals have attempted to shut POFs, particularly specialty hospitals, out of
the market, which has resulted in some POFs initiating antitrust lawsuits, claiming that such
exclusionary behavior violates the Sherman Act.483 Many of these cases have failed because, as
alleged by industry commentators, antitrust authorities are protective of general hospitals that
have taken measures to combat, what they claim to be, cream skimming by specialty hospitals.484
In the case of Little Rock Cardiology Clinic PA (LRCC) v. Baptist Health, LRCC, the owner of
the cardiologic specialty hospital Arkansas Heart Hospital, filed a claim against Baptist, the area
provider of general healthcare services, alleging violations of Sections 1 and 2 of the Sherman
Act.485 LRCC claimed that Baptist conspired with Blue Cross Blue Shield to restrain trade and
monopolize market power for cardiology services by forming a jointly owned HMO with Blue
Cross, agreeing to an exclusive in-network contract with Blue Cross, and agreeing with Blue
Cross that LRCC would be removed from the Blue Cross network.486 The District Court
dismissed all the antitrust complaints brought by LRCC, finding that LRCC failed to properly
define a relevant patient market through which Baptist allegedly committed exclusive dealing.487
On appeal to the 8th Circuit Court of Appeals the decision was affirmed,488 followed by a denial
for certiorari review by the Supreme Court.489 The Court found that LRCC had been too
restrictive in its market definition of available patients, and ruled in favor of the hospital.490
However, some courts have found in favor of POFs in cases when a general hospital abused its
market power to pressure other hospitals and payors into agreeing to exclude the POF from the
market.
Heartland Surgical Specialty Hospital, L.L.C. v. Midwest Division, Inc. is such a case where the
Court found with the POF. In this case, Heartland alleged that the defendant hospitals and
480 “GRIPA Advisory Opinion” By Markus Meier, To Christi Braun and John Miles, September 17, 2007, http://www.ftc.gov/sites/default/
files/documents/public_statements/ftc-staff-will-not-recommend-antitrust-challenge-proposal-provide-member-physicians-servicesthrough/070921finalgripamcd.pdf (Accessed 2/4/15) p. 29.
481 “In the Matter of Southwest Health Alliances, Inc.” Federal Trade Commission Complaint, FTC No. C-4327 (July 15, 2011) p. 4.
482 “Antitrust Implications of Competition Between Physician-Owned Facilities and General Hospitals: Competition or Exclusion?” By
William E. Berlin, Esq., The Health Lawyer, Volume 20, No. 5 (June 2008), p. 3-5.
483 Ibid.
484 “Physician-Owned Hospital Can Pursue Antitrust Lawsuit” By Amy Lynn Sorrel, Amednews.com, Nov. 12, 2007,
http://www.ama-assn.org/amednews/2007/11/12/gvsa1112.htm (Accessed 6/30/08).
485 “Little Rock Cardiology Clinic PA v. Baptist Health”591 F. 3d 591, 593-94 (Dec. 29, 2009).
486 “Little Rock Cardiology Clinic PA v. Baptist Health”591 F. 3d 591, 594 (Dec. 29, 2009).
487 “Little Rock Cardiology Clinic PA v. Baptist Health”591 F. 3d 591, 593-94 (Dec. 29, 2009).
488 “Little Rock Cardiology Clinic PA v. Baptist Health”591 F. 3d 591, 594 (Dec. 29, 2009).
489 “Little Rock Cardiology Clinic PA v. Baptist Health” 130 S. Ct. 3506, 3506 (June 28, 2010).
490 “Little Rock Cardiology Clinic PA v. Baptist Health”591 F. 3d 591, 597-98 (Dec. 29, 2009).
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managed care organizations used boycotting, tortious interference with a business relationship,
and civil conspiracy to exclude it from and reduce its share in the market.491 The District Court
found Heartland had demonstrated enough antitrust behavior on the part of the defendants to
allow the case to proceed with the conspiracy claims.492 Eventually, the parties settled out of
court;493 however, the District Court’s ruling remains pertinent, as it is one of the relatively few
instances where a Court found evidence of horizontal conspiracy, on the part of general
hospitals, to exclude a POF from the market.
While antitrust challenges by POFs may not always fail, important and unresolved issues still
exist that the courts have yet to determine. One of the most important elements of any antitrust
challenge is the requirement of an agreement between competitors in the restraint of trade.494 In a
majority of these cases, the allegations of agreement are launched at hospital boards that are in
supposed agreements with their medical staff.495 The circuits are split, however, on whether or
not a hospital and members of its medical staff can be considered separate entities for the
purposes of forming an agreement to restrain trade.496 In the absence of an agreement by separate
entities, unilateral activity, as long as it is not predatory, is legal.497 Some circuits argue that a
medical staff is simply a subpart of a larger hospital entity and, therefore, cannot be judged as
separate decision-making entities.498 Therefore, the determination of whether a hospital and
medical staff are a single entity is of paramount importance to these cases.
Courts also are split on the question of whether certain actions taken by hospitals in response to
POFs can be considered to have legitimate business justifications.499 If a general hospital can
show that its actions are in pursuit of a legitimate business goal, such as protecting its ability to
cross-subsidize unprofitable services so that the hospital may continue to provide those services
to the community or to protect from cream skimming, then some courts may find the actions
justified even if detrimental to the POF.500 Interestingly, neither the DOJ’s Antitrust division nor
the FTC has brought an enforcement action regarding a general hospital’s attempt to reduce the
entry or expansion of a physician-owned hospital.501

“Any Willing Provider” Statutes
Since the 1980s, states have enacted any willing provider statutes that typically require health
insurers to accept any healthcare provider into their network as long as the provider will agree to

491 “Heartland Surgical Specialty Hospital, LLC v. Midwest Division, Inc.” 527 F.Supp. 2d 1257, 1264-66 (D. Kan. 2007).
492 “Heartland Surgical Specialty Hospital, LLC v. Midwest Division, Inc.” 527 F.Supp. 2d 1257, 1321-1325 (D. Kan. 2007).
493 “SSH Wins Settlement in Case Brought by Specialty Hospital” Stueve, Siegel, Hanson, LLP, March 2008,
http://www.stuevesiegel.com/ssh/results/ssh-wins-settlement-in-case-brought-by-specialty-hospital-against-hospitals-and-insurers/
(Accessed 3/12/15).
494 “Trust, etc., in Restraint of Trade, Illegal” 15 U.S.C. § 1 (2009).
495 “Antitrust Implications of Competition Between Physician-Owned Facilities and General Hospitals: Competition or Exclusion?” By
William E. Berlin, Esq., The Health Lawyer, Volume 20, No. 5 (June 2008), p. 3-5.
496 Ibid, p. 5.
497 Ibid, p. 5.
498 Ibid, p. 5-6.
499 “Williamson v. Sacred Heart Hospital of Pensacola” 1993 WL 543002 (N.D. Fla. 1993), p. *34-37; “Antitrust Implications of Competition
Between Physician-Owned Facilities and General Hospitals: Competition or Exclusion?” By William E. Berlin, Esq., The Health Lawyer,
Volume 20, No. 5 (June 2008), p. 9.
500 Ibid.
501 “§ 14A.4 Application of Antitrust Principles” By John Miles, Health Care and Antitrust Law (November 2014).
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the terms and conditions of the plan.502 There are 17 states that apply these laws to hospitals
and/or physicians, and even more states apply these laws to pharmacies.503 While these statutes
are beneficial for providers who are concerned they will be shut out of markets and to consumers
who don’t want restrictions on their available provider options, they may be detrimental to
consumers and the industry, as they have the potential to interfere with consumer demand for
low-priced healthcare.504
There is considerable opposition to any willing provider statutes because these statutes have the
ability to reduce efficiency and lower care quality.505 The FTC also recognizes that these statutes
have the potential to limit competition in the healthcare sector, because without the selectivity of
choosing providers, it will likely be more difficult for insurers to negotiate discounts for services,
as there would be no incentive to providers to offer better rates in exchange for assurances of
volume or better treatment.506 As a result, the FTC is concerned that any willing provider laws
are likely to cause increased costs to consumers paying for healthcare.507 However, supporters of
the laws argue that insurers can limit providers through the terms and conditions in the plan,
including reimbursement rates and quality and utilization metrics.508

Covenants Not to Compete
Covenants not to compete are frequently used by healthcare providers to ensure their physicians
do not open competing physician practices. However, covenants not to compete are often
considered restrictive and disfavored as a restraint on trade and competition.509 The American
Medical Association (AMA) has previously noted that such restrictions on the practice of
medicine go against public interest because the nature of healthcare is one in which quality and
affordability improve with greater competition.510 By restricting the geographic location of
physicians for specific time periods, competition is reduced in the area, and quality of care may
suffer.511 Overall, state laws vary on whether they will allow such covenants and the degree to
which they will enforce them.512
In 2010, Renown Health, a Nevada health network, acquired Sierra Nevada Cardiology
Associates, one of two medical groups in the area, and, in the process of hiring the cardiologists
from the group, required all of them to sign a non-compete agreement to extend two years

502 “Analysis: How Any Willing Provider Makes Health Care More Expensive” By Paul Ginsburg, American Health Insurance Plans, Posted
on Washington Post, Sept. 23, 2014, http://www.washingtonpost.com/blogs/wonkblog/files/2014/09/Analysis-Any-Willing-Provider.pdf
(Accessed 2/11/15) p. 1
503 Ibid.
504 Ibid.
505 Ibid.
506 “Re: Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs”
Federal Trade Commission, March 7, 2014, http://www.ftc.gov/system/files/documents/advocacy_documents/federal-trade-commissionstaff-comment-centers-medicare-medicaid-services-regarding-proposed-rule/140310cmscomment.pdf (Accessed 2/18/15) p. 3.
507 Ibid.
508 “Ch. 6 - Providers Versus Payors: Common Legal Disputes in Managed Care” By Julie Barnes, ABA Health Law Section, Managed Care
Litigation, Washington D.C.: The Bureau of National Affairs, Inc., 2005, p. 373.
509 “Regional Urology, L.L.C. v. Price” 966 So. 2d 1087, 1095 (La. Ct. App. 2007) (Brown, C.J., dissenting).
510 “Regional Urology, L.L.C. v. Price” 966 So. 2d 1087, 1095-96 (La. Ct. App. 2007) (Brown, C.J., dissenting).
511 “Regional Urology, L.L.C. v. Price” 966 So. 2d 1087, 1096 (La. Ct. App. 2007) (Brown, C.J., dissenting).
512 “National Survey on Restrictive Covenants” Fox Rothschild, LLP, 2013, http://www.foxrothschild.com/uploadedfiles/practiceareas/
securitiesfinancialinstitution/survey_nationalSurveyRestrictiveCovenants.pdf (Accessed 2/9/15).
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beyond termination of employment.513 A year later, Renown acquired Reno Heart Physicians, the
other remaining medical group in the area, and hired its cardiologists with a two-year noncompete contract agreement.514 The FTC investigated and found that the two acquisitions gave
Renown an 88% share of the cardiology market.515 The FTC determined that this 88% market
share combined with the non-compete agreements sufficiently reduced competition for adult
cardiology services in the Reno, Nevada area.516 In the settlement that followed, Renown agreed
to temporarily suspend the non-compete provisions and allow ten cardiologists to join competing
groups.517 When considering vertical or horizontal mergers, the FTC may be more critical if the
mergers include agreements with covenants not to compete because these covenants can
effectively limit or eliminate competition in a market area.

Hospital Acquisitions of Physician Groups
The FTC, DOJ, and state attorneys general have raised numerous complaints and initiated
various investigations relating to hospital acquisitions of medical groups over the past few years.
As the ACA’s healthcare reform initiatives take effect, the resulting market consolidation may
become increasingly relevant for healthcare groups and systems.518 In a recent case, St.
Alphonsus Medical Center-Nampa Inc. et al. v. St Luke’s Health System, Ltd. et al., St. Luke’s, a
large health system in Idaho, attempted an acquisition of Saltzer Medical Group P.A., the largest
independent physician group in Idaho.519 The acquisition gave St. Luke’s 80% of the market’s
primary care physicians,520 and the U.S. District Court for Idaho ultimately found that the
acquisition violated Section 7 of the Clayton Act,521 in that the arrangement would enable St.
Luke’s to demand higher rates for services, resulting in higher costs to consumers in the relevant
geographic market despite St. Luke’s argument that the agreement would create greater
efficiencies through integrated electronic health records and quality-based initiatives.522 In early
2015, the Ninth Circuit affirmed the lower court’s decision.523
Similarly, in Florida, a court recently denied a motion to dismiss antitrust allegations against
Health First, a large, fully integrated health system in the state.524 The suit was brought by Omni
Healthcare, Inc. and other physician groups who alleged that Health First excluded them from
the market by refusing to include the physician groups in insurance provider networks, refusing
to refer patients to the physician groups, and revoking the physicians’ hospital privileges at
513 “FTC Order Will Restore Competition for Adult Cardiology Services in Reno, Nevada” Federal Trade Commission (Aug. 6, 2012)
http://www.ftc.gov/news-events/press-releases/2012/08/ftc-order-will-restore-competition-adult-cardiology-services-reno (Accessed
2/11/15).
514 Ibid.
515 Ibid.
516 Ibid.
517 “In the Matter of Renown Health” Federal Trade Commission Complaint, FTC No. C-4366 (Nov. 30, 2012) p. 4-12.
518 “Antitrust Implications of the Affordable Care Act” By Toby Singer, Journal of Health and Life Sciences Law, Vol. 6, No. 2 (February
2013), p. 59.
519 “St. Luke’s Health System, Ltd., and Saltzer Medical Group, P.A.” Federal Trade Commission, 2014, http://www.ftc.gov/enforcement/
cases-proceedings/121-0069/st-lukes-health-system-ltd-saltzer-medical-group-pa (Accessed 2/2/15).
520 “Saint Alphonsus Medical Center-Nampa Inc. v. St. Luke’s Health System, Ltd.” No. 1:12-CV-00560-BLW, (D. Idaho 2014),
Memorandum Decision and Order, p. 3.
521 Ibid, p. 4.
522 “Saint Alphonsus Medical Center-Nampa Inc. v. St. Luke’s Health System, Ltd.” No. 1:12-CV-00560-BLW, (D. Idaho 2014),
Memorandum Decision and Order, p. 3-4; “Saint Alphonsus Medical Center-Nampa Inc., v. St. Luke’s Health System” No. 14-35173 (9th
Cir. 2015), Opinion, p. 3-6.
523 “Saint Alphonsus Medical Center-Nampa Inc. v. St. Luke’s Health System” No. 14-35173 (9th Cir. 2015), Opinion, p. 3-4 .
524 “Omni Healthcare, Inc. et al. v. Health First, Inc., et al.” Case No. 6:13-cv-1509-Orl-37DAB (M.D. Fla. January 21, 2015), Order, p. 2.
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Health First hospitals.525 They also alleged that Health First coordinated group boycotts of
physicians who would not exclusively refer their patients to Health First physicians.526 As a
result of Health First’s actions, Omni Healthcare physicians claim they lost access to patients and
facilities needed to operate and compete in the market.527 These cases represent the delicate
balance associated with the integration of services in furtherance of ACA initiatives, and the
potential antitrust enforcement associated therewith.

Horizontal Mergers
The horizontal integration of hospitals and health systems in response to the ACA’s coordination
of care initiatives has come under similar antitrust scrutiny. A recent example is Commonwealth
of Massachusetts v. Partners Healthcare System, Inc., in which Partners, a massive health system
and ACO in Massachusetts, attempted to acquire a large hospital, South Shore, and a hospital
system, Hallmark Health, the combination of which would have given it a significantly greater
market share in the associated market area.528 Instead of offering structural remedies, which are
the generally preferred solution for anticompetitive behavior, the Attorney General offered
Partners a settlement consisting of conduct remedies.529 Typically, this type of anticompetitive
behavior is handled through structural remedies, meaning that the mergers are refused, accepted,
or accepted with conditions of other divestiture.530 The conduct remedies offered to Partners
limited the health system’s ability to negotiate higher physician rates or acquire additional
physicians for 5-10 years, but allowed the mergers to continue.531 However, this settlement was
rejected by the Superior Court judge for its inability to demonstrate how efficiencies would be
realized without increased costs to consumers.532 The judge found that the conduct remedies
alone were insufficient to effectively control Partners from obtaining more of the healthcare
market, and, thus, the proposed settlement would have been against public interest.533
Similarly, in 2014, the 6th Circuit denied a petition from ProMedica Health System, seeking an
appeal of the District Court’s order to divest St. Luke’s Hospital after the acquisition of St.
Luke’s had given ProMedica more than a 50% share in primary and secondary services and 80%
share in obstetrical services.534 The 6th Circuit noted that ProMedica failed to argue that the
merger would yield procompetitive effects and conceded to the potential that the merger could
525 “Federal Judge Denies Health First’s Motion to Dismiss Suit by Physicians Alleging Unlawful Exclusion” By Toby Singer and Nathaniel
Harris, American Health Lawyers Association, Feb. 2. 2015, https://www.healthlawyers.org/Members/PracticeGroups/Antitrust/
emailalerts/Pages/Federal_Judge_Denies_Health_Firsts_Motion_to_Dismiss_Suit_by_Physicians_Alleging_Unlawful_Exclusion.aspx
(Accessed 2/11/15); “Omni Healthcare, Inc. et al. v. Health First, Inc. et al.” Case No. 6:13-cv-1509-Orl-37DAB (M.D. Fl. January 21,
2015), Order, p. 2.
526 “Omni Healthcare, Inc. et al. v. Health First, Inc., et al.” Case No. 6:13-cv-1509-Orl-37DAB (M.D. Fla. January 21, 2015), Order, p. 10-11.
527 Ibid, p. 11-13.
528 “Partners Ruling Could Have National Implications” By Priyanka Dayal McCluskey, Boston Globe, January 31, 2015,
http://www.bostonglobe.com/business/2015/01/30/partners-ruling-could-have-nationalimplications/sXotXb3VEFUfyySeHMgPzO/story.html (Accessed 2/9/15).
529 Ibid.
530 “Re: Comments on the Proposed Final Judgment in Massachusetts v. Partners Healthcare System, Inc. et al., Civ. No. 14-2033 (BLS)” By
John Kwoka, The American Antitrust Institute, To Honorable Judge Sanders, September 11, 2014,
http://www.mass.gov/ago/docs/partners/aai.pdf (Accessed 2/2/15), p. 7.
531 “Partners Agrees to Price Cap for Hallmark Health as Part of Amended Settlement” Attorney General of Massachusetts, September 25,
2014, http://www.mass.gov/ago/news-and-updates/press-releases/2014/2014-09-25-partners-proposed-consent-judgment.html (Accessed
2/9/15).
532 “Commonwealth vs. Partners Healthcare System, Inc., & others” SUCV2014-02033-BLS2 (Mass. Dist. Ct. January 29, 2015),
Memorandum of Decision and Order on Joint Motion for Entry of Amended Final Judgment by Consent, p. 28-29.
533 Ibid, p. 2.
534 “ProMedica Health System, Inc. v. FTC” 749 F.3d 559, 561 (6th Cir. 2014).
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force consumers in the area to pay higher prices for services.535 This decision was significant
because the court adopted the FTC method of creating product market definitions using a cluster
of services approach, despite ProMedica’s insistence on using a package-deal theory. In the
cluster of services approach, the FTC clusters primary and secondary services together
(excluding obstetric and tertiary services) because these services have similar competitive
conditions, while the package-deal theory includes all services, even though market forces do not
bind these services together.536 Also important, the court used the FTC’s finding that the merger
was anticompetitive by comparing market concentration levels post-merger, instead of following
ProMedica’s recommendation of determining consumer’s next preferred choice for care, and
relied extensively on the FTC and DOJ’s 2010 Horizontal Merger Guidelines.537 ProMedica has
since filed a petition with the Supreme Court to review the decision, alleging that the 6th Circuit
used non-accepted antitrust law practices to formulate its decision.538
Another case of contention is that of Phoebe Putney Health System’s acquisition of Palmyra Park
Hospital, Inc. in Georgia, where the only two hospitals in the area decided to merge. In 2011, the
FTC challenged the proposed acquisition, citing the increase in prices that would occur for
general acute-care hospital services; however, the 11th Circuit decided the deal was immune from
antitrust scrutiny because of the state action doctrine.539 Eventually, the Supreme Court reversed
the 11th Circuit, finding in favor of the FTC and remanded the case for further consideration,
despite the fact that the two entities had already merged at that point.540 The FTC was unable to
order divestiture because the entities had already received authorization to merge under
Georgia’s Certificate of Need law, and the agency believed the CON law would not authorize
another buyer.541 After a series of discussions, the FTC has announced its intention to seek a
settlement, unless the parties cannot come to an agreement, in which case they will continue
before an administrative law judge.542
The consolidation of healthcare systems has also raised concerns with antitrust authorities
because such mergers are likely to have a significant effect on the markets in which they exist. In
2012, the FTC was rewarded for its investigation and complaint issued against OSF Healthcare

535 “Sixth Circuit Rules for FTC in Challenge to Ohio Hospital Merger” By Tiffany Milone and Peyton Sturges, Bloomberg BNA: Health Law
Reporter, April 22, 2014, http://healthlawrc.bna.com/hlrc/4237/split_display.adp?fedfid=45362962&vname=
hlrnotallissues&jd=a0e9k5y1d1&split=0 (Accessed 2/6/15).
536 Ibid.
537 “Sixth Circuit Rules for FTC In Challenge to Ohio Hospital Merger” By Tiffany Milone and Peyton Sturges, Bloomberg BNA: Health Law
Reporter, April 22, 2014, http://healthlawrc.bna.com/hlrc/4237/split_display.adp?fedfid=45362962&vname=hlrnotallissues&jd=
a0e9k5y1d1&split=0 (Accessed 2/6/15); “The Potential Impact of ProMedica: Health Care and Beyond” By Clifford H. Aronson, Gregory
M. Luce, and Steven C. Sunshine, April 30, 2014, http://www.skadden.com/insights/potential-impact-ipromedicai-health-care-and-beyond
(Accessed 3/11/15).
538 “Ohio Hospital Seeks High Court Review of Sixth Circuit Ruling Requiring Divestiture” By Peyton Sturges, Bloomberg BNA: Health Law
Reporter, January 13, 2015, http://healthlawrc.bna.com/hlrc/4237/split_display.adp?fedfid=61889821&vname=hlrnotallissues&wsn=
487907000&searchid=24449989&doctypeid=9&type=oadate4news&mode=doc&split=0&scm=4237&pg=0 (Accessed 2/6/15).
539 “Federal Trade Commission v. Phoebe Putney Health System” 793 F. Supp.2d 1356, 1360, 1375 (M.D. Ga. June 27, 2011); “Federal Trade
Commission v. Phoebe Putney Health System” 663 F.3d 1369, 1378 (11th Cir. 2011); “FTC Halts Phoebe Putney Merger Challenge to Talk
Deal” By Y. Peter Kang, Law 360, January 29, 2015, http://www.law360.com/articles/616561/ftc-halts-phoebe-putney-merger-challengeto-talk-deal (Accessed 2/19/15).
540 “Federal Trade Commission v. Phoebe Putney Health System” 133 S. Ct. 1003, 1016-1017 (2013); “FTC Halts Phoebe Putney Merger
Challenge to Talk Deal” By Y. Peter Kang, Law 360, January 29, 2015, http://www.law360.com/articles/616561/ftc-halts-phoebe-putneymerger-challenge-to-talk-deal (Accessed 2/19/15).
541 “FTC Halts Phoebe Putney Merger Challenge to Talk Deal” By Y. Peter Kang, Law 360, January 29, 2015, http://www.law360.com/
articles/616561/ftc-halts-phoebe-putney-merger-challenge-to-talk-deal (Accessed 2/19/15).
542 Ibid.
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System’s acquisition of rival Rockford Health System when OSF announced it would no longer
pursue Rockford.543 The intended merger would have given the two hospitals joint control of
more than 99% of the general acute-care services market and reduced competition from three
systems to two. In response to OSF’s decision to abandon the merger, the FTC dropped the
complaint against OSF, noting it will continue to challenge and pursue agreements that could
reduce competition.544

ACOS AND ANTITRUST
Since the establishment of the ACA, antitrust concerns have developed for recently formed
accountable care organizations (ACOs). ACOs are designed to promote more efficient,
coordinated care in order to reduce costs; however, they involve the integration of various
healthcare entities.545 In October 2011, the FTC and DOJ issued a joint statement that created
safety zones from antitrust enforcement in order to allow MSSP ACOs more freedom to
consolidate and improve coordinated care.546 These safety zones allow ACOs’ participants to
have up to a 30% share of each common service within the participants’ primary service areas.547
However, the agencies stressed that if there seems to be a greater likelihood of anticompetitive
effects, the organizations must also prove a greater likelihood of efficiencies in order to avoid
agency interference.548
The joint statement also removed the mandatory antitrust review requirement for ACOs entering
the MSSP, allowing ACOs to submit to such review on a voluntary basis.549 However, these
safety zones only extend to MSSP ACOs, so additional caution must be taken for commercial
ACOs that are not participating in the Medicare program, although they may still utilize
exceptions and safe harbors to applicable regulations and may seek use of the participation
waiver in some transactions.550 A caveat to the Statement’s application states that the Joint
Statement only applies to ACOs formed by collaboration among independent provider groups
and not those formed by mergers because ACOs formed by mergers are evaluated under the
Horizontal Merger Guidelines released by the FTC and DOJ.551 Similarly, the Statement does not
apply to a standalone integrated care organization.552

543 “OSF Healthcare System Abandons Plan to Buy Rockford in Light of FTC Lawsuit; FTC Dismisses its Complaint Seeking to Block the
Transaction” Federal Trade Commission, April 13, 2012, http://www.ftc.gov/news-events/press-releases/2012/04/osf-healthcare-systemabandons-plan-buy-rockford-light-ftc (Accessed 3/11/15).
544 Ibid.
545 “Accountable Care Organizations (ACO)” Centers for Medicare & Medicaid Services, January 6, 2015, http://www.cms.gov/
Medicare/Medicare-Fee-for-Service-Payment/ACO/index.html?redirect=/aco/ (Accessed 1/29/15); “Antitrust Implications of the Affordable
Care Act” By Toby Singer, Journal of Health and Life Sciences Law, Vol. 6, No. 2 (February 2013), p. 59.
546 “Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings
Program” Federal Register, Vol. 76, No. 209 (October 28, 2011), p. 67028.
547 Ibid.
548 “Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings
Program” Federal Register, Vol. 76, No. 209 (October 28, 2011), p. 67029-30.
549 Ibid, p. 67029.
550 “Medicare Program; Final Waivers in Connection With the Shared Savings Program; Interim Final Rule” Federal Register Vol. 76, No. 212
(November 2, 2011), p. 68006.
551 “Rule of Reason Analysis for Accountable Care Organizations” By Gregory J Pelnar and Gretchen M. Weiss, The Antitrust Source,
American Bar Association, December 2011, http://www.americanbar.org/content/dam/aba/publishing/antitrust_source/
dec11_pelnar_12_21f.authcheckdam.pdf (Accessed 2/19/15) p. 3.
552 Ibid.
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The final joint statement listed types of conduct that are discouraged or will likely invoke an
investigation by antitrust agencies for ACOs participating in the Medicare Shared Savings
Program (MSSP).553 This list includes:
(1) Sharing competitively sensitive information;
(2) Restricting payors’ ability to share the ACO’s cost, quality, efficiency, and performance
information with their enrollees;
(3) Exclusive contracting; and
(4) Employing anti-steering provisions.554
This list serves as an addendum to the rule of reason test described previously by providing more
narrow conditions that are helpful for ACOs to consider when self-monitoring. Specific to
ACOs, the rule of reason test requires that ACOs be sufficiently “financially or clinically
integrated” in order to avoid agency review.555 Otherwise, these ACOs could be found in
violation of antitrust laws like the Sherman or Clayton Acts.556 Commercial ACOs can expect
that agencies will likely use a similar approach when determining potential antitrust violations,
though these ACOs will be more closely monitored for compliance with market power and
integration requirements.557

INTERNAL REVENUE SERVICE AND THE INTERNAL
REVENUE CODE
IRS TAX STATUS
Healthcare providers may qualify for a federal tax exemption if they meet the IRS requirements
for charitable organizations under section 501(c)(3) of the Internal Revenue Code (IRC).558 In
2002, nonprofit hospitals nationwide saved an estimated $12.6 billion from tax exemptions;559
Forbes estimated this savings expanded to $20 billion in 2012.560 The benefits of federal tax
exemption come with corresponding burdens. To maintain tax-exempt status, an organization has
to prove that it benefits the public, is organized and operated exclusively for exempt purposes,
and none of its earnings are allocated to private shareholders or individuals.561 Exempt purposes
include those that are charitable, religious, educational, and scientific. The federal tax regulations
553 “Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings
Program” Federal Register, Vol. 76, No. 209 (October 28, 2011), p. 67029.
554 Ibid, p. 67029-30.
555 Ibid, p. 67027.
556 “Antitrust Implications of the Affordable Care Act” By Toby Singer, Journal of Health and Life Sciences Law, Vol. 6, No. 2, February
2013, p. 60-61, 74.
557 Ibid, p. 74.
558 “Nonprofit, For-Profit, and Government Hospitals: Uncompensated Care and Other Community Benefits” Testimony of David M. Walker:
Comptroller General of the United States, Before the Committee on Ways and Means of the House of Representatives, Washington, D.C.:
United States Government Accountability Office (May 26, 2005), http://www.gao.gov/new.items/d05743t.pdf (Accessed 02/08/10).
559 “Nonprofit Hospitals and the Provision of Community Benefits” Congressional Budget Office, December 2006, http://www.cbo.gov/
ftpdocs/76xx/doc7695/12-06-Nonprofit.pdf (Accessed 02/09/10).
560 “ObamaCare Could Cause Nonprofit Hospitals to Lose their Tax-Exempt Status: Here’s How” By David Whelan, Forbes, September 17,
2012, http://www.forbes.com/sites/davidwhelan/2012/09/17/obamacare-could-cause-nonprofit-hospitals-to-lose-their-tax-exempt-statusheres-how/ (Accessed 2/21/15).
561 “Exemption Requirements—Section 501(c)(3) Organizations” Internal Revenue Service, December 7, 2009, http://www.irs.gov/charities/
charitable/article/0,,id=96099,00.html (Accessed 2/9/10).
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define charitable activities as relief of the poor, the distressed, or the underprivileged; lessening
the burdens of government; lessening neighborhood tensions; and combating community
deterioration and juvenile delinquency.562 Most healthcare organizations that are tax-exempt
under federal law have that status because they are classified as charitable organizations.563
In 1969, the IRS expanded the definition of the term “charitable” and declared that to qualify as
a healthcare provider that promotes health as its charitable purpose, an organization must meet
the community benefit standard described in revised ruling 69-545 as well as the other
requirements of IRC 501(c)(3).564 The community benefit standard lists several requirements for
section 501(c)(3) qualification, such as the requirement of a community-based board without
financial interests in the institution, a full-time emergency room open to all without regard to
ability to pay, treatment of Medicare and Medicaid patients without discrimination, and
appropriate mission-related use of net earnings.565
In a demonstrative case for integrating healthcare systems, the IRS granted tax-exempt status to
Friendly Hills HealthCare Network, which included a vertically Integrated Delivery System
(IDS), in what has been considered as a landmark determination in defining what constitutes
community benefit. The IRS granted tax-exempt status after identifying several critical elements
regarding Friendly Hills HealthCare Network’s acquisitions and medical practice operations:
(1) The stated goal of the reorganization into the IDS was to “enhance the
accessibility, quality and cost-efficiency of services rendered to the
community;”
(2) The community benefit provided by the IDS against the private benefits
provided to the physicians by Friendly Hills HealthCare Network was
considered by the IRS to be part purchase and part donation; and
(3) The board of directors had established a “20 percent safe harbor” of physician
membership on the board.566
In granting tax-exempt status, the IRS required the IDS to treat Medicaid patients, provide
charity care, and engage in medical research in addition to maintaining an open medical staff and
24-hour emergency room.567

562 Ibid.
563 “The Law of Tax-Exempt Healthcare Organizations” By Thomas K. Hyatt and Bruce R. Hopkins, Hoboken, NJ: John Wiley & Sons
Publishers, 1995, p. 13.
564 “Health Care Provider Reference Guide” By Janet E. Gitterman and Marvin Friedlander, Internal Revenue Service, 2004,
http://www.irs.gov/pub/irs-tege/eotopicc04.pdf (Accessed 02/09/10).
565 “Revenue Ruling 69-545” Internal Revenue Service, 1969, http://www.irs.gov/pub/irs-tege/rr69-545.pdf (Accessed 3/16/15);“IRS Begins
Hospital Community Benefit Compliance Initiative” By David Flynn, ABA Health eSource, June 2006, http://www.abanet.org/health/
esource/Volume2/vol2no10/flynn.html (Accessed 02/09/10).
566 “IRS Exemption Rulings (IER): Friendly Hills Healthcare Network” U.S. Internal Revenue Service, 7 Exempt Org. Tax Rev. 490 (March
1993), p. 490-491; “Colloquium Report on Legal Issues Related to Tax Exemption and Community Benefit,” National Health Lawyers
Association, 1996, p. 18.
567 “IRS Exemption Rulings (IER): Friendly Hills Healthcare Network” U.S. Internal Revenue Service, 7 Exempt Org. Tax Rev. 490 (March
1993), p. 491; “Colloquium Report on Legal Issues Related to Tax Exemption and Community Benefit,” National Health Lawyers
Association, 1996, p. 18.
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INUREMENT OF PRIVATE BENEFIT AND EXCESS BENEFIT
TRANSACTIONS
In addition to the requirement that a tax-exempt organization meet charitable purpose standards,
the IRS prohibits excess benefit transactions and inurement of private benefits between taxexempt organizations and third parties in which “the value of the economic benefit provided
exceeds the value of the consideration received for providing the benefit.”568
According to the IRS, an “excess benefit transaction [is a] transaction in which an economic
benefit is provided by an applicable tax-exempt organization, directly or indirectly, to or for the
use of any disqualified person, if the value of the economic benefit provided [by the
organization] exceeds the value of the consideration received for providing such benefits.”569 In
addition to excess benefit transactions, the IRS has strictly prohibited the inurement of private
benefits, i.e., when an exempt organization is “…organized or operated for the benefit of private
interests…,” stating:
“[n]o part of the net earnings of a section 501(c)(3) organization may inure to the
benefit of any private shareholder or individual[, whereby] a private shareholder
or individual is a person having a personal and private interest in the activities of
the organization.”570
If an exempt organization (EO) has engaged in an excess benefit transaction, the IRS may
impose an array of punishments, including: (1) an excise tax on the individual and/or the exempt
organization or (2) total revocation of the organization’s tax-exempt status.571 In the final
regulations published on March 28, 2008, the IRS identified five factors to be considered when
determining the appropriate punishment:
The size and scope of the organization’s ongoing activities;
The size and scope of the excess benefit transaction in relation to regular activities;
Whether excess benefit transactions happened in the past;
Whether the organization has implemented safeguards against this type of transaction;
and
(5) Whether the excess benefit transaction has been corrected, or there has been a good faith
effort to do so.572

(1)
(2)
(3)
(4)

In those cases in which the EO has worked to remedy the situation, IRS will give the last two
factors greater weight when considering whether to allow EO’s tax-exempt status to remain.573
568 “Excess Benefit Transaction” 26 C.F.R. § 53.4958-4(a)(1) (2012).
569 "Taxes on excess benefit transaction" 26 U.S.C. § 4958(c)(1)(a) (2012).
570 “Inurement/Private Benefit - Charitable Organizations” Internal Revenue Services, February 2, 2012, http://www.irs.gov/charities/
charitable/article/0,,id=123297,00.html (Accessed 8/7/2012); "Exemption from tax on corporations, certain trusts, etc." 26 U.S.C. §
501(c)(3) (2011).
571 “IRS Policing of Tax-Exempt Organizations” By Charles R. Brodbeck and Mark R. Stabile, Physician’s News Digest, February 1997,
http://www.physiciansnews.com/finance/297.html (Accessed 9/24/12); “Taxpayer Bill of Rights” Pub. L. 104-168, § 1311, 110 Stat. 1452,
1475-1479 (July 30, 1996).
572 “Standards for Recognition of Tax-Exempt Status if Private Benefit Exists of if an Applicable Tax-Exempt Organization Has Engaged in
Excess Benefit Transaction(s)” Federal Register Vol. 73 No. 61 (March 28, 2008), p. 16522.
573 Ibid.
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Despite the IRS prohibitions against excess benefit transactions, compensation arrangements
involving tax-exempt organizations may include financial incentives if the arrangement involves
“reasonable compensation.”574

“REASONABLE COMPENSATION” DEFINED BY THE IRS
Under Treasury Regulation 53.4958-4, the IRS equates reasonable compensation to the value of
services provided and further defines reasonable compensation as “the amount that would
ordinarily be paid for like services by the enterprises (whether taxable or tax-exempt) under like
circumstances.”575 Significantly, the IRS states that the valuation standard is that of “fair market
value (i.e., the price at which property or the right to use property would change hands between a
willing buyer and a willing seller, neither being under any compulsion to buy, sell or transfer
property or the right to use property, and both having reasonable knowledge of relevant
facts).”576
Treasury Regulation 53.4958-6 further states that, “payments under a compensation arrangement
are presumed to be reasonable...if the following conditions are satisfied:
(1) The compensation arrangement…[is] approved in advance by an authorized body of the
applicable tax-exempt organization composed entirely of individuals who do not have a
conflict of interest with respect to the compensation arrangement;
(2) The authorized body obtained and relied upon appropriate data as to comparability prior
to making its determination; and
(3) The authorized body adequately documented the basis for its determination concurrently
with making that determination.”577 [Emphasis added].

IRS DEFINITIONS OF “BONA FIDE EMPLOYEES” AND “FORM 1099
INDEPENDENT CONTRACTORS”
What constitutes an “employee” versus a “1099 independent contractor,” as set forth in 26
U.S.C. § 312(d)(2),578 is significant for purposes of many fraud and abuse regulations governing
healthcare providers. For example, the term “employee” under Anti-Kickback statute and Stark
law utilizes the IRS definitions in many of its safe harbors and exceptions, respectively. To
determine whether a person is a “bona fide employee,” the IRS has developed an 11 factor test,
which can be broken down into three general categories, i.e., (1) behavioral control, (2) financial
control, and (3) type of relationship between the parties.579 It is not necessary that all 11 factors
be met, and no single factor is dispositive in determining employment status. Rather, facts
574 In General Counsel Memorandum (GCM) 35638, published on January 28, 1974, the IRS stated that compensation arrangements involving
shared savings related to quality improvements could be acceptable if they were at arm’s length and were “…a means of providing
reasonable compensation to employees without any potential for reducing the charitable services or benefits otherwise provided…”
[emphasis added]. “Section 4958 Update” By Lawrence M. Brauer and Marvin Friedlander,” in “2000 Exempt Organization (EO) CPE
Text” Internal Revenue Service, 2000, p. 29.
575 “Excess benefit transaction” 26 C.F.R. § 53.4958-4(b)(ii)(A) (2012).
576 “Excess benefit transaction” 26 C.F.R. § 53.4958-4(b)(i) (2012).
577 “Rebuttable presumption that a transaction is not an excess benefit transaction” 26 C.F.R. § 53.4958-6.
578 “Effect on Earnings and Profits” 26 U.S.C. § 312(d)(2) (2012).
579 “Employer’s Supplemental Tax Guide (Supplement to Publication 15 (Circular E), Employer’s Tax Guide” Publication 15-A, Department
of the Treasury, Internal Revenue Service, 2012, p. 7.
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related to the 11 factors, taken together in the aggregate, serve as evidence of whether or not a
bona fide employee relationship exists.580

INTERNAL REVENUE CODE SECTION 501(R)
In addition to the requirements outlined above, the ACA added Section 501(r) to the IRC, which
provided new requirements for hospitals to satisfy in order to maintain their tax-exempt status.581
The final regulations, published December 31, 2014, affect five categories of tax-exempt hospital
operations:
(1)
(2)
(3)
(4)
(5)

Community Health Needs Assessments (CHNA);
Financial Assistance Policies (FAP);
Limitation on Patient Charges;
Billing and Collection Policies; and
Miscellaneous requirements.582

The new 501(r) rules become enforceable “for taxable years beginning after December 29,
2015.”583

Community Health Needs Assessments (CHNA)
In its modification to Section 501(r) of the IRC, the ACA requires charitable hospitals to conduct
a CHNA every three years and adopt an appropriate implementation strategy that satisfies the
needs identified in the CHNA.584 To satisfy this statutory threshold, the final regulations provide
specific requirements for charitable hospitals when conducting their CHNA. First, charitable
hospitals have discretion to define their “community” for CHNA purposes as long as the
definition does not exclude medically underserved, low-income, or minorities.585 Second, the
regulations expand the scope of “health needs” for a CHNA beyond financial and barriers to
care, and requires hospitals to include all “significant” health needs in the community.586
Notably, charitable hospitals “have flexibility to choose how best to prioritize the significant
health needs of their particular communities” and may base their priorities on factors such as the
burden of the health need, the “feasibility and effectiveness of possible interventions,” and
disparities within the community concerning a particular health need.587 Finally, hospitals must
make reasonable efforts to secure input on its CHNA from three specific sources:

580 Ibid.
581 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9007, 124 Stat. 119, 855 (2010).
582 “Creeping Normality: IRS Releases Final Regulations Under Section 501(r)” McDermott Will & Emery, January 15, 2015,
http://www.mwe.com/files/Uploads/Documents/Pubs/Creeping-Normality.pdf (Accessed 2/21/15).
583 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78996.
584 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9007, 124 Stat. 119, 856 (2010).
585 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78962.
586 Ibid, p. 78963.
587 Ibid, p. 78963.
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(1) Government public health departments;
(2) Those in low-income, minority, or medically underserved communities; and
(3) Written comments of the hospital’s previous CHNA.588

Financial Assistance Policies (FAP)
The ACA further modifies Section 501(r) of the IRC by requiring charitable hospitals to adopt
adequate FAPs in order to maintain their 501(c)(3) status.589 The final regulations require these
policies to contain five specific elements:
(1) Eligibility criteria for financial assistance;
(2) Whether such assistance includes free or discounted care;
(3) Methodology for calculating charges and applying financial assistance;
(4) The possible collection actions a hospital may take; and
(5) A list of where the FAP is available.590
A charitable hospital’s FAP must be available online for patients and other members of the
public to access.591 Notwithstanding a charitable hospital’s FAP, a charitable hospital cannot
refuse to provide emergency care based on if a patient is eligible for financial assistance.592

Limitation on Patient Charges
The ACA also modified Section 501(r) of the IRC by limiting what charitable hospitals can
charge patients who are eligible for discounts under a hospital’s FAP.593 The final regulations
implementing Section 501(r) note that patients qualifying under a hospital’s FAP must pay no
more than the amounts generally billed (AGB) to insured patients for emergency or other
medically necessary care.594 The final regulations provide three methods charitable hospitals may
utilize to calculate AGB:
(1) Look-Back Method—AGB determined by “multiplying the hospital facility’s gross
charges for that care by one or more percentages of gross charges;”595
(2) Prospective Method—AGB determined by “setting AGB for that care at the amount that
Medicare and the Medicare beneficiary together would be expected to pay for the
care;”596 or
(3) Medicaid Method—AGB determined by applicable Medicaid rates.597
588 Ibid, p. 78963.
589 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9007, 124 Stat. 119, 856 (2010).
590 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014) p.
78972-78977; “Creeping Normality: IRS Releases Final Regulations Under Section 501(r)” McDermott Will & Emery, January 15, 2015,
http://www.mwe.com/files/Uploads/Documents/Pubs/Creeping-Normality.pdf (Accessed 2/21/15).
591 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78974.
592 Ibid, p. 78977.
593 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9007, 124 Stat. 119, 857 (2010).
594 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78978.
595 Ibid, p. 78980.
596 Ibid, p. 78982.
597 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78979-78982; “Creeping Normality: IRS Releases Final Regulations Under Section 501(r)” McDermott Will & Emery, January 15, 2015,
http://www.mwe.com/files/Uploads/Documents/Pubs/Creeping-Normality.pdf (Accessed 2/21/15).
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Charitable hospitals may only utilize one methodology at a time, although a hospital is free to
switch methodologies.598 In addition, charitable hospitals must limit the amounts charged to
FAP-eligible individuals “for all other medical care covered under (a charitable hospital’s) FAP
to less than the gross charges for that care.”599

Billing and Collection Policies
The ACA’s modifications to Section 501(r) of the IRC constrain the ability of charitable
hospitals to engage in extraordinary collection efforts (ECA) from its patients.600 The final
regulations provide that certain actions are not ECAs under Section 501(r):
(1)
(2)
(3)
(4)

Non-judicial processes, such as calling a patient or sending a bill;
Placing a lien on 3rd parties who caused the patient’s injuries;
Charging interest on medical debt; and
Filing a claim in any bankruptcy proceeding.601

Under Section 501(r) and its final regulations, hospitals may institute ECAs only if it uses
“reasonable efforts” to determine a patient’s eligibility under a FAP.602 To satisfy the reasonable
efforts requirement, charitable hospitals must allow patients 240 days after receipt of a medical
bill, post-discharge, to apply for assistance under a hospital’s FAP.603 Further, charitable
hospitals must send an ECA Initiation Notice, a written communication that notifies the patient
of a hospital’s option to engage in ECAs, the existence of the hospital’s FAP, and how to apply
for the FAP.604 If an ECA Initiation Notice is not received within 30 days of sending, then the
hospital may engage in ECAs.

Miscellaneous Requirements
Significantly, the final regulations implementing the ACA’s amendments to Section 501(r) note
that “minor omissions and errors” regarding 501(r) requirements will not doom a hospital’s
501(c)(3) status.605 To constitute a “minor omission and error” under 501(r), the hospital’s
mistake must satisfy the following conditions:

598 “Creeping Normality: IRS Releases Final Regulations Under Section 501(r)” McDermott Will & Emery, January 15, 2015,
http://www.mwe.com/files/Uploads/Documents/Pubs/Creeping-Normality.pdf (Accessed 2/21/15); “Additional Requirements for Charitable
Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a Section 4959 Excise Tax Return and Time for
Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014) p. 78978.
599 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78978.
600 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9007, 124 Stat. 119, 857 (2010).
601 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78984-78985.
602 Ibid, p. 78983.
603 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014)
p. 78987.
604 Ibid, p. 78989.
605 Ibid, p. 78960.
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(1) The error or omission was minor;
(2) The error or omission was inadvertent or due to reasonable cause; and
(3) The hospital corrects the omission or error promptly after discovery.606
With potentially $20 billion at stake, tax-exempt organizations must sufficiently portray their
tax-exempt status to the IRS. To support this reporting, the IRS issued an updated version of
Form 990, the return that charities and other tax-exempt organizations are required to file
annually. The redesign of Form 990 is based on three guiding principles: “(1) enhancing
transparency; (2) promoting tax compliance; and, (3) minimizing the burden on the filing
organization.”607 The most significant changes to Form 990 include: (1) adding a summary page
that provides “a snapshot of the organization’s key financial, compensation, governance, and
operational information;” (2) “requiring governance information, including the composition of
the board and financial practices;” and (3) revising and adding “schedules that will focus
reporting on certain areas of interest to the public and the IRS.”608 Further, Form 990 will be
revised with the issuance of the 501(r) regulations for taxable years beginning after December
29, 2015.

IRS AUDITS AND COMPLIANCE WITH SECTION 409A
Beginning in February 2010 and renewed in May 2014, the Tax Exempt and Government
Entities Division of the IRS called for random audits of tax-exempt organizations to ensure their
compliance with section 409A. This section requires that, unless certain requirements are met,
tax-exempt organizations include nonqualified deferred compensation in an individual’s gross
income for the tax year in which the deferred compensation is actually paid.609 The IRS is
seeking a thorough examination of all executive compensation and benefit arrangements,
including executive retirement contracts and deferred compensation arrangements.610 The
increased enforcement comes amid a growing public outcry against excessive executive
compensation arrangements in both for-profit and nonprofit companies. Similar to the new Form
990, the goal of the audits is to increase transparency and hold tax-exempt organizations
accountable for the benefits they receive. Renewed 409A audits in May 2014 may be a sign that
the IRS is developing streamlined audit techniques before the scope of the program is
expanded.611

606 “Additional Requirements for Charitable Hospitals; Community Health Needs Assessments for Charitable Hospitals; Requirement of a
Section 4959 Excise Tax Return and Time for Filing the Return; Final Rule” Federal Register Vol. 79, No. 250 (December 31, 2014) p.
78960-78961; “Creeping Normality: IRS Releases Final Regulations Under Section 501(r)” McDermott Will & Emery, January 15, 2015,
http://www.mwe.com/files/Uploads/Documents/Pubs/Creeping-Normality.pdf (Accessed 2/21/15).
607 “Do Nonprofit Hospitals Provide Community Benefit? A Critique of the Standards for Proving Deservedness of Federal Tax Exemptions”
By Laura Folkerts, The Journal of Corporation Law, Vol. 34, No. 2 (2009), p. 627; “Background Paper: Redesigned Draft Form 990”
Internal Revenue Service, 2007, http://www.irs.gov/pub/irs-tege/form_990_cover_sheet.pdf (Accessed 02/09/10).
608 “Do Nonprofit Hospitals Provide Community Benefit? A Critique of the Standards for Proving Deservedness of Federal Tax Exemptions”
By Laura Folkerts, The Journal of Corporation Law, Vol. 34, No. 2 (2009), p. 627; ; “Highlights of Redesigned Form 990” Internal
Revenue Service, June 3, 2007, http://www.irs.gov/pub/irs-tege/highlightsform990redesign_ 061307.pdf (Accessed 3/5/15).
609 “Inclusion in Gross Income of Deferred Compensation under Nonqualified Deferred Compensation Plans” 26 U.S.C. § 409A(a)(1)(A)(i)
(2013); “Application of Section 409A to Nonqualified Deferred Compensation Plans” Federal Register Vol. 72, No. 73 (April 17, 2007),
p. 19234.
610 “Enforcement Efforts Take Aim at Executive Compensation of Tax-Exempt Health Care Entities” By Candace L. Quinn and Jeffrey D.
Mamorsky, Health Law Reporter Vol. 18 No. 1640, December 17, 2009 https://www.bloomberglaw.com/print/X1VTN9R36Q80 (Accessed
3/5/15).
611 “Look Out Below”—409A Audits Starting” American Appraisal, 2014, http://www.american-appraisal.com/AA-Files/Library/PDF/
409AAudits.pdf (Accessed 2/25/15).
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If an exempt organization is found to not be in compliance with section 409A, then the IRS has the
ability to impose: (1) additional payroll taxes and interest; (2) significant tax penalties on
individuals for failure of nonqualified deferred compensation plans to meet the requirements of
section 409A; and (3) substantial monetary sanctions if the IRS determines that the executive
compensation arrangement constitutes an excess benefit transaction, which are those transactions
“… in which an economic benefit is provided by an applicable tax-exempt organization, directly or
indirectly, to or for the use of a disqualified person, and the value of the economic benefit provided
by the organization exceeds the value of the consideration received by the organization.”612
The 2014 effort is expected to examine the top 10 “most highly compensated individuals” within
50 companies across all industries over a twelve-month period.613 If fringe benefits for
executives in these exempt organizations were incorrectly treated as tax-free, they could result in
additional taxes owed by both the recipient and the employer.614

OTHER TAX PROVISIONS
Individual Health Insurance Mandate
Arguably, one of the most publicized provisions of the ACA is the individual mandate, the
requirement that U.S. citizens and legal residents maintain minimum amounts of health insurance
coverage, i.e., essential coverage. Essential coverage includes: (1) government sponsored
programs; (2) certain employer-sponsored programs; (3) insurance plans sold on the individual
market; (4) grandfathered group health plans; and, (5) some other types of coverage.615 Some
individuals are excluded from this broad requirement, including: (1) members of a recognized
religion who are conscientiously opposed to the requirement; (2) members of a healthcaresharing ministry; (3) individuals not lawfully present in the U.S.; (4) incarcerated individuals;
(5) individuals who cannot afford coverage; (6) taxpayers whose income is less than 100 percent
of the federal poverty limit; and (7) members of Indian tribes.616 To assist U.S. citizens in paying
for health insurance premiums purchased through a state health benefit exchange, the ACA
provides refundable premium tax credit for taxpayers whose income is 9.5 percent under the
lowest cost plan.617 Individuals who are not in compliance with the law, which went into effect
on January 1, 2014, are subject to the greater of: (1) $95 per individual or (2) 1.0% of household
income over the filing threshold.618 For those without coverage in 2015, these penalties increase
to: (1) $325 per individual or (2) 2.0 percent of household income over the filing threshold,
respectively.619
612 “Intermediate Sanctions—Excess Benefit Transactions” Internal Revenue Service, August 28, 2014, http://www.irs.gov/Charities-&-NonProfits/Charitable-Organizations/Intermediate-Sanctions-Excess-Benefit-Transactions (Accessed 03/05/15); “Enforcement Efforts Take
Aim at Executive Compensation of Tax-Exempt Health Care Entities” By Candace L. Quinn and Jeffrey D. Mamorsky, 18 Health Law
Reporter 1640, December 17, 2009 https://www.bloomberglaw.com/print/X1VTN9R36Q80 (Accessed 3/5/15).
613 “Initiative Gathers Section 409A Data for Compliance Check, IRS Official Says” By Mary Hughes, Bloomberg BNA, August 6, 2014,
http://www.bna.com/initiative-gathers-section-b17179893402/ (Accessed 2/25/15), p. 1-2.
614 “Exempt Organizations: Employment Tax Audits of Exempt Hospitals Could Turn Up Other Issues Attorneys Warn” BNA’s Health Law
Reporter, Vol. 18, No. 1653, December 24, 2009, https://www.bloomberglaw.com/print/X1VTNHR36Q80 (Accessed 3/5/15).
615 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1501, 124 Stat. 119, 242-249 (March 23, 2010).
616 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1501, 124 Stat. 119, 246-248 (March 23, 2010).
617 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1411, 124 Stat. 119, 224-231. (March 23, 2010). Of note, this section was
amended to include Social Security benefits in the modified adjusted gross income in order to calculate the premium tax credit. “Three
Percent Withholding Repeal and Job Creation Act” Pub. L. 112-56, § 401, 125 Stat. 711, 734 (November 21, 2011).
618 “The Fee You Pay if You Don’t Have Health Coverage” Healthcare.gov, 2015, https://www.healthcare.gov/fees-exemptions/fee-for-notbeing-covered/ (Accessed 3/6/15).
619 Ibid.
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Tax-Exempt, Consumer-Operated Plan (CO-OP) Program
The ACA also established the Consumer Operated and Oriented Plan (CO-OP) Program, a new
form of tax-exempt organization under I.R.C. § 501(c)(29)620 that incentivizes tax-exempt health
insurers to offer health plans in individual and small-group markets.621 These plans will receive
federal funding, provided that they satisfy the requirements of the I.R.C. § 501(c)(29) exemption
as well as meet the ACA’s Consumer Operated and Oriented Plan (CO-OP) Program
requirements that:
(1) The organization provides notice to the Secretary of HHS that it is applying for
§ 501(c)(29) status;
(2) Net profits will be inured only to health plan benefit members (e.g., lower premiums,
improve benefits, etc.), not to private individuals;
(3) It does not propagandize or otherwise attempt to influence legislation; and
(4) It refrains from any participation in, on behalf of, or in opposition to any campaign
or candidate for political office.622
Failure of the exempt organization to meet the above criteria will result in a penalty mandating
repayment of 110 percent of their loan or grant, plus interest.623

Provider Taxes
In response to recent laws, such as the 2009 American Reinvestment and Recovery Act
(ARRA),624 many states have passed provider taxes on healthcare providers in their state. The
state may not tax providers more than 25 percent of its share of Medicaid expenditures and may
not guarantee any return of that tax to providers.625 As of 2014, 49 states and Washington, D.C.
have some type of Medicaid related provider tax.626 Provider taxes are funneled back to
providers by way of increased Medicaid reimbursement rates, while states can retain the
federally matched funds.627

Ad Valorem Tax and Personal Property Tax
In addition to provider taxes, healthcare providers may also be subject to personal property taxes
and ad valorem taxes. An ad valorem tax is a tax that is generally determined to be a fixed or
calculated proportion of the value of the property “as assessed or appraised on a regular basis.”628
Frequently assessed by state and local authorities, ad valorem taxes generally pertain to real
620
621
622
623
624
625
626
627
628

“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1322, 124 Stat. 119, 187-192 (March 23, 2010).
Ibid.
“CO–OP Health Insurance Issuers” 26 U.S.C. § 501(c)(29) (2011).
“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1322, 124 Stat. 119, 188 (March 23, 2010).
“Health Care Provider and Industry Taxes/Fees” National Conference of State Legislatures, July 2012, http://www.ncsl.org/issuesresearch/health/health-provider-and-industry-state-taxes-and-fees.aspx (Accessed 9/8/12); “American Recovery and Reinvestment Act”
Pub. L. No. 111-5, § 5001, 123 Stat. 115, 496 (February 17, 2009).
“Prohibition on use of voluntary contributions, and limitation on use of provider-specific taxes to obtain Federal financial participation
under Medicaid” 42 U.S.C. § 1396b(w)(2010).
“Health Provider and Industry State Taxes and Fees” National Conference of State Legislatures, July 10, 2014, http://www.ncsl.org/
research/health/health-provider-and-industry-state-taxes-and-fees.aspx#2914_guidance (Accessed 3/6/15).
“Health Care Provider and Industry Taxes/Fees” National Conference of State Legislatures, July 2012, http://www.ncsl.org/issuesresearch/health/health-provider-and-industry-state-taxes-and-fees.aspx (Accessed 9/8/12).
“State and Local Taxation” 71 Am. Jur. 2d, § 18 (2012).
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property and sales, but are also applicable to imported goods. For imported goods, the ACA
includes a provision that “any manufacturer or importer with gross receipts from branded
prescription drug sales” must pay an annual fee for any drugs—whose sales did not exceed $5
million in a calendar year—that were submitted for U.S. Food and Drug Administration (FDA)
approval (excluding orphan drugs), and any biological products submitted for licensing under the
Public Health Service Act.629

Excise, Sales, and Use Taxes
Effective January 1, 2018, the ACA created a 40 percent excise tax against employees with highcost health coverage, i.e., an employer-sponsored health insurance plan that provides the
employee excess benefit above certain thresholds.630 These thresholds include the following:
(1) for employees possessing self-only coverage, the product of $10,200 and the health cost
adjustment percentage for such employees and (2) for employees possessing any other type
coverage, the product of $27,500 and the health cost adjustment percentage for such
employees.631 Additionally, the ACA includes an excise tax on medical devices, effective
January 1, 2013, in which the device manufacturer, producer, or importer must pay a tax
equivalent to 2.3 percent of the sale price of the medical device.632

OTHER FEDERAL REGULATIONS
OCCUPATIONAL SAFETY AND HEALTH ACT (OSHA)
The Occupational Safety and Health Act of 1970 (OSHA) established standards for occupational
health and safety, and it requires states to enact legislation implementing standards and
procedures developed by the Department of Labor.633 OSHA promulgated regulations include
those designed to protect health care employees from blood borne diseases, latex allergies,
needle sticks, tuberculosis, patient violence, ionizing radiation, and anesthetic gasses that leak
into the surrounding room during medical procedures, among others.634

CLINICAL LABORATORY IMPROVEMENT ACT (CLIA)
Congress passed the Clinical Laboratory Improvement Act (CLIA) and its subsequent
amendments in order to improve the accuracy, reliability, and timeliness of test results.635 The
629 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 9008, 124 Stat. 119, 859-862 (March 23, 2010).
630 “Patient Protection and Affordable Care Act” Pub. L. 111-148, §§ 9001, 10901, 124 Stat. 119, 847-853, 1015-1016 (March 23, 2010), as
amended by "Health Care and Education Reconciliation Act" Pub. L. 111-152, § 1401, 124 Stat. 1029, 1059-1060 (March 30, 2010).
631 Ibid.
632 “Patient Protection and Affordable Care Act” Pub. L. 111-148, §§ 9009, 10904, 124 Stat. 119, 862-865, 1016-1017 (March 23, 2010), as
amended by "Health Care and Education Reconciliation Act, Sec.1405" Pub. L. 111-152, § 1405, 124 Stat. 1029, 1064-1065 (March 30,
2010).
633 “Problems in Health Care Law: Challenges for the 21st Century” By John E. Steiner, Jr., Tenth Edition, Burlington, MA: Jones and Bartlett
Publishers, 2014, p. 108.
634 “Problems in Health Care Law: Challenges for the 21st Century” By John E. Steiner, Jr., Tenth Edition, Burlington, MA: Jones and Bartlett
Publishers, 2014, p. 108; “Radon in the Workplace, The OSHA Ionizing Radiation Regulations” By Robert K. Lewis, Bureau of Radiation
Protection, 2004, http://www.aarst.org/proceedings/2004/2004_07_Radon_in_the_Workplace_The_OSHA_Ionizing_Radiation.pdf
(Accessed 10/13/2009).
635 “Clinical Laboratory Improvement Amendments” Medicare Learning Network, Centers for Medicare & Medicaid Services, July 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/CLIABrochure.pdf (Accessed
3/5/15), p. 1.
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act requires laboratories to regulate all laboratory testing performed on humans, except the
testing performed for research purposes.636 CMS assumes the responsibility for overseeing the
CLIA program.637 CLIA requires that healthcare providers who perform laboratory testing on
specimens derived from humans in order to gain information for the diagnosis, prevention, or
treatment of disease or the assessment of health to abide by federally established quality
standards in order to operate these services.638

UNITED STATES NUCLEAR REGULATORY COMMISSION (NRC)
The United States Nuclear Regulatory Commission (NRC) is an independent agency created by
Congress in 1974.639 The goal of the agency is to ensure the safe use of radioactive material for
civilian purposes through a combination of regulatory requirements, licensing, safety oversight,
operational evaluation, and support activities.640 Under section 274 of the Atomic Energy Act of
1954, the NRC is authorized to delegate its authority to oversee certain licensees to state
regulatory commissions, or agreement states.641 An agreement state then has the authority to
regulate the use of nuclear material by certain licensees. To date, the NRC has entered into
agreements with thirty-seven states.642
The NRC or the agreement state regulates the medical use of radioactive material through the
licensing of medical facilities and physicians, inspection of facilities, and enforcement of
regulations and procedures. The types of medical use regulated by the NRC and the agreement
state include the production of radiation from imaging devices used by hospitals, physicians,
dental offices, and podiatry offices; the use of nuclear material to deliver pain reliving or
therapeutic doses to parts of the body; and medical research involving the use of nuclear material
in human subjects.643

EMERGENCY MEDICAL TREATMENT AND ACTIVE LABOR ACT
(EMTALA)
The Emergency Medical Treatment and Labor Act (EMTALA), enacted in 1986 by the
Consolidated Omnibus Budget Reconciliation Act of 1985, requires covered hospitals to provide
an “appropriate medical screening examination” to any patient presented to the hospital’s
emergency department.644 “Participating hospitals” under EMTALA are hospitals that
participate in the Medicare program and have an emergency room, leaving some hospitals
outside the purview of the statute.645 Patients who suffer harm as a “direct result” of a hospital’s
636 “Clinical Laboratory Improvement Amendments: Overview” Centers for Medicare & Medicaid Services, http://www.cms.hhs.gov/clia/
(Accessed 09/01/09).
637 Ibid.
638 “Clinical Laboratory Improvement Amendments” Medicare Learning Network, Centers for Medicare & Medicaid Services, July 2014,
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/CLIABrochure.pdf (Accessed
3/5/15), p. 1.
639 “About NRC” United States Nuclear Regulatory Commission, January 14, 2015, http://www.nrc.gov/about-nrc.html (Accessed 3/05/15).
640 “Medical, Industrial, and Academic Uses of Nuclear Material” United States Nuclear Regulatory Commission, February 10, 2015,
http://www.nrc.gov/materials/medical.html (Accessed 3/5/15).
641 “Governing Legislation” United States Nuclear Regulatory Commission, September 30, 2014, http://www.nrc.gov/about-nrc/governinglaws.html#top (Accessed 3/5/15).
642 “Agreement State Program” United States Nuclear Regulatory Commission, April 10, 2013, http://www.nrc.gov/about-nrc/statetribal/agreement-states.html (Accessed 3/5/15).
643 “Medical Uses of Nuclear Material” United States Nuclear Regulatory Commission, November 12, 2014, http://www.nrc.gov/materials/
miau/med-use.html (Accessed 3/5/15).
644 “Medical Screening Requirement” 42 U.S.C. § 1395dd(a) (2013).
645 “Definitions” 42 U.S.C. § 1395dd(e)(2) (2013).).
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violation of EMTALA are authorized to bring a claim against the hospital, but patients lack a
private right of action under EMTALA against the specific treating physician.646 Additionally,
EMTALA provides for civil penalties against the hospital.647
As noted above, EMTALA does not require hospitals to have an emergency department;
however, some specialty hospitals are required by state licensure laws to have emergency
departments.648

TORT REFORM
Malpractice, defined as “an instance of negligence or incompetence on the part of a
professional,”649 has always been a risk inherent in the practice of medicine. Specifically,
medical malpractice is defined as “a doctor’s failure to exercise the degree of care and skill that
a physician or surgeon of the same medical specialty would use under similar circumstances.”650
The U.S. tort system allows patients who are injured or wronged in some way to sue the
wrongdoer, or tortfeasor. The medical malpractice system was designed to operate as a quality
control measure, creating an incentive for prevention of medical errors and reducing accident
producing behavior by awarding damages, “money claimed by or ordered to be paid to a person
as compensation for loss or injury,”651 to plaintiffs who have been harmed by the error.652 The
result is that the wrongdoer is essentially held accountable for his or her actions, the injured party
is able to recover for damages incurred as a result of the tort, and the public is provided with a
means to incentivize physicians and hospitals to improve the quality of their care.653
Damages for medical malpractice are monetary and are typically awarded for (1) economic
losses; (2) non-economic losses; and/or (3) punitive losses. Economic damages compensate
victims for actual monetary losses, such as medical expenses, lost wages, and rehabilitation
costs, while non-economic damages compensate victims for losses that are not traditionally
measured in monetary terms, including pain and suffering, disfigurement, and loss of
companionship.654 In addition, to punish the defendant’s conduct and deter future wrongdoers,
punitive damages may be awarded in cases where the defendant has acted in a reckless or
deceitful manner.655
As advancements in research and technology have advanced medical practice, the ability to
diagnose and treat patients has led to an increased volume of medical assessments and
procedures performed. Unfortunately, increases in the volume of procedures performed often
646 “Personal Harm” 42 U.S.C. § 1395dd(d)(2)(A) (2013).
647 “Civil Money Penalties” 42 U.S.C. § 1395cc(d)(1)(A)-(B) (2013).
648 “Specialty Hospitals: Focused Factories or Cream Skimmers?” By Kelly Devers, Linda R. Brewster, and Paul B. Ginsburg, Center for
Studying Health System Change, Issue Brief No. 62 (April 2003), http://www.hschange.com/CONTENT/552/ (Accessed 5/10/10).
649 “Malpractice” Black’s Law Dictionary, 9th ed., West Publishing Co., 2009.
650 “Medical Malpractice” Black’s Law Dictionary 9th ed., West Publishing Co., 2009.
651 “Damages” Black’s Law Dictionary 9th ed., West Publishing Co., 2009
652 “Health Law: Cases, Materials, and Problems” By Barry R. Furrow, et al., 7th Edition, St. Paul, MN: West Publishing Company, 2013,
p. 508.
653 “Justice for the Injured: Defending the Civil Justice System from the Corporate ‘Tort Reform’ Movement.” Multinational Monitor, (March
2003), p. 23-26.
654 “Addressing the Medical Malpractice Insurance Crisis” National Governors Association Center for Best Practices, December 5, 2002, p. 5.
655 “Tort Law and Alternatives: Cases and Materials” By Marc A. Franklin, Robert L. Rabin, and Michael D. Green, 9th ed., New York, NY
Foundation Press, 2011, p. 750.
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increase both the risk of harm to patients and the exposure to liability for physicians.656 With the
growth of ACOs contributing to an increase in managed care, concerns about physician volume
and associated medical errors are prominent. Today, most healthcare services are delivered
through an institution, group practice, or hospital system. While there are many advantages to
providing care this way, some managed care mechanisms—such as diminishing physician
autonomy, requiring physicians to see a certain amount of patients, and limiting the amount of
time physicians spend with patients—may contribute to medical errors, which are one of the
foundations of a medical malpractice claim. The result of these increased risks, medical errors,
and disgruntled patients has produced an environment that is ripe for malpractice litigation.657

State Tort Reform
The malpractice crisis of the 2000s resulted in a patchwork of state political and legal actions
meant to limit problems such as preventable medical errors and/or jury verdicts. While actions
taken by the public and its political representatives addressed certain issues at the heart of this
malpractice crisis, i.e., excessive verdicts and the validation of expert witness testimony, actions
taken in response to the crisis of the early 2000s did not effectively decrease medical errors
nationally, nor were they uniform nationally. As a result, this jumble left medical liability
insurers, doctors, and patients to grapple with the effects of patchwork solutions; reconciling this
patchwork continues to date.
States commonly worked to resolve the tort reform crisis by enacting a cap on payments for noneconomic damages, including pain and suffering, loss of consortium, and emotional distress. In
1975, California first modeled this approach by passing the Medical Injury Compensation
Reform Act (MICRA), which enacted a cap of $250,000 for awards based on non-economic
damages.658 After the passage of MICRA, other states followed California’s lead in enacting
similar legislation. Similarly, states passed laws creating punitive damage caps and other
limitations sought to limit the “prospect of receiving a big ‘bonus’” that may prolong cases that
otherwise would be settled.659 However, the number of states with active caps on noneconomic
and/or punitive damages has decreased slightly over the past 15 years. From 2002 to 2013, the
number of states with active caps specifically for noneconomic damages decreased slightly from
30 to 27,660 reflecting the actions of state supreme courts invalidating such caps.661 Similarly,
within the same time frame, the number of states with active caps specifically targeted at
punitive damages decreased from 20 to 19.662

656 “Overview of Medical Errors and Adverse Events” By Maité Garrouste-Orgeas et al., Annals of Intensive Care, Vol. 2, No. 2, 2012, p. 6.
657 “Health Law: Cases, Materials, and Problems” By Barry R. Furrow et al., 7th Edition St. Paul, MN: West Publishing Company, 2013,
p. 506-507.
658 “Damages for Wrongs” Cal. Civ. Code § 3333.2 (1975); “Voters Turn Down Proposition 46 to Lift Medical Malpractice Cap, Require Drug
Tests for Doctors” CBS San Francisco, November 4, 2014,
http://sanfrancisco.cbslocal.com/2014/11/04/proposition46doctorsdrugtestsresults/ (Accessed 12/10/14).
659 “Liability System” Insurance Information Institute, September 2014, http://www.iii.org/issue-update/liability-system (Accessed 10/31/14),
p. 4.
660 “Health Care: Medical Malpractice Tort Reform (Statutes)” Thomson Reuters, September 2013.
661 Various state supreme courts have invalidated relevant state statutes that imposed caps on noneconomic damages. For example, see McCall
v. U.S., No. SC11-1148 (Fla. Mar. 13, 2014); “Health Care: Medical Malpractice Tort Reform (Statutes)” Thomson Reuters, September
2013.
662 “Health Care: Medical Malpractice Tort Reform (Statutes)” Thomson Reuters, September 2013.
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Federal Tort Reform
Though medical malpractice law has traditionally been regulated at the state level, the federal
government has taken an interest in tort reform. A 2002 HHS report alleged that the legal system
was to blame for rising medical malpractice premiums, citing California’s noneconomic damages
cap as a model for national tort reform.663 While there have been efforts at federal tort reform, a
federal cap on damages has yet to be signed into law. The most recent effort to cap damages at
the federal level, the Help Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2009, was
introduced before the House of Representatives in February 2009.664 This bill is a new attempt to
pass a federal cap on noneconomic damages in medical malpractice suits, which has been a
continuing congressional goal since the same bill was first introduced in the House in 2002.665
Similar bills have repeatedly passed in the House; however, no version of the bill has yet to be
passed in the United States Senate.666
Proponents of tort reform have historically pushed for caps on punitive damage awards.667
However, more viable reform proposals include shifting tribunals (for example, from judicial to
administrative panels) or creating federal safe harbors for physicians who practice in accordance
with credible comparative-effectiveness research.668 Additionally, insurance companies are
experimenting with disclosure and offer programs in which providers offer compensation to
patients immediately upon disclosure of a negative outcome, reducing the number of malpractice
lawsuits.669

PHYSICIAN PAYMENTS SUNSHINE ACT

When the ACA was passed, it included the Physician Payments Sunshine Act as part of its
initiative to promote transparency in the healthcare industry.670 In October 2014, CMS issued its
final rule regarding the Sunshine Act, which required the establishment of a transparency
program, now known as the Open Payments Program, to monitor and report on payments or
other “transfers of value” by manufacturers and applicable group purchasing organizations to
healthcare providers.671 The program is voluntary for physicians to register, but mandatory for
manufacturers of medical devices and drugs, although all data is reported regardless of the
registration status of the physician.672 The published financial data, which is updated at least
663 “Confronting the New Health Care Crisis: Improving Health Care Quality and Lowering Costs By Fixing Our Medical Liability System”
Department of Health and Human Services, (July 24, 2002), p. 1.
664 “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2009” H.R. 1086 (February 13, 2009).
665 “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2002” H.R. 4600 (April 25, 2002).
666 “Bill Text Versions 112th Congress (2011-2012) H.R.5” The Library of Congress, 2015, http://thomas.loc.gov/cgi-bin/query/z?c112:H.R.5:
(Accessed 3/6/15); “Bill Text Versions 107th Congress (2001-2002) H.R. 4600” The Library of Congress, 2015, http://thomas.loc.gov/cgibin/query/z?c107:H.R.4600: (Accessed 3/6/15).
667 “Beyond MICRA: New Ideas for Liability Reform” American College of Physicians, Annals of Internal Medicine, Vol. 122, No. 6 (1995),
p. 466-67; “The Role of Medical Liability Reform in Federal Health Care Reform” By Michelle M. Mello, and Troyen V. Brennan, New
England Journal of Medicine, Vol. 361, No. 1 (July 2, 2009), p. 1.
668 “The Role of Medical Liability Reform in Federal Health Care Reform” By Michelle M. Mello and Troyen V. Brennan, New England
Journal of Medicine, Vol. 361, No. 1 (July 2, 2009), p. 3.
669 Ibid, p. 2-3.
670 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 6002, 124 Stat. 119, 571 (March 23, 2010).
671 “Open Payments (Physician Payments Sunshine Act) Fact Sheet” Centers for Medicare & Medicaid Services, 2013, http://www.cms.gov/
Regulations-and-Guidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Physician-fact-sheet.pdf (Accessed
2/25/15), p. 1.
672 “Open Payments (Physician Payments Sunshine Act) Fact Sheet” Centers for Medicare & Medicaid Services, 2013, http://www.cms.gov/
Regulations-and-Guidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Physician-fact-sheet.pdf (Accessed
2/25/15), p. 1.

281

Adviser's Guide to Healthcare

once annually by CMS, is accessible by anyone after such data is submitted by manufacturers
and aggregated by CMS.673 In 2015, CMS released additional changes that will go into effect for
the 2016 program year, with reporting to CMS in 2017.674 These changes include:
(1) Deletion of the definition of “covered device,” because specific device definitions are
already included in the Open Payments Rule;
(2) Deletion of the provision excluding compensation (both indirect and direct) provided to
physician speakers at continuing education events;
(3) Requirement that the marketed name and therapeutic area, or product category of the
related covered drugs, devices, biological, or medical supplies, be reported unless the
payment or other transfer of value is not related to a particular covered or non-covered
drug, device, biological or medical supply; and
(4) Requirement that stocks, stock options, or any other ownership interest be reported as
distinct categories.675

CONCLUSION
“Perhaps this complex, hybrid regulatory structure has emerged because it fits
America’s temperament. It may, in fact, be the only kind with which the country
would be truly comfortable. The decentralization and complexity of health care
regulation are distinctively American in the interplay of layers of government,
different agencies within each level, and private forces. It is a system of checks
and balances that prevents any single regulatory authority from becoming too
influential and that encourages diversity in programs and approaches. There is
almost a ‘marketplace’ of regulation, with a competitive harness that disciplines
government policy in a similar manner to the discipline of a private market for
goods and services. The system in unquestionably less efficient than one that is
more centralized, but perhaps the inefficiency has its advantages. It may even
enhance overall regulatory effectiveness.”676—Robert I. Field
In his 1982 book, The Social Transformation of American Medicine, Paul Starr asserted that the
once sovereign medical profession (at the turn of the twentieth century) was relatively free from
the shackles of government regulation relating to the profession’s control over its organization;
standard of practice; and the markets in which it operated. However, recently, with the rise of the
“corporatization of medicine,” physician control has been gradually eroded by “[e]mployers and
the government becom[ing] critical intermediaries in the system because of their financial role,”
who are “using their power to reorient the system.”677

673 Ibid, p. 5.
674 “Law and Policy: CMS Implements Final Rule Changes for Open Payments” Centers for Medicare & Medicaid Services, 2014
http://www.cms.gov/OpenPayments/About/Law-and-Policy.html (Accessed 2/25/15).
675 Ibid.
676 “Health Care Regulation in America: Complexity, Confrontation, and Compromise” By Robert I. Field, New York, NY: Oxford University
Press, 2007, p. 241-242.
677 “The Social Transformation of American Medicine” By Paul Starr, New York, NY: Basic Books, Inc., 1982, p. 445.
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As a result of the corporatization of the U.S. healthcare delivery system, as well as the
increasing consolidation stemming from healthcare reform efforts, the potential exists for
healthcare entities to become subject to substantial penalties arising from the their entrance into
transactions and arrangements that may subsequently be found to be legally impermissible. In
considering any potential transactions, providers should take note of this heightened regulatory
environment and work closely and with competent healthcare legal counsel and certified
valuation professionals to ensure that prospective transactions and arrangements are in
compliance with current laws, as well as satisfy applicable regulatory thresholds. A
determination that a transaction has met the requisite tax, corporate, organizational, licensure,
and certification requirements may only be the first steps. Providers may feel more comfortable
with also obtaining a certified opinion prepared in compliance with professional standards by an
independent credential valuation professional (under the advice of legal counsel) and supported
by adequate documentation as to whether each of the proposed elements of the transaction are
both at Fair Market Value and commercially reasonable, so as to establish a risk adverse,
defensible position that the transactional arrangement can withstand regulatory scrutiny.
Key Sources
Key Source

Description

Citation

Website

The Library of
Congress: THOMAS

Provides up-to-date copies of
pending legislation in the United
States Congress.

“About Thomas” The Library of
Congress: THOMAS, http://
thomas.loc.gov/home/abt_thom.h
tml, (Accessed 4/1/15).

https://www.congress.go
v

“About the Joint Commission”
The Joint Commission, http://
www.jointcommission.org/
about_us/about_the_joint_
commission_main.aspx
(Accessed 4/1/15).

www.jointcommission.o
rg

“About NCQA” The National
Committee for Quality
Assurance, www.ncqa.org/
tabid/675/Default.aspx
(Accessed 4/1/15).

www.ncqa.org

The Joint Commission

National Committee
for Quality Assurance

United States
Department of Health
And Human Services
(HHS) Office of
Inspector General

Centers for Medicare
and Medicaid Services
(CMS)

Provides information on
accreditation and certification
standards for more than 17,000
healthcare organizations and
programs. Joint Commission
accreditation and certification is
recognized nationwide as a symbol
of quality that reflects an
organization’s commitment to
meeting certain performance
standards.
Provides standards of accreditation
and certification to various types of
healthcare entities, as well as
performance measures, and
recognizes providers that
consistently provide high-quality
care in order to provide consumers
with information on provider
quality.
The Office of the Inspector General
of the HHS oversees all HHS
programs in order to protect the
integrity of the programs and the
health and welfare of beneficiaries.
The CMS administers the
Medicare, Medicaid, and CHIP
programs. The CMS website
contains important information for
beneficiaries of these programs, as
well as for guidelines for providers.

“Office of the Inspector General”
U.S. Department of Health and
Human Services,
http://oig.hhs.gov (Accessed
4/1/15).
“Guidelines for Ensuring the
Quality of Information
Disseminated to the Public: E.
Centers for Medicare &
Medicaid Services” Department
of Health and Human Services,
http://aspe.hhs.gov/infoquality/
Guidelines/CMS-9-20.shtml
(Accessed 4/1/15).

http://oig.hhs.gov

www.cms.hhs.gov
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Associations
Type of
Association

Professional
Association

National

American
Health
Lawyers
Association
(AHLA)

National

American
Bar
Association
(ABA):
Health Law
Section

National

National

National
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American
Medical
Association
(AMA)

American
Osteopathic
Association

American
Hospital
Association
(AHA)

Description
The AHLA website (Health
Lawyers) “provides resources to
address the issues facing its active
members who practice in law
firms, government, in-house
settings and academia and who
represent the entire spectrum of the
health industry: physicians,
hospitals and health systems,
health maintenance organizations,
health insurers, life sciences,
managed care companies, nursing
facilities, home care providers, and
consumers.”
ABA provides resources dedicated
specifically to health lawyers.
Provides access to all legal issues
related to health and allows
lawyers to connect with the latest
legal developments in public
health, federal healthcare
regulations, managed care,
Medicare, or healthcare fraud, as
seen from a national perspective.
Publishes The Health Lawyer and
Health eSource.
Founded in 1847, the AMA’s
mission is to promote the art and
science of medicine and the
betterment of public health and
provides a variety of data and
resources to the healthcare
community.
The AOA is the main board
certifying entity for osteopathic
physicians and is the accrediting
body for every osteopathic
healthcare facility and medical
college. It strives to promote the
practice of osteopathic medicine by
ensuring quality in education,
research, and the delivery of
healthcare services.
Founded in 1898, the AHA
provides education for healthcare
leaders and is a source of
information on healthcare issues
and trends and is comprised of
close to 5,000 hospitals, healthcare
systems, networks, other providers
of care, and 37,000 individual
members.

Citation

Contact Information

“About AHLA: Our
Mission,”
www.healthlawyers.
org/About/WhoWe
Are/Pages/default.
aspx (Accessed
4/1/15).

American Health Lawyers
Association
1025 Connecticut Avenue, NW
Suite 600
Washington, DC 20036
Phone: 202-833-1100
Fax: 202-833-1105
E-mail: n/a
www.health
lawyers.org/Pages/Default.aspx

“Health Law
Section” American
Bar Association,
http://www.american
bar.org/groups/health
_law.html (Accessed
4/1/15).

Health Law Section
American Bar Association
321 N. Clark St.
Chicago, IL 60654
Phone: n/a
Fax: 312-988-5814
E-mail: healthlaw@abanet.org
http://www.americanbar.org

“About AMA,”
American Medical
Association,
www.amaassn.org/ama/pub/
about-ama.shtml
(accessed December
4, 2009).

American Medical Association
515 N. State Street
Chicago, IL 60654
Phone: 800-621-8335
Fax: n/a
E-mail: n/a
www.ama-assn.org

“About the AOA”
American
Osteopathic
Association,
www.osteopathic.org
/index.cfm?PageID=
aoa_main, (accessed
June 30, 2009).
“About the American
Hospital
Association”
American Hospital
Association,
http://www.aha.org/
about/index.shtml
(accessed December
4, 2009).

American Osteopathic
Association
Main Headquarters 142
East Ontario Street
Chicago, IL 60611
Phone: 312-202-8000 / 800621-1773
Fax: 312-202-8200
E-mail: info@osteotech.org
www.osteopathic.org
American Hospital Association
One North Franklin
Chicago, IL 60606
Phone: 312-422-3000
Fax: n/a
E-mail: n/a
www.aha.org
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Type of
Association

Professional
Association

Description

Citation

National

Ambulatory
Surgery
Center
Association
(ASC
Association)

A membership and advocacy
organization that provides
advocacy support and assistance
for ASCs across the nation on a
state and federal level.

“ASC Association,”
By Ambulatory
Surgery Center
Association,
http://ascassociation.
org/about/association
(accessed December
4, 2009).

National

American
Health
Planning
Association
(AHPA)

“A non-profit public interest
organization committed to health
policies and practices that promote
equal access health care at a
reasonable cost.”

“About AHPA: Who
We Are,” By
American Health
Planning Association,
www.ahpanet.org/
about_ahpa1.html
(accessed
December 4, 2009).

Contact Information
Ambulatory Surgery Center
Association
1012 Cameron Street
Alexandria, VA 22314
Phone: 703-836-8808
Fax: 703-549-0976
E-mail: ASC@
ascassociation.org
www.ascassociation.org
American Health Planning
Association
7245 Arlington Boulevard,
Suite 300
Falls Church, VA 22042
Phone: 703-573-3103
Fax: n/a
E-mail: info@ahpanet.org
www.ahpanet.org
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Impact of
Competitive Forces

There are perhaps few things upon which all men
are so agreed as that the problems which beset
them today surpass in difficulty those which
confronted any previous generation.
It is maintained that never has knowledge been
so complex nor the pace of life so insistent;
that never has it been so difficult to take thought
on those larger considerations which allow men
to appreciate the trend of events and the
measures by which they might be controlled.
Harold Himsworth, 1953

KEY TERMS

Cherry-pick or Cream-skim
Economic Demand
Economic Supply
Monopsony
Purple Pill
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Key Concept
Normal Markets
versus Healthcare
Markets

Definition
Competition in healthcare is unique from
competition in other sectors because traditional
theories of economic forces do not always govern
the choices made.

Three-Legged Stool
Model of
Healthcare

Cost, quality, and access are each considered
distinct elements of healthcare administration.

Emergency Medical
Treatment and
Labor Act

Hospital emergency departments are required to
provide care under certain circumstances, even to
patients who are uninsured and unable to pay for
that care.

Most Favored
Nation Status

A provider contractually agrees to not charge an
insurance company any more than it charges any
other customer.

Trend Toward
Physician
Ownership

Physicians have become owners and investors in
surgical facilities, such as ambulatory surgery
centers, and specialty hospitals that compete with
the same general hospitals to which the
physicians traditionally have referred patients.

Effect of Declining
Patient Volumes

Hospitals began offering additional services and
entering into the practice of providing insurance
and primary care services, taking on a powerful
role as both provider and insurer through
integrated delivery systems. In addition, hospitals
began to merge with each other so that they could
leverage their consolidated bargaining power
against private insurers.

“Why Competition Law Matters to
Health Care Quality,” by William
M. Sage, David A. Hyman, and
Warren Greenberg, Health Affairs,
Vol. 22, No. 2 (March/April
2003), p. 35–36.
"Examination and Treatment for
Emergency Medical Conditions
and
Women in Labor" 42 U.S.C. !
1395dd (2011).
“Improving Health Care: A Dose
of Competition: Chapter 6,
Competition Law: Insurers,” A
Report by the Federal Trade
Commission and Department of
Justice, July 2004, p. 20.
“Hospital-Physician Relations:
Cooperation, Competition, or
Separation?” by Robert A.
Berenson, Paul B. Ginsburg, and
Jessica H. May, Health Affairs,
Web Exclusive, (Dec. 5, 2006),
p. w33-34.
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293

294

298-301

297

“Banning Physician Self-Referral
is an Important Step Toward
Health Reform,” by Rich
Umbdenstock and Chip Kahn. HA
News Now, www.ahanews.com/
ahanews_app/jsp/display.jsp?dcrpa
th=AHANEWS/AHANewsArticle/
data/AHA_News_090720_
Physician&domain=AHANEWS
(accessed November 9, 2009).

300

“Competitive Strategy: Techniques
for Analyzing Industries and
Competitors,” by Michael E.
Porter, The Free Press, 1980, p. 4.

310-19

Porter’s three generic strategies are (1) overall
cost leadership, (2) differentiation, and (3) market
niche or segmentation.

“On Competition” By Michael E.
Porter, Boston, MA: Harvard
Business School Publishing, 2008,
p. 53.

312

Limits federal scrutiny of insurers and places
states in primary control of antitrust enforcement.

“McCarran-Ferguson Act” 15
U.S.C 1011 et seq. March 9, 1945.

318

The limiting or terminating physician-investors’
privileges and medical staff membership.

Michael Porter’s
Five Competitive
Forces

(1) The threat of new market entrants. (2) The
bargaining power of suppliers. (3) Threats from
substitute products or services. (4) The bargaining
power of buyers. (5) Rivalry among existing
firms.
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OVERVIEW
Competition in healthcare is unique from competition in other sectors because traditional
theories of economic forces do not always govern the choices made by professional practice
enterprises within the healthcare industry. Unlike other markets, in which competition is viewed
positively as a necessary element of capitalism, competition in the healthcare sector frequently is
considered to be resistant to the universal availability and accessibility of quality care.
Although traditional notions of economic supply and demand, and the inherent concept of
competition, have gained influence over healthcare professional practice enterprises in recent
years, these factors historically were subjugated to a normative argument in favor of the missioncentered provision of services regardless of cost. This has led to the perception that healthcare
demand is supply-driven and operates within an inelastic pricing mechanism, the circumstances
of which will be discussed in detail later in this chapter.
The relationship between price and quality of care generally has been defined by providers rather
than patients, meaning consumers (that is, patients) were less equipped to make informed
healthcare purchase decisions than they were in other markets. However, recent pressure for
transparency in the healthcare industry has led to the disclosure of reimbursement rates by
insurers, which may lead to a more consumer-driven healthcare system in the future.1 Further,
the intensive regulation of medical professionals, new technologies and treatments, and evolving
drug therapies may delay or disable the development of substitutes and, therefore, stymie
innovation, which is one of the fundamental drivers of quality improvement and the underlying
dynamic of an organization’s ability to compete.
In addition to the impact of regulation on the delivery of healthcare services, the government’s
role as the single largest payor for healthcare services exerts enormous pressure on providers to
reduce costs.2 The impact of these changes has not been limited to Medicare and Medicaid fees;
it is also reflected in reimbursement policies of other third-party payors.3 This pre-eminent
influence on, and pervasive dominance of, government over the healthcare industry presents a
significant and essentially unique differential between healthcare and other industries.
Finally, the past two decades have seen the accelerated transformation of U.S. healthcare
professions into a service industry enterprise, whereby many believe that professional health
services have been unitized, protocolized, and homogenized in order to facilitate their sale, as if
they were any other market commodity (e.g., frozen orange juice, soy beans, or pork bellies).
These changes have accelerated the corporatization of medicine as demonstrated by the increase
in for-profit healthcare in hospitals, outpatient technical component providers (e.g., independent
diagnostic testing facilities [IDTFs] and ambulatory surgery centers [ASCs]), and large forprofit health insurance payors.
1
2
3

“Blue Cross North Carolina’s Price Tool Could Shake Up Medical Industry” By John Murawski and Ann Doss Helms, Kaiser Health News,
February 4, 2015, http://kaiserhealthnews.org/news/blue-cross-north-carolinas-price-tool-could-shake-up-medical-industry/ (Accessed
3/28/15).
Discussed in Chapter 3: Regulatory Environment.
“Bargaining in the Shadow of a Giant: Medicare’s Influence on Private Payment Systems” by Jeffrey Clemens and Joshua D. Gottlieb,
National Bureau of Economic Research, October 2013, p. 3.
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These issues, in part, moved healthcare to the forefront of consumer and political discourse,
which led to the passage of the 2010 Patient Protection and Affordable Care Act (ACA). Some
other persistent issues that may have factored into the passage of the ACA include:
(1) Rapid rise in healthcare costs;4
(2) Socioeconomic disparities in both access to and quality of healthcare;5 and
(3) Perceived threats of budget deficits and national debt related to the cost of care for a baby
boomer generation now becoming eligible for Medicare.6
Various provisions of the ACA seek to address these concerns, including the development of
new emerging healthcare organizations (EHOs) and healthcare delivery models, e.g.,
accountable care organizations (ACOs) and patient centered medical homes (PCMHs), which
aim to improve quality while reducing cost by providing for better communication and
collaboration among providers along the patient’s continuum of care. Other ACA provisions that
have affected competition in the healthcare industry include those establishing health insurance
exchanges (HIEs) and various value-based purchasing (VBP) initiatives.7

ECONOMICS OF HEALTHCARE
While the growth rate in healthcare costs has begun to level off, it has been growing over the
past few decades at a proportionally greater rate compared to the rise in cost of other goods and
services in the U.S. economy.8 The percentage of the U.S. gross domestic product (GDP)
devoted to healthcare services has grown from 5.3% in 1960 to 17.2% in 2012, and it is projected
to be 19.3% by 2023.9 Although many causes exist for this gap between growth in healthcare
spending and growth in GDP, note that the impact of the economic recession, which started in
2008, had a greater negative impact on GDP than it did on healthcare spending, though the
growth rate of the latter did decline slightly.10

4
5
6
7
8
9

10

290

“Trends in Health Care Cost Growth and the Role of the Affordable Care Act” Executive Office of the President of the United States,
November 2013, https://www.whitehouse.gov/sites/default/files/docs/healthcostreport_final_noembargo_v2.pdf (Accessed 3/31/15), p. 1.
“Focus on Health Care Disparities” The Henry J. Kaiser Family Foundation, December 2012,
https://kaiserfamilyfoundation.files.wordpress.com/2012/11/8396-disparities-in-health-and-health-care-five-key-questions-and-answers.pdf
(Accessed 3/31/15), p. 1.
“The Boomer Challenge” By Paul Barr, Hospitals & Health Networks, January 14, 2014, http://www.hhnmag.com/display/HHN-newsarticle.dhtml?dcrPath=/templatedata/HF_Common/NewsArticle/data/HHN/Magazine/2014/Jan/cover-story-baby-boomers (Accessed
3/31/15).
“Patient Protection and Affordable Care Act” Pub. L. 111-148, §§ 1311 et seq., 3001 et seq., 214 Stat. 119, 173, 353 (March 23, 2010).
“Health Spending Projections Through 2018: Recession Effects Add Uncertainty to the Outlook” By Andrea Sisko et al., Health Affairs,
Vol. 28, No.2, Web Exclusive, (February 24, 2009), http://content.healthaffairs.org/cgi/content/abstract/hlthaff.28.2.w346 (Accessed
05/21/10), p. w346.
“National Health Expenditure Projections: 2013-2023” Centers for Medicare and Medicaid Services, http://www.cms.gov/ResearchStatistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2013.pdf (Accessed 3/25/15);
“Three Decades of Government-Financed Health Care in the United States” By Patrick Fleenor, Tax Foundation, August 1994,
http://www.taxfoundation.org/files/bd006ece1a4b8166023dbc913175b7b7.pdf (Accessed 11/11/09).
“Health Spending Projections Through 2018: Recession Effects Add Uncertainty to the Outlook” By Andrea Sisko et al., Health Affairs,
Vol. 28, No.2, Web Exclusive, (February 24, 2009), http://content.healthaffairs.org/cgi/content/abstract/hlthaff.28.2.w346 (Accessed
05/21/10), p. w349.
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The percentage of the gross domestic product (GDP) devoted to healthcare services has grown from 5.3% in
1965 to almost 18% at the time of publication, and is projected to almost reach 20% by 2023.
Patrick Fleenor, August 1994, Centers for Medicare and Medicaid Services.

Some economists have cited the aging population as the reason for the increase in healthcare’s
share of the GDP. Other voices have asserted that greed among health maintenance
organizations (HMO), pharmaceutical companies, hospitals, and medical providers, such as
doctors and nurses, is responsible.11 In reality, there is no single force driving the increase in
healthcare costs, but rather a combination of forces that have led to such a dramatic rise in costs
that the U.S. now spends more per capita than any other country on its healthcare.12
Documented and significant differences exist in productivity growth between the healthcare
sector of the economy and the economy as a whole. Healthcare services have experienced
significantly lower productivity growth rates than other industry sectors for three main reasons.
First, healthcare services are inherently resistant to automation, so innovation (in the form of
technological advancement) has not made the same impact on healthcare productivity as it has on
productivity in other industries. The manufacturing assembly line robot increases assembly line
productivity by accelerating the process and reducing labor input. In contrast, most medical
technology is still applied in a labor-intensive process, that is, patients are cared for one at a time,
and diseased or ill patients cannot be disposed of as routine work product error like automated
factories can cost-effectively reject a percentage of defective items. Healthcare providers cannot
(and, most would agree, should not) try to operate as factories, because each patient is unique
and disease is widely variable. This makes providers unable to adapt to the productivity gains
and efficiency derived from mass production techniques.13
Second, unlike other labor-intensive industries, healthcare is local in nature and cannot be
imported. Despite the technological advances described previously, healthcare services are
mainly provided by skilled workers within the local market. Within that market, providers
compete locally14 and may be compensated at higher levels than those implied by national
statistics.
Third, healthcare consumers believe that quality of service is correlated with the amount of labor
expended in its provision, in contrast to mass production, in which the number of man-hours per
unit is not an important predictor of product quality.15
11

12

13
14
15

“Why U.S. Health Care is So Expensive and So Pathetic” By Kent Sepkowitz, The Daily Beast, June 18, 2014, http://www.thedailybeast.
com/articles/2014/06/18/why-u-s-health-care-is-so-expensive-and-so-pathetic.html (Accessed 3/31/15); “Tangible and Unseen Health-Care
Costs” By Dionne Searcey and Jacob Goldstein, The Wall Street Journal, September 3, 2009, http://online.wsj.com/article/
SB125193312967181349.html (Accessed 1/6/10); “The High Concentration of U.S. Health Care Expenditures” By Mark W. Stanton,
Research in Action, Vol. 19, June 2006, http://www.ahrq.gov/research/ria19/expendria.htm (Accessed 01/05/10); “Why Are Healthcare
Costs So High?” Planet Money Blog, November 11, 2008, http://www.npr.org/blogs/money/2008/11/why_are_healthcare_costs_
so_high.html (Accessed 1/6/10).
“Seven Factors Driving Up Your Health Care Costs” By Julie Appleby, Kaiser Health News, October 24, 2012, http://kaiserhealthnews.org/
news/health-care-costs/ (Accessed 3/25/15); “Main Indicators: /capita, US$ purchasing power parity—total expenditrues” Organisation for
Economic Co-Operation and Develoment, April 1, 2015, http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT (Accessed
4/1/15).
“Do Health Care Costs Matter?” By William J. Baumol, The New Republic, November 22, 1993, p. 17.
“A Checkup on Health Care Markets” By Patricia E. Powers, MPPA and Michael W. Painter, MD, Robert Wood Johnson Foundation,
2007, p. 2; “The Effect of Health Care Cost Growth on the U.S. Economy” By Neeraj Sood, Arkadipta Ghosh, and Jose J. Escarse, U.S.
Department of Health and Human Services, September 2007, p. 6, 9, 15, 22.
“Do Health Care Costs Matter?” By William J. Baumol, The New Republic, November 22, 1993, p. 17.
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Since healthcare productivity tends to grow at a slower rate than other industries, the higher
relative costs for healthcare services pose a serious consequence, even though higher costs are an
unavoidable and indelible part of a developed economy. For example, as technological
advancements increased efficiency and productivity in the computer manufacturing industry,
computer industry labor wages also increased. However, the total cost per produced computer
declined. But in healthcare, wherein technological advancements do not (currently) have the
same impact on the rate of growth of productivity, wage increases that would be consistent with
other sectors of the economy would be problematic, i.e., the cost per unit of healthcare produced
grows, resulting in healthcare’s share of the U.S. GDP increasing relative to other industry
sectors, which have experienced greater productivity (see above).
Despite both the slow productivity growth and the continually rising percentage of healthcare as
a part of U.S. GDP, Baumol noted that growth in other areas of the economy may be utilized to
offset the relative cost growth experienced in the healthcare sector, to wit:
“…productivity growth in the entire economy means we can afford more of
everything. In an economy in which productivity is growing in almost every sector
and declining in none … consumers can have more of every good and service; they
simply have to transfer gains from the sector that’s becoming more productive into
the sector that’s only becoming a little more productive.”16
Consequently, Baumol posited that if U.S. society deems health to be important, then its
employers and governments must be willing to implement policies that share productivity gains
in other sectors with healthcare providers. Enterprises cannot accrue increasing profits and
governments cannot take escalating taxes from an expanding, technologically efficient economy
and expect healthcare services to survive at acceptable levels of quality and access. This
economic theory has been implemented through various ACA provisions and other policies that
impact the supply of, and demand for, healthcare delivery services.

SUPPLY AND DEMAND IN HEALTHCARE
Historically, healthcare was considered a special economic market, in which quality of care
traditionally trumped general economic notions of the consumer-driven model of supply and
demand. Competition law, which considers quality as only one element of a good or service,
inherently conflicts with the traditional perspectives of providers who see quality as “an
irreducible minimum standard, to be determined by physicians without reference to cost.”17 Prior
to the mid–twentieth century, healthcare was dominated by these providers who justified
anticompetitive behavior under the guise of quality control. In the mid- to late-twentieth century,
however, the scrutiny of competition in healthcare increased to address such behavior among
providers and, as such, competition laws have begun to regulate the healthcare sector as an
economic market more directly.18
16
17
18

292

“Do Health Care Costs Matter?” By William J. Baumol, The New Republic, Nov. 22, 1993, p. 18.
“Why Competition Law Matters to Health Care Quality” By William M. Sage, David A. Hyman, and Warren Greenberg, Health Affairs,
Vol. 22, No. 2, (March/April 2003), p. 39.
Ibid, p. 34-35.
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Prior to the mid–twentieth century, healthcare was dominated by these providers that justified anticompetitive
behavior under the guise of quality control.
William M. Sage, David A. Hyman, and Warren Greenberg, March/April 2003.

Additionally, competition law now addresses the traditional notion of the three-legged stool
model of healthcare, under which cost, quality, and access are considered distinct elements of
healthcare administration. As the impact of competition law on healthcare policy has grown,
these three “legs” have demonstrated their interconnectedness, with price being viewed as having
a direct impact on quality of care. Competition laws have been used to combat the practice of
increasing prices above competitive levels, as well as to prevent providers from excising certain
competitors from the market in the pursuit of “higher quality of care”.19
Also unique to the healthcare sector is the widespread notion of providing services irrespective
of the client’s (i.e., the patient’s) ability to pay. Under laws such as the Emergency Medical
Treatment and Labor Act (EMTALA), hospital emergency departments are required to provide
care under certain circumstances, even to patients who are uninsured and unable to pay for
services rendered.20 Additionally, the power of Medicare and Medicaid, as the largest payors for
healthcare services, forces providers to operate at a loss for many services because those
programs typically reimburse providers only for a fraction of the amount the services cost. As
these payors provide more than 50% of a hospital’s revenue, the general relationship between
cost and price found in other markets is not commonly followed in the healthcare sector.21
Medicare and Medicaid provide more than 50% of a hospital’s revenue.
Hospital Accounts Receivable Analysis, HARA Report, December 1, 2014.

Also, competition in healthcare does not divide neatly between supply and demand, further
contributing to the complexity that distinguishes competition within the healthcare market from
other industry sectors. Ultimately, the major players on the supply side of the healthcare industry
are powerful private insurance companies and large hospital systems. Despite the fact that
providers actually supply services to treat patients, insurance companies are able to limit access
to these healthcare services through the use of provider networks, e.g., health maintenance
organizations (HMO) and preferred provider organizations (PPO). Hospital and physician
providers, on the other hand, are incentivized to keep costs low and maximize utilization of those
services that have the highest reimbursement yield.22 HMOs and PPOs have sought to combine
the role of insurance companies, utilization review organizations, and healthcare providers to
offer prepaid medical plans to subscribers. Primary care physicians practicing within an HMO or
PPO are considered to be a gatekeeper who restricts access to, and utilization of, services in
order to contain costs.
19
20
21
22
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No. 1 (January/February 2006), p. 11-12; “Emergency Medical Treatment and Labor Act” 42 U.S.C 1395dd, January 5, 2009 p. 2534-2541.
“Medicare, Managed Care, and Other Sources of Revenue” By Hospital Accounts Receivable Analysis, HARA Report, Third Quarter
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To date, cost containment has continued to affect the way in which healthcare services are
delivered, and current reform efforts seek to further tie reimbursement to both cost and quality
metrics. For example, public and private payors have implemented bundled payment initiatives
into provider reimbursement models, which initiatives aim to “…align the incentives for both
hospitals and physicians, leading to better quality and greater efficiency in the care that is
delivered.”23 Narrow networks have also been a tool used in cost containment, wherein networks
only offer a select group of covered physicians and services at a lower price than plans with
greater coverage in order to reduce costs for the insurer and the consumer.24
Payors operate as both suppliers and consumers of healthcare services by supplying insurance
and paying for the services provided, deferring the direct payment of those costs from the
patient.25 As suppliers and consumers, large insurance companies have been able to benefit from
monopsony (i.e., one buyer many sellers) power in the U.S., allowing them to demand Most
Favored Nation provisions in their provider contracts (i.e., the provider contractually charges the
insurance company the same as, or less than, any other customer).26 This provision has allowed
insurance companies to prevent the entry of new competitors27 and, in combination with multiple
insurance company mergers, has led to a highly concentrated U.S. health insurance market that
reimburses providers at lower rates, resulting in a significant fiscal burden on physician groups
and small hospitals, driving them out of business or forcing them to join large health systems.28
Conversely, private payors have asserted that, due to increasing leverage on the part of large
hospitals and health systems, they are often unable to contain rate increases, which in turn are
passed along to insurance beneficiaries in the form of premium increases.29 Despite the potential
to raise premiums, much of the healthcare industry consolidation will likely avoid scrutiny under
antitrust regulations, as the majority of mergers occur over broad geographic areas and do not
result in excessive market concentration as it has been defined by the Federal Trade Commission
(FTC) and Department of Justice (DOJ).30 Myriad factors beyond mergers and acquisitions can
aid in increasing hospitals’ market power,31 such as a hospital’s brand recognition or its ability to
provide a specialized service, which may confer significant leverage in negotiations with private
payors.32 Additionally, the ability of multi-hospital systems to negotiate a single contract on
behalf of all of its facilities allows systems to bargain for higher reimbursement rates.33
23
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Community hospitals have an increasing difficulty in cost shifting and cross-subsidizing costineffective services due to competition from specialty providers.34 Decreasing reimbursement
yields, which have restricted hospitals’ revenue streams, as well as difficulties in accessing
capital to support the provision of money-losing services are among the reasons that smaller
hospital systems are consolidating with larger, for-profit systems.35 By merging with larger
health systems, smaller hospitals may be able to maintain sustainable margins by increasing
efficiency and lowering costs, and more easily address their capital requirements. Additionally,
mergers may aid larger health systems in reducing costs through economies of scale, care
coordination, and consolidation.36 The acquisition of other hospitals and physician group
practices confers significant leverage to the purchasing hospitals when they negotiate rates with
private payors.37
Within the current hospital growth trend, hospitals have developed a method for securing
revenue that may result in provider supply disparities. In what has been called the “geographic
expansion race,” U.S. hospitals have begun implementing new strategies to expand their market
presence and compete for valuable insured patients.38 In a study of 12 healthcare markets, the
Center for Studying Health System Change observed facility growth in large metropolitan areas,
analyzing the different expansion strategies employed and the resulting market composition.39
Though the study acknowledged that it is likely too early to predict the impact that the
geographic expansion of hospitals will have on access, quality, and costs, other healthcare
industry commentators have both praised and sharply criticized this new trend for its anticipated
effects.40
In order to target well-insured patients during geographic expansion, hospitals are increasingly
employing one or more expansion strategies, including:
(1)
(2)
(3)
(4)
(5)

34
35
36

37
38
39
40
41

Acquiring existing full-service hospitals or constructing new ones;
Building ambulatory care facilities;
Building freestanding emergency departments;
Strengthening relationships with emergency medical transport systems; and/or
Operating their own emergency medical transport systems.41
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Though hospitals offer both efficiency and quality justifications for these expansion strategies,
others in the healthcare industry assert that these strategies have the potential to raise costs,
diminish the quality of care, and eliminate access to care for some patients.42
A growing trend in consumer-driven healthcare is increased rate transparency by providers and
insurers.43 Because of greater transparency, consumers have more opportunities to determine a
health plan that fits their financial needs. With this knowledge, some consumers enduring the
repercussions of high insurance premiums have chosen to switch to more consumer-driven
healthcare insurance by contributing to a health saving account (HSA) from which to pay their
medical expenses, then supplementing the HSA with high-deductible health plans (HDHP) to
cover catastrophic conditions.44 Another recent trend is narrow networks, which were developed
in an effort to offer low-cost health plans to consumers.45 While narrow networks offer lowercost options to consumers, they may be too restrictive for many consumers because of the limited
choice of providers offered under these plans.46 There are also some potential problems for states
with any willing provider laws who also offer narrow networks.47 If a state requires insurers to
accept all providers that meet certain requirements, the concern is that these insurers will not be
able to reduce costs for consumers, thus interfering with the structure of narrow networks.48
These concerns aside, this shift to consumer-driven healthcare has changed the demand
environment of the healthcare industry such that providers are now dealing directly with patients
who are starting to more closely scrutinize the procedures and services they purchase.49 By
making these purchasing decisions directly rather than relying on an insurance provider to pay
most of the cost of treatment, the ability of healthcare consumers to affect demand in the
healthcare market has increased, and the demand side of this sector is finally beginning, in some
capacity, to mimic that of other industries.50

IMPACT OF GOVERNMENT REGULATION
Healthcare enterprises are subject to extensive regulatory control at both the state and federal
levels of government. Some of the most significant regulations address the financial relationships
between providers51 State and federal fraud and abuse laws have profoundly affected the
provision of healthcare services in the U.S. because they, in part, prohibit particular financial
42
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relationships between healthcare providers. Proponents of these laws contend that practitioner
medical judgment is influenced by financial relationships with referral sources.52 However,
substantial regulation has the capacity to limit free market competition in the healthcare
industry.53 Additionally, the influence of the government as both a regulator and purchaser of
healthcare services may distort provider responses to patient demand, restrict access to care, and
reduce potential rewards resulting from medical innovation.54

SUPPLY: COOPERATION AND COMPETITION BETWEEN HOSPITALS
AND PHYSICIANS
Historically, physicians and hospitals each provided distinct services to patients, with physicians
providing physician services and hospitals providing surgical facilities and other related services
to patients referred to the hospital in which the physicians enjoyed staff privileges.55 Under this
symbiotic dynamic, there was relatively little to no competition between physicians and
hospitals.56 However, this trend has begun to shift as physicians have become owners and
investors in surgical facilities such as ASCs and specialty hospitals that compete with the same
general hospitals to which the physicians traditionally have referred patients. Additionally, the
willingness of physicians to volunteer for responsibilities within a hospital has declined
significantly in recent years, marking another shift toward a more competitive and adversarial
relationship between physicians and hospitals.57

Hospitals
During the 1990s, the focus of managed care on the role of primary care physicians as
gatekeepers resulted in declined patient volumes for hospitals.58 Due in part to these reduced
patient volumes, hospitals began offering additional services and entering into the practice of
providing insurance and primary care services, taking on a powerful role as both provider and
insurer through integrated delivery systems.59 Declining patient volumes also prompted hospitals
to merge with each other so that they could leverage their consolidated bargaining power against
private insurers, in addition to competition from specialty providers.60 As time progressed,
concerns regarding access to capital have led to continued hospital consolidation,61 such that
smaller, typically nonprofit, hospitals are faced with the grim choice of going bankrupt or joining
52
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larger, for-profit hospital systems to survive and reduce costs through economies of scale and
other methods, as mentioned in the earlier Supply and Demand in Healthcare section.
Physician-Owned Healthcare Facilities
Physician-owned hospitals have long prompted debate due to their potential for ethical violations
related to physician referrals and the perception that these hospitals often cherry-pick and creamskim the most profitable patients and procedures.62 Despite contentions that the profits of general
hospitals have been negatively impacted as specialty hospitals have selectively siphoned off
more profitable services such as surgical and specialty procedures (e.g., orthopedic surgery,
cardiac services), there is no conclusive evidence to support this assertion.63 Further, physicianowned hospital proponents cite statistics indicating that patients often receive higher quality care
and are more satisfied with their care at physician-owned hospitals.64 Supporters have asserted
that action against physician ownership is counter-productive to the aims of healthcare reform,
i.e., to limit care facilities at the same time health insurance coverage is expanded to improve
access to care for a greater percentage of the U.S. population.65
Further, physicians who provide outpatient services receive only the physician fee component
reimbursement rate under the Medicare Physician Fee Schedule (MPFS).66 Conversely, when
procedures are performed in a hospital outpatient department (HOPD), hospitals (in the absence
of bundled payments) receive both the physician fee (with which they reimburse their doctors)
and the facility fee reimbursed under the OPPS rate.67 Although the payment differential between
HOPDs and ASCs is mostly standardized, the payment differential between services provided in
HOPDs or ASCs and services provided in physicians’ offices varies considerably by both payor
and service.68
Campaign Against Physician Ownership
As the physician ownership of hospitals and other healthcare facilities has increased, so has the
legislation restricting it. Incessant legislative and regulatory efforts have been undertaken at both
the federal and state levels due in large part to massive lobbying initiatives by oligopoly
hospitals (and their trade associations) to reverse the trend of physician investment in ancillary
services and technical component (ASTC) revenue stream enterprises, e.g., ASCs, IDTFs,
surgical/specialty hospitals, physical therapy, etc. These measures have served to relegate
independent physicians in private practice to receiving only professional fee component revenues
62
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65
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or to accept employee status under the substantial control of hospital systems or large corporate
players.
The Stark Law prohibits physicians from referring their patients to facilities in which they have a
financial interest.69 Historically, physicians were able to refer patients through the whole hospital
exception. This exception allowed physicians to perform certain services despite their financial
interest(s) as long as that financial interest was invested in the hospital generally and not in a
particular subdivision.70 Elimination of the Stark whole hospital exception was first introduced in
Section 651 of the 2007 U.S. House of Representatives Bill 3162 entitled, The Children’s Health
and Medicare Protection Act of 2007 (CHAMP). Although Section 651 of CHAMP was never
signed into law, Section 6001 of the ACA bans future physician-owned hospitals from forming
and, additionally, limits the expansion of existing facilities, effectively eliminating the use of the
whole hospital exception for any healthcare facility established after 2010.71
Additional legislative actions against physician ownership include:
(1) The November 20, 2007 New Jersey court holding in Health Net of New Jersey, Inc. v.
Wayne Surgical Center, LLC, that physicians who refer their patients to an ASC in which
they have an ownership interest violates the 1989 Codey Act prohibitions against selfreferral;72
(2) Stark III updates prohibiting “under arrangements” and “per click” leasing ventures; 73
(3) Various state tax acts (applicable only to ASCs, IDTFs, and cancer treatment centers),
whereby physicians subsidize care provided in hospitals; and
(4) CMS’s 2008 restrictions whereby IDTFs are no longer allowed to share practice
locations, operations, and diagnostic testing equipment with other Medicare-enrolled
providers, including leasing and subleasing agreements.74
Exclusionary Boycotts
In response to the threat from specialty hospitals, many community hospitals have also fought
back in ways that may be perceived as being in violation of antitrust laws. In situations when
specialty hospitals are owned in whole or in part by physicians with privileges on the medical
staff of a general acute care hospital and when the specialty hospital competes with the general
hospital either on an inpatient or outpatient basis, many general hospitals have engaged in
activities that attempt to shut the physician-owned healthcare enterprise out of the market. Some
of these practices include refusing to assist or cooperate with the enterprise, pressuring other
members of the medical staff or community physicians to not do business with the specialty
69
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hospital, pressuring payors to exclude specialty hospitals from their networks, and limiting or
terminating physician-investors’ privileges and medical staff membership (conflict of interest
credentialing).75 In response to these practices, some physician-owned healthcare enterprises
have initiated antitrust suits, claiming that general hospitals are engaging in illegal exclusionary
boycotts.76
Although courts have typically favored general hospitals that have tried to combat creamskimming by specialty hospitals, one notable case brought by Heartland Surgical Specialty
Hospital, a Kansas City–area hospital, in 2005 demonstrates that courts will not always overlook
anticompetitive behavior by hospitals. The specialty hospital filed an antitrust lawsuit alleging
horizontal conspiracies between multiple health plans and multiple hospitals, as well as vertical
conspiracies between the hospitals and payors directly, resulting in pressure on payors, as well as
direct agreements with them, to exclude the specialty service hospital from their networks.77 The
eventual settlement in this case demonstrates that antitrust laws still protect against entities with
market power from using that market power to pressure others (in this case, other hospitals and
payors) into agreeing to exclude a competitor from the market.78

Physicians
Competition in the healthcare industry operates predominantly at the level of hospitals, health
plans, and provider networks rather than at the level of healthcare delivery with an independent
practitioner.79 This has incentivized physicians to join together in one of many types of emerging
healthcare models so that they may improve their positioning vis-à-vis third-party payors.80
However, because physician manpower shortages are projected through the first quarter of this
century, the independent practice of medicine may become less common.
Consolidation with Other Physicians
There has also been a noticeable shift in competition among physicians in recent years.
Originally, many physicians operated as independent competitors, perhaps allied only with the
hospital(s) to which they referred patients.81 The more recent trend has been for physicians to
join networks with other physicians and to clinically integrate their services in an effort to lower
costs and improve quality.82 Managed care and reforms associated with the ACA have placed
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pressure on these organizations to reduce costs, maintain quality, and protect market share.83 A
key driver of physician integration has been the potential negotiating power it merits, namely for
contracting with hospitals and managed care organizations (MCOs).84 The independent
physician association (IPA) may be an extremely popular model, with the advent of ACOs and
favorable rulings regarding clinical integration.85
Manpower Shortage
In 1980, the Graduate Medical Education National Advisory Committee (GMENAC) projected a
surplus of 70,000 physicians in the year 1990 and a surplus of 145,000 physicians by 2000,
which led to the implementation of a cap on medical school enrollment to control supply of
physicians to the market.86 Due to tightly controlled managed care in the 1990s, the projections
of a physician surplus in the next decade were reaffirmed and the number of graduates per year
remained unchanged for nearly twenty-five years.87 As the Great Recession hit in 2008, the
physician workforce, like many other professions, experienced a shortage that is expected to
continue through the next decade, reaching a possible shortage of up to 90,000 physicians by the
year 2025.88 The shortage can be attributed to both the increased demand resulting from the
growing baby boomer population and the misaligned cap on medical school enrollment.
The physician workforce shortage is expected to continue through the next decade, reaching a possible a
shortage of 160,000 physicians by the year 2025.
Jeff Goldsmith, Feb. 15, 2012.

In its physician workforce assessment, despite a projected 14% increase in the demand for
primary care physician services by 2020, the U.S. Department of Health and Human Services
(HHS) noted that the primary care physician shortage is expected to continue.89 HHS attributed a
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Your Own Canoe” By Robert James Cimasi, Health Capital Consultants: St. Louis, MO, March 29, 2000.
“Industry Perspective: Best of Both Worlds—Physician Benefits of Joining Clinically Integrated Networks” By Lori Fox Ward, Valence
Health, http://valencehealth.com/uploads/files/Valence_Health_Industry_Perspective_Best_of_Both_Worlds.pdf (Accessed 3/31/15);
“Lessons From Market Competition in Healthcare: Love Everyone, Trust No One & Paddle Your Own Canoe” By Robert James Cimasi,
Health Capital Consultants: St. Louis, MO, March 29, 2000.
“The Basics of Independent Practice Associations” By Martin merritt, Physicians Practice, November 18, 2012,
http://www.physicianspractice.com/blog/basics-independent-practice-associations (Accessed 3/31/15); See generally “RE: Norman PHO
Advisory Opinion” By Markus H. Meier, Federal Trade Commission, February 13, 2013, http://www.ftc.gov/sites/default/files/documents/
advisory-opinions/norman-physician-hospital-organization/130213normanphoadvltr_0.pdf (Accessed 3/2/2015); For detail on each of these
types of physician integration models, see Chapter 6 of Consulting with Professional Practices.
“The Physicians Workforce: Projections and Research into Current Issues Affecting Supply and Demand” By U.S. Department of Health
and Human Services and Health Resources and Services Administration, December 2008, p. 3.
“Looming Shortage of Physicians Raises Concerns About Access to Care” By Mike Mitka, Journal of the American Medical Association,
Vol. 297, No. 10 (March 14, 2007), http://jama.ama-assn.org/cgi/content/full/297/10/1045 (Accessed 10/26/09) p. 1045-1046; “The
Complex Dynamics of the Physician Workforce: Projected Supply and Demand through 2025” By Michael J. Dill and Edward S. Salsberg,
Center for Workforce Studies, Association of American Medical Colleges, November 2008, p. 12.
“The Complexities of Physician Supply and Demand: Projectinos from 2013 to 2025: Final Report” IHS, Inc., March 2015,
https://www.aamc.org/download/426242/data/ihsreportdownload.pdf (Accessed 3/31/15), p. v.
“Projecting the Supply and Demand for Primary Care Practitioners Through 2020-In Brief” Bureau of Health Professions, Health Resources
and Services Administration, U.S. Department of Health and Human Services, November 2013, http://bhpr.hrsa.gov/
healthworkforce/supplydemand/usworkforce/primarycare/primarycarebrief.pdf (Accessed 3/25/15) p. 2.
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significant portion of this growth in demand to specialties that care for elderly patients, e,g.,
cardiology and internal medicine.90 Despite the growing need for primary care physicians,
interest in the field from medical students remains low.91 Lower incomes, less prestige, and
difficult workloads are all listed as major factors in medical students’ decision to enter specialties
instead of primary care, and rural areas in particular are seen as nonviable locations for physician
practices.92 In addition to a declining supply of new primary care physicians, the existing
workforce is anticipated to experience a significant shift over the next two decades as the baby
boomer population of physicians is likely to retire in the near-term, with many of the soon to be
retirees being primary care physicians.93 Combined with an aging population and healthcare
reform’s significant expansion in access to care, the strain on the physician workforce is rapidly
becoming untenable.
Primary care is one of the practice areas suffering most from the physician shortage, which likely
can be attributed to the gap in pay between primary care physicians and specialists.94 Further
exacerbating this particular shortage is the focus of medical schools on advanced specialization
arising from low reimbursement rates for academic medical centers (AMCs). As a result, AMCs
are forced to rely on higher reimbursement rates for training by subspecialists, leading to a focus
on subspecialties.95 Additionally, many surgeons have specialized so much that they do not feel
qualified to provide emergency services, with some surgeons only providing outpatient care.96
Furthermore, today's physicians are seeking a greater work-life balance than those in the past,
and this work-life balance only exacerbates the problem of physician shortage.97 In the future, a
greater emphasis on flexible hours may be the key to maintaining satisfaction for both patients
and physicians.98 The healthcare industry has begun to address anticipated primary care
shortages by establishing new medical schools and residency programs, some of which
specifically promote a primary care focus. In 2006, the Association of American Medical
Colleges (AAMC) set a goal to increase medical school enrollment 30% by 2015 (based on 2002
enrollment statistics).99 Current studies suggest the enrollment goal was almost met, as medical
schools saw a 29.5% increase in enrollment, 85 spots shy of the targeted 30% goal.100 The
projected growth in medical school enrollment is anticipated to be attributed to current (two90

“The Physicians Workforce: Projections and Research into Current Issues Affecting Supply and Demand” By U.S. Department of Health
and Human Services and Health Resources and Services Administration, December 2008, p. iv, 59.
91 “Why is There a Shortage of Primary Care Doctors?” Association of American Medical Colleges, https://www.aamc.org/
linkableblob/70310-6/data/primarycarefs-data.pdf (Accessed 6/30/12).
92 “Why is There a Shortage of Primary Care Doctors?” Association of American Medical Colleges, https://www.aamc.org/linkableblob/
70310-6/data/primarycarefs-data.pdf (Accessed 6/30/12); “Rural Research Focus: Rural Physician Shortages” By George E. Wright et al.,
Health Resources and Services Administration, ftp://ftp.hrsa.gov/ruralhealth/RRF-RHHA.pdf (Accessed 6/30/12).
93 “Why is There a Shortage of Primary Care Doctors?” Association of American Medical Colleges,
https://www.aamc.org/linkableblob/70310-6/data/primarycarefs-data.pdf (Accessed 6/30/12). “The Future of Medical Practice: Creating
Options for Practicing Physicians to Control Their Professional Destiny” By Jeff Goldsmith, The Physicians Foundation, Feb. 15, 2012,
http://www.physiciansfoundation.org/uploads/default/Physicians_Foundation_Future_of_Medical_Practices.pdf (Accessed 3/25/15)
p. 48-50.
94 “Match Day: High-Paid Specialties Still IN, Primary Care Still Out” By Jacob Goldstein, Wall Street Journal Blogs, (March 19, 2009),
http://blogs.wsj.com/health/2009/03/19/match-day-high-paid-specialties-still-in-primary-care-still-out/ (Accessed 03/27/09).
95 “Fewer Medical Students Choose Family Medicine in 2009 Match” By Barbara Bein, American Academy of Family Physicians, March 19,
2009, http://www.aafp.org/online/en/home/publications/news/news-now/resident-student-focus/20090319match.html (Accessed 3/27/09).
96 “Statement on the Surgical Workforce” American College of Surgeons, Bulletin of the American College of Surgeons, Vol. 92, No. 8,
(August 2007), Accessed at http://www.facs.org/fellows_info/statements/st-57.html (Accessed 5/10/10).
97 See Chapter 6: Healthcare Reform; “Wanting It All: A New Generation of Doctors Places Higher Value on Work-Life Balance” By Eve
Glicksman, AAMC Reporter, May 2013, https://www.aamc.org/newsroom/reporter/336402/work-life.html (Accessed 3/28/15).
98 Ibid.
99 “Results of the 2011 Medical School Enrollment Survey” Association of American Medical College, Center for Workforce Studies, May
2012, p. 4.
100 “Results of the 2013 Medical School Enrollment Survey” Association of American Medical Colleges, Center for Workforce Studies, March
2014, https://members.aamc.org/eweb/upload/13-239%20Enrollment%20Survey%20201310.pdf (Accessed 3/25/15), p. 3.
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thirds) as well as new (one-third) medical schools.101 In response to the pending shortage and the
AAMC goal, 16 institutions were granted some form of accreditation as of March 2014,102 a
stark contrast to the period between 1980 and 1990, where no new medical schools were
established (due to the GMENAC report).103 While academic institutions may be motivated by
the prestige a medical school affiliation may lend to both the university and the surrounding
community,104 the establishment of new sources of physicians may also positively impact the
physician manpower shortage. In addition to the development of new medical schools, some
existing facilities have established broader primary care programs in rural communities to
address access to care and physician shortage issues, e.g., the University of Kansas School of
Medicine north-central campus rural program and the Columbia University College of Physicians
and Surgeons Columbia-Basset rural program, both established in 2011.105
The historical and projected increase in the perceived physician shortage is illustrated below in
Figure 4-1.
Figure 4-1: Physician Supply and Demand106

The physician manpower shortage is not projected to be restricted to primary care. A comparison
between the perceived physician shortage for both primary and specialist care is illustrated below
in Figure 4-2.

101 “Results of the 2013 Medical School Enrollment Survey” Association of American Medical Colleges, Center for Workforce Studies, March
2014, https://members.aamc.org/eweb/upload/13-239%20Enrollment%20Survey%20201310.pdf (Accessed 3/25/15), p. 3.
102 For standards to become a medical school see “Functions and Structure of a Medical School” Liaison Committee on Medical Education,
http://www.lcme.org/publications/2015-16-functions-and-structure-march-2014.doc (Accessed 3/28/15).
103 “New Medical Schools in the United States” By Michael E. Whitcomb, New England Journal of Medicine, Vol. 362, No. 14, April 8, 2010,
p. 1255-56.
104 Ibid, p. 1258.
105 “More Medical Schools Boost Primary Care Doctors Through Small-Town Campuses” By Gina Shaw, AAMC Reporter, Association of
American Medical Colleges, July 2012, https://www.aamc.org/newsroom/reporter/july2012/297208/small-town.html (Accessed 8/14/2012).
106 “Physician Shortages to Worsen Without Increases in Residency Training” Association of American Medical College, 2010,
https://www.aamc.org/download/286592/data/physicianshortage.pdf (Accessed 8/2/2012).
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Figure 4-2: The Physician Shortage for Both Primary and Specialist Care107

These projections and subsequent concerns regarding patient access to care have prompted
several initiatives, including: (1) increased funding incentives for primary care students
(contained within the ACA); (2) increased incentives for physician movement to rural and
underserved areas (contained within the ACA); and (3) less restrictive scope of practice laws for
midlevel providers (i.e., various state laws allowing the unsupervised practice of medicine by
physician assistants, nurse practitioners, and certified registered nurses).
The current and impending physician manpower shortage paired with declining reimbursement
rates has fueled physician demand for manpower relief. To meet this demand, the healthcare
workforce continues to diversify, with versatility no longer limited to the horizontal expansion of
specialty and subspecialty areas of medical expertise. Rather, current trends have solicited a
vertical expansion in the role of the non-physician workforce to provide services that support,
supplement, and parallel physician services. Midlevel providers are afforded a significant level
of autonomy within their scope of practice, which authorizes them to act not only incident-to, but
also in lieu of, physicians under certain conditions, and for the provision of previously
determined services.108 The degree of practice autonomy typically differs from state to state and
for each type of midlevel provider.109 In the next few years, the midlevel provider population is
expected to continue to grow in both scope and volume. From 1987 to 1997 alone, the number of
patients treated by non-physician providers grew to 1.4 times the original amount.110 According
to a 2009 Office of Inspector General (OIG) report, 51% of Medicare-billed physician services
107 “Physician Shortages to Worsen Without Increases in Residency Training” Association of American Medical College, 2010,
https://www.aamc.org/download/286592/data/physicianshortage.pdf (Accessed 8/2/2012).
108 “Interprofessional Healthcare: A Common Taxonomy to Assist with Understanding,” by Alice B. Aiken, PT, PhD and Mary Ann McColl,
PhD, Journal of Allied Health, Volume 38, Number 3 (Fall 2009), p. e-94.
109 “Health and Health Care 2010: the Forecast, The Challenge”, by the Institute for the Future and the Robert Wood Johnson Foundation,
Princeton, NJ: Jossey-Bass, 2003, p. 108; “Report of the Council on Medical Service: Ratio of Physician to Physician Extenders”, presented
by Kay K. Hanley, December 1998, p. 1; For a further discussion of midlevel providers, see Chapter 8 of Consulting with Professional
Practices.
110 “Trends in Care by Nonphysician Clinicians in the United States” By Benjamin G. Druss et al., The New England Journal of Medicine, Vol.
348, No. 2, 2003, p. 134.
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that exceed a 24-hour workday were actually performed by qualified non-physician practitioners
(i.e., midlevel providers which may have been performing “incident to” services).111 Further, the
services provided by non-physician clinicians (both qualified and non-qualified) over a threemonth period totaled approximately $85 million in Medicare claims.112

DEMAND: THIRD-PARTY PAYORS AND CONSUMER-DRIVEN
HEALTHCARE
Although Chapter 2, Reimbursement Environment, provides an extensive discussion of thirdparty payor reimbursement, it is important to understand the significant power of third-party
payors as purchasers of healthcare services. Insurers essentially hold all the cards when dealing
with both providers and patient-consumers. Although there will always be a significant amount
of patient demand, how that demand affects the market is affected by the existence of an
intermediary between supplier and consumer that takes most of the purchasing burden off the
consumer and, as a result, eliminates traditional demand forces that work in other markets to
keep prices at reasonable levels.

Insurance and Managed Care
With regard to demand, as noted in the FTC's and DOJ's 2004 report entitled, "Improving Health
Care: A Dose of Competition," the presence of third-party payors in the healthcare industry may
be capable of distorting the traditional supply and demand model by shifting the risks associated
with ill health from patient (consumer) to a third party that pays for the management of those
risks.113 By shifting that risk, consumers are insulated from the cost of the services needed to
manage their health and, therefore, do not make entirely informed choices when balancing costs
and benefits, resulting in an imperfect demand curve.114 Conversely, insurance companies bear
the costs associated with healthcare services, but generally do not capture the full benefits, which
may further discredit the application of a traditional supply and demand model to the healthcare
competitive market.115
Health insurance has previously affected the healthcare marketplace by offering misaligned
incentives to physicians who are reimbursed by third-party payors at levels that do not reflect
quality of care, but rather focus mainly on the procedural volumes.116 As a result, physicians
were neither rewarded nor punished based on the quality of their work.117 This insulated
physicians from traditional competitive forces that force low-performing participants out of other
markets.118 However, recent changes encourage providers to place quality over quantity in
regards to patient treatment. Previous payment systems rewarded physicians for the number of
procedures performed, thus encouraging overuse and overspending, but the new system of value111 “Prevalence and Qualifications of Nonphysicians Who Performed Medicare Physician Services” Office of the Inspector General, August
2009, p. 8.
112 Ibid.
113 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Executive
Summary, p. 5.
114 Ibid.
115 Ibid.
116 Ibid.
117 Ibid.
118 Ibid.
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based purchasing scores physician performance with quality considerations to determine
payment for services.119
MCOs, such as HMOs and PPOs, also can distort the traditional competitive marketplace model
by integrating the financing and delivery of healthcare services under the administration of one
organization.120 MCOs may be attractive to consumers because they offer lower premiums,
deductibles, and co-payments than traditional third-party payors.121 However, MCOs also take
many choices out of a patient’s hands by creating restricted networks of providers from which
the insured must choose in order to obtain those lower prices.122 One way of reducing the cost of
care employed by MCOs is to contract with select physicians who agree to lower costs in order
to be admitted to the MCO’s provider network. In this way, MCOs force price competition
between providers, which allows them to negotiate volume discounts with providers, something
that would not be possible for individual consumers to do on their own.123 This same approach is
used by narrow networks that contract with a select number of physicians to keep costs low for
consumers and the network itself.124
However, when the popularity of more restrictive forms of managed care began to wane at the
end of the twentieth century, flexibility began to re-emerge in managed care, which has reintroduced traditional supply and demand back into the health industry. As the popularity of
point-of-service (POS), PPOs, and pay-for-performance (P4P) plans has grown, patients have
been able to once again take a more active role as consumers in the healthcare marketplace.125
POS plans mandate that patients use a primary care gatekeeper, but allow patients to use out-ofplan specialty physicians for some services; PPOs allow patients to choose out-of-plan providers
listed as preferred providers without the need for a gatekeeper.126
MCOs are beginning to push their way into smaller markets, offering broader provider networks
in the process. In recent years, there has been a shift in the consolidation of healthcare entities.
Historically, mergers were motivated by financial necessity, wherein they had to merge to
survive, but new mergers are often motivated by strategy, 127 meaning that entities are finding it
more important to merge to increase their market share of a field or spread costs. Many states

119 “Hospital Value-Based Purchasing” Centers for Medicare and Medicaid Services, http://www.medicare.gov/hospitalcompare/Data/hospitalvbp.html?AspxAutoDetectCookieSupport=1 (Accessed 3/28/15); See Chapter 2: Reimbursement Environment.
120 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Executive
Summary, p. 11.
121 Ibid.
122 Ibid.
123 Ibid.
124 “Providers, Advocates, Seek Tougher Rules on Network Adequacy” By Paul Demko, Posted on Modern Healthcare,
http://www.modernhealthcare.com/article/20141120/NEWS/311209971/providers-advocates-seek-tougher-rules-on-networkadequacy?CSReferrer=accessControl-modernhealthcare-metered (Accessed 3/28/15).
125 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Executive
Summary, p. 12.
126 Ibid.
127 “Mergers and Acquisitions in the Health Care Industry Hit Highest Volume Since 2007”Managed Care Outlook, Vol. 26, No. 24, December
15, 2013, p. 6.
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have approximately three insurers that insure more than half of the individual, small, and large
group markets.128
The state health insurance exchange (HIE) provision of the ACA (which became effective in
2014) is designed to have a significant impact on competition between private payors by
providing patients with an online portal on which to compare various options for coverage.
Although these exchanges were under contention by many states, the U.S. Supreme Court’s
decision upholding the constitutionality of the ACA, and specifically the individual mandate
provision, has insured that these managed competition marketplaces will be fully implemented in
2014.129 At this time, 13 states and the District of Columbia have established state-based
exchanges, three states have established federally-supported marketplaces, and seven have
established state-partnership marketplaces,130 while the remaining twenty-seven state exchanges
are run by the federal government.131 The validity of these federally-run state exchanges has
come under scrutiny recently in the case of King v. Burwell; however, on June 25, 2015, the
Supreme Court upheld the legality of health insurance subsidies for these exchanges.132

Public Payors
Prior to 1983, Medicare and most private insurers reimbursed providers on a fee-for-service
(FFS) basis, which paid hospitals and physicians based on the cost and the number of services
they provided.133 Beginning in 1983, however, CMS adopted the hospital Inpatient Prospective
Payment System (IPPS) as a means of combating rising costs associated with FFS.134 The IPPS
reimbursed hospitals based on the DRG of the patient’s diagnosis at the time he or she was
discharged, which reflected the average cost of treating patients in that DRG.135 By reimbursing
hospitals at this fixed amount, the IPPS introduced a more competitive, market-like environment
for hospital reimbursement and encouraged hospitals to reduce costs so that procedures remained
profitable.136 Similarly, the hospital Outpatient Prospective Payment System (OPPS) was
implemented in 2000 to accomplish the same competitive environment for outpatient procedures
by reimbursing hospitals based on a number of Ambulatory Payment Classifications (APCs).137
In the past few years, public payors have placed a greater emphasis on quality of services, with
payment structures reflecting that change. This has been particularly emphasized with the value128 “Market Share and Enrollment of Largest Three Insurers—Individual Market” The Henry J. Kaiser Family Foundation, 2013,
http://kff.org/other/state-indicator/market-share-and-enrollment-of-largest-three-insurers-individual-market/ (Accessed 4/1/15); “Market
Share and Enrollment of Largest Three Insurers—Small Group Market” The Henry J. Kaiser Family Foundation, 2013,
http://kff.org/other/state-indicator/market-share-and-enrollment-of-largest-three-insurers-small-group-market/ (Accessed 4/1/15); “Market
Share and Enrollment of Largest Three Insurers—Large Group Market” The Henry J. Kaiser Family Foundation, 2013,
http://kff.org/other/state-indicator/market-share-and-enrollment-of-largest-three-insurers-large-group-market/ (Accessed 4/1/15).
129 “After ACA Ruling, HHS Moves Ahead with Insurance Exchanges” by Jennifer Lubell, American Medical Association, July 6, 2012,
(Accessed 7/9/2012).
130 “State Health Insurance Marketplace Types 2015” Kaiser Family Foundation, November 2014, http://kff.org/health-reform/stateindicator/state-health-insurance-marketplace-types/ (Accessed 3/25/15);“Establishing Health Insurance Exchanges: An Overview of State
Efforts” Kaiser Family Foundation, Publication #8213, August 2012, p. 1.
131 State Health Insurance Marketplace Types 2015” Kaiser Family Foundation, November 2014, http://kff.org/health-reform/stateindicator/state-health-insurance-marketplace-types/ (Accessed 3/25/15).
132 See chapter 6 Healthcare Reform; “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015),
Slip Opinion, p. 4, 21.
133 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Executive
Summary, p. 8.
134 Ibid, p. 9.
135 Ibid, p. 9.
136 Ibid, p. 9.
137 Ibid, p. 9.
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based purchasing program, healthcare-associated infection reduction efforts, and hospital
readmission and reduction programs.138

Consumer-Driven Healthcare
Third-party payors deflect a substantial portion of the true cost of services away from the
consumer (i.e., the patient).139 However, the rise of consumer-driven healthcare (CDHC)
indicates that healthcare markets may be shifting away from the traditional model and that the
market distortion which arises out of the third-party payor system may be beginning to
dissolve.140 A significant competitive trend in health insurance is the rise of individual, highpremium insurance plans coupled with HSAs as well as narrow network plans to accommodate
low-income consumers or employers looking to limit healthcare costs.141
However, the rise of Consumer-Driven Healthcare (CDHC) shows that healthcare markets may be shifting
away from the traditional model and that the market distortion which arises out of the third-party payor system
may be beginning to dissolve.
Stuart H. Altman, David Shactman, and Efrat Eilat, Jan/Feb 2006.

CDHC is a growing trend based on neoclassical economic theory and studies that have shown
that insured individuals with higher deductibles tend to purchase less healthcare services than
insured individuals with low deductibles.142 CDHC advocates the idea that consumers who pay
for services directly are more likely to compare price to quality and demand higher-quality care,
a theory which supports the use of HSAs coupled with HDHPs.143 Generally, HSAs are
personalized accounts into which an individual (and possibly an individual's employer)
contributes. The individual then may withdraw funds to cover healthcare expenses.144 HSAs put
the purchasing power directly into the hands of the patient, who may use the tax-free funds to
cover basic qualified medical expenses, including preventive care and over-the-counter drugs.145
HDHPs are then used in the traditional insurance context to pay the costs associated with
catastrophic events like trauma and chronic disease.146 Proponents of CDHC encourage the
implementation of narrow networks to create small provider networks at a lower cost for

138 “Linking Quality to Payment” Centers for Medicare and Medicaid Services, http://www.medicare.gov/hospitalcompare/linking-quality-topayment.html (Accessed 3/28/15); See Chapter 2: Reimbursement Environment.
139 “Healthy Competition: What’s Holding Back Healthcare and How to Free It” By Michael F. Cannon and Michael D. Tanner, Cato Institute,
2007, p. 46-47; “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004,
Executive Summary, p. 5.
140 See Chapter 2: Reimbursement Environment.
141 “Could U.S. Hospitals Go The Way Of U.S. Airlines?” By Stuart H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol. 25,
No. 1 (January/February 2006), p. 16; “2014 Employer Health Benefit Survey” Kaiser Family Foundation, September 10, 2014,
http://kff.org/report-section/ehbs-2014-summary-of-findings/ (Accessed 3/25/15).
142 “Is Health Insurance a Bad Idea? The Consumer-Driven Perspective” By Timothy Stoltzfus Jost, Connecticut Insurance Law Journal,
Vol. 14 (Spring 2008), p. 378-379; “The Health Insurance Experiment: A Classic RAND Study Speaks to the Current Health Care Reform
Debate” RAND Health, http://www.rand.org/pubs/research_briefs/2006/RAND_RB9174.pdf (Accessed 10/27/09), p. 2.
143 “Is Health Insurance a Bad Idea? The Consumer-Driven Perspective” By Timothy Stoltzfus Jost, Connecticut Insurance Law Journal,
Vol. 14 (Spring 2008), p. 379-80.
144 “All About HSAs” U.S. Treasury Department, July 22, 2007, http://www.treas.gov/offices/public-affairs/hsa/pdf/all-aboutHSAs_072208.pdf (Accessed 07/01/09), p. 2.
145 Ibid.
146 “Is Health Insurance a Bad Idea? The Consumer-Driven Perspective” By Timothy Stoltzfus Jost, Connecticut Insurance Law Journal,
Vol. 14 (Spring 2008), p. 380.
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consumers.147 These narrow networks are capable of great success if regulations can be
implemented to ensure that the provider plans are not so small as to be inefficient for
consumers.148 The idea is that consumers with narrow networks will have essential providers
included in their network but with little provider-variety and a potential lack of providerspecialization.149
Although proponents of CDHC argue that the use of HSAs and HDHPs will promote better
analysis of cost and quality at the point of service,150 skeptics argue that there is not enough
evidence to demonstrate that CDHC leads to better informed choices based on quality.151
Nonetheless, CDHC plans have the capacity to alter the traditional healthcare marketplace,
which has become accustomed to the third-party payor system. The mere existence of CDHPs
may alter the healthcare industry landscape to look more like markets in other industries in
which consumers make purchasing decisions and more carefully scrutinize what they receive for
their money. Additionally, by making consumers more aware of the actual cost of procedures,
this trend may affect the ability of hospitals to cross-subsidize for costly care.152

BARRIERS TO FREE MARKET COMPETITION IN
HEALTHCARE DELIVERY
Perfectly competitive markets exist only in economic theory. In reality, industries and markets
have varying constraints on competition. The healthcare industry has often been characterized as
unique in its numerous significant barriers to free market competition. Much of the inhibition
from market controls on price and quality result from factors that can be expressed in three
general categories:
(1) The nature of health creates an unpredictable, urgent, and infinite level of demand;
(2) The ubiquitous involvement of insurance, both private and governmental, as an
intermediary in the purchase of healthcare services interferes with consumer motivations
and consequently their choice of providers and services; and
(3) The difficulties in measuring healthcare quality and beneficial outcomes (both of
quantifying and qualifying outcomes data) and the lack of information related to the
relative costs of healthcare providers and services also inhibits consumer selection,
further removing incentives to providers to increase quality and lower costs.
More specific examples of barriers to competition in healthcare delivery are provided below, in
Table 4-1.
147 “Narrow Provider Networks in New Health Plans: Balancing Affordability with Access to Quality Care” By Sabrina Corlette, et al., Report
for The Center of Health Insurance Reforms and the Urban Institute, May 2014, Robert Wood Johnson Foundation, p. 1.
148 Ibid.
149 “Narrow Provider Networks in New Health Plans: Balancing Affordability with Access to Quality Care” By Sabrina Corlette, et al., Report
for The Center of Health Insurance Reforms and the Urban Institute, May 2014, Robert Wood Johnson Foundation, p. 1, 3.
150 “Is Health Insurance a Bad Idea? The Consumer-Driven Perspective” By Timothy Stoltzfus Jost, Connecticut Insurance Law Journal,
Vol. 14 (Spring 2008), p. 379-80.
151 Ibid, p. 383.
152 “Could U.S. Hospitals Go The Way Of U.S. Airlines?” By Stuart H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol. 25,
No. 1 (January/February 2006), p. 17.
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Table 4-1: Barriers to Competition in Healthcare
Patients Do Not Purchase Services Directly from Providers
Patients
Patients Do Not Compare Prices Between Providers
The Government is the Largest Purchaser of Healthcare
Payors
Private Purchasers Often Lack Market Power
Many Providers Have Monopoly or Near Monopoly Power (Yet Antitrust
Laws Prevent Some Potentially Beneficial Integration)
Providers Are Rewarded for Increasing Costs
Providers
Capital Investments Are Overly Subsidized
Certificate of Need, Regulation, and Licensing Laws are an Entry Barrier to
Competing and Substitute Providers and Services
Exit Barriers Protect Low Quality Providers
Patients, Purchasers, and Providers Lack Information

DIFFICULTIES IN MEASURING QUALITY AND OUTCOMES
As discussed above, the difficulties in measuring healthcare quality and beneficial outcomes and
the lack of information related to the relative costs of healthcare providers and services inhibits
consumer selection. However, as transparency initiatives and electronic health record (EHR)
technologies become more common, the difficulties associated with measuring quality and
outcomes may diminish. More significantly, the current spread of VBP initiatives, which tie
reimbursement to quality metrics, will likely incentivize providers to utilize those health
information technologies (HIT) more so than the mere existence of HIT. CMS is funding many
of these incentives through the Hospital VBP program, which makes distributions to hospitals
for inpatient acute care services based upon quality performance measurements.153 The hospital
VBP program continues to undergo changes as CMS determines the best ways to allocate
payments and measure quality of services. In August 2014, CMS announced the 2015 IPPS Final
Rule, which includes new policies specifically for 2017 and 2018-2020.154

THE APPLICATION OF PORTER’S FIVE FORCES TO HOSPITALS AND
PHYSICIAN GROUPS
Michael Porter, a Harvard Business School professor, is considered by many to be one of the
leading international authorities on competitive strategy and international competitiveness. Porter
asserts that all businesses must respond to five competitive forces: (1) the threat of new market
entrants; (2) the bargaining power of suppliers; (3) threats from substitute products or services;
153 “Hospital Value-Based Purchasing” Centers for Medicare and Medicaid Services, December 18, 2014 https://www.cms.gov/Medicare/
Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html?redirect=/hospital-value-based-purchasing/
(Accessed 3/26/15).
154 “Hospital Value-Based Purchasing” Centers for Medicare and Medicaid Services, December 18, 2014 https://www.cms.gov/Medicare/
Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html?redirect=/hospital-value-based-purchasing/
(Accessed 3/26/15); “Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term
Care Hospital Prospective Payment System and Fiscal Year 2015 Rates; Quality Reporting Requirements for Specific Providers;
Reasonable Compensation Equivalents for Physician Services in Excluded Hospitals and Certain Teaching Hospitals; Provider
Administrative Appeals and Judicial Review; Enforcement Provisions for Organ Transplant Centers; and Electronic Health Record (EHR)
Incentive Program; Final Rule” Federal Register Vol. 79, No. 163 (August 22, 2014) p. 49864, 50048, 50055-87; A further discussion of
value-based reimbursement can be found in Chapter 2: Reimbursement Environment.
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(4) the bargaining power of buyers; and (5) rivalry among existing firms.155 A visual depiction of
the five fundamental forces of competition is set forth in Figure 4-3, below. When attempting to
understand competitors and select competitive strategies, a review of these five forces may be
useful to understand the underlying fundamentals of competition.156
Exhibit 4-3: Porter’s Five Forces157

Healthcare often is described as being different from other industries for a number of reasons
including the:
(1)
(2)
(3)
(4)
(5)

Large role of governmental regulation and reimbursement;
Seemingly limitless demand for healthcare;
Necessity of having local providers;
Absence of normal consumer motivation due to the use of third party payors; and
Difficulties in quantifying health and the quality and costs of care.

However, these differences may be found individually in other industries and, increasingly, the
barriers to competition in healthcare are under pressure to be removed, diminished, or altered
155 “Competitive Strategy: Techniques for Analyzing Industries and Competitors” By Michael E. Porter, New York, New York: The Free
Press, 1980, p. 4.
156 “Competitive Strategy: Techniques for Analyzing Industries and Competitors” By Michael E. Porter, New York, New York: The Free
Press, 1980, p. 4.
157 Ibid.
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because of rising costs. Therefore, Porter’s five forces model may well be applicable to
healthcare just like any other industry.158 Porter has further explored the value of his model as a
process or framework for use when examining competition in healthcare.159
Because Porter’s model applies to a company operating within a given industry, it is necessary to
define “healthcare industry,” which contains numerous subsets interacting with each other
including, among others, hospitals, nursing homes, medical practices, home health agencies, subacute providers, ASCs, and urgent care centers. The totality of these facilities and providers,
along with the administrators, equipment suppliers, pharmaceutical companies, and other support
and managerial providers may be considered for this exercise in definition, because they share
the common goal of maximizing human health. While this is not an easily quantifiable outcome,
it can be viewed as the common denominator among all the factions in the healthcare industry,
and advances are being made in the sciences of quality and outcomes research.
A hospital that does not acknowledge the local independent family medical practice or
cardiology group as working in the same industry as a competitor (as well as a customer) may
have missed the point. There is a complex relationship between the various subsets of the
healthcare industry and any competitive evaluation should assess this relationship from several
different perspectives.
Porter recommends three generic strategies to out-perform competitors or maintain a market
position against competition: (1) overall cost leadership; (2) differentiation; and (3) market niche
or segmentation.160 Each of these is a strategy that has a different set of ethical considerations
related to its application by healthcare providers in a care and treatment environment.

Threat of New Market Entrants
Historically, many hospitals and physicians believed that there was a low risk (or even no risk)
of new market competitors due to the entry barriers in their segments of the industry. Healthcare
has been viewed as a localized industry because providers must personally administer services to
their patients. In the current healthcare environment, however, new entrants do not necessarily
compete within their local market. Advances in technology and communication, as well as the
ability to recruit providers nationally, are changing some aspects of the direct physician–patient
relationship, such that this emphasis on localized competitive markets is no longer universal or
absolute.161
Overall, the threat from new market entrants may be related to the size of the financial return in
that particular segment of the industry. Traditionally, healthcare has differed from many
industries because financial return does not always drive the decision process. The goals of
education, charity, and community service make some healthcare business decisions appear
economically or financially irrational. The interest(s) held by society in the consolidation and
158 “Making Competition in Health Care Work” By Elizabeth Olmsted Teisberg et al., Harvard Business Review, July/August, 1994,
http://hardvardbusinessonline.hbsp.harvard.edu/hbsp/hbr/articles/article.jsp?artilcleID=9440, (Accessed 09/11/08), p. 140.
159 Ibid.
160 “On Competition” By Michael E. Porter, Boston, MA: Harvard Business School Publishing, 2008, p. 53; See generally “Making
Competition in Health Care Work” By Elizabeth Olmsted Teisberg et al., Harvard Business Review, July/August, 1994,
http://hardvardbusinessonline.hbsp.harvard.edu/hbsp/hbr/articles/article.jsp?artilcleID=9440 (Accessed 09/11/08).
161 See Chapter 5: Technological Development.
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creation of new market entrants is a positive social externality. The value a new entrant conveys
to society can be defined as the perceived future benefits that the entrant will contribute to the
U.S. population, or a sub-population. When identifying and establishing the scope of a positive
social externality within a large external group, the appropriate selection of defined measures of
comparison (e.g., benchmarking health outcomes against industry norms and historical trends)
that must be in place to quantify the value added by such entrants is especially important.
Benchmarks for patient populations before and after its creation on a national and/or regional
level are useful in determining the existence of statistically significant evidence of improved
population health outcomes, which can be utilized as an indication of a new market entrant’s
societal value.
Boutique and Concierge Medicine
Concierge, or boutique, medical practices began in 1996 in Seattle and are now in several major
metropolitan areas. Concierge medical practices are concentrated principally on the East and
West coasts, with most practices focused on providing primary care services.162 Concierge
medicine is basically a return to old fashioned medicine, in which physicians limit their client
base and devote more time to each patient.163 Patients usually can see their physician within a
day of requesting an appointment, and most have twenty-four-hour access to their physician by
cell phone. Concierge medical practices typically charge patients an annual retainer fee, which
provides for guaranteed, around-the-clock access to standard healthcare services, as well as an
increased access to personalized physician care.164 Physicians, tired of working long hours, not
having enough time with their patients, and dealing with overbooked caseloads, are turning to
concierge medicine as a way of balancing their work and their life and providing quality care for
their patients.165 Patients who have physicians in this type of practice appreciate the perks
received in exchange for a yearly fee—similar to annual membership dues. These fees can range
anywhere from $60 to $15,000 per year depending on a variety of factors such as patient age,
benefits received, residence location, and type of practice.166 Amenities vary by practice, but
some include more time with the physician (e.g., a thirty-minute office visit), increased access to
physicians, newsletters or condition-specific information sent by e-mail, wellness planning, and
house calls.167
Although concierge medicine may provide many benefits for patients, including more, and in
some cases nearly unlimited, access to their physicians, it has been met with some scrutiny.
Some say that this type of medicine is elitist—that it is available only to wealthy patients who
can pay the annual fees.168 However, many concierge clinics appeal to middle-income people
who are willing to pay for the immediacy of physician services, and many charge low rates in

162 “Physician Services: Concierge Care Characteristics and Considerations for Medicare (GAO-05-929)” By the U.S. Government
Accountability Office, For Congressional Committees, August 2005, p. 3.
163 For more information, see Chapter 2: Reimbursement Environment and Chapters 7 and 8 of Consulting with Professional Practices.
164 “Impact of Concierge Care on Healthcare and Clinical Practice” By Anthony J. Linz, DO et al., Journal of the American Osteopathic
Association, Vol. 105, No. 11 (November 2005), p. 515.
165 Ibid.
166 “Physician Services: Concierge Care Characteristics and Considerations for Medicare (GAO-05-929)” By the U.S. Government
Accountability Office, For Congressional Committees, August 2005, p. 4.
167 “The Three Faces of Retainer Care” By Frank Pasquale, Yale Journal of Health Policy, Law, and Ethics , Vol. 7, No. 1 (March 3, 2013)
http://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1142&context=yjhple (Accessed 3/26/15), p. 60-61.
168 Ibid, p. 40.
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exchange for cash.169 Concierge medicine can be a substitute for traditional insurance, but
patients typically keep their traditional health insurance to pay for any tests or scans ordered by
the concierge physician.170 Medicare beneficiaries cannot be charged more than 115% of the rate
for services,171 and many politicians have said that the annual fee requirement is significantly
greater than the Medicare rate and, consequently, is illegal billing.
Certificate of Need
A Certificate of Need (CON) program is one in which government determines where, when, and
how capital expenditures will be made for public healthcare facilities and major equipment.172
By their very nature, CON programs are anticompetitive, a principle that serves as, de minimis,
part of the rationale for the inception of state CON programs, in response to concern that market
forces were not adequate to prevent providers from overinvesting in equipment and facilities and,
as a result, driving up the cost of healthcare.173 Various shifts in the healthcare industry in the
years since CON legislation was introduced have fueled disputes against the implementation of
CON programs in order to avoid excess capacity.174
A central argument against CON regulatory policy is that intervention disrupts the natural market
forces and is significantly anticompetitive. As a result, CON often serves as a barrier to new
market entrants and has been viewed by many healthcare economists as a strong disincentive to
the introduction of potentially advantageous innovations and technologies. As stated by
Elizabeth Teisberg and Michael Porter, in any industry:
"…the underlying dynamic is the same: competition compels companies to
deliver increasing value to customers. The fundamental driver of this continuous
quality improvement and cost reduction is innovation. Without incentives to
sustain innovation in [healthcare], short-term cost savings will soon be
overwhelmed by the desire to widen access to care, the growing health needs of
an aging population, and the unwillingness of Americans to settle for anything
less than the best treatments available. Inevitably, the failure to promote
innovation will lead to lower quality or more rationing of care—two results
viewed as equally undesirable results."175
This assertion resembles the continuing consensus among health economic analysts that
competition between providers drives patient quality of care and beneficial outcomes and acts as
169 “Pros and Cons of Concierge Medicine” By Jen Wieczner, The Wall Street Journal, November 10, 2013, http://www.wsj.com/articles/
SB10001424052702303471004579165470633112630 (Accessed 3/26/15).
170 “Physician Services: Concierge Care Characteristics and Considerations for Medicare” By the United States Government Accountability
Office, August 2005, p. 3; “Pros and Cons of Concierge Medicine” By Jen Wieczner, The Wall Street Journal, November 10, 2013,
http://www.wsj.com/articles/SB10001424052702303471004579165470633112630 (Accessed 3/26/15).
171 “Physician Services: Concierge Care Characteristics and Considerations for Medicare (GAO-05-929)” By the U.S. Government
Accountability Office, For Congressional Committees, August 2005, p. 6; “The Public Health and Welfare” 42 U.S.C. § 1395w-4(g)(2)(c)
(2006).
172 “Certificate of Need: State Health Laws and Programs” National Conference of State Legislature, April 30, 2009, http://www.ncsl.org/
IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (Accessed 01/13/10).
173 “Monopoly is Not the Answer” By Clark C. Havighurst, Health Affairs, Web Exclusive (August 9, 2005), http://content.healthaffairs.org/
cgi/content/full/hlthaff.w5.373/DC1 (Accessed 05/21/10), p. W5-373-374
174 “Improving Health Care: A Dose of Competition” Federal Trade Commission and the Department of Justice, July 2004, Chapter 8, p. 2,5, 6;
See Chapter 3: Regulatory Environment.
175 “Making Competition in Health Care Work” By Elizabeth Olmsted Teisberg et al., Harvard Business Review, July/August, 1994,
http://hardvardbusinessonline.hbsp.harvard.edu/hbsp/hbr/articles/article.jsp?artilcleID=9440..., (Accessed 09/11/08) (emphasis added).
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a force for cost efficiency. Hospitals in more competitive markets have exhibited lower levels of
spending on average than hospitals found in less competitive markets.176 Healthy competition
appears to offer both patients and payors a means of economic leverage by creating choices for
consumers and raising quality standards as providers compete for patient loyalty. When patient
choice is diminished, decisions about access, quality, and beneficial outcomes become the sole
purview of oligopoly market players that, as decision makers acting in the absence of healthy
competition, are free to ignore patient demands and needs.177
The implementations of CON legislation in competitive markets have been perceived as a
notable shift from CON's original purpose of supporting competition by preventing
overinvestment in healthcare facilities.178 Most notably, proponents of CON programs argue that
CON legislation may prevent healthcare markets from becoming oversaturated with ASCs and
other specialty hospitals; this is a position that has helped community hospitals use the regulatory
environment in their campaign against physician-owned healthcare facilities.179
Rise of Urgent Care Walk-In Clinics
Urgent care centers have become increasingly more popular in the U.S. with up to 9,000
facilities already in existence that serve between 71 and 160 million people each year.180 Acute
care patients, tired of the progressively longer waits for appointments with primary care
physicians or for emergency room services, are attracted to the convenience of urgent care
centers (e.g., the extended hours and the availability of walk-in appointments).181 With the
supply of primary care physicians dwindling combined with many family physicians declining to
accept new Medicare FFS patients and fewer emergency departments nationally, urgent care
utilization will likely continue to rise.182 In fact, a survey of 326 urgent care centers in 2013
found that 88% of centers expected to see an increase in patients and/or expansion of the
location.183
Medical Tourism
Another competitive force in the healthcare industry is the growing incidence of medical
tourism, which is the practice of patients traveling to countries, such as India, Thailand, or any
number of other countries, to receive medical procedures at a fraction of what they may cost in

176 “Health Policy Reform: Competition and Controls” By J. Zwanziger, G. Melnick G, A. Bamezai, & R. Helms, ed., Washington, DC:
American Enterprise Institute Press, 1993, p. 241-58.
177 See the Supply and Demand in Healthcare section and the Consumer Driven Healthcare section earlier in this chapter.
178 “Monopoly is Not the Answer” By Clark C. Havighurst, Health Affairs, Web Exclusive (August 9, 2005), http://content.healthaffairs.org/
cgi/content/full/hlthaff.w5.373/DC1 (Accessed 05/21/10), p. W5-373.
179 “Specialty Versus Community Hospitals: What Role for the Law?” By Sujit Choudhry, et al., Health Affairs, Web Exclusive (August 9,
2005), http://content.healthaffairs.org/cgi/content/full/hlthaff.w5.361/DC1 (Accessed 5/21/10), p. w5-367.
180 “The Case for Urgent Care” Urgent Care Association of America, September 1, 2011, http://c.ymcdn.com/sites/www.ucaoa.org/resource/
resmgr/Files/WhitePaperTheCaseforUrgentCa.pdf (Accessed 3/26/15) p. 1, 2.
181 Ibid, p. 1.
182 “Urgent Care Centers in the U.S.: Findings from a National Survey” By Robin M. Weinick, et. al., BMC Health Services Research, Vol. 79
(2009), p. 6.
183 “Benchmarking Survey Headlines Summary” Urgent Care Association of America, http://c.ymcdn.com/sites/www.ucaoa.org/
resource/resmgr/Benchmarking/UCAOA-BenchmarkSurvey_Infogr.pdf (Accessed 3/26/15).
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the U.S.184 By avoiding the structural, regulatory, and legal barriers that are present in the U.S.,
foreign hospitals may be more free to innovate in ways that potentially can decrease the cost of
many procedures.185 Generally, these procedures are performed by skilled physicians who may
have been trained in the U.S. and who may employ the latest technology with a risk of infection
and mortality no higher than in the U.S.186 According to the CDC, 750,000 U.S. residents utilize
foreign medical tourism each year, often because of the lower costs associated with treatment.187
This trend demonstrates the reach of globalization on the healthcare industry and, as with
globalization in other sectors, it could mean that new competition for domestic suppliers is
worldwide.

The Bargaining Power of Buyers
Most healthcare services are paid for by insurance, whether private or governmental. Most
private health insurance is purchased through employers that, to a great degree, make most of the
buying decisions. Employer coalitions have emerged, but most command leverage on price
rather than quality or value. This often leaves healthcare providers as the only advocates for
consumers (i.e., patients). Corporate buyers have asserted substantial, if disproportionate,
influence over healthcare companies, but not always in the best interests of the consumers or the
community at large.
Recently, payors have begun to shift toward P4P plans that assess certain performance outcomes
and offer financial incentives to providers that attain them.188 P4P programs have been shown to
improve quality of care189 and, by offering financial incentives to providers, P4P also will allow
consumers to recognize the quality of care when making choices for provision of services.190
These traditional means of procuring insurance changed dramatically in 2014 with the advent of
state health insurance exchanges and the small business health options program (SHOP)
exchanges, both of which are mandated under the ACA.191 The ACA provision requiring the
provision of minimal essential health benefits and restricting the payor’s ability to reject
coverage based on preexisting conditions has further decreased the bargaining power of buyers
and has placed more decision power with patients. To ease the burden on small businesses with
25 or fewer full time employees, the ACA implemented a federal tax credit, which, depending on
need, will offset up to half of insurance premiums.192 To qualify for the credits, a small employer
184 “Could U.S. Hospitals Go The Way Of U.S. Airlines?” By Stuart H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol. 25, No.
1 (January/February 2006), p. 18; “2014 Yellow Book: Chapter 2 The Pre-Travel Consultation: Medical Tourism” By C. Virginia Lee and
Victor Balaban, Centers for Disease Control and Prevention,August 1, 2013, http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-2-thepre-travel-consultation/medical-tourism (Accessed 3/26/15).
185 “Innovation Abroad” Health Affairs, Vol. 27, No. 5, (September/October 2008), p. 1259.
186 “Lessons From India In Organizational Innovation: A Tale of Two Heart Hospitals” By Barak D. Richman et al., Health Affairs, Vol. 27,
No. 5 (September/October 2008), p. 1261.
187 “Medical Tourism” Centers for Disease Control and Prevention, February 23, 2015, http://www.cdc.gov/features/medicaltourism/
(Accessed 3/26/15).
188 See Chapter 2: Reimbursement Environment.
189 “Hospital Quality Improving, Cost, Mortality Rate Trends Declining for Participants in Medicare Pay-For-Performance Project” Premier
Inc., Press Release (January 31, 2008), http://premierinc.com/about/news/08-jan/performance-pays-2.jsp (Accessed 04/25/08).; “Patient
outcomes and evidence-based medicine in a preferred provider organization setting: a six-year evaluation of a physician pay-forperformance program” By Amanda S. Gilmore, et al., Health Services Research, (December 2007), http://findarticles.com/
p/articles/mi_m4149/is_6_42/ai_n21157693/print (Accessed 4/21/08).
190 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Chapter 1, p. 8.
191 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1311(b), 124 Stat. 119, 173 (March 23, 2010).
192 “Patient Protection and Affordable Care Act” Pub. L. 111-148 (March 23, 2010), p. 102.
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must pay at least half of each employee's premium.193 As of 2012, up to four million companies
were deemed eligible for this tax credit.194
The bargaining power of buyers, particularly insurance companies, is also subject to increasing
scrutiny under the ACA, specifically regarding new limitations on the medical loss ratio (MLR).
On December 2, 2011, HHS issued a final rule regarding the MLR, creating a significant change
in industry oversight by considering insurance broker and agent fees as administrative costs for
purposes of a MLR calculation195 (i.e., that portion of insurance premium revenues spent on
items other than clinical services, quality improvement, and other non-administrative
activities196). The MLR final rule requires insurance companies to spend 80% of insurance
premiums on medical care and healthcare quality improvement in the individual and small group
markets and 85% of premiums on these components in the large group markets, exclusive of
administrative costs.197 Beginning in 2011, insurance companies were required to annually report
their MLR data to HHS in an effort to allow consumers to evaluate available health plans based
on the value they provide. Beginning in 2012, private payors who failed to meet MLR
requirements are required to provide their customers with rebates.198 The final rule allows the
Secretary of HHS, through The Center for Consumer Information and Insurance Oversight
(CCIIO), to adjust the MLR standard in states where it is determined that meeting the 80% MLR
standard might destabilize the individual market.199 To date, 17 states have applied for an
adjustment to the MLR standard, but only Maine has received a constant adjustment (maintained
at 65%).200 However, CCIIMO has allowed various models of leniency regarding the MLR
standard for those approved, including gradual adjustments201 and temporary adjustments.202
Insurance companies are the main opponents of the MLR rebate, maybe in part because they
were required to issue $332 million in rebates to 6.8 million consumers based on their 2013
performance.203 Concern specifically surrounds the inclusion of insurance broker and agent fees
in administrative costs, with the insurance industry asserting that these activities are necessary
services for consumers that will be hindered by the regulations. While the insurance industry
claims that the MLR rule will create a “desperate economic situation,” consumer groups support
193 “Small Business Health Care Tax Credit for Small Employers” Internal Revenue Service, January, 15, 2015, http://www.irs.gov/uac/SmallBusiness-Health-Care-Tax-Credit-for-Small-Employers (Accessed 3/27/15).
194 “Why Health Care Tax Credit Eludes Many Small Business” By Robb Mandelbaum, New York Times, Sept. 25, 2012,
http://boss.blogs.nytimes.com/2012/09/25/why-the-health-care-tax-credit-eludes-many-small-businesses/?_r=0 (Accessed 3/27/15).
195 “Medical Loss Ratio Requirements under the Patient Protection and Affordable Care Act” Federal Register, Vol. 76 No. 235, (December 2,
2011), p. 76574-76594.
196 “Medical Loss Ratio” Center for Consumer Information and Insurance Oversight, http://cciio.cms.gov/programs/marketreforms/
mlr/index.html (Accessed 1/4/2012).
197 “Medical Loss Ratio: Getting Your Money’s Worth on Health Insurance” Center for Consumer Information and Insurance Oversight,
http://cciio.cms.gov/resources/factsheets/mlrfinalrule.html (Accessed 12/13/2011).
198 Ibid.
199 “Patient Protection and Affordable Care Act” Pub. L. 111-148, § 2718, 124 Stat. 119, 886 (March 23, 2010).
200 “Medical Loss Ratio Requirement Under the Patient Protection and Affordable Care Act (ACA): Issues for Congress” By Suzanne M.
Kirchhoff, Congressional Research Service, August 26, 2014, https://fas.o http://www.irs.gov/uac/Small-Business-Health-Care-Tax-Creditfor-Small-Employers rg/sgp/crs/misc/R42735.pdf (Accessed 3/27/15), p. 14.
201 “Re: State of New Hampshire’s Request for Adjustment to Medical Loss Ratio Standard” By Steven B. Larsen, Letter to Roger A. Sevigny,
State of New Hampshire Insurance Departmetn, May 13, 2011, http://www.cms.gov/CCIIO/Programs-and-Initiatives/Health-InsuranceMarket-Reforms/Downloads/nh_mlr_adj_decletter.pdf (Accessed 3/31/15), p. 2; For other examples, see generally “State Requests for
MLR Adjustment” Center for Consumer Information & Insurance Oversight, http://www.cms.gov/CCIIO/Programs-and-Initiatives/HealthInsurance-Market-Reforms/state_mlr_adj_requests.html (Accessed 3/31/15).
202 Ibid.
203 “Medical Loss Ratio Requirement Under the Patient Protection and Affordable Care Act (ACA): Issues for Congress” By Suzanne M.
Kirchhoff, Congressional Research Service, August 26, 2014, https://fas.org/sgp/crs/misc/R42735.pdf (Accessed 3/27/15) p. 2; “Consumers
Benefitted from 80/20 Rule in 2013” Department of Health and Human Services, July 22, 2014, http://www.cms.gov/
CCIIO/Resources/Forms-Reports-and-Other-Resources/Downloads/Final-MLR-Report_07-22-2014.pdf (Accessed 3/27/15).
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including insurance broker and agent fees in administrative costs, touting the rule as “a great
victory for consumers … maintain[ing] the integrity of incredibly important consumer
protections that hold the insurance industry accountable.”204
Power of the Insurance Lobby
The rise of antitrust law in the healthcare marketplace has indirectly led to the courts supporting
the preferences of insurance companies. As agents for the consumers protected under the laws
(i.e., patients), insurance companies have emerged as the dominant force in articulating
competitive preferences for price and quality. Courts have deemed insurance providers to be the
best voice for the needs of consumer patients and, therefore, have overlooked the traditional
competitive transgressions of insurance companies (i.e., selective contracts with health
professionals or onerous contractual requirements on network providers).205
Further adding to the power of the industry, insurance companies as an industry sector have
enjoyed an exemption from federal antitrust laws since 1945. The McCarran-Ferguson Act
limits federal scrutiny of insurers and places states in primary control of antitrust enforcement.206
State legislation is preserved in the bill, but whether states are powerful enough to prevent
insurance companies from engaging in price fixing, bid rigging, market allocations, deterring
competition, and impairing consumers has been questioned.207
Power of Medicare and Other Public Payors
The government is the largest third-party payor in the U.S. Through programs like Medicare,
Medicaid, and TRICARE, it exerts one of the most influential competitive forces in the health
insurance industry. As the largest national purchaser of health services, the government exerts
influence over not only the public delivery of health services, but also over the private sector.208
Many private insurers negotiate their own arrangements with providers, but some private thirdparty payors base their arrangements on the Medicare payment systems or use those systems as a
starting point for negotiations with providers.209
Medicare’s influence on competition in certain sectors is limited, however. Under the MMA, the
secretary of HHS is prohibited from negotiating drug prices with pharmaceutical manufacturers
under Medicare Part D, a prohibition which also inhibits free market competition in
healthcare.210 Instead, negotiations are undertaken by private insurers and Pharmacy Benefit
204 “MLR Final Rule Keeps Broker Fees as Administrative Costs” By Margaret Dick Tockness, HealthLeaders Media, December 5, 2011,
http://www.healthleadersmedia.com/print/HEP-273901/MLR-Final-Rule-Keeps-Broker-Fees-as-Administrative-Costs (Accessed 1/4/2012).
205 “Why Competition Law Matters to Health Care Quality” By William M. Sage, David A. Hyman, and Warren Greenberg, Health Affairs,
Vol. 22, No. 2, (March/April 2003), p. 38.
206 “McCarran-Ferguson Act” 15 U.S.C 1011, March 9, 1945.
207 “House Panel Approves Bill Curbing Insurers’ Antitrust Exemption” By David M. Herszenhorn, New York Times, October 21, 2009. *As
of March 27, 2015, the MacCarren-Ferguson Act has not been repealed, but attempts have been made. “McCarran-Ferguson Act’s Antitrust
Exemption Dodges Another Attempt at Repeal” By James Burns and Williams Mullen, TAGLaw, 2015, http://www.taglaw.com/index.php?
option=com_content&id=1656:mccarran-ferguson-acts-antitrust-exemption-dodges-another-attempt-at-repeal&Itemid=100074 (Accessed
3/27/15).
208 “The Next Antitrust Agenda: The American Antitrust Institute’s Transition Report on Competition Policy to the 44th President of the
United States” By Albert A. Foer, Ed., Vandeplas Publishing (2008), p. 344.
209 “How Medicare Shapes the US Health Sector” By Jeffrey Clemens, Economics in Action, Issue 10 (May 14, 2014) http://economics.
ucsd.edu/economicsinaction/issue-10/headline.php (Accessed 3/27/15).
210 “The Medicare Prescription Drug Benefit Fact Sheet” The Henry J. Kaiser Family Foundation, September 19, 2014, http://kff.org/medicare/
fact-sheet/the-medicare-prescription-drug-benefit-fact-sheet/ (Accessed 3/27/15) p. 9.
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Managers (PBMs) that then offer prices they obtain through those negotiations to Medicare
beneficiaries.211 Under this system, the Medicare program is unable to use its power as what
would be the largest purchaser of prescription drugs to bring the cost of such drugs down.212
Proponents of the noninterference provision argue, however, that it prevents the federal
government, which is motivated by taxpayers, voters, and Medicare beneficiaries alike,
monopsony power to affect the price of prescription drugs, consequently stifling the ability of
pharmaceutical companies to earn the profits that allow them to develop new drugs.213

Rivalry Among Existing Firms
Integrated physician organizations and other types of emerging healthcare organizations (EHOs)
may be viewed as new market entrants or simply as a reorganization of existing providers in
order to better compete. Provider organization and EHO volumes have grown significantly
through integration, consolidation, and mergers, but in many ways their effectiveness as
competitors is still uncertain. The collapse of PPMCs, or poor performance of hospital managed
physician practices (including physician-hospital organizations [PHOs]), the failure of capitated
groups and IPAs in California, and the previous trend toward divestiture of acquired practices
would seem to indicate that some EHOs may not have been effective competitors. However, as a
result of HHS Secretary Sylvia Burwell's January 2015 announcement that by 2016, HHS
anticipates transitioning the majority of Medicare reimbursement from volume-based to valuebased payments, EHOs such as ACOs and clinically integrated networks (CINs) may change the
competitive dynamics in the healthcare industry.214 Nonetheless, a strong argument could be
made that the competitive forces that led to the formation of these integrated organizations still
exist and that these initial failures have more to do with mismanagement and poor planning than
the concept of physician integration itself.
Integration, affiliation, and collaboration among providers may, in some cases, be viewed as a
means of circumventing competition unless the clinical benefits to patients can be demonstrated.
Because the overarching mission of the healthcare delivery system is inherently human valuebased, it is often deemed to be in conflict with the economic and financial goals of healthcare
organizations, especially in the for-profit arena, as well as incompatible with the competitive
forces that have been successful in other industries. These differences in basic values and the
manifestation of these values between businesses in other industries, as well as the various
existing organizations in healthcare, are deeply rooted and important to understand in assessing
the impact of rivalry on the potential for competition to succeed in stimulating quality and
efficiency.

211 “The Human Cost of Federal Price Negotiations: The Medicare Prescription Drug Benefit and Pharmaceutical Innovation” By Benjamin
Zycher, Center for Medical Progress at the Manhattan Institute, November 2006, http://www.heartland.org/custom/semod_policybot/
pdf/20365.pdf (Accessed 11/10/09), p. 1.
212 Ibid, p. 2.
213 Ibid, p. 3.
214 “Better, Smarter, Healthier: In historic announcement, HHS sets clear goals and timeline for shifting Medicare reimbursements from
volume to value” U.S. Department of Health & Human Services, January 26, 2015, http://www.hhs.gov/news/press/2015pres/01/
20150126a.html (Accessed 3/27/15).
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ANTITRUST ISSUES
Antitrust law has traditionally been used to combat anticompetitive behavior arising from
contractual- and/or payor-imposed barriers to competition (e.g., covenants not to compete,
narrow networks), as well as against consolidations (either by collaboration or merger) by
provider groups and health systems. However, around 2004 the FTC began paying special
attention to antitrust enforcement in the pharmaceutical segment of the healthcare industry.215
During that timeframe, antitrust jurisprudence began to experience a significantly increased level
of judicial deference to professionalism in health market transactions which chilled the ability of
federal antitrust authorities to bring effective enforcement actions against violators.216
Additionally, federal enforcement agencies generally won cases against hospital mergers
between the mid-1980s and the mid-1990s; those agencies lost all of the hospital merger cases
brought in federal court between 1995 and 2001.217 During this timeframe, courts tended to
examine elements of antitrust decisions (such as a provider’s market share and price) from a
purely economic perspective and ignored other elements germane to healthcare, such as patients’
personal and logistical considerations when choosing a provider.218
More recently, the DOJ and FTC have focused their efforts on evaluating the effect of horizontal
consolidation of certain healthcare organizations (e.g., pharmaceutical giants, payors, outpatient
clinics, and hospitals) to determine whether their respective market sectors experience a decrease
in competition as a result.219 The FTC and DOJ have also begun analyzing antitrust threats in
vertical mergers, like the case of St. Luke's Health System and Saltzer Medical Group.220
Most research conducted to date suggests a potential correlation between hospital consolidation
and higher prices for hospital services; the magnitude of price increase is estimated to range from
three percent to nearly 50%.221 While the impact of consolidation on quality of care is still a
controversial topic, studies have shown that hospital consolidation may result in a reduced level
of quality.222 Surmising a sudden surge of hospital consolidation as a result of healthcare reform
and continued technological growth, the FTC and DOJ may heighten the stringency of
regulations and guidelines in order to ensure competitive veracity within the hospital sector.223

215 “Improving Health Care: A Dose of Competition” Federal Trade Commission and the Department of Justice, White Paper, July 2004,
Chapter 1, p. 35.
216 “Whither Antitrust? The Uncertain Future of Competition Law in Health Care” By Thomas L. Greaney, Health Affairs, Vol. 21, No. 2
(March/April 2002), p. 185-186.
217 Ibid, p. 186.
218 Ibid, p. 187.
219 “Commission Order Restores Competition Eliminated by Carilion Clinic’s Acquisition of Two Outpatient Clinics” Federal Trade
Commission, Press Release (October 7, 2009), http://www.ftc.gov/opa/2009/10/carilion.shtm (Accessed 11/11/09); “FTC Order Prevents
Anticompetitive Effects from Pfizer’s Acquisition of Wyeth” Federal Trade Commission, Press Release (October 14, 2009),
http://www.ftc.gov/opa/2009/10/pfizer.shtm (Accessed 11/11/09); “FTC Order Restores Competition Lost Through Schering-Plough’s
Acquisition of Merck” Federal Trade Commission, Press Release, (October 29, 2009), http://www.ftc.gov/opa/2009/10/merck.shtm
(Accessed 11/11/09).
220 See Chapter 3: Regulatory Environment.
221 “Medical Mergers Are Driving Up Health Costs” By Suzanne Delbanco, The Wall Street Journal, September 30, 2014, p.1
http://www.wsj.com/articles/suzanne-f-delbanco-medical-mergers-are-driving-up-health-costs-1412119178 (Accessed 3/27/15).
222 “Hospital Market Consolidation: Trends and Consequences” By William B. Vogt, PhD, National Institute for Health Care Management,
November 2009; “How Has Hospital Consolidation Affected the Price and Quality of Hospital Care?” By Claudia H. Williams, William B.
Vogt, Ph.D., and Robert Town, Ph.D., Robert Wood Johnson Foundation, Policy Brief No. 9, February 2006.
223 “Hospital Market Consolidation: Trends and Consequences” By William B. Vogt, PhD, National Institute for Health Care Management,
November 2009.
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Clinical Integration
One area of antitrust enforcement that did not suffer a significant decline in the beginning of the
new millennium was the prosecution of collective actions by healthcare professionals that
thwarted competition in violation of Section 1 of the Sherman Antitrust Act (which prohibits
agreements between competitors in restraint of trade).224 Commonly taking the form of IPAs and
PHOs that wish to clinically integrate, these groups are generally found to be in violation of
antitrust laws. In the wake of several FTC advisory opinions favorable toward clinical
integration, it is likely that there may be a resurgence of IPAs and PHOs in the near future.
Clinical integration among provider networks has traditionally been scrutinized by the FTC as
generally being anticompetitive and in violation of antitrust laws, in part because provider
networks typically involve competing providers that agree to fix prices between them. Such
practices are per se unlawful under antitrust law.225 However, since the 2002 FTC Advisory
Opinion for MedSouth,226 the 2007 Advisory Opinion for the Greater Rochester Independent
Practice Association Inc. (GRIPA),227 and the 2013 Advisory Opinion for the Norman
Physician-Owned Hospital (PHO),228 it has become clear that clinical integration is not
necessarily considered to be a per se violation of antitrust regulations. If the subject transaction is
not deemed to be a per se violation, the FTC reviews joint contracting arrangements under a rule
of reason analysis to determine whether the arrangement may lead to procompetitive outcomes.
Clinical integration is beneficial in that it allows a network of competing providers to participate
in both joint-pricing and risk sharing, thereby leading to improved efficiency that will benefit
consumers.229
It is important to note, however, that the MedSouth and GRIPA opinions do not mean that all
clinical integration programs will be subsequently approved by antitrust enforcement agencies.
In fact, a 2005 FTC decision striking down a clinical integration program in Texas was affirmed
by the Fifth Circuit Court of Appeals in 2008.230 When analyzing any clinical integration
scheme, the FTC first asks whether the proposed collaboration offers the potential for proconsumer cost savings or qualitative improvements in the provision of healthcare services and
then asks whether any price or other agreements exist among participants, in particular the terms
on which they will deal with third-party payors, and if the terms are reasonably necessary to
achieve those benefits.231 If both questions are answered affirmatively, only then will the FTC
consider the procompetitive and anticompetitive effects of the collaboration.232 At that point, “as
224 “The Sherman Antitrust Act” Pub. L. No. 111-25, June 2, 2009.
225 “The Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care” Prepared Statement of the Federal
Trade Commission, July 16, 2009, p. 6.
226 “Advisory Opinion Related to the Proposal of MedSouth, Inc.” By Jeffrey W. Brennan: Federal Trade Commission Bureau of Competition,
Letter To John J. Miles: Law firm of Ober, Kaler, Grimes & Shriver (February 19, 2002), Accessed at http://www.ftc.gov/bc/
adops/medsouth.shtm (Accessed 4/18/08).
227 “Greater Rochester Independent Practice Association, Inc., Advisory Opinion” By Markus H. Meier, Letter to Christi J. Braun and John J.
Miles, Law firm of Ober, Kaler, Grimes & Shriver, September 17, 2007, Accessed at http://www.ftc.gov/bc/adops/gripa.pdf (Accessed
4/18/08).
228 “Letter from Markus H. Meier to Michael Joseph, Concerning Norman PHO’s Proposal to Create a ‘Clinically Integrate’ Network”
Prepared Statement of the Federal Trade Commission, February 13, 2013, p. 2.
229 “The Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care” Prepared Statement of the Federal
Trade Commission, July 16, 2009, p. 7.
230 “North Texas Specialty Physicians v FTC” Dkt. No. 9312, (July 18, 2005).
231 “The Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care” Prepared Statement of the Federal
Trade Commission, July 16, 2009, p. 8.
232 Ibid.
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long as such collaborations cannot exercise market power, they are unlikely to raise significant
antitrust concerns, precisely because they have the potential to benefit, not harm, consumers.”233
It is important to note that the antitrust enforcement agencies support the procompetitive clinical
integration of provider networks as a means of increasing efficiency and reducing costs,
especially in a healthcare reform environment in which these objectives are two of the overall
goals. Collaborations among providers often result in the implementation of efficiencyproducing tools, such as electronic health records, as well as collaboration among clinicians to
create guidelines, measure performance, and develop remedial measures and consequences for
failure to meet those guidelines.234
Antitrust enforcement agencies will likely continue to carefully scrutinize healthcare mergers to
ensure that no single entity gains enough market share such that patients are deprived of choices,
and that the entity is able to increase prices to both patients and payors.235

HEALTHCARE REFORM AND ITS EFFECT ON
COMPETITION
MANAGED COMPETITION
The dominant competition theory of 1990’s healthcare reform was managed competition.236 As
proposed by Stanford University’s Alain Enthoven, competing healthcare entities (particularly
payors) should be monitored by a supervisory body that established equitable rules, created
price-elastic demand, and avoided uncompensated risk selection237—not a far cry from current
EHO structures, e.g. ACO/payor relationships.238 This model was a combination of competitive
and regulatory strategies that Enthoven suggested must strive to co-exist in the healthcare
industry in order to achieve maximum value for both consumers and providers.239 Several
healthcare industry commentators viewed this compromise as springing from a “belief that health
care is both a right and an obligation”—heralding the ACA’s individual mandate, i.e., that people
have a right to access, and an obligation to pay for, their share.240 An illustration of the
comparative features of the evolution of models of managed competition, from managed access
to managed outcomes (i.e., VBP), is set forth in Figure 4-4, below.

233 The Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care” Prepared Statement of the Federal
Trade Commission, July 16, 2009, p. 8.
234 Ibid, p. 9.
235 Ibid, p. 12; See Chapter 3: Regulatory Environment for ACO Safety Zones and other agency considerations.
236 “The New American Compromise” By Ian Morrison, Trustee, Vol. 61, No. 8, September 2008, p. 32.
237 “The History and Principles of Managed Competition” By Alain C. Enthoven, Health Affairs, Vol. 12, no. suppl 1, 1993, p. 24, 30-35.
238 “Chasing Unicorns,” By Ian Morrison, H&HN Weekly, January 3, 2011, http://www.hhnmag.com/hhnmag_app/jsp/articledisplay.jsp?
dcrpath=HHNMAG/Article/data/01JAN2011/010411HHN_Weekly_Morrison&domain=HHNMAG (Accessed 3/29/2012).
239 “The History and Principles of Managed Competition” By Alain C. Enthoven, Health Affairs, Vol. 12, no. suppl 1, 1993, p. 25.
240 “The New American Compromise” By Ian Morrison, Trustee, Vol. 61, No. 8, September 2008, p. 32.
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Figure 4-4: The Four Phases of Managed Competition

The regulatory safeguards in the healthcare industry related to competition go beyond specific
laws monitoring the market size of various enterprises. As illustrated by the theory of managed
competition, regulations monitoring what must be publically reported will also have an impact
on the competitive nature of the healthcare industry.

REFORM OF THE INSURANCE AND PHARMACEUTICAL INDUSTRIES
Insurance Industry
Over the past year, transaction volume in the health insurance industry has increased, with this
growth in merger and acquisition activity expected to continue into the near future.241 These
increased transaction volumes have resulted in a highly consolidated market and myriad
consequences for consumers (e.g., higher costs, but also a potentially higher quality of care due
to an increased continuum of care).242 One reason for this consolidation is that there have only
been two cases in the last decade in which the DOJ has required the restructuring of a merger
agreement between two insurers.243 The prevalence of these mergers without a strong
enforcement of antitrust law permitted a variety of anticompetitive behavior by major insurers,
resulting in higher costs (whether from higher premiums, deductibles, or co-pays) and
compromised patient care.244

241 “Wall Street Ponders Plan Megamergers as M&A Spreads in Many Forms Across Sector (with Table: Top 10 Provider-Sponsored Health
Plans, By Medical Membership),” Steve Davis, AIS Health Plan Week, March 23, 2015, http://aishealth.com/archive/nhpw032315-01
(Accessed 3/27/15).
242 “A Second Opinion: Rescuing America’s Health Care: A Plan for Universal Coverage Serving Patients Over Profit” By Arnold S. Relman,
New York, NY: PublicAffairs, 2007.
243 “The Next Antitrust Agenda: The American Antitrust Institute’s Transition Report on Competition Policy to the 44th President of the
United States” By Albert A. Foer, Ed., Vandeplas Publishing (2008), p. 323.
244 Ibid.
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To reverse the insurer consolidation trend, healthcare reform proposals are likely to include
provisions for identifying exclusionary conduct by insurers. As some critics blame the ability of
insurers to consolidate (and the resulting monopoly/monopsony power enjoyed by large firms)
on the federal antitrust exemption for insurance companies contained in the McCarran-Ferguson
Act, industry commentators have suggested a modification or repeal of the exemption.245
Although the act exempts all types of insurance providers, the application of the act to the
healthcare industry has drawn particular criticism from the DOJ and lawmakers, both of which
claim that the exemption has led to anticompetitive behavior that has resulted in higher
healthcare costs to both providers and patients.246 On the payor side, proponents of the act argue
that states are capable of preventing anticompetitive behavior by private payors, so federal action
is unnecessary.247

Pharmaceutical Industry
The constantly maturing PBM industry has grown as consumer use of pharmaceutical drugs has
increased and insurers have worked pharmacy benefits into their plans.248 Due to the extremely
concentrated state of the PBM industry, careful attention should be paid to ensure fair
competition in this industry as more and more healthcare spending is devoted to
pharmaceuticals.249 Specific competition concerns include the impact of factors such as PBM
pricing, generic substitution, therapeutic interchange, and repackaging practices, in addition to
industry practices such as PBM ownership of mail-order pharmacies.250
The PBM industry’s expansion has received both positive and negative responses from the
healthcare industry, which responses were memorialized in part in the FTC’s approval of the
April 2012 acquisition of Medco Health Solutions, Inc. by Express Scripts Inc. (which created
one of the largest PBM companies in the U.S.).251 The FTC approved the merger after eight
months of investigation, noting that it was not an “easy decision,” with one FTC Commissioner
dissenting from the others, calling the transaction a “merger-to-duopoly.”252 Despite that
Commissioner’s dissent, the FTC’s opinion notes that the PBM industry is only moderately
concentrated (with at least ten significant competitors) and will remain competitive after the
proposed merger.253 Chairman Jon Leibowitz and Commissioners J. Thomas Rosch and Edith
Ramirez concluded that, although the merger would result in higher market concentration, the
market would remain highly competitive due to the presence of nine remaining firms and noted
245 “The McCarran-Ferguson Act” 15 U.S.C. § 1011 et seq. (2006); “Health Insurance Industry Antitrust Enforcement Act of 2012” H.R.
5838, 112th Congress, May 18, 2012; “Repeal McCarran_Ferguson—Before It’s Too Late” By David A. Balto, The Hill, April 8, 2013,
http://thehill.com/blogs/congress-blog/economy-a-budget/292405-repeal-mccarran-ferguson-before-its-too-late (Accessed 3/31/15).
246 “Health Insurance and Federal Antitrust Law: An Analysis of Recent Congressional Action” By Michael G. Cowie, The Antitrust Source
(December 2009), http://www.americanbar.org/content/dam/aba/publishing/antitrust_source/Dec09_Cowie12_17f.authcheckdam.pdf,
(Accessed 3/28/15), p. 4-6.
247 Ibid, p. 2, 6.
248 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Executive
Summary, p. 20.
249 “The Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care” Prepared Statement of the Federal
Trade Commission, White Paper, July 16, 2009, p. 1-2.
250 “Improving Health Care: A Dose of Competition” Federal Trade Commission and The Department of Justice, July 2004, Chapter 7, p. 12;
Executive Summary, p. 20.
251 “Statement of the Federal Trade Commission Concerning the Proposed Acquisition of Medco Health Solutions by Express Scripts, Inc.,”
FTC File No. 111-0210, April 2, 2012, https://www.ftc.gov/sites/default/files/documents/public_statements/statement-commissionconcerning-proposed-acquisition-medco-health-solutions-express-scripts-inc./120402expressmedcostatement.pdf (Accessed 2/27/15) p. 1-2.
252 Ibid.
253 Ibid, p. 2.
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that the merged company posed little risk of utilizing monopsony power because the PBM
market does not incentivize coordinated interaction.254
It should be noted that previous reform efforts have addressed the possibility of removing the
noninterference provision, which would result in granting the secretary of HHS the ability to
negotiate directly with pharmaceutical companies.255 In such an event, the market power of
PBMs may cease to be a threat to healthcare competition.

COMMODITIZATION OF HEALTHCARE
Payment for healthcare services has evolved over the past few decades, starting with the
implementation of Medicare in 1965 under an FFS paradigm, followed by the creation of the
prospective payment system (PPS) for hospital and physician services through the 1980s and
1990s, to the current framework based on bundled payments that combines institutional and
professional charges, or inpatient and post-discharge fees, into a single payment.256 Beginning
with the implementation of the PPS, whereby patients are classified into diagnostic related
groups (DRGs) based on the average cost of services for a particular diagnosis, healthcare
services are now bought and sold based on homogenous units of payment.257 Even MedPAC’s
Payment Basics publications discuss Medicare reimbursement under the heading of “the
products that Medicare buys.”258
With the recent focus on bundling, hospitals are incentivized to provide the appropriate amount
of care to make the procedure cost-effective, rather than the appropriate amount of care to treat
the patient’s condition.259 Similar to how healthcare evolved under capitation systems, hospitals
will receive payments based on a charge per episode of care methodology, which the hospitals
will then distribute to physicians and other providers within the hospital who provided care for
that patient.260 The charge-per system focuses on the amount of money a hospital will receive for
a given diagnosis and will incentivize providers to reduce services to save money as well as
hospitals to hire physicians who are not as expensive (i.e., not as well qualified) so that the
healthcare enterprise may retain as much of the payment as possible.261
Further evidence of the commoditization of the American healthcare system is reflected in the
presence of a marketplace for durable medical equipment (DME), whereby DME manufacturers
submit competing bids to Medicare based on the charge per unit, the lowest of which is then

254 Ibid, p. 6.
255 “Affordable Health Care for America Act” H.R. 3962, 111th Cong., § 1186 (October 29, 2009).
256 “Medicare Hospital Prospective Payment System: How DRG Rates Are Calculated and Updated” Office of Inspector General, Office of
Evaluation and Inspections, Region IX, August 2001, p. 1, 5.
257 Ibid.
258 “Ambulatory Surgical Centers Payment System” MedPAC Payment Basics, October 2008, http://www.medpac.gov/documents/
MedPAC_Payment_Basics_08_ASC.pdf (Accessed 09/24/09), p. 1.
259 “Payment Reform Options: Episode Payment is a Good Place to Start” By Robert E. Mechanic and Stuard H. Altman, Health Affairs, Web
Exclusive (January 27, 2009), p. w262, w264, w265, w269.
260 “Are Bundled Payments the Answer?” By Elyas Bakhtiari, HealthLeaders Media, February 5, 2009, http://www.healthleadersmedia.com/
content/227798/topic/WS_HLM2_PHY/Are-Bundled-Payments-the-Answer.html (Accessed 11/12/09).
261 “Payment Reform Options: Episode Payment is a Good Place to Start” By Robert E. Mechanic and Stuard H. Altman, Health Affairs, Vol.
228, No. 2 (January 27, 2009), Web Exclusive, http://content.healthaffairs.org/cgi/content/abstract/hlthaff.28.2.w262?ijkey=
D/mPrZnyJkrDA&keytype=ref&siteid=healthaff (Accessed 5/21/10), p. w262, w264, w265, w269.
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chosen to be the only Medicare provider of DME in ten different metropolitan areas.262 The
competitive bidding program was implemented in 2008, but an 18 month moratorium was
enacted under MIPPA in response to pressure from DME suppliers that claimed that the program
would lower quality of care and reduce access.263 Re-launched on January 1, 2011,264 the DME
competitive bidding program demonstrates how competition has influenced the healthcare
industry by turning healthcare into a commodity that can be freely bought and sold.
Although commoditization is an often criticized aspect of the healthcare industry, its
development may be essential to the continued evolution of the healthcare industry. Mass
retailers have been providing access to in-store health clinics and low-cost generic drugs to
simplify the supply chain and increase volume in an attempt to save consumers money and
improve patient care. The retail industry has become involved with the healthcare delivery
system for a number of reasons, including: (1) customers’ increased access to health information;
(2) rising healthcare costs; (3) evidence-based medicine approaches; and (4) increased scope of
practice considerations for midlevel providers (e.g., physician assistants and NPs).
Timothy P. Doty wrote about the commoditization of healthcare, to wit:
“…[I]f health care is ‘fungible,’ then by implication the parts of health care are
also interchangeable. Practically speaking, this also includes providers and
patients as they are simply reduced to their identity and purpose within the
confines of a business relationship. Just as the seller is interested only in
providing that which the buyer needs (or desires) in so far as there is sufficient
financial reward, the buyer is only concerned with obtaining the desired object (or
service). Who they are makes no real difference. Commodification dictates that a
physician is like any other, as long as they are matched with respect to specialty.
He or she ceases to be the indispensable community caregiver, and instead
becomes the link between company and profit, or shareholder and dividend.
Patients, by the same token, are no longer seen as individuals with unique
personalities and health care needs but as a source of revenue; they become
‘covered lives’ and a ‘business asset whose value is inversely proportional to the
cost of health care resources their care is predicted (statistically or otherwise) to
consume.’”265

Provider Consolidation
In recent years there has also been a noticeable shift in competition among physicians.
Historically, most physicians operated as independent competitors, allied only with the
hospital(s) to which they referred patients.266 The mid-1990s experienced a flurry of physician
262 “Durable Medical Equipment Competitive Bidding Program” Medicare.gov, http://www.medicare.gov/what-medicare-covers/partb/durable-medical-equipment-bidding.html (Accessed 3/27/15).
263 “Medicare DME Bidding Program Set to Relaunch in 2010” By Chris Silva, American Medical News, May 4, 2009,
http://www.amednews.com/article/20090504/government/305049980/7/ (Accessed 11/10/09); "Medicare Improvements for Patients and
Providers Act of 2008" Public Law No. 110-275, § 122 STAT. 2547, Sec. 145 (July 15, 2008).
264 “Bidding Results from CMS’s Durable Medical Equipment Competitive Bidding Program” US Government Accountability Office,
November 2014, http://www.gao.gov/assets/670/666806.pdf (Accessed 3/27/15) p. 2.
265 “Health Care as a Commodity: The Consequences of Letting Business Run Healthcare,” By Timothy P. Doty, March 2008 p.2.
266 “Unhealthy Trends: The Future of Physician Services,” by Hoangmai H. Pham and Paul B. Ginsburg, Health Affairs, Volume 26,
Number 6, (November/December 2007), p. 1587.
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practice acquisitions by hospitals, health systems, and large integrated groups as MCOs (and
HMOs) boomed. With the collapse of those managed care driven integration efforts, buyers of
those acquisitions experienced significant financial losses, and many integrated systems divested
physician practices;267 several physicians even bought back elements of their previous
practices.268
Although the managed care boom of the 1990s was short-lived, consolidation efforts have
revitalized in recent years due to various legislative initiatives (e.g., ACOs, PCMHs);
reimbursement cuts; increases in the cost to maintain independent practices; growing
technological demands for reporting (i.e., ICD-10 conversion); restrictions on physician
ownership; increased regulatory scrutiny; and shifting physician demographics and demands
(e.g., a greater number of older physicians and an increased importance of physician work/life
balance).
Provider consolidation (either through physician employment or mergers and joint ventures
between healthcare organizations) has already impacted the competitive nature of the healthcare
industry. Regulations designed to limit and monitor competition have been modified to facilitate
ACA initiatives, i.e., Stark Law, anti-kickback statute, and antitrust law waivers for ACOs.269
Hospital leverage has increased, especially in urban areas, as more physicians become hospital
employees. Coordination of care efforts will force cooperation between primary care providers
and specialists, which will likely require a new alignment of objectives between hospitals,
physicians, and outpatient facilities. With the rapid sea change resulting from environmental and
reform drivers, the once stable business landscape of U.S. healthcare delivery now presents an
unpredictable environment of new provider configurations, strategies, and tactics to which the
healthcare industry and the competitive forces that govern it must adapt.

Co-Management Arrangements
Physicians and hospitals are increasingly attempting to integrate in order to effectively respond
to healthcare reforms (e.g., ACOs and PCMHs) and provide more coordinated care. One method
of achieving this common goal is through co-management arrangements, which have re-emerged
in recent years as an alternative care model.270
Under these new co-management models, a hospital may enter into a management agreement
with an organization that is either jointly or completely owned by a physician to provide daily
management services for the inpatient and/or outpatient components of a particular medical
267 “Back to the Future for Many Hospital-Physician Relationships: Where Do We Go From Here?” By Ronald L. Vance and Ronald B.
Goodspeed, Journal of Ambulatory Care Management, Vol. 25, No. 4, 2002, p. 59; "Hospitals That Gobbled Up Physician Practices Feel
Ill—High Costs and a Decline in Productivity Among Doctors Bring Losses” By George Anders, Wall Street Journal, June 17, 1997, p.
B4.”
268 “Physicians Buying Back Their Practices from PPMs, Hospitals” By Julie A. Jacob, American Medical Association, August 1, 2000,
http://www.ama-assn.org/amednews/2000/08/21/bil20821.htm (Accessed 5/4/2012); “Disintegration: How Employed Doctors are Landing
on Their Feet” By Martha C. Collins, Family Practice Management, Vol. 6, No. 10, November-December, 1999, p. 38; “Regrouping After
Disintegration” By Rod Aymond and Theodore Hariton, Family Practice Management, Vol. 7, No. 3, March 2000, http://www.aafp.org/
fpm/2000/0300/p37.html?printable=fpm (Accessed 8/27/2012).
269 "Medicare Program; Final Waivers in Connection With the Shared Savings Program; Continuation of Effectiveness and Extension of
Timeline for Publication of Final Rule" Federal Register, Vol. 79, No. 201, (October 17, 2014) p. 62357; "ACOs: Fraud & Abuse Waivers
and Analysis" By Robert G. Homchick and Sarah Fellows, Davis Wright Tremaine, LLP, https://www.healthlawyers.org/Events/
Programs/Materials/Documents/HCT13/h_homchick.pdf (Accessed 3/27/15) p. 1.
270 “Co-management emerges as alternative to joint ventures, employment by hospitals” By Melanie Evans, Modern Physician, May 10, 2010,
http://www.modernphysician.com/apps/pbcs.dll/article?AID=/20100510/MODERNPHYSI# (Accessed 0718/2012).
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specialty service line.271 A co-management arrangement incentivizes physicians to develop,
manage, and improve quality and efficiency, as well as makes the service line more competitive
in the target market.272
Accountable Care Organizations (ACOs)
ACOs are the latest iteration in an evolving dialogue as to how to manage rising healthcare costs
in a manner that addresses both cost and quality. The concept of accountable care has existed in
the American healthcare industry for decades, long before the emergence of ACOs. Most
notably, the 1990s managed care boom promised some of the same fundamental objectives of
accountable care, i.e., lower costs and higher quality outcomes for patients. Managed care took
off in response to the emergence of HMOs, pre-paid health plan models that utilized provider
networks with a system of primary care gatekeepers and capitated payments to providers, which
incentivized decreases in utilization and increases in the efficiency of care for HMO members.
ACOs hold the promise of being more successful than their managed care predecessors. Current
trends in hospital-physician alignment have led to physician consolidation and have made
incentives for physician compensation more agreeable to realignment with healthcare reform
goals and reimbursement models. Integrated health systems, particularly those with an internal
payor, have already recognized physician employment as beneficial to their quality and cost
efficiencies. The clinical and management collaborations between healthcare providers within
ACOs will likely result in the desired synchronization of patient care and reduction in the
duplication of patient care, both of which are necessary to lower healthcare costs for both
providers and payors.
Ultimately, the success or failure of ACOs will be in their ability to achieve the required cost
reductions and quality metrics. The success of ACOs may not be contingent on addressing other
healthcare reform issues, such as the referral of patients by primary care physicians to specialists,
healthcare access, and the increasing health disparities across socioeconomic classes. Their
potential success, continued evolution, and positive public perception within the healthcare
industry may be the definitive distinction between the ACOs to today and the managed care of
the 1990s and is likely to be the primary measure of their value.273

CONCLUSION
The healthcare professional practice, while still a business, has been buffered from the full
onslaught of commercialism, including the ever-present attraction of competition. Whether to
control quality or cost, outside forces have regulated competitive forces within the healthcare
industry. Supported by the provider shortage and increased population demands (i.e., the baby
boomer generation), regulations regarding the scope of midlevel providers have been lessening
and physicians have begun expanding the services they offer. This is creating an overlap of
271 “Clinical Co-Management: Hospitals and Oncologists Working Together” By Paul F. Danello, Journal of Oncology Practice, Vol. 2 No. 1,
2006.
272 “Clinical Co-Management: Hospitals and Oncologists Working Together” By Paul F. Danello, Journal of Oncology Practice, Vol. 2
No. 1, 2006.
273 For a more complete discussion of ACOs, see Volume 2, Chapter 6 Emerging Models of this Guide.
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services, which will likely continue to fuel the emergence of new competitors in the healthcare
market. Additionally, the rise in CDHC will continue to change the way in which the healthcare
professional practice, as a business, is run, further removing the buffer between healthcare and
pure commercialism. As the impact of competitive forces grows in response to a changing
system, government regulations will also need to adapt to the new healthcare environment.
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https://www.cms.gov/Medicare/
Medicare-Fee-for-ServicePayment/PhysicianFeeSched/
index.html?redirect=/Physician
FeeSched/ (Accessed 4/1/15).

https://www.cms.gov/
Medicare/Medicare-Feefor-Service-Payment/
PhysicianFeeSched/index.
html?redirect=/Physician
FeeSched/

“About PHA” Physician
Hospitals of America,
http://www.physicianhospitals.or
g/?page=About (Accessed
4/1/15).

http://www.physician
hospitals.org/

“About GAO” U.S. Government
Accountability Office,
http://www.gao.gov/about/
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In these days when science is clearly in the
saddle and when our knowledge of disease is
consequently advancing at a breathless pace, we
are apt to forget that not all can ride and that he
also serves who waits and who applies what the
horseman discovers.
Harvey Williams Cushing, 1926
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Licensed Independent
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Molecular
Diagnostics
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Advanced Imaging
Modalities
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Definition
Created by the Federal
Communications Commission to
increase patient access to telemedicine
and support the transfer of EMRs.
Sixty-seven nationwide projects in
forty-two states and 6,000 health
facilities are eligible for the $417
million in grants under the program.
Provided $30 million in grants to
health facilities to pay for telehealth
equipment and expand telehealth
support services. Was introduced to
Congress on April 23, 2009, referred to
the House Ways and Means committee
(without further advancement) and
addressed The Joint Commission and
CMS credentialing issues.
The Joint Commission (TJC)
accreditation, according to TJC
standards, suffices to license
practitioners who diagnose or treat
patients by way of telemedicine link.
CMS, however, requires LIPs to be
credentialed at their originating site.
The revised standards released in
November 2008 compromise the
difference between JCAHO and CMS
standards, but the commission reverted
back to their original opinion in March
of 2009.
Geron Corporation’s investigational
new drug that became the first human
embryonic stem cell-based therapy
approved for clinical trial. It is used in
patients with acute spinal cord injury.
A more accurate and effective
diagnosis than traditional methods.
The capabilities of molecular
diagnostics have since evolved to
include genetic disorder screening, preimplantation screening, and cancer
screening procedures.
Allows practitioners to diagnose
cancer, choose and develop
personalized treatment plans, and
identify predispositions twice as
quickly as other assays and for only a
fraction of the drug development costs.
Magnetic resonance imaging,
computerized tomography (CT), and
nuclear medicine; these modalities are
also expensive services, accounting for
54 percent of total imaging
expenditures.
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Key Concept

Definition

Multidetector Row
CT (MDCT)

MDCT has raised the standard for
image quality and accuracy in
identifying differences in patients. In
addition to greater acuity, MDCT
(namely 64-slice technology) also
operates at an increased speed
compared to previously existing CT
technology.

“Fusion” Imaging

A hybrid technology that combines
nuclear medicine cameras with CT
detection methods.

Positron emission
tomography-CT
(PET-CT) and single,
photon emission
computed
tomography-CT
(SPECT-CT) systems

PET technology allows for
substantially higher sensitivity than
single-photon imaging technologies,
such as SPECT. However, due to the
longer half-life of single-photon
emitters, SPECT tracers last six hours;
PET tracers have only a 75 second
half-life. A longer half-life enables the
use of a wider observational time
window. SPECT is much more
available, widely used, and more
affordable than PET-CT technology.
However, SPECT is subject to longer
scan times and can produce lowresolution images that are prone to
artifacts and attenuation (especially in
larger patients).

Image Guided
Radiotherapy (IGRT)

Technology implemented by one-third
of all radiation oncology sites at the
time of publication and implements
ultrasound, x-ray, and CT most
frequently.

Stereotactic
Radiosurgery

A nonsurgical innovation that serves as
an increasingly preferred alternative to
invasive surgery for soft tissue tumors.

Minimally Invasive
Procedures

Procedures that avoid many of the
risks traditionally associated with
surgical procedures through use of
several small incisions to guide fiberoptic cameras to areas that necessitate
treatment.

Cell Culture Market

Influential in the manufacture of
biopharmaceuticals, most specifically
vaccines, monoclonal antibodies,
recombinant proteins, and stem cells.

Citation

Concept
Mentioned on
Page #

“CT Flexes Muscle in Coronary
Disease Detection” By James Brice,
Rheumatology Network, November 29,
2005, http://www.rheumatology
network.com/ct/ct-flexes-musclecoronary-disease-detection (Accessed
4/1/15).

373

“Nuclear Medicine Usage, Grows, Led
By PET” IMV Medical Information
Inc. Newsline, Vol. 47, No. 10 (2006),
p. 13N.

375

“PET Versus SPECT: Strengths,
Limitations, and Challenges” By
Arman Rahmim and Habib Zaidi,
Nuclear Medicine Communications,
Vol. 29 (2008).

375

“IMV Reports Increased Use of ImageGuided Radiotherapy in Radiation
Oncology” By Gale Group,
BusinessWire, April 9, 2007,
http://www.businesswire.com/news/ho
me/20070409005049/en/IMV-ReportsIncreased-Image-GuidedRadiotherapy-Radiation-Oncology
(Accessed 4/1/15).
“DOTmed Industry Sector Report:
Linear Accelerators and Simulators,”
by Barbara Kram, DOTmed News,
November 19, 2008, www.dotmed.
com/news/story/7013/ (Accessed
4/1/15).

384

384

Minimally Invasive Surgery,” Mayo
Clinic, 2009, www.mayoclinic.org/
minimally-invasive-surgery/ (accessed
April 6, 2009).

385

“Biopharmaceutical benchmarks 2006:
The rate of biopharmaceutical
approvals has leveled off, but some
milestones bode well for the future,”
by Gary Walsh, Nature Biotechnology,
Vol. 24, No. 7, July 2006, p. 769–76.

377

(continued)

333

Adviser's Guide to Healthcare

Key Concept

Definition

Molecular
Engineering

Molecular revision has defined
development and advancement in
biopharmaceuticals.

Gendicine

The first gene therapy commercially
approved (2004) for treatment of head
and neck squamous cell carcinomas.

Public Health Service
Act

Legislation that has kept generic
biopharmaceuticals from being
marketed.

Da Vinci System

A robotic system that was introduced
in 1996 that revolutionized minimally
invasive surgery by overcoming the
limitations of both traditional surgical
procedures and conventionally
implemented noninvasive technology.

Automated
Endoscopic System
for Optimal
Positioning (AESOP)

The first laparoscopic camera holder.

EndoWrist
Technology

Allows the surgeon to fully rotate his
or her hand, therefore giving the
surgeon the capacity to reach around,
beyond or behind The EndoWrist
technology provides the surgeon with
seven degrees of freedom.
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OVERVIEW
The term technology has a broad meaning in the healthcare industry. It can range from the
tangible tools, pharmaceuticals, and software that healthcare providers utilize when providing
care and managing patient records to the procedures that standardize the course of care. The
word technology stems from the Greek word tekhnologia, meaning systematic treatment.1 While
the scope of technology has changed dramatically since the 17th century, the concept of
technology still resembles its origins.
Improvements in diagnostic and therapeutic medicine, paired with the efficient use of available
resources in both management and clinical arenas, have the capacity to improve quality of care
while minimizing the number of medical errors. Through the effective use of electronic health
records and prescription management systems providers are able to save money for themselves
as well as for their patients.2 Also, progressive and dynamic research findings in molecular and
imaging technology continue to affect the diagnostic industry’s influence as a driver of the
therapeutic market.3

MANAGEMENT TECHNOLOGY
The patient demand for healthcare services is increasing at a rapid rate due to: (1) improved
access to care; (2) the growth of the general population;4 (3) the increase in the number of
individuals over the age of 65;5 and (4) the worsening of the physician manpower shortage.6
Particularly due to the influx of previously uninsured individuals (an estimated 9.5 million adults
gained insurance by the end of the Patient Protection and Affordable Care Act’s (ACA’s) first
open enrollment period),7 providers will have to implement methods of managing added patient
throughput. This growth in demand for healthcare services is a significant driver of more
sophisticated patient management technologies as well as the infrastructure for gathering and
interpreting quality and outcomes data to support evidence-based performance metrics as the
foundation for value-based reimbursement. The demand for management technology vis à vis the
current U.S. healthcare delivery system was characterized in the 2012 Futurescan Report, to wit:
1
2
3

4
5
6
7

“Merriam-Webster’s Collegiate Dictionary” Tenth Edition, Springfield, MA: Merriam-Webster, Inc., 1999, p. 1210.
“Studies Show Electronic Medical Records Make Financial Sense” By Stacy Lawrence, CIO Insight, September 14, 2005,
http://www.cioinsight.com/c/a/Health-Care/Studies-Show-Electronic-Medical-Records-Make-Financial-Sense/ (Accessed 8/12/08),
http://www.genengnews.com/articles/chitem_print.aspx?aid=2852&chid=0 (Accessed 07/06/09).
“Studies Show Electronic Medical Records Make Financial Sense” By Stacy Lawrence, CIO Insight, September 14, 2005,
http://www.cioinsight.com/c/a/Health-Care/Studies-Show-Electronic-Medical-Records-Make-Financial-Sense/ (Accessed 8/12/08); “Cancer
Molecular Diagnostics Take the Stage: CMDS Are at the Forefront of Evolving Healthcare Practices” By Sudeep Basu, Genetic
Engineering and Biotechnology News, Vol. 29, No. 7 (April 1, 2009), http://www.genengnews.com/articles/chitem_print.aspx?
aid=2852&chid=0 (Accessed 07/06/09).
“Population” in “Statistical Abstract of the United States: 2015” U.S. Census Bureau, Washington, DC, 2014, p. 9.
“Why Population Aging Matters: A Global Perspective” National Institute on Aging, National Institute of Health, the United States
Department of Health and Human Services, http://www.nia.nih.gov/sites/default/files/WPAM.pdf (Accessed 05/14/12).
“Physician Shortages to Worsen Without Increases in Residency Training” Association of American Medical College, 2010,
https://www.aamc.org/download/286592/data/physicianshortage.pdf (Accessed 8/2/12).
“New Survey: After First ACA Enrollment Period, Uninsured Rate Dropped from 20 Percent to 15 Percent; Largest Declines Among
Young Adults, Latinos, and Low-Income People” The Commonwealth Fund, July 10, 2014, http://www.commonwealthfund.org/
publications/press-releases/2014/jul/after-first-aca-enrollment-period (Accessed 3/5/15).
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“The healthcare industry cannot bend the cost and quality curve without relentless
technology-enhanced innovation—a constant stream of new ideas, new methods,
and new ways of providing and payment for care. Such innovations will be most
effective if it comes from healthcare executives and clinicians ‘in the trenches’
who are no longer willing to do things in ways that clearly have been shown not
to work.”8
Management technologies include: (1) the processes and procedures through which providers
organize patient encounters, charge entry, and the billing process and (2) the software and
devices that support these activities. While there are myriad methods through which a healthcare
enterprise may choose to approach management, the most publicized involve the interoperable
exchange and consolidation of patient data and treatment standards. Most of the current
management systems are implemented as a single package and many contain: (1) electronic
health records (EHRs); (2) computerized physician order entry (CPOE); and (3) billing
components.

TECHNOLOGY AS PROCESS
Typically, the term medical technology conjures images of large, industrial machines or complex
computer programs used to organize and track patient data. While this chapter focuses on
management and clinical technologies, the term healthcare technology goes beyond the
hardware and software utilized by providers to include intangible concepts such as healthcare
processes.
Process technologies can affect the manner and structure by which healthcare is delivered and
measured on both a clinical and management level, including treatment protocols, care
mapping, and case management. For example, a three-year study of a pediatric intensive care
unit found that more rigorous hand hygiene, oral care, and central-line catheter care protocols
reduced hospital-acquired infections (HAIs) and associated healthcare costs, as patients spent, on
average, 2.3 fewer days in the hospital.9
Management protocols, on the other hand, aim to reduce the cost of healthcare without lowering
the level of quality care delivered by establishing protocols that allow providers to appropriately
identify those procedures in which the expected treatment benefits to the patient are outweighed
by the costs of delivering such care,10 including early prostate cancer detection testing, routine
EKGs, or annual Pap smears.11 In addition to the utilization of such management technologies by
providers, payors may also influence providers in this regard. For example, in 2008 Medicare

8
9
10
11
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began withholding payments for the treatment of conditions arising from 28 “never events,” 12
defined by the National Quality Forum (NQF) as: (1) serious medical errors, such as performing
the wrong surgical procedure; (2) product or device events, such as contaminated drugs or
devices; and (3) criminal events, such as abduction of a patient.13
Although the 2012 Institute of Medicine Report (IOM) entitled, “Best Care at Lower Cost: The
Path to Continuously Learning Health Care in America,” did not specifically define the concept
of technology as process, it nevertheless recommended several steps to facilitate the
development of relationships between technology and providers if the U.S. healthcare delivery
system is to learn from its past errors, asserting that:
“…[t]o help achieve a learning healthcare system, digital technology developers need to play the
following roles:
• Ensure that electronic health record systems and other digital technologies capture and
deliver the core data elements needed to support knowledge generation.
• Partner with patients, the delivery system, insurers, researchers, innovators, regulators,
and other stakeholders.
• Collaborate in the development of core data sets for different diseases and conditions to
support clinical care, improvement, and research.
• Develop tools that assist individuals in managing their health and health care and that
provide opportunities for building communities to support patient efforts.
• Consider interoperability and integration in clinical workflows in designing digital health
systems.”14
Further, the 2012 IOM Report emphasized the importance of maintaining a digital infrastructure
as the backbone for U.S. healthcare delivery, and recommended that the U.S. healthcare system:
“Improve the capacity to capture clinical, care delivery process and financial data for
better care, system improvement, and the generation of new knowledge. Data generated
in the course of care delivery should be digitally collected, compiled and protected as a
reliable and accessible resource for care management, process improvement, public
health, and the generation of new knowledge.”15 [Emphasis added].

The development of minimally invasive technology, pharmaceutical advances, increased
demand for services, and higher costs associated with inpatient care has fueled a growth in
outpatient care, whereby outpatient visits to community hospitals nearly doubled from over 366
million in 1993 to nearly 678 million in 2013.16 Simultaneously, the technology utilized in the
delivery of healthcare has augmented the quality and efficiency of care for inpatient beneficiaries
12

13
14
15
16

“Strict Hand Hygiene and Other Practices Shortened Stats and Cut Costs and Mortality in a Pediatric Intensive Care Unit” By Bradford D.
Harris, et al., Health Affairs, Vol. 30, No. 9 (September 2011), p. 1751; “State Medical Director Letter” By Herb B. Kuhn, Centers for
Medicare & Medicaid Services, To State Medical Director, July 31, 2008, http://downloads.cms.gov/cmsgov/archived-downloads/SMDL/
downloads/SMD073108.pdf (Accessed 10/07/12).
“Never Event Fact Sheet” By The Leapfrog Group, March 2008, http://www.leapfroggroup.org/media/file/LeapfrogNever_Events_Fact_Sheet.pdf (Accessed 2/8/11).
“Best Care at Lower Cost: The Path to Continuously Learning Health Care in America” By Mark Smith et al., Institute of Medicine,
Washington, DC: The National Academics Press, 2012, p. 10-21 (pre-publication copy-uncorrected page proofs).
Ibid.
“Table 3.4: Outpatient Utilization in Community Hospitals, 1993-2013” in “Trendwatch Chartbook 2015” American Hospital Association,
February 19, 2015, http://www.aha.org/research/reports/tw/chartbook/ch3.shtml (Accessed 3/5/15).
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over the age of 65, the population of which is projected to surpass 71 million by 2029.17 This
demographic shift indicates that efforts to maximize technological implementation in the
delivery of home care and patient compliance monitoring systems should be employed to
increase both access to and quality of care.
Outpatient visits to community hospitals nearly doubled from 366 million, in 1993, to nearly 678 million in
2013.
American Hospital Association, February 19, 2015.

ELECTRONIC HEALTH RECORDS (EHR)
Electronic health records (EHR) work through a system of longitudinal data collection and
maintenance to “automate and streamline the clinician’s workflow.”18 As noted by the Healthcare
Information and Management Systems Society (HIMSS), “EHR has the ability to generate a
complete record of a clinical patient encounter—as well as supporting other care-related
activities directly or indirectly via interface –including evidence-based decision support, quality
management, and outcomes reporting.”19 Facilities that use EHR systems increase the ease with
which practitioners can file, manage, organize, and find their patients’ demographic data,
progress notes, problems, medications, vital signs, past medical histories, immunizations,
laboratory data, and radiology reports.20
Healthcare providers are responsible for the collection, maintenance, and analysis of patient data
during the course of each patient encounter.21 Electronic patient records may avoid some of the
pitfalls of paper records, such as: (1) wasted resources; (2) storage concerns; (3) misplacement;
and (4) retrieval issues. Further, paper records do not allow for the efficient search for the
requisite data extraction and analysis of voluminous patient clinical, demographic, and financial
information.22 In contrast to paper records, most EHR systems can be instantly searched,
categorized, and analyzed electronically, thereby improving providers’ ability to provide more
informed treatment plans to their patients.23 Although EHR systems have been in the market for
well over a decade, the prevalence of these systems had been relatively low until various health
reform efforts and legislations promoted the utilization of EHR systems. EHR systems come in a
variety of forms with small, but important, differences.
Of note, there is a distinction between an electronic medical record (EMR) and an EHR,
although the two terms are often incorrectly used synonymously. Although both terms refer to
17
18
19
20
21
22
23
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“The Boomer Challenge” By Paul Barr, Hospitals & Health Networks, January 14, 2014, http://www.hhnmag.com/display/HHN-newsarticle.dhtml?dcrPath=/templatedata/HF_Common/NewsArticle/data/HHN/Magazine/2014/Jan/cover-story-baby-boomers (Accessed
3/5/15).
“Adaptive Health Management Information Systems: Concepts, Cases, and Practical Applications” By Joseph Tan and Fay Cobb Payton,
Sudbury, MA: Jones and Bartlett Publishers, 2010, p. 121.
“Electronic Health Record” Healthcare Information and Management Systems Society, http://www.himss.org/ASP/topics_ehr.asp
(Accessed 6/22/09).
Ibid.
“Defining Key Health Information Technology Terms” National Alliance for Health Information Technology, To The National Coordinator
for Health Information Technology, Department of Health & Human Services, April 28, 2008, p. 16.
“Benefits of EMR” Medical Systems Development Corporation, 2003, http://msdc.com/EMR_Benefits.htm (Accessed 8/13/09).
“Defining Key Health Information Technology Terms” By The National Alliance for Health Information Technology, To The National
Coordinator for Health Information Technology—Department of Health & Human Services, April 28, 2008, p. 16.
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the electronic collection and management of health related information, EHRs are subject to
additional regulatory scrutiny and interoperability standards, i.e., meaningful use (discussed
below). Both terms can be juxtaposed with personal health records (PHRs), another related but
distinct term that describes an electronic record system that is controlled by the patient, in
contrast to the provider.24 To note the importance of interoperability in regards to regulation
funding, and emerging healthcare initiatives, discussion in this chapter will be focused on EHRs
and PHRs. The varying scopes of these terms are illustrated below in Figure 5-1: Scope of
Electronic Record Systems.
Figure 5-1: Scope of Electronic Record Systems25

Through the use of EHRs, healthcare providers are able develop and maintain a complete record
of a clinical patient encounter, as well as supporting other care-related activities, such as
“evidence-based decision support, quality management, and outcomes reporting.”26 Enabled by
advances in computers and electronic communication, EHRs collect observations, test results,
and narratives by multiple providers in one location,27 which allows for the communication
among different providers in the treatment of a patient. If presented in a simple, user-friendly
interface, EHRs have the potential to improve the ability of healthcare providers to make
diagnosis, treatment, and health management decisions.28
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“Defining Key Health Information Technology Terms” By TheNational Alliance for Health Information Technology, To The National
Coordinator for Health Information Technology, Department of Health & Human Services, April 28, 2008, p. 15.
Ibid.
“Electronic Health Record” Healthcare Information and Management Systems Society, http://www.himss.org/ASP/topics_ehr.asp
(Accessed 6/22/09).
“Defining Key Health Information Technology Terms” By The National Alliance for Health Information Technology, To The National
Coordinator for Health Information Technology—Department of Health & Human Services, April 28, 2008, p. 17.
“Defining Key Health Information Technology Terms” National Alliance for Health Information Technology, To The National Coordinator
for Health Information Technology, Department of Health & Human Services, April 28, 2008, p. 17.
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Trends in EHR Utilization
The first EHRs were adopted in the 1960s, but many healthcare providers at the time did not
consider updates to their anachronistic medical record systems to be a priority.29 Modern EHR
systems are based on the research and pilot testing conducted in academic medical centers
developed for use by governmental clinical care organizations. Some noteworthy attempts in
EHR development are set forth below, in Table 5-1: Notable Precursors of EHR Technology.
Table 5-1: Notable Precursors of EHR Technology30
Year

Program

Developer
Lockheed and El Camino
Hospital
University of Utah and
Latter-Day Saints Hospital
(brought to market by the
3M Corporation)

Impact

1960s1970s

Technicon Data System
(TDS)

Processing speed and flexibility let multiple
users into the system at one time

1960s

Health Evaluation
through Logical
Processing (HELP)

1968-1975

Computer Stored
Ambulatory Record
(COSTAR)

Harvard University and
Massachusetts General
Hospital

1970s

Decentralized Hospital
Computer Program
(DHCP)

Compartmentalized design increased
efficiency; flexible vocabulary accounted for
terminology variations; first to be made
available in public domain

U.S. Department of
Veterans’ Affairs

First time the federal government began using
EHR

1983

THERESA

Emory University and Grady
Memorial Hospital

1986

The Medical Record
(TMR)

Duke University Medical
Center

1988

Composite Health Care
System (CHCS)

U.S. Departments of Defense

First system to encourage direct physician data
entry
Made data easy to manipulate and sort for ease
of reference, giving way to Duke’s Health
Information System
Renowned for lowering medical errors
integrating various health record components

One of the first clinical decision support
programs

Early attempts to design and implement EHR technology encountered several difficulties and,
although many improvements have been made, certain lingering problems with current EHR
systems may explain why EHRs were not widely implemented on an expedited basis (See Table
5-2, below, as well as the Barriers to Implementation section).

29
30

340

“Electronic Health Records Overview” MITRE Center for Enterprise Modernization, To National Institutes of Health, National Center for
Research Resources, McLean, VA: MITRE, April 2006, p. 2.
“Electronic Health Records Overview” MITRE Center for Enterprise Modernization, To National Institutes of Health, National Center for
Research Resources, McLean, VA: MITRE, April 2006, p. 2; “History of Medicine: Development of the Electronic Health Record” By Jim
Atherton, American Medical Association Journal of Ethics, Vol. 13, No. 3 (March 2011), p. 187; “Computer-Based Patient Record
Technologies” National Research Council, The Computer-Based Patient Record: An Essential Technology for Health Care, Revised
Edition, Washington, DC, The National Academies Press, 1997, p. 114-115, 117-118; “History of Health Informatics at Duke” Duke Center
for Health Informatics, Durham, N.C.: 2010, http://www.google.com/url?sa=t&rct=j&q=%22the%20medical%20record%22%20
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Table 5-2: Status of Electronic Health Record Implementation (2011)31
Stage of Implementation

Percentage

Not Yet Begun
Developed a Plan
Signed a Contract
Begun to Install in One Facility
Fully Operational in One Facility
Fully Operational Across Whole Organization
Unknown

2%
7%
2%
34%
26%
27%
1%

Though paper health records have been used effectively by providers in the past, practices that
continue to utilize non-electronic documentation of patient information are experiencing
significant drawbacks.32 In addition to hindering the delivery of quality medical care, studies
have indicated that paper records are costly, cumbersome, easily misplaced, and difficult to use
for meaningful decision analysis.33 Furthermore, paper records cannot be effectively searched or
used to track, analyze, or chart voluminous clinical medical information and they cannot be
easily copied or saved off-site.34
Although EHR implementation has progressed at a relatively slow rate, it has continued to
increase steadily since 2003. Notably, the share of office based physicians that utilize any EHR
system has increased from 18% in 2001 to 78% in 2013, while the percentage of office based
physicians that utilize a “basic” EHR system has increased from 11% in 2001 to 48% in 2013.35
The states with the greatest percentage of office-based physicians using basic EHR systems
include: (1) North Dakota, 82.9%; (2) Minnesota, 75.5%; (3) Massachusetts, 70.6%; (4)
Wisconsin, 67.9%; (5) Iowa, 65.5%; and (6) Utah, 65.5%.36 States with the lowest percentage of
office-based physicians using basic EHR systems include: (1) New Jersey, 21.2%; (2)
Connecticut, 30.1%; (3) Washington, DC, 31.0%; (4) Nevada, 33.0%; (5) West Virginia, 36.9%;
and (6) Oklahoma, 36.9%.37
EHR system adoption also seems to be creating a widening divide between specialists (47%) and
primary care providers (78%) who have implemented EHR systems that meet meaningful use
criteria.38 Other divergences in EHR adoption include: (1) age, i.e., in 2012, office-based
physicians under the age of 45 were approximately 15% more likely to use an EHR system than
office-based physicians age 55 and older; (2) practice size, i.e., in 2012, practices with eleven or
more physicians were approximately 19% more likely to use EHR systems than practices with
only one or two physicians; and (3) ownership, i.e., in 2012, practices owned by a community
health center were more likely to adopt an EHR system than those owned by a physician or
31
32
33
34
35
36
37
38
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“Electronic Health Records” Healthcare Information and Management Systems Society, http://www.himss.org/ASP/topics_ehr.asp
(Accessed 6/22/09).
“Benefits and Drawbacks of Electronic Health Record Systems” By Nir Menachemi & Taleah H. Collum, Risk Management and
Healthcare Policy, Vol. 4, No. 1 (2011), p. 50-51.
“Electronic Health Record” Healthcare Information and Management Systems Society, http://www.himss.org/ASP/topics_ehr.asp
(Accessed 6/22/09).
“Use and Characteristics of Electronic Health Record Systems Among Office-based Physician Practices: United States, 2001-2013” By
Chun-Ju Hsiao, PhD and Esther Hing, MPH, NCHS Data Brief No. 143, Centers for Disease Control and Prevention, January 2014,
http://www.cdc.gov/nchs/data/databriefs/db143.pdf (Accessed 3/5/15), p. 1.
Ibid, p. 2.
Ibid, p. 2.
“Regional Extension Centers (REC) Enrolled Physicians Adoption of Electronic Health Records” Office of the National Coordinator for
Health Information Technology, February 2015, http://dashboard.healthit.gov/quickstats/pages/FIG-REC-Physicians-Live-MUSpeciality.php (Accessed 3/11/15).
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physician groups.39Additionally, EHR adoption seems to be further along outside of physician
practices with 97% of physicians in health maintenance organizations (HMOs) utilizing EHRs in
2012 and 80% of physicians in community health centers utilizing EHRs in 2012.40
Cost-Benefit Analysis
Using computer-based programs to track patients’ medical records, approve physician orders,
and prescribe medication can drastically improve patient outcomes and reduce costs. According
to the American Medical Association (AMA), practices that implement EHR technology will
benefit from a system of documenting patient vitals and test results, better supporting
documentation in medical malpractice claims, improved reporting regarding patient practices,
and improved communication between physicians.41 Furthermore, research suggests that
implementation of EHRs has a positive impact on physician productivity and may generate
savings by slowing the growth of healthcare costs.42
Additionally, EHR system implementation allows for the utilization of a computerized physician
order entry (CPOE), which may aid in reducing adverse drug events in inpatient and ambulatory
settings.43 These point-of-care technology systems make patient clinical data readily available,
and they provide physicians with access to scientific information essential to patient care and
decision-making.44
Practices that utilize EHR technology reduce their costs associated with utilizing and maintaining
traditional paper medical records.45 In addition to superior physician accessibility, EHRs allow
physicians to enter key findings and progress notes at the point of care, minimizing duplicate
documentation.46 Additionally, problems with legibility are eliminated, reducing potential
interpretation errors and saving time.47
Barriers to Implementation
Obstacles such as cost and physician resistance to change have delayed the widespread adoption
of EHRs.48 In 2014, 19% of senior healthcare executives noted that the most significant barrier to
39
40
41
42
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44
45
46
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48
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American Journal of Managed Care, Vol. 19, No. 10, November 25, 2013, http://www.ajmc.com/publications/issue/2013/2013-11-vol19SP/The-Impact-of-Electronic-Health-Record-Use-on-Physician-Productivity (Accessed 3/5/15); “Effect of Electronic Health Records on
Health Care Costs: Longitudinal Comparative Evidence From Community Practices” By Julia Adler-Milstein et al., Annals of Internal
Medicine, Vol. 159, No. 2, July 16, 2013, http://annals.org/article.aspx?articleid=1709804 (Accessed 3/5/15).
“Can Electronic Medical Record Systems Transform Health Care? Potential Health Benefits, Savings, and Costs” Health Affairs, Vol. 24
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implementing health information technologies such as EHRs involved a “lack of financial
resources,” serving as the most widely cited obstacle in the survey.49 The cost associated with
utilizing EHR technology can vary based on facility size, patient volume, and type of software,
which extends beyond the software license. Often, the cost of the software is only 50% of the
cost for a new system.50 For example, the cost of implementing an EHR system that is small in
scope (for a small physician group practice) has been estimated at approximately $46,00 in the
first year when including both financial costs (i.e. depreciable capital expenses, e.g. the cost of
hardware) and nonfinancial costs (e.g. the time expended by physicians and other staff).51
Accounting for the potential loss of productivity associated with the initial implementation may
further increase the cost of transitioning to an EHR system.52
However, research suggests that providers who increase their utilization of EHRs could have a
5% increase in physician productivity, while providers who increase their delegation of EHR
tasks could have an 11% increase in physician productivity.53 Some cardiology practices have
already reported substantial EHR benefits, including: (1) improvements in lowering Medicare
rejection rates; (2) improvements in their days in accounts receivable; (3) ability to increase
patient volume without increasing staff; (4) increased revenue; and (5) reduction in transcription
and postage costs.54 EHR benefits may also extend to hospitals, with an article in Healthcare
Financial Management estimating potential benefits over a 5-year period of over $37 million.55
In addition to governmental incentives and requirements (discussed further below in this
section), EHRs are imperative for current emerging value-based purchasing and evidence-based
trends, e.g., accountable care organizations (ACOs) and the hospital value-based purchasing
program. Variations on, or extensions of, EHR systems facilitate the growth and success of such
programs in addition to furthering consumer driven healthcare and accountability and access to
care.
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Providers who increase their utilization of EHRs could have a 5% increase in physician productivity, while
providers who increase their delegation of EHR tasks could have an 11% increase in physician productivity.
Julia Adler-Milstein, PhD and Robert S. Huckman, PhD, November 25, 2013.

Regulatory and Reimbursement
Regulatory
As with all medical records, EHRs must align with current Health Insurance Portability and
Accountability Act (HIPAA) regulations.56 Due to the ease of transferability and accessibility,
practitioners and healthcare facilities that use EHR technology must be abundantly cautious
about compliance.
In 2007, the Federal Trade Commission (FTC) issued a set of regulations known as the Red
Flags Rules, which required that certain entities develop and enforce written identity theft
prevention and detection programs by August 1, 2009.57 These programs are targeted at all
transferable personal files, including EHRs.58
On February 17, 2009, President Barack Obama signed into law the American Recovery and
Reinvestment Act of 2009 (ARRA), which allotted $19.2 billion to ensure that every patient has a
complete, interoperable EHR by 2014.59 The ARRA established both the Health Information
Technology for Economic and Clinical Health (HITECH) Act60 and an Office of National
Coordinator for Health Information Technology (ONC) within the Department of Health and
Human Services (HHS).61 Under HITECH and subsequent regulations, Medicare hospitals must
achieve “meaningful use” of EHR by October 2014 to avoid reimbursement penalties, while
Medicare-eligible professionals must achieve “meaningful use” by January 2015 to avoid
penalties.62 HITECH also provides both programmatic support and financial incentives to
overcome barriers that have previously dissuaded providers from adopting some form of an
electronic record system.63
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See the Health Insurance Portability and Accountability Act of 1996 (HIPAA) section in Chapter 3: Regulatory Environment.
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See the Red Flags Rule section in Chapter 3: Regulatory Environment.
“American Reinvestment and Recovery Act” Pub. L. No. 111-5, § 13101, 123 Stat. 115, 404 (February 7, 2009); “Signed, sealed, delivered:
ARRA” By Macon Phillips, The White House, February 17, 2009, http://www.whitehouse.gov/blog/09/02/17/signed-sealed-delivered-arra
(Accessed 5/15/12).
Specific provisions of the ARRA, namely, Title IV of Division B and Title XIII of Division A, are collectively known as the Health
Information Technology for Economic and Clinical Health Act (HITECH Act).
“Office of the National Coordinator for Health Information Technology” 42 U.S.C. § 300JJ-11 (July 9, 2010); “American Recovery and
Reinvestment Act of 2009, Sec. 13101” Pub. L. No. 111-5, 123 Stat. 115, 226, 230-234 (February 17, 2009).
“American Reinvestment and Recovery Act” Pub. L. No. 111-5, § 13101, 123 Stat. 115, 231 (February 7, 2009); “Payment Adjustments &
Hardship Exceptions” Centers for Medicare & Medicaid Services, March 5, 2015, http://www.cms.gov/Regulations-andGuidance/Legislation/EHRIncentivePrograms/paymentadj_hardship.html (Accessed 3/13/15).
“Meaningful Use of Health Information Technology: From Public Policy to Changing Care” By Paul Tang, Futurescan 2011: Healthcare
Trends and Implications 2011-2016, 2011, p. 33.
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Under the HITECH Act, the HIT Policy Committee was established to develop a framework to
be used by CMS to decide whether a provider has met the meaningful use requirements.64 The
framework established by the HIT Policy Committee consists of five categories (four clinical and
one foundational), including:
(1)
(2)
(3)
(4)
(5)

“Improve quality, safety, and efficiency of healthcare to reduce healthcare disparities.
Engage patients and families.
Improve care coordination.
Improve population and public health.
Ensure privacy and security of health information.”65

For both Medicare and Medicaid healthcare providers to qualify for HITECH incentives, they
must fulfill the three meaningful use requirements of EHRs:
“(1) Use of certified EHR technology in a meaningful manner (for example, electronic
prescribing);
(2) The certified EHR technology is connected in a manner that provides for the electronic
exchange of health information to improve the quality of care; and
(3) In using certified EHR technology, the provider submits…information on clinical quality
measures and such other measures selected by the Secretary.”66
Since the introduction of HITECH, CMS has rolled out the Medicare and Medicaid EHR
Incentive Programs in stages. In March 2015, CMS issued its Stage 3 Meaningful Use Proposed
Rule consisting of eight objectives to which all providers will be required to attest beginning in
2018. However, CMS proposed to incorporate flexibility within some of the objectives by
allowing providers to choose measures for meeting those requirements that are “most relevant to
their unique practice setting,” meaning that while providers must report on all required reportable
measures, they need only meet thresholds for a certain percentage of them and can choose on
which measures to do so.67 CMS intends for Stage 3 to be the final stage of meaningful use, but
has not foreclosed the possibility of future rule makings addressing EHR technology.68 It should
be noted however, that this proposed rule could change following the public comment period and
should be monitored accordingly by healthcare professionals working closely with EHRs.
Medicaid also requires that healthcare providers receiving incentives under the HITECH Act
must indicate their efforts to “adopt, implement, or upgrade certified EHR technology” wherever
possible.69 States may implement additional requirements for meaningful use beyond the
minimum standard upheld by Medicare, but such requirements must relate to four public health
objectives:
64
65
66
67
68
69
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(1) Generation of “lists of patients by specific conditions to use for quality improvement,
reduction of disparities, research, or outreach;”
(2) “Capability to submit electronic data to immunization registries…;”
(3) “Capability to submit electronic data on reportable…lab results to public health
agencies;” and
(4) “Capability to submit electronic syndromic surveillance data to public health agencies.”70
Reimbursement
As discussed above, in response to the slow transition to EHRs, the government has prioritized
proactive legislation promoting universal access to electronic records, in part, by passing the
ARRA and the HITECH Act. The net return of this investment was anticipated to include
improved outcomes, long-term cost savings, and increased ease of communication between
providers.71 In an effort to incentivize the implementation of EHR use, beginning in 2011,
reimbursement funding increased for Medicare and Medicaid providers (up to $65,000 per
physician and $11 million per hospital) who use EHRs.72 Conversely, physicians who were not
using EHRs by January 2015 were penalized through reduced reimbursement.73
The ARRA allotted $19.2 billion to ensure that each American has a complete, interoperable EHR by 2014.74

From May 2011 to January 2015, CMS provided more than $19.5 billion in Medicare EHR
incentive payments to Medicare providers.75 Although providers were first eligible to
demonstrate Stage 2 meaningful use in 2014,76 the HITECH Act Final Rule allowed any
Medicare eligible professional (EP) or hospital that was able to demonstrate meaningful use in
the two-year reporting period, prior to the 2015 payment adjustment year, to avoid the Medicare
payment adjustments.77 Providers that first demonstrated meaningful use in 2014 were able to
avoid this penalty if they registered and attested to their achievement of meaningful use standards
by July 1, 2014 for hospitals, or October 1, 2014 for EPs.78 EPs who were eligible for either
Medicare or Medicaid could also make meaningful use attestations to state Medicaid agencies in
order to avoid the Medicare penalty.79
70
71
72
73
74
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76
77
78
79
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“Health Care and the American Recovery and Reinvestment Act” By Robert Steinbrook, The New England Journal of Medicine, Vol. 360
No. 11 (March 12, 2009), p. 3.
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ELECTRONIC PRESCRIBING: COMPUTERIZED PHYSICIAN ORDER
ENTRY (CPOE)
Computerized physician order entry (CPOE) allows physicians and other healthcare providers
“to electronically order laboratory, pharmacy, and radiology services.”80 Entering orders
electronically minimizes error by eliminating the hassle and ambiguity associated with
handwritten orders.81 CPOE is designed to “streamline medication ordering by standardizing the
process, introducing controls, eliminating bad handwriting, making an order easily traceable to a
provider; additionally, with decision support installed, CPOE can also help assure adherence to
evidence-based guidelines.”82
Approximately 7,000 patients die every year in U.S as the result of medication errors.83 A 2012
Joint Commission study noted that, on average, adverse drug events (ADE) cost hospitals more
than $3,000 per incident.84 In the aggregate, preventable medical errors cost society, at a
minimum, $73.5 billion in quality-adjusted life years.85 An ADE is any injury caused by a
medication error, often in the form of an allergic reaction or adverse physiological response to a
certain combination of medications, i.e., (1) a drug to drug interaction or (2) a drug to allergy
interaction, while preventable ADEs are injuries resulting from human error, such as prescribing
or administering the wrong dose of a drug.86

Trends in CPOE
CPOE systems were first introduced in the late 1960s, but CPOE use was fairly sporadic until a
1999 study by the IOM entitled, “To Err Is Human,” found that 44,000 deaths were attributable
to medical errors annually.87 The study touted CPOE adoption as the solution to this newly
recognized national crisis.88
A 2008 Leapfrog Group study further touted the benefits of CPOE systems for hospitals, finding
that fully implemented CPOE systems could potentially reduce the frequency of ADEs by as
much at 88%.89 To qualify as having a fully implemented CPOE system, hospitals had to achieve
certain requirements, including: (1) 75% of all orders had to go through its CPOE system; (2) the
system had to alert physicians of possible errors; and (3) the system had to require a physician

80
81
82
83
84
85
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89

“Electronic Health Records Overview” National Institutes of Health: National Center for Research Resources, April 2006, p. 7.
“Welcome to CPOE.org” Oregon Health and Science University, http://www.ohsu.edu/academic/dmice/research/cpoe/index.php (Accessed
6/22/09).
“Full Implementation of Computerized Physician Order Entry and Medication-Related Quality Outcomes: A Study of 3364 Hospitals” By
Feliciano B. Yu et al., American Journal of Medical Quality, American College of Medical Quality (June 5, 2009), p. 6.
“To Err is Human: Building a Safer Health System” The Institute of Medicine, Washington, DC: National Academy Press, 2000, p. 1.
“The Cost of Adverse Drug Events in Community Hospitals” By Balthasar L. Hug, MD, MBA, MPH et al., The Joint Commission Journal
on Quality and Patient Safety, Vol. 38, No. 3 (March 2012), p. 125.
“The Economics of Health Care Quality and Medical Errors” By Charles Andel et al., Journal of Health Care Finance, Vol. 39, No. 1 (Fall
2012), p. 49.
“Saving Lives, Saving Money: The Imperative for Computerized Physician Order Entry In Massachusetts Hospitals” Massachusetts
Technology Collaborative, New England Healthcare Institute, February 2008, p.14.
“Impact of a Computerized Physician Order-Entry System” By William M. Stone et al., Journal of the American College of Surgeons, Vol.
208, Issue 5 (May 2009), p. 7; “To Err is Human: Building a Safer Health System” Institute of Medicine, November 1999, p. 1.
“To Err is Human: Building a Safer Health System” The Institute of Medicine, November 1999, p. 1.
“Leapfrog Hospital Survey Results” The Leapfrog Group, 2008, p. 3.
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response if an alert was overridden.90 Based on the Leapfrog Group’s findings, HHS, specifically
the Agency for Healthcare Research & Quality (AHRQ), encouraged (through federal funding)
CPOE adoption by hospitals as a way to improve care and reduce costs.91
As of 2013, 616 U.S. hospitals had some form of CPOE system in place.92 The ARRA and its
incentive program have significantly increased the number of providers implementing CPOE
systems with the incidence of fully implemented CPOE increasing from 87 hospitals annually
pre-ARRA, to 233 in 2010 and 616 in 2013.93 This increased adoption rate may be driven in part
by the Stage I meaningful use requirements, applicable to all healthcare providers, which
mandates that 30% of patients have a least one medication ordered through a CPOE system.94
The status of CPOE implementation by hospitals is illustrated below, in Table 5-3: Increased
Rate of CPOE Implementation, 2009 to 2013.
Table 5-3: Increased Rate of CPOE Implementation, 2009 to 2013 95
Year
2009
2010
2011
2012
2013

Percent Implementation Growth in Implementation
10%
14%
18%
31%
43%

N/A
40%
29%
72%
39%

Only 8% of hospitals have fully implemented CPOE systems. In addition, CPOE hospitals tend to be larger,
nonprofit, and teaching hospitals.
Feliciano B. Yu et. al, June 5, 2009.

CPOEs received much public attention following both the IOM’s call for the use of electronic
prescribing systems in all healthcare organizations by 2010 and the decision by the Leapfrog
Group to encourage CPOE adoption by hospitals as a means to improve care and reduce costs.96
Despite these initiatives, a 2009 study published in the American Journal of Medical Quality
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94
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96
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found that only 8.0% of hospitals had a fully implemented CPOE system, much of which were
larger, nonprofit teaching hospitals.97
Studies indicate that institutions that adopt CPOE systems are primarily focused on the safe and
proper delivery of clinical services.98 Political interests in clinical safety are more prevalent in
governmental facilities than in for-profit hospitals. Physicians are also the stakeholders most
opposed to the adoption of CPOE systems, due to a “perceived negative impact on physicians’
workflow,”99 and, accordingly, “[i]t may be that physicians are sufficiently powerful to prevent
(CPOE) adoption at private hospitals but not sufficiently powerful to delay (CPOE) adoption at
public institutions.”100 Additionally, the large percentage of teaching hospitals implementing
CPOE systems could be explained as a correlation between education and a heightened
commitment to innovation, as “results suggest that information about CPOE’s benefits has not
spread widely enough among key physicians or hospital decisionmakers [sic] outside of teaching
institutions.”101
Cost-Benefit Analysis
Prudent prescription and medication use has a substantial impact on the total cost of
healthcare.102 Overall, the financial impact of reported CPOE use has had a positive effect on the
net operating income of an institution.103 A 2014 study published in Perspectives in Health
Information Management noted that “cost savings due to avoided ADEs rang[ed] from $7 to $16
million,” with further annual savings of $92,000 due to reductions in tests performed by hospital
physicians.104 Further, a 2013 study published in the Journal of the American Medical
Informatics Association noted that CPOE systems reduced medication errors by 12.5%.105
Although some studies have shown that implementation of CPOE systems has resulted in
considerable gains in ordering process efficiency, other potential benefits of CPOE systems
appear to have been disproved.106 For example, although CPOEs are touted for their potential to
promote effective leadership and other quality performance indicators, studies have so far shown
that hospitals with complete CPOE systems do not systematically outperform, with regard to
these factors, as compared to those without.107 In addition, studies of CPOE systems are
97
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100
101
102
103
104
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107

“Full Implementation of Computerized Physician Order Entry and Medication-Related Quality Outcomes: A Study of 3364 Hospitals” By
Feliciano B. Yu et al., American Journal of Medical Quality, American College of Medical Quality, June 5, 2009, p. 1.
“U.S. Adoption of Computerized Physician Order Entry Systems” By David M. Cutler, Naomi E. Feldman and Jill R. Horitz, Health
Affairs, Vol. 24, No. 6 (November/December 2005), p. 1660.
“Overcoming Barriers To Adopting And Implementing Computerized Physician Order Entry Systems In U.S. Hospitals”
“U.S. Adoption of Computerized Physician Order Entry Systems” By David M. Cutler, Naomi E. Feldman and Jill R. Horitz, Health
Affairs, Vol. 24, No. 6 (November/December 2005), p. 201, 1661.
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“Saving Lives, Saving Money: The Imperative for Computerized Physician Order Entry In Massachusetts Hospitals” By Mitchell Adams et
al., Massachusetts Technology Collaborative, New England Healthcare Institute, February 2008, p. 15.
“Impact of a Computerized Physician Order-Entry System” By William M. Stone et al., Journal of the American College of Surgeons, Vol.
208, Issue 5 (May 2009), p. 9.
“Can Utilizing a Computerized Provider Order Entry (CPOE) System Prevent Hospital Medical Errors and Adverse Drug Events?” By
Krista Charles, MS, et al., Perspectives in Health Information Management, Fall 2014, p. 4.
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Journal of the American Medical Informatics Association, Vol. 20, No. 3 (March 2013), p. 473.
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208, Issue 5 (May 2009), p. 7.
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constrained by the technology’s comparative youth, continued evolution, emphasis on evaluation
of potential rather than actual errors, and limited dissemination.108
Despite these cost concerns, research has indicated that many hospitals respond proactively to
financial incentives, especially for-profit hospitals, which have been shown to make calculated
decisions based on profitability.109 According to The Joint Commission, “investments in patient
safety—although a moral obligation—usually provide financial benefits to payors and purchasers
rather than to the organization, a point not lost on stressed organization leaders.”110 Additionally,
changing the reimbursement structure to favor adoption of CPOE systems could offer a shortterm solution to increasing investment in these systems.111
From 2004 to 2008, the AHRQ awarded more than $260 million in funding for health
information technology (HIT), much of which focused on implementation and evaluation of
CPOE.112 This amount only covered part of the capital needed to secure and implement a CPOE
system. Providers were required to utilize alternate funding sources, including payors, statebased loan programs, and organizational IT budgets. However, with the significant capital
outlays required as well as resistance from physicians, the task of funding CPOE implementation
can be daunting for hospital administrators.113 To demonstrate, the 2014 Perspectives in Health
Information Management study noted that only 30% of small hospitals had adopted CPOE,
significantly lower than the 56% adoption rate by large hospitals.114
“Since 2004, AHRQ has invested over $260 in contracts and grants to over 150 communities, hospitals,
providers, and health care systems in 48 states to promote access to and encourage adoption of health IT.”
Agency for Healthcare Research and Quality, August 2008,.

Clinical Decision Support (CDS)
Clinical decision support (CDS) is a technology that provides clinicians with real-time feedback
for a wide range of diagnostic- and treatment-related decisions as they are entering electronic
patient records.115 CPOE systems with CDS can minimize the incidence of medical errors by
informing practitioners of potential drug interactions; patient allergies to prescribed
medication(s); medication contraindications; and renal- and weight-based dosing by providing
pop-up warnings when a complication exists with an order. However, alert fatigue, an
108 “Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors” By Ross Koppel et al, Journal of the American
Medical Association, Vol. 293, No. 10 (March 9, 2005), p. 1198.
109 “Making Profits and Providing Care: Comparing Non-profit, For-profit, and Governmental Hospitals” By Jill R. Horwitz, Health Affairs,
Vol.24, No.3, (May/June 2005), p. 796.
110 “Patient Safety: Instilling Hospitals with a Culture of Continuous Improvement” Testimony of Dennis O’Leary, The Joint Commission,
Testimony Before the Senate Committee on Governmental Affairs, (June 11, 2003), p. 4.
111 “Information Technology for Healthcare Quality Act” S.1223, Introduced (June 9, 2005); “The Future of Healthcare—Granting Access to
Innovation in America Act” H.R.3607, Introduced (July 28, 2005).
112 “Decisionmaker Brief: Computerized Provider Order Entry” Agency for Healthcare Research and Quality, August 2008,
http://healthit.ahrq.gov/sites/default/files/docs/page/08-0093_cpoe.pdf (Accessed 3/13/15).
113 “Lessons Learned from Implementation of Computerized Provider Order Entry in 5 Community Hospitals: A Qualitative Study” By Steven
R. Simon et al., BMC Medical Informatics and Decision Making, Vol. 13, No. 67, June 24, 2013, p. 2.
114 “Can Utilizing a Computerized Provider Order Entry (CPOE) System Prevent Hospital Medical Errors and Adverse Drug Events?” By
Krista Charles, MS, et al., Perspectives in Health Information Management, Fall 2014, p. 5.
115 “Inpatient Computerized Provider Order Entry (CPOE): Findings from the AHRQ Health IT Portfolio” By Brian E. Dixon and Atif Zafar,
U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, January 2009,
http://healthit.ahrq.gov/images/jan09cpoerport/cpoe_issue_paper.htm (Accessed 6/22/09).
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overabundance of warnings that can occur when there is a combination of critical medical alerts
and a high volume of marginally medically consequential alerts,116 may desensitize and annoy
practitioners, causing them to ignore vital alerts and potentially harm their patients.117
Quality of Care Improvements
A 2009 study in the American Journal of Medical Quality found significant positive associations
between specific objective quality indicators and CPOE implementation.118 Hospitals with CPOE
systems noted that errors related to the legibility of paper orders were eliminated and alerts for
potential allergies, drug interactions, and dosing standards improved patient safety. Further, the
ability of a pharmacy to receive orders instantaneously resulted in “stat”119 orders being filled
faster.120 In addition to preventing ADEs, CPOE systems also alert providers to available generic
options for any prescription drug; notify clinicians of redundant orders or laboratory test entries;
and list the drug delivery methods suitable for any prescribed drug to prevent delivery errors
(e.g., intravenous administration of orally administered drugs). 121 CPOE systems could be even
more beneficial to long-term care facility residents who, on average, have over six concurrent
drug therapies, which, exacerbated by problems associated with advanced age, can increase the
risk of an ADE.122
Barriers to Implementation
In addition to the costs associated with implementing a CPOE system, several other challenges
should be considered, including: (1) technical issues; (2) unintended errors; and (3) physician
reluctance.123
Technical Issues
It should be noted that there is no “one size fits all” CPOE system; therefore, many hospitals may
need to customize their systems, including the integration of current systems.124 This process
necessitates thorough project planning and execution, which may hinder production and cause
unforeseen delays.

116 Ibid.
117 “CPOE: It Don’t Come Easy” By Howard J. Anderson, Health Data Management, Vol. 17, No. 1 (January 2009), p. 19.
118 “Full Implementation of Computerized Physician Order Entry and Medication-Related Quality Outcomes: A Study of 3364 Hospitals” By
Feliciano B. Yu et al., American Journal of Medical Quality, June 5, 2009, p. 1.
119 The term “stat” is short for the Latin word “statim,” for immediately.
120 “CPOE: It Don’t Come Easy” By Howard J. Anderson, Health Data Management, Vol. 17, No. 1 (January 2009), p. 20.
121 “Can Utilizing a Computerized Provider Order Entry (CPOE) System Prevent Hospital Medical Errors and Adverse Drug Events?” By
Krista Charles, MS, et al., Perspectives in Health Information Management, Fall 2014, p. 2; “The Value of Computerized Provider Order
Entry in Ambulatory Settings” Center for Information Technology Leadership, Partners HealthCare,
http://www.partners.org/cird/pdfs/CITL_ACPOE_Full.pdf (Accessed 3/13/15), p. 4, 12, 54.
122 “Clinical Application of a Computerized System for Physician Order Entry With Clinical Decision Support to Prevent Adverse Drug Events
in Long-Term Care” By Paula A. Rochon et al., Canadian Medical Association Journal, Vol. 174, No.1 (January 3, 2006), p. 52..
123 “Principles for a Successful Computerized Physician Order Entry Implementation” By Joan S. Ash, et al., American Medical Informatics
Symposium Proceedings, 2003, p. 23; see Cost-Benefit Analysis, above.
124 “Inpatient Computerized Provider Order Entry (CPOE): Findings from the AHRQ Health IT Portfolio” By Brian E. Dixon and Atif Zafar,
U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, January 2009,
http://healthit.ahrq.gov/images/jan09cpoerport/cpoe_issue_paper.htm (Accessed 6/22/09).
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Given the customization needed to integrate a CPOE system into any facility’s infrastructure, a
fair amount of training is required to ensure that clinicians, technicians, and practitioners will
maintain and use the system consistently and correctly.125
Unintended Errors
CPOE system technology introduces other potential unintended errors, which include delivery of
orders on incorrect patients, errors of clinician omission, lack of communication among clinical
staff regarding the status of an order, loss of information during care transitions, and overlapping
medication orders.126 A 2005 study in the Journal of the American Medical Association found
that one CPOE system facilitated 22 types of medication error risks generated by: (1) data
fragmentation; (2) failure to integrate various computer and information systems; and (3) humanmachine interface flaws.127 However, as CPOE systems become more advanced, some of these
unforeseen problems have decreased in frequency. For example, the average number of
electronic patient entries in 2003 being re-entered was 48%, which percentage dropped to 21%
by 2008.128
Physician Reluctance
Another potential barrier to use of CPOE is related to utilization by providers, i.e., (1) resistance
to workflow changes (63%) and (2) too many clicks to place an order (32%).129 User satisfaction
has been identified as an important predictor of the success of CPOE adoption and compliance.130
Typically, younger interns and residents are more willing to use CPOE, while older, more
experienced physicians tend to be less satisfied with CPOE.131
One of the primary complaints from physicians is that it takes longer to enter an order
electronically. Physicians also have reported a loss of professional autonomy because CPOE
systems can prevent them from ordering the type of test(s) or medication(s) they prefer, force
them to comply with clinical guidelines they do not embrace, and limit their flexibility through
structured, rather than free-text clinical, documentation.132

125 Ibid.
126 “Impact of a Computerized Physician Order-Entry System” By William M. Stone, et al., Journal of the American College of Surgeons, Vol.
208, Issue 5 (May 2009), p. 7.
127 “Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors” By Ross Koppel et al, Journal of the American
Medical Association, Vol. 293, No. 10 (March 9, 2005), p. 1201.
128 “Computerized Physician Order Entry Usage in North America: The Doctor is In” By Stacilee Oakes Whiting and Adam Gale, HIT Report
from KLAS, Healthcare Quarterly, Vol. 11, No. 3 (2008), p. 95.
129 “2012 CPOE and Meaningful Use Research Brief” Imprivata, p. 5.
130 “Does User Satisfaction Relate to Adoption Behavior?: An Exploratory Analysis using CPRS Implementation” By Charlene R. Weir et al,
American Medical Informatics Association Symposium, 2000, p. 916.
131 “User Satisfaction with Computerized Order Entry System and its Effect on Workplace Level of Stress” By Nasrollah Ghahramani et al,
Journal of Medical Systems, Vol. 33, No. 3 (July 2, 2008), p. 199.
132 “Types of Unintended Consequences Related to Computerized Provider Order Entry” By Emily M. Campbell, et al., Journal of the
American Medical Informatics Association, Vol. 13, No. 5 (September/October 2006), p. 552.
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Regulatory and Reimbursement
Regulatory
Individual states have enacted laws to reduce medical errors. The California Health and Safety
Code Section 1339.63 states: “As a condition of licensure under this division, every general
acute care hospital…special hospital…and surgical clinic…shall adopt a formal plan to eliminate
or substantially reduce medication-related errors….This plan shall include technology
implementation, such as, but not limited to, computerized physician order entry.”133 This law
required all plans to be submitted by 2002, with the licensure changes taking effect on January 1,
2005.134 A similar law in Massachusetts requires statewide implementation of CPOE systems by
2012.135
On a federal level, there have been several bills proposed in both the U.S. Senate and the U.S.
House of Representatives regarding implementation of CPOE systems.136 Although none of the
bills specifically requiring CPOE implementation has been passed, the Patient Safety and
Quality Improvement Act of 2005 called for a report including suggestions on the reduction of
medical errors to be submitted to the IOM.137 In addition, the CMS 2004 Final Rule entitled,
Medicare and Medicaid Programs; Hospital Conditions of Participation: Quality Assessment
and Performance Improvement, created a quality assessment and performance improvement
program to reduce medical errors, including medication errors.138
Reimbursement
In the past, financial incentives to support investments in CPOE technology were lacking, in part
because public payors paid the same reimbursement for unsafe care as they did for safe care.139
To combat this, some private insurers are leading the charge to incentivize hospitals to
incorporate CPOE.140
The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) created an
incentive program for professionals to start e-prescribing. Section 132 of MIPPA established
incentives for years 2009 through 2013, in which Medicare professionals who are successful eprescribers received payments of 2.0 percent for 2009 and 2010, 1.0 percent for 2011 and 2012,
and 0.5 percent for 2013.141 The goal of these incentives was to allow the Government
133 “Minimization of Medication-Related Errors” Health and Safety Code Section 1339.63, California Code, September 2000.
134 Ibid.
135 “An Act to Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care” The Commonwealth of
Massachusetts, Senate, No. 2863, July 31, 2008.
136 “The Future of Healthcare—Granting Access to Innovation in America Act” House of Representatives Bill, H.R. 3607, July 28, 2005;
“Information Technology for Health Care Quality Act” Senate Bill 1223, June 9, 2005; “A Bill to Provide for the Use of Improved Health
Information Technology with Respect to Certain Safety Net Health Care Providers” United States Senate, S.890, April 23, 2009.
137 “Patient Safety and Quality Improvement Act of 2005” Pub. L. No. 109-41,119 Stat. 424, 430-431 (July 29, 2005).
138 “Medicare and Medicaid Programs; Hospital Conditions of Participation: Quality Assessment and Performance Improvement” Centers for
Medicare & Medicaid Services, Department of Health & Human Services, Federal Register Vol. 68, No. 16 (January 24, 2003), p. 3435.
139 “Patient Safety: Instilling Hospitals with a Culture of Continuous Improvement” Testimony of Dennis O’Leary, The Joint Commission,
Testimony Before the Senate Committee on Governmental Affairs (June 11, 2003), p. 2.
140 “Massachusetts Hospitals Should Adopt CPOE Systems, Group Says” iHealth Beat, February 15, 2008, http://www.ihealthbeat.org/
Articles/2008/2/15/Massachusetts-Hospitals-Should-Adopt-CPOE-Systems-Groups-Say.aspx (Accessed 6/26/09).
141 “Medicare Improvements for Patients and Providers Act of 2008” H.R. Bill 6331 (January 3, 2008), p. 34-38.
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Accountability Office (GAO) to submit a report on the implementation of the incentives for
electronic prescribing to Congress by September 1, 2012.142

OUTSOURCING BILLING SERVICES
With physician professional practices under economic pressure to cut costs and adhere to
heightened regulations regarding security and compliance, a greater number of practices use
outsourcing as a “tool for survival and growth.”143
Outsourcing in healthcare has yielded higher efficiency levels and more cost-effective outcomes
and has also provided increased physician and patient satisfaction.144 Many health practices are
utilizing foreign companies for medical billing in response to those companies’ guarantees of
dramatic savings compared to their American counterparts.145
Despite the financial benefits of outsourcing billing, it also raises issues of compliance with
HIPAA. A 2005 study showed that although many outsourcing service providers have
implemented HIPAA requirements, others have chosen not to comply, citing “no public relations
or brand problems anticipated with noncompliance” and “no anticipated legal consequences for
non-compliance.”146 With lawmakers increasing penalties for noncompliance with privacy
laws,147 it is likely that outsourcing services providers will begin to increase their compliance
efforts. The HITECH Act, enacted as part of ARRA,148 delineates a tiered system for determining
the appropriate penalties for HIPAA privacy violations.149 HITECH Act provisions significantly
increased the penalties for violations of HIPAA, allowing for penalties up to $1.5 million.150

TELEMEDICINE AND TELEHEALTH
Telemedicine is the transfer of electronic medical data (high resolution images, sounds, live
video, and patient records) from one location to another in order to enhance the quality and
efficiency of patient comfort and care. This technology utilizes a variety of telecommunication
technologies, including, but not limited to, ordinary phone lines, integrated services digital
network, fractional to full T-1 lines, ATMs, the Internet, and satellites.151 Telehealth is closely
142 “CRS Report for Congress: P.L. 110-275: Medicare Improvement for Patients and Providers Act of 2008” By Hinda Chaikind et al., July
23, 2008, p. 11-12.
143 “Outsourcing of Healthcare Services: Issues & a Framework for Success” By Ram Misra, et al., Journal of Information Technology and
Applications, Vol. 1, No. 2 (September 2006), p. 79-88.
144 Ibid.
145 “Offshore Outsourcing: Current and Future Effects on American IT Industry” By Laura L. Pfannenstein and Ray J. Tsai, Information
Systems Management Journal (Fall 2004), p. 79.
146 “Outsourcing of Healthcare Services: Issues & a Framework for Success” By Ram Misra, et al., Journal of Information Technology and
Applications, Vol. 1, No. 2 (September 2006), p. 79.
147 “Summary of the HIPAA Privacy Rule: Enforcement and Penalties for Noncompliance” U.S. Department of Health and Human Services,
http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/index.html (Accessed 3/16/15).
148 “HHS Strengthens HIPAA Enforcement” News Release, U.S. Department of Health and Human Services, October 30, 2009,
http://www.hhs.gov/news/press/2009pres/10/20091030a.html (Accessed 11/20/09).
149 “HIPAA and the HITECH Act: Know the Level of Penalties” HIPAA Weekly Advisor, Mar. 16, 2009, http://www.hcpro.com/print/HIM229707-866/HIPAA-and-the-HITECH-Act-Know-the-level-of-penalties.html (Accessed 11/20/09).
150 “HHS Strengthens HIPAA Enforcement” News Release, U.S. Department of Health and Human Services, October 30, 2009,
http://www.hhs.gov/news/press/2009pres/10/20091030a.html (Accessed 11/20/09).
151 “Telemedicine 101: A Brief History of Telemedicine” By Nancy Brown, Telemedicine Information Exchange, American Telemedicine
Association, http://tie.telemed.org, May 30, 1995.
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related to telemedicine and is used to describe remote healthcare, in a broader sense, that does
not necessarily involve clinical services, although the two terms are often used
interchangeably.152
According to former acting CMS Administrator Kerry Weems, utilizing communication
equipment to link healthcare practitioners and patients in different locations “results in cost
efficiency, reduced transportation expenses, improved patient access to specialists and mental
health providers, improved quality of care, and better communication among providers.”153
As of 2012, telemedicine services have been integrated into approximately 50 different medical
subspecialties,154 and approximately 200 telemedicine networks are established in the country,
involving over 3000 medical and healthcare institutions.155 Services offered through telemedicine
include, but are not limited to:
(1)
(2)
(3)
(4)
(5)

Specialized and primary care consultations; imaging services;
Remote patient monitoring;
Remote medical education and consumer information;
Networked programs linking hospitals to rural clinics;
Point-to-point connection using private networks between hospitals and ambulatory care
sites;
(6) Primary or specialty care to the home connections;
(7) Home to monitoring centers; and
(8) Web-based e-health patient service sites.156
Telemedicine services have been successfully integrated into approximately 50 different medical
subspecialties.
American Telemedicine Association, 2012)

Trends in Telemedicine
The range of telemedicine technology is divided into two main application groups: (1) Store and
forward is the transfer of digital images between locations, most commonly seen in teleradiology
and telepathology (the use of pathology slides for diagnostic consultation)157 and (2) two-way
interactive television is used in telemedicine for face-to-face consultation. These real-time
consultations often occur between patients or nurses in rural environments and practitioners.158
152 “Telemedicine Defined?” American Telemedicine Association, http:// www.@americantelemed.org/i4a/pagees/index.cfm?pageid=3333
(Accessed 6/30/09).
153 "Medicare's and Medicaid's New Reimbursement Policies for Telemedicine" By Alan Naditz, Telemedicine and eHealth, Vol. 14, No. 1
(January/February 2008), p. 21.
154 “Telemedicine Defined” American Telemedicine Association, http://www.americantelemed.org/i4a/pages/index.cfm?pageid=3333
(Accessed 07/16/12).
155 “About Telemedicine” American Telemedicine Association, 2012, http://www.americantelemed.org/i4a/pages/index.cfm?pageid3331
(Accessed 07/16/12); “What is Telemedicine” American Telemedicine Association, http://www.americantelemed.org/abouttelemedicine/what-is-telemedicine#.VQcGgdJ4oqc (Accessed 3/16/15).
156 “Telemedicine Defined” American Telemedicine Association, http://www.americantelemed.org/i4a/pages/index.cfm?pageid=3333
(Accessed 7/16/12).
157 “Telemedicine 101: Telemedicine Coming of Age” By Nancy Brown, Telemedicine Information Exchange, American Telemedicine
Association, http://tie.telemed.org, January 13, 2005.
158 Ibid.
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One form of store and forward technology is related to the use of patient monitoring. Some of
the situations most associated with telemedicine are those where patients’ levels are monitored
through a device that reports their health status to a remote provider through a satellite or cellular
network. The top five conditions for remote monitoring are: (1) diabetes; (2) prescription
compliance; (3) active heart monitoring; (4) blood pressure; and (5) sleep apnea.159 Remote
monitoring allows patients to receive more treatments in an outpatient setting and to be
discharged more quickly because the patient can be observed outside of the hospital. As access to
faster and higher bandwidth Internet and cellular providers improves, access to remote
technologies similarly improves.160
One example of remote monitoring is the Savacor Dynamic Rx patient-operated handheld digital
assistant, which is part of an integrated system that, using implantable heart monitoring devices,
regularly monitors the patient for specific indicators (which are pre-programmed by the
physician) specific to the individual patient. Those indicators then instruct the patient on how to
adjust their medication, and they even provide instructions if the patient requires medical
attention.161 A potentially viable alternative to invasive techniques is noninvasive physiologic
monitoring, such as wearable body sensors that measure heart and respiratory rates, posture,
and activity levels. These vitals are then analyzed to identify potential diseases before the patient
becomes symptomatic.162
Virtual clinics using telehealth technologies have been implemented nationwide and typically
require patients to pay a flat fee to communicate with a physician using a webcam and an instant
messaging program over the Internet for approximately ten minutes.163 Telehealth clinics have
been implemented on a broader scale throughout the country, with many states requiring
coverage of the services. As of 2014, 46 states and the District of Columbia provide
reimbursement through Medicaid, and 20 states and the District of Columbia require
reimbursement through private insurance for telehealth services.164 However, most states have
restrictions on physician licensure that make interstate telemedicine difficult to implement.165
Hospitals, in efforts to reduce readmission rates, have begun utilizing telehealth technology. One
such patient monitoring system, VitalPoint Pro by CJPS Healthcare Supplies & Equipment,
LLC, emails or texts patient data to physicians for monitoring and also alerts clinicians when any
of the 61 physiological indicators falls out of the preset parameters.166 The capability to manage
patients through telemedicine and the use of a monitoring network accessible through mobile
devices has improved patient outcomes for conditions such as stroke by allowing providers to
159 “Top 5 Conditions for Telemedicine Treatment” By Steff Descgebes, Healthcare IT News, July 27, 2012, http://www.healthcareitnews.com/
news/top-5-health-conditions-telemedicine-treatment (Accessed 9/26/12).
160 “Telecommuting” National Learning Consortium, October 21, 2011, p. 31.
161 “Heart Failure Devices: Raising Roadblocks To Readmission” By Mary Thompson, Medtech Insight, Vol. 14, No. 1 (January 2012), p. 7.
162 Ibid, p. 7-8.
163 “Visiting Your Doctor Online is a Virtual Reality” By Megan Johnson, U.S. News, http://health.usnews.com/health-news/familyhealth/articles/2009/10/27/visiting-your-doctor-online-is-a-virtual-reality (Accessed 3/16/15).
164 “50 State Telemedicine Gaps Analysis: Coverage & Reimbursement” By Latoya Thomas and Gary Capistrant, American Telemedicine
Association, September 2014, http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gaps-analysis---coverageand-reimbursement.pdf (Accessed 3/16/15), p. 2.
165 “50 State Telemedicine Gaps Analysis: Physician Practice Standards & Licensure” By Latoya Thomas and Gary Capistrant, American
Telemedicine Association, September 2014, http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gapsanalysis--physician-practice-standards-licensure.pdf (Accessed 3/16/15), p. 2-3.
166 “CJPS Medical Systems VitalPoint® PRO User Manual” CJPS Medical Systems, 2011, p. v, 36-42.
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view patient scans and send emergency room (ER) notifications to specialists immediately,
facilitating more timely and accurate care decisions.167
Another example hospital utilization of telehealth technologies is Mercy, a multistate healthcare
system in the Midwest, which announced the development of a $50 million, 120,000 square-foot
virtual care center in 2015.168 A 2015 projection estimated this center to manage more than three
million telehealth visits between 2015 and 2020.169 Currently, the system uses home monitoring
for discharged patients with conditions such as heart failure and chronic obstructive pulmonary
disease and is testing patients’ follow-up coordination with their primary care physician through
telehealth technology.170 Mercy hopes to expand this innovation to hospitals without an
intensivist or neurologist on staff in an effort to prevent readmissions and enable the treatment of
potential Intensive Care Unit and stroke patients.171
The chief catalyst of teleradiology is the demand for night coverage, also known as nighthawk
coverage, i.e., where physicians provide preliminary readings remotely when a patient need
arises at a hospital operating with a limited staff during the night. Almost 50% of all radiology
practices have supplemented their staff with external, remote providers,172 and many
teleradiology firms are competing to provide those services. As competition in this field has
increased, pricing has become a significant market factor and, consequently, the average price
per procedure has begun to decline, which in turn has triggered aggressive merger and
acquisition activities among teleradiology firms173 that are now attempting to establish
themselves as full-service professional radiology service providers.174 The largest provider on the
market according to FTEs and total studies done is currently Virtual Radiologic (vRad),175 which
acquired its main competitor, Nighthawk, in September 2010.176
Advances in robotics now allow telehealth to have a tangible component. Mercy Folsom
Hospital in California recently unveiled a robot diagnostic tool (costing approximately $500,000)
that can be operated by a neurospecialist remotely to examine stroke victims.177 Additionally,

167 “Smartphone Teleradiology Application is Successfully Incorporated into a Telestroke Network Environment” By Bart M. Demaerschalk,
et al., Stroke, Journal of the American Heart Association, Vol. 43, No. 11 (November 2012), p. 1-2.
168 “Transforming the Health of Our Communities” Mercy, 2015, http://www.mercy.net/about/transforming-the-health-of-our-communities
(Accessed 3/26/15); “Telehealth Promises to Reshape Health Care” By Geri Aston, Hospitals & Health Networks: American Hospitals
Association, March 10, 2015, http://www.hhnmag.com/display/HHN-news-article.dhtml?dcrPath=/templatedata/HF_Common/
NewsArticle/data/HHN/Magazine/2015/Mar/cov-telehealth-patients-connect, (Accessed 3/26/15).
169 “Telehealth Promises to Reshape Health Care” By Geri Aston, Hospitals & Health Networks: American Hospitals Association, March 10,
2015, http://www.hhnmag.com/display/HHN-news-article.dhtml?dcrPath=/templatedata/HF_Common/NewsArticle/data/
HHN/Magazine/2015/Mar/cov-telehealth-patients-connect, (Accessed 3/26/15).
170 Ibid.
171 Ibid.
172 “What Primary Considerations Govern Vendor Selection and Contract Administration in the Burgeoning Teleradiology Market” By Dara
O'Brien, Imaging Economics, April 2012, http://www.imagingeconomics.com/issues/articles/2012-04_02.asp (Accessed 10/8/12).
173 “Teleradiology Firms Move in on PACS” By Nadim Daher, Diagnostic Imaging.com, http://www.diagnosticimaging.com/radblog/
display/article/113619/1978195 (Accessed 10/8/12).
174 “Lines Blur Between Private and Corporate Radiology as Teleradiology Evolves” By Cheryl Proval, Radiology Business Journal,
http://www.radiologybusiness.com/topics/care-delivery/lines-blur-between-private-and-corporate-radiology-teleradiologyevolves?nopaging=1 (Accessed 3/16/15).
175 “The 20 Largest Radiology-Services Companies: 2014” Radiology Business Journal, February 2014, https://s3.amazonaws.com/imagingbiz/
img/top20.pdf (Accessed 3/16/15).
176 “Teleradiology Firms Move in on PACS” By Nadim Daher, Diagnostic Imaging.com, http://www.diagnosticimaging.com/radblog/
display/article/113619/1978195 (Accessed 10/8/12).
177 “State Telehealth News” Telemedicine Information Exchange, April 30, 2009, http://tie.telemed.org/funding/news.asp (Accessed 7/1/09),
p. 15.
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Night Hospitalist Company, LLC (NHC) provides telephonic medical care from 7 PM to 7 AM for
hospitals with ongoing staffing shortages. NHC employs both allopathic and osteopathic
physicians who are licensed in multiple states to provide medical services from their homes for
$500 per night.178 NHC costs $60 per hour for services in hospitals with up to 50 beds,
approximately half the cost of an in-house hospitalist.179 Another pilot telehealth initiative, the
RP-7 robot at Eagle Hospital in Atlanta, Georgia, is a mobile computer work station linked
through a telehealth connection that is remotely controlled by a physician to traverse clinics, take
histories, perform physicals, and admit patients remotely.180 While the pilot program began with
only ten hospitalists,181 Eagle is continually seeking greater physician participation in the
program.182
Digital telemedicine is allowing x-rays to be read overnight in India, psychotherapy to be
conducted remotely, and mammograms to be screened automatically through digital scanning.
As noted by PricewaterhouseCoopers, “[t]his explosion of technology applications holds not
only the promise of more efficient and more effectively distributed care but also the potential for
significant disruption for certain medical specialties.”183
Cost-Benefit Analysis
A 2015 study performed by IHS Inc. at the request of the Association of American Medical
Colleges (AAMC) predicted that, by 2025, there may be a shortage of up to 94,800 physicians
(an estimated shortage of 12,500 to 31,100 primary care physicians and an estimated shortage of
28,200 to 63,700 non-primary care physicians184—including medical, surgical, and other
specialists).185 For hospitals that are experiencing physician shortages, telemedicine facilitates
hospitalist recruitment, providing more attractive work hours for providers and allowing a single
practitioner to provide services to multiple hospitals at one time. Additionally, telemedicine has
improved access between hospitalists and specialists. Telemedicine also allows hospitals to
expand their market service area by employing telemedicine technology at outlying medical
clinics and offices.186
The VA is the largest provider of remote medical services, serving over 690,000 veterans in
Fiscal Year 2014 alone.187 Through telemedicine, by 2009 the VA had reduced the average

178 “Physician Partners” Night Hospitalist Company, http://www.nighthospitalist.com/physician-partners/ (Accessed 3/16/15).
179 “FAQ” Night Hospitalist Company, http://www.nighthospitalist.com/faq/ (Accessed 3/16/15).
180 “Night-Shift Solutions” By Lisa Ryan, The Hospitalist, April 2009, http://www.the-hospitalist.org/detains/article/183090/
NightShift_Solutions.html (Accessed 6/20/09).
181 Ibid.
182 “Eagle Telemedicine FAQs” Eagle Hospital Physicians, http://www.eaglehospitalphysicians.com/pdf/TelemedicineFAQs.pdf (Accessed
3/16/15).
183 “What Works: Healing the Healthcare Staffing Shortage” PricewaterhouseCoopers’ Health Research Institute, 2007, p. 27.
184 “The Complexities of Physician Supply and Demand: Projections from 2013 to 2025” IHS Inc. for Association of American Medical
Colleges, March 2015, https://www.aamc.org/download/426242/data/ihsreportdownload.pdf (Accessed 3/16/15).
185 “Physician Supply and Demand Through 2025: Key Findings” Association of American Medical Colleges, https://www.aamc.org/
download/426260/data/physiciansupplyanddemandthrough2025keyfindings.pdf (Accessed 3/16/15).
186 “Night-Shift Solutions” By Lisa Ryan, The Hospitalist, April 2009, http://www.the-hospitalist.org/detains/article/183090/
NightShift_Solutions.html (Accessed 6/20/09).
187 “VA Telehealth Services Served Over 690,000 Veterans in Fiscal Year 2014” U.S. Department of Veterans Affairs, http://www.va.gov/
opa/pressrel/pressrelease.cfm?id=2646 (Accessed 3/18/15).
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length of stay at hospitals by 25%, and hospitalization by 19% for patients using home health
services.188
Through telemedicine, by 2009 the VA had reduced the average number of days hospitalized by 25% and
reduced hospitalization by 19% for patients using home health.
Government Health IT News, 2009.

On May 5, 2011, CMS issued a Final Rule on telemedicine credentialing and privileging, which
may aid in facilitating the implementation of innovative medicine at non-urban hospitals. This
Rule allows privileges and credentialing reciprocity between an institution where a physician
seeks to provide telemedicine services to Medicare and Medicaid patients and the hospital where
a physician is already privileged.189 Several professional associations have expressed approval of
the new regulations. The Joint Commission, which controls much of telemedicine accreditation
and has intimately involved with CMS policy surrounding this topic, touted the Final Rule as a
positive step for improving access to care for patients in rural areas.190 Additionally, the
American Hospital Association (AHA) commended the Final Rule’s flexibility and the inclusion
of non-hospital entities, such as radiology groups and independent physicians, within the scope
of the law.191
Despite this Final Rule, regulatory hurdles still remain. Physicians still face restrictions by state
licensure laws in areas that do not extend reciprocity to physicians seeking to provide
telemedicine services to hospitals in another state. Although every state, the District of
Columbia, Puerto Rico, and Guam have some form of legislation addressing licensure for
telemedicine services, these laws vary widely in flexibility and the scope of services covered,
with many only permitting consultations.192 Additionally, the degree of regulatory variations
becomes even more fragmented in some states, with different laws for allopathic physicians
(MD) and for osteopathic physicians (DO).193
Many healthcare practitioners have obtained federal funds for investments in telemedicine
technology through grants, contracts, and direct services. The ARRA set aside $2.5 billion to be
put into affiliated grants and loans for telemedicine. The act also called for complete adoption of
EHRs by 2014, without which the implementation of telemedicine may have been hindered.194
Additionally, the Federal Communications Commission created the Rural Health Care Pilot
Program to increase patient access to telemedicine and support the transfer of EHRs. Sixty-nine
nationwide projects across 38 states and the territories of Guam, American Samoa, and the
188 “VA Study Finds Home Telehealth Reduces Amount and Duration of Hospitalizations” Government Health IT News, Feb 26, 2009
http://telemed.org/homehealth/news.asp#item1744 (Accessed 9/24/09).
189 “Medicare and Medicaid Programs: Changes Affecting Hospital and Critical Access Hospital Conditions of Participation: Telemedicine
Credentialing and Privileging” Federal Register Vol. 76, No. 87 (May 5, 2011), p. 25550.
190 "The Joint Commission Applauds CMS' Revised Telemedicine Requirements" By Elizabeth E. Zhani, The Joint Commission, News
Details, May 6, 2011, http://www.jointcommission.org/the_joint_commission_applauds_cms_revised_telemedicine_requirements/
(Accessed 5/19/11).
191 "CMS Issues Final Rule on Telemedicine Credentialing Privileging" American Hospital Association, AHA News Now, May 2, 2011,
http://www.ahanews.com/ahanews_app/jsp/display.jsp?dcrpath=AHANEWS/AHANewsNowArticle/data/ann_050211_telemedicine&doma
in=AHANEWS (Accessed 5/19/11).
192 “Telemedicine Overview: Board-by-Board Approach” Federation of State Medical Boards, August 2012.
193 Ibid.
194 “The American Recovery and Reinvestment Act of 2009: Summary of Key Health Information Technology Provisions” Healthcare
Information and Management Systems Society, February 18, 2009.
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Northern Mariana Islands were granted one-time funding (combined total of $418 million) to
cover up to 85% of the cost of the construction of broadband networks to support participating
healthcare providers in rural and urban areas.195
Barriers to Implementation
The two main barriers to telemedicine implementation are: (1) reimbursement obstacles from
Medicare and certain private health insurers and (2) medical licensing. Depending on the
licensing practices of the state, practitioners who utilize interstate telemedicine may have to be
licensed in each of the states in which they treat patients, which can be time-consuming and
expensive.196
Some physicians refrain from using telemedicine systems due to liability issues and skepticism
regarding the competency of the technology. Generally, patients expect physicians at their
bedside, not a video or voice transmitted through the Internet or satellite. Without traditional
bedside care, there may be an increased likelihood of being sued if a problem occurs.197 As with
any form of technology, startup and training costs are associated with telemedicine. These vary
depending on the technology being implemented and have the potential to hinder implementation
for some providers, including some of the rural geographic locations most in need.198

Regulatory and Reimbursement
Regulatory
State
Physicians practicing medicine in any state must be approved by the licensure board of that
particular state. In 2014, the American Telemedicine Association (ATA) released a
comprehensive report addressing state telemedicine gaps in physician practice standards and
licensure.199 The report investigated the licensure and out-of-state practice laws of all 50 states
and assigned a report card grade to each state ranging from A to F depending on how restrictive
or friendly each state's laws were toward telemedicine.200 Not a single state received an “A”
grade, with the report finding that every state has some type of policy that makes practicing
medicine across state lines difficult.201 According to the report, five states (Massachusetts,
Michigan, North Dakota, Pennsylvania, and South Dakota) received “F” grades and have fully
restrictive licensure laws regarding interstate telemedicine,202 which generally require a
195 “Wireline Competition Bureau Evaluation of Rural Health Care Pilot Program Staff Report” By Federal Communications Commission,
August 13, 2012, https://apps.fcc.gov/edocs_public/attachmatch/DA-12-1332A1.pdf (Accessed 3/18/15), p. 2.
196 “Interstate Licensure of Telemedicine Practitioners” By Glenn W. Wachter, Telemedicine Information Exchange, March 10, 2000, updated
by TIE on November 15, 2006.
197 “Night-Shift Solutions” By Lisa Ryan, The Hospitalist, April 2009, http://www.the-hospitalist.org/detains/article/183090/
NightShift_Solutions.html (Accessed 6/20/09).
198 “Wireline Competition Bureau Evaluation of Rural Health Care Pilot Program Staff Report” By Federal Communications Commission,
August 13, 2012, https://apps.fcc.gov/edocs_public/attachmatch/DA-12-1332A1.pdf (Accessed 3/18/15), p. 2-4.
199 “State Telemedicine Gap Analysis: Physician Practice Standards & Licensure” American Telemedicine Association, September 2014,
http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gaps-analysis--physician-practice-standardslicensure.pdf?sfvrsn=12 (Accessed 3/18/15).
200 Ibid, p. 1-3.
201 Ibid, p. 9.
202 Ibid, p. 9.
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practitioner to be fully licensed in each state in which he or she provides medical care to deliver
telemedicine care across state lines.203 However, other states with restrictive laws typically have
several exceptions that allow telemedicine to be practiced interstate without a license from both
states if:
(1)
(2)
(3)
(4)
(5)
(6)
(7)

Interstate telemedicine is infrequent;
A contractual relationship with compensation is not formed;
Consultations are between two providers only (i.e., there is no patient involvement);
Telemedicine is used for educational purposes;
Telemedicine is used in a medical emergency or natural disaster;
The referring practitioner retains primary medical control; or
Telemedicine is used in service of the U.S. military.204

Reciprocal, or limited licensure, provides an interstate license for use with telemedicine for
which practitioners can apply through a simple application process with reduced licensing fees.
Reciprocal licenses work through a mutual exchange of privileges and permit one state to
recognize the license of another jurisdiction, subjecting the practitioner to the rules of the
jurisdiction in which the practitioner resides.205 This license is solely for the practice of
telemedicine and may not be used by practitioners to provide bedside care in another state. The
2014 ATA report found that D.C., Maryland, New York, and Virginia allowed reciprocal
licenses for bordering states and found that Alabama, Louisiana, Minnesota, Montana, Nevada,
New Mexico, Ohio, Oregon, Tennessee, and Texas extended reciprocal licenses to out of state
physicians.206 See table 5-4, below, for a summary of ATA's state telemedicine licensing grades.
Table 5-4: Summary of ATA State Ratings for Licensure and Out-of-State Practice, 2014207
Grade Received
Number of States

"A"
0

"B"
13 + DC

"C"
32

"D"
0

"F"
5

In contrast to physician reciprocal licenses, an interstate license for nurses, first created in 2000,
has been widely accepted by the National Council of State Boards of Nursing. A nurse residing
in a state that participates in the Nurse Licensure Compact may hold a license in his or her
“home state” and practice either physically or remotely in another state, while being subject to
the practice laws and regulations of both states.208

203 “Telemedicine Licensure Report” Center for Telemedicine Law, Office for the Advancement of Telehealth, June, 2003; “Updated numbers
from “Interstate Licensure of Telemedicine Practitioners” By Glenn W. Wachter, Telemedicine Information Exchange, March 10, 2000,
undated By TIE on November 15, 2006, http://tie.telemed.org/articles/article.asp?path=article&article=interstateLicensure_gw_tie0
(Accessed 7/1/09).
204 Ibid.
205 “Telemedicine Licensure Report” Center for Telemedicine Law, Office for the Advancement of Telehealth, June, 2003; “Interstate
Licensure of Telemedicine Practitioners” By Glenn W. Wachter, Telemedicine Information Exchange, March 10, 2000, undated By TIE on
November 15, 2006, http://tie.telemed.org/articles/article.asp?path=article&article=interstateLicensure_gw_tie0 (Accessed 7/1/09).
206 “State Telemedicine Gap Analysis: Physician Practice Standards & Licensure” American Telemedicine Association, September 2014,
http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gaps-analysis--physician-practice-standardslicensure.pdf?sfvrsn=12 (Accessed 3/18/15).
207 “State Telemedicine Gap Analysis: Physician Practice Standards & Licensure” American Telemedicine Association, September 2014,
http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gaps-analysis--physician-practice-standardslicensure.pdf?sfvrsn=12 (Accessed 3/18/15).
208 “Nurse Licensure Compact” Nurse Licensure Compact Administration, National Council of State Boards of Nursing,
https://www.ncsbn.org/nlc.htm (Accessed 7/2/09).
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Telehealth and telemedicine are also subject to The Joint Commission standards.209

Federal
Similar to any electronic transfer of patient medical information, telemedicine practitioners must
comply with HIPAA regulations. Telehealth and telemedicine are also subject to The Joint
Commission standards.210 Current Joint Commission standards focus on services provided by
licensed independent practitioners (LIPs) who diagnose or treat patients by way of a
telemedicine link.211 Under the current standards, most recently revised in 2012, a hospital may
rely on the site of the LIP providing the service (referred to as the distant site) for credentialing
as long as that site is accredited by the Joint Commission.212 Otherwise, the LIP must be
credentialed at the site where the patient is located (the originating site).213 Additionally, the
originating site must make certain that all distant-site credentialing and privileging processes
cooperate with the Medicare Conditions of Participation at a minimum.214
The same Joint Commission standards also apply to practitioners who provide interpretive
services (e.g., teleradiology and telepathology) and those who provide consultations, only “for
the sole purpose of offering an expert opinion and/or advising the treating practitioner but not
directing the patient’s care.”215 These services are usually contracted out for and must therefore
also meet the contracted service standard (i.e., LD.3.50).216 In contrast, CMS requires LIPs to be
credentialed at the originating site. In November 2008, the Joint Commission revised its
standards to reflect this discrepancy, but reverted back to its original opinion in March 2009.217
The Medicare Telehealth Enhancement Act of 2009 (HR 2068), introduced to Congress on April
23, 2009, was referred to the House Ways and Means committee (without further advancement)
and addressed The Joint Commission and CMS credentialing issues.218

209 “Hospital-wide PACS Need Tighter Data Security” Diagnostic Imaging PACS Supplement, Feb. 2000, www.dimag.com/db_area/
archives/2000/0002pnews.3-7.html (accessed March 31, 2000).
210 “JCAHO Published New Hospital Credentialing Standards for Telemedicine” Mondaq Business Briefing, November 5 2003,
http://www.thefreelibrary.com/_/print/PrintArticle.aspx?id=109771648 (Accessed 7/1/09); “Final HIPAA Privacy Rules” By the Health
Resources and Services Administration, February 2001, http://www.hrsa.gov/telehealth/pubs/hippa.htm (Accessed 11/19/09).
211 “Existing Requirements for Telemedicine Practitioners Explained” Joint Commission Perspectives, February 2003, p. 4.
212 “Final Revisions to Telemedicine Standards” The Joint Commission, Joint Commission Perspectives, January 2012,
http://www.jointcommission.org/assets/1/6/Revisions_telemedicine_standards.pdf (Accessed 3/18/15).
213 “The Joint Commission and Telemedicine: The Final Word?” Accreditation Monthly, May 13, 2009
http://www.accreditationcenter.com/The-Joint-Commission-and-Telemedicine-The-Final-Word.html (Accessed 7/1/09); “Existing
Requirements for Telemedicine Practitioners Explained” Joint Commission Perspectives, February 2003; “JCAHO Published New Hospital
Credentialing Standards for Telemedicine” Mondaq Business Briefing, November 5 2003, http://www.thefreelibrary.com/_/
print/PrintArticle.aspx?id=109771648 (Accessed 7/1/09).
214 “Final Revisions to Telemedicine Standards” The Joint Commission, Joint Commission Perspectives, January 2012, http://www.joint
commission.org/assets/1/6/Revisions_telemedicine_standards.pdf (Accessed 3/18/15).
215 “Existing Requirements for Telemedicine Practitioners Explained” Joint Commission Perspectives, February 2003.
216 “JCAHO Published New Hospital Credentialing Standards for Telemedicine” Mondaq Business Briefing, November 5, 2003,
http://www.thefreelibrary.com/_/print/PrintArticle.aspx?id=109771648 (Accessed 7/1/09).
217 “The Joint Commission and Telemedicine: The Final Word? Accreditation Monthly, May 13, 2009, http://www.accreditationcenter.com/
The-Joint-Commission-and-Telemedicine-The-Final-Word.html (Accessed 7/1/09).
218 “Medicare Telehealth Enhancement Act of 2009” 111th Congress, Bill H.R. 2068, introduced April 23, 2009; “Waters: Telemedicine
Boosts Access to Needed Care” By Robert J. Waters, Roll Call, June 8, 2009, http://www.rollcall.com/features/Mission-Ahead_HealthCare/ma_healthcare/-35540-1.html (Accessed 4/1/15).
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Reimbursement
State
As of March 2015, approximately 22 states have laws requiring private insurers to reimburse for
telehealth-related services at the same rate as in-person services (known as parity laws), while in
states without such laws, it is at the discretion of the insurer whether or not to reimburse
providers for telehealth services.219 To track the reimbursement of healthcare services, some
states utilize code modifiers in addition to their CPT codes to indicate that the service provided
was through a telemedicine format. For example, Ohio uses their modifier to indicate that
telemedicine was the originating service for the delivery of evaluation and management care or
for psychiatric services.220
A 2007 survey study regarding private payer reimbursement for telemedicine, which updated a
2003 survey performed by ATA, found that 58% of telemedicine programs that offered billable
services received private payer reimbursement, an increase of 5 from 2003.221 As of February
2015, 46 states and the District of Columbia had one or more policies in place to provide at least
some reimbursement through Medicaid, with only Massachusetts, New Hampshire, and Rhode
Island not reimbursing for telehealth services.222 Iowa does not have any formal codified policy
but recently posted a letter on their website indicating that their Medicaid program will pay for
covered services if they are rendered via telemedicine if the standard medical community would
support rendering these services through telemedicine.223
Federal
The Balanced Budget Act of 1997 limited the scope of Medicare telehealth coverage to
consultation services only.224 Section 223 of the Medicare, Medicaid and State Children’s Health
Insurance Program (SCHIP) Benefits Improvement and Protection Act of 2000 (BIPA), however,
revised Medicare reimbursement to cover telehealth serviced on or after October 1, 2001 to
include consultations, office visits, individual psychotherapy, and pharmacologic management.225
Services were only covered for cases with interactive audio and video telecommunication
systems when the patient was present and participating in the telemedicine visit. Eligible
219 “State Telemedicine Gaps Analysis: Coverage & Reimbursement” American Telemedicine Association, September 2014,
http://www.americantelemed.org/docs/default-source/policy/50-state-telemedicine-gaps-analysis---coverage-and-reimbursement.pdf
(Accessed 3/18/15); “NY Governor Signs Telemedicine Law While Other States Make Progress with New Proposals” American
Telemedicine Association, January 7, 2015, http://www.americantelemed.org/news-landing/2015/01/07/ny-governor-signs-telemedicinelaw-while-other-states-make-progress-with-new-proposals#.VQnurU05Cig (Accessed 3/18/15).
220 “Medicaid Coverage of Telemedicine and Related Services” Ohio Department of Medicaid, Medicaid Handbook Transmittal Letter No.
3334-15-01, January 2, 2015, http://emanuals.odjfs.state.oh.us/emanuals/DataImages.srv/emanuals/pdf/pdf_books/
GeneralInformationForMedicaidProviders.pdf (Accessed 3/26/15), p. 8.
221 “Private Payer Reimbursement for Telemedicine Services in the United States” By Pamela Whitten and Lorraine Buis, Telemedicine and eHealth, Vol. 13, No. 1 (2007), p. 15.
222 “State Telehealth Laws and Medicaid Program Policies” Center for Connected Health Policy, February 2015, http://cchpca.org/sites/
default/files/resources/State%20Laws%20and%20Reimbursement%20Policies%20Report%20Feb%20%202015.pdf (Accessed 3/26/15),
p. 5.
223 “State Telehealth Laws and Medicaid Program Policies” Center for Connected Health Policy, February 2015, http://cchpca.org/sites/
default/files/resources/State%20Laws%20and%20Reimbursement%20Policies%20Report%20Feb%20%202015.pdf (Accessed 3/26/15),
p. 5.
224 “The Balanced Budget Act of 1997” Pub. L. No. 105-33, § 4206, 111 Stat. 251, 377-378 (August 5, 1997).
225 “Medicare, Medicaid, SCHIP Balanced Budget Improvement and Protection Act of 2000” Pub. L. No. 106-554, §223, 114 Stat. 2763A-463,
2763A-487 - 2763A-490.
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geographic areas included rural health areas with practitioner shortages and counties not
classified as part of an established metropolitan statistical area.226
Additionally, section 149 of MIPPA amended BIPA to reimburse services provided on or after
January 1, 2009 for telehealth services performed in the office of a physician or practitioner,
hospital, critical access hospital (CAH), rural health clinic, federally qualified health center,
hospital-based or CAH-based renal dialysis facility, skilled nursing facility, or community
medical center.227 In addition, the act requires both the distant practitioner and patient to be
present at the telehealth “visit” and interact in real-time communication.228
Currently, Medicare only provides reimbursement for services to patients who receive care from
facilities in rural Health Professional Shortage Areas, and only from those specific facilities that
are listed in the law, e.g., skilled nursing facilities, physician offices, or hospitals.229
Additionally, Medicare only reimburses for a small set of services (e.g., office visits,
pharmacological management, individual and group diabetes self-management training services,
and consultations) that are provided through a real-time video-and-voice telecommunication
system.230 These services amount to roughly 75 service codes out of 10,000.231 In January 2015,
the U.S. House of Representatives Committee on Energy and Commerce released a draft bill that
would modernize Medicare’s approach to telehealth reimbursement.232 However, this draft has
been heavily criticized by healthcare associations, such as the American Hospital Association,
for not taking a more global approach to permitting the use of telehealth services.233

CLINICAL TECHNOLOGY
In addition to the development and utilization of healthcare management information technology,
there have also been advances in the development of clinical technology, which have led to
numerous treatment discoveries and innovations. Clinical technology encompasses any method
or device used in patient treatment procedures, e.g., (1) pharmaceuticals; (2) surgical devices;
and (3) minimally invasive techniques. Notably, in an effective and efficiently operated healthcare
enterprise, management and clinical technologies complement each other and may, in many
cases, overlap234.
One significant effect of clinical technology advancements is the transition to more procedures
being offered in outpatient settings. Specifically, advancements have resulted in: (1) less invasive
procedures; (2) shorter recovery times; and (3) lower probability of complications, all of which
226 “Medicare Claims: Adding Certain Entities as Originative Sites for Payment of Telehealth Services—Section 149 on the Medicare
Improvements for Patients and Providers Act of 2008 (MIPPA)” Centers for Medicare & Medicaid Services, Pub 100-04, November 14,
2008.
227 “Medicare Improvements for Patients and Providers Act of 2008” Pub. L. No. 110-275, §149, 122 Stat. 2494, 2549 (July 15, 2008).
228 “Medicare Claims: Adding Certain Entities as Originative Sites for Payment of Telehealth Services—Section 149 on the Medicare
Improvements for Patients and Providers Act of 2008” Centers for Medicare & Medicaid Services, Pub 100-04, November 14, 2008.
229 “Re: Telehealth Discussion Draft” American Hospital Association, Letter to Chairman Upton, January 26, 2015, p. 1-2.
230 Ibid.
231 Ibid.
232 “[Discussion Draft]: Sec. ___. Advancing Telehealth Opportunities in Medicare” House Committee on Energy and Commerce, January 9,
2015.
233 “Re: Telehealth Discussion Draft” American Hospital Association, Letter to Chairman Upton, January 26, 2015, p. 3-4.
234 Discussed above in the Technology section as “Process”.
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have allowed for procedures that have traditionally been performed in an inpatient setting to be
offered on an outpatient basis. Outpatient procedures comprised approximately 64% of U.S.
surgeries in 2010, with that figure increasing slightly through 2013.235 The increased costs
associated with inpatient care, as well as the overall increase in healthcare demand, have
contributed to increased outpatient service utilization from 366 million visits in 1993 to over 677
million in 2013,236 a growth pattern that will likely continue in response to persistent cost
containment pressures,237 and the advancements in technology that have facilitated the shift from
inpatient to outpatient.
As technology has advanced, so too has the way patient care is viewed, leading to technological
developments related not only to the treatment setting (e.g., movement from inpatient to
outpatient), but also the manner by which diseases are understood and treatments are managed
by providers. Recent developments regarding genetics, gene therapy, and personalized medicine
have largely been made possible by the science of genomics.

THE GATEWAY: GENETICS, GENOMICS, AND GENOME
TECHNOLOGY
The term personalized medicine has been used in several venues, such as customized
pharmaceuticals and customized diagnoses. The landmark discoveries accompanying the advent
of genome sequencing was the first step toward much of the technological advancement that
served as the basis for a new genre of pharmaceutical and therapeutic medicine. In 2003, the
Human Genome Project at the National Institutes of Health completed the initial mapping of the
human genome, a milestone that fueled interest in the field of genomics.238 The technological
advancements that followed served as the foundation for a new genre of pharmaceutical and
therapeutic medicine. Biotechnology and biopharmaceuticals are influential drivers in today’s
market, accounting for the highest valued mergers and acquisitions in 2015.239
Genomics is the evaluation of the hereditary information provided by an organism’s DNA and
the application of research findings to the fields of genetic engineering and enhancement,
cloning, stem cell research, and eugenics.240 The National Center for Human Genome Research
Institute (NCHGRI) is comprised of more than 50 researchers who are dedicated to specific
facets of genetic and genomic research and contribute accordingly to one of seven branches of
the NCHGRI: (1) Cancer Genetics; (2) Genetic Disease Research; (3) Genetics and Molecular
Biology; (4) Genome Technology; (5) Inherited Disease Research; (6) Medical Genetics; and
235 “Chart 3.11: Percentage Share of Inpatient vs. Outpatient Surgeries, 1993—2013, in “Trendwatch Chartbook 2015: Trends Affecting
Hospitals and Health Systems” American Hospital Association and Avalere, 2015, retrieved from http://www.aha.org/research/
reports/tw/chartbook/ch3.shtml (Accessed 3/26/15).
236 “Table 3.4: Outpatient Utilization in Community Hospitals, 1993-2013” in “Trendwatch Chartbook 2015: Trends Affecting Hospitals and
Health Systems” American Hospital Association and Avalere, 2015, retrieved from http://www.aha.org/research/reports/
tw/chartbook/ch3.shtml (Accessed 3/26/15), p. A-29.
237 “Payments to Hospitals for Inpatient Hospital Services” 42 U.S.C. § 1395(ww)(b)(2) (2010).
238 “Human Genome Project: Fact Sheet” By National Institutes of Health, October 2010, http://report.nih.gov/NIHfactsheets/
Pdfs/HumanGenomeProject(NHGRI).pdf (Accessed 3/19/15), p. 1.
239 “US M&A News and Trends” BY FACTSET, Flashwire US Monthly, February 2015, https://www.factset.com/mergerstat_em/monthly
/US_Flashwire_Monthly.pdf (Accessed 3/18/15), p. 3.
240 “Talking Glossary of Genetic Terms: Genomics” By National Human Genome Research Institute, http://www.genome.gov/
Glossary/index.cfm?id=532 (Accessed 3/19/15); “Biomedical Research Issues in Genetics” By the National Human Genome Research
Institute, January 6, 2009, http://www.genome.gov/10001740 (Accessed 6/29/09).
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(7) Social and Behavioral Research.241 Several areas of genomics, cell-based therapies, and
molecular targeting therapies also seem to hold promise for future advancements in the
treatment of cardiac disease.242 For example, pharmacogenomics applies the “genetic variability
in patients’ responsiveness to a drug in order to inform clinical decisions about dosing and
selection.”243 A “broader vision for personalized medicine extends beyond the development of
individual treatment [plans] to individualized [disease] prevention [and early intervention]
strategies, e.g., Type 2 diabetes.”244
One means of achieving this “vision” of personalized medicine may be through the use of mobile
medical applications (“m-health apps”), which may be downloaded on smartphones and
computer tablets. It is expected that these “m-health apps”, which have expanded rapidly in the
marketplace, will allow healthcare providers to efficiently develop and distribute “best-practice”
standards and treatment protocols to providers.245 Additionally, “m-health apps” are beginning to
be utilized by patients to monitor chronic conditions by reporting such information as blood
pressure levels or sugar levels to their physicians.246
Genomic understanding has given pharmaceutical companies new therapeutic targets as well as
the ability to improve existing drugs.247 It is possible that genetic composition may be at least
partly responsible for some adverse drug reactions, and understanding that composition may
allow pharmaceutical companies to design more compatible drugs or to identify those patients
who should not be given particular therapies.248 In recent years, certain genes have been
associated with an increased risk of developing particular diseases or conditions, and the
identification of such genes may allow individuals to take preventative measures against such
conditions, particularly various forms of cancer. However, other findings indicate that such
unsubstantiated information may present more harm than good,249 e.g.: (1) stress on the
individual being diagnosed or (2) unnecessary medical procedures, such as premature
mastectomies.
As the market for personalized medicine expands and additional research related to genetic
diagnoses saturates consumer driven healthcare channels, several companies offering
personalized genetic mapping, known as genotyping, have appeared (e.g., 23andme.com). These
direct-to-consumer genetic testing companies sell genetic kits that take a small sample of cells,
241 “Overview of the Division of Intramural Research” By National Human Genome Research Institute, August 27, 2009,
http://www.genome.gov/10001634 (Accessed 11/25/09).
242 “A Tale of Coronary Artery Disease and Myocardial Infarction” By Elizabeth G. Nabel and Eugene Braunwald, The New England Journal
of Medicine, Vol. 366, No. 1 (January 5, 2012), p. 61.
243 Ibid.
244 “Personalized Medicine To Identify Genetic Risks for Type 2 Diabetes and Focus” By Allen M. Spiegel, and Meredith Hawkins, Health
Affairs, Vol. 31, No. 1 (January 2012), p. 44; “Improving Health by Taking It Personally” By Ralph Snyderman, and Michaela A. Dinan,
Journal of the American Medical Association, Vol. 303, No. 4 (January 27, 2010), p. 363.
245 “Chapter 1: Healthcare Reform: The Transformation of America’s Hospitals: Economics Drives a New Business Model” in “Futurescan
2012: Healthcare Trends and Implications 2012-2017” By Kenneth Kaufman and Mark E. Grubs, VHA Inc., Irving, Texas (2012), p. 8;
“Beyond UX: Best Practices for Medical App Development” By Mithun Sridharan, Innovation Insights, August 4, 2014,
http://insights.wired.com/profiles/blogs/beyond-ux-best-practices-for-medical-app-development#axzz3UleZE3Fn (Accessed 3/18/15).
246 “5 Critical Technologies Health Systems Should Require” By Michelle McNickle, Healthcare IT News, July 30, 2012,
http://www.healthcareitnews.com/news/5-critical-technologies-health-systems-should-require (Accessed 9/21/12).
247 “Technology and the Boundaries of the Hospital: Three Emerging Technologies” By Jeff Goldsmith, Health Affairs, Vol. 23, No. 6 (2004),
p. 150.
248 “Technology and the Boundaries of the Hospital: Three Emerging Technologies” By Jeff Goldsmith, Health Affairs, Vol. 23, No. 6 (2004),
p. 150.
249 “Letting the Genome Out of the Bottle: Will We Get Our Wish?” By David J. Hunter, et al., New England Journal of Medicine, Vol. 358,
No. 2 (January 10, 2008), p. 106-107.
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typically via a cheek swab, and generate a genetic profile for the customer, which may indicate
any diseases to which the individual may be prone.250 The FTC and CDC have warned that some
of these at-home genetic testing kits lack scientific validity and caution against reviewing test
results without a doctor’s counsel.251 Some states, such as California and New York, have
intervened in the distribution of an individual’s genetic profile and potential future diseases
without physician direction and have sent cease and desist letters to several companies.252
Additionally, four states, i.e.: (1) California; (2) Nevada; (3) Nebraska; and (4) Pennsylvania
have passed legislation prohibiting misleading advertisements for genetic tests.253
The realities of personalized medicine produce a multitude of regulatory and reimbursement
issues. Although HIPAA was designed to protect individual health information, the advancement
of genetic testing has surpassed the regulatory standards as set forth under HIPAA. Subsequent
legislation has attempted to protect an individual’s genetic information while allowing for the
furtherance of personalized medicine.254 Similar to HIPAA, the Genetic Information
Nondiscrimination Act of 2008 (GINA), enacted on May 21, 2008, was promulgated to protect
against the misuse of their personal health information.255 GINA prohibits the use of genetic
information for discriminatory purposes by employers and health insurance companies and
amends both the Employee Retirement Income Security Act and the Internal Revenue Code.256

STEM CELL RESEARCH
Within any living organism, each cell is specialized to a specific biological system. Stem cells
are “unspecialized cells capable of renewing themselves through cell division, sometimes after
long periods of inactivity,” and capable of adapting their function to accommodate a certain type
of tissue or organ under the proper conditions.257 The unique regenerative capacity of stem cells
has the potential to change the way health problems, e.g., diabetes and heart disease, are treated.
As such, efforts to advance reparative medicine (therapies that heal the body’s natural tissue) by
developing efficacious cell therapies are at the forefront of medical research.258 In June 2011, the
first completely synthetic human organ (a trachea) was successfully grown from human stem
cells and transplanted.259 However, synthetic organs only function at a fraction of their natural
250 “How does 23andMe genotype my DNA?” 23andme Customer Care, https://customercare.23andme.com/entries/21263328 (Accessed
9/26/12).
251 “Direct-to-Consumer Genetic Tests” Federal Trade Commission: Consumer Information, January 2014, http://www.consumer.ftc.gov/
articles/0166-direct-consumer-genetic-tests (Accessed 3/18/15).
252 “Federal and State Responses to Dangers of At-Home Genetic Testing” By Sara Hoverter and Danielle Perlman from Georgetown School
of Law, Memorandum to Steve Sakamoto-Wengel, Maryland Office of the Attorney General Paul Ballard, Maryland Office of the Attorney
General, February 4, 2011.
253 “Federal and State Responses to Dangers of At-Home Genetic Testing” By Sara Hoverter and Danielle Perlman from Georgetown School
of Law, Memorandum to Steve Sakamoto-Wengel, Maryland Office of the Attorney General Paul Ballard, Maryland Office of the Attorney
General, February 4, 2011; West's Annotated California Business & Professional Code § 17508(a); Nevada Revised Statutes Annotated §
598.0925(1)(a); Nebraska Revised Statute § 87-302(a)(14); 18 Pennsylvania C.S.A. § 4107 (a)(10).
254 “Personalized Medicine-Part 2: Ethical, Legal, and Regulatory Issues” By F. Randy Vogenberg, et al., Journal of Pharmacy and
Therapeutics, Vol. 35, No. 11 (November 2010), p. 629. See the Privacy Laws section in Chapter 3: Regulatory Environment for a further
discussion of HIPAA and protected health information
255 “Genetic Information Nondiscrimination Act” Pub. L. No. 110-233, 112 Stat. 881 (May 21, 2008).
256 Ibid.
257 “Stem Cell Information: Stem Cell Basics” By the National Institutes of Health, U.S. Department of Health & Human Services, April 28,
2009, http://stemcells.nih.gov/staticresources/info/basics/SCprimer2009.pdf (Accessed 3/19/15), p. 1-2.
258 Ibid, p. 2.
259 “World’s First Synthetic Organ Transplant” Discovery News, July 8, 2011, http://news.discovery.com/human/first-artificial-organtransplant-110708.html (Accessed 3/19/15).
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counterparts, e.g., a synthetic lung grown from stem cells functioned at approximately five
percent of the effective rate of a natural lung when tested in rats at Yale University.260
On January 23, 2009, the first human embryonic stem cell (hESC)-based therapy was approved
for clinical trial when Geron Corporation announced the clearance of their Investigational New
Drug (IND) application for the clinical trial of GRNOPC1, which manipulates the growthstimulating properties of nerve cells to aid in rehabilitating acute spinal cord injuries.261 Stem cell
research is also being to: (1) investigate the causes of birth defects; (2) enhance drug
development by providing molecular insight; and (3) expedite the drug approval process through
the facilitation of preliminary drug testing.262 Additionally, understanding the differences
between embryonic and non-embryonic stem cell proliferation may be the key to understanding and treating - cancer.263 Recent trends and advances in stem cell technology have proved
promising, with approximately 28 adult stem cell clinical studies completed, 20 actively
underway, another 14 currently recruiting volunteers, and 5 approved for conducting a clinical
study but not yet recruiting volunteers as of 2015.264
The completion of the draft human genome sequence in 2001 was followed by research inquiries
targeting transcripts (transcriptomics); RNAi/miRNAs (interferomics and micro-RNomics);
proteins (proteomics); interacting proteins (interactomics); DNA and chromatin modifications
(epigenomics); and metabolites (metabolomics).265 Developments in these areas contributed
significantly to the molecular understanding of biology, pathology, and pharmacology; any
advances in molecular research are dictated by progress in these genomic substrata.266
Furthermore, molecular diagnostics represent the sector of the genomics market with the most
promise.267
On January 23, 2009, the first human embryonic stem cell (hESC)-based therapy was approved for clinical
trial.
Geron: Visionary Therapeutics, 2009.

DIAGNOSTIC MEDICINE & TECHNOLOGY
Diagnostic medicine is utilized in both acute and chronic care for the purposes of prevention,
screening, monitoring of health conditions, and disease detection and management. This staple of
healthcare claims that, “a penny of prevention is worth a pound of cure . . . The pharmaceutical
260 “Scientist Are Solving Our Donor Crisis with Lab-Grown Organs” By Jennifer Welsh, Business Insider, August 28, 2012,
http://www.businessinsider.com/lab-grown-organs-2012-8?op=1 (Accessed 3/19/15), p. 2.
261 “Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy” Geron, Press
Release, January 23, 2009, http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1636192 (Accessed 4/1/15), p. 1.
262 “Stem Cell Basics” National Institutes of Health, U.S. Department of Health & Human Services, April 28, 2009, http://stemcells.nih.gov/
staticresources/info/basics/SCprimer2009.pdf (Accessed 3/19/15), p. 2, 14.
263 Ibid, p. 14.
264 “List of Studies for Adult Stem Cell” National Institutes of Health, March 19, 2015,
https://clinicaltrials.gov/ct2/results?term=%22Adult+stem+cell%22 (Accessed 3/19/15); Author looked up current status of clinical trials at
the U.S. National Institutes of Health website, ClinicalTrial.gov, by searching “Adult Stem Cell”.
265 “The Era of ‘Omics Unlimited” By Raj P. Kandpal, Beatrice Saviola, and Jeffrey Felton, BioTechniques, Vol. 46, No. 5 (April 2009),
p. 351.
266 Ibid, p. 352.
267 “Proteomics—Technologies, Markets, and Companies” By LeadDiscovery, 1999, https://www.leaddiscovery.co.uk/registration/ (Accessed
7/01/09).
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industry has long been focused on treatment of disease but it will be far more cost-effective to
prevent disease than cure it, and this will be a driver of innovation.”268 Recent diagnostic
advances support an attitude of prevention that, though inherently accepted, has not been
practiced sufficiently in healthcare to date.
In addition to diagnostic medicine, diagnostic technology is the backbone of much technological
advancement, including, but not limited to: (1) minimally invasive surgery; (2) preventative
procedures; (3) telemedicine; and (4) therapeutics. Diagnostics may also play an important role
in the advancement of current quality metrics reporting and associated value-based purchasing
initiatives. While these aforementioned characteristics provide clinical benefits to providers,
patients, and payors, the economic value metrics of diagnostic imaging is unclear, as the
technology is also associated with patterns of overuse and increased healthcare costs.269
Diagnostics can be categorized in two distinct fields: (1) molecular diagnostics and (2) imaging
technology.

Molecular Diagnostics
Molecular diagnostics were originally used to screen for infections (e.g., HIV, hepatitis, and
tuberculosis) more accurately and effectively than traditional methods.270 The capabilities of
molecular diagnostics since have evolved to include genetic disorder screening, pre-implantation
screening, and cancer screening procedures, thereby facilitating the transition toward
preventative healthcare.271 Similarly, advances in genetic engineering and enhancement,
pharmacogenetics, and pharmacogenomics have led to a fusion of molecular diagnostics and
therapeutic measures for specialized screening and treatment plans, which fusion is characteristic
of personalized medicine. The capabilities afforded by molecular diagnostics have relied on
developments in polymerase chain reaction (PCR)-based technology, electrochemical detection
of DNA, biochip technology, nanotechnology, and proteomic technologies.272 Nanotechnology,
the engineering of body systems on a molecular level,273 has been utilized in the study of: (1)
viruses; (2) biomarkers; (3) neural regeneration; and (4) drug delivery membranes, among other
fields.274 The ability to influence healthcare delivery through “highly integrated, miniaturized,
and smart micro-nano-bio-systems” is at the forefront of U.S. healthcare delivery, as it presents
the capabilities to “enable the delivery of individualized health services with better access and
outcomes at lower costs than previously deemed possible.”275 The developments that
268 “Biomarket Trends: Pharmaceutical Industry Undergoing Transformation, Companies Must Start Preparing Now for Changes to Come in
2020” By Steve Arlington and Anthony Farino, Genetic Engineering and Biotechnology News, Vol. 27, No. 15 (September 1, 2007),
http://www.genengnews.com/articles/chitem.aspx?aid=2197 (Accessed 2/2/10).
269 “Expanding Use of Imaging Technology and the Challenge of Measuring Value” By Laurence C. Baker, et al., Health Affairs, Vol. 27, No.
6, November / December 2008, p. 1467-68, 1471-72.
270 “The Molecular Diagnostics Industry Today” By Harry Glorikan, Drug Discovery & Development, Vol. 9, No. 9 (September 1, 2006),
p. 68.
271 “Proteomics—Technologies, Markets, and Companies” By LeadDiscovery, 1999, https://www.leaddiscovery.co.uk/registration/ (Accessed
7/1/09).
272 “Proteomics—Technologies, Markets, and Companies” By LeadDiscovery, 1999, https://www.leaddiscovery.co.uk/registration/ (Accessed
7/1/09).
273 “What is Nanotechnology” Center for Responsible Nanotechnology, http://www.crnano.org/whatis.htm (Accessed 10/25/12).
274 “NNI Accomplishments in Nanotechnology” National Nanotechnology Initiative, 2013, http://www.nano.gov/nanotechnologyinitiatives/nano-achievements/results?keywords=health&category[0]=all&agencies[0]=all&submitted=1&op=Search%20
Nano%20Achievements&form_build_id=form-af109379a72299af2604516ede8682ff&form_id=omni_achievements_filter_
achievements_form (Accessed 10/15/12).
275 “R&D in Micro-Nano-Bio Systems and Contribution to pHealth” By Andreas Lymberis, Studies in Health Technology and Informatics,
IOS Press, 2012, p. 26.
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materialized as a result of these molecular capabilities continue to affect the molecular,
nonmolecular, and in vitro diagnostic markets.276
The field of cancer diagnostics, utilizing molecular technologies, has been influential in the
transition to personalized care. Cancer molecular diagnostics (CMD) most likely will not replace
traditional pathological examinations, but rather serve to supplement and enhance these methods
by employing them in conjunction with microarrays, reverse transcriptase polymerase chain
reaction (RT-PCR), mass spectrometric proteomic analyses, and protein chips.277 CMD
technology will allow practitioners to diagnose cancer, choose and develop personalized
treatment plans, and identify predispositions twice as quickly as other assays for only a fraction
of the drug development costs.278
The identification of medical predispositions based on genomic characteristics is a relatively
new market. In addition to the identification of particular genes that may be utilized to identify
those individuals who may be predisposed to certain cancers or diseases, molecular diagnostics
are able to identify over 1,900 heritable disorders.279 Although clinical laboratories are seeking
to obtain a broader base for more diagnostic tests, a lack of standards among laboratories has led
to a high level of variability and, consequently, inconclusive results. Direct-to-consumer
commercial “testing kits” have further diluted the standards for molecular diagnostics, raising
concerns regarding the regulation of the field.280
Trends in Molecular Diagnostics
Although the field of molecular diagnostics has grown beyond its original scope, which focused
on screening for infectious disease, this field is still the fastest growing segment of the molecular
diagnostics market, making up 50% to 60% of the market’s revenue.281 As of 2012, the U.S.
diagnostics market made up roughly 34% of the global market with an estimated value of $15.5
billion.282 While the Asian Pacific markets have the highest growth region predicted, the U.S.
diagnostics market has a forecasted five-year growth rate of 5.8%.283 The potential profitability
for suppliers in the personalized medicine market has led to increased transactional activity
among molecular diagnostic companies, as large companies are diversifying to maximize their
presence in market, by purchasing specialized diagnostic entities such as in vitro diagnostic
companies.284

276 “The Molecular Diagnostics Industry Today” By Harry Glorikan, Drug Discovery & Development, Vol. 9, No. 9 (September 1, 2006),
p. 68.
277 “Cancer Molecular Diagnostics Take the Stage: CMDS Are at the Forefront of Evolving Healthcare Practices” By Sudeep Basu, Genetic
Engineering and Biotechnology News, Vol. 29, No. 7 (April 1, 2009), http://www.genengnews.com/articles/chitem_print.aspx?
aid=2852&chid=0 (Accessed 7/6/09).
278 Ibid.
279 “Molecular Diagnostics: Harmonization Through Reference Materials, Documentary Standards and Proficiency Testing” By Marcia J.
Holden et al., Expert Review of Molecular Diagnostics, Vol. 11, No. 7 (2011), p. 741.
280 Ibid, p. 741-742.
281 “Introduction to Molecular Diagnostics: The Essentials of Diagnostics Series” AdvaMedDx and DxInsights, 2013, http://advameddx.org/
download/files/AdvaMedDx_DxInsights_FINAL(2).pdf (Accessed 3/20/15), p. 6.
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Regulatory and Reimbursement
Many molecular diagnostic technologies are not subject to the stringent compliance
requirements set by the FDA for most device technologies. Rather, the laboratory developed
tests (LDT) that encompass the many genetic diagnostic tests on the market are subject to FDA
discretional enforcement, which is typically determined through the laboratory requirements
prescribed in the Clinical Laboratory Improvement Amendments (CLIA) of 1988.285
As noted by The Lewin Group in its 2008 report on laboratory medicine, “[d]espite this scope of
influence, spending on laboratory services accounts for only 2.3% of U.S. health care
expenditures and 2% of Medicare expenditures.”286 However, with the shift from fee for service
to paying for performance, it is evident that cost-related assessments that help improve the value
per health expenditure are growing in popularity.287 The result of this is that a growing number of
stakeholders who seek evidence to support decisions are developing and utilizing laboratory
tests.288
Despite this scope of influence, spending on laboratory services accounts for only 2.3% of U.S. health care
expenditures and 2% of Medicare expenditures.289

Imaging Technology
Medical imaging is defined as a “non-invasive process used to obtain pictures of the internal
anatomy or function of the anatomy using one of many different types of imaging equipment and
media for creating the image.”290 Imaging is one the fastest growing categories of services
covered under Medicare Part B across all modalities, namely computed tomography (CT),
magnetic resonance imaging (MRI), nuclear medicine, ultrasound, x-ray, and other standard
imaging techniques.291 Under the 2005 Deficit Reduction Act, CMS moved to constrain spending
on these services. The act stated that, with certain exceptions, physician payments under the
CMS fee schedule must be capped at the levels established for independent diagnostic testing

285 “The Human Genome and Translational Research: How Much Evidence is Enough?” By Janet Woodcock, Health Affairs, Vol. 27, No. 6
(November/December 2008), p. 1617; “LDT Oversight Should be Strengthened: Frequently Asked Questions” College of American
Pathologists, October 31, 2011, http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2
FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm.contentReference}=advocacy%2Fldt%2Fldt_oversight_faq.
html&_state=maximized&_pageLabel=cntvwr#regulated (Accessed 9/27/12). See the Other Federal Regulations section in Chapter 3:
Regulatory Environment for a further discussion of FDA regulation regarding medical devices and the Clinical Laboratory Improvement
Amendments of 1988.
286 “Laboratory Medicine: A National Status Report” By Julie Wolcott, Amanda Schwartz, and Clifford Goodman, To Division of Laboratory
Systems National Center for Preparedness, Detection, and Control of Infectious Diseases, Center for Disease Control and Prevention, The
Lewin Group, May 2008, p. 2.
287 “The Value of Laboratory Screening and Diagnostic Tests for Prevention and Health Care Improvement” By Julie Wolcott and Clifford
Goodman, To American Clinical Laboratory Association and Advanced Medical Technology Association, The Lewin Group, September
2009, p. 7.
288 Ibid.
289 “A Policy Primer on Diagnostics” AdvaMedDx, June 2011, http://advameddx.org/download/files/sections/Policy/Innovation/AdvaMedDxPolicy-Primer-on-Diagnostics-June-2011.pdf (Accessed 3/20/15), p. 12-13; “Laboratory Medicine: A National Status Report” By Julie
Wolcott, Amanda Schwartz, & Clifford Goodman, To Division of Laboratory Systems National Center for Preparedness, Detection, and
Control of Infectious Diseases, Center for Disease Control and Prevention, The Lewin Group May 2008, p. 2
290 “Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional
Management Practices” Government Accountability Office, June 2008, GAO-08-452.
291 Ibid.
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facilities under the Outpatient Prospective Payment System (OPPS).292 The utilization of
diagnostic imaging has grown at a much faster rate than other physician services, likely due to
advances in technology allowing for more efficient, effective, and safe procedures. As indicated
in the June 2012 MedPAC publication entitled, A Data Book: Health Care Spending and the
Medicare Program, the number of CT and MRI scans per 1,000 Medicare B fee-for-service
beneficiaries, grew significantly between 2000 and 2009, with a slight decrease from 2009 to
2010.293 The number of CT scans performed on parts of the body other than the head more than
doubled between 2000 and 2012, from 185 scans per 1,000 Medicare Part B beneficiaries in
2000 to 396 scans per 1,000 Medicare Part B beneficiaries in 2010.294 Similarly, the number of
MRI scans performed on parts of the body other than brain for Medicare Part B beneficiaries
more than doubled between during the same time period.295 Corresponding with the increased
utilization of diagnostic imaging, Medicare spending for these services has also increased over
time, though spending did actually decline from $10.6 billion in 2011 to $10 billion in 2012.296
The allocation of Medicare spending for diagnostic imaging under the 2012 Physician Fee
Schedule is set forth below, in Table 5-5: Medicare Spending on Diagnostic Imaging in 2010.
Table 5-5: Medicare Spending on Diagnostic Imaging in 2010 297
Procedure

Percent of Total Medicare
Spending

Standard Imaging
CT
MRI
Echocardiography
Other Echography (ultrasound)
Nuclear Medicine
Imaging Procedures
PET

23%
18%
15%
10%
17%
8%
5%
4%

Trends in Imaging Technology
Continuous development and improvement of existing technology has characterized much of
imaging development. For example, ultrasound is undergoing extremely promising
improvements, with greater speed and enhanced quality affording higher frequency, better
resolution, and three-dimensional (3D) imaging. This increased strength will foster an array of
possibilities, including added specificity of results, a reduction in the necessity of biopsies, and
more standardized ultrasound use. One substantial drawback to ultrasound is its reliance on
operator competence. Compounded by the healthcare manpower deficit, the shortage of
professionals qualified to perform ultrasound procedures can be affected additionally by lagging
reimbursement and liability concerns. Accordingly, professionals believe the repercussions of
relying on operator capabilities will result in increased interest in technologies that promote easeof-use.298
292
293
294
295
296
297
298
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Advances in Magnetic Resonance Imaging (MRI)
Functional MRI (fMRI), a combined positron emission tomography (PET) and MRI system,
enables physicians to observe brain function while patients perform physical and mental tasks.299
FMRI is one of the most popular methods of brain imaging in today’s market.300 Open MRI
systems, or short bore magnet systems, are another example of technological improvements to
existing imaging technologies. These systems reduce claustrophobia for patients but generate
images of comparable quality to those produced by traditional imaging technology.301
As a result of these technological advances, an estimated 34.9 million MRI procedures were
performed in 2014, a significant growth from the 26.6 million procedures conducted in 2006.302
Spending on MRI and CT services accounted for nearly one third of the approximate $10 billion
expenditure on imaging services in 2012.303
Advances in Computed Tomography (CT)
CT has transformed both diagnostic and interventional medicine. The quality of CT images
appears to surpass the anatomical detail of competing imaging technologies due to the crosssectional scanning capabilities they afford.304 CT produces tomographic images (slices) of a
specific body part by using a computer to process numerous x-rays of the area to create a crosssectional image, which is obtained by rotating the x-ray device around the patient’s body in a
process known as CT scanning.305 The clearer images provided by CT are partly due to the
elimination of image superimposition outside the area of interest and the high contrast resolution,
which can differentiate between varying tissue densities. Additionally, CT appears to expedite
and improve the initial triage of patients on an outpatient basis, as well as in the ER, allowing
patients to either return home or be admitted to the hospital for further evaluation.306 Since its
inception in 1970, use of CT has grown rapidly;307 as of 2011, approximately 85.3 million scans
were performed in the U.S.308
Multidetector Row Computed Tomography (MDCT)
The advent of multidetector row (also known as multi-slice) CT (MDCT) technology has
redefined imaging on the molecular and cellular levels309 and thereby enhanced patient
299 “MRI Systems Market: Clinical Application Trends” Frost and Sullivan, October 10, 2007, http://www.frost.com/prod/servlet/marketinsight-top.pag?docid=108958393 (Accessed 6/29/09).
300 Ibid.
301 “Magnetic Resonance Imaging: Market Trends” Darshana De-Frost and Sullivan Research Analyst, OBBeC Worldwide Biotech Exchange
Network, March 4, 2008, http://www.obbec.com/analysis/1038-medical-imaging/1676-magnetic-resonance-imaging markettrends?showall=1 (Accessed 6/29/09).
302 “2014 MR Market Outlook Report” IMV, November 2014, http://www.imvinfo.com/index.aspx?sec=mri&sub=dis&itemid=200085
(Accessed 3/23/15); “Latest IMV Market Report Shows Continued Demand for High Field MRI Systems” IMV, January 16, 2007,
http://www.imvinfo.com/user/documents/content_documents/nws_rad/MS_MRI_PressRelease.pdf (Accessed 6/29/09).
303 “A Data Book: Health Care Spending and the Medicare Program” Medicare Payment Advisory Commission, June 2014, p. 106.
304 “Computed Tomography—An Increasing Source of Radiation Exposure” By David J. Brenner, Eric J. Hall, and D.Phil, The New England
Journal of Medicine, Vol. 357, No. 22 (November 29, 2007), p. 2277.
305 “Computed Tomography (CT): Questions and Answers” National Cancer Institute, September 8, 2003.
306 “CT Shines as Cardiac Triage Tool in the ER” By James Brice, Diagnosticimaging.com, November 2005, http://www.diagnostic
imaging.com/showArticle.jhtml?articleID=174402997 (Accessed 7/14/06).
307 “CT Scanning: Patterns of Use and Dose” Fred A. Mettler, et al., Journal of Radiological Protection Vol. 20, No. 4 (2000), p. 353.
308 “Latest IMV CT Survey Shows Hospitals Seek to Improve Productivity to Manage Increased Outpatient and Emergency CT Procedure
Volume” Press Release, PRWeb, June 5, 2012.
309 “Dynamic Volume: A Macroevolution?” By Jagat Narula, Radiology Today, Vol. 9, No. 23 (November 17, 2008), p. 10.
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management and care. Through the evolution from the 4-slice CT scanner, the 16-slice CT
scanner, and, finally, the 64-slice CT scanner, MDCT has raised the standard for image quality
and accuracy allowing for the production of 3D images.310
64-Slice CT is the most popular CT technology in use, as it made cardiac and cerebral CT imaging possible.311

In addition to producing images with greater acuity, the 64-slice CT also operates at an increased
speed compared to previously existing CT technology. The average scanning time for the 64slice scanner was 313 seconds, which was 64 seconds faster than second generation 16-slice
scanners.312 A 64-slice CT scanner can complete a scan in as little as 8 to 12 seconds, compared
to a traditional CT scanner’s time of 20 to 30 seconds.313
With diagnostic imaging trends indicating that continued growth in the field is largely due to
adult diagnosis and screening procedures by proxy of the available MDCT technology, the four
areas of most interest at present are: (1) CT cardiac screening; (2) CT colonography; (3) CT lung
screening; and (4) CT whole body screening.314
Dynamic Volume Computed Tomography
The latest in CT technologies, the 256- and 320- detector row systems, collectively are referred
to as dynamic volume CT. Dynamic volume CT technology is capable of imaging an entire organ
with isotropic resolution in one rotation and as a complete volume. The temporally uniform data
are then reconstructed as a whole unit, thereby reducing the chance of artifacts and
misregistrations in the image caused by creating a composite image.315 In addition to being
quicker and more accurate, dynamic volume CT exposes a patient to a significantly lower dose
of radiation than both 64-slice imaging and invasive diagnostic technologies. Similarly, dynamic
volume CT scanning is sensitive enough to allow physicians to detect subclinical problems,
facilitating earlier diagnosis and treatment.316

310 “Computed Tomography in the 21st Century: Changing Practice for Medical Imaging and Radiation Therapy Professionals” By Sal
Martino, Jerry Reid, and Teresa G. Odle, American Society of Radiologic Technologists, 2008, p. 2.
311 “Nuclear cardiology adopts hybrid and dynamic imaging” by David Berman, M.D., Diagnostic Imaging.com, October 2006,
www.diagnosticimaging.com/display/article/113619/1193342 (Accessed 2/10/09).
312 “CT Flexes Muscle in Coronary Disease Detection” By James Brice, Rheumatology Network, November 29, 2005,
http://www.rheumatologynetwork.com/ct/ct-flexes-muscle-coronary-disease-detection (Accessed 4/1/15).
313 “State-of-the-art Cardiac CT Prompts Better, Quicker, Diagnosis and Shorter Hospital Stays” Cardiovascular Business (March/April 2009)
p. 22-2; “Cardiac CT for Calcium Scoring” By Radiological Society of North America, October 1, 2008, http://www.radiologyinfo.org/
en/info.cfm?PG=ct_calscoring (Accessed 4/30/09).
314 “Cardiac CT: 64-Slice and Beyond” Clinical Advancements in Volumetric CT, Toshiba Medical Systems, February 2006; “Virtual
Colonoscopy for Colorectal Cancer Screening: Current Status” By Jay P. Heiken, Christine M. Peterson, and Christine O. Menias, Cancer
Imaging, Vol. 5 (2005), p. S133-S139; “Computed Tomography Screening and Lung Cancer Outcomes” By Peter B. Bach, James R. Jett,
Ugo Pastorino, et al., Journal of the American Medical Association, Vol. 297, No. 9 (June 23, 2009), p. 953-961; “Cost-Effectiveness of
Whole Body CT Screening” By Molly T. Beinfeld, Eve Wittenberg, G. Scott Gazelle, Radiology, Vol. 234, No. 2 (2005), p. 415-422.
315 “CT Beyond 64 Slices: ‘Dynamic Volume CT’ Promises to Streamline Workflow, Improve the Bottom Line” By Tony DeFrance,
Cardiovascular Business, January/February 2009, p. 24.
316 “Dynamic Volume CT: A Macroevolution?” By Jagat Narula, Radiology Today, Vol. 9, No. 23 (November 17, 2008), p. 10.
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“Fusion” Imaging—Nuclear Medicine and Combined Technologies
The adoption of CT in nuclear medicine has resulted in a hybrid technology known as “fusion”
imaging that combines nuclear medicine cameras with CT detection methods.317 Positron
emission tomography-CT (PET-CT) as well as single, photon emission computed tomographyCT (SPECT-CT) systems have various qualities that may prove advantageous in addressing the
problems posed by each independent system. By using a dual-system (SPECT-CT or PET-CT),
patients can undergo both procedures at once, resulting in minimized error rates and better
images.318 According to IMV Medical Information Inc. (IMV), a leading market research firm,
“PET-CT scanners have become the preferred technology for PET imaging, as the integration of
functional PET images with anatomical visualization of CT has allowed more accurate and faster
diagnosis.”319
PET technology allows for substantially higher sensitivity than single-photon imaging
technologies, such as SPECT.320 However, due to the longer half-life of single-photon emitters,
SPECT tracers last six hours; PET tracers have only a 75 second half-life. A longer half-life
enables the use of a wider observational time window.321 SPECT is much more available, widely
used and more affordable than PET-CT technology (a SPECT camera costs between $400,000
and $600,000, and the PET-CT can cost $2 million).322 Utilization trends are changing for
SPECT and PET technologies. PET procedure volume increased by 11% from 2011-2012, while
SPECT procedure volume remained flat from 2011-2012.323 However, SPECT is subject to
longer scan times and can produce low-resolution images that are prone to artifacts and
attenuation (especially in larger patients).324
Pr PET technology allows for substantially higher sensitivity than single-photon imaging technologies like the
SPECT.325

IMV also reported increased use of SPECT-CT, capable of CT-based attenuation correction
which, paired with CT calcium scanning, will significantly increase accuracy and interpreter
confidence. Due to the insufficient sensitivity of current SPECT imaging technology, SPECT-CT
may become the standard way in which SPECT studies are performed.326

317 “Nuclear Medicine Usage, Grows, Led By PET” IMV Medical Information Inc. Newsline, Vol. 47, No. 10 (2006), p. 13N; “SPECT vs.
PET, Which is Best?” By Dave Fornell, October 2008, http://www.dicardiology.net/node/28668 (Accessed 2/10/09).
318 “Nuclear cardiology adopts hybrid and dynamic imaging” By David Berman, Diagnostic Imaging.com, October 2006,
http://www.diagnosticimaging.com/display/article/113619/1193342 (Accessed 2/10/09).
319 “Nuclear Medicine Usage, Grows, Led By PET” IMV Medical Information Inc. Newsline, Vol. 47, No. 10 (2006), p. 13N.
320 “PET Versus SPECT: Strengths, Limitations, and Challenges” By Arman Rahmim and Habib Zaidi, Nuclear Medicine Communications,
Vol. 29 (2008), p. 193.
321 “PET Versus SPECT: Strengths, Limitations, and Challenges” By Arman Rahmim and Habib Zaidi, Nuclear Medicine Communications,
Vol. 29 (2008), p. 193-207.
322 “Report: U.S. SPECT, PET Market Looks Promising in Coming Years” By Wayne Forrest, AuntMinner.com, July 30, 2013,
http://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=104103 (Accessed 3/25/15).
323 “SPECT vs. PET, Which is Best?” By Dave Fornell. Diagnostic and Invasive Cardiology, October 2008, http://new.reillycomm.com/
diagnostic/article_detail.php?id=672 (Accessed 02/10/09).
324 Ibid.
325 “PET versus SPECT: strengths, limitations, and challenges,” by Arman Rahmim and Habib Zaidi, Nuclear Medicine Communications,
Vol. 29, (2008) p. 193–207.
326 “Nuclear Cardiology Adopts Hybrid and Dynamic Imaging” By David Berman, Diagnostic Imaging.com, October 2006,
http://www.diagnosticimaging.com/display/article/113619/1193342 (Accessed 2/10/09).
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Despite these international trends, over 60% of all SPECT and PET purchases in the U.S. are still
SPECT.327 However, SPECT-CT trends are unlikely to mimic the dynamic increases in PET-CT
use. Compounded by the current reimbursement environment, the main barrier to the SPECT-CT
market is a shortage in technetium, the isotope most frequently needed for such nuclear
procedures.328 Additionally, the majority of SPECT procedures are performed in the field of
cardiology,329 where SPECT-CT is only beneficial if it can generate 64 or more slices. Often, the
cost allocated to such technologies is beyond the budgeting capacity of many cardiology
departments.330 By contrast, PET-CT technology has been incorporated into many oncology
practices, where budgets appropriately match the necessity of such technology.331
PET-CT technology has been most incorporated in oncology practices, in instances when budgets appropriately
match the need.
Greg Freiherr, 2009.

Telemedicine and Imaging: Picture Archives and Communications Systems
(PACSs) and Other Advances in Teleradiology
Teleradiology is the electronic transfer and storage of electronic imaging data. It is the market’s
solution to ensure a greater number of radiologists in the marketplace (the number of radiology
and diagnostic radiology physicians increased 8.2% from 2000 to 2010332) and to increase the
number of images a radiologist must interpret.333
One of the fastest growing specialties in telemedicine is teleradiology, i.e., the electronic
transfer and storage of electronic imaging data, which allows for an increased ability to read
scans remotely, alleviating the off-hours burden that night reads pose to radiology groups.334
Other advances in teleradiology technology have allowed for the connection of digital x-rays and
other such imaging modalities to Picture Archives and Communications Systems (PACS), which
has significantly improved the efficiency of imaging care by providing improved access to even
higher quality images with reduced delays. Many of these systems result from infrastructures
implemented in hospital radiology departments and have since expanded into a wider area of
networks for health systems, outpatient providers, and managed care organizations.335

327 “Report: U.S. SPECT, PET Market Looks Promising in Coming Years” By Wayne Forrest, AuntMinner.com, July 30, 2013,
http://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=104103 (Accessed 3/25/15).
328 “Great Expectations and the Saga of SPECT-CT” By Greg Freiherr, Diagnostic Imaging, June 25, 2009, http://www.diagnostic
imaging.com/display/article/113619/1425226?CID=rss (Accessed 6/29/09).
329 “PET versus SPECT: strengths, limitations, and challenges” By Arman Rahmim and HabibZaidi, Nuclear Medicine Communications,
Vol. 29, No. 3 (2008), p. 193.
330 “Great Expectations and the Saga of SPECT-CT” By Greg Freiherr, Rheumatology Network, June 25, 2009, http://www.diagnostici
maging.com/display/article/113619/1425226?CID=rss (Accessed 4/1/15).
331 Ibid.
332 “2012 Physician Specialty Data Book” Center for Workforce Studies, Association of American Medical Colleges, November 2012,
https://www.aamc.org/download/313228/data/2012physicianspecialtydatabook.pdf (Accessed 3/25/15), p. 26.
333 Discussed above in the Trends in Telemedicine section.
334 “Teleradiology: New Players, High Stakes Create Capital Opportunity” By John C. Hayes, Diagnostic Imaging, November 1, 2006,
http://www.diagnosticimaging.com/display/article/113619/1193477 (Accessed 6/29/09).
335 “DOTmed Industry Sector Report: PACS/RIS/HIS” By Barbara Kram, DOTmed Business News, March 2009,
http://www.dotmed.com/news/story/8313/.
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Companies providing day reads in subspecialty areas have begun to show market expansion.336
Full-field digital mammography makes telemammography and computer-aided detection
possible, increasing facility appeal without additional burden on staff. Furthermore, digital
mammography has the potential to decrease patient anxiety because the technologist can stay in
the exam room for the duration of the screening, and this technology has proven to be useful in
imaging dense breast tissue, thereby improving quality of care.337
Regulatory and Reimbursement
With regard to PET technology, federal regulations were updated in 2009 to ensure compliance
of drug production and manufacturing practices with federal regulations regarding safety and
quality of radiologic tracers used in PET procedures.338 These regulations required all PET
production facilities to comply with the updated requirements, including updating standard
operating procedure for manufacturing of all PET drugs and PET drug product and activities
related to quality assurance; facilities; equipment; personnel; and production, process, and
laboratory controls.339

THERAPEUTIC TECHNOLOGY
The range of use for therapeutic technologies has grown substantially over the last century, and
innovation in the arena continues to lead to groundbreaking medical discoveries in the fields of
molecular pharmacology; radiation therapy; robotics and surgical technology: minimally
invasive surgery; transplant technologies; home infusion therapy; and pain management.

Molecular Pharmacology
Biopharmaceuticals are drugs and biologics that treat an organism through the genetic
manipulation of foreign DNA. Biologics are therapeutic products that are developed using living
sources, such as vaccines, blood and blood products, and allergenic extracts and tissues.340 The
manufacturing of biopharmaceuticals, most specifically vaccines, monoclonal antibodies,
recombinant proteins, and stem cells relies heavily on the cell culture market.341 In turn, the
necessary in-depth knowledge of cell culture that fortifies molecular pharmacology was made
possible with the advent of the genomic era.
The FDA has approved drugs and biologics in eight categories of biopharmaceuticals: (1)
recombinant blood factors; (2) recombinant thrombolytics and anticoagulants; (3) recombinant
hormones; (4) recombinant growth factors; (5) recombinant interferons and interleukins;
336 “Teleradiology: New Players, High Stakes Create Capital Opportunity” By John C. Hayes, DiagnosticImaging, November 1, 2006,
http://www.diagnosticimaging.com/display/article/113619/1193477 (Accessed 6/26/09).
337 “Trends in Radiology, Special Report: Managing the Transition to Digital Mammography” By Kate Madden Lee, Siemens, March 1, 2007,
http://www.auntminnie.com/index.aspx?sec=spt&sub=tir&pag=dis&itemID=74564, (Accessed 10/1/09).
338 “Current Good Manufacturing Practice for the Positron Emission Tomography Drugs” Federal Register Vol. 74, No. 236 (December 10,
2009), p. 65409.
339 “Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Final Rule”, Food and Drug Administration, U.S.
Department of Health & Human Services, 21 CFR Part 212, Federal Register Vol. 74, No. 236 (December 10, 2009), p. 65409, 6543265435.
340 “Biologics” Dictionary.com, Dictionary.com, 2009, http://dictionary.reference.com/browse/biologic (Accessed 10/1/09).
341 “Biopharmaceutical Benchmarks 2006: The Rate of Biopharmaceutical Approvals has Leveled Off, but some Milestones Bode Well for the
Future” By Gary Walsh, Nature Biotechnology, Vol. 24, No. 7 (July 2006), p. 775.
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(6) recombinant vaccines; (7) monoclonal antibody-based products; and (8) miscellaneous
recombinant products.342
The NIH’s Intramural Research Program (IRP) encourages “bench-to-bedside” translational
research,343 and includes programs such as: the Therapeutics for Rare and Neglected Diseases
(TRND) Program under the National Center for Advancing Translational Sciences (NCATS); the
Psychoactive Drug Screening Program under the National Institute of Mental Health (NIMH);
and, the Laboratory of Molecular Pharmacology under the National Cancer Institute’s (NCI)
Center for Cancer Research (CCR).344 The IRP has repositories for both natural and synthetic
products and compounds and has access to the NCI-60, a databank of 60 cancer cell lines against
which the NCI’s Developmental Therapeutics Program screens hundreds of thousands of
compounds.345
Trends in Molecular Pharmacology
Advances in Proteomics
Therapeutic protein technology has experienced developments of innumerable implications.
Insulin, the first recombinant protein to be approved, remains the prototype for
biopharmaceutical development, and it was one of the first biopharmaceuticals to undergo
molecular engineering, a process that has since defined development and advancement in
biopharmaceuticals.346 Since the early 2000s, an increasing number of rapid-acting or timereleasing engineered analogs for insulin have been approved, including the most recent drug,
Afrezza, an inhalable recombinant insulin that received FDA approval in June 2014.347 With an
increased incidence and prevalence rate of diabetes, it is probable that the demand and market for
such products will continue to grow.348
Therapeutic proteomic technology has similarly seen developments with innumerable
implications for correcting defective proteins or filling in a gap where a protein is absent.349
Several protein kinase inhibitors are currently subjects of FDA clinical trials, and have boosted
proteomic research in phosphorylation-triggered signaling, known as “phosphoproteomics.”350
Additionally, more accurate mass spectrometry techniques have allowed researchers to target
cancer and tumor suppression proteins with more specificity.351 Continued advances in this field
are expected to support developments in personalized medicine technology, which are
particularly emerging in the area of oncology, where specific therapies are being targeted to
342 Ibid, p. 769 (table 1).
343 “Molecular Pharmacology” Intramural Research Program, National Institutes of Health, http://irp.nih.gov/our-research/scientific-focusareas/molecular-pharmacology (Accessed 9/28/12).
344 Ibid.
345 Ibid.
346 “Biopharmaceutical Benchmarks 2006: The Rate of Biopharmaceutical Approvals has Leveled Off, but some Milestones Bode Well for the
Future” By Gary Walsh, Nature Biotechnology, Vol. 24, No. 7 (July 2006), p. 770.
347 “FDA Approves Afrezza to Treat Diabetes” Food and Drug Administration News Release, June 30, 2014, http://www.fda.gov/NewsEvents/
Newsroom/PressAnnouncements/ucm403122.htm (Accessed 3/19/15).
348 “Biopharmaceutical Benchmarks 2006: The Rate of Biopharmaceutical Approvals has Leveled Off, but some Milestones Bode Well for the
Future” By Gary Walsh, Nature Biotechnology, Vol. 24, No. 7 (July 2006), p. 770.
349 “Current Topics: Proteomics” American Medical Association, 2012, http://www.ama-assn.org/ama/pub/physician-resources/medicalscience/genetics-molecular-medicine/current-topics/proteomics.page# (Accessed 9/27/12).
350 “Proteomics Retrenches” By Peter Mitchell, Nature Biotechnology, Vol. 28, No. 7 (July 2010), p. 669-670.
351 Ibid, p. 670.

378

Chapter 5: Technology Development

genetically derived tumor types. Consequently, many pharmaceutical and diagnostic companies
are entering the personalized medicine market at an accelerating pace.352
Nucleic Acid-Based (RNAi) Therapeutics
Other advances in therapeutic genome technology include nucleic acid-based technologies,
which have clinical applications involving both deoxyribonucleic acid (DNA) and ribonucleic
acid (RNA). Advances in DNA nanotechnology have opened the door to specifically targeted
drug delivery, while advances in RNA technology have moved toward therapeutic interference
with the genome. RNA interference (RNAi) is a natural cellular process where specific genes
(e.g., a cancer gene) can be targeted and silenced so that it cannot reproduce and become
symptomatic. Since its initial discovery in 1998, RNAi has become increasingly prevalent in the
biomedical industry.353 Recent market reports predict RNAi therapeutics to generate sales of
approximately $1.2 billion by 2020.354 These biopharmaceuticals show tremendous promise in
countless areas, the most notable of which are Hepatitis C and cancer treatment.355 MicroRNAs
are believed to regulate almost one-third of the entire genome, and they are anticipated to change
therapeutic capabilities. “MicroRNAs developed as regulators over millions of years to regulate
complex diseases… [They] may turn out to be enormously beneficial in terms of drug
discovery.”356 Though this area of technology has developed at a relatively slow pace, with
fifteen years of research and only two approved products, approval of the first commercial gene
therapy (molecular means of cancer treatment), Gendicine, reset the tone for nucleic acid-based
RNAi drug development.357 Approval of Gendicine by the State Food and Drug Administration
of China for treatment of head and neck squamous cell carcinoma will facilitate further
developments in RNAi therapeutics and gene therapy.358
These biopharmaceuticals hold tremendous promise in countless areas, the most notable of
which include anti-viral, Hepatitis C, and cancer treatment.359 In general, the number of
biopharmaceuticals that are available for commercial use is continually growing, with 22 new
products approved by the FDA in 2014.360 However, the rate of FDA approval slowed beginning
in 2006, with the approval of new biological entities (NBEs), stated as a percentage of all new
approvals, decreasing from 24% between 2003 and 2006, to 21% between 2006 and 2010.361

352 “Integrated Diagnostics and Personalized Care: An Interview with GE Healthcare” By Ann Staylor and Mary Thompson, Medtech Insight,
June/July 2011, p. 16, 18.
353 “RNA Interference Fact Sheet” National Institute of General Medical Sciences, National Institutes of Health, January 30, 2012,
http://www.nigms.nih.gov/News/Extras/RNAi/factsheet.htm (Accessed 9/24/12).
354 “Global RNA Based Therapeutics Market (Technology, Application, End Users and Geography)—Size, Share, Global Trends, Company
Profiles, Demand, Insights, Analysis, Research, Report Opportunities, Segmentation and Forecast, 2013-2020: Report Overview” Allied
Market Research, September 2014, http://www.alliedmarketresearch.com/RNA-based-therapeutics-market (Accessed 3/20/15).
355 “Improving Delivery of RNAi Drugs: Abundance of Vehicles are in Development to Help Translate the Technology into Therapeutics” By
Nina Flanagan, Genetic Engineering and Biotechnology News, Vol. 29, No. 3 (February 1, 2009), http://www.genengnews.com/
articles/chitem.aspx?aid=2758 (Accessed 6/26/09).
356 Ibid.
357 “Biopharmaceutical Benchmarks 2006: The Rate of Biopharmaceutical Approvals has Leveled Off, but some Milestones Bode Well for the
Future” By Gary Walsh, Nature Biotechnology, Vol. 24, No. 7 (July 2006), p. 773.
358 Ibid.
359 “RNA Interference Fact Sheet” National Institute of General Medical Sciences, National Institutes of Health, January 30, 2012,
http://www.nigms.nih.gov/News/Extras/RNAi/factsheet.htm (Accessed 9/24/12).
360 “Biopharmaceutical Products in the U.S. and European Markets: U.S. Approvals, 2002 - Present” Biotechnology Information Institute,
2012, http://www.biopharma.com/approvals.html (Accessed 3/20/15).
361 “Biopharmaceutical Benchmarks 2010” By Gary Walsh, Nature Biotechnology, Vol. 28, No. 9 (September 2010), p. 918.
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More recently, however, the low FDA approval rate trend may be starting to reverse itself. A
2013 McKinsey study investigating 2012’s ten-year high FDA pharmaceutical approval rate
determined that an increase in the number of filings by biopharmaceutical companies and a
quicker average review time helped drive a surge of greater approval, though the study was
inconclusive as to whether the upward trend could continue.362
However, recent government initiatives could shed more light into the viability of the positive
trend. In January 2015, President Obama announced a $215 million 2016 budget allotment to
begin the Precision Medicine Initiative, which promised to “accelerate biomedical discoveries
and provide clinicians with new tools, knowledge, and therapies to select which treatments will
work best for which patients” [Emphasis added].363 Participants in the initiative share their
genomic information and biological specimens, which researchers will use to study how genomic
variations and other health factors affect the development of disease.364 Initial reaction to the
initiative by groups such as the Pharmaceutical Research and Manufacturers of America
(PhRMA) was positive and reinforced the strong commitment of the industry to the
biopharmaceutical research sector.365 Trends in biopharmaceutical approval will have to be
tracked moving forward to determine the lasting effect of the initiative on the industry.
Regulatory and Reimbursement
As of 2014, 212 recombinant proteins, monoclonal antibodies, and nucleic acid-based drugs have
been approved by the U.S. and Europe as treatments for cancer, diabetes, growth disturbance,
hemophilia, and hepatitis.366 In 2013, the market size for biopharmaceuticals was estimated to be
roughly $140 billion, “a value which exceeds the reported gross domestic product (GDP) of
three-quarters of the economies in the World Bank GDP ranking database.”367 Although
biopharmaceuticals are nowhere near the peak of their development, they are already expensive,
with some biologics costing up to $500,000 per year.368 Furthermore, research by the American
Association of Retired Persons (AARP) has indicated that prices of these biopharmaceuticals are
rising at a rate greater than both inflation and the prices of other prescription drugs.369
The high-priced market for biopharmaceuticals is a result of a disparity in the approval processes
of biologic and nonbiologic drugs. To date, the majority of biologics have been regulated by the
Public Health Service Act, which prohibited generic biopharmaceuticals from being marketed.370
362 “What’s Driving the Surge in New-drug Approvals?” By Phillip Ma et al., McKinsey & Company, November 2013,
http://www.mckinsey.com/insights/public_sector/whats_driving_the_surge_in_new_drug_approvals (Accessed 3/20/15).
363 “Fact Sheet: President Obama’s Precision Medicine Initiative” The White House, January 2015, https://www.whitehouse.gov/the-pressoffice/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative (Accessed 3/20/15).
364 “Precision Medicine Initiative: What are the Longer-term Goals?” National Institutes of Health, February 2015,
http://www.nih.gov/precisionmedicine/future.htm (Accessed 3/20/15).
365 “PhRMA Statement on Precision Medicine Initiative” Pharmaceutical Research and Manufacturers of America, January 21, 2015,
http://www.phrma.org/media-releases/phrma-statement-on-precision-medicine-initiative (Accessed 3/20/15).
366 “Biopharmaceutical Benchmarks 2014” By Gary Walsh, Nature Biotechnology, Vol. 32, No. 10 (October 2014), p. 992.
367 Ibid, p. 994.
368 “Biopharmaceuticals: Entering a New World” Angle by NNE Pharmaplan, April 2012, p. 40.
369 “Rx Watchdog Report Trends in Manufacturer Prices of Specialty Prescription Drugs Used By Medicare Beneficiaries 2004-2007” By
Stephen W. Schondelmeyer, Leigh Purvis, and David J. Gross, American Association of Retired Persons, September 2008,
http://assets.aarp.org/rgcenter/health/2008_15_specialty_q407.pdf (Accessed 4/1/15).
370 “Rx Watchdog Report Trends in Manufacturer Prices of Specialty Prescription Drugs Used By Medicare Beneficiaries 2004 to 2007” By
Stephen W. Schlondelmeyer, Leigh Purvis, and David J. Gross, American Association of Retired Persons, September 2008,
http://assets.aarp.org/rgcenter/health/2008_15_specialty_q407.pdf (Accessed 4/1/15); “Biologics in Perspective: The Case For Generic
Biologic Drugs” By Leigh Purvis, American Association of Retired Persons, May 2009, http://www.aarp.org/research/health/
drugs/fs155_biologics.html (Accessed 7/06/09).
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Biopharmaceutical companies require a substantially longer monopoly period to see a return on
their investment, which can lead to higher prices charged for their products.371
A 2012 AARP Rx Price Watch Report suggested that the wholesale price of specialty drugs rose
8.9% during the course of 2009 while the average market price of those drugs rose 50.4%
between December 2004 and December 2009.372 In contrast, non-specialty branded drugs rose
only 8.3%, and the price of generics fell 7.8%.373 These inflated prices have not been received
well by insurers, many of which have raised the percentage of medication costs that patients are
expected to pay. Some insurers require that beneficiaries use cheaper alternatives before
approving the use of an expensive biologic option.374
Legislation to accelerate the process of developing and approving biosimilars by way of an FDA
process for biosimilar or follow-on generic drug approval could potentially save taxpayers,
insurers, and patients billions of dollars.375 The Congressional Budget Office (CBO) estimated in
2008 that such legislation could reduce total expenditures on biologics by roughly $25 billion
over ten years from 2009 to 2018.376 The Biologics Price Competition and Innovation Act of
2009 (adopted in Sections 7001-7003 of the Patient Protection and Affordable Care Act) which
established an abbreviated pathway for biosimilars to navigate the FDA approval process,
attempted to realize these goals.377 However, recent evaluations of the process suggest that the
prospects for significant cost savings are far more limited than the CBO originally estimated due
to the high cost of bringing biosimilars to market, current regulatory hurdles, and competition
from both new biologics in similar therapeutic classes and reference products.378

Radiation Therapy
Trends in Radiation Therapy
Much like imaging technology, radiation therapies have been developed, adapted, and improved
since the discovery of the x-ray in 1895.379 Radiation therapy uses high-energy light beams or
charged particles to stunt the proliferation of cancer cells, which are very susceptible to damage
371 “Biologics in Perspective: The Case For Generic Biologic Drugs” By Leigh Purvis, American Association of Retired Persons, May 2009,
http://www.aarp.org/research/health/drugs/fs155_biologics.html (Accessed 7/06/09).
372 “Rx Price Watch Report, Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Medicare Beneficiaries 2005-2009” By
Stephen W. Schondelmeyer and Leigh Purvis, American Association of Retired Persons, January 2012, http://www.aarp.org/
content/dam/aarp/research/public_policy_institute/health/2011/rx-pricewatch-01-2012.pdf (Accessed 3/20/15), p. v, 1.
373 Ibid.
374 “Rx Watchdog Report, Trends in Manufacturer Prices of Specialty Prescription Drugs Used By Medicare Beneficiaries, 2004-2007” By
Stephen W. Schlondelmeyer, Leigh Purvis, and David J. Gross, American Association of Retired Persons, September 2008,
http://assets.aarp.org/rgcenter/health/2008_15_specialty_q407.pdf (Accessed 4/1/15), p. 1; “Priced Out Pain Relief: Insurers Balk At High
Costs of Promising New Treatments” By Victoria Colliver, San Francisco Chronicle, May 8, 2007, http://www.sfgate.com/cgibin/article.cgi?f=/c/a/2007/05/08/BUGHAPMN021.DTL&type=printable (Accessed 7/06/09).
375 “Obama Backing Generic Biologics” By Lisa Wangsness and Todd Wallack, The Boston Globe, February 26, 2009,
http://www.boston.com/business/healthcare/articles/2009/02/26/obama_backing_generic_biologics/ (Accessed 6/26/09); “Follow-on
Biologics: The Right Model Means Differentiating from Traditional Drugs” By Zoe Lofgren, Michael Capuano, Mike Rogers, and Kevin
McCarthy, the Congress of the United States, June 18, 2009, http://www.chi.org/uploadedFiles/Legislative_Action/Federal_Issues/FOBs
percent20dear percent20colleague.pdf (Accessed 7/06/09).
376 “S. 1695 Biologics Price Competition and Innovation Act of 2007” Congressional Budget Office, June 2008, http://www.cbo.gov/sites/
default/files/s1695.pdf (Accessed 3/20/15), p. 5.
377 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 7001-7003, 124 Stat. 119, 804-821 (2010).
378 “Regulatory and Cost Barriers are Likely to Limit Biosimilar Development and Expected Savings in the Near Future” By Henry G.
Grabowski et al., Health Affairs, Vol. 33, No. 6 (2014), p. 1048.
379 “Introduction to Cancer Therapy (Radiation Oncology)” By Radiological Society of North America, RadiologyInfo, June 10, 2009,
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from radiation due to rapid proliferation and an inability to regenerate.380 However, radiation
therapy also has the potential to damage healthy cells. Most side effects of radiation therapy are
short term and are usually confined to the area being treated. Typically, treatments are
administered on an outpatient basis over the course of multiple sessions.381 Radiation may be
administered alone or simultaneously with chemotherapy either prior to, or in the absence of,
surgery. Approximately 60% of cancer patients are treated using radiation at some point during
their disease.382 The continuous development of increasingly sophisticated imaging technologies
and procedures has resulted in earlier diagnoses and improved outcomes for patients through
radiation therapies.383
Devices
Technology is the leading driver of radiation therapy’s competitive market.384 The development
of linear accelerators and gamma knives has increased therapeutic capability, precision, and ease
of use, all of which enhance the quality of care. These tools are utilized in the various modalities
to deliver highly advanced therapy procedures, such as intensity-modulated radiation therapy and
stereotactic radiosurgery. In addition to executing treatment plans developed based on imaging
scans, image guided radiotherapy is implemented by one-third of all radiation oncology sites to
date, with ultrasound, x-ray, and CT imaging technologies used most frequently.385 As radiation
therapy has become one of the dominant methods of cancer treatment, demand is likely to
increase as the population ages.386
Linear Accelerators
The linear accelerator (LINAC) is the device most commonly used in external beam radiation
therapy treatments for patients with cancer.387 Linear accelerators deliver uniform doses of highenergy x-rays to the localized area of a patient’s tumor. LINAC accelerates electrons to allow the
electrons to collide with a heavy metal target, which scatters the high energy x-rays. Then, “[a]
portion of these x-rays are collected and then shaped to form a beam that matches the patient’s
tumor.”388 The beam emanates from a gantry that rotates around the patient. During this process,
the patient lies on a movable treatment couch.389 Lasers are utilized to ensure that the patient is
properly positioned to receive the treatment. Radiation can be delivered to the tumor from
various angles by rotating the gantry and the treatment couch. By modifying LINAC systems to

380 “Radiotherapy Overview” International Radiosurgery Association, 2008, http://www.irsa.org/radiotherapy.html (Accessed 6/26/09).
381 Ibid.
382 “Introduction to Cancer Therapy (Radiation Oncology)” By Radiological Society of North America, RadiologyInfo, April 22, 2013,
http://www.radiologyinfo.org/en/info.cfm?pg=intro_onco (Accessed 3/20/15).
383 “Radiotherapy Overview” International Radiosurgery Association, 2008, http://www.irsa.org/radiotherapy.html (Accessed 6/26/09).
384 “DOTmed Industry Sector Report: Linear Accelerators and Simulators” By Barbara Kram, DOTmed News, November 19, 2008,
http://www.dotmed.com/news/story/7013/ (Accessed 6/29/09).
385 “IMV Reports Increased Use of Image-Guided Radiotherapy in Radiation Oncology” By Gale Group, BusinessWire, April 9, 2007,
http://www.businesswire.com/news/home/20070409005049/en/IMV-Reports-Increased-Image-Guided-Radiotherapy-Radiation-Oncology
(Accessed 4/1/15).
386 “DOTmed Industry Sector Report: Linear Accelerators and Simulators” By Barbara Kram, DOTmed News, November 19, 2008,
http://www.dotmed.com/news/story/7013/ (Accessed 6/29/09).
387 Ibid. See Procedures section, below.
388 “Linear Accelerator” By Radiological Society of North America, RadiologyInfo, June 10, 2009, http://www.radiologyinfo.org/
content/therapy/linear_accelerator.htm, (Accessed 6/29/09).
389 Ibid.

382

Chapter 5: Technology Development

include multileaf collimators, they can be used in intensity modulated radiation therapy.390
However, without the necessary modifications, LINAC systems are simply machines used for
stereotactic radiosurgery.391 A new linear accelerator can cost anywhere from $1.5 million to
$3 million.392
Gamma Knives
Development of the gamma knife revolutionized stereotactic radiosurgery by employing
computerized robotic technology to move patients at submillimeter increments during treatment.
This maximizes the procedure’s practical utility, allowing a physician to accurately target safe
but high-dose radiation treatment.393 Gamma knife treatments are administered in a single session
and require CT or MRI communication with the gamma knife’s computer planning system to
identify targets and normal anatomical structures and calculate the gamma knife treatment
parameters. The gamma knife can be used for treatment of a variety of health problems, namely
malignant and benign brain tumors, blood vessel defects, and functional problems. Research is
currently underway to implement gamma knife technology in epilepsy and Parkinson’s disease
treatments.394
Procedures
External beam radiation therapy (EBRT) involves the administration of high-energy x-ray
beams to kill cancer cells and treat tumors.395 Often, some x-ray, ultrasound, or CT imaging is
used prior to the delivery to ensure that the path of the beam will align with the target area.396
Proton therapy is administered in a similar manner, but instead of administering x-ray beams,
beams of protons are used to irradiate a variety of tumors, skull base sarcomas, and eye
melanomas.397 Alternately, brachytherapy, a form of internal radiation therapy, is used to treat a
smaller area in a shorter period of time at higher doses of radiation by placing
radiopharmaceuticals directly inside or next to the tumor.398 Brachytherapy can be temporary or
permanent, with variable administration rates and doses. During permanent brachytherapy, also
known as seed implantation, a radioactive seed is placed in or near the tumor where it gradually
decreases in radioactivity over a predetermined period of time. After the seed is rendered
inactive, it remains in the body with no lasting effect on the patient.399

390 “DOTmed Industry Sector Report: Linear Accelerators and Simulators” By Barbara Kram, DOTmed News, November 19, 2008,
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394 “Gamma Knife Surgery” International RadioSurgery Association, irsa.org, June 10, 2009.
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Intensity-Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) is an advanced form of radiation therapy using
3D imaging and treatment delivery. It differs from 3D conformal radiation therapy (3D CRT),
which uses linear accelerators to administer varying intensities of radiation without IMRT
capabilities.400 Currently, CT scans are most commonly used for IGRT, such as IMRT, because
the CT can provide timely volumetric data.401 Despite reported safety concerns related to certain
procedures, e.g., nonmetastatic prostate cancer, IMRT has been associated with better patient
outcomes than other similar therapeutic radiation procedures. 402 IMRT treatments, customtailored using 3D CT images alongside computer generated dose calculations, most effectively
treat the unique three-dimensional shape of a tumor. This method allows for increased precision
in the administration of high dose radiation while preserving the surrounding tissue.403
In 2007, Varian Medical Systems introduced a new IMRT treatment technique called
RapidArc,TM404 which delivers a radiation dose over a single rotation and utilizes a new software
algorithm that can simultaneously control three parameters of treatment: (1) the speed of the
gantry rotation; (2) the shape and position of the aperture created by the movement of multileaf
collimator (MLC) leaves; and (3) the dose rate of delivery.405 RapidArcTM uses volumetric
modulated arc therapy, which allows treatment to be delivered in a single dose to the entire
volume of the cancerous cell, in contrast to slice by slice. RapidArcTM is able to deliver a precise
3D dose distribution with a single 360-degree rotation and with treatments times two to eight
times faster than typical IMRT techniques.406
Stereotactic Radiosurgery
Stereotactic radiosurgery is a nonsurgical procedure involving the single, high-dose delivery of
targeted gamma-ray or x-ray beams typically used to treat various areas of the brain. It serves as
an increasingly preferred alternative to invasive surgery for soft tissue tumors (e.g., brain
tumors).407 Most frequently, stereotactic radiosurgery is administered in one session; however,
physicians may recommend fractionated stereotactic surgery (two to five treatments) or
stereotactic radiotherapy (more than five treatments) in circumstances in which tumors are larger
than an inch in diameter.408 Linear accelerators, proton beams or heavy-charged particle beams,
and gamma knives are all used to perform stereotactic procedures.409
400 “Intensity-Modulated Radiation Therapy (IMRT)” By Radiological Society of North America, RadiologyInfo, June 10, 2009,
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Stereotactic radiotherapy has been used more recently to treat tumors located in areas other than
the brain in procedures referred to as stereotactic body radiotherapy. The most common sites for
which stereotactic body radiotherapy is currently being utilized include: (1) lungs; (2) liver;
(3) abdomen; (4) spine; (5) prostate; and (6) the head and neck.410

Robotics and Surgical Technology
Trends in Robotics and Surgical Technology
Historical Developments in Minimally Invasive Surgery
Laparoscopy, a form of minimally invasive surgery, involves the insertion of a slender, tubular
endoscope and other surgical instruments through the abdomen wall, allowing a practitioner
direct internal visual navigation and control of a surgery.411 Laparoscopy and other forms of
minimally invasive surgery have evolved from continuous improvements in surgical technology
to increase ease-of-use, comfort, and accuracy. In the early 1990s, countless attempts at robotic
prototyping were made, namely in the area of laparoscopic surgical procedures, but nothing
materialized.412 The U.S. military, with the intention of designing a prototype to provide remote
operative care in combat regions, actually pioneered the realm of surgical robotics. Introduced by
Intuitive Surgical in 1996, this prototype came to be known as the da Vinci system; it was
approved by the FDA in 2000. Simultaneously, Computer Motion released to the market the first
laparoscopic camera holder, which it called Automated Endoscopic System for Optimal
Positioning, or AESOP.413
Medical device manufacturers are consistently designing new minimally invasive surgery
products to make surgery less invasive for the patient while still improving the surgeon’s
precision and visualization.414 The main barrier to expanding the scope of minimally invasive
surgery technologies may be providers’ lack of awareness of, and training in, advanced
laparoscopic techniques. To avoid the circumstance of manufacturers outpacing efficient
implementation within the industry, manufacturers are focusing development on ease of use of
new technologies, in addition to development of innovative surgical techniques.415
The availability of these newly developed energy devices has expanded the market for the
utilization of minimally invasive techniques to include such devices as: (1) electrosurgical
generators; (2) instruments; (3) accessories; and (4) thermal ligature systems, which allow for
more accurate and less invasive procedures by advancing dissecting, cutting, coagulating, and
ligature creation surgical procedures.416 As of 2015, market reports predict that the
410 “Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT)” Radiological Society of North America and American
College of Radiology, 2012, http://www.radiologyinfo.org/en/info.cfm?PG=stereotactic, (Accessed 11/1/12).
411 “Minimally Invasive Surgery” Mayo Clinic, 2009, http://www.mayoclinic.org/minimally-invasive-surgery/ (Accessed 4/6/09).
412 “Robotic Assisted Laparoscopic Radical Prostatectomy: A Review of the Current State of Affairs” By V.R. Patel, M. F. Chammas Jr., and
S. Shah, International Journal of Clinical Practice, Vol. 61, No. 2 (February 2007), p. 309-314.
413 “Robotic Assisted Laparoscopic Radical Prostatectomy: A Review of the Current State of Affairs” By V.R. Patel, M. F. Chammas Jr., and
S. Shah, Int. J. Clin. Pract, Vol. 61, No. 2 (February 2007), p. 309-314; “Robot-Assisted Surgery” Mayo Clinic, 2009,
http://www.mayoclinic.org/robotic-surgery/ (Accessed 4/1/15).
414 “Trends in MIS, Part I: Pushing Surgical Boundaries” By Anne Staylor, Medtech Insight, Vol. 14, No. 5 (May 2012), p. 18.
415 “Trends in MIS, Part II” By Anne Staylor, Medtech Insight, Vol. 14, No. 6, June/July 2012, p. 18.
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electrosurgical market will grow at an annual rate of roughly 5.9% through 2019, with the global
market expected to reach approximately $4.0 billion.417
The da Vinci System Versus Laparoscopy
Minimally invasive procedures lessen many of the risks traditionally associated with surgery
through the use of several small incisions to guide fiber-optic cameras to the area(s) of interest.418
Some minimally invasive instruments, such as the da Vinci System, employ robotic equipment,
which serves as an added benefit compared to laparoscopic methods due to increases in
maneuverability, visibility, and precision. Laparoscopic techniques project a mirror image onto
the screen, which has proven to be counterintuitive for physicians. Robotic technology features
digital correction to cater to the physician’s intuitive, natural tendencies, and thereby increases
overall accuracy.419
The da Vinci System revolutionized minimally invasive surgery by overcoming the limitations of
both traditional surgical procedures and conventionally implemented noninvasive laparoscopic
technology. The procedure performed with this technology was originally limited to cardiac
endoscopy, but it has expanded to include gastrointestinal, cardiothoracic, gynecologic, urologic,
and other specialty surgical procedures.420 The da Vinci system uses small incisions for the
placement of robotic appendages, which result in fewer scars that require less healing time,
decrease patient discomfort, shorten post-operative hospital stays, lower hospital costs, and
decrease patient morbidity and mortality.421 Further, effective use of the da Vinci system reduces
total operative time while minimizing blood loss.422
The da Vinci System revolutionized minimally invasive surgery by overcoming the limitations of both
traditional surgical procedures and conventionally implemented noninvasive laparoscopic technology.423

A keynote feature of the da Vinci system is its EndoWrist technology, which allows a surgeon to
fully rotate his or her hand, therefore giving the surgeon the capacity to reach around, beyond, or
behind. The EndoWrist technology provides the surgeon with seven degrees of freedom (that is,
the number of different rotations by the robot “hand”), more than most other surgical robots on
the market.424
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A fairly recent sojourn in minimally invasive surgery, robotic-assisted laparoscopic
prostatectomy, combines da Vinci robotics with laparoscopy and “allow[s] for greater surgical
precision . . . [leading] to improvements in cancer control, potency, and urinary function.” The
da Vinci system has also been used to treat small and complex renal tumors.425
Despite its proven benefits in the field, the system has its limitations. Surgeons struggle with the
lack of tactile feedback. This would be remedied by strain sensor feedback, which is under
development for implementation in future models. Additionally, the size and complexity of
robotic appendages still limit the extent to which accurate movement can be controlled.426
Further, the system requires a significant amount of space—something that many hospitals and
facilities cannot spare.427
Demand for Robotic Surgery
Despite the difficulties associated with robotic surgery, minimally invasive technologies are
replacing traditional methods as quickly as the technology will allow. The global market was
valued at an estimated $25.03 billion in 2012; it is expected to reach $50.6 billion by 2019.428
During the past twenty years, the number of general surgical, gastrointestinal, gynecological,
neurosurgical, orthopedic, pediatric, radiosurgical, and urological procedures that employ either
robotically assisted or robotically controlled capabilities has grown steadily, most frequently
through adoption of the da Vinci system.429 As of December 2014, 3,266 da Vinci units had been
installed internationally, 2,223 of which belong to facilities in the United States.430 In 2014
Intuitive Surgical, who manufactures the da Vinci system, saw its net income and revenue drop
by 37% ($418.8 million) and 6% ($2.13 billion) respectively, though reported procedures using
the units rose 10%.431 Until recently, the da Vinci system was the only approved system on the
market; however, in early 2009, CUREXO Technology Corporation announced FDA clearance
of its robotic orthopedic surgical device, ROBODOC, for total hip arthroplasty.432
The CBO’s 2007 report, The Long-Term Outlook for Healthcare Spending, predicted that the
United States would see a rise in total healthcare spending from 16% of GDP as of March 2007
to 25% in 2025, 37% in 2050, and 49% in 2082.433 More recent CBO estimates put near-term
projections for healthcare spending around 19.3% of GDP in 2023 however.434 These projections
425 “Robotic Surgery” By Joan Trombetti, DotMed News, January 7, 2009, http://www.dotmed.com/news/story/7463 (Accessed 07/06/09) (as
noted on the DotMed webpage, “This article originally appeared in the December 2008 issue of DOTmed Business News”).
426 “Recent Trends in Minimally Invasive Cardiac Surgery” By Alan P. Kypson, Cardiology, Vol. 107 (2007), p. 156.
427 “Robotic Technology in Surgery: Past, Present, and Future” By David B. Camarillo, Thomas M. Krummel, and J. Kenneth Salisbury, The
American Journal of Surgery, Vol. 188, No. 4A (Supplement to October 2004), p. 11S.
428 “Global Minimally Invasive Surgery Market to Expand at a 10.5% CAGR During the Forecast Period 2013 - 2019 Due to Rising
Expenditure on Healthcare” Transparency Market Research, May 19, 2015, http://www.transparencymarketresearch.com/
pressrelease/minimally-invasive-surgery-market.htm (Accessed 7/2/2015).
429 “Robotic Surgery” By Joan Trombetti, DotMed News, January 7, 2009, http://www.dotmed.com/news/story/7463 (Accessed 07/06/09) (as
noted on the DotMed webpage, “This article originally appeared in the December 2008 issue of DOTmed Business News”).
430 “Investor FAQ” Intuitive Surgical, 2015, http://phx.corporate-ir.net/phoenix.zhtml?c=122359&p=irol-faq (Accessed 3/23/15).
431 “Intuitive Surgical Earnings Dampened by Robotic Surgery Debate” By Jaimy Lee, Modern Healthcare, January 22, 2015,
http://www.modernhealthcare.com/article/20150122/NEWS/301229963/intuitive-surgical-earnings-dampened-by-robotic-surgery-debate
(Accessed 3/23/15).
432 “CUREXO to Launch New Robotic Surgery Technology” By Diana Manos, Healthcare IT News, February 23, 2009,
http://www.healthcareitnews.com/news/curexo-launch-new-robotic-surgery-technology (Accessed 6/30/09).
433 “The Long-Term Outlook for Health Care Spending” By Congressional Budget Office, November 2007, http://www.cbo.gov/ftpdocs
/87xx/doc8758/11-13-LT-Health.pdf (Accessed 07/06/09).
434 “National Health Expenditure Projections 2013-2023: Forecast Summary” CMS, 2014, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2013.pdf (Accessed 3/23/15).
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are fueled by the perpetual technological advancement, dynamic availability of the most
accelerated technologies, fear of potential malpractice suits, and efforts to procure economic gain
that support the necessary supply factors to perpetuate this inevitable expansion. Diagnostic and
therapeutic technologies continue to emerge, replacing outdated and risky techniques with less
invasive, yet more expensive, alternatives. This ongoing development of new technologies
undoubtedly contributes to the role of the U.S. as the global leader in healthcare expenditures.435
In addition to the rising costs are the technical demands associated with the accumulating
intricacies that make noninvasive procedures desirable. The required skill sets are challenging
and demand extensive training, and improper use of these technologies can be more dangerous
than the older alternatives.436 Although the da Vinci system has been used successfully in an
array of surgical procedures, many surgeons remain skeptical of its continued use in the medical
profession. Due to the excessive start-up and per procedural costs of robotic surgery, as well as
the complexity of many procedures, such as cardiac and thoracic surgeries, many institutions do
not use the da Vinci robot as much as was expected, often utilizing it only for less complicated
procedures (for example, urological surgery). Although minimally invasive technology is clearly
a potential asset in the future of surgery, it is uncertain at what point and to what extent robotic
surgery will become a regularly feasible procedure for many specialized and intensive surgical
programs.437
A “tortuous learning curve,” paired with economic barriers to use, necessarily indicates that
surgeons proficient in robotic surgical procedures are scarce; however, surgeons and other
medical professionals agree that this is bound to change.438 With time, evolving criteria,
perspectives, and credentials will foster a new “breed” of surgeons, trained to take full advantage
of the benefits that robotic, noninvasive procedures provide.439 Upon approving the da Vinci
robot for cardiac procedures, the FDA mandated training of all surgical teams and professionals
intending to use the product.440 Surgeons who have pioneered the infusion of robotic technology
into their programs believe that success is imminent with the right team; dedication to
administrative and clinical commitment; a properly devised curriculum targeted at surgeons,
their teams, and other members of their departments; multispecialty training; and patience.441 As
more institutions and surgical teams follow in their footsteps, a new tier of surgical competition
will lead to different expectations in medical care.

435 “Economics Issues in Medical Care” in “Goldman Cecil Medicine, 23rd Edition” By Lee Goldman, MD and Dennis Arthur Ausiello, MD,
Saunders, 2008, http://www.mdconsult.com.ezp.slu.edu/das/book/body/1301180599-5/826126389/1492/28.htm (Accessed April 4, 2008).
436 “Economics Issues in Medical Care” in “Goldman Cecil Medicine, 23rd Edition” By Lee Goldman, MD and Dennis Arthur Ausiello, MD,
2008, http://www.mdconsult.com.ezp.slu.edu/das/book/body/1301180599-5/826126389/1492/28.htm (Accessed April 7, 2008).
437 “Robotic Cardiac Surgery: Time Told!” By Francis Robicsek, Journal of Thoracic Cardiovascular Surgery, Vol. 135 (2008), p. 245.
438 “Minimally Invasive Surgery: Continued Growth Opens New Doors” By Michelle Beaver, Surgistrategies, 2009,
http://www.surgistrategies.com/articles/751feat3.html (Accessed 4/7/08).
439 Ibid.
440 “Robotic Surgical Training in an Academic Institution” By W. Randolph Chitwood et al., Annals of Surgery, Vol. 234 No. 4 (October
2001), p. 478.
441 “Building a Surgical Robotics Program” By Wiley Nifong and Randolph Chitwood, The American Journal of Surgery, Vol. 188, No. 4A
(2004), p. 16S.

388

Chapter 5: Technology Development

Regulatory and Reimbursement
Although each insurance company differs in what procedures it reimburses, Medicare covers
most laparoscopic and thoracoscopic procedures.442 Currently, reimbursement for procedures that
use robotic technologies is limited to the agreed-upon reimbursement for the baseline
procedure.443 However, as more studies show that noninvasive cardiac technology is improving
patient outcome metrics and policymakers move toward incentive-based programs that improve
the quality of robotically assisted procedures, robotic procedures may procure higher
reimbursement.444

HOME HEALTH TECHNOLOGY
Home care patients represented approximately 3.8 percent of the U.S. population as of 2008, an
increase from 2.5 percent in 2000.445 Additionally, the growing segment of older Americans will
invariably contribute to the increased use of home infusion therapies. Although the Bureau of
Health Professions predicted in 2006 that, between 2000 and 2020, the U.S. population would
increase by 18 percent, the number of Americans aged sixty-five and older is anticipated to reach
88.5 million in 2050, with the “oldest old,” those 85 and older, expected to triple from “6.3
million in 2015 to 17.9 million in 2050, accounting for 4.5% of the total population.”446
Approximately 69 percent of those receiving home care services are older than age sixty-five.447
In addition, the aging baby boomer population, the first cohort of which reached eligibility in
2011, will continue to inflate the number of candidates for home healthcare.448

Trends in Home Infusion Therapy
According to The Braff Group, a healthcare M&A firm, home infusion therapy experienced a
60% increase in transactional market activity between 2010 and 2011.449 According to Braff,
with 16 deals in 2011 (11 of which had different buyers), the home infusion therapy market
posted its highest transaction volume since 2008.450
442 “Bariatric surgery, Medicare.gov, http://www.medicare.gov/coverage/bariatric-surgery.html (Accessed 3/30/15); “2014 Thoracic Medicare
Reimbursement Coding Guide: Effective January 1, 2014” Covidien, http://www.covidien.com/imageServer.aspx/doc265365.pdf?
contentID=43864&contenttype=application/pdf (Accessed 3/30/15), p. 1.
443 Note: The baseline procedure is denoted by HCPCS Code S2900.
444 “Superior Financial and Quality Metrics with Robotically-Assisted (DaVinci) Coronary Artery Revascularization” By Robert S. Poston,
American Surgeon Association, 2008, http://www.americansurgical.info/abstracts/2008/26.cgi (Accessed 4/7/09); “ASA: Robotic CABG
Paint Cost-Effective Benefits for Patients” By Crystal Phend, 2008, MedPage Today, http://www.medpagetoday.com/Cardiology/
CoronaryArteryDisease/9254 (Accessed 4/7/09); “ASA: Robotic CABG Paint Cost-Effective Benefits for Patients” By Crystal Phend,
2008, MedPage Today, http://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/9254 (Accessed 4/7/09).
445 “Basic Statistics About Home Care, Updated 2010” By The National Association for Home Care & Hospice, Washington, DC: National
Association for Home Care & Hospice, 2010, http://www.nahc.org/assets/1/7/10HC_Stats.pdf (Accessed 3/23/15), p. 1, 6; “Interactive
Population Map, U.S. Census Bureau, http://www.census.gov/2010census/popmap/ (Accessed 3/30/15).
446 “Long-Term Care Services in the United States: 2013 Overview” By Lauren Harris-Kojetin, Manisha Sengupta, Eunice Park-Lee, and
Roberto Valverde, Hyattsville, MD: National Center for Health Statistics, December 2013, http://www.cdc.gov/nchs/data/nhsr/nhsr052.pdf
(Accessed 3/23/15), p. 3.
447 “Basic Statistics About Home Care, Updated 2010” National Association for Home Care & Hospice, Washington, DC: National
Association for Home Care & Hospice, 2010, http://www.nahc.org/assets/1/7/10HC_Stats.pdf (Accessed 3/23/15), p. 6.
448 “The Nation’s Health Care Conundrum: Where Do We Go From Here” By David Kroitz, The Concord Coalition, May 15, 2009,
http://www.concordcoalition.org/issue-briefs/2009/0515/nations-health-care-conundrum-where-do-we-go-here (Accessed 12/10/09).
449 “4 Perspectives: 2011 Fourth Quarter” The Braff Group, 2011, http://www.thebraffgroup.com/Articles/articlespdfs/perspectives/Q42011.pdf
(Accessed 9/28/12), p. 2, 6.
450 “Market Watch 2012: Pharmacy Services” The Braff Group, 2012, http://www.thebraffgroup.com/Articles/articlespdfs/MarketWatch/
MW_Pharmacy_Service.pdf (Accessed 9/28/12), p. 2.
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Infusion therapy, growing in popularity, involves the administration of medications, nutrients, or
other solutions intravenously, subcutaneously, enterally, or epidurally (into the bloodstream,
under the skin, into the digestive system, or into the membranes surrounding the spinal cord).
Specific home infusion therapies include anti-infectives, chemotherapy, pain management,
parenteral and enteral nutrition, hydration therapy, and immunotherapy.451 By 2030, it is
expected that approximately 20%, or 72 million, of Americans will be older than the age of 65,
twice as many as the 65 and older population in 2000,452 which will lead to an increase in the
demand for home- and community-based services. Skilled nursing services are the most
commonly used by home healthcare patients 65 and older, with infusion therapy being one of the
primary services performed.453
The implementation in 1983 of the Prospective Payment System (PPS) for inpatient hospital
services with its diagnosis-related group (DRG) payment system touched off a number of
dramatic changes in the healthcare field.454 These changes affected not only inpatient hospital
care, but also virtually every aspect of the U.S. healthcare delivery system. As a result of the
DRG payment methodology, traditional indicators of inpatient hospital utilization showed
substantial changes. Between 1980 and 1990, the number of hospitals and hospital beds declined,
admissions and average daily census fell, and average length of stay decreased. Combined, these
indicators of inpatient utilization pointed the way to a dramatic shift in the way healthcare
services would be delivered. The types of services provided, as well as the location of service
delivery, began to shift from the inpatient to the outpatient setting. As length of stay for
Medicare patients shortened in the early 1980s, the percentage of Medicare patients discharged
to home health increased from 9.1% in 1981 to 17.9% in 1985.455
In June 2012, the Medicare Payment Advisory Commission (MedPAC) submitted its report to
Congress regarding the feasibility of expanding Medicare to include home-based infusion
therapy, in addition to the infusion therapy performed in inpatient, outpatient, hospice, and
skilled nursing facility settings.456 About 36,000 Medicare Part B beneficiaries and about
100,000 Medicare Part D beneficiaries received home infusion therapy in 2009.457 Both
Medicare spending on home infusion therapy drugs and the number of beneficiaries receiving
these drugs increased rapidly between 2006 and 2009, with the number of Part D enrollees
receiving Part D-covered home infusion drugs increasing at a rate of 21% per year, as compared
to a growth rate of five percent per year for the overall Part D population.458 Additionally,
Medicare fee-for-service spending for Part B-covered home infusion therapy drugs increased at
an average rate of 17% per year, as compared to an average growth rate of six percent in the
number beneficiaries using Part B home infusion drugs.459 Home infusion antibiotics covered by
451 “Home Infusion Therapy” BlueCross BlueShield of Illinois, BlueCross BlueShield of Illinois, 2008 http://www.bcbsil.com/PDF/
providermanual/home_infusion_therapy.pdf, (Accessed 10/2/09).
452 “Older Americans 2012: Key Indicators of Well-Being” By Federal Interagency Forum on Aging-Related Statistics, Washington, DC:
U.S. Government Printing Office, June 2012, p. 2.
453 “National Health Statistics Reports: Characteristics and Use of Home Health Care by Men and Women Aged 65 and Over” By Adrienne L.
Jones, Lauren Harris-Kojetin, Roberto Valverde, Hyattsville, MD: National Center for Health Statistics, No. 52, April 18, 2012, p. 3;
“Option Care, Inc. Form 10K for Fiscal Year Ending December 31, 2005, Securities Exchange Commission, p. 8.
454 See Chapter 2 for further discussion of the PPS and DRG payment system.
455 “Basic Statistics About Home Care, Updated 2010” By The National Association for Home Care & Hospice, Washington, DC: National
Association for Home Care & Hospice, 2010, http://www.nahc.org/assets/1/7/10HC_Stats.pdf (Accessed 3/23/15), p. 6.
456 “Report to the Congress: Medicare and the Health Care Delivery System” Medicare Payment Advisory Commission, Washington, DC, June
2012, p. 169-207.
457 Ibid, p. 177-178.
458 Ibid, p. 178.
459 Ibid, p. 177-178.
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Part D accounted for the greatest number of users of Medicare covered home infusion drugs,
followed by immune globulin and alpha-1-proteniase inhibitor drugs, and several drugs used to
treat rheumatoid arthritis.460 Similarly, antibiotics were the most common type of home infusion
therapy drug covered by commercial insurers.461
The decrease of traditional inpatient utilization led to a virtual explosion of healthcare services in
other areas, both on the hospital campus and in freestanding facilities located in the community.
However, the location of service delivery also moved into the most convenient location
possible—the patient’s home.462 Despite adequate patient access to home health services, the
number of providers continues to grow, exceeding the growth rate of Medicare enrollees.463 As of
2009, more than 10,000 active home health agencies participated in the Medicare payments
program for home healthcare, with nearly 85% of the agencies being freestanding centers.464

Regulatory and Reimbursement
Medicare and Medicaid remain the largest single payors of home healthcare services, paying
roughly 43 percent and 37 percent respectively, of all home health expenditures in 2012,
although private insurance represented a small portion of home health payments (7 percent).465
Out-of-pocket spending growth decreased from 5.2 percent in 2005 to 3.8 percent in 2006,
largely due to the introduction of Medicare Part D466 and has stayed relatively stable in that time
with most recent 2013 NHE data showing a growth rate of 3.2 percent.467 In fact, total out-ofpocket spending declined from 14 percent in 2001468 to 12 percent in 2013.469 However, it is
estimated that the rate of out-of-pocket expenditures will increase and peak at roughly 6 percent
by 2020.470 This would bring parity to the ratio of out-of-pocket spending to private health
insurance spending.471
Although Medicare Part D covers both the ingredient costs and dispensing fees associated with
home infusion therapy, it excludes any costs associated with equipment, supplies, and
professional services.472 Due to regulatory action in 2014, home health reimbursement will be cut
by $60 million, or 0.3%, in 2015 as a part of a four-year phase-in of lower payment rates for
home health services, which the National Association for Homecare & Hospice has estimated to
460
461
462
463
464
465
466
467
468
469
470
471
472

Ibid, p. 178.
Ibid.
“Report to the Congress: Home Health Services” Medicare Payment Advisory Commission, March 2008, p. 171.
“Home Health Care Services Payment System” Medicare Payment Advisory Commission, October 2008, p. 171.
“Home Health Study Report” By Judy Goldberg Dey, et al., To Centers for Medicare & Medicaid Services, Baltimore, MD: L&M Policy
Research, January 11, 2011, p. 12.
“Health Care Costs 101: Slow Growth Persists” California Healthcare Foundation, July 2014, http://www.chcf.org/~/media/MEDIA%
20LIBRARY%20Files/PDF/H/PDF%20HealthCareCosts14.pdf (Accessed 3/23/15).
“Basic Statistics About Home Care” National Association for Home Care and Hospice, 2008, http://www.nahc.org/facts/08HC_Stats.pdf
(Accessed 4/28/09).
“NHE Fact Sheet” Centers for Medicare & Medicaid Services, 2014, http://www.cms.gov/Research-Statistics-Data-and-Systems/StatisticsTrends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html (Accessed 3/23/15).
“Trends in U.S. Health Care Spending, 2001” By Katharine Levit, Cynthia Smith, Cathy Cowan, Helen Lazenby, Art Sensenig, and Aaron
Catlin, Health Affairs, Vol. 22 No. 1 (2003), p. 162.
“NHE Fact Sheet” Centers for Medicare & Medicaid Services, 2014, http://www.cms.gov/Research-Statistics-Data-and-Systems/StatisticsTrends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html (Accessed 3/23/15).
“National Health Expenditure Projections 2013-2023: Forecast Summary” CMS, 2014, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2013.pdf (Accessed 3/23/15).
“Basic Statistics About Home Care” National Association for Home Care and Hospice, 2008, http://www.nahc.org/facts/08HC_Stats.pdf,
(Accessed 04/28/09).
“Memorandum to All Part D Sponsors from Gary Bailey, Deputy Director, Center for Beneficiary Choices Regarding Home Infusion
Therapy” By Center for Beneficiary Choices, CMS, March 10, 2006, p. 1.
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result in a nearly 14% reimbursement cut by 2017.473 Despite the relatively stable reimbursement
environment, numerous attempts have been made by both the House of Representatives and the
Senate to pass legislation for the reimbursement of equipment, supplies, and professional
services. Senators proposed bills in 2007 and 2008 (S 870 and S 3505, respectively) that were
not passed.474 Additionally, in 2006 and 2007, the House of Representatives unsuccessfully
proposed HR 5791 and HR 2567.475 Most recently in 2009, Eliot Engel (D-NY) proposed The
Medicare Home Infusion Therapy Coverage Act of 2009 (HR 574), proposed that Part D
coverage of home infusion services include equipment, supplies, and professional services.476
However, the bill was never enacted and a subsequent attempt to introduce the bill in 2011 also
failed.477

CONCLUSION
Over the course of human history, healthcare trends have been driven by advances in our medical
capabilities, which are largely dependent on our technological progress. Current total spending
on healthcare is 17.4% of GDP and grew at a rate of 3.6 percent in 2013 to an estimated $2.9
trillion.478 This growth is driven in part by the perpetual technological advancement; dynamic
availability of the most accelerated technologies; fear of potential malpractice suits; and efforts
to procure economic gain that support the necessary supply factors to perpetuate this invincible
expansion. With the current market demand for both chronic and acute services undergoing
continuous growth, available technologies, as well as future technological developments, will
augment the healthcare practice with the clinical and administrative tools necessary to provide
efficient, effective, and affordable healthcare services.

473 “CMS Finalizes 2015 Payment Cuts to Home Healthcare Agencies” By Paul Demko, Modern Healthcare, October 31, 2014,
http://www.modernhealthcare.com/article/20141031/NEWS/310319961 (Accessed 3/23/15).
474 “S. 3505 Medicare Home Infusion Therapy Coverage Act of 2008” 110th Congress, September 17, 2008, http://www.govtrack.us/
congress/bill.xpd?bill=s110-3505 (Accessed 5/05/09); “S. 870: Medicare Home Infusion Therapy Consolidated Coverage Act of 2007”
110th Congress, March 14, 2007, http://www.opencongress.org/bill/110-s870/show (Accessed 5/05/09).
475 “H.R. 2567 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007” 110th Congress, June 12, 2007,
http://www.govtrack.us/congress/bill.xpd?bill=h110-2567 (Accessed 5/05/09); “H.R. 5791 Medicare Home Infusion Therapy Consolidated
Coverage Act of 2006” 110th Congress, August 1, 2006, http://www.govtrack.us/congress/bill.xpd?bill=h109-5791 (Accessed 5/05/09).
476 “H.R. 574 Medicare Home Infusion Therapy Consolidated Coverage Act of 2009” 111th Congress, January 15, 2009.
477 “All Bill Information (Except Text) for H.R. 2195 - Medicare Home Infusion Therapy Coverage Act of 2011” United States Congress,
2011, https://www.congress.gov/bill/112th-congress/house-bill/2195 (Accessed 3/23/15).
478 “National Health Expenditures 2013 Highlights” Centers for Medicare & Medicaid Services, 2014, http://www.cms.gov/ResearchStatistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf (Accessed 3/23/15).
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Key Sources
Key Source
“Electronic Health
Records Overview”

“To Err is Human:
Building a Safer
Health System”

Leapfrog Hospital
Survey Results

Description

Citation

Website

Overview of EHR.

“Electronic Health Records
Overview” National Institutes of
Health: National Center for
Research Resources, April 2006,
p. 1.

n/a

“To Err is Human: Building a
Safer Health System” Institute of
Medicine, Nov. 1999, p. 1.

n/a

“Leapfrog Hospital Survey
Results” The Leapfrog Group,
2008, p. 3.

www.leapfroggroup.org

The first study to show the need for
Computerized Physician Order
Entry (CPOE). Gained national
attention and is still quoted today
as reasoning for CPOE
implementation.
Leapfrog is a voluntary program
aimed at mobilizing employer
purchasing power to alert
America’s health industry that big
leaps in healthcare safety, quality,
and customer value will be
recognized and rewarded.

“Inpatient
Computerized
Provider Order Entry
(CPOE): Findings
from the AHRQ
Health IT Portfolio”

A study of CPOE benefits and
statistics resulting in the Agency
for Healthcare Research and
Quality’s promotion of CPOE
implementation.

“Computerized
Physician Order Entry
Usage in North
America: The Doctor
is In”

Statistics regarding levels of
hospital integration of CPOE
systems.

“U.S. Adoption of
Computerized
Physician Order Entry
Systems”

Statistics and trends about the
United States’ adoption of CPOE
systems.

“Saving Lives, Saving
Money: The
Imperative for
Computerized
Physician Order Entry
In Massachusetts
Hospitals”

The ramifications and necessity of
CPOE use in hospitals. Also a
highly quoted and comprehensive
study regarding CPOE use in
Massachusetts’ hospitals.

“Inpatient Computerized
Provider Order Entry (CPOE):
Findings from the AHRQ Health
IT Portfolio” By Brian E. Dixon
and Atif Zafar, U.S. Department
of Health and Human Services,
Agency for Healthcare Research
and Quality, January 2009,
http://healthit.ahrq.gov/ahrqfunded-projects/emerginglessons/computerized-providerorder-entry-inpatient/inpatientcomputerized-provider-orderentry-cpoe (Accessed 4/1/15),
p. 1.
“Computerized Physician Order
Entry Usage in North America:
The Doctor is In” By Stacilee
Oakes Whiting and Adam Gale,
HIT Report from KLAS,
Healthcare Quarterly, Vol. 11,
No. 3 (2008), p. 94.
“U.S. Adoption of Computerized
Physician Order Entry Systems”
By David M. Cutler, Naomi E.
Feldman and Jill R. Horitz,
Health Affairs, Vol. 24, No. 6
(November/December 2005),
p. 1660.
“Saving Lives, Saving Money:
The Imperative for
Computerized Physician Order
Entry In Massachusetts
Hospitals” By Mitchell Adams et
al., Massachusetts Technology
Collaborative, New England
Healthcare Institute, February
2008.

n/a

n/a

n/a

n/a
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Key Source

Description

“Biopharmaceutical
benchmarks 2006: The
rate of
biopharmaceutical
approvals has leveled
off, but some
milestones bode well
for the future”

Information regarding the
biopharmaceutical market.

“Rx Watchdog Report,
Trends in
Manufacturer Prices of
Specialty Prescription
Drugs Used by
Medicare
Beneficiaries, 20042007”

Trends in biopharmaceutical
pricing.

“Report to the
Congress: Medicare
Payment Policy”

MedPac report with Chapter 9
Dedicated to Home Health Care
Services

National Institutes of
Health

A resource for stem cell research.

Citation

Website

“Biopharmaceutical Benchmarks
2006: The rate of
biopharmaceutical approvals has
leveled off, but some milestones
bode well for the future” By
Gary Walsh, Nature
Biotechnology, Vol. 24, No. 7
(July 2006), p. 769–776.
“Rx Watchdog Report, Trends in
Manufacturer Prices of Specialty
Prescription Drugs Used by
Medicare Beneficiaries, 20042007” By Stephen W.
Schlondelmeyer, Leigh Purvis,
and David J. Gross, American
Association of Retired Persons,
September 2008,
http://assets.aarp.org/rgcenter/
health/2008_15_specialty_q407.
pdf (Accessed 4/1/15).
“Report to the Congress:
Medicare Payment Policy”
Medicare Payment Advisory
Commission, March 2014,
Chapter 9: Home Health Care
Services.
“Stem Cell Information: Stem
Cell Basics” National Institutes
of Health Resource for Stem Cell
Research, April 28, 2009,
http://stemcells.nih.gov/info/basi
cs/ (Accessed 4/1/15).

n/a

n/a

n/a

http://stemcells.nih.gov

Associations
Type of
Association

Name

Description

Citation

Contact Information

International

The
International
Radiosurgery
Association
(IRSA)

The IRSA provides
information on current
radiation therapy
technologies.

Radiological
Society of
North America
(RSNA)

Founded in 1915, RSNA is a
membership of medical
imaging professionals
committed to patient care
through education and
research. RSNA hosts the
world’s largest annual
radiological meeting.

“About Us”
International
Radiosurgery
Association,
www.irsa.org/about_us.
html (Accessed 4/1/15).

American
Telemedicine
Society (ATA)

The ATA is the leading
resource and advocate
promoting access to medical
care for consumers and
health professionals by way
of telecommunications
technology.

The International Radiosurgery
Association
P.O. Box 5186
Harrisburg, PA 17110
Phone: 717-260-9808
www.irsa.org
Radiological Society of North
America, Inc.
820 Jorie Blvd.
Oak Brook, IL 60523
Phone: 630-571-2670,
800-381-6660
Fax: 630-571-7837
www.rsna.org
American Telemedicine
Association
1100 Connecticut Avenue, NW
Suite 540
Washington, DC 20036
Phone: 202-223-3333
Fax: 202-223-2787
E-mail:

International

National
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“About RSNA”
Radiological Society of
North America,
http://www.rsna.org/
AboutRSNA.aspx
(Accessed 4/1/15).
"Who is ATA?”
American Telemedicine
Association,
http://www.americantel
emed.org/aboutata/who-is-ata#.
VRxW7vnF91Y
(Accessed 4/1/15).

info@americantelemed.org
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Everybody knows that the dice are loaded
Everybody rolls with their fingers crossed
Everybody knows that the war is over
Everybody knows the good guys lost
Everybody knows the fight was fixed
The poor stay poor, the rich get rich
That’s how it goes
Everybody knows
Everybody knows that the boat is leaking
Everybody knows that the captain lied
Everybody got this broken feeling
Like their father or their dog just died
Everybody talking to their pockets
Everybody wants a box of chocolates
And a long stem rose
Everybody knows
Leonard Cohen
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Definition
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Methods by which providers of
healthcare services may be reimbursed
for said services, that deviate from the
traditional fee-for-service
reimbursement model. APMs include:
(1) payment models under the Center
for Medicare and Medicaid Innovation;
(2) Accountable Care Organizations
(ACOs); or, (3) demonstrations of
payment models under certain federal
laws.
Practices that are designed to improve
patient engagement with ACOs,
including: (1) a process by which
beneficiaries may enroll with Next
Generation ACOs; (2) improved access
to home visits, telehealth services, and
skilled nursing facilities; (3) financial
rewards for beneficiaries who receive
care from ACOs; and (4) collaboration
between CMS and Next Generation
ACOs to improve communication with
beneficiaries regarding their ACOs,
and the potential benefits of receiving
care from their ACOs.
A method of reimbursement that
combines institutional and professional
charges into a single payment.
An economic phenomenon that can
occur in health insurance markets,
wherein the healthiest people drop out
of the market due to price concerns,
thus raising the average healthcare
expenditures per capita in the market.
In response, health insurance
companies raise premiums, which in
turn drives more healthy people out of
the market. This creates a perpetual
loop that drives up health insurance
premiums and the share of the
population that is uninsured.
An online marketplace created by the
ACA, which is intended to reduce the
cost associated with health insurance
and ease the process of selecting a
health insurance plan by providing a
single place for consumers to:
(1) search for and compare health
plans; (2) ask questions regarding
coverage; (3) check eligibility for
programs and tax credits; and (4)
ultimately enroll in a health plan.
A risk model that is available to Next
Generation ACOs, wherein the Next
Generation ACO reaps 100% of any
generated savings or losses, capped at
15% of the Next Generation ACO’s
financial benchmark.

“Medicare Access and CHIP
Reauthorization Act of 2015” Pub. L.
No. 114-10, § 101, 129 Stat. 87, 121
(April 16, 2015); “Center for Medicare
and Medicaid Innovation” Letter to
Senator Tom Coburn, From Jim Hahn,
Congressional Research Service,
February 24, 2012, http://www.law.
umaryland.edu/marshall/crsreports/
crsdocuments/022412B_04242012.pdf
(Accessed 4/22/2015), p. 1.
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“Next Generation ACO Model
Frequently Asked Questions” Centers
for Medicare & Medicaid Services,
March 10, 2015, http://innovation.
cms.gov/Files/x/nextgenacofaq.pdf
(Accessed 3/18/2015), p. 1.
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“The Managed Health Care Handbook”
By Peter R. Kongstvedt, 3rd Ed.,
Aspen Publishers, Inc., 1996, p. 187.
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“David King et al. v. Sylvia Mathews
Burwell et al.” Case No. 14-114
(SCOTUS 2015), Oral Argument,
p. 15; “Will concern for states’ rights
win out in subsidies battle? Today’s
argument in Plain English” By Amy
Howe, SCOTUSblog, March 4, 2015,
http://www.scotusblog.com/2015/03/
will-concern-for-states-rights-win-outin-subsidies-battle-todays-argument-inplain-english/ (Accessed 3/18/2015).
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“Affordable Insurance Exchanges”
U.S. Department of Health and Human
Services, August 23, 2012, http://www.
healthcare.gov/law/features/choices/
exchanges/index.html (accessed March
20, 2012); “Patient Protection and
Affordable Care Act” Pub. L. No. 111148, § 1311(b), 124 Stat. 119, 173
(March 23, 2010).
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17, 2015, http://innovation.cms.gov/
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(Accessed 3/20/2015), p. 14.
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Grandfathered Health
Plan

Any group health plan or individual
coverage that was effective on March
23, 2010, the date of the ACA’s
enactment. These plans are not subject
to some of the ACA’s provisions.
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Next Generation
Accountable Care
Organization

A new model of ACOs announced by
CMS in March of 2015, which may
utilize new reimbursement models
(other than fee-for-service, as used by
standard Medicare ACOs) and feature
a higher degree of shared savings and
losses.

“‘Grandfathered’ Plans Spared Some
Reform Mandates” By Paul M.
Hamburger and James R. Napoli,
Society for Human Resource
Management, April 9, 2010,
http://www.shrm.org/hrdisciplines/ben
efits/Articles/Pages/GrandfatheredPlan
s.aspx
(Accessed 4/15/2010); “Patient
Protection and Affordable Care Act”
Pub. L. No. 111-148, § 1251, 124 Stat.
119, 161 (March 23, 2010).
“Next Generation ACO Model”
Centers for Medicare & Medicaid
Services, http://innovation.cms.gov/
initiatives/Next-Generation-ACOModel/ (Accessed 3/18/2015).
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“Patient Protection and Affordable
Care Act; Establishment of Exchanges
and Qualified Health Plans; Exchange
Standards for Employers” Federal
Register 77, No. 59 (March 27, 2012),
p. 18310-18311; “Affordable Insurance
Exchanges: Choices, Competition and
Clout for States” U.S. Department of
Health and Human Services, July 11,
2011, http://www.healthcare.gov/
news/factsheets/2011/07/exchanges071
12011a.html (Accessed August 7,
2012).
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Small Business
Health Options
Programs (SHOPs)

A sub-set of the ACA’s Exchanges,
which offer health insurance options
for small employers.
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OVERVIEW
Motivated by the current economic conditions, trends in the reimbursement, regulatory,
competitive, and technology aspects of the healthcare environment have facilitated the
emergence of a historical reform initiative. In March of 2010, sweeping changes in federal
healthcare policy were enacted, following months of partisan controversy, political drama, and
often rancorous debates. The Patient Protection and Affordable Care Act, HR 3590, was signed
into law on March 23, 2010, and one week later, President Barack Obama signed the Health
Care and Education Reconciliation Act of 2010, HR 4872, into law. As singular and perhaps as
chaotic as these events may seem to have been, they should not have been totally unexpected
within the context of the history of healthcare reform efforts.

A HISTORICAL PERSPECTIVE ON HEALTHCARE
REFORM
Political and legislative initiatives related to U.S. healthcare reform date back to the early 1900s.
President Theodore Roosevelt and the Progressive movement were among the first major
political parties to endorse the idea of health insurance, and President Franklin D. Roosevelt
(FDR) continued to support efforts for national health reform, mainly with the Social Security
Act, which was passed by the United States Congress in 1935. Healthcare reform efforts
continued through the late 1930s and early- to mid-1940s with the establishment of the
Department of Health and Human Services (HHS) in 1939 and other national efforts to support a
national health insurance plan. Early healthcare reform efforts also faced significant opposition,
however. Following his election to a full term, President Harry S. Truman attempted to pass
FDR’s healthcare reform program, but it was defeated as a result of strong opposition, some of
which equated national health insurance to communism.1
Healthcare reform reached a major milestone with the creation of the Medicare and Medicaid
programs, which President Lyndon B. Johnson signed into law in 1965. However, as growing
healthcare expenditures began to raise concern throughout the 1970s, cost-containment efforts
replaced national healthcare coverage initiatives as the main focus of lawmakers. This emphasis
on cost savings and the corresponding lack of support for healthcare reform initiatives continued
through President William J. Clinton’s administration. His healthcare reform initiatives, led by
First Lady Hilary Clinton, ultimately failed to garner adequate support for passage of the Health
Security Act of 1993.2

1
2
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“Timeline: History of Health Reform in the U.S.” The Henry J. Kaiser Family Foundation, 2010, http://healthreform.kff.org/flash/health_
reform-print.html (Accessed 4/2/2010).
Ibid.

Chapter 6: Healthcare Reform: Past as Prologue to the Future

THE AFFORDABLE CARE ACT AND HEALTHCARE REFORM
The 2010 healthcare reform legislation marks the beginning of a new era in the long history of
healthcare reform. The 2010 healthcare reform will substantially affect many, if not all, aspects
of the delivery of healthcare in the United States by affecting healthcare providers, insurers,
employers, and individual citizens.
Figure 6-1 provides an overview of key historical healthcare reform events that paved the way
for the current 2010 healthcare reform legislation.

399

40
1927

1929

1930-1934
1935

1935-1936
1937

1938

National Health
Conference convened in
Washington, D.C

1939

Physicians start to organize the
first Blue Shield plans to cover
the costs of physician care.

Department of Health and Human Services born
as the Federal Security Agency bringing together
federal agencies concerned with health, welfare,
and social insurance.

Sen. Wagner introduces National Health Bill
incorporating recommendations from the National
Health Conference. Proposal dies in committee.

National Health Survey conducted under the
auspices of the U.S. Public Health Service to
assess the nation's health and the underlying
social and economic factors affecting health

President Roosevelt continued to support
national health reform throughout his
terms. His second push for national
health insurance came after the Social
Security Act passed. However, the
momentum from FDR’s Technical
Committee on Medical Care and a
National Health Conference were not
enough to overcome a Congress that was
no longer supportive of further
government expansions.

1930-1934

Baylor Hospital introduces a
pre-paid hospital insurance plan
for a group of school teachers

Women reformers persuade
Congress to pass the
Sheppard-Towner Act

1915

1921

Teddy Roosevelt and Progressive
Party endorse social insurance as
part of their platform

1912

Technical Committee on Medical
Care established under
Interdepartmental Committee to
Coordinate Health and Welfare
Activities; publishes its report, A
National Health Program in 1938

FDR forms Interdepartmental
Committee to Coordinate Health
and Welfare Activities

Hard economic times called for social
policies to secure employment,
retirement, and medical care. President
Roosevelt appointed a committee to work
on all these issues, but in the end did not
risk the passage of the Social Security
Act to advance national health reform.

Committee on the Costs of
Medical Care forms to study the
economic organization of
medical care

The All American Association
for Labor Legislation publishes
a draft bill for compulsory
health insurance

National Convention of
Insurance Commissions
develops first model of state law
for regulating health insurance

Figure 6-1: Healthcare Reform Historical Timeline—1912–1939
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1944

Senators Wagner and Murray,
along with Representative Dingell
introduce legislation as part of
broader vision to operate health
insurance as part of social security.

1943

FDR outlines 'economic
bill of rights'

Social Security Board calls
for compulsory national
health insurance as part of
the Social Security system.

War Labor Board rules wage
freeze does not apply to
fringe benefits, including
health insurance benefits

National Conference on
Aging is convened by
Federal Security Agency.

1945-1949

1951

1952

First year that the National Health
Interview Survey was conducted;
survey has been continuously
fielded ever since

1957

AFL-CIO decides to support
government health
insurance, while the AMA
reiterates opposition to
national health insurance.

Legislation introduced in the
House (the Forand bill) to
provide health insurance for
social security beneficiaries;
reintroduced again in 1959.

1954

Federal Security Agency
made a cabinet level agency,
renamed Department of
Health Education and
Welfare (DHEW).

1953

1956

Military "medicare" program
enacted, providing government
health insurance for dependents of
those in the Armed Forces.

Revenue Act of 1954 excludes
employers' contributions to
employee's health plans from
taxable income.

Federal Security Agency
proposes enactment of health
insurance for Social Security
beneficiaries.

Joint Commission on the
Accreditation of Hospitals
(JCAH) formed to improve
the quality of hospital care
through the voluntary
accreditation of hospitals.

1950

President Truman picked up the mantle for a
national health program just months after the end
of World War II. His election in 1948 appeared to
be a mandate for national health insurance, but the
opposition, using fear of socialism, coupled with
the power of southern Democrats who believed a
federal role in health care might require
desegregation, effectively blocked all proposals.

Figure 6-1: Healthcare Reform Historical Timeline—1940–1959
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1980

Emergency Medical Treatment and Active
Labor Act (EMTALA) requires hospitals
participating in Medicare to screen and
stabilize all persons who use their
emergency rooms regardless of ability to pay

1981

1982
1983

Federal budget reconciliation
(OBRA 86) gives states Medicaid
option to cover infants, young
children and pregnant women up
to 100% of the poverty level

1986

Medicare introduces Diagnostic
Related Groups (DRGs) as a
prospective payment system for
hospital payment.

Federal budget reconciliation (OBRA
81) requires states to make additional
Medicaid payments to hospitals who
serve a disproportionate share of
Medicaid and low-income patients

Department of Health,
Education, and Welfare
renamed the Department
of Health and Human
Services (DHHS)

States allowed to expand Medicaid to children with disabilities
who require institutional care but can be cared for at home and
would not otherwise qualify for Medicaid if not institutionalized;
popularly referred to as the Katie Beckett option for the disabled
child who garnered national attention on the issue.

In the face of stagflation and rapidly rising health care costs,
President Carter prioritizes health care cost containment over
expanding coverage. Sen. Kennedy, however, drafts another
national health insurance proposal, which is then followed by
Carter’s own plan that would delay implementation until 1983.
National health reform efforts were completely stalled in the face
of an economic recession and uncontrollable health care costs .

1970-1974

1975-1979

General inflation and unchecked health care costs
were a growing concern by the early 1970s. Sen.
Kennedy’s proposal for national health insurance
was countered by President Nixon’s own
Comprehensive Health Insurance Plan (CHIP).
Other Congressmen wrote more incremental
plans, all of which splintered support for any one
reform. Action on national health insurance was
eventually overshadowed by the Watergate
hearings and President Nixon’s resignation.
While President Ford supported national reform
in 1974 and Rep. Mills drafted yet another
compromise bill, its progress stalled without
Mills' leadership following a personal scandal.

Medicare and Medicaid were incorporated under the Social Security
Act and signed by President Johnson in 1965 with Truman by his side.
The combination of Johnson’s political skills, a large Congressional
Democratic majority, public approval, the support of the hospital and
insurance industries, and the fact that no government cost controls or
physician fee schedules were enacted contributed to the passage of the
most significant health reform of the century.

1960-1964

1965-1969

The groundwork for the enactment of
Medicare and Medicaid began in the
late 1950s and early 1960s. As
employer-based health coverage grew,
private plans began to set premiums
based on their experience with health
costs and the retired and disabled found
it harder to get affordable coverage.
Health reformers refocused their efforts
toward the elderly.

Figure 6-1: Healthcare Reform Historical Timeline— 1960-1986
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Medicare Catastrophic
Coverage Act
(MCCA) expands
Medicare coverage to
include prescription
drugs and a cap on
beneficiaries' out-ofpocket expenses

1999
2000

•

•

•

•

•

2007

2008

•

•

•

•

•

President Obama establishes Office of Health Reform
The Children's Health Insurance Program (CHIP) is
reauthorized
The American Reinvestment and Recovery Act
(ARRA) makes substantial investments
White House holds a Health Reform Summit with
key stakeholders.
President Obama releases FY 2010 budget

2009

Mental Health Parity
Act amended to
require full parity

Senators Wyden and Bennett
introduce the Healthy
Americans Act.
Congress passes two versions of
a bill to reauthorize the State
Children’s Health Insurance
Program, but President Bush
vetoes both bills

Medicare Part D Drug benefit goes into effect in
January
Massachusetts passes and implements legislation to
provide health care coverage to nearly all state
residents.
Vermont passes comprehensive health care reform
also aiming for near-universal coverage.
City of San Francisco creates the Healthy San
Francisco program

2005

2006

Deficit Reduction
Act of 2005

Maine passes the Dirigo
Health Reform Act
Medicare Drug, Improvement,
and Modernization Act
Medicare legislation creates
Health Savings Accounts

•

•

•

•

2002 2003

Breast and Cervical
Cancer Treatment and
Prevention Act of 2000

President Bush launches Health
Center Growth Initiative

Ticket to Work and Work Incentives
Improvement Act of 1999

1996

1997

Health Insurance Portability and
Accountability Act (HIPAA)
Personal Responsibility and
Work Opportunity Act
Mental Health Parity Act

Balanced Budget Act

1990-1994

•

•

•

Making national health reform a priority early in his Presidency, President Clinton proposed
a "managed competition" approach, sending a detailed plan to Congress in 1993. It called
for universal coverage, employer and individual mandates, competition between insurers,
with government regulation to control costs. Support from key stakeholders was often
limited and conditional. The opposition was led largely by two groups: the Health Insurance
Association of America and the National Federation of Independent Businesses, both
believing reform would create hardship for their smaller members. Congressional
Democrats were divided in their support, and further splintered by a variety of alternative
proposals that were then generated all of which blocked progress on the President's plan.

Federal budget
reconciliation
(OBRA 89) mandates
coverage for
pregnant women and
children under age 6

1988

The Family Support
Act requires states
to extend 12 months
of transitional
Medicaid coverage
to families leaving
welfare due to
earnings from work.

Figure 6-1: Healthcare Reform Historical Timeline— 1987-2009
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WHAT IS DRIVING HEALTHCARE REFORM?
The continued rise in healthcare expenditures, which may soon impose an unsustainable
economic burden on the United States’ economy, served as one of several catalysts that
precipitated the need for the most recent national healthcare reform initiatives. Widespread lack
of access to care, the aging baby-boomer population, declining reimbursement for physician
services and provider manpower shortages, as well as increasing public concern with the quality
of healthcare services are also forces which helped to drive national healthcare reform. So long
as these circumstances persist, they may continue to fuel real changes to the current system of
healthcare delivery in the United States. Furthermore, future implementation of healthcare
reform may be molded by the recent economic recession, an unprecedented intensity in political
discourse regarding U.S. government deficits and debt, and increasing political polarization and
governance, especially related to an ardent renewal of asserting states’ rights in opposing federal
initiatives.

EXPLODING TIME BOMB: CHANGING PATIENT POPULATION
DEMOGRAPHIC
As mentioned throughout this Guide, the changing patient population demographic is one of the
major factors driving healthcare reform. The changing age and ethnic distribution of the
population substantially affects the demand for healthcare reform, and the projected growth of
the U.S. elderly population plays an important role in the anticipated demand for healthcare
services. The population over the age of sixty-five is projected to grow from an estimated 47.8
million in 2015 to 98.1 million in 2060, an increase from 14.9% to 23.6% of the total
population.3 Due to the fact that the elderly population typically has a greater per capita
utilization of healthcare services when compared to younger populations,4 this demographic shift
will likely result in greatly increased demand for healthcare services for the next several decades.
The ethnicity of the U.S. patient population is also changing, with the 2015 to 2060 projections
figures indicating an increasing degree of racial and ethnic diversity.5 Perhaps best illustrating
this change is the fact that in 2012 the number of minority births surpassed the number of
Caucasian births in the United States for the first time in history.6 The healthcare industry may
need to adjust its practices in response to this shift in the country's ethnic demographic
composition. Recent research has suggested that linguistic minorities (i.e., non-English speaking
3

4
5

6

“Table 3. Projections of the Population by Sex and Selected Age Groups for the United States: 2015 to 2060 (NP2014-T3)” U.S. Census
Bureau, Population Division, December 2014, http://www.census.gov/population/projections/data/national/2014/summarytables.html
(Accessed 3/4/15). Share of population calculated using data presented in source. 2015 share of population over the age of 65 = 47,830,000
/ 321,369,000 = 14.9%. 2060 share of population over the age of 65 = 98,164,000 / 416,795,000 = 23.6%.
“US Health Spending Trends By Age And Gender: Selected Years 2002-10” By David Lassman et al., Health Affairs, Vol. 33, No. 5, May
2014, http://content.healthaffairs.org/content/33/5/815.full.pdf (Accessed 8/6/2014), p. 820.
“Table 10. Projections of the Population by Sex, Hispanic Origin, and Race in the United States: 2015 to 2060 (NP2014-T10)” U.S. Census
Bureau, Population Division, December 2014, http://www.census.gov/population/projections/data/national/2014/summarytables.html
(Accessed 3/4/15). Data in source shows that share of population that is “one race” and “white” drops from 77% in 2015 (248,369,000 out
of 321,369,000) to 68% in 2060 (285,314,000 out of 416,795,000).
“Whites Account for Under Half of Births in U.S.” By Sabrina Tavernise, New York Times, May 17, 2012,
http://www.nytimes.com/2012/05/17/us/whites-account-for-under-half-of-births-in-us.html?pagewanted=all (Accessed June 8, 2012).
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populations) often experience reduced access to healthcare services.7 As such, the healthcare
delivery system will need to identify disparities in access to care and differences in culture that
impact the provision of care in order to adjust the availability of services, so as to adequately
meet the healthcare needs of this growing segment of the U.S. population.8

HEALTHCARE EXPENDITURES
Rising healthcare expenditures as a percentage of gross domestic product (GDP) may continue to
drive healthcare reform efforts. In 2013, total national health expenditures (NHE) in the United
States grew to $2.9 trillion, a 3.6 percent increase from 2012.9 Although this growth rate is slow
compared to historical trends,10 NHE growth is projected to accelerate to an annual rate of nearly
6 percent between the years of 2013 to 2023.11 This rate, which is faster than the anticipated
annual growth for the GDP, is projected to drive NHE from 17.2 percent of GDP in 2012 to 19.3
percent of GDP by 2023.12 A 2009 study published in Health Affairs found that the greatest
contributor to rising personal healthcare expenses (a subset of NHE) is growing medical prices.13

INCREASED SCRUTINY OF FRAUD AND ABUSE
In addition to the goals for increased and affordable healthcare coverage, the 2010 healthcare
reform legislation also responds to concerns related to fraud and abuse in the healthcare system.
The legislation includes significant initiatives aimed at reducing fraud and increasing
transparency in the Medicare and Medicaid programs, through such efforts as implementing
transparency requirements for pharmaceutical and medical device manufacturers and amending
various federal enforcement tools, including the federal Anti-Kickback Statute (AKS), the False
Claims Act (FCA), and the federal physician self-referral law (Stark law).14
The healthcare reform legislation incorporates extensive reporting and public disclosure of
financial arrangements between certain provider customers (e.g., physicians) and medical
product manufacturers in the form of the Physician Payments Sunshine Act (Sunshine Act).15
This disclosure is intended to encourage voluntary avoidance of conflicts of interest that
7
8
9
10

11
12
13
14
15

“Disparities in Rates of Inpatient Mortality and Adverse Events: Race/Ethnicity and Language as Independent Contributors” By Anika L.
Hines et al., International Journal of Environmental Research and Public Health, Vol. 11, No. 12, December 12, 2014, p. 13018, 13026.
“Changing Demographics: Implications for Physicians, Nurses, and Other Health Workers” Health Resources and Services Administration,
2003, p. 37-38.
“NHE Fact Sheet” Centers For Medicare & Medicaid Services, December 3, 2014, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html (Accessed 1/29/15).
“Table 1: National Health Expenditures; Aggregate and Per Capita Amounts, Annual Percent Change and Percent Distribution: Selected
Calendar Years 1960-2012” in “National Health Expenditures Data” Centers for Medicare & Medicaid Services, May 5, 2014,
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/ (Accessed
12/8/2014).
“NHE Fact Sheet” Centers For Medicare & Medicaid Services, December 3, 2014, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html (Accessed 1/29/15).
Ibid.
“Health Spending Projections Through 2019: Recession Effects Add Uncertainty to the Outlook” By Christopher J. Truffer et al., Health
Affairs, Vol. 28, No. 2 (February 24, 2009), p. 526.
“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 6001, §1128J, 124 Stat. 119, 684, 755, 759 ; “Health Care Reform:
Substantial Fraud and Abuse and Program Integrity Measures Enacted” McDermott Will & Emery, April 12, 2010, p. 2.
“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 6002, 124 Stat. 119, 689; “Health Policy Brief: The Physician Payments
Sunshine Act” Health Affairs, October 2, 2014, http://healthaffairs.org/healthpolicybriefs/brief_pdfs/healthpolicybrief_127.pdf (Accessed
3/25/2015), p. 1.
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potentially can jeopardize the quality, integrity, and safety of clinical care, biomedical and
academic research, and medical education, as well as lead to violations of federal fraud and
abuse regulations.16
In addition to the new transparency and disclosure requirements, the healthcare reform
legislation amends various fraud and abuse enforcement activities. One new requirement is that
overpayments made by Medicare or Medicaid must be reported within sixty days after the date
the recipient identified the overpayment. The requirement further states that failure to make a
timely repayment gives rise to liability under the FCA.17
The healthcare reform legislation also makes two changes to the intent standards relating to fraud
and abuse. First, the legislation amends the AKS by stating that a person need not have actual
knowledge of, or specific intent to, commit a violation of the statute for the government to prove
a kickback violation.18 Second, the ACA provides that “…a claim that includes items or services
resulting from a violation [of the AKS] constitutes a false or fraudulent claim for purposes…” of
the FCA, which results in a law that any violation of the AKS is sufficient to state a claim under
the FCA.19
The ACA also significantly changes the FCA by eliminating the jurisdictional bar for allegations
based on publicly disclosed information and by relaxing the requirements for a qui tam action to
be eligible as an “original source.”20 These changes have the potential to increase providers’
FCA exposure by allowing for a greater number of whistleblowers to bring a claim.21
Alternatively, the ACA also requires the secretary of HHS to set up a Stark law self-referral
disclosure protocol, which will permit HHS to receive payment lower than the full Stark law
measure of damages in appropriate circumstances. This initiative will potentially provide
considerable monetary relief for certain providers.22
In Chapter 3, Regulatory Environment, we addressed the current regulatory environment of the
healthcare industry and provided a more detailed analysis of the additional fraud and abuse
initiatives that have evolved during the era of healthcare reform. These efforts have resulted in
increased scrutiny regarding the regulation of the healthcare industry. Recent reports suggest that
this is well worth the investment, as recoveries on fraud and abuse investigations are currently

16
17
18
19
20
21
22
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“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1128J, 124 Stat. 119, 755 ; “Health Care Reform: Substantial Fraud and
Abuse and Program Integrity Measures Enacted” McDermott Will & Emery, April 12, 2010, p. 3.
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 10606, 124 Stat. 119, 1008 (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1128J, 124 Stat. 119, 759; “Health Care Reform: Substantial Fraud and
Abuse and Program Integrity Measures Enacted” McDermott Will & Emery, April 12, 2010, p. 3.
“Patient Protection and Affordable Care Act” Pub. L. 111-148, § 1303, 124 Stat. 119, 901; “KABOOM! The Explosion of Qui Tam False
Claims Under the Health Reform Law” By Beverly Cohen, Penn State Law Review, Vol. 116, No. 1 (2011), http://www.pennstatelaw
review.org/116/1/116%20Penn%20St.%20L.%20Rev.%2077.pdf (Accessed 3/25/2015), p. 78-79.
“KABOOM! The Explosion of Qui Tam False Claims Under the Health Reform Law” By Beverly Cohen, Penn State Law Review, Vol.
116, No. 1 (2011), http://www.pennstatelawreview.org/116/1/116%20Penn%20St.%20L.%20Rev.%2077.pdf (Accessed 3/25/2015),
p. 78-79.
“Patient Protection and Affordable Care Act" Pub. L. No. 111-148, § 6409. 124 Stat. 119, 772-773 (March 23, 2010); “Self-Referral
Disclosure Protocol” Centers for Medicare & Medicaid Services, December 27, 2011
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yielding $7.70 (on average) for every dollar spent pursuing fraud cases,23 up from 4 to 1 in
2009.24

HEALTHCARE PROVIDER MANPOWER: SUPPLY AND DEMAND
As discussed in several other sections in this Guide, recent reports have indicated that the United
States will face a growing physician manpower shortage, especially in primary care. A 2015
projection estimated a shortage of 46,000 to 90,000 physicians by 2025, of which approximately
one third will be primary care providers.25 One of the primary drivers of this projected shortage
is the growth in the number of insured individuals due to the healthcare reform provisions under
the ACA.26 Projections of the shortage of physicians include the impact of younger physicians
working fewer hours, as well as retirement patterns of current physicians (over 240,000 of whom
were older than 65 in 2013).27 Adding to the increased population with insurance coverage under
the ACA, younger physicians are more interested in obtaining a sustainable work-life balance
than the older generation, thereby reducing the average hours worked for physicians,28 and
increasing the demand on the physician workforce. However, the dynamic change and the
versatility of non-physician providers (e.g., nurse practitioners and physician assistants) as to
their scope of practice has been growing to accommodate the changing reimbursement,
regulatory, competitive, and technological aspects of an evolving healthcare industry.29 The
Association of American Medical Colleges (AAMC) has indicated that solving the predicted
physician shortage will not only depend on training more physicians, but also on reconfiguring
healthcare delivery and increasing efficiency.30
The 2010 healthcare legislation responds to this projected shortage in physician manpower by:
(1) increasing the number of graduate medical education training positions; (2) giving priority to
primary care and general surgery fields and to those states with the lowest resident physician-topatient population; (3) increasing workforce supply and support by providing health
23
24

25
26
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“Departments of Justice and Health and Human Services Announce Record-breaking Recoveries Resulting from Joint Efforts to Combat
Health Care Fraud” Department of Health and Human Services, February 26, 2014, http://www.hhs.gov/news/press/2014pres/
02/20140226a.html (Accessed March 4, 2015).
“Departments of Justice and Health and Human Services announce over $27.8 billion in returns from joint efforts to combat health care
fraud” U.S. Department of Health and Human Services, March 19, 2015, http://www.hhs.gov/news/press/2015pres/03/20150319a.html
(Accessed 4/28/2015); “Annual Report of the Departments of Health and Human Services and Justice: Health Care Fraud and Abuse
Control Program FY 2014” U.S. Department of Health and Human Services and U.S. Department of Justice, March 19, 2015,
http://oig.hhs.gov/publications/docs/hcfac/FY2014-hcfac.pdf (Accessed 6/30/15), p. 8; “Sebelius: New Fraud Prevention Team Will Turn
Up HEAT” By Ben Amirault, Health Leaders Media, May 21, 2009, http://www.healthleadersmedia.com/content/233446/topic/
WS_HLM2_FIN/Sebelius-New-Fraud-Prevention-Team-will-Turn-up-Heat.html (Accessed May 21, 2009).
“The Complexities of Physician supply and Demand: Projections from 2013 to 2025—Final Report” IHS, Inc., March 2015, p. v-vi. Source
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“The Complexities of Physician supply and Demand: Projections from 2013 to 2025—Final Report” IHS, Inc., March 2015, p. vi. See the
Healthcare Reform Impact on the Future of U.S. Healthcare Delivery section for a discussion on the ACA’s provisions, many of which are
aimed at increasing the number of individuals with health insurance coverage.
“The Complexities of Physician supply and Demand: Projections from 2013 to 2025—Final Report” IHS, Inc., March 2015, p. 6-8;
“Physician Characteristics and Distribution in the US” 2015 Edition, American Medical Association, 2014, p. 9.
“Wanting it All: A New Generation of Doctors Places Higher Value on Work-Life Balance” By Eve Glicksman, Association of American
Medical Colleges, May 2013, https://www.aamc.org/newsroom/reporter/336402/work-life.html (Accessed 3/30/2015).
“Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice” By Fred G. DoniniLenhoff, Journal of Allied Health Vol. 37, no. 1, 2008, p. 47; “Interprofessional Healthcare: A Common Taxonomy to Assist with
Understanding” By Alice B. Aiken and Mary Ann McColl, Journal of Allied Health Vol. 38, No. 3, 2009, p. e-92.
“GME Funding: How to Fix the Doctor Shortage” Association of American Medical Colleges, https://www.aamc.org/advocacy/
campaigns_and_coalitions/fixdocshortage/ (Accessed 3/25/2015).
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professionals with training-related scholarships and loans; (4) increasing the capacity for nurse
education, the support for nurse training programs, and the number of loan repayment and
retention grants; (5) creating a career ladder to nursing; and (6) establishing a Prevention and
Public Health Fund for prevention, wellness, and public health activities.31

RESTRUCTURING REIMBURSEMENT
The continuing controversy regarding physician reimbursement levels and the sustainable growth
rate (SGR) formula for determining the annual conversion factor (CF) under the Medicare
physician fee schedule are partial drivers of the efforts that have supported the progression of
healthcare reform initiatives under the Obama administration. At the same time, the movement
from a capitated fee reimbursement system to a fee-for-service (FFS) and managed care payment
system has facilitated an increase in NHE. This growth in NHE during the past several years has
prompted recent efforts to downshift reimbursement for physician services (for example, by way
of bundled payments) in an effort designed to contain healthcare costs.

Repeal of the Sustainable Growth Rate (SGR)
The SGR method replaced the Medicare Volume Performance Standard (MVPS) provision in
1997 to provide annual target updates to the physician fee schedule for Medicare Part B. The
SGR formula is designed to control aggregate growth in Medicare expenditures by raising or
lowering the proposed payment target to reflect actual cumulative expenditures.32 The
calculation of SGR relies upon four factors, according to the Centers for Medicare & Medicaid
Services (CMS):33
(1)
(2)
(3)
(4)

The estimated percentage change in fees for physicians’ services.
The estimated percentage change in the average number of Medicare fee-for-service
beneficiaries.
The estimated 10-year average annual percentage change in real gross domestic product
(GDP) per capita.
The estimated percentage change in expenditures due to changes in law or regulations.

The SGR was intended to predictably control federal spending on Medicare Part B.34 Since its
enactment, actual Medicare expenditures remained below target expenditures through 2001.
However, every year since 2002, actual expenditures have exceeded target expenditures, with the
discrepancy growing annually.35 Because of actual expenditures exceeding target expenditures,
31
32
33
34
35

“Summary of The Affordable Care Act” The Henry J. Kaiser Family Foundation, April 23, 2013, https://kaiserfamilyfoundation.files.
wordpress.com/2011/04/8061-021.pdf (Accessed 3/28/15), p. 10, 12.
“Estimated Sustainable Growth Rate and Conversion Factor, for Medicare Payments to Physicians in 2015” Centers for Medicare &
Medicaid Services, November 2014, https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/SustainableGRatesConFact/
Downloads/SGR2015f.pdf (Accessed 3/19/2015), p. 1.
Ibid.
“Reform Medicare Physician Payent Formula” American College of Emergency Physicians, http://www.acep.org/workarea/Download
Asset.aspx?id=48579 (Accessed 3/25/2015), p. 1.
“Medicare Physician Payment Updates and the Sustainable Growth Rate (SGR) System” By Jim Hahn, Congressional Research Service,
June 12, 2014, http://greenbook.waysandmeans.house.gov/sites/greenbook.waysandmeans.house.gov/files/R40907_gb.pdf (Accessed
3/13/2015), p. 5.
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the SGR formula dictated a reduction in the fee schedule.36 Despite this, Congressional action to
suspend the impending cuts to payments for physician services every year since 2003 has
resulted in a widening gap between the cumulative spending and cumulative target each year the
proposed cuts were overridden.37 A January 2015 projection by the Congressional Budget Office
(CBO) estimated that a Congressional override of the scheduled reductions to physician
payments would result in approximately $6.0 billion in increased Medicare outlays.38 However,
in April of 2015, Congress passed legislation that significantly reformed the methodology for
updating physician payments. This legislation had its own associated costs, which are described
in the following section below.
Medicare Access and CHIP Reauthorization Act of 2015
For years, many healthcare industry stakeholders including the American Medical Association,
the American Hospital Association, and the Medicare Payment Advisory Committee urged for
the repeal of the SGR.39 After multiple failed attempts,40 in April 2015, Congress passed the
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which President Obama
signed into law on April 16, 2015.41 Among its provisions, MACRA repeals the SGR, replacing
it with a series of pre-determined updates to the MPFS, which are modified based on a given
provider’s utilization of certain alternative payment models (APMs), as opposed to traditional
fee-for-service payments.42
According to the text of the statute, APMs include models under section 1115A (i.e., the Center
for Medicare and Medicaid Innovation),43 accountable care organizations (ACOs), or
demonstrations under section 1866C or another federal law.44 In general, to qualify as an APM
participant, a provider must meet certain thresholds, i.e.:45
(1) 2019-2020: At least 25% of payments through an eligible alternative payment entity;
(2) 2021-2022: At least 50% of payments through an eligible alternative payment entity; and,
(3) 2023 forward: At least 75% of payments through an eligible alternative payment entity.
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sites/default/files/cbofiles/attachments/49892-Outlook2015.pdf (Accessed 3/28/2015), p. 24-26.
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“Summary: H.R.2—114th Congress (2015-2016)” Congress.gov, https://www.congress.gov/bill/114thcongress/housebill/2 (Accessed
4/22/2015); “Medicare Access and CHIP Reauthorization Act of 2015” Pub. L. No. 114-10, § 101 et seq., 129 Stat. 87 (April 16, 2015).
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4/22/2015).
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24, 2012, http://www.law.umaryland.edu/marshall/crsreports/crsdocuments/022412B_04242012.pdf (Accessed 4/22/2015), p. 1.
“Medicare Access and CHIP Reauthorization Act of 2015” Pub. L. No. 114-10, § 101, 129 Stat. 87, 121 (April 16, 2015).
Ibid, .129 Stat. 87, 118-121. See the text of the statute for specific requirements for each period.

409

Adviser's Guide to Healthcare

Furthermore, an alternative payment entity is defined as an entity that:46
(1) Participates in an APM and meets the following requirements;
a. requires participants in the model to use certified EHR technology and
b. provides for payment based on certain quality measures;
(2) Bears financial risk for material monetary losses under the APM; or
(3) Is a medical home.
If a provider qualifies as an APM participant, they are eligible for certain financial incentives.
First, providers that qualify as APM participants between 2019 and 2024 receive a 5% bonus
payment for services furnished to Medicare beneficiaries paid in an annual lump sum.47
Furthermore, beginning in 2026, the annual update to Medicare payments to providers who do
not qualify as APM participants is 0.25%, while the annual update to Medicare payments for
qualifying APM participants is 0.75%.48
It is worth noting that, although many were happy to see the SGR repealed,49 there is a
significant cost associated with replacing the update methodology. Indeed, the Office of the
Actuary of CMS estimates that MACRA will cost just over $100 billion between 2015 and 2025.
The greatest annual costs are concentrated in the early stages of implementation, with 2016 and
2017 costs at $13.1 billion and $15.7 billion, respectively. The greatest component of the cost of
MACRA is, in fact, the physician payment update reform at $150.5 billion, followed by the
reforms to Medicaid and CHIP at $25.0 billion. These costs are offset by savings in other areas
of Medicare (savings of $62.2 billion) and savings in the health insurance marketplaces (savings
of $10.5 billion).50

Downshifting Reimbursement
As Medicare reimbursement has remained stagnant or has decreased for the professional
component of healthcare reimbursement since the 1990s, physicians have looked to the ancillary
services and technical component (ASTC) revenue stream to supplement their income, by way of
ownership investment in ambulatory surgical centers, independent diagnostic testing facilities,
and specialty or surgical hospitals. However, legislative and regulatory opposition at the federal
and state levels to limit physician ownership of or investment in ASTC revenue stream
enterprises have served to restrict physicians in private practice to receiving only professional fee
component revenues. This is viewed by some as relegating physicians to the status of
sharecroppers or hired help or compelling many physicians to acquiesce by accepting employee
status under the substantial control of hospital systems or large corporate players.
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The reduction in reimbursement levels for physicians may have had more widespread effects
than adversely affecting physician revenue and income levels. A study published in the Journal
of the American Medical Association in February 2010 found that a sample of more than 40,000
physicians reported that their hours worked have decreased an average of 7.2 percent from the
periods 1996–98 through 2006–08 (from an average of 54.9 to 51 hours per week).51
Additionally, the authors found that inflation-adjusted physician fees had decreased by
approximately 25 percent between 1996 and 2006, which coincided with the decrease in
physician hours worked, suggesting that the decrease in physician work hours may have been
partially a result of decreasing incentives due to reduced levels of reimbursement.52 In light of
the impending physician shortage, these trends may be particularly troubling.53
The continuing two-pronged attack on niche providers pertains to both specialty physicians and
physician owners of practices and specialty hospitals. It includes: (1) increasing the reduction of
reimbursement yield, most notably for traditionally high-reimbursement yield specialty
procedures (for example, echocardiography, nuclear imaging, etc.) and (2) the continued attack
on physicians sharing in the ownership of the ASTC revenue stream, as evidenced by the
provisions restricting physician ownership of specialty hospitals in the 2010 healthcare reform
legislation.
These changes limit revenue streams available to physicians and give rise to several current
trends, such as the rise of hospital acquisitions of physician practices and employment of
physicians, especially for more profitable specialties that are well-suited to provide services in a
hospital-based setting (for example, cardiology, orthopedics, radiology, etc.). While this attack
on niche providers persists, these trends are likely to continue.
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle
management regulations, will force providers to assess their revenue cycle management systems.
This assessment will likely result in providers making system upgrades and purchasing new
systems.54 Providers with older revenue cycle management systems could possibly upgrade these
systems to improve patient satisfaction and convenience, as well as to realize certain government
financial incentives.55 Furthermore, providers will likely benefit from new systems that improve
efficiency. These systems are capable of (1) easily checking payors’ rules to ensure that the
services to be performed are covered; (2) automatically creating bills from patients’ electronic
medical records; (3) bypassing clearinghouses and submitting claims directly to payors, which
enables providers to receive electronic funds transferred directly from payors to the provider’s
bank; and (4) allowing providers to integrate their financial and clinical data.56 Nonetheless, the
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significant changes to the reimbursement landscape lay an unsteady and uncertain foundation for
the future of reimbursement for providers.

Bundling Payments
Bundling is a method of reimbursement that combines institutional and professional charges into
a single payment.57 Despite the various industry stake holder opinions, in January of 2013, CMS
launched the three year Bundled Payments for Care Improvement (BPCI) initiative.58 Providers
in this program may enter into payment bundling agreements with CMS, selecting from one of
four models of care that define episodes of care and payment arrangements around inpatient
stays in acute care hospitals (the four models available under the BCPI are discussed in more
detail in Chapter 2: Reimbursement Environment).59 An analysis of preliminary data from the
BPCI initiative indicates that a hospital could achieve up to $900,000 in cost savings across
300 episodes of care.60

Next Generation ACOs
In March of 2015, CMS announced a new classification of ACOs, called the Next Generation
model. Compared to current models (which are described in Chapter 2: Reimbursement
Environment), Next Generation ACOs feature a higher degree of shared savings or losses.61
Specifically, Next Generation ACOs may opt for an arrangement with risk sharing rates of 80%
(which grows to 85% after three years) or a Full Performance Risk arrangement, wherein the
Next Generation ACO bears 100% of the risk for their savings or losses.62 In both of these
arrangements, savings and losses are subject to a cap (set at 15% of the Next Generation ACO’s
financial performance benchmark), and Next Generation ACOs are not responsible for the costs
of beneficiaries who are beyond the 99th percentile of medical expenditures.63
Next Generation ACOs also set their financial benchmarks differently from previous models. In
addition to utilizing the ACO’s previous financial performance adjusted based on the risk
characteristics of the ACO’s population of beneficiaries, benchmarks for Next Generation ACOs
also incorporate projected regional trends in expenditures and are discounted based on: (1) the
Next Generation ACO’s performance on quality metrics; (2) the Next Generation ACO’s
expenditures relative to regional FFS expenditures; and (3) the Next Generation ACO’s
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expenditures relative to national FFS expenditures.64 Notably, this discount will replace the
minimum savings rate (MSR) that is utilized by previous models of ACOs.65
In addition to these modifications to previous risk sharing arrangements, Next Generation ACOs
introduce several elements that are distinct from those present in current models of ACOs. For
example, Next Generation ACOs may elect to use four different payment mechanisms,
including: (1) normal FFS payments; (2) per-beneficiary per-month (PBPM) infrastructure
payments in addition to normal FFS payments, which must be repaid to CMS; (3) an
arrangement in which the Next Generation ACO’s providers receive reduced FFS payments, and
in return, CMS gives the Next Generation ACO a monthly payment based on the projected
aggregate annual reduction in FFS payments; and (4) capitation, beginning in 2017.66
Aside from new payment methodologies, the Next Generation ACO model also incorporates
provisions that are designed to improve patient engagement. These “benefit enhancement tools”
include: (1) a process by which beneficiaries may enroll with Next Generation ACOs;
(2) improved access to home visits, telehealth services, and skilled nursing facilities;
(3) financial rewards for beneficiaries who receive care from ACOs; and (4) collaboration
between CMS and Next Generation ACOs to improve communication with beneficiaries
regarding their ACOs, and the potential benefits of receiving care from their ACOs.67 ACOs
have noted the lack of an ability to engage with patients in the past, which these provisions may
help to address.68 If successful, this improved level of patient engagement may help a Next
Generation ACO to have a greater ability to control their patient’s medical costs.

DEMAND FOR QUALITY IMPROVEMENTS
Patient concerns regarding the quality of healthcare delivered in the United States, in relation to
the high costs associated with such healthcare services, were another significant driver of
healthcare reform.69 Although the United States spends a relatively large share of its GDP per
capita on healthcare compared to other developed countries, the United States is ranked very low
in terms of health status, due in part to poor access to care, poor health behaviors (e.g. abuse of
drugs and alcohol), and high levels of socioeconomic inequality.70
64
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Such discrepancies in cost and quality outcomes, in conjunction with limited data on healthcare
enterprises quality metrics, have resulted in increased demands for transparency and
accountability in healthcare, two issues addressed in the 2010 reform legislation.

PASSAGE OF THE PATIENT PROTECTION AND
AFFORDABLE CARE ACT AND THE HEALTH CARE AND
EDUCATION RECONCILIATION ACT OF 2010
LEGISLATIVE EVENTS LEADING TO THE PASSAGE OF
HEALTHCARE REFORM
With the Obama administration in the White House and a Democratic majority in both the
Senate and the House of Representatives, the favorable time to approach healthcare reform
appeared imminent to some. After a long and heated debate regarding the content of potential
healthcare reform initiatives to be included in the proposed legislation, the Patient Protection and
Affordable Care Act, HR 3590 (PPACA), and the Health Care and Education Reconciliation Act
of 2010, HR 4872 (HCRA), collectively referred to as the ACA, were enacted on March 23,
2010 and March 25, 2010, respectively. Although the 2010 healthcare reform legislation may not
satisfy those who sought a single payor healthcare system, it did mark the beginning of a new era
in the long march toward U.S. healthcare reform. Indeed, this reform may result in a changed
paradigm for the way in which healthcare services are delivered and paid for in the United
States. The reform’s most recent initiatives have already modified or improved several aspects of
the healthcare delivery system, including, for example: (1) increased regulatory scrutiny aimed at
combating fraud and abuse and antitrust violations; (2) health plan regulation; (3) addressing
physician shortages; (4) access to, and quality of, care initiatives; and (5) increased attention to
public health/wellness activities, among others.71

Summary of Key Provisions
The ACA will continue to result in significant changes to the country’s healthcare landscape.
Table 6-1 provides a brief overview of the various entities and sectors of the healthcare industry
that are affected by provisions included in the 2010 healthcare reform legislation.
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Table 6-1: Chart of Key Provisions of the ACA72
Target for Reform

Provision

Effective Date

Insurance Industry

Insurance market rules
Grandfathered Plans - Eliminate preexisting condition exclusions for
children
Provide dependent coverage for adult children up to age 26 for all
individual and group policies

September 23, 2010

Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Insurance Industry
Individuals and
Employers
Individuals and
Employers
Individuals and
Employers
Individuals and
Employers
Individuals and
Employers
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare
Medicare

72

National Association of Insurance Commissioners must establish uniform
definitions and standard methodologies
Simplify health insurance administration by adopting a single set of rules
for eligibility verification and claims status
Consumer Operated and Oriented Plans (CO-OPs)
Grandfathered Plans - Eliminate preexisting condition exclusions for adults
Limit deductibles for health plans in the small group market to
$2,000/individual and $4,000/family
Health insurance exchanges for individual states
Deadline for all health plans to document compliance with the new rules
(penalty for noncompliance is $1 per covered life)
Provide grants for up to five years for small businesses that establish
wellness programs
All individuals required to obtain health insurance coverage
Employers with 100 or more employees that do not offer coverage assessed
tax penalties
Employers with fewer than 50 employees that offer insurance receive tax
credits and exemption from tax penalties
Employers with 50-99 employees that do not offer coverage assessed tax
penalties
Ban new physician-owned hospitals in Medicare (and require hospitals to
have a provider agreement in effect by 12/31/10)
Improve care coordination for dual eligible by creating the Federal
Coordinated Health Care Office
50% discount from pharmaceutical manufacturers on brand-name
prescriptions filled in the Medicare Part D coverage gap
Prohibit higher cost-sharing requirements for some Medicare benefits than
is required under the traditional FFS program
Restructure payments to Medicare Advantage plans
Freeze income threshold for income-related Medicare Part B premiums at
2010 levels
Provide a 10% Medicare bonus payment to primary care physicians
Provide a 10% Medicare bonus payment to general surgeons practicing in
areas lacking in health professionals
Make Medicare Part D cost-sharing for full-benefit dual-eligible
beneficiaries receiving home or community-based care services equal to the
cost-sharing for those receiving institutional care
Allow ACOs to share in the cost savings that they achieve for the
Medicare program
Reduce rebates for Medicare Advantage plans
Provide bonus payments to high-quality Medicare Advantage plans
Begin phasing in federal subsidies for brand-name prescriptions filled in the
Medicare Part D coverage gap
Establish a national Medicare pilot program

September 23, 2010
2010
December 31, 2010
January 1, 2013
July 1, 2013
2014
2014
January 1, 2014
April 1, 2014
2011
March 1, 2014
2015
2015
2016
2010
2010
2011
2011
2011
2011, effective through
2019
2011, effective through
2015
2011, effective through
2015
2012
2012
2012
2012
2013
2013
(continued)

“Health Reform Implementation Timeline” The Henry J. Kaiser Family Foundation, http://kff.org/interactive/implementation-timeline/
(Accessed 4/1/15).
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Target for Reform

Provision

Effective Date

Medicare

Reduce Medicare Disproportionate Share Hospital (DSH) payments
Reduce the out-of-pocket amount required to qualify for catastrophic
coverage
Establish an Independent Payment Advisory Board (IPAB)
Restrictions on revenue spending for Medicare Advantage plans
Reduce Medicare payments to certain hospitals by 1% for certain hospitalacquired conditions
Reduce the gap between generic and brand-name drugs
Create a state option to cover childless adults through a Medicaid state plan
amendment
Establish the State Balancing Incentive Program
Create a new state plan option to permit enrollees with: (a) at least two
chronic conditions; (b) one condition and a risk of developing another; or
(c) at least one serious mental health condition
Create new demonstration projects
Increase payments for primary care services
Increase Federal CHIP matching to states by 23%
Provide a sliding scale tax credit to small employers with fewer than 25
full-time equivalent employees
Impose additional requirements on non-profit hospitals, for which failure to
comply will result in a $50,000 tax per year of noncompliance
Limit the deductibility of executive and employee compensation to
$500,000 per individual for health insurance providers
10% tax on indoor tanning services implemented
Impose new annual fees on pharmaceutical manufacturers
Increase the threshold for the itemized deduction for the for unreimbursed
medical expenses from 7.5% adjusted gross income (AGI) to 10% AGI for
regular tax purposes
Increase the Medicare Part A tax rate on wages by 0.9%
Excise tax on taxable medical devices
Provide a refundable credit for coverage under a qualified health plan
Tax penalty assessed on individuals who do not obtain coverage by March
31, 2014
Tax penalty assessed on large employers (more than 100 employees) that do
not offer coverage
Tax penalty assessed on mid-sized employers (50-99 employees) who do
not offer coverage
Excise Tax on high-cost "Cadillac" insurance plans
Establish the National Prevention, Health Promotion, and Public Health
Council to improve overall national health
Create a personalized prevention plan that provides incentives to Medicare
and Medicaid beneficiaries to complete behavior modification systems
Provide Medicare beneficiaries access to a comprehensive health risk
assessment
Allow employers to offer employees rewards of up to 30% (and increasing
to 50%, if appropriate) of the cost of coverage for participation in a wellness
program and meeting certain wellness-related standards

2014

Medicare
Medicare
Medicare
Medicare
Medicare
Medicaid
Medicaid
Medicaid
Medicaid
Medicaid
Medicaid
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Tax Provisions
Prevention and
Wellness
Prevention and
Wellness
Prevention and
Wellness
Prevention and
Wellness
Prevention and
Wellness
Prevention and
Wellness
Prevention and
Wellness
Fraud and Abuse
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2014
2014
2014
2015
2020
2010
2011
2011
Begin 2012
2013 and 2014
October 1, 2015
2010
2010
2010
2010
2012
2013
2013
2013
January 1, 2014
2014
2015
2016
2018
2011
2011
2011
2014

Coordination of federal prevention, wellness, and public health activities

2014

Create the Prevention and Public Health Fund

2014

Create task forces on Preventive Services and Community Preventive
Services
Streamline Medicare prepayment medical review limitations and additional
funds for programs focusing on reducing healthcare fraud

2014
Implementation dates
will vary
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The various entities and sectors of the healthcare industry that are affected by provisions
included in the 2010 healthcare reform legislation include:
(1) Insurance industry. The 2010 healthcare reform legislation subjects the insurance
industry to increasing restrictions regarding expanding coverage requirements.73
(2) Individual states. All states are required to establish an American Health Benefit
Exchange to facilitate the purchase of qualified health plans and a Small Business Health
Options Program (SHOP) that will assist small employers (fewer than 100 employees) in
obtaining coverage for employees.74
(3) Individuals. Perhaps the most controversial mandate is that individuals are required to
obtain or provide some minimum level of health insurance coverage. The healthcare
legislation requires all individuals to obtain health insurance coverage or pay penalties.
Exemptions will be granted for financial hardship, religious objections, American
Indians, those without coverage for less than three months, undocumented immigrants,
incarcerated individuals, those for whom the lowest cost plan option exceeds 8% of
individual income, and those whose individual (or household) income was below the tax
filing thresholds.75
(4) Employers. Although the 2010 healthcare reform legislation does not require employers
to offer health coverage to employees, employers can face significant penalties if they
choose not to do so.76
(5) Medicare. The program is required to provide, among other topics, a productivity
adjustment and reductions to market basket updates for many providers; make several
concessions to expand primary care, coordinated care, and delivery system reform;
support quality, transparency, and fraud and abuse enforcement initiatives; provide a
rebate for Medicare Part D beneficiaries required to pay out-of-pocket for prescription
drug coverage in 2010; enforce provisions to continuously reduce the gap between
generic and brand-name drugs by 2020; add restrictions on revenue spending for
Medicare Advantage plans; update Disproportionate Share Hospital (DSH) payments;
address the impact of physician ownership; and control the diagnostic imaging utilization
rate.77
(6) Medicaid. Reform initiatives related to Medicaid were phased in between 2010 and 2014
and include several provisions related to expanding enrollee eligibility, prescription drug
coverage, and primary care and preventive services coverage, among others.
Additionally, Medicaid will be required to designate new matching payments for eligible
individuals and increase Medicaid payment rates for primary care physicians.78

73
74
75
76
77
78

“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 1101, 1102, 1201, 1251, 124 Stat. 119, 119-120. (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 1321, 1322, 1331, 1332, 1333, 124 Stat. 119, 120. (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1501, 124 Stat. 119, 242 et seq. (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 1511, 1512, 1513, 1514, 1515, 124 Stat. 119, 121. (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 3133, 3135, 3201, 3301, 3401, 5501, 6001, 6402, 124 Stat. 119, 119130. (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 2001, 2501, 2502, 2503, 124 Stat. 119, 119-130. (March 23, 2010).
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(7) Public health. The ACA also supports public health workforce training and expansion,
as well as support for prevention and wellness initiatives.79 Additionally, ACA
establishes the National Prevention, Health Promotion, and Public Health Council to
coordinate federal prevention, wellness, and public health activities, as well as the
creation of a Prevention and Public Health fund to expand funding for prevention and
public health programs. Further, the legislation creates task forces related to preventive
services and community preventive services for the purpose of developing, updating, and
disseminating evidence-based recommendations on the use of clinical and community
prevention services.80
(8) Tax payers. The ACA contains certain tax provisions, including the provision of a
refundable credit for coverage under a qualified health plan, effective January 1, 2011, as
well as a sliding-scale tax credit to small employers (those with fewer than twenty-five
employees and average annual wages of less than $50,000) that purchase health insurance
for their employees. Funding mechanisms to support the implementation of these reform
initiatives include imposing a tax on high-cost insurance (that is, insurance that exceeds a
maximum premium payment level while increasing premiums for those in high-risk
professions). The legislation additionally expands the Medicare tax base for taxpayers
with higher income revenue provisions.81

TIMELINE FOR IMPLEMENTATION OF THE ACA
Figure 6-2 provides an overview of the implementation timeline related to certain key healthcare
reform initiatives.

79
80
81

“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 4001, 4002, 4103, 4104, 5204, 5307, 5314, 124 Stat. 119, 124-125
(March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 4001, 4002, 4003, 4105, 124 Stat. 119, 124-125 (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 1421, 9001, 9015, 124 Stat. 119, 119-130. (March 23, 2010).
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Rebates; and,
Expand Coverage

High risk Pool Established;
No pre-existing condition exclusion for children;
Health plans must provide minimum coverage;
Tax Credits to small employers; and,
Reinsurance program for Medical Loss ratio reporting.

2010

September, 2010

Part D cost-sharing for full-benefit dual eligible
beneficiaries equal cost-sharing for institutional
care;
Allow ACOs share in cost savings;
Reduce Medicare payments;
Establish a hospital value-based purchasing;
and,
Reduce rebates for Medicare Advantage plans.

2012

data.

2014

2015

2016 and beyond

Employer Requirements
U.S. citizens and legal residents to have qualifying health coverage.
Insurance
Reduce the out-of-pocket limits;
Limit deductibles for health plans in the small group market
Premium Subsidies
Provide refundable and advanceable premium credits and cost sharing
subsidies
Medicare
Reduce the out-of-pocket amount that qualifies enrollee for catastrophic
coverage;
Establish an Independent Payment Advisory Board;
Reduce Medicare Disproportionate Share Hospital (DSH) payments;
Medicaid
Expand Medicaid.
Tax Changes
Impose fees on the health insurance sector.
Individual Mandate
Imposition of tax on individuals without qualifying coverage.

Employer Requirements (2016)
Employers with 50-99 employees are required to provide qualified health plans or face tax
penalties.
High Cost Plan Excise Tax (2018)
Excise tax on insurers of employer sponsored health plans with aggregate values that
exceed $10,200 for individual coverage and $27,500 for family coverage.
Medicare
Coverage Gap eliminated by 2020.

Insurance
Permit states to form health care choice compacts and allow insurers to sell
policies in any state participating in the compact.
Medicare
Reduce Medicare payments to certain hospitals for hospital-acquired conditions
by 1%.
Medicaid
Increase federal matching of CHIP funds to states by 23 percent
Employer Requirements
Employers with 100 or more employees are required to provide qualified health
plans or face tax penalties.
Insurance
American Health Benefit Exchanges and Small Business Health Options Program.

2013

Create new demonstration projects in
Medicaid.
Quality Improvements
Require enhanced collection and reporting of

Medicaid

Medicare

Insurance
Create the Consumer Operated and Oriented Plan (COOP) program; and,
Simplify health insurance administration by adopting a
single set of operating rules
Medicare
Begin phasing-in federal subsidies for brand-name
prescriptions; and,
Establish a national Medicare pilot program.
Medicaid
Increase Medicaid payments for primary care services.
Tax Changes
Increase the threshold for the itemized deduction for
unreimbursed medical expenses;
Increase the Medicare Part A (hospital insurance) tax
rate on wages;
Limit amount of contributions to a flexible spending
account for medical expenses; and,
Impose an excise tax on medical devices

2011

Dependent Coverage for
adult children to age 26

Voluntary insurance program for long term
care.
Prevention / Wellness
Grants to small employers with wellness
programs.
Medicare
50% discount from pharma manufacturers on
brand name drugs;
10% bonus payment to primary care
physicians and general surgeons in shortage
areas;
Prohibit higher cost sharing requirements for
Medicare vs. free-for-service.
Medicaid
Prohibit federal payments for health care
acquired conditions;
Permit enrollees with at least two chronic
conditions; and,
State Balancing incentive program.
Quality Improvement
Increase funding to community health
centers by $11 million.

Insurance

March 23, 2010

President Obama signs
Healthcare Reform Bill
•
H.R. 3950
•
H.R. 3962

Limit deductibility of executive compensation;

Medicaid State Plan Amendment;
Increases drug rebate percentage to 23.1%; and,
Increases non-innovator multiple source drug to 13%.
Tax Changes
Additional requirements on non-profit hospitals and
concurrent $50,000 fine; and,

Medicaid

Medicare

Insurance:

Figure 6-2: A Brief Primer on Healthcare Reform —Healthcare Reform Timeline P.L. 111-148 • P.L. 111-152
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OBSTACLES TO THE IMPLEMENTATION OF HEALTHCARE REFORM
The continued success of the implementation of the healthcare reform timeline will depend
largely on the continued political and fiscal support for the measures proposed in the ACA, and
although the current political environment on the federal level may support the bill, individual
states are responsible for much of its implementation, leaving ample room for delays created by
lack of aggressive oversight or support.82 The states’ major implementation responsibilities
include establishing the insurance exchanges for small businesses and individuals, enforcing the
new insurance requirements, and administering the new Medicaid expansion.83 Without
continued support of the Obama administration, Congress, other stakeholder groups, the media,
and the public, the strides made in healthcare reform by the passage of the ACA may be
countered, similar to when the Medicare Catastrophic Coverage Act of 1988 was repealed
slightly more than a year after its passage.84 Recently, the ACA faced its second major test in the
Supreme Court in David King et al. v. Sylvia Mathews Burwell et al. Although the court ruled in
favor of the administration, preserving the ACA, there may still be other challenges to the
ACA.85
After passage of the ACA, there remained heated opposition from the Republican Party
regarding the content and implementation of the bill’s provisions. Several of the attorneys
general that were running for political office or up for re-election challenged the reform bill.86
State attorneys general filed lawsuits in federal court within minutes of President Obama’s
signing of the healthcare reform legislation into law, each claiming that the healthcare reform
legislation violates the United States Constitution.87 One lawsuit, led by Florida Attorney
General Bill McCollum, and joined by twelve other state attorneys general, claimed that the
reform legislation exceeds Congress’s power to regulate commerce, violated the 10th
Amendment protection of state sovereignty, and imposed an unconstitutional direct tax.88
These states took legal action in The State of Florida et al. v. United States Department of Health
and Human Services et al. (commonly referred to as Florida v. HHS), in which the 26 states
disputed the constitutionality of the ACA’s individual mandate provision and the
constitutionality of the ACA itself.89 The National Federation of Independent Business (NFIB)
also filed a suit challenging the constitutionality of the ACA, questioning “whether the ACA
must be invalidated in its entirety because it is non-severable from the individual mandate that
82
83
84
85
86
87
88
89

“The War Isn’t Over” By Henry J. Aaron, and Robert D. Reischauer, New England Journal of Medicine, March 24, 2010,
http://www.brookings.edu/~/media/research/files/opinions/2010/3/24-health-reform-aaron/0324_health_reform_aaron.pdf (Accessed
5/17/2010), p. 1-2.
“Implementation is Forever” By Drew Aultman, The Henry J. Kaiser Family Foundation, April 6, 2010, http://www.kff.org/
pullingittogether/040610_altman.cfm (Accessed 5/17/2010).
“The War Isn’t Over” By Henry J. Aaron, and Robert D. Reischauer, New England Journal of Medicine, March 24, 2010,
http://www.brookings.edu/~/media/research/files/opinions/2010/3/24-health-reform-aaron/0324_health_reform_aaron.pdf (Accessed
5/5/2010), p. 1-3.
See the Future of the ACA section below, for a further discussion related to challenges to the ACA.
“Democratic, Republican Attorneys General Continue Health Reform Lawsuit Battle” Kaiser Health News, April 1, 2010,
http://www.kaiserhealthnews.org/daily-reports/2010/april/01/thursday-state-lawsuits-health-reform.aspx (Accessed 5/5/2010).
“15 State Attorneys General to Sue to Block Health Care Reform Law” By Joanne Dechenaux, Society for Human Resource Management,
March 31, 2010, http://www.shrm.org/LegalIssues/EmploymentLawAreas/Pages/15StateAttorneysGeneral.aspx (Accessed 5/5/2010).
Ibid.
“State of Florida et al. v. United States Department of Health and Human Services, et al.” Case No. 11-398 (SCOTUS 2011), Petition for
Writ of Certiorari, p. I.
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exceeds Congress’ limited and enumerated powers under the Constitution.”90 After a series of
opposing circuit court decisions, the Supreme Court of the U.S. (SCOTUS) decided to combine
the cases and issue one ruling for both of the underlying cases.
In March of 2012, two years after the passage of the ACA, SCOTUS began hearing oral
arguments to consider four key questions related to the ACA: (1) whether the individual mandate
was a “tax” or a “penalty,” thereby addressing the question of the “ripeness” necessary for a
constitutional challenge; (2) whether the individual mandate was a violation of the U.S.
Constitution’s Commerce Clause; (3) whether the individual mandate provision was severable
from the rest of the law; and (4) whether the federal requirement that states expand Medicaid
coverage was a violation of the U.S. Constitution’s Supremacy Clause.91
On June 28, 2012, SCOTUS issued a ruling that passed over issues of ripeness and chose to
uphold the constitutionality of the individual mandate. Despite agreeing with the argument that
the individual mandate violated the U.S. Constitution’s Commerce clause, SCOTUS reasoned
that the individual mandate was an exercise of the Federal taxing power.92 SCOTUS held that the
“penalty” mandated against those individuals that do not purchase insurance under the individual
mandate was a tax, because it: (1) is paid upon filing an annual income tax return; (2) only
applies to those individuals who pay federal income tax; (3) takes into account similar factors as
taxes, for example, number of dependents, joint filing status, and taxable income; and (4) is
codified in the Internal Revenue Code and enforced by the Internal Revenue Service (IRS).93
Chief Justice Roberts stated in his opinion that, “the Constitution permits such a tax, it is
[therefore] not our role to forbid it, or to pass upon its wisdom or fairness.”94 With regards to the
Medicaid expansion, the Court limited Congress’s attempt to “pressure” states into participating,
comparing the termination of all Medicaid funding to those states that chose not to participate to
a “gun to the head.”95 Under the SCOTUS ruling, Congress could attempt to entice states to
expand Medicaid by offering additional funding, but could not withdraw existing funds.
Additionally, SCOTUS noted that a lack of participation by any number of the states did not
invalidate the entire Medicaid expansion provision, thus upholding its constitutionality within the
ACA.96
In addition to political obstacles to the enactment of healthcare reform, some consider physicians
a potential barrier to certain reform initiatives, namely, cost-containment measures.97 Research
studies have shown that the regional variance in healthcare spending is correlated with physician
recommendation of additional tests of discretionary or uncertain benefit to the patient, and that

90
91
92
93
94
95
96
97

“National Federation of Independent Businesses et al. v. Kathleen Sebelius et al.” Case No. 11-393 (SCOTUS 2011), Petition for a Writ of
Certiorari, p. i.
“Supreme Court Review of the Healthcare Reform Law” By Gregory D. Curfman, Brendan S. Abel and Renee M. Landers et al., New
England Journal of Medicine, Vol. 366, Nno. 11, March 15, 2012, p. 978-979.
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2600 (2012).
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2653 (2012).
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2600 (2012).
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2604 (2012).
“National Federation of Independent Business et al. v. Sebelius et al.” 132 S. Ct. 2566, 2607-08 (2012).
“Medicine’s Ethical Responsibility for Health Care Reform—The Top Five List” By Howard Brody, New England Journal of Medicine,
Vol. 362, No. 4 (January 28, 2010), p. 284.
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reform efforts focused on reducing spending in high-cost regions (for example, limiting
unnecessary visits, procedures, etc.) would greatly assist in cost-containment initiatives.98

PROPOSED SUPPLEMENTAL REFORM INITIATIVES
Despite the monumental passage of the ACA, one thing that remains clear amid the looming
uncertainty regarding what this reform means is that healthcare reform must be viewed as a
process rather than an event. In the months (and years) ahead, additional healthcare reform
initiatives will be proposed and implemented. The implementation of the 2010 healthcare reform
legislation has been and will be adaptive and possibly erratic, as its implementation not only
depends on what is contained within the actual text of the legislation but also how it responds to
outside factors, such as the public’s support of the legislation; the changing political and
economic landscape; the private sector’s response; the healthcare professionals’ real-life, day-today application of the law; and the governors’, attorneys’ general, and states’ response to the
reform. Accordingly, consultants advising individuals and businesses in these matters should
keep abreast not only regarding the impact of the healthcare reform legislation that has been
passed to date, but also forthcoming proposals and initiatives.
In this era of continuing healthcare reform, the future of the competitive landscape for the
healthcare industry may prove difficult to predict. Features of this evolving landscape include:
(1) The emergence of health insurance exchanges;
(2) The growing role of value-based reimbursement and VBP initiatives, such as the recently
announced Oncology Care Model;99
(3) The looming physician manpower shortage in the face of a growing demand from the
anticipated influx of the newly insured under the ACA’s individual mandate and
Medicaid expansion, as well as the aging baby boomer demographic;100 and
(4) The consolidation of healthcare providers,101 as well as expanding numbers of physicians
becoming employed by hospitals and health systems.102
These trends, together with the continuing advance toward the “corporatization” and “Walmartization” of medicine,103 have led to a restructuring of the very nature of healthcare
competition. This restructuring is likely energized in part by the aggressive pursuit of measurable

98
99
100
101
102

103

“Discretionary Decision Making by Primary Care Physicians and the Cost of U.S. Health Care” By Brenda Sirovich et al., Health Affairs,
Vol. 27, No. 3 (May/June 2008), p. 819; “Slowing the Growth of Health Care Costs—Lessons from Regional Variation” By Elliott S.
Fisher, Julie P. Bynum, and Jonathan S. Skinner, New England Journal of Medicine, Vol. 360, No. 9 (February 26, 2009), p. 851-852.
“Oncology Care Model” Centers for Medicare & Medicaid Services, http://innovation.cms.gov/initiatives/Oncology-Care/ (Accessed
3/16/2015).
“The Complexities of Physician Supply and Demand: Projections from 2013 to 2025—Final Report” IHS, Inc., March 2015, p. v-vi.
“Hospital Consolidation Trend to Continue” By Rich Daly, Healthcare Financial Management Association, June 16, 2014,
http://www.hfma.org/Content.aspx?id=23307 (Accessed 3/28/15).
“Understanding the Physician Employment ‘Movement’” By Bonnie Darves, New England Journal of Medicine Career Center, July 23,
2014, http://www.nejmcareercenter.org/article/understanding-the-physician-employment-movement-/ (Accessed 3/28/15); “A Guide to
Physician Integration Models for Sustainable Success” Chicago, IL: Health Research and Educational Trust and Kaufman, Hall &
Associates, Inc., September 2012, http://www.hpoe.org/ReportsHPOE/guide_to_physician_integration_models_for_sustainable_success.pdf (Accessed 3/24/2015), p. 5.
“The Wal-Martization of Health Care” By William M. Sage, The Journal of Legal Medicine, Vol. 28, No. 4 (2007), p. 503-504.
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enhancement of patient care outcomes by means of coordinated care efforts across medical
specialties, treatment modalities, and facility types.104

PAYING FOR HEALTHCARE REFORM
Reforming healthcare in America may cost the government billions of dollars, which may be
funded in a variety of ways including: (1) cutting waste, fraud, and abuse within existing
government health programs; (2) removing large subsidies to insurance companies; and (3)
increasing healthcare delivery efficiency through streamlining paper work and coordinating
care.105 The CBO has recently released an updated estimate of the budgetary effects of the
insurance provisions of the ACA. The CBO projects the insurance provisions of the legislation
will cost approximately $1,707 billion between 2016 and 2025, which will be partially offset by
$499 billion in penalty payments and other sources, resulting in a net cost of approximately
$1,207 billion over that time frame.106 It should be noted that, under the CBO’s normal
procedures, the remaining budgetary effects of the ACA (i.e., those provisions that are not
related to insurance) are not estimated. The CBO has stated that the remaining budgetary effects
of the ACA would need to be compared to a “counterfactual benchmark that exclude[s] the
ACA.”107 Furthermore, the CBO has described the creation of such a counterfactual benchmark
as a highly complicated task that would result in a benchmark that is “…hugely uncertain and
speculative.”108 Accordingly, those remaining budgetary effects have not been estimated since
the CBO’s initial projection of the budgetary effects of the ACA in its entirety. However, the
CBO recently noted that it has no reason to suspect that its initial estimate of these remaining
budgetary effects relating to the ACA is incorrect.109
Based on the CBO’s 2010 estimate, the budgetary effects of the ACA’s provisions that are not
related to insurance (i.e., those provisions for which the CBO does not create regularly updated
estimations) are projected to result in net savings of $931 billion.110 However, this includes $70
billion in savings resulting from the Community Living Assistance Services and Supports

104 “When and how provider competition can improve health care delivery” By Penelope Dash, MD and David Meredith, McKinsey &
Company, November 2010, http://www.mckinsey.com/insights/health_systems_and_services/when_and_how_provider_competition_can_
improve_health_care_delivery (Accessed 3/24/2015); “Bringing Home the Continuum of Care” Amedisys, http://www.amedisys.com/
delivering_new_models_of_care (Accessed 3/28/15), p. 3.
105 “Frequently Asked Questions about Health Insurance Reform” The White House, http://www.whitehouse.gov/realitycheck/faq#c1
(Accessed 8/7/2012).
106 “Insurance Coverage Provisions of the Affordable Care Act—CBO’s March 2015 Baseline” Congressional Budget Office, March 2015,
https://www.cbo.gov/sites/default/files/cbofiles/attachments/43900-2015-03-ACAtables.pdf (Accessed 3/28/15), table 1.
107 “Estimating the Budgetary Effects of the Affordable Care Act” By Doug Elmendorf, Congressional Budget Office, June 17, 2014,
https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
108 “Estimating the Budgetary Effects of the Affordable Care Act” By Doug Elmendorf, Congressional Budget Office, June 17, 2014,
https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
109 “Estimating the Budgetary Effects of the Affordable Care Act” By Doug Elmendorf, Congressional Budget Office, June 17, 2014,
https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
110 “Estimate of Direct Spending and Revenue Effects of HR 3590 and HR 4872” By Douglas W. Elmendorf, Congressional Budget Office,
Letter to Nancy Pelosi, U.S. House of Representatives, March 20, 2010, https://www.cbo.gov/sites/default/files/amendreconprop.pdf
(Accessed 8/7/2012), p. 5.
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(CLASS) program, which has been eliminated since the CBO conducted its original
projection.111
Other sources of funding for the 2010 healthcare reform legislation may include (1) new annual
fees paid by insurers, estimated to yield $60.1 billion from 2014 to 2019; (2) new annual fees
paid by pharmaceutical manufacturers, estimated to raise $27 billion from 2013 to 2019; (3) a
2.9 percent excise tax on medical device manufacturers, estimated to raise $20 billion from 2013
to 2019; and (4) an excise tax on high-cost insurance plans, estimated to raise $32 billion from
2018 to 2019.112

HEALTHCARE REFORM IMPACT ON THE FUTURE OF
U.S. HEALTHCARE DELIVERY
In June 2014, the CBO reiterated its 2010 estimate that the enactment of the Patient Protection
and Affordable Care Act would reduce federal budget deficits by $150 billion from 2010 to
2019.113 Combined with the CBO’s 2010 estimate of the reduction of the federal deficit
associated with the Health Care and Education Reconciliation Act of 2010, the federal deficit is
estimated to be reduced by $175 billion.114 In addition to the budgetary benefits of bill passage,
the Office of the Assistant Secretary for Planning and Evaluation estimates that 16.4 million
people have gained health insurance coverage as a result of the ACA, which has reduced the
percentage of uninsured from 20.3 percent (in October of 2013) to 13.2 percent (in March of
2015).115

IMPACT ON INDIVIDUALS
The 2010 healthcare reform legislation requires U.S. citizens and legal residents to maintain
minimum amounts of health insurance coverage, a controversial provision of the ACA that was
upheld in NFIB v. Sebelius.116 Minimum essential coverage includes government-sponsored
programs, eligible employer-sponsored programs, plans in the individual market, grandfathered
group health plans, as well as some other types of coverage.117

111 “Estimate of Direct Spending and Revenue Effects of HR 3590 and HR 4872” By Douglas W. Elmendorf, Congressional Budget Office,
Letter to Nancy Pelosi, U.S. House of Representatives, March 20, 2010, https://www.cbo.gov/sites/default/files/amendreconprop.pdf
Accessed 8/7/2012), Table 5; “Estimating the Budgetary Effects of the Affordable Care Act” By Doug Elmendorf, Congressional Budget
Office, June 17, 2014, https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
112 “What Will Happen Under Health Reform- and What’s Next?” The Commonwealth Fund, April 30, 2010, http://www.cailg.org/sites/main/files/file-attachments/2010_cjr_insert_what_next_web_415.pdf (Accessed 3/24/2015).
113 “Estimating the Budgetary Effects of the Affordable Care Act” By Doug Elmendorf, Congressional Budget Office, June 17, 2014,
https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
114 “Estimate of direct spending and revenue effects of H.R. 3590 and H.R. 4872” Congressional Budget Office, Letter to Nancy Pelosi,
Speaker U.S. House of Representatives, March 20, 2010, p. 2-3; “Estimating the Budgetary Effects of the Affordable Care Act” By Doug
Elmendorf, Congressional Budget Office, June 17, 2014, https://www.cbo.gov/publication/45447 (Accessed 3/28/2015).
115 “Health Insurance and the Affordable Care Act” Assistant Secretary for Planning and Evaluation, Department of Health and Human
Services, March 16, 2015, http://aspe.hhs.gov/health/reports/2015/uninsured_change/ib_uninsured_change.pdf (Accessed 3/28/15), p. 1.
116 See the Obstacles to the Implementation of Healthcare Reform section above
117 “Requirement to Maintain Minimum Essential Coverage” 26 U.S.C. § 5000A(f) (2012).
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To assist U.S. citizens in paying for this coverage, the legislation provides for refundable tax
credits that eligible taxpayers may use toward health insurance premiums (for both the individual
taxpayer and his or her family) for health insurance purchased through a state health benefit
exchange.118 Each individual enrolled in a plan offered through an exchange will be required to
report his or her income to the exchange. Based on this information provided by the individual,
the individual will receive a premium assistance credit by the treasury paying the credit directly
to the insurance plan in which the individual is enrolled. The individual will then pay the
difference between the credit amount and the total premium charged.119 The legality of these tax
credits was recently reviewed by the Supreme Court, as specified in the section on King v.
Burwell, below. The Supreme Court concluded that the tax credits were, in fact, legal.
Individuals who fail to maintain this minimum essential coverage will be subject to the following
excise taxes: $95 in 2014, $325 in 2015, and $695 in 2016 and years beyond.120 This penalty also
is applied to any dependents who do not maintain minimum essential coverage. Individuals who
qualify for hardship or religious exemptions are excluded.121
Significant provisions of the initial healthcare reform legislation affecting individuals are related
to the exclusion of pre-existing conditions by health plans and the extension of health insurance
coverage for dependent children. Effective September 23, 2010, all health insurance plans are
prohibited from excluding children on the basis of a pre-existing condition. Later, during the
second half of 2010, a temporary national high-risk pool was created to permit adults with preexisting conditions to obtain subsidized coverage with maximum cost sharing capped at the
current health savings account limit. This high-risk pool was dissolved as of January 1, 2014, as
all insurers and group health plans are prohibited from excluding persons with pre-existing
conditions.122 Additionally, beginning on January 1, 2011, health plans must report the
proportion of premium dollars spent on clinical services and quality improvement and other
costs, and provide rebates to consumers for any medical loss ratio less than 85% for large group
plans and 80% for individual and small group plans.123 In addition, in 2010, a process for
reviewing increases in health plan premiums was established, which requires insurance
companies to justify increases.124
Also effective September 23, 2010, insurance plans are required to provide dependent coverage
for children up to age twenty-six for all individual and group policies.125 Eligible children up to

118 “Eligibility for Premium Tax Credit” 26 C.F.R. § 1.36B-2 (2013).
119 “Tax Provisions in the Health Care Act” Journal of Accountancy, March 22, 2010, http://www.journalofaccountancy.com/
Web/20102724.htm (Accessed April 10, 2010).
120 “Individual Mandate Under ACA” By Annie L. Mach, Congressional Research Service, August 12, 2014, http://fas.org/sgp/crs/misc/
R41331.pdf (Accessed 3/25/2015), p. 2; “Requirement to Maintain Minimum Essential Coverage” 26 U.S.C. § 5000A (2012).
121 “Tax Provisions in the Health Care Act” Journal of Accountancy, March 22, 2010, http://www.journalofaccountancy.com/Web/
20102724.htm (Accessed April 10, 2010); “Requirement to Maintain Minimum Essential Coverage” 26 U.S.C. § 5000A(f) (2012).
122 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1101 124 Stat. 119, 141 (March 23, 2010).
123 “Minimum Medical Loss Ratio” 45 C.F.R. 158.210 (2015); “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 2718, 124
Stat. 119, 886 (March 23, 2010).
124 “Rate Increases Subject to Review” 45 C.F.R. § 154.200 (2011).
125 “Summary of New Health Reform Law” The Henry J. Kaiser Family Foundation, April 21, 2010, http://www.kff.org/healthreform/
upload/8061.pdf (Accessed 5/6/2010), p. 6; “Eligibility of Children until at least age 26” 29 C.F.R. § 2590.715-2714 (2011).
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twenty-six years of age who do not qualify for other coverage must be covered under their
parents’ employer’s plan.126

IMPACT ON SMALL AND MID-SIZED EMPLOYERS
The impact of the ACA is not limited to individuals. States were required to establish Affordable
Insurance Exchanges by January 1, 2014.127 These exchanges will facilitate the purchase of
qualified health plans and establish a SHOP, which will assist small employers to obtain
coverage for their employees.128 Employers with 100 or fewer employees may enroll in the
exchange. Effective 2017, employers with more than 100 employees may obtain coverage
through an exchange at the discretion of the state.129
Beginning in 2010, an eligible small employer that purchases health insurance for its employees
receives a tax credit for amounts spent on health insurance coverage for employees.130 An
eligible small employer meets the following conditions when: (1) it has no more than twenty-five
full-time equivalent employees for the taxable year; (2) the average wages it pays during the
taxable year do not exceed $50,000; and (3) it pays at least half of the premium cost.131
Between 2010 and 2013, small employers providing healthcare coverage for employees were
eligible to receive a tax credit up to 35 percent of the employer’s contribution toward its
employees’ health insurance premiums if the employer contributed at least 50 percent of the total
premium cost of 50 percent of the benchmark premium.132 In 2014, the applicable tax credit
percentage increased to 50 percent.133 Employers with ten or fewer employees and average
wages of less than $20,000 will receive 100 percent of the credit.134 Employers with fifty or
fewer employees are exempt from penalties assessed for failure to either (1) offer no health
coverage to full-time employees or (2) provide coverage to full-time employees that is not
affordable.135
An estimated four million small businesses may be eligible for the tax credit if they provide
healthcare to their employees.136 Indeed, the Congressional Budget Office estimated that from

126 “Health Care Reform Memo: April 12, 2010” Deloitte Center for Health Solutions, April 12, 2010, http://www.deloitte.com/view/en_US/
us/Insights/Browse-by-Content-Type/Newsletters/health-care-reform-memo/6a8e7661b62f7210VgnVCM100000ba42f00aRCRD.htm
(Accessed 4/19/2010).
127 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1311(b), 124 Stat. 119, 173 (March 23, 2010).
128 “Key Provisions of Comprehensive Health Care Reform Legislation” Sonnenschein Nath & Rosenthal, LLP, March 30, 2010, p. 3; “Patient
Protection and Affordable Care Act” Pub. L. No. 111-148, § 1311(b), 124 Stat. 119, 173 (March 23, 2010).
129 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1311, 124 Stat. 119, 184 (March 23, 2010).
130 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 45R, 124 Stat. 119, 238 (March 23, 2010); “Health Care Reform
Legislation: Provisions Affecting Employer-Sponsored Group Health Plans,” Sonnenschein Nath & Rosenthal, LLP, April 14, 2010.
131 Ibid.
132 “Summary of New Health Reform Law” The Henry J. Kaiser Family Foundation, April 21, 2010, http://www.kff.org/healthreform/upload/
8061.pdf (Accessed 4/14/2010), p. 3; “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 45R(g), 124 Stat. 119, 241
(March 23, 2010).
133 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 45R(b), 124 Stat. 119, 238 (March 23, 2010).
134 Ibid.
135 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1513, 124 Stat. 119, 253 (March 23, 2010).
136 “A Helping Hand for Small Businesses” Families USA and Small Business Majority, July 2010, http://www.smallbusinessmajority.org/
_pdf/tax_credit/Helping_Small_Businesses.pdf (Accessed 3/30/2015), p. 2.
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2016 to 2025, the federal government will provide $11 billion in support to small businesses and
organizations through the premium tax credit program.137

IMPACT ON ALL LARGER EMPLOYERS
Although the 2010 healthcare reform legislation does not require larger employers to offer
healthcare coverage to employees, employers can face significant penalties if they choose not to
do so. Employers with more than fifty employees must offer “eligible employer sponsored
plan[s]” to their employees.138 These eligible employer-sponsored plans consist of governmentsponsored coverage, employer-sponsored coverage, grandfathered health plans, and plans offered
in the individual market.139 These health plans must:140 (1) provide the essential health benefits
package; (2) limit annual cost-sharing to the high-deductible health plan limit; (3) limit the
annual deductible for small group market plans to $2,000 for individual and $4,000 for families;
and (4) not require cost-sharing for preventive services or immunization.141
Additionally, an applicable large employer (defined as an employer that employs an average of
at least fifty full-time employees during the preceding calendar year) that (1) does not provide
coverage for all of its full-time employees, (2) provides minimum essential coverage that is
unaffordable, or (3) provides minimum essential coverage that consists of a plan in which the
plan’s share of the total allowed cost of benefits is less than 60 percent is required to pay a
penalty if any full-time employee is certified to the employer as having purchased health
insurance through a state exchange with respect to which a tax credit or cost-sharing reduction is
allowed or paid to the employee.142 If an employer offers unaffordable coverage, that is, if the
premium exceeds 9.5 percent of a family’s income, the employer must pay a $3,000 penalty for
each full-time employee who is given a government subsidy and purchases coverage through a
health exchange.143
Originally, the 2010 healthcare reform legislation included a provision that required employers
who offer health coverage to provide their employees with a voucher, such that they could
choose their own health insurance plan.144 However, this provision was repealed as part of a
budget deal in April 2011.145

137 “Insurance Coverage Provisions of the Affordable Care Act—CBO’s March 2015 Baseline” Congressional Budget Office, March 2015,
https://www.cbo.gov/sites/default/files/cbofiles/attachments/43900-2015-03-ACAtables.pdf (Accessed 3/28/15), table 1.
138 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1513, 124 Stat. 119, 253 (March 23, 2010).
139 “Requirement to Maintain Minimum Essential Coverage” 26 U.S.C. § 5000A(f)(2) (2012).
140 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1513, 124 Stat. 119, 253 (March 23, 2010).
141 “Key Provisions of Comprehensive Health Care Reform Legislation” Sonnenschein Nath & Rosenthal, LLP, March 30, 2010, p. 4;
“Qualified Health Plan Defined” 42 U.S.C. § 18021 (2011); “Essential Health Benefits Requirements” 42 U.S.C. § 18022 (2011).
142 “Tax Provisions in the Health Care Act” Journal of Accountancy, March 22, 2010, http://www.journalofaccountancy.com/
Web/20102724.htm (Accessed April 10, 2010); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1513, 124 Stat. 114,
253 (March 23, 2010).
143 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1513, 124 Stat. 119, 253 (March 23, 2010); “Shared Responsibility for
Employers Regarding Health Coverage; Final Rule” Federal Register Vol. 79, No. 29 (February 12, 2014), p. 8544; “Questions and
Answers on Employer Shared Responsibility Provisions Under the Affordable Care Act” Internal Revenue Service, February 18, 2015,
http://www.irs.gov/Affordable-Care-Act/Employers/Questions-and-Answers-on-Employer-Shared-Responsibility-Provisions-Under-theAffordable-Care-Act (Accessed 4/1/15).
144 “Lobbyists Won Key Concessions in Budget Deal” By Eric Lichtblau, New York Times, April 12, 2011, http://www.nytimes.com/2011/
04/13/us/politics/13lobby.html?_r=0 (Accessed 3/16/2015).
145 Ibid.
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It should be noted that the 2010 healthcare reform legislation provides special rules for
grandfathered health plans. A grandfathered health plan is any group health plan or individual
coverage that was effective on March 23, 2010, the date of the legislation’s enactment.146 The
healthcare legislation allows an employer to maintain current health coverage for individuals that
are already enrolled in plans and for subsequently enrolled family members and new hires, which
will not negate the grandfathered status as long as the plan allowed for dependent or family
coverage on March 23, 2010.147 Collectively bargained agreements are grandfathered until the
date on which the last of the collective bargaining agreements relating to the grandfathered
coverage terminates.148
Effective in 2018, a 40 percent excise tax on high-cost employer-sponsored plans will be
assessed to plans costing more than $10,200 for individual coverage or more than $27,500 for
family coverage.149 The tax percentage will be adjusted for certain factors such as age, gender,
and high-risk professions.150

IMPACT ON INSURERS
The provisions of the ACA that have the greatest impact on health insurers may be those that
regulate: (1) the benefits that must be included in health plans; (2) the individuals that may not
be excluded from health plans; and (3) the individuals that are required to purchase a health
insurance plan. For example, effective September 23, 2010, all health insurance plans: (1) are
prohibited from excluding children under age 19 on the basis of a preexisting condition; (2) are
required to provide dependent coverage for children up to age 26 for all individual and group
policies; and (3) may not impose annual maximum benefit limits for “essential benefits,” except
those limits that may be permitted by regulations at a later date.151 Furthermore, effective
January 1, 2014, group health plans are prohibited from excluding any patient on the basis of
preexisting conditions.152 In addition, under the ACA, self-funded plans are required to provide
covered individuals with the option to seek external independent medical review of certain
claims, such as claims that are denied based on a purported lack of medical necessity.153
Insurance plans also may not require prior authorization or increased cost sharing for emergency
services, even if those services are provided out-of-network, and are prohibited from
146 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1251, 124 Stat. 119, 161 (March 23, 2010).
147 “‘Grandfathered’ Plans Spared Some Reform Mandates” By Paul M. Hamburger and James R. Napoli, Society for Human Resource
Management, April 9, 2010, http://www.shrm.org/hrdisciplines/benefits/Articles/Pages/GrandfatheredPlans.aspx
(Accessed 4/15/2010); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1251, 124 Stat. 119, 161 (March 23, 2010).
148 “Federal Health Care Reform: Impacts on Employers” Anthem, April 7, 2010, http://preferredinscenter.com/learn/Anthem-EmployerHealthcareAct-Full.pdf, (Accessed 4/14/2010), p. 2; “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1251, 124 Stat.
119, 162 (March 23, 2010).
149 “Tax Provisions in the Health Care Act” Journal of Accountancy, March 22, 2010, http://www.journalofaccountancy.com/Web/
20102724.htm (Accessed April 10, 2010); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9001, 124 Stat. 119, 124,
847 (March 23, 2010).
150 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 9001, 124 Stat. 119, 848 (March 23, 2010); “Tax Provisions in the
Health Care Act” Journal of Accountancy, March 22, 2010, http://www.journalofaccountancy.com/Web/20102724.htm (Accessed April 10,
2010).
151 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 1302, 2714, 124 Stat. 119, 132, 163-164 (March 23, 2010); “Health
Care Reform Memo: April 12, 2010” Deloitte Center for Health Solutions, April 12, 2010, http://www.deloitte.com/view/en_US/
us/Insights/Browse-by-Content-Type/Newsletters/health-care-reformmemo/6a8e7661b62f7210VgnVCM100000ba42f00aRCRD.htm
(Accessed May 19, 2010).
152 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1101, 124 Stat. 119, 141-143 (March 23, 2010).
153 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 10101, 124 Stat. 119, 887-888 (March 23, 2010).

428

Chapter 6: Healthcare Reform: Past as Prologue to the Future

discriminating in favor of highly compensated employees.154 Despite these limitations, payors
may still be able to incentivize beneficiaries to lower health expenditures. For example, under the
ACA, group health plans may increase incentives for wellness program investments from
20 percent to 30 percent of the cost of the insurance premium.155
As noted above, the ACA provides special rules for grandfathered health plans, i.e., any group
health plan or individual coverage that was effective before the enactment of the ACA.156
Although grandfathered plans may avoid many of the ACA’s requirements pertaining to health
insurers, they are still subject to the following key provisions: (1) dependent coverage;
(2) elimination of coverage rescissions; (3) lifetime coverage limits; and (4) as of 2014,
excessive waiting periods.157

Medicare
In addition to its impact on insurers in general, the ACA made substantial changes to the
Medicare program, which is the largest health insurance program in the country.158
The ACA mandates that the Medicare program:159
(1) Reduce payments to many providers through the application of productivity adjustments
to market basket updates;160
(2) Significantly enhance the provision of primary care, the coordination of care, and reform
healthcare delivery systems;161
(3) Support quality, transparency, and fraud and abuse enforcement initiatives;162
(4) Add restrictions on revenue spending for Medicare Advantage plans in 2014;163
(5) Reduce payments to disproportionate share hospitals (DSHs);164
(6) Address the impact of physician ownership of healthcare facilities;165
154 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 10101, 124 Stat. 119, 888-889 (March 23, 2010).
155 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1201, 124 Stat. 119, 156-159 (March 23, 2010); “Federal Health Care
Reform: Impacts on Employers” Anthem, April 7, 2010, http://preferredinscenter.com/learn/Anthem-Employer-HealthcareAct-Full.pdf
(accessed April 14, 2010), p. 6.
156 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1251, 124 Stat. 119, 887-888 (March 23, 2010).
157 “Grandfathered Health Insurance Plance” Healthcare.gov, https://www.healthcare.gov/health-care-law-protections/grandfathered-plans/
(Accessed 3/30/2015); “‘Grandfathered’ Plans Spared Some Reform Mandates” Paul M. Hamburger and James R. Napoli, Society for
Human Resource Management, April 9, 2010, http://www.shrm.org/hrdisciplines/benefits/Articles/Pages/GrandfatheredPlans.aspx
(accessed April 15, 2010); “FAQ: Grandfathered Health Plans” By Sarah Bar, Kaiser Health News, November 13, 2013,
http://kaiserhealthnews.org/news/grandfathered-plans-faq/ (Accessed 4/1/15); “FAQs about Grandfathered Health Plans for 2014” United
Benefit Advisors, Society for Human Resource management, August 26, 2013, http://www.shrm.org/hrdisciplines/benefits/articles/
pages/faqs-grandfathered-plans.aspx (Accessed 4/1/15).
158 “Health Policy Brief: Health Reform’s Changes in Medicare” By Amanda Cassidy, Health Affairs, May 20, 2010, p. 1; “CMS Press
Toolkit” Centers for Medicare & Medicaid Services, http://www.cms.gov/Newsroom/PressToolkit.html (Accessed 3/30/2015).
159 “Summary of Key changes to Medicare in 2010 Health Reform Law” The Henry J. Kaiser Family Foundation, www.kff.org/
healthreform/upload/7948-02.pdf (Accessed 8/24/2010); “Closing the Coverage Gap—Medicare Prescription Drugs are Becoming More
Affordable” Centers for Medicare & Medicaid Services, January 2015, https://www.medicare.gov/Pubs/pdf/11493.pdf (Accessed
3/30/2015), p. 6.
160 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3401, 124 Stat. 119, 480-488 (March 23, 2010).
161 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 3022, 5501 et seq., 124 Stat. 119, 395-399, 652 et seq. (March 23,
2010).
162 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 6002, 6003, 6004, 124 Stat. 119, 689-698 (March 23, 2010).
163 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3201 et seq., 124 Stat. 119, 442 et seq. (March 23, 2010).
164 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2551, 124 Stat. 119, 312-314, (March 23, 2010).
165 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 6001, 124 Stat. 119, 684-689. (March 23, 2010).
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(7) Enact programs to incentivize hospitals to reduce unnecessary readmissions and
hospital-acquired conditions;166
(8) Reduce the costs of prescription drugs for Medicare Part D beneficiaries in the coverage
gap;167 and
(9) Reduce the coverage gap between generic and brand-name drugs through 2020.168
The ACA includes several provisions that requires Medicare to reform the manner by which
providers are reimbursed, in many cases reducing payments to facilities. For example, the ACA
applies a productivity adjustment to the market basket updates for inpatient and outpatient
hospitals, skilled nursing facilities, inpatient rehab facilities, long term care hospitals, and
inpatient psychiatric facilities (as of 2012), as well as home health agencies (as of 2015).169 Since
their enactment, these productivity adjustments have reduced annual updates to the payment
systems for these varied facilities by 0.5% to 1.0%.170 Over the life of the program, market
basket reductions may total more than $100 billon for hospitals alone.171
The ACA reduced Medicare payments to hospitals by other means—in addition to productivity
adjustments—such as through the creation of a new payment structure for Medicare payments to
DSH-qualifying hospitals. As of 2014, Medicare DSHs receive a base payment equal to 25
percent of the standard DSH allocation, as well as an additional payment, based on the
prevalence of uncompensated care for a particular hospital, relative to uncompensated care
provided by hospitals nationwide.172 In total, reductions in Medicare DSH payments are
projected at approximately $22 billion from 2014 to 2019.173
In addition to the reductions to hospital reimbursement created by productivity adjustments and
reductions in DSH payments, the ACA also reduced Medicare payments to hospitals through
value-based reimbursement (VBP) programs. For example, the ACA created the Hospital
Readmissions Reduction Program (HRRP) to reduce Medicare payments to hospitals with excess
readmissions for a specified set of conditions, such as acute myocardial infarction, heart failure,
pneumonia, chronic obstructive pulmonary disease, and total hip or knee arthroplasty.174 For
fiscal year 2015, the maximum penalty for excess readmissions is three percent of the sum of a
hospital’s base operating diagnosis-related group (DRG) payments for all discharges.175 In
addition to the HRRP, in 2015, CMS implemented the hospital acquired condition (HAC)
reduction program. The HAC program will reduce Medicare payments to hospitals whose
166
167
168
169
170
171
172
173
174
175

“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 3008, 3025, 124 Stat. 119, 376-378, 408-413 (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3301, 124 Stat. 119, 461-468 (March 23, 2010).
“Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3301, 124 Stat. 119, 461-468 (March 23, 2010).
“Actual Regulation Market Basket Updates” Centers for Medicare & Medicaid Services, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/MedicareProgramRatesStats/downloads/mktbskt-actual.pdf (Accessed 3/18/2015); “Patient
Protection and Affordable Care Act” Pub. L. No. 111-148, § 3401, 124 Stat. 119, 480-488 (March 23, 2010).
“Actual Regulation Market Basket Updates” Centers for Medicare & Medicaid Services, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/MedicareProgramRatesStats/downloads/mktbskt-actual.pdf (Accessed 3/18/2015).
“Provider Reimbursement Changes in Healthcare Reform Law” By Eric D. Fader et al., Edwards, Angell, Palmer & Dodge, LLP, May 18,
2010, http://www.martindale.com/health-care-law/article_Edwards-Angell-Palmer-Dodge-LLP_1025278.htm (Accessed 5/25/2010).
“Disproportionate Share Hospital (DSH)” Centers for Medicare & Medicaid Services, Aug. 4, 2014, http://www.cms.gov/
Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/dsh.html (Accessed 10/3/14).
“Medicare DSH Fact Sheet” American Hospital Association, March 11, 2015, http://www.aha.org/content/13/fs-dsh.pdf (Accessed
3/30/2015), p. 1.
“Readmissions Reduction Program” Centers for Medicare & Medicaid Services, Aug. 4, 2014, http://cms.gov/Medicare/Medicare-Fee-forService-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html/ (Accessed 10/3/14).
Ibid. Note that the federal government’s fiscal year runs from October 1 to September 30.
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patients acquire certain conditions during their hospitals stay,176 which may ultimately improve
patient safety. To accomplish this, the HAC reduction program rates hospitals based upon certain
quality standards that are composed of HAC measures.177 Hospitals with the poorest
performance (i.e., those in the top quartile for incidence of HACs) will have their inpatient
Medicare payments reduced by 1.0 percent.178
Although the ACA reduces some Medicare payments (e.g., payments to hospitals and other
facilities), it also includes provisions for a 10 percent bonus payment for primary care services
that are delivered by primary care physicians, as well as certain nurse practitioners, clinical nurse
specialists, and physician assistants.179 Furthermore, the ACA provided that general surgeons
practicing in health professional shortage areas received a 10% bonus payment from 2011 to
2015.180
Among the most significant changes to Medicare in the 2010 healthcare reform legislation are
the changes to the Medicare Advantage (MA) Program. Although the majority of beneficiaries
participate in traditional fee-for-service Medicare, over a quarter of Medicare beneficiaries
receive coverage through the MA program.181 The ACA reduces the federal payments made to
the MA program over the next several years.182 Prior to the passage of the ACA, Medicare
payments per beneficiary were higher for beneficiaries covered by MA plans compared to
traditional fee-for-service beneficiaries.183 In an attempt to correct for this inequity, the 2010
healthcare reform restructures the payments made to MA plans, making their payments closer to
the average costs of traditional Medicare beneficiaries.184 These changes include: (1) revising the
benchmarks used to calculate local payment rates; (2) altering the amount of money that may be
paid as rebates to insurers; and (3) utilizing quality measures to adjust benchmarks that
determine MA payment rates.185
Another reform to the Medicare program is given in Section 3403 of the ACA, which established
an Independent Payment Advisory Board, comprised of 15 members who will be responsible for
developing and submitting proposals to Congress in an effort to reduce excess cost growth and

176 “Fact Sheets: CMS Final Rule to Improve Quality of Care During Hospital Inpatient Stays” Centers for Medicare & Medicaid Services,
8/2/2013, http://www.cms.gov/newsroom/mediareleasedatabase/fact-sheets/2013-fact-sheets-items/2013-08-02-3.html (Accessed
6/11/2014).
177 Ibid.
178 “Fact Sheets: Fiscal Year 2015 Proposed Policy and Payment Changes for Inpatient Stays in Acute-Care Hospitals and Long-Term Care
Hospitals” Centers for Medicare & Medicaid Services, 4/30/2014, http://www.cms.gov/Newsroom/MediaReleaseDatabase/Factsheets/2014-Fact-sheets-items/2014-04-30.html (Accessed 6/11/2014); “Fact Sheets: CMS Final Rule to Improve Quality of Care During
Hospital Inpatient Stays” Centers for Medicare & Medicaid Services, 8/2/2013, http://www.cms.gov/newsroom/mediareleasedatabase/factsheets/2013-fact-sheets-items/2013-08-02-3.html (Accessed 6/11/2014).
179 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 5501, 124 Stat. 119, 652 (March 23, 2010).
180 “Summary of Key changes to Medicare in 2010 Health Reform Law” The Henry J. Kaiser Family Foundation, www.kff.org/healthreform/
upload/7948-02.pdf (Accessed 8/24/2010); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 5501, 124 Stat. 119, 653
(March 23, 2010).
181 “Medicare Advantage 2013 Spotlight: Enrollment Market Update” The Henry J. Kaiser Family Foundation, 6/10/2013,
http://kaiserfamilyfoundation.files.wordpress.com/2013/06/8448.pdf (Accessed 4/22/2014), p. 2.
182 “Summary of Key changes to Medicare in 2010 Health Reform Law” The Henry J. Kaiser Family Foundation, www.kff.org/healthreform/
upload/7948-02.pdf (Accessed 8/24/2010); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3201, 124 Stat. 119, 442
(March 23, 2010).
183 “Health Policy Brief: Health Reform’s Changes in Medicare” By Amanda Cassidy, Health Affairs, May 20, 2010, p. 2-3.
184 “Summary of Key changes to Medicare in 2010 Health Reform Law” The Henry J. Kaiser Family Foundation, www.kff.org/healthreform/
upload/7948-02.pdf (Accessed 8/24/2010), p. 2.
185 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 3201 et seq., 124 Stat. 119, 442 (March 23, 2010).
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improve the quality of care for Medicare beneficiaries.186 Under Section 10320 of the ACA, the
Board must: (1) make annual recommendations to the President, Congress, and private entities
regarding actions they can take to improve quality and constrain the rate of cost growth in the
private sector; (2) make nonbinding recommendations to Congress in years in which Medicare
expenditure growth is below the targeted growth rate; and (3) to specifically prohibit the Board
from making recommendations that would reduce premium supports for low-income Medicare
beneficiaries.187

Medicaid
The ACA also includes provisions to reform Medicaid. Certain provisions create state options to
expand Medicaid coverage, such as:
(1) A state option to cover childless adults through a Medicaid State Plan Amendment;188
(2) A state option to provide coverage for family planning services to certain low-income
individuals up to the highest level of eligibility for pregnant women;189 and
(3) An option for states to provide Children’s Health Insurance Plan (CHIP) coverage for
children of state employees.190
Reforms to Medicaid also include several provisions targeting coverage of prescription drugs,
such as:
(1) An increase in the drug rebate percentage for brand name drugs up to 23.1 percent;
(2) An increase in the drug rebate percentage for generic drugs up to 13 percent of the
average manufacturer price; and
(3) Extension of the drug rebate to Medicaid managed care plans.191
Other revisions to Medicaid include providing additional funding for the Medicaid and CHIP
Payment & Access Commission to include assessments of adult services (including those
persons who are dually eligible for Medicare and Medicaid), and requiring the Secretary of HHS
to issue regulations establishing a process for public notice and comment for Section 1115
waivers in Medicaid and CHIP.192

186 “Section-by-Section Analysis with Changes Made by Title X and Reconciliation included within Titles I-IX” Democratic Policy
Committee, http://dpc.senate.gov/healthreformbill/healthbill96.pdf (Accessed 8/24/2010); “Patient Protection and Affordable Care Act”
Pub. L. No. 111-148, § 3403, 124 Stat. 119, 489 (March 23, 2010).
187 “Section-by-Section Analysis with Changes Made by Title X and Reconciliation included within Titles I-IX” Democratic Policy
Committee, http://dpc.senate.gov/healthreformbill/healthbill96.pdf (Accessed 8/24/2010); “Patient Protection and Affordable Care Act”
Pub. L. No. 111-148, § 10320, 124 Stat. 119, 949-952 (March 23, 2010).
188 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2001, 124 Stat. 119, 271-279 (March 23, 2010).
189 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2303, 124 Stat. 119, 293-296 (March 23, 2010).
190 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 10203, 124 Stat. 119, 927-931 (March 23, 2010).
191 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2501 et seq., 124 Stat. 119, 306 (March 23, 2010).
192 “Focus on Health Reform: Medicaid and CHIP Health Reform Implementation Timeline” The Henry J. Kaiser Family Foundation, April 12,
2010, http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8064.pdf, (Accessed 3/5/2014), p. 1; “Patient Protection and Affordable
Care Act” Pub. L. No. 111-148, § 2801, 124 Stat. 119, 328 (March 23, 2010).
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Beginning in 2011, several Medicaid reform initiatives went into effect, including:193
(1) The prohibition of federal payments to states for Medicaid services related to healthcare
acquired conditions;194
(2) The creation of a new Medicaid state plan option to permit certain high risk enrollees to
designate a provider as a “health home”;195 and
(3) The establishment of the Medicaid Community First Choice Option to provide
community-based attendant support services to certain people with disabilities.196
In addition to the provisions listed above, several ACA reforms modified Medicaid’s operations.
For example, through 2015, the ACA expanded Medicaid payments to institutions of mental
disease for adult enrollees who require stabilization of an emergency condition (effective
October 1, 2011).197 In addition, the ACA created new demonstration projects (from 2012 to
2016) to evaluate the use of global payments for episodes of care that include hospitalization, as
well as pediatric Accountable Care Organizations.198
Regarding CHIP, the ACA requires states to maintain current income eligibility levels for
children in Medicaid and CHIP at 2010 levels, and extends funding levels for CHIP through
2015, with the CHIP benefit package and cost-sharing rules to continue under current laws.199
As of 2015, states have the option to receive a 23 percent increase in the CHIP match rate up to a
cap of 100 percent.200 The Medicare Access and CHIP Reauthorization Act of 2015 (i.e.,
MACRA) contains provisions that will preserve and extend CHIP funding through 2017.201
Following the SCOTUS decision that invalidated the ACA provisions that mandated states to
expand their Medicaid programs or lose all matching federal funds, states were given the choice
of whether to: (1) opt into the Medicaid expansion in exchange for significant federal assistance
or (2) maintain their Medicaid program’s status quo, which could deny access to potentially
millions of poor and uninsured constituents. For states that choose to participate in Medicaid
expansion, the federal government will pay 100 percent of the costs of the expansion for three
years, gradually reducing its matching funds down to 90 percent of the cost of the expansion by
2020 and beyond.202 Despite the fact that, beginning in 2017 states will become responsible for a
percentage of the healthcare expenses for those adults who are newly-eligible under the
expansion, as well as those adults who enroll in Medicaid as required by the ACA’s individual
193 “The Patient Protection and Affordable Care Act as Passed: Section-by-Section Analysis with Changes Made by Title X and Reconciliation
included within Titles I—IX, where Appropriate” Democratic Policy Committee, http://dpc.senate.gov/healthreformbill/healthbill53.pdf
(Accessed 8/20/10), p. 19, 21, 24; See specified sections of “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, 124 Stat.
119 (March 23, 2010).
194 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2702, 124 Stat. 119, 318-319 (March 23, 2010).
195 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2703, 124 Stat. 119, 319-323 (March 23, 2010).
196 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2401, 124 Stat. 119, 297-301 (March 23, 2010).
197 “The Patient Protection and Affordable Care Actas Passed: Section-by-Section Analysis with Changes Made by Title X and Reconciliation
included within Titles I—IX, where Appropriate” Democratic Policy Committee, http://dpc.senate.gov/healthreformbill/healthbill53.pdf
(Accessed 8/20/10), p. 21; “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 2707, 124 Stat. 119, 326 (March 23, 2010).
198 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, §§ 2705, 2706, 124 Stat. 119, 324 (March 23, 2010). See the Impact on
Professional Practice Providers section below, for more detail on ACOs.
199 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 10203, 124 Stat. 119, 927 (March 23, 2010).
200 “Payments to States” 42 U.S.C. § 1397ee(b) (2012).
201 “Medicare Access and CHIP Reauthorization Act of 2015” Pub. L. No. 114-10, § 301, 129 Stat. 87, 154-158.
202 “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 2001, 124 Stat. 119, 272 (March 23, 2010).
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mandate;203 states may stand to experience significant financial gain should they elect to expand
their Medicaid programs. This is because the federal government would: (1) pay a significantly
higher percentage of the healthcare costs incurred by certain currently-eligible adults; (2) provide
coverage for poor and near-poor uninsured adults, which may decrease some of the nonMedicaid costs associated with these individuals; and (3) increase overall economic activity in
the state as a result of the increased amount of federal matching funds.204
To further illustrate the impact of increased economic activity resulting from improved federal
matching funds, consider the example of Missouri. One study found that the Medicaid expansion
was expected to cost approximately $8.6 billion to implement in Missouri between 2014 and
2020 with approximately $8.2 billion of that cost borne by the federal government.205 Despite
these costs, the Medicaid expansion was expected to add $9.6 billion to the gross state product
over the same time period206 and result in coverage of an additional 161,281 individuals by
2020.207
As of March 6, 2015, 29 states, including the District of Columbia, have opted in to the Medicaid
expansion, 9 states remain undecided about whether to expand their Medicaid programs, and 16
states have announced they will not move forward with Medicaid expansion at this time.208 It is
estimated that approximately 6.7 billion individuals will remain uninsured in the states that have
not expanded Medicaid in 2016.209 In addition, states that do not expand their Medicaid
programs will increase the per-person cost to the federal government, in contrast to the perperson costs if those individuals were covered by Medicaid.210 Further, many individuals will be
rendered ineligible for both Medicaid and private insurance subsidies, which may leave them
without health coverage at all.211

Private Insurers
In addition to reforming public payors, the ACA also created new rules to regulate the activity of
commercial payors. For example, the ACA provides standards regarding certain risk shifting
activities, which are necessary in the likely event of insurers targeting the healthiest patients and
attempting to avoid high cost beneficiaries. First, the ACA’s risk adjustment (RA) works to
reduce the incentives for insurers to avoid enrolling individuals with high medical costs, and to

203 “Considerations in Assessing State-Specific Fiscal Effects of the ACA’s Medicaid Expansion” By Stan Dorn, The Urban Institute Health
Policy Center, August 20, 2012, p. 1; “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 2001, 124 Stat. 119, 272 (March
23, 2010).
204 “Considerations in Assessing State-Specific Fiscal Effects of the ACA’s Medicaid Expansion” By Stan Dorn, The Urban Institute Health
Policy Center, August 20, 2012, p. 1.
205 “The Economic Impacts of Medicaid Expansion on Missouri” By University of Missouri School of Medicine—Department of Health
Management and Informatics and Dobson DaVanzo & Associaties, LLC, November 2012,
http://www.mffh.org/mm/files/MUMedicaidExpansionReport.pdf (Accessed 3/30/15), p. 18.
206 Ibid.
207 Ibid, p. 7.
208 “Status of State Action on the Medicaid Expansion Decision” The Henry J. Kaiser Family Foundation, March 6, 2015, http://kff.org/healthreform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ (Accessed 3/16/2015).
209 “What is the Result of Not Expanding Medicaid” By Stan Dorn et al., Robert Wood Johnson Foundation, August 2014,
http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2014/rwjf414946 (Accessed 3/30/2015), p. 1.
210 “Estimates for the Insurance Coverage Provisions of the Affordable Care Act Updated for the Recent Supreme Court Decision”
Congressional Budget Office, July 2012, p. 2.
211 Ibid.
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force insurers to compete based upon the value and efficiencies of their plans.212 The RA
program requires health plans to assign individual risk scores to their enrollees based upon the
individual’s age, sex, and diagnoses. The average of these risk scores is then used to calculate the
plans’ predicted expenses.213 Plans are compared to a baseline premium, and plans with lower
actuarial risk will make payments to plans with higher actuarial risk, thus balancing some of the
expenses associated with high cost health insurance.214 In addition to the RA program, the
temporary reinsurance program (TRP) works to stabilize individual market premiums by
providing funding for insurers who have enrolled high cost individuals. Insurers across the U.S.
contribute payments to the TRP, to a total of $10 billion in 2014, $6 billion in 2015, and $4
billion in 2016.215 These payments are then transferred to insurers who meet certain cost
thresholds relative to their covered benefits.216 The TRP only applies to the individual market
(which many small businesses will likely utilize when providing health benefits to employees),
and will be in place from 2014 through 2016.217 Finally, the risk corridors (RC) program
protects against inaccurate rate settings due to lack of familiarity with rating the newly insured
population.218 The RC program creates conditions for plans in the individual market to receive
additional reimbursement or pay charges to HHS based on how close its actual costs are from its
targeted costs, and will be in effect from 2014 to 2016.219
In addition to regulations regarding risk shifting activities, the 2010 health reform legislation
includes provisions that regulate certain aspects of health plans’ premiums. As specified in the
Impact on Individuals section above, health plans created on or after January 1, 2011 must report
the proportion of premium dollars spent on clinical services and quality. If less than a given
threshold (85 percent for large group plans and 80 percent for individual and small group plans)
of the revenue generated from beneficiaries’ premiums is spent on clinical services or quality
initiatives, the plans must provide rebates for their consumers.220 Furthermore, CMS has
implemented rate review regulations, requiring an independent review of increases in premium
rates of 10 percent or more.221 In addition, insurance companies must provide simple, easily

212 “Fact Sheet: ACA Risk-Sharing Mechanisms,” American Academy of Actuaries, 2013, http://www.actuary.org/files/ACA_Risk_Share_
Fact_Sheet_FINAL120413.pdf (Accessed 4/27/2014), p. 1; “Explaining Health Care Reform: Risk Adjustment, Reinsurance, and Risk
Corridors” The Henry J. Kaiser Family Foundation, 1/22/2014, http://kff.org/health-reform/issue-brief/explaining-health-care-reform-riskadjustment-reinsurance-and-risk-corridors/ (Accessed 4/27/2014), p. 3; “Patient Protection and Affordable Care Act” Pub. Law 111-148,
§ 1343, 124 Stat. 119, 212 (March 23, 2010).
213 “Explaining Health Care Reform: Risk Adjustment, Reinsurance, and Risk Corridors” The Henry J. Kaiser Family Foundation, 1/22/2014,
http://kff.org/health-reform/issue-brief/explaining-health-care-reform-risk-adjustment-reinsurance-and-risk-corridors/ (Accessed
4/27/2014), p. 3-4.
214 “Explaining Health Care Reform: Risk Adjustment, Reinsurance, and Risk Corridors” The Henry J. Kaiser Family Foundation, 1/22/2014,
http://kff.org/health-reform/issue-brief/explaining-health-care-reform-risk-adjustment-reinsurance-and-risk-corridors/ (Accessed
4/27/2014), p. 4; “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 1341, 124 Stat. 119, 208 (March 23, 2010).
215 “Patient Protection and Affordable Care Act; Standards related to Reinsurance, Risk Corridors and Risk Adjustment; Final Rule” Federal
Register Vol. 77, No. 57 (March 23, 2012), p. 17246, 17248.
216 Ibid.
217 “In the Spotlight: Healthcare Reform and Risk Assessment” Blue Cross Blue Shield of North Carolina, 9/29/2011, www.bcbsnc.com/assets/
hcr/pdfs/spotlight_risk.pdf (Accessed 4/27/2014), p. 1-2.
218 “In the Spotlight: Healthcare Reform and Risk Assessment,” Blue Cross Blue Shield of North Carolina, 9/29/2011, www.bcbsnc.com/
assets/hcr/pdfs/spotlight_risk.pdf (Accessed 4/27/2014), p. 2; “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 1342, 124
Stat. 119, 211 (March 23, 2010).
219 “Patient Protection and Affordable Care Act; Standards related to Reinsurance, Risk Corridors and Risk Adjustment; Final Rule” Federal
Register Vol. 77, No. 57 (March 23, 2012), p. 17251.
220 “Minimum Medical Loss Ratio” 45 C.F.R. 158.210 (2015); “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 2718, 124
Stat. 119, 886 (March 23, 2010).
221 “Rate Increase Disclosure and Review; Final Rule” Federal Register Vol. 76, No. 99 (May 23, 2011), p. 29985; “Rate Increases Subject to
Review” 45 C.F.R. § 154.200 (2011).
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understood information to consumers about their reasons for any significant rate increases, and
post such information on their website.222

Establishment of the Health Insurance Marketplace
According to the 2010 health reform legislation, states were required to have a state health
insurance exchange (Exchange) in operation by the beginning of 2014.223 These Exchanges are
intended to reduce the cost associated with health insurance and ease the process of selecting a
health insurance plan by providing a single place for consumers to: (1) search for and compare
health plans; (2) ask questions regarding coverage; (3) check eligibility for programs and tax
credits; and (4) ultimately enroll in a health plan.224
The final rule regarding Exchanges offers states significant flexibility in the design and operation
of their Exchanges and provides states with more options through which to customize their
Exchanges with respect to member eligibility, health plan participation, and the overall operation
of the Exchange.225 Flexibility is also a key part of a state’s operation of the Small Business
Health Options Programs (SHOPs), which offer health insurance options for small employers
within state Exchanges.226 Through SHOPs, employers may choose a level of coverage to offer
to their employees. Furthermore, states may determine the size of the small group market that
participates in SHOPs, thus improving the flexibility of individual states’ SHOPs.227

IMPACT ON PROFESSIONAL PRACTICE PROVIDERS
In addition to the 2010 healthcare reform legislation’s effect on individuals, employers, and
payors, the recent reform efforts will have major implications for healthcare providers. For
example, as stated in the Medicaid section above, primary care physicians (including family
medicine, internal medicine, geriatric, and pediatric physician providers) whose Medicare
charges for office, nursing facility, and home visits comprise at least 60 percent of their total
Medicare charges will be eligible for a 10 percent bonus payment for services performed from

222 “The Center for Consumer Information & Insurance Oversight: State Effective Rate Review Programs” Center for Medicare & Medicaid
Services, 1/1/2014, http://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/rate_review_fact_sheet.html (Accessed 4/27/2014).
223 “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 1311, 124 Stat. 119, 173 (March 23, 2010).
224 “Affordable Insurance Exchanges” U.S. Department of Health and Human Services, August 23, 2012, http://www.healthcare.gov/law/
features/choices/exchanges/index.html (accessed March 20, 2012); “Patient Protection and Affordable Care Act” Pub. L. No. 111-148,
§ 1311(b), 124 Stat. 119, 173 (March 23, 2010).
225 “Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans; Exchange Standards for Employers”
Federal Register Vol. 77, No. 59 (March 27, 2012), p. 18310-18311; “HIX Final Rule Released” By Margaret Dick Tocknell, Health
Leaders Media, March 13, 2012, http://www.healthleadersmedia.com/page-1/HEP-277640/HIX-Final-Rule-Released (Accessed March 20,
2012).
226 “Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans; Exchange Standards for Employers”
Federal Register 77, No. 59 (March 27, 2012), p. 18310-18311; “Affordable Insurance Exchanges: Choices, Competition and Clout for
States” U.S. Department of Health and Human Services, July 11, 2011,
http://www.healthcare.gov/news/factsheets/2011/07/exchanges07112011a.html (Accessed August 7, 2012).
227 “Affordable Insurance Exchanges: Choices, Competition and Clout for States” U.S. Department of Health and Human Services, July 11,
2011, http://www.healthcare.gov/news/factsheets/2011/07/exchanges07112011a.html (Accessed August 7, 2012); “SHOP and the Small
Group Market” Center for Consumer Information and Insurance Exchange, May 21, 2012, https://www.cms.gov/CCIIO/Resources/
Presentations/Downloads/hie-shop-and-the-small-group-market-policies.pdf (Accessed 4/1/15), slide 13.
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2011 through 2015.228 Additionally, general surgeons who conduct major procedures in a
designated health professional shortage area will be eligible for a 10 percent bonus payment for
these services from 2011 to 2016.229 Medicare also increased payment by 0.5 percent from 2012
to 2014 for voluntary participation in Medicare’s Physician Quality Reporting Initiative
(PQRI).230 From 2015 forward, physician providers who do not successfully participate in the
PQRI program will have their payments reduced by 1.5 percent in 2015 and 2 percent in
subsequent years.231
While the ACA incorporates several provisions that are beneficial for primary care providers, it
also places new restrictions on certain specialty providers, most notably physician-owned
specialty hospitals. Having stymied similar restrictions in several other bills during the past
decade or so, physician-owned specialty hospitals are now subject to new provisions the 2010
healthcare reform legislation, which places heavy restrictions on the growth or expansion of
existing specialty hospitals with physician ownership.232 Not only does this provision reduce the
beneficial effects of healthcare provider competition and create a greater likelihood of potential
for hospital and health system monopolies, as the current regulatory and reimbursement
healthcare environments facilitate trends of hospital consolidation and practice roll-up, but it
further sustains the two-pronged attack on niche providers.
Another reimbursement change for healthcare providers is related to the establishment of an
ACO, which provides a framework for providers to work in a coordinated and efficient manner
across the patient continuum of care. Under the ACO model, both hospital and physician
providers will continue to bill Medicare under the current FFS reimbursement system, but they
may be eligible to share in certain cost savings if the patient care delivered meets CMS quality
standards and the cost of delivery (including both Medicare Part A and Medicare Part B
expenditures) is below a predetermined threshold, as specified in Chapter 2: Reimbursement
Environment.233
ACOs have already taken effect in both the federal market (under the Medicare Shared Savings
Program) and the commercial market. In the month after the issuance of the final rule regarding
the establishment of ACOs on November 2, 2011, CMS announced the names of 32
organizations that would participate in its Pioneer ACO Model, which began on January 1,

228 “How the Passage of Federal Health System Reform Legislation Impacts Your Practice” American Hospital Association, 2010,
http://www.ama-assn.org/ama/pub/health-system-reform/hsr-impacts-practice.shtml (Accessed 4/19/2010), p. 1; “Patient Protection and
Affordable Care Act” Pub. L. No. 111-148, § 5501, 124 Stat. 119, 652 (March 23, 2010).
229 “How the Passage of Federal Health System Reform Legislation Impacts Your Practice” American Hospital Association, 2010,
http://www.ama-assn.org/ama/pub/health-system-reform/hsr-impacts-practice.shtml (Accessed 4/19/2010), p. 1; “Patient Protection and
Affordable Care Act” Pub. L. No. 111-148, § 5501, 124 Stat. 119, 653 (March 23, 2010).
230 “How the Passage of Federal Health System Reform Legislation Impacts Your Practice” American Hospital Association, 2010,
http://www.ama-assn.org/ama/pub/health-system-reform/hsr-impacts-practice.shtml (Accessed 4/19/2010), p. 1; “Physician Quality
Reporting System (PQRS) Overview” Centers for Medicare & Medicaid Services, http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/Downloads/PQRS_OverviewFactSheet_2013_08_06.pdf (Accessed 3/30/15), p. 2.
231 “2013 Physician Quality Reporting System (PQRS): 2015 PQRS Payment Adjustment” Centers for Medicare & Medicaid Services, August
2013, http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/PQRS/Downloads/2013MLNSE13__Avoiding
PQRSPaymentAdjustment_083013.pdf (Accessed 3/30/15), p. 1.
232 “Patient Protection and Affordable Care Act” Pub. Law 111-148, § 6001, 124 Stat. 119, 684 et seq. (March 23, 2010).
233 “Provider Participation in ACOs May Hinge on HHS Regulations” By Robert Belfort, BNA Health Law Reporter, Vol. 19, No. 546
(April 15, 2010), http://news.bna.com/hlln/display/batch_print_display.adp (Accessed 4/15/2010).
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2012.234 By May of 2014, the total number of Medicare ACOs grew to 361, covering 5.6 million
beneficiaries in 47 states, Washington, DC, and Puerto Rico.235 Despite this rapid proliferation of
ACOs across the country and general health policy support of the accountable care concept, the
long-term clinical and economic feasibility of the ACO model have not yet been demonstrated
by a robust body of research. However, preliminary indications may support the expectation that
ACOs can reduce growth in healthcare expenditures. For example, a study published in
November 2013 found that, on average, Medicare beneficiaries who were covered by Pioneer
ACOs in 2011 and 2012 had modest reductions in the growth of healthcare expenditures.236
Although most Pioneer ACOs performed similarly to traditional Medicare FFS in their regions, a
select few had significant reductions in expenditure growth,237 which may indicate the success
potential of certain best practices.
Since the advent of the ACA 744 ACOs have been formed, over 400 of which are Medicare
ACOs (with 404 ACOs in the MSSP and 19 ACOs in the Pioneer ACO program).238 These
ACOs provide care for an estimated 23.5 million patients in all 50 states, Washington, D.C., and
Puerto Rico.239
As discussed above, states have the option to participate in an expansion of the Medicaid
program, which expands Medicaid coverage to all non-Medicare eligible individuals under age
65 (including children, pregnant women, parents, and adults without dependent children) with
incomes up to 133 percent of the federal poverty level.240 Providers may be able to leverage such
an expansion in Medicaid coverage into additional revenues by avoiding uncompensated care
from these previously uninsured patients and capitalizing on increased state economic activity.241
Although there appears to be an increase in reimbursement for some physician services, other
physician providers will face a decrease in reimbursement. As of July 2, 2012, Medicare
reimbursement for the technical component of diagnostic imaging services has been reduced by
234 “CMS Announces Pioneer ACO Participants” American Hospital Association News, December 19, 2011, http://www.ahanews.com/
ahanews/jsp/display.jsp?domain=AHANEWS&dcrpath=AHANEWS/AHANewsNowArticle/data/ann_121911_ACOs (Accessed July 21,
2012).
235 “Fast Facts—All Medicare Shared Savings Program and Medicarae Pioneer ACOs” Centers for Medicare & Medicaid Services, May 2014,
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/PioneersMSSPCombinedFast
Facts.pdf (Accessed 3/24/2015), p. 1.
236 “Evaluation of CMMI Accountable Care Organization Initiatives: Effect of Pioneer ACOs on Medicare Spending in the First Year” L&M
Policy Research, LLC, Report for Centers for Medicare & Medicaid Services, November 3, 2013, http://innovation.cms.gov/files/
reports/pioneeracoevalreport1.pdf (Accessed 3/18/2015), p. iv.
237 Ibid.
238 “Growth And Dispersion of Accountable Care Organizations in 2015” By David Muhlestein, Health Affairs, March 31, 2015,
http://healthaffairs.org/blog/2015/03/31/growth-and-dispersion-of-accountable-care-organizations-in-2015-2/ (Accessed 7/8/2015); “Fast
Facts—All Medicare Shared Savings Program and Medicarae Pioneer ACOs” Centers for Medicare & Medicaid Services, April 2015,
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/PioneersMSSPCombined
FastFacts.pdf (Accessed 7/8/2015), p. 1; “Growth and Dispersion of Accountable Care Organizations: June 2014 Update” By Matthew
Peterson, et al., Leavitt Partners, June 2014, http://leavittpartners.com/wp-content/uploads/2014/06/Growth-and-Dispersion-ofAccountable-Care-Organizations-June2014.pdf (Accessed 9/4/2014), p. 3.
239 “Growth And Dispersion of Accountable Care Organizations in 2015” By David Muhlestein, Health Affairs, March 31, 2015,
http://healthaffairs.org/blog/2015/03/31/growth-and-dispersion-of-accountable-care-organizations-in-2015-2/ (Accessed 7/8/2015);
“Growth and Dispersion of Accountable Care Organizations: June 2014 Update” By Matthew Peterson, et al., Leavitt Partners, June 2014,
http://leavittpartners.com/wp-content/uploads/2014/06/Growth-and-Dispersion-of-Accountable-Care-Organizations-June2014.pdf
(Accessed 9/4/2014), p. 3.
240 “Eligibility” Centers for Medicare & Medicaid Services, http://www.medicaid.gov/AffordableCareAct/Provisions/Eligibility.html
(Accessed 3/24/2015); “Focus on Health Reform: Health Reform Implementation Timeline” The Henry J. Kaiser Family Foundation,
March 31, 2010, https://www.nln.org/governmentaffairs/health_care/pdf/timelineHCKFF0510.pdf (Accessed 3/24/2015), p. 4.
241 See the Medicaid section above.
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25 percent for subsequent procedures on consecutive body parts.242 Additionally, the market
basket update for both inpatient and outpatient hospital services will be reduced by 0.25 percent
for fiscal year (FY) 2010–11, 0.1 percent for FY 2012–13, 0.3 percent for FY 2014–15, 0.2
percent for FY 2015–6, and 0.75 percent for FY 2017–19.243

FUTURE OF THE ACA
Despite the June 2012 SCOTUS decision confirming the constitutionality of the ACA, there is
still a considerable level of uncertainty as to the ultimate impact of the ACA’s implementation
and whether the ACA will remain intact as it currently stands. This is due in large part to
repeated legislative and judicial attempts to revise or repeal the 2010 health reform legislation.
For example, since the enactment of the ACA in 2010, various members of Congress have staged
numerous votes to repeal, revise, or defund the legislation, with varying degrees of success.244 In
the future, the election of a Republican president or a Republican supermajority in Congress
could lead to the defunding, undercutting, amendment, or repeal of the ACA. Future presidents
of either party will be able to exercise extensive political leverage to attempt to modify the health
reform law, either by pressuring Congress or by enacting changes through HHS.245 Indeed, the
ACA gives the President discretion in implementing many of its provisions, including employer
contributions to health savings accounts (HSAs), quality improvement measures for providers
who contract with private insurers, and CO-OP insurer tax-exempt status.246
Due to the fact that the ACA establishes its own budget authority within the law, any attempt to
defund certain mandatory spending provisions would be impossible without a Senate supermajority (60 votes).247 That said, defunding of the ACA’s non-mandatory spending provisions is
possible. For example, funding for the Prevention and Public Health Fund (PPHF) has already
been cut by $5 billion over 10 years by the Middle Class Tax Relief and Job Creation Act of
2012.248 Discretionary spending provisions for programs such as Pediatric Accountable Care
Organizations and Rural Hospital Flexibility Grants, inter alia, are at more risk of defunding, as
they are subject to annual budget appropriations review.249

KING V. BURWELL
In 2015, the SCOTUS heard arguments regarding a challenge to one of the major provisions of
the ACA. In David King et al. v. Sylvia Mathews Burwell et al. (commonly referred to as King v.
Burwell), the petitioners argued that the Internal Revenue Service (IRS) had mistakenly
242 “Pub 100-04 Medicare Claims Processing: Transmittal 2395” Centers for Medicare & Medicaid Services, January 26, 2012,
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R2395CP.pdf (Accessed 11/21/2014), p. 3.
243 Ibid, p. 1-2.
244 “Legislative Actions to Repeal, Defund, or Delay the Affordable Care Act” By C. Stephen Redhead and Janet Kinzer, Congressional
Research Service, March 2, 2015, http://fas.org/sgp/crs/misc/R43289.pdf (Accessed 3/17/2015), p. 1.
245 “The Supreme Court’s PPACA Decision: Substance and Implications for HLS Clients” Oliver Wyman, June 28, 2012, p. 6.
246 Ibid, p. 9.
247 Ibid, p. 8.
248 Ibid, p. 8.
249 “Discretionary Spending in the Patient Protection and Affordable Care Act (ACA)” By C. Stephen Redhead et al., Congressional Research
Service, May 18, 2012, p. 34–35.
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interpreted the provision of the ACA that provides tax credits to individuals who purchase health
insurance using Exchanges.250 The IRS interpreted the statute to provide for these tax credits to
individuals regardless of whether the Exchange that the individuals utilized was run by an
individual state or the federal government.251 However, the specific text of the statute states that
the tax credit may be distributed to taxpayers who enrolled in a health plan “…through an
Exchange established by the State…” (Emphasis added).252 Based on this language, the
petitioners argued that the tax credit should only apply to individuals who enrolled in health
plans using Exchanges that their state established and should not apply to individuals who used
the Exchange established by the federal government.253 The respondents, in turn, argued that this
reading of the statute is inappropriate, declaring such an interpretation to be “…contrary to the
[ACA]’s text and structure and would render the Act unrecognizable to the Congress that passed
it.”254 Furthermore, the respondents argued that an Exchange established and operated by HHS
within a state (i.e., a federal Exchange) satisfied the ACA’s legal definition of an Exchange
established by the state.255 Ultimately, the SCOTUS upheld the government’s interpretation of
the ACA. In the majority opinion, Chief Justice Roberts noted that the petitioners’ reading of the
statute would result in serious damage to the health insurance markets that the ACA was
designed to reform,256 as described further below.
Importantly, the SCOTUS interprets an agency’s interpretation of a statute utilizing the Chevron
doctrine, which first asks “whether a statute is ambiguous, and, if so, whether the agency’s
approach is reasonable.”257 However, in King v. Burwell, the SCOTUS declined to follow the
Chevron doctrine, and instead stated that the case represented a situation where the SCOTUS
should “hesitate before concluding that Congress has intended such an implicit delegation” of
authority to the IRS and petitioners.258 The SCOTUS reasoned that it was unlikely that Congress
would have delegated such a health insurance policy to the IRS, which has “no expertise in
crafting” such polices, and, accordingly, declined to follow the Chevron doctrine, allowing the
SCOTUS to render its ultimate decision upholding the ACA.259
A SCOTUS decision in favor of the petitioners would have rendered IRS tax credits to millions
of individuals who obtained health insurance through a federally operated exchange, living in 34
states that elected not to establish their own Exchange, to be illegal.260 As of April 19, 2014, over
4.6 million people had received tax credits for signing up for a health plan using a federal
Exchange,261 and a 2015 projection estimated that this population will grow to over 13.4 million

250 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2014), Petition for a Writ of Certiorari, p. i.
251 “Health Insurance Premium Tax Credit” Federal Register Vol. 77, No. 100 (May 23, 2012), p. 30387. Note that the regulation identifies as
eligible those individuals who “…enrolled in one or more qualified health plans through an Exchange…” without specifying whether the
Exchange was run by a state or by the federal government.
252 “Patient Protection and Affordable Care Act” Pub. L. No. 111-148, § 1401, 124 Stat. 119, 213 (March 23, 2010).
253 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2015), Brief for Petitioners, p. 6.
254 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2015), Brief for the Respondents in Opposition, p. 12.
255 Ibid.
256 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 21.
257 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 8.
258 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 8.
259 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 8.
260 Ibid.
261 “Health Insurance Marketplace: Summary Enrollment Report for the Initial Annual Open Enrollment Period” Office of the Assistant
Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, June 18, 2014, http://aspe.hhs.gov/
health/reports/2014/MarketPlaceEnrollment/Apr2014/ib_2014Apr_enrollment.pdf (Accessed 3/18/2015), p. 19.
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people in 2016.262 Furthermore, the tax credit in question accounts for an average 76 percent of
the beneficiary’s premium.263 This indicates that, without the use of tax credits, a great number
of people would be unable to afford health insurance. Accordingly, a SCOTUS decision in favor
of the petitioners would have crippled the ACA’s ability to provide coverage to health insurance
to many Americans.
In addition, a SCOTUS decision in favor of the petitioners may have destabilized state health
insurance markets. Such a decision may have deprived the ACA of the ability to compel
individuals to purchase health insurance in states that did not provide their own Exchange, while
insurers would still be required to offer health insurance to an increased number of
individuals.264 In such a situation, SCOTUS Justice Sonia Sotomayor described a “death spiral,”
wherein fewer healthy people would purchase health insurance, but sick people still would.265
This would drive up the average cost of a health insurance plan, a cost that payors would pass on
to consumers in the form of higher premiums. Higher prices would force more healthy
consumers out of the market for health insurance, which would in turn drive the average cost of
an insurance plan higher, which would once again raise premiums.266 In preparation for such an
outcome, several states proposed legislation to establish their own Exchanges, in an attempt to
avoid significant damage to their health insurance markets.267
It is important to note that the majority opinion indicated that the hazards described above
influenced the SCOTUS’ conclusion. On June 25, 2015, the SCOTUS announced its decision to
uphold the legality of health insurance subsidies for individuals participating in federally-run
insurance exchanges.268 In a 6 to 3 landmark decision, with the majority opinion written by Chief
Justice Roberts, the Court upheld the federal government’s interpretation of the ACA, allowing
the IRS to issue tax credits, or subsidies, to participants who purchase insurance on federallyfunded and run exchanges.269 The SCOTUS concluded that the text of the statute was
ambiguous, and thus relied on the “…broader structure…” of the law in order to make a
decision.270 In the majority opinion, Chief Justice Roberts stated, “Congress passed the
Affordable Care Act to improve health insurance markets, not to destroy them. If at all possible,
we must interpret the Act in a way that is consistent with the former, and avoids the latter.

262 “Map: How Many Amerians Could Lose Subisdies If the Supreme Court Rules for the Plaintiffs in King vs. Burwell?” The Henry J. Kaiser
Family Foundation, http://kff.org/interactive/king-v-burwell/?utm_campaign=KFF%3A+Drew%27s+Columns&utm_
source=hs_email&utm_medium=email&utm_content=14964169&_hsenc=p2ANqtz-_KtyDmOogfZF7c-bHazTuM0t4hvIVsQgN7eRgC_
rqK3dYZjOZibCcr_T0lUVgbt2Q0rRnhlEAcRXpPnL9MhXll6QfVEA&_hsmi=14964169 (Accessed 3/18/2015).
263 “Premium Affordability, Competition, and Choice in the Health Insurance Marketplace, 2014” By Amy Burke et al., Office of the Assistant
Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, June 18, 2014, http://aspe.hhs.gov/health/reports/
2014/premiums/2014mktplaceprembrf.pdf (Accessed 3/18/2015), p. 2.
264 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2015), Oral Argument, p. 15. Discussed in the Impact on
Insurers section above.
265 “David King et al. v. Sylvia Mathews Burwell et al.” Case No. 14-114 (SCOTUS 2015), Oral Argument, p. 15; “Will concern for states’
rights win out in subsidies battle? Today’s argument in Plain English” By Amy Howe, SCOTUSblog, March 4, 2015,
http://www.scotusblog.com/2015/03/will-concern-for-states-rights-win-out-in-subsidies-battle-todays-argument-in-plain-english/ (Accessed
3/18/2015).
266 Ibid.
267 “King v. Burwell Obamacare Case Makes States Consider Creating Exchanges If Subsidies Are Struck Down” by Elizabeth Whitman,
International Business Times, March 4, 2015, http://www.ibtimes.com/king-v-burwell-obamacare-case-makes-states-consider-creatingexchanges-if-subsidies-1834820 (Accessed 3/25/2015).
268 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 4, 21.
269 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 4, 21.
270 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 15.
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Section 36B can fairly be read consistent with what we see as Congress’s plan, and that is the
reading we adopt.” 271
Although the landmark decision in King v. Burwell preserved the ACA for a time, supporters of
the law should not assume that the ACA is safe from further tests. As of June 2015, dozens of
lawsuits have been filed challenging various aspects of the law, many of which target the ACA’s
rules regarding coverage of contraceptives.272 Another lawsuit, filed by Republicans in the House
of Representatives, claims that the ACA violates the House’s constitutional power of
appropriations.273 These challenges illustrate the reality that the ACA will likely face opposition
again in the future.

CONCLUSION
Some feel that the passage of HR 3590 and HR 4872 is one of the most important fundamental
changes to federal healthcare policy and, on a similar scale, to the implementation of the
Medicare and Medicaid programs.274 Analyses and published opinion regarding the necessity of
healthcare reform to institute effective cost-containment measures on healthcare expenditures
have been growing in number, lending more weight to proponents of reform measures.275
However, the successful implementation and potential impact of the new provisions detailed in
this legislation depends largely on the outcomes of key judicial cases, as well as continued
political, financial, and public support of federal, state, and individual stakeholders during the
next few years. Additionally, without a permanent fix or reconciliation of growing Medicare
expenditures and the SGR formula, problems regarding physician reimbursement and cost
containment will continue to plague the U.S. healthcare industry, indirectly fueling problems,
such as those related to access to care, the competitive healthcare environment, and the continued
attack on niche providers. As evidenced by the debate and wide-ranging concerns and opinions
regarding healthcare reform and, specifically, the provisions contained within the 2010 reform
legislation, the public and political fight regarding the U.S. healthcare delivery system reform
may be far from over.
Young physicians, who are plagued by medical school debt, are seeking a more comfortable
lifestyle and are opting out of private, independent practices and pursuing salaried employment
in hospitals and health systems. This trend has made it increasingly difficult for older
independent practitioners to recruit junior partners, a struggle which, paired with the burden of
rising costs and downshifting reimbursement, has led many physician-owners to sell their
practices to hospitals and enter into salaried employment arrangements.
271 “King et al. v. Burwell, Secretary of Health and Human Services, et al” No. 14-114 (U.S. June 25, 2015), Slip Opinion, p. 21.
272 “Legal Challenges Remain for Health Law” By Robert Pear, The New York Times, June 26, 2015, http://www.nytimes.com/
2015/06/27/us/legal-challenges-remain-for-health-law.html?_r=0 (Accessed 7/7/2015).
273 “Legal Challenges Remain for Health Law” By Robert Pear, The New York Times, June 26, 2015, http://www.nytimes.com/
2015/06/27/us/legal-challenges-remain-for-health-law.html?_r=0 (Accessed 7/7/2015).
274 “Historic Passage - Reform at Last” By John K. Iglehart, New England Journal of Medicine, March 24, 2010, http://healthcarereform.
nejm.org/?p=3219&query=TOC (Accessed 3/24/2010).
275 Selected contrasting 2010 studies regarding healthcare reform and cost containment: “Health Reform Essential for Reducing Deficit and
Slowing Health Care Costs” By Paul N. Van de Water, Center on Budget and Policy Priorities, February 3, 2010, p. 1; “Will Health Reform
Slow Cost Growth” By John Sheils, The Lewin Group, March 26, 2010.
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At the same time, the legislative and regulatory agenda at both federal and state levels to limit
physician ownership of or investment in ASTC revenue stream enterprises has restricted
physicians in private practice to receiving only professional fee component revenues. This has
been viewed by some as a circumstance akin to relegating physicians to the status of
sharecroppers or hired help, compelling many physicians to acquiesce to an untenable
profitability squeeze and accept employee status under the substantial control of hospital systems
or large corporate players.
Overall, this shift from small, physician- or provider-owned, independent private practices to
captive practices within larger integrated health systems may also be viewed as the
corporatization of healthcare professional practices, which may result in a weakening of the
independent physician or provider-patient relationship, a characteristic of the cottage industry
healthcare delivery system of old.276 As discussed in this Guide, the current healthcare
environment is one of the most dramatic and challenging in U.S. history, as indicated by recent
efforts at regulatory and reimbursement reform, as well as the increasing change and complexity
of the reimbursement, regulatory, competitive, and technological pillars of healthcare.277 Given
this trend in the delivery of care by professional practices, the days of the cottage industry of
medicine may be coming to end, thus fulfilling the statement: “Marcus Welby278 is dead!”
Healthcare reform is driven by complex, polar, and potentially conflicting market factors,
including increased spending; a growing and graying demographic; workforce shortages and
inefficiencies; problematic chronic and acute health indicators; and shortcomings in the delivery
of efficient, quality care. The chapters in this Guide detail these issues, their implications, and
the 2010 reform initiatives proposed to delicately counterbalance the U.S. healthcare delivery
system on the nation’s scale of justice. With increased regulatory scrutiny related to Stark and
antitrust laws, the complete upheaval of the reimbursement landscape from new insurance
industry rules and changing Medicare and Medicaid payments, the changing competitive
environment of various sectors of the healthcare industry, and the rapid advance of technological
developments, the 2010 healthcare reform has set the stage for a tumultuous and uncertain future
for advisors in this era of reform. This book has addressed each of these very important aspects
of reimbursement, regulatory, competition, and technology that are now part of an ever changing
and increasingly unpredictable landscape of new provider configurations, tactics, and strategies,
particularly in light of the 2010 healthcare reform legislation.
With the passage of healthcare reform, it is vital for providers to maintain an applied
understanding of healthcare payment sources (for example, Medicare, Medicaid, State Children’s
Health Insurance Program, etc.), revenue and billing procedures (for example, the resource-based
relative value scale payment system, relative value units and their components, Current
Procedural Terminology codes, etc.), payment plans (for example, FFS plans, performance-based
276 “More Doctors Giving Up Private Practices” By Gardiner Harris, New York Times, March 25, 2010, http://www.nytimes.com/
2010/03/26/health/policy/26docs.html (Accessed 4/12/2010); “The Social Transformation of American Medicine” By Paul Starr, New
York, NY: Basic Books Inc., 1982, p. ix.
277 “Top 10 challenges facing physicians in 2014” by Jeffrey Bendix et al., Medical Economics, December 25, 2013, http://medicaleconomics.
modernmedicine.com/medical-economics/content/tags/affordable-care-act/top-10-challenges-facing-physicians-2014 (Accessed 3/24/2015).
278 Marcus Welby was the main character in the television show, Marcus Welby, M.D, portrayed by Robert Young between 1969 and 1976,
who portrayed Dr. Welby as an idealized version of the quintessentially altruistic, kindly, and unfailingly non-corporate family physician.
“Marcus Welby, M.D.” Internet Movie Database, http://www.imdb.com/title/tt0063927/?ref_=ttep_ep_tt (Accessed 7/9/2015).
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payment plans, and consumer driven health plans), and the new rules related to overall insurance
industry practices. Chapter 2, Reimbursement Environment, provides an overview of current and
future trends in healthcare reimbursement.
The U.S. healthcare industry is governed by a network of ever-changing state and federal
regulations relating to both physician and nonphysician professionals and is facing a completely
new landscape of federal regulations in light of the 2010 healthcare reform, especially with
increased scrutiny of fraud and abuse violations. Chapter 3, Regulatory Environment, contains a
detailed overview of the general provisions that apply to the various practitioners and providers
in the healthcare industry.
Changes in the healthcare competitive market may be attributed to 2010 healthcare reform,
which attempts to address access and quality issues with individual insurance mandates and
extensive quality requirements. These issues, and numerous others implicated by healthcare
reform, shape the unique and dynamic healthcare competitive environment. Chapter 4, Impact of
Competitive Forces, examines these issues in further detail within the context of Porter’s five
forces of competition.
Finally, advancements in medical technology have helped to revolutionize medicine as we know
it, and they also have been significant factors in the passage of the 2010 healthcare reform
legislation. The future of healthcare may well depend on a compromise between the
advancement of medical technological capabilities and the cost of supporting those technologies
that allows practitioners to provide the best quality care possible, a central issue in the 2010
healthcare reform legislation. Chapter 5, Technology Development, contains a discussion of the
impact of technology on healthcare practices.
A multitude of unresolved issues remain related to the impact of these initial healthcare reform
initiatives. In order to survive these dynamic changes, as during all times of significant upheaval
and change, providers (both small and large) will need to seek the guidance of their professional
advisors and informed managers, and consultants will need to stay knowledgeable of the
changing aspects of the U.S. healthcare delivery system in an era of reform. This Guide was
written to assist these professional advisors in meeting that objective.
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Accreditation: A process in which private organizations assess participating institutions and
programs and issue accreditation certificates to those that meet their requirements. Ensuring the
quality and safety of services is the focus of most accreditation standards; however, many also
include documentation and other requirements.
Adverse Drug Effect (ADE): An injury caused by drugs, typically in the form of an allergic
reaction or adverse physiological responses to a certain combination of medications. Preventable
ADEs are injuries that are caused by human error.
Alert Fatigue: A CPOE error caused by a combination of critical medical alerts and a high
volume of marginally medically consequential alerts.
Allopathic Medicine: “A method of healing founded on a scientific basis.”
Ambulatory Surgery Center: A Medicare-certified healthcare facility that exclusively provides
surgical services to patients not requiring an overnight stay.
Antitrust: A body of law charged with combating anticompetitive behavior that would impair
the ability of free markets to function properly. Antitrust involves the regulation of mergers and
acquisitions, as well as scrutiny of behavior between competitors which may restrain trade.
Biologics: Therapeutic products that are developed using living sources; examples of biologics
include: vaccines, blood and blood products, and allergenic extracts and tissues.
Biopharmaceuticals: Drugs and biologics that treat an organism through the genetic
manipulation of foreign DNA.
Biosimilar Production: Redevelopment of new generation biologics.
BlueCross/BlueShield: BlueCross provides beneficiaries with health insurance to cover hospital
expenses, while BlueShield provides insurance to cover expenses associated with physician
services. Together, they form BlueCross BlueShield, and the BlueCross Blue Shield Association
(works to coordinate the nationwide plans by establishing standards for new plans and programs;
assisting local plans with enrollment activities, national advertising, public education,
professional relations, and statistical and research activities; and serving as the primary
contractor for processing Medicare hospital, hospice, and home health claims.
Brachytherapy: Allows for treatment at higher doses of radiation to treat a smaller area in a
shorter time by placing radiopharmaceuticals directly inside or next to the tumor. Brachytherapy
can be temporary or permanent, with variable administration rates and doses.
Bundling: A form of reimbursement that combines institutional and professional charges into a
single payment, including all staff for preoperative and postoperative care. Bundled payment
schemes generally include outlier provisions for cases that become catastrophic.
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Capitation: A pre-paid reimbursement method that pays a provider a set price for providing
medical services to a defined population for a defined set of services, regardless of service
utilization. Providers must manage the financial risk of providing adequate care by calculating
the expected volume of referrals, the average cost, and their ability to control utilization.
Charge Capture: A process that entails the transfer of the provider’s coding and documentation
to the actual bill. Providers are tasked with recording the appropriate procedure and diagnosis
codes on an encounter form, and the business staff is responsible for ensuring that the encounter
form is accurate and then using it to bill patients and third-party insurers.
Cherry-pick or Cream-skim: To pick the best of a group and leaving the least desirable
portion; for healthcare, choosing the most profitable patients and leaving the rest.
Children’s Health Insurance Program: A state-federal partnership that provides assistance to
children and pregnant women in families whose income is above the threshold for Medicaid. It
was formerly known as the State Children’s Health Insurance Program.
Chiropractic: A form of alternative medicine originating from the belief that vertebral aligning
would serve to remedy diseases.
Civil Monetary Penalty: Financial penalties levied against parties found guilty of violating the
antikickback statute or submitting false claims for government reimbursement.
Civilian Health and Medical Program of the Department of Veteran Affairs: The
Department of Veterans Affairs’ healthcare program for the spouses and children of veterans
who meet certain eligibility requirements.
Civilian Health and Medical Program of the Uniformed Services: The former name for
TRICARE.
Clinical Decision Support (CDS): A technology that provides clinicians with real-time
feedback about a wide-range of diagnostic and treatment related information as they are entering
electronic orders.
Commercial Reasonableness: The Department of Health and Human Services has interpreted
“commercially reasonable” to mean that an arrangement appears to be “a sensible, prudent
business agreement, from the perspective of the particular parties involved, even in the absence
of any potential referrals.” The Stark II Phase II commentary also suggests that “an arrangement
will be considered ‘commercially reasonable’ in the absence of referrals if the arrangement
would make commercial sense if entered into by a reasonable entity of similar type and size and
a reasonable physician of similar scope and specialty, even if there were no potential DHS
referrals.”
Computerized Physician Order Entry (CPOE): A computer system that permits clinical
providers to electronically order laboratory, pharmacy, and radiology services.
Corpus: A collection of works written by Hippocrates and his pupils. These works discuss
specialties and pathologies, the practice of medicine, and medical ethics.
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Cream Skimming: In healthcare, the purposeful targeting of patients that are considered the
most profitable customers for a given provider, for example, specialty hospitals have been
accused of cream-skimming more profitable services, such as cardiac and orthopedic care, from
general hospitals, who serve a broader patient base.
Customary Prevailing and Reasonable: The historically implemented methodology that based
Medicare-allowed amounts on past payments for the service.
Degrees of Freedom: The number of possible rotations that can be made by a robotic “hand.”
Designated Health Service: One of eleven categories of healthcare entities subject to the Stark
law:
1. Clinical lab services

2. Physical therapy, occupational therapy, and speech-language pathology services

3. Radiology and other imaging services (including nuclear medicine as of 01/01/07)
4. Radiation therapy services and supplies

5. Durable medical equipment and supplies

6. Prosthetics, orthotics and prosthetic devices and supplies
7. Home health services

8. Outpatient prescription drugs
9. Inpatient hospital services

10. Outpatient hospital services

11. Parental and enteral nutrients, associated equipment, and supplies

Diagnostic Related Groups: A classification system of patients by surgical procedure or
diagnosis into major diagnostic categories for the purpose of Medicare reimbursement of
hospitalization costs.
Disproportionate Share Hospital (DSH) Payments: A form of additional reimbursement under
Medicaid for hospitals that care for a large number of Medicaid and uninsured patients. DSH
payments are allotments from the federal government that augment basic Medicaid
reimbursement, and under federal law, states are required to supplement disproportionate share
hospitals in order to receive this additional Medicaid funding.
Eclectic Medicine: A school of medicine that uses herbal medicines and remedies to treat
pathologic conditions; among less threatening therapies, eclectics were branded for their use of
arsenic and mercury treatments.
Economic Demand: “Relationship between the price of a healthcare item or service and the
quantity demanded.”
Economic Supply: “Relationship between the price of a healthcare good, product, or service and
the quantity provided my medical sellers.”
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Electronic Health Record (EHR): A longitudinal electronic record of patient health
information generated and maintained within an institution containing information entered by a
treating physician or clinician.
Electronic Health Record (EHR): Electronically maintained patient health information, such as
patient demographics, notes, medications, medical history, laboratory date, or medical reports,
that is generated by one or more encounters in any care delivery setting.
Enteral: Into the digestive system.
Epidural: Into the membranes surrounding the spinal cord.
External Beam Radiation Therapy (EBT): A procedure that involves the administration of
high-energy x-ray beams to kill cancer cells and treat tumors. Often, some x-ray, ultrasound, or
computerized tomography imaging is used prior to the delivery to insure that the path of the
beam will align with the target area.
Fair Market Value (FMV): As defined by Stark II Phase I for the purpose of scrutinizing
transactions between healthcare professionals, FMV is “the value in arm’s-length transactions,
consistent with general market value,” without taking into account any ability between parties to
refer business to each other.
Fee Schedule: A payment system under which the fees for procedures are explicitly laid out and
the physician agrees to accept those fees as full payment unless the discounted charges are less
than the fee schedule in which case the plan pays the lesser of the two.
Fee-for-Service: A payment policy under which providers receive a fee for each service
provided (for example, an office visit, test, procedure, etc.).
Financial Relationship: The Stark law defines financial relationships as an ownership or
investment interest in the DHS entity or a compensation arrangement between the DHS entity
and the referring physician or a member of his immediate family. The law further describes
“ownership/investment interest” to include debt, equity or other means. The term also includes
an interest in an entity that holds an ownership or investment interest in any entity providing
DHS services.
Follow-on Biologics: New generation biologics.
Gainsharing: An arrangement “under which a hospital gives physicians a share of the reduction
in the hospital’s costs (that is, the hospital’s cost savings) attributable in part to the physician’s
efforts.”
Gamma Knife: Employs computerized robotic technology to move patients at submillimeter
increments during treatment.
Gene Therapy: A molecular means of cancer treatment.
Genomics: The evaluation of the hereditary information provided by an organism’s DNA and
the application of research findings to the fields of genetic engineering and enhancement,
cloning, stem cell research, and eugenics.
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Health Maintenance Organization (HMO): The entity responsible for providing, or arranging
for the provision of, healthcare services (including preventative care) for plan enrollees by way
of contractual arrangements with providers. HMO enrollees must receive all of their care from
the plan’s participating providers except for care provided in emergency situations or in
instances in which the plan offers a point of service option.
Health Maintenance Organization: Any organization that, through an organized system of
healthcare, provides or ensures the delivery of an agreed-upon set of comprehensive health
maintenance and treatment services for an enrolled group of persons commonly under a
capitation or prepaid fixed sum arrangement.
Health Savings Accounts: Special accounts into which employers and employees both
contribute, and from which the employee can draw funds to pay for health services. If the
employer contributes, the value of those contributions is not taxable to the employee. Similarly,
if the employee makes contributions, they count as “above-the-line” deductions.
Homeopathic Medicine: A school of medicine that involves the assessment of overall health
and environment, not just symptoms.
Independent Practice Association: An association of independent physicians who maintain
their own private practices but have joined together to enter into an agreement to treat the plan’s
enrollees.
Industrial Hygiene: “The science of keeping people safe at work and in their communities.
Industrial hygienists (IHs) are professionals dedicated to the health and well-being of workers.
Originally industrial hygienists worked primarily in factories and other industrial settings but as
our society has changed, so has the definition of industrial hygiene. Today, IHs can be found in
almost every type of work setting. Industrial hygienists also use the term OEHS or occupational
and environmental health and safety to refer to the work that they do.”
Intensity Modulated Radiation Therapy (IMRT): An advanced form of radiation therapy
using three-dimensional imaging and treatment delivery.
International Classification of Diseases, Ninth Revision (ICD-9): A system that has codes that
supply the payor with information regarding both the patient diagnosis and the procedures
performed in treating the diagnosis. The Health Insurance Portability and Accountability Act
(HIPAA) requires all healthcare providers to use the ICD-9 codes when reporting diagnosis
information to payors. In addition, HIPAA requires that hospitals use the ICD-9 procedural
codes when reporting information to payors detailing the treatment of hospital inpatients.
International Classification of Diseases, Tenth Revision (ICD-10): In early 2009, the United
States Department of Health and Human Services announced a final rule that called for the
replacement of the current ICD-9 code set used to report healthcare diagnoses and procedures
with the ICD-10 code set by October 1, 2013. The adoption of the new system offers several
benefits, including the facilitation of quality data reporting, support for pay for performance
payment methodologies, improved billing accuracy, and allowances for international comparison
of the incidence and spread of disease.
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Intravenous: Through the bloodstream.
Kickback: Remuneration received in return for referring an individual to a person for the
furnishing of any item or service for which payment may be made under a federal health care
program or remuneration received in return for purchasing, leasing, ordering, or arranging for or
recommending purchasing, leasing, or ordering any good, facility, service, or item for which
payment may be made under a federal health care program.
Laparoscopy: Minimally invasive surgery that involves the insertion of a slender, tubular
endoscope through the abdomen wall. A laparoscopy involves the use of surgical instruments
that the practitioner controls and fiber optic technology for visual navigation.
Legal Medicine: Referred to as “medical jurisprudence,” involves the implementation of
medical expertise for legal and judicial purposes.
Licensure: A set of minimum qualifications an individual must possess in order to practice a
given profession. In healthcare, almost all practitioners are required to be licensed, and there
exist state statutes in place to penalize those who practice without proper licensure.
Linear Accelerator (LINAC): Delivers uniform doses of high-energy x-rays to the localized
area of the patient’s tumor although sparing the surrounding normal tissue. It is the device most
commonly used for EBT treatments for patients with cancer.
Lockboxes: Instead of handling the collection and processing of payments themselves, providers
may decide to use a lockbox service. For a fee, lockbox services open a provider’s mail, collect
payments, and deposit the money into the provider’s account.
Managed Care: Plans that integrate the financing (that is, insurance) and provision of health
services under the administration of one organization in an effort to contain costs.
Medicaid: “The expanded assistance to the states for medical care.”
Medicaid: A means-tested, state administered health insurance program for individuals below
certain income thresholds predetermined by the state in which they reside. The federal
government establishes coverage requirement guidelines for the categorically needy (for
example, children, pregnant women), medically needy (for example, individuals with income
above the threshold but who have a large amount of medical bills), and special groups. Although
the federal government determines the medical services that will be covered and paid for by the
federal portion of the program, Medicaid programs vary widely from state to state as state
governments are free to add additional services or expand eligibility to additional groups.
Medical Imaging: A “non-invasive process used to obtain pictures of the internal anatomy or
function of the anatomy using one of many different types of imaging equipment and media for
creating the image.”
Medicare Part A: “The Democratic plan for a compulsory hospital insurance program under
Social Security.”
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Medicare Part B: “The revised Republican program of government-subsidized voluntary
insurance to cover physicians’ bills.”
Medicare: An entitlement program available to individuals over the age of sixty-five and
individuals with end-stage renal disease. Medicare is divided into four parts: (1) Part A, which
covers inpatient hospital care; (2) Part B, which covers outpatient visits; (3) Part C, which people
can choose as a managed care replacement of Part A and B; and (4) Part D, which covers
prescription drug benefits.
Medicare: Passed by the United States Congress in 1964 and signed by President Lyndon B.
Johnson on July 30, 1965; comprised of three layers: Part A, Part B, and Medicaid.
Monopsony: “A single purchaser in a healthcare market without rivals.”
National Committee on Quality Assurance (NCQA): A nonprofit organization that works to
improve the quality of healthcare through the accreditation of managed care plans. NCQA
performs this duty, much like other accrediting bodies, through the setting of standards and
collection of outcome and performance data.
Naturopathic Medicine: A school of medicine that utilizes natural elements (such as water,
heat, and massage) in its therapies.
Niche Providers: Providers who focus on a section or group of buyers, a segment of a product
line, or a specific area of a geographic market. What specific area niche providers focus on
changes based on who is creating the definition.
NightHawk Radiology Services: The nation’s first nighthawk company.
Nonparenteral Drug Delivery: A means of drug delivery in which the distribution is through a
means other than a digestive one.
Nonparticipating Provider: Providers who have not agreed to accept the Medicare
reimbursement amount for every claim. Yet, nonparticipating providers are allowed to accept
Medicare assignment on a claim-by-claim basis, if they agree certain conditions. However, it
should be noted that even though they have not accepted Medicare’s fee as payment in full,
nonparticipating providers are subject to a “limiting charge,” that dictates what they may charge
Medicare beneficiaries for covered services.
Nurse Licensure Compact: An interstate license for nurses created in 2000 by the National
Council of State Boards of Nursing.
Osteopathic: A school of medicine that involves the assessment of overall health and
environment, not just symptoms.
Participating Provider: A physician who has agreed to accept the reimbursement amount set by
the Medicare Fee Schedule as payment in full for every claim. The physician’s office may bill
the patient for its share of the co-insurance and its deductible, but it cannot balance bill the
patient, (that is, attempt to collect the difference between its usual fee and Medicare’s lower
allowed charge).
451

Adviser's Guide to Healthcare

Pasteurization: Widely used in the preservation of perishable products, pasteurization involves
the strategic application of heat to kill microbes without injuring the quality of its media (for
example, wine, beer, etc.).
Personalized Medicine: The fusion of molecular diagnostics and therapeutic measures for
specialized screening and treatment plans.
Physician-Owned Facilities: Healthcare entities in which their practicing physicians also have
ownership investment in the facility, supplementing professional income with revenue from
facility services. Many physician-owned facilities include limited-service facilities, such as
surgical and specialty hospitals.
Physiotherapy: A term used to describe various kinds of medical therapy, including
hydrotherapy, massage, mechanotherapy, electrotherapy, and heat therapy.
Picture Archives and Communications Systems (PACS): Used to connect digital x-rays and
other imaging modalities. Has become a must for efficient imaging services, as it provides
improved access to images with reduced delays.
Point-of-Care Technology: New technologies that help to manage patient treatment plans.
Point-of-Service Plans (POS): Plans that combine many of the elements of HMOs and PPOs.
POS plans are usually an addition to an HMO product that allows members the benefit of
seeking care from non-participating providers. As with an HMO, when members seek care from
in-network providers they typically pay no deductible or coinsurance. However, similar to a
PPO, members are free to seek services outside the network subject to higher cost sharing in the
form of deductibles and coinsurance.
Preferred Provider Organization (PPO): “A health care delivery system where providers
contract with the PPO at various reimbursement levels in return for patient steerage into their
practices and/or timely payment.”
Preferred Provider Organization (PPO): A hybrid of an HMO and traditional health insurance
plan. It is a managed care plan that allows members to choose from an array of healthcare
providers who have contracted with the plan to provide services on a discounted basis.
Prospective Payment System: The federal medical system that reimburses hospitals for
Medicare Part A services based on diagnosis related groups.
Protected Health Information (PHI): Individually identifiable health information that is
transmitted by, or maintained in, electronic media or any other form or medium. This
information must relate to (1) the past, present, or future physical or mental health, or condition
of an individual; (2) provision of healthcare to an individual; or (3) payment for the provision of
healthcare to an individual.
Public Health: An area of healthcare centered around “community health point of view,” that
considers “the means of defen(s)e against disease a social problem.”
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Purple Pill: A treatment for bleeding ulcer patients, with a proton-pump inhibitor like Prilosec
(omeprazole), that stops bleeding prior to endoscopy.
Qui Tam Action: Also known as a “whistleblower” suit, this action is filed by an individual
who alleges that a particular entity has submitted false claims for reimbursement to the
government in violation of the False Claims Act, including violations of the Stark law and the
antikickback statute. Qui tam actions may be brought by employees, former employees,
competitors, subcontractors, state and local governments, current and former federal employees,
public interest groups, corporations, and other private organizations.
Radiation Therapies: Procedures that use high energy light beams or charged particles to stunt
tumor cell proliferation thereby treating cancer.
Reciprocal (Limited) Licensure: Provides an interstate license for use with telemedicine
practitioners applied for through a simple application process and reduced licensing fees. This
license is solely used for telemedicine and may not be used to physically practice in another
state.
Reparative Medicine: Therapies that heal the body’s natural tissue.
Resource Based Relative Value System: A relative value scale that is based on the necessary
resources used to perform a medical service.
Revenue Cycle: The process by which a provider practice schedules patients, diagnoses
conditions, documents diagnoses, bills payors, and collects billable charges from the payor and
the patient to recover revenue for the services provided.
Self-Insurance: Self-insuring employers make a conscious choice to undertake the risks
associated with the cost of healthcare and set aside money to pay these costs as they arise. Often,
a self-insurer will hire a commercial insurer or third-party administrator to run its medical
benefits program and adjudicate claims.
Self-Referral: The practice of referring a patient for a designated health service (DHS) to an
entity in which the referring physician (or a member of his immediate family) has an ownership
or investment interest.
Stem Cells: Unspecialized cells capable of (1) renewing themselves through cell division,
sometimes after long periods of inactivity and (2) specializing to a certain type of tissue or organ
under the proper conditions.
Stereotactic Radiosurgery: A highly precise procedure involving the single, high-dose delivery
of precisely-targeted gamma-ray or x-ray beams that is used in different parts of the body, but
most frequently to treat brain tumors.
Store and Forward: The transfer of digital images between locations, most commonly seen in
teleradiology and telepathology.
Studia Generalia: Universities in the Roman Empire at which law, theology, and philosophy
were taught in addition to medicine.
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Subcutaneous: Under the skin.
Telehealth: Closely related to telemedicine and is used to describe the broader definition of
remote healthcare that does not always involve clinical services, although the two terms are often
used interchangeably.
Telemedicine: The transfer of electronic medical data (high resolution images, sounds, live
video, and patient records) from one location to another in order to enhance the quality and
efficiency of patient comfort and care.
Teleradiology: Electronic transfer and storage of electronic imaging data.
The Joint Commission: An independent, nonprofit organization responsible for the certification
and accreditation of health care organizations across the United States.
The National Center for Human Genome Research Institute (NCHGRI): Comprised of
more than fifty researchers that are each dedicated to specific facets of genetic and genomic
research and contribute accordingly to one of seven branches of the NCHGRI.
Treble Damages: Damages equal to three times the amount of the illegal remuneration in
violation of the antikickback statute.
TRICARE: The Department of Defense’s healthcare program for active duty military personnel;
members of the National Guard and Reserves; retirees, their dependents, and survivors; and
certain former spouses. The program uses military healthcare as the main provider of services,
supplemented by civilian healthcare providers, facilities, pharmacies, and suppliers. TRICARE
covers approximately 9.4 million beneficiaries worldwide through a variety of plans.
Two-Way Interactive Television: Used telemedicine for face-to-face consultations.
Upcoding: Inflating bills by using diagnosis billing codes that suggest a more expensive illness
or treatment.
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